Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytoplasmic translation (GO:0002181),-0.4879360189012635,-2.116278769940894,0.0,0.13504287075261986,0.086,36/91,14.02%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;ETF1;RPS29;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;EIF3I;RPS5;RPL30;RPL6;RPL37A;TMA7;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;RPL32;RPL36;RPL31;RPL23A;RPL41;RPL3
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.48581430351701094,-2.0649152899937366,0.0,0.15141170357111924,0.172,36/87,14.02%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;SEC63;RPL9;RPL32;RPL36;SRP72;RPL31;RPL23A;SEC61A1;RPL41;RPL3
prerank,modulation by symbiont of host process (GO:0044003),-0.8209296743006402,-2.040926319457094,0.0,0.13913507895724472,0.231,6/10,13.38%,MRC1;TLR2;ENO1;UBC;UBA52;B2M
prerank,regulation of phagocytosis (GO:0050764),-0.5188533937629767,-2.0343250323721644,0.0,0.1108306388752562,0.241,18/53,16.29%,FCGR2B;IL15;GAS6;PIP4P2;PTPRC;CD47;TLR2;DOCK2;SYK;IL1B;HCK;DYSF;CYBA;SLC11A1;RACK1;TNF;TUB;FCER1G
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4520967941347755,-2.0328839222023936,0.0,0.09193827766390486,0.25,58/110,26.15%,PPP2R2A;UPF3A;RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;NCBP1;RPL28;ETF1;RPS29;RBM8A;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;RPL32;RPL36;RPL31;RPL23A;RPL41;RPL3;RPL8;UPF3B;HELZ2;UPF2;SMG6;RPL37;MAGOH;MAGOHB;RPL36A;RPL26;RPL11;RPS15;EIF3E;CTIF;PYM1;RPS6;RPS17;RPLP2;RPS18;RPS21
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.4520804598588841,-1.963658151894946,0.0,0.1993814775253327,0.545,36/91,14.02%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;SEC63;RPL9;RPL32;RPL36;SRP72;RPL31;RPL23A;SEC61A1;RPL41;RPL3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.550815452652514,-1.944821959730713,0.0,0.2127948266404919,0.627,17/34,25.63%,NEDD9;NRP1;CASS4;CRK;LIMS1;CRKL;CARMIL1;CIB1;S100A10;MYOC;FLNA;MYADM;DOCK1;RREB1;OLFM4;ILK;RAC1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6903594489644207,-1.9377265953621263,0.0,0.20239379745373712,0.651,5/15,13.27%,FCGR2B;CD300A;CD300LF;ZC3H12A;NR1H3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.7356236473611919,1.9303135074353805,0.0,0.6545317920048497,0.501,7/15,3.78%,YWHAE;KCNJ3;KCNH2;KCNA5;ATP1B1;KCNE2;KCNJ8
prerank,protein targeting to ER (GO:0045047),-0.4347915461306391,-1.9284763865005827,0.0,0.2026400877623488,0.702,39/99,14.02%,CHMP4B;CHMP4A;RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;SEC63;RPL9;RPL32;RPL36;SRP72;RPL31;RPL23A;EDEM1;SEC61A1;RPL41;RPL3
prerank,regulation of stem cell proliferation (GO:0072091),-0.6554562123192855,-1.92836307441061,0.007481296758104738,0.1825124859262681,0.702,10/17,25.43%,PTPRC;HMGB2;SOX11;YAP1;GJA1;HMGA2;HNRNPU;EIF2AK2;TERT;FBLN1
prerank,response to interferon-alpha (GO:0035455),-0.6645275924750584,-1.9192380186318414,0.0,0.1856374449188907,0.739,8/16,7.08%,IFNAR1;GAS6;AXL;KLHL20;IFITM3;IFNAR2;BST2;RO60
prerank,response to interferon-beta (GO:0035456),-0.5916395118001593,-1.899044562316545,0.0023584905660377358,0.21222646438984957,0.795,13/22,23.52%,UBE2K;IFITM3;IFNAR2;SHFL;BST2;CDC34;STAT1;ACOD1;AIM2;IFITM1;NDUFA13;XAF1;PLSCR1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.7464757410486043,-1.8985359379290319,0.0,0.19674077906850215,0.796,5/11,17.15%,ALOX5;THBS1;SEMA6A;CREB3L1;KLF2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.7230754509089578,-1.8970420631657205,0.0022522522522522522,0.18492883743757035,0.798,7/12,15.85%,PIBF1;ERLIN2;BRCA1;WDTC1;CEACAM1;APOC1;ACADL
prerank,cellular response to type I interferon (GO:0071357),-0.5178576481780373,-1.8925124158792281,0.0,0.1699118948295274,0.813,14/41,6.74%,SP100;IFNAR1;OAS2;IFIT2;IRF9;IRF7;IFITM3;IFNAR2;STAT2;IFIT1;OASL;IRF4;BST2;IFIT3
prerank,type I interferon signaling pathway (GO:0060337),-0.5178576481780373,-1.8925124158792281,0.0,0.1699118948295274,0.813,14/41,6.74%,SP100;IFNAR1;OAS2;IFIT2;IRF9;IRF7;IFITM3;IFNAR2;STAT2;IFIT1;OASL;IRF4;BST2;IFIT3
prerank,heterochromatin assembly (GO:0031507),-0.6114908005659564,-1.889796206336149,0.0025380710659898475,0.16457096132716778,0.827,10/20,21.17%,ZNFX1;SMCHD1;MBD2;H3-3A;HDAC1;HMGA2;CDKN2A;POLE3;HMGA1;SIRT2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.6883945082149019,-1.8864195478283678,0.0,0.16133909754900544,0.842,7/13,16.34%,OAS2;IL6ST;IL27;OASL;STAT1;EBI3;IL27RA
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.534461267786229,1.8856204151597784,0.0,0.628145733001044,0.741,20/54,16.52%,KCNMA1;YWHAE;KCNJ3;KCNH2;BIN1;GABBR1;NOS1AP;KCNE2;KCNIP3;KCNIP4;FHL1;NEDD4;STK39;CACNA1D;GABBR2;KCNN4;NEDD4L;KCNJ5;KCNMB3;KCNN3
prerank,ribosome biogenesis (GO:0042254),-0.38599967433730914,-1.8837326012109046,0.0,0.1572987399356673,0.849,68/187,19.63%,UTP6;NOL11;EIF2A;RPL39;RPL5;RPS24;CUL4A;URB2;RPS16;MALSU1;WDR43;DHX29;RPL28;RPS14;DDX49;RPL35A;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPF2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;METTL17;UTP11;UTP15;EXOSC10;XPO1;DDX27;RPL14;XRN2;RPL9;MPHOSPH6;RPL32;RPL36;NOP58;RPL31;RPL23A;MDN1;UTP18;RPL41;RPL3;EXOSC9;NPM1;WDR3;TBL3;RPL8;TEX10;FBL;NOP53;GTF3A;RPL37;EMG1;RPL36A;DKC1;RPL26;SDAD1
prerank,regulation of macrophage activation (GO:0043030),-0.5492325298103993,-1.8733498434501465,0.0,0.1686671815006207,0.888,13/30,18.52%,FCGR2B;CD74;PJA2;THBS1;HSPD1;GPR137B;ZC3H12A;SHPK;NR1H3;LBP;WNT5A;TLR4;MMP8
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6524925053089051,1.863053457116458,0.0,0.5655280705890277,0.838,11/20,23.15%,LACC1;KCNMA1;ATP1B1;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.5397976913639325,-1.8569124345169479,0.0,0.19395767776206008,0.92,16/31,24.01%,NBR1;NOCT;CDK6;LIMD1;PPARG;NOTCH1;TRPM4;SMAD6;GREM1;RIOX1;BAMBI;PTCH1;SEMA4D;TWIST1;TNN;GDF10
prerank,cellular potassium ion homeostasis (GO:0030007),0.7259083695311391,1.848611674371058,0.0,0.5076362694911258,0.892,7/13,19.85%,KCNMA1;ATP1B1;SLC12A2;ATP1B3;ATP1A3;ATP1A4;ATP1A1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.7055203470222964,-1.8358393380742177,0.00966183574879227,0.2329458518905385,0.955,6/11,16.34%,STAT4;IL12RB2;IL6ST;STAT1;EBI3;IL27RA
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6022812946447714,1.833264727543465,0.0,0.4963729666924864,0.932,16/25,24.52%,ATP1B1;DMD;ATP1B3;NDUFA4;ACTN2;CFTR;STK39;TRPC6;ANK2;WNK1;COX17;SLC6A9;CTSS;GLRX;PDZK1;ANK3
prerank,rRNA metabolic process (GO:0016072),-0.38304043992859654,-1.8260810493444541,0.0,0.2463034880261881,0.968,58/160,19.55%,UTP6;NOL11;RPL39;RPL5;RPS24;RPS16;WDR43;RPL28;RPS14;DDX49;RPL35A;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;DDX27;RPL14;XRN2;RPL9;MPHOSPH6;RPL32;RPL36;NOP58;RPL31;RPL23A;MDN1;UTP18;RPL41;RPL3;EXOSC9;WDR3;TBL3;RPL8;TEX10;FBL;NOP53;TRIR;RPL37;EMG1;RPL36A;DKC1;RPL26
prerank,negative regulation of phagocytosis (GO:0050765),-0.6292224883072518,-1.8252613191414595,0.0025188916876574307,0.23808694679407605,0.969,8/17,13.53%,FCGR2B;PIP4P2;CD300A;CD47;TLR2;CD300LF;DYSF;RACK1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.4771430627208713,-1.8216053856249237,0.0,0.23614769479488437,0.972,19/48,17.14%,BCL2;FNIP2;BCL2L1;MCL1;AEN;BAX;USP28;BCL3;BRCA1;BAG6;TMEM109;SNW1;EP300;HIPK1;TNFRSF1B;BCL2L11;CRIP1;EPHA2;HIPK2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.5600156296464163,-1.819126220601871,0.0,0.23210165509308095,0.972,11/25,19.74%,RBPJ;HIP1;CNOT9;HIP1R;BCAR3;ARAP1;PLAUR;CBL;NUP62;PDE6H;AFAP1L2
prerank,toll-like receptor signaling pathway (GO:0002224),-0.4329475102682448,-1.8188721347820875,0.0,0.22375790294177084,0.972,39/84,25.12%,RFTN1;MAP3K1;UBE2D3;PIK3C3;SFTPA2;SFTPA1;PIK3R4;TLR2;CD36;MAPKAPK2;TLR7;CD14;HSPD1;TNIP3;RIPK1;CTSL;EPG5;UBC;TLR8;CTSB;TAB1;UBA52;S100A1;MAPKAPK3;BIRC2;IRAK4;LBP;SCIMP;TLR4;TLR1;MYD88;TNIP1;NR1H4;TLR5;TICAM2;FADD;RPS6KA3;TLR9;TAB3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4884016058714172,-1.817683128831816,0.0,0.21820238748231763,0.972,18/45,14.35%,SP100;OAS2;CD44;TRIM25;IRF9;CIITA;IRF7;OASL;IRF4;TRIM62;MID1;HCK;CAMK2D;STAT1;TRIM5;OAS3;B2M;IRF2
prerank,cellular sodium ion homeostasis (GO:0006883),0.6851355636885511,1.8019757704554646,0.003246753246753247,0.6110801227000753,0.976,9/15,23.15%,ATP1B1;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,positive regulation of T cell activation (GO:0050870),-0.4462667063806516,-1.8009805854587047,0.0,0.2497658111098612,0.984,19/62,10.61%,IL15;FLOT2;CD274;CCDC88B;SLC7A1;PTPRC;CD47;CCR2;IL6ST;NCK1;NOD2;HSPD1;TFRC;ZMIZ1;ANXA1;PRKCQ;IL1B;CD28;LCK
prerank,negative regulation of B cell proliferation (GO:0030889),-0.7036312059272141,-1.8002389873549984,0.009433962264150943,0.242986229394613,0.984,5/11,10.65%,FCGR2B;CD300A;TYROBP;LYN;RC3H1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.564712414317398,1.7981884103580228,0.0015772870662460567,0.5460620227951754,0.983,9/31,9.38%,SCAMP5;SYT4;CBARP;SYT13;SYT1;SYT6;DOC2B;ADRA2A;CACNA1G
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.6611199260295725,1.790781869107216,0.0016233766233766235,0.5196478336645001,0.991,7/17,10.82%,SLC4A8;SCAMP5;SYT4;RAB3A;DOC2B;CACNA1G;RAB3D
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5988542141867581,1.7880968942262958,0.0032102728731942215,0.4787122479297403,0.991,11/26,17.90%,YWHAE;ATP1B1;KCNE2;ATP1B3;FHL1;ACTN2;NEDD4;STK39;CACNA1D;NEDD4L;ANK2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.6558241670281552,-1.7849192560089804,0.016706443914081145,0.2734739138897141,0.988,7/13,19.00%,RBPJ;CPE;NOTCH1;NPY5R;HEY2;SMAD4;NPY2R
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5337648762579612,-1.7836459168665586,0.0026954177897574125,0.2680396374029273,0.988,14/27,22.30%,MAP3K1;TLR2;CD36;CD14;HSPD1;UBC;TAB1;UBA52;IRAK4;TLR4;TLR1;MYD88;TNIP1;TLR5
prerank,regulation of leukocyte activation (GO:0002694),-0.6259355801857163,-1.7823754711611475,0.011961722488038277,0.2628933755698385,0.988,8/14,23.52%,CD74;PJA2;LYN;GPR137B;LCK;SHPK;CD33;PLSCR1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.37160438475997815,-1.7784897367335686,0.0,0.2647097032756346,0.99,76/168,26.15%,DIS3L2;PPP2R2A;UPF3A;RPS26;RPL39;RPS23;RPL5;RPS24;CNOT9;RPS16;NCBP1;RPL28;ETF1;RPS29;RBM8A;RPS14;RPS20;SAMD4A;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;TENT2;EXOSC8;UBA52;ZC3H12A;EXOSC10;RPS10;RPL14;DCP1B;XRN2;RPL9;RC3H1;RPL32;RPL36;RPL31;RPL23A;RPL41;RPL3;EXOSC9;RC3H2;RPL8;UPF3B;HELZ2;UPF2;SMG6;RPL37;TENT4B;MAGOH;MAGOHB;RPL36A;RPL26;RPL11;PAN3;CNOT6L;RPS15;EIF3E;CTIF;PYM1;RPS6;EXOSC7;RPS17;CSDE1;RPLP2;TNKS1BP1;RPS18;RPS21
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.6092670658551029,-1.7749818497467587,0.007142857142857143,0.2659935333006149,0.993,6/17,9.43%,APOE;KPNB1;ERLIN2;FGF1;MBTPS1;ABCG1
prerank,receptor-mediated endocytosis (GO:0006898),-0.3827526499829059,-1.774952223428257,0.0,0.2586048240422645,0.993,44/132,18.47%,DAB2;MRC1;FCGR2B;CD163;APOE;AP2A2;DNAJC6;TPCN2;MSR1;CD36;GAK;SNX1;CXCL16;M6PR;FCHO2;AP2B1;HIP1R;LDLRAP1;SYK;TFRC;PICALM;CAV1;LDLR;SNX9;EPS15;CTSL;STAB2;IGF2R;GRB2;DNM2;CLTA;LRP1;DNAJC13;LILRB1;WASF1;RAMP2;CALCRL;CLN3;FCER1G;CLTB;RAB31;FCHO1;HPX;LRP6
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.6236228916993024,-1.7730030482111678,0.009389671361502348,0.2562975805274948,0.993,8/16,20.22%,ERLIN2;BRCA1;WDTC1;CEACAM1;APOC1;ACADL;APPL2;NCOR1
prerank,positive regulation of phagocytosis (GO:0050766),-0.4642932573862965,-1.7724432092484306,0.0,0.25084518363086333,0.993,18/47,20.04%,FCGR2B;IL15;GAS6;STAP1;PTPRC;CD47;DOCK2;CD300LF;IL1B;C4B;CYBA;SLC11A1;TNF;TUB;FCER1G;RAB31;APPL2;C2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.7002446272110547,-1.767301549469632,0.007246376811594203,0.255605620165798,0.993,6/11,12.82%,ATP6V0D1;ATG7;FAS;CAV1;FOXO1;ATP6V1A
prerank,natural killer cell mediated immunity (GO:0002228),-0.6369034240248359,-1.7672423506263182,0.002506265664160401,0.2492495813966916,0.993,10/15,28.12%,ULBP1;LYST;SLAMF7;CEBPG;RAET1E;KLRD1;TUBB4B;KLRK1;PLEKHM2;KLRC2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.43186723316806436,-1.7646878507773274,0.0,0.25012375026316735,0.994,32/67,26.08%,NEDD9;NRP1;CASS4;CRK;CDK6;CD36;LIMS1;CCL25;UTRN;CRKL;CARMIL1;CIB1;S100A10;SKAP1;EMP2;MYOC;PTK2B;CCL28;FLNA;FN1;MYADM;ECM2;PPM1F;DOCK1;RREB1;CD3E;ARL2;OLFM4;ILK;RAC1;CSF1;ALOX15
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5408058909603067,-1.7633694001494944,0.0049382716049382715,0.24728629579375846,0.994,12/26,16.17%,BCL2;PPP2R1B;BCL2L1;MCL1;PF4;IL1B;EYA1;RET;EYA3;EYA2;TNF;MAPK7
prerank,dendrite morphogenesis (GO:0048813),0.5426142707874618,1.760074012903874,0.004724409448818898,0.5967975196174182,0.998,25/35,28.99%,MAP6;CTNNA2;SHANK3;KLF7;CTNND2;BTBD3;MINK1;DOCK10;EPHB2;WNT7A;SHANK1;CHRNA7;SDC2;CDC42;MAP2;FARP1;WASL;MEF2A;TAOK2;DLG4;PHACTR1;DIP2A;CELSR2;PTEN;DCDC2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5675716518283128,-1.754563534394434,0.0049382716049382715,0.26047381060600466,0.996,8/19,10.41%,AEN;USP28;BCL3;BAG6;TMEM109;SNW1;EP300;HIPK1
prerank,positive regulation of histone deacetylation (GO:0031065),0.7043950837587878,1.7523993853842292,0.0069084628670120895,0.5936684265958,0.998,8/12,21.73%,CTBP1;AKAP8L;PRKD2;AKAP8;SAP30BP;PRKD1;ZBTB7B;ING2
prerank,response to interferon-gamma (GO:0034341),-0.42764258311520265,-1.7516649867415592,0.006896551724137931,0.261250291972527,0.999,29/67,25.24%,SP100;CD74;CD47;TLR2;CIITA;IFITM3;CXCL16;CCL25;SHFL;BST2;GBP3;STAT1;ACOD1;DAPK1;SLC11A1;SYNCRIP;GBP4;WNT5A;TLR4;GBP6;CASP1;TRIM21;IFITM1;KYNU;GBP7;MEFV;CCL7;SLC26A6;IL12RB1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5642670741139328,-1.7507146135230571,0.00966183574879227,0.2572634891307486,0.999,6/21,1.22%,FCGR2B;PTPN22;STAP1;PRKCH;CD300A;SLC39A10
prerank,fatty acid transport (GO:0015908),-0.5822430513059569,-1.7465178031036952,0.0069124423963133645,0.2613082514431459,0.999,6/17,5.55%,APOE;PPARG;CD36;FABP4;SLC27A4;PPARD
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.7345636324631156,1.7434587144311897,0.01056338028169014,0.6004469347433177,0.999,5/10,6.94%,YWHAE;CBARP;BIN1;VDAC1;ADRA2A
prerank,regulation of multicellular organismal development (GO:2000026),-0.5371784896764366,-1.7396016979224822,0.016,0.27168199293257567,0.999,12/25,13.54%,OAS2;CD24;BAG6;RACGAP1;HPSE;MYSM1;TRIP12;CDK1;EHMT1;CCSAP;PTN;SCX
prerank,response to copper ion (GO:0046688),0.6090468027844029,1.7376884157767942,0.006389776357827476,0.5890967891940344,0.999,12/20,18.11%,PRNP;AOC1;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;IL1A
prerank,ncRNA processing (GO:0034470),-0.3521454497451898,-1.7375173272215223,0.0,0.27002890528017554,0.999,67/200,19.55%,UTP6;NOL11;RPL39;RPL5;RPS24;INTS2;RPS16;WDR43;RPL28;RPS14;DDX49;RPL35A;RPL18A;RPL27;RPL21;RPS7;SMAD3;DDX52;RPF1;FARS2;RPL30;MRM2;RPL6;RPL37A;RRP12;SRRT;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;RPP21;DDX27;SSB;RPL14;XRN2;RPL9;MPHOSPH6;RPL32;RPL36;NOP58;RPL31;HNRNPA2B1;RPL23A;INTS12;AGO2;MDN1;UTP18;RPL41;RPL3;EXOSC9;WDR3;TBL3;RPL8;TEX10;FBL;NOP53;POP1;RPL37;EMG1;RPL36A;DKC1;RPL26
prerank,C21-steroid hormone metabolic process (GO:0008207),0.6112906104259515,1.7361472122739992,0.003257328990228013,0.5554012249159254,0.999,6/20,6.31%,STARD3;TSPOAP1;STAR;AKR1C1;FDX2;AKR1B1
prerank,regulation of B cell proliferation (GO:0030888),-0.46463101165839554,-1.735852396632708,0.0028653295128939827,0.2684711287442313,0.999,14/44,10.65%,VAV3;FCGR2B;BCL2;CD74;CD38;CD300A;PTPRC;TYROBP;AHR;GPR183;TFRC;LYN;IKZF3;RC3H1
prerank,chloride transmembrane transport (GO:1902476),0.5032545650408131,1.7349348175366401,0.0,0.524465586726389,0.999,19/48,16.61%,SLC4A8;GABRQ;GLRA3;GABRG1;GABRD;SLC12A2;GABRG2;SLC1A1;GLRB;GABRA2;ANO2;SLC12A6;GLRA2;CFTR;SLC1A3;SLC6A1;GABRB1;GABRR2;ANO3
prerank,cardiac muscle cell action potential (GO:0086001),0.5602066663701013,1.7336698272721671,0.0015772870662460567,0.49818454686289704,0.999,14/30,22.35%,YWHAE;KCNH2;FGF12;ATP1B1;KCNE2;DMD;CACNA1G;SLC8A1;CACNA1D;CACNA2D1;ANK2;ATP1A1;SCN1B;SCN3B
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6374451805043666,1.7301268517218886,0.006944444444444444,0.4885243303531631,1.0,8/15,22.60%,HOGA1;GGT7;GGT5;ABHD12;ALDH4A1;GGACT;CHAC2;PRODH
prerank,positive regulation of viral life cycle (GO:1903902),-0.5340752552330579,-1.7255795150698272,0.010025062656641603,0.28765495539709574,0.999,4/22,4.02%,CD74;AXL;LGALS1;KPNA2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.6162292837224246,-1.7244702300210601,0.0048543689320388345,0.28490327971022117,0.999,10/14,25.11%,DDX60;ANKRD17;TLR2;PUM2;OASL;USP15;PUM1;TLR5;TLR9;DHX58
prerank,cellular response to interferon-gamma (GO:0071346),-0.39723580388626617,-1.7238054205114923,0.0,0.2810769930292001,0.999,28/88,16.40%,SP100;OAS2;CD44;TRIM25;CD47;TLR2;IRF9;CIITA;IRF7;CCL25;OASL;IRF4;TRIM62;MID1;GBP3;HCK;CAMK2D;STAT1;ACOD1;DAPK1;TRIM5;OAS3;SYNCRIP;B2M;GBP4;IRF2;WNT5A;TLR4
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6663128057619189,1.7222291222022785,0.014059753954305799,0.5015539109479601,1.0,5/13,10.08%,B3GNT9;B3GNT6;B4GAT1;B3GALT2;B3GALNT1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.6597025533348666,-1.721665152364156,0.011111111111111112,0.28074092513237614,0.999,10/12,28.08%,PTPN22;CD300A;PTPRC;LYN;RC3H1;PAX5;ELF2;BLK;CBFB;CD19
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5557558804345765,-1.7176204096535155,0.013054830287206266,0.28534311036692744,0.999,8/21,13.37%,APOE;EEPD1;PPARG;PLTP;CAV1;NR1H2;NR1H3;LRP1
prerank,synapse organization (GO:0050808),0.421522632360209,1.716507451687284,0.0013089005235602095,0.5042991481245802,1.0,49/125,23.81%,AGRN;PCDHB9;CACNB4;PCDHB4;OBSL1;CACNB2;PTPRD;PDZRN3;PCDHB5;CNTN2;SPOCK2;NRXN1;CBLN2;DSCAM;PPFIBP1;RYK;SHANK3;ADGRL3;ACHE;SDK1;CX3CR1;CTNND2;NEDD4;PPFIA4;UNC13B;PCDHB3;DCTN1;NRCAM;GPC4;CYFIP1;CHCHD10;SLC6A1;SLC8A3;REST;PTPRS;NTNG1;SNCB;CHRNA7;PIN1;UNC13C;DOK7;LRRC4C;CDC42;GPM6A;FARP1;CAST;ZC4H2;BDNF;LRRC4B
prerank,B cell receptor signaling pathway (GO:0050853),-0.49514294885153015,-1.7164929337853645,0.01358695652173913,0.28270958378496125,0.999,15/32,20.75%,VAV3;RFTN1;BCL2;CD38;PTPRC;TEC;BAX;SYK;BLNK;LCK;CD79B;BCAR1;CD79A;NFATC2;PIK3CD
prerank,neuromuscular junction development (GO:0007528),0.5760218292977181,1.714074563121887,0.014754098360655738,0.49137143013504864,1.0,13/24,24.52%,AGRN;CACNB4;CACNB2;PDZRN3;PPFIBP1;NEDD4;UNC13B;DCTN1;DNAJA3;UNC13C;DOK7;ZC4H2;ANK3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.4798283620131051,1.7132514347020902,0.004559270516717325,0.47153594000830723,1.0,22/57,17.85%,CACNG5;CACNG2;DLG2;NPTXR;CNIH2;GRIA2;MEF2C;NPTX1;GRIA1;ACTN2;GRIN1;GRIA4;GRIN2B;CACNG7;MINK1;CRHBP;DLGAP1;DLGAP2;OPRM1;CACNG3;DLGAP3;SHANK1
prerank,membrane repolarization during action potential (GO:0086011),0.6823451557110451,1.7131247754549617,0.010771992818671455,0.4505679139252287,1.0,4/13,3.06%,YWHAE;KCNH2;ATP1B1;KCNE2
prerank,positive regulation of potassium ion transport (GO:0043268),0.5137102810153271,1.7120846824933367,0.003169572107765452,0.4353614122198322,1.0,14/38,17.90%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ADRA2A;FHL1;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.6738776694504297,-1.7110558830839475,0.014354066985645933,0.2907660079678974,0.999,5/11,15.41%,ANXA1;SOCS5;ZC3H12A;RC3H1;RC3H2
prerank,epidermal cell differentiation (GO:0009913),-0.46171422090818753,-1.7083322377755332,0.008928571428571428,0.2927723694466687,0.999,24/41,36.48%,ST14;ADAM9;CLIC4;ANXA1;TXNIP;CTNNB1;HDAC2;HDAC1;WNT5A;EPHA2;OPN3;BCR;DSP;EVPL;SCEL;SPINK5;KRT10;ASAH1;UGCG;OVOL2;OVOL1;PITX2;GLI1;SPRR1A
prerank,negative regulation of macrophage activation (GO:0043031),-0.5993038630832602,-1.7072134610000314,0.014669926650366748,0.2906173378422368,0.999,5/16,13.27%,FCGR2B;PTPRC;LDLR;ZC3H12A;NR1H3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.4984963645378587,-1.7053081214869161,0.01634877384196185,0.2908935798338407,0.999,10/30,11.76%,UBE2D3;IRF7;TBK1;CD300LF;CD14;TNIP3;RIPK1;UBC;UBA52;BIRC2
prerank,negative regulation of viral genome replication (GO:0045071),-0.4680203238784189,-1.7025696280591613,0.008264462809917356,0.2923655417304195,0.999,21/40,23.52%,OAS2;IFIH1;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;BANF1;OAS3;INPP5K;TNF;HMGA2;ZC3HAV1;LTF;TNIP1;IFITM1;ILF3;TASOR;EIF2AK2;PLSCR1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4550839326838106,-1.7024873897122266,0.005633802816901409,0.28775155834487703,0.999,24/47,29.63%,NEDD9;NRP1;CASS4;CRK;CORO1C;LIMS1;CRKL;CARMIL1;CIB1;S100A10;MYOC;SPRY4;FLNA;MYADM;DOCK1;RREB1;OLFM4;FBLN1;PDPN;ILK;RAC1;TESK1;ACTN4;C1QBP
prerank,bicarbonate transport (GO:0015701),0.5647950146614478,1.7015830554515674,0.0016638935108153079,0.46490660677600776,1.0,10/25,13.42%,SLC4A8;CA1;CA3;CA4;CFTR;CYB5R2;SLC26A7;SLC39A8;SLC4A10;SLC4A7
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5337130465009209,-1.700739986171509,0.007692307692307693,0.28722461350202877,0.999,10/24,17.15%,RBPJ;ATF3;CEBPB;HIF1A;HSF1;NOTCH1;CREB3L1;MAPK7;SESN2;KLF2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.5253746211305017,-1.699842240091996,0.010050251256281407,0.28470077080747136,0.999,8/25,9.84%,FBXL17;VCP;CUL3;YME1L1;UGGT1;BAG6;KLHL15;CLPP
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6377077348042819,-1.6989018838339254,0.02242152466367713,0.28227711178151793,0.999,8/12,35.84%,CAV1;CAMK2D;CALM3;CALM2;PDE4D;CALM1;SRI;IRX3
prerank,modulation by host of viral genome replication (GO:0044827),0.6646015922934941,1.6986465701389177,0.006920415224913495,0.45998383457380526,1.0,8/13,16.62%,NUCKS1;YTHDC2;PPIB;PRKN;IFI27;CCNK;EIF2AK4;FBXL2
prerank,homocysteine metabolic process (GO:0050667),-0.6474034652451521,-1.698624492349298,0.017114914425427872,0.27871085725960293,0.999,6/11,24.23%,MTHFR;MTRR;MPST;CBS;CTH;NOX4
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.4139912633780654,-1.6985541827987378,0.0,0.27467397494678886,0.999,34/69,24.91%,OAS2;PTPRC;IFIH1;TLR2;LILRA5;CCR2;TYROBP;CD14;THBS1;PF4;NOD2;SYK;RIPK1;PSEN1;LPL;CYBA;CD2;OAS3;SPHK2;LBP;AGER;HSPB1;WNT5A;SPN;TLR4;MMP8;ARHGEF2;TLR1;ISL1;TWIST1;APP;TNFRSF8;FADD;TLR9
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6649117661446062,1.69709241337819,0.0034782608695652175,0.44895682484087157,1.0,5/13,9.38%,SCAMP5;SYT4;SYT1;DOC2B;CACNA1G
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4712005327830383,1.6960372423462482,0.004373177842565598,0.4370546556053241,1.0,20/59,15.86%,PLXNB2;OBSL1;ROBO4;CADM1;MYPN;CNTN2;PTPRT;DSCAM;IGSF21;IGSF11;SDK1;NECTIN3;TENM3;BSG;FAT2;CDH4;PKD1;CADM3;DSCAML1;HMCN1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.5083218306501832,-1.6951180320793602,0.01084010840108401,0.27839231338328424,0.999,12/27,18.71%,CD74;GAS6;IGF1;CDK6;NDUFS4;S100A6;BMI1;PDGFC;LIG4;WNT5A;FN1;PDGFRA
prerank,myelin assembly (GO:0032288),0.7038589354205853,1.6947709193031968,0.012544802867383513,0.4267058944869161,1.0,3/10,5.19%,TPPP;CNTNAP1;GPC1
prerank,rRNA processing (GO:0006364),-0.3535515354905521,-1.6936846498843303,0.0,0.27736746492817516,0.999,59/172,19.55%,UTP6;NOL11;RPL39;RPL5;RPS24;RPS16;WDR43;RPL28;RPS14;DDX49;RPL35A;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;MRPL1;DDX27;RPL14;XRN2;RPL9;MPHOSPH6;RPL32;RPL36;NOP58;RPL31;RPL23A;MDN1;UTP18;RPL41;RPL3;EXOSC9;WDR3;TBL3;RPL8;TEX10;FBL;NOP53;RPL37;EMG1;NAT10;RPL36A;DKC1;RPL26
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6679649650880441,1.6908213516876776,0.01592920353982301,0.4299718992169291,1.0,5/12,10.08%,B3GNT9;B3GNT6;B4GAT1;B3GALT2;B3GALNT1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.6374912715841643,-1.6905226594183669,0.021634615384615384,0.2806424525258661,1.0,5/12,12.21%,CCR2;PRKCQ;CLEC6A;IL1B;SLC11A1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5701360443659204,-1.6898814731605496,0.014423076923076924,0.2780363174456537,1.0,6/18,14.67%,DAB2;PTPN23;MTMR2;MSN;RAB21;DNAJC13
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5632338430892849,1.6884067611230535,0.01020408163265306,0.4256688304763188,1.0,14/25,22.80%,TPPP;STMN4;STMN3;STMN2;NCKAP5;CKAP5;FGF13;NCKAP5L;KIF2A;KIF14;HDGFL3;PIN1;MAP7D3;TPPP3
prerank,lysosome localization (GO:0032418),0.5144407010904851,1.6876814933076356,0.0015455950540958269,0.4145545871026407,1.0,13/37,17.27%,MAP6;BLOC1S2;RAB3A;SYTL4;SNAPIN;BORCS6;PIK3CG;S100A13;TFEB;RAB34;FLCN;BORCS5;VPS33B
prerank,cellular response to copper ion (GO:0071280),0.629280451491869,1.6875031543281143,0.014975041597337771,0.40238739980803556,1.0,11/16,18.07%,PRNP;AOC1;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,synapse assembly (GO:0007416),0.4623943342675349,1.6872251016931936,0.0,0.3911724296819269,1.0,20/67,12.85%,PCDHB9;PCDHB4;PLXNB2;OBSL1;PCDHB5;SPOCK2;NRXN1;DSCAM;GABRG2;RYK;LRRTM3;GABRA2;SHANK3;GRID2;ADGRL3;ACHE;SDK1;FGF13;PCDHB3;NRCAM
prerank,positive regulation of macrophage activation (GO:0043032),-0.5682874958042057,-1.680837815966521,0.01358695652173913,0.29475426420354167,1.0,7/17,18.52%,STAP1;THBS1;HSPD1;LBP;WNT5A;TLR4;MMP8
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.584076182156089,-1.674645813579231,0.007177033492822967,0.3043011489939086,1.0,4/15,9.55%,IQGAP2;ACTR3;ARPC2;ARPC5
prerank,regulation of response to stress (GO:0080134),0.6982990285333792,1.6736948770058369,0.00865051903114187,0.43327345175432513,1.0,5/10,16.91%,ADCY8;SLC38A2;CORO2B;CRHBP;OPRM1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.5318181699609021,-1.671694701229481,0.01240694789081886,0.30697167299350203,1.0,9/22,14.85%,SASH1;XDH;PJA2;RELL1;IL1B;ZC3H12A;GADD45G;BMP2;AGER
prerank,cytosolic transport (GO:0016482),-0.37299559267325577,-1.6702292487201813,0.0,0.30604924694318153,1.0,41/108,17.96%,STX6;RIC1;PIK3C3;KIF16B;VPS26A;KLHL20;PTPN23;STX5;TMEM87B;GAK;RAB7A;SNX1;VPS35;GBF1;LMTK2;EPS15;CLN5;RAB6A;AP4M1;DENND2A;WDR91;VPS26B;AKTIP;WDR81;TBC1D10C;LAMP1;TBC1D10A;DENND5A;EMP2;VPS54;EEA1;YKT6;RBSN;RGP1;CORO7;CLN3;VPS52;DOP1B;GCC2;ERC1;RILP
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5340708433425869,-1.6667025273286222,0.01488833746898263,0.311098761511591,1.0,9/20,16.40%,PTPN22;PRKCE;CD14;LYN;IL1B;HCK;LBP;TNF;TLR4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.6488848916295956,1.6655644469304356,0.011764705882352941,0.45541550197016134,1.0,6/14,17.13%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;MRNIP
prerank,sterol transport (GO:0015918),-0.5482018423134603,-1.6639304302907885,0.017543859649122806,0.31396929001536145,1.0,8/19,9.14%,NPC2;MSR1;OSBP;CD36;LDLRAP1;CAV1;LDLR;OSBPL2
prerank,early endosome to Golgi transport (GO:0034498),-0.6537923744642442,-1.6615234474635132,0.02247191011235955,0.3159503607336974,1.0,6/11,14.31%,SNX8;STX5;SNX1;RAB6A;TMED9;RBSN
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.6017927061901556,-1.6591605650085677,0.036036036036036036,0.3178806347669479,1.0,6/13,13.19%,CD74;CD44;DYRK1A;YJU2;PTTG1IP;PSMD10
prerank,actin filament network formation (GO:0051639),-0.6425283746160804,-1.655988619026574,0.024886877828054297,0.32100524359569826,1.0,6/11,17.48%,ACTN1;CARMIL1;LCP1;COBL;PLS1;CARMIL2
prerank,intracellular cholesterol transport (GO:0032367),-0.5901096669269846,-1.6532327641746627,0.024509803921568627,0.3237277707208638,1.0,7/15,9.43%,NPC2;OSBP;LDLRAP1;LDLR;SERAC1;OSBPL2;ABCG1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.6687832170170576,1.6503224399522376,0.015358361774744027,0.5120120670041949,1.0,6/12,13.15%,STARD3;TSPOAP1;STAR;FDX2;AKR1B1;TSPO
prerank,negative regulation of immune effector process (GO:0002698),-0.6288897223742732,-1.6497621936881641,0.019559902200488997,0.32880808722345717,1.0,6/13,14.97%,CD300A;CD47;ENPP3;RC3H1;CD55;LILRB1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5219946504000236,1.6496892529014198,0.010852713178294573,0.5014947785491349,1.0,9/35,11.41%,PCDHB9;PCDHGB4;PCDHB4;CDH23;DCHS1;PCDHB5;CDH18;ATP2C1;PCDHB3
prerank,stabilization of membrane potential (GO:0030322),0.6070126655870979,1.6487645957232266,0.010067114093959731,0.4928990440773743,1.0,7/16,19.18%,KCNK12;KCNK3;KCNK6;KCNN4;CHCHD10;KCNK9;KCNK2
prerank,sodium ion homeostasis (GO:0055078),0.568442988103347,1.6474240677300884,0.01088646967340591,0.4856125440080412,1.0,10/21,23.15%,ATP1B1;SCNN1A;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,regulation of aerobic respiration (GO:1903715),-0.5728700998920456,-1.6449563666380838,0.004889975550122249,0.3364094574070253,1.0,6/15,16.87%,VCP;ATP7A;CBFA2T3;UQCC2;SLC25A33;NOP53
prerank,regulation of neuron projection development (GO:0010975),0.39381416893098375,1.6446871935511365,0.0,0.48514904607146464,1.0,55/163,19.62%,CSMD3;ABI3;TANC2;PLXNB2;DCC;ARHGAP44;CHN1;CTNNA2;PAK1;NTRK1;ARSB;STMN2;CRMP1;PLA2G3;PTPRO;NTRK3;FBXO7;ITM2C;RTN4RL1;PTK7;PRKCI;GPC2;PRAG1;RIT2;MINAR1;DAB2IP;SHANK3;TWF2;SRCIN1;CDKL5;TENM3;IL1RAPL1;CFL1;MAG;ARHGAP35;MYLIP;LZTS3;NDRG4;EPHA4;NDNF;STYXL1;NTRK2;PRKD1;TWF1;SETX;ITGA6;PTPRS;SCARB2;ULK4;NTNG2;NTNG1;FES;MAGI2;LRRC4C;ROR1
prerank,chloride transport (GO:0006821),0.4435781812433254,1.6433614238277485,0.002881844380403458,0.47944439356241475,1.0,23/74,16.61%,SLC4A8;GABRQ;GLRA3;GABRG1;NMUR1;GABRD;SLC12A2;GABRG2;SLC1A1;GLRB;GABRA2;ANO2;CLCN6;SLC12A6;GLRA2;CFTR;SLC26A7;SLC1A3;SLC4A10;SLC6A1;GABRB1;GABRR2;ANO3
prerank,protein depolymerization (GO:0051261),0.5364069290978183,1.6431566851749049,0.012841091492776886,0.46898547517211847,1.0,12/27,16.39%,STMN4;STMN3;STMN2;NCKAP5;MICAL3;TWF2;CKAP5;CFL1;NCKAP5L;KIF2A;TWF1;KIF14
prerank,lipoprotein biosynthetic process (GO:0042158),-0.640826666981284,-1.6419677388266158,0.03117505995203837,0.33955467355724467,1.0,3/11,4.87%,APOE;PIK3C3;ATG7
prerank,retinoic acid metabolic process (GO:0042573),0.6333935628050666,1.639787214935058,0.012131715771230503,0.4720915645297341,1.0,3/14,4.32%,CYP2S1;CYP26C1;BCO2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.643582621976003,-1.6381556853982484,0.022727272727272728,0.3451582753543693,1.0,6/10,28.33%,MAD2L2;NOTCH1;NOTCH4;RGCC;PPM1F;PLG
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5500184462023336,-1.6375265273173125,0.019851116625310174,0.3427505209191272,1.0,9/17,19.66%,CD300A;PTPRC;PTPA;PPP1R12A;CALM3;CALM2;ITGA1;PPP1R15A;CD33
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.6840858646018236,1.6363684021999216,0.02422145328719723,0.47657805214268434,1.0,4/11,2.48%,YWHAE;KCNJ3;KCNH2;ATP1B1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.49577664867421406,-1.6348244197502402,0.03260869565217391,0.3455853967533571,1.0,12/24,26.27%,EPC1;RBBP7;PPHLN1;DNMT1;BMI1;H3-3A;PHF19;EED;TASOR;EZH2;MTF2;DNMT3A
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.39885972670731773,1.634600698605281,0.0,0.4733037622035871,1.0,44/159,17.82%,PCDHB9;PCDHGB4;PCDHB4;PLXNB2;OBSL1;CDH23;PTPRD;DCHS1;MPZ;CLDN16;ROBO4;CADM1;TENM1;MYPN;PCDHB5;CNTN2;PTPRT;DSCAM;IGSF21;IGSF11;CDH18;GRID2;ADGRL3;SDK1;NECTIN3;TENM3;BSG;IL1RAPL1;FAT2;ATP2C1;CRTAM;ICAM1;PCDHB3;CDH4;MAG;PKD1;CADM3;GPC4;DSCAML1;FAT4;HMCN1;CXADR;PTPRS;NTNG1
prerank,inorganic anion transmembrane transport (GO:0098661),0.4528949655563005,1.6333871752185962,0.0,0.46820272381574335,1.0,22/63,17.65%,SLC4A8;GABRQ;GLRA3;GABRG1;GABRD;SLC37A4;SLC12A2;GABRG2;SLC1A1;GLRB;SLC20A1;GABRA2;ANO2;SLC12A6;GLRA2;CFTR;SLC1A3;SLC6A1;GABRB1;GABRR2;ANO3;SLC37A1
prerank,response to cytokine (GO:0034097),-0.34932749142722486,-1.6328317846354863,0.0,0.3466931334125079,1.0,55/141,23.52%,PID1;SP100;BCL2;CD74;CD274;BCL2L1;KLHL20;PTPN23;LIFR;CIITA;MCL1;TBK1;IFITM3;IFNAR2;MAPKAPK2;IL6ST;CXCL16;ADAM9;SHFL;SMAD3;LDLRAP1;BST2;RIPK1;ANXA1;IL1B;PTPN7;STAT1;MAPKAPK3;SLC11A1;TIMP4;ASAH2;IFNLR1;RELB;MAPK8;CRNN;IL18R1;MAP2K7;COL3A1;OSMR;MYD88;ALDH1A2;TIMP1;CDK9;CASP1;SETD2;TRIM21;HDAC4;PTPN4;IFITM1;APP;KYNU;MEFV;XAF1;EIF2AK2;PLSCR1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5541263744862384,1.6327014181053114,0.01615508885298869,0.4614418130643299,1.0,10/21,24.33%,KCNH2;KCNA5;NOS1AP;KCNE2;GJA5;CACNA1D;CACNA2D1;ANK2;SCN1B;SNTA1
prerank,sarcomere organization (GO:0045214),0.5372727794850687,1.632267223860404,0.008103727714748784,0.45369909539566,1.0,4/27,9.01%,CAPN3;SIX4;MYPN;ACTN2
prerank,defense response to symbiont (GO:0140546),-0.3809642663056178,-1.6308555953964397,0.0,0.34805470843426617,1.0,32/92,14.97%,BCL2;OAS2;BCL2L1;PTPRC;IFIH1;TLR2;IFIT2;IRF7;LYST;ZBP1;IFITM3;IFNAR2;STAT2;TLR7;IFIT1;ATG7;OASL;SHFL;BST2;IFIT3;TLR8;AGBL5;STAT1;ACOD1;NDUFAF4;NLRC5;TRIM5;OAS3;IRF2;PMAIP1;IFNLR1;LILRB1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4662791753837982,-1.6283819053153095,0.007874015748031496,0.35117890109576433,1.0,15/32,17.92%,CLSPN;CDC14B;TOPBP1;NBN;BRCA1;ABRAXAS1;TAOK3;CDK1;TICRR;PLK1;NOP53;UIMC1;BRCC3;DTL;HMGA2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5448608858343632,-1.6272915454401098,0.024875621890547265,0.3498231761886891,1.0,10/18,20.89%,DDX60;ANKRD17;PUM2;OASL;BIRC2;NOP53;NPLOC4;USP15;PUM1;RNF125
prerank,defense response to virus (GO:0051607),-0.3706195655660366,-1.6267954720941395,0.0,0.34728307576830914,1.0,33/100,14.97%,BCL2;OAS2;BCL2L1;PTPRC;ATAD3A;IFIH1;TLR2;IFIT2;IRF7;LYST;ZBP1;IFITM3;IFNAR2;STAT2;TLR7;IFIT1;ATG7;OASL;SHFL;BST2;IFIT3;TLR8;AGBL5;STAT1;ACOD1;NDUFAF4;NLRC5;TRIM5;OAS3;IRF2;PMAIP1;IFNLR1;LILRB1
prerank,neuron projection development (GO:0031175),0.3908278199514412,1.626088126482469,0.0,0.47054468791861204,1.0,76/168,27.76%,CTTN;PLP1;STMN4;STMN3;WHRN;CNTNAP1;SRGAP2;NYAP2;PQBP1;BLOC1S2;PAK1;STMN2;SNAPIN;NCKAP1;NCKAP1L;OMG;IL6;LGI1;MAP1S;RYK;MANF;DAB2IP;SHANK3;SAMD14;ADCYAP1;SH3GL2;GPRIN1;MAP4K4;CTNND2;NEDD4;RASGRF1;BTG2;STX3;EHD1;MINK1;DOCK10;CAMSAP1;ANKRD27;VASH2;MICALL1;IFT88;EPHA4;HMGB1;EPHB2;ERCC6;WNT7A;PPP1R9A;ROCK1;TAOK1;HDGFL3;ALS2;SHANK1;PLXNB1;CDC42;MAP2;GPM6A;ZFYVE27;ULK1;OPHN1;WASL;PTPRM;BDNF;VAPA;TAOK2;RAPGEF2;DCLK1;FLRT3;CNTNAP2;MYO16;MAPT;DLG4;TBC1D24;GRM7;RAB13;DIP2A;EPB41L3
prerank,transferrin transport (GO:0033572),-0.47442344744688697,-1.624286342966331,0.0,0.3497948404474976,1.0,10/33,12.82%,ATP6V0D1;ATP6V0D2;STEAP3;ATP6V1B2;ATP6V0A1;ATP6V0B;LMTK2;TFRC;DNM2;ATP6V1A
prerank,regulation of cation channel activity (GO:2001257),0.42309623097769,1.6231923983389067,0.0013831258644536654,0.47335802209274913,1.0,28/89,17.90%,FGF14;CACNB4;CACNG5;CACNG2;DLG2;FGF12;CACNB2;FGF11;KCNE2;CNIH2;DMD;GRIA2;MEF2C;GRIA1;ACTN2;GRIN1;GRIA4;GRIN2B;FGF13;CACNG7;MINK1;JPH1;CRHBP;HPCA;OPRM1;CACNG3;SHANK1;ANK2
prerank,membrane organization (GO:0061024),-0.32449088314562297,-1.6222467126572961,0.0,0.3513432090809446,1.0,71/227,16.87%,DAB2;ITSN1;MYOF;RABEP1;TMCC1;HIP1;ACTR3;SYNJ2;CHMP4B;CHMP4A;AP2A2;DNAJC6;REPS2;CORO1C;AGFG1;GAK;SH3GLB1;TOR1AIP1;M6PR;AP3D1;FCHO2;AP2B1;HIP1R;CHRM2;ARPC2;PLEKHA3;LDLRAP1;TFRC;PICALM;LDLR;SNX9;EPS15;FNBP1;CTDNEP1;GAPVD1;UBC;SLC2A8;AMPH;LEMD3;TOR1B;SNAP23;OSBPL2;UBA52;ARPC5;DYSF;SNAP29;IGF2R;GRB2;DNM2;CLTA;CBL;NEMP1;PACSIN2;REEP1;PDCD6IP;CHMP1B;FER1L6;STAM;GCA;TIMM50;EGFR;UBXN2B;WNT5A;CHP1;CLN3;RTP4;KIF20A;CLTB;NAPG;STX18;USO1
prerank,steroid hormone biosynthetic process (GO:0120178),0.5216984973080312,1.6211918140712076,0.007836990595611285,0.47258613141144373,1.0,8/29,13.15%,STARD3;HSD17B2;TSPOAP1;STAR;FDX2;AKR1B1;HSD17B11;TSPO
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4864427713770475,-1.6149629336808184,0.010230179028132993,0.3667460211187365,1.0,13/26,22.22%,DAB2;CNOT9;KANK2;SMARCA4;BRCA1;CRY2;PIAS2;CRY1;HDAC1;FOXP1;NCOR1;HEYL;ISL1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.4752578176722883,-1.613345198179675,0.025139664804469275,0.36713568976860583,1.0,9/29,11.76%,UBE2D3;IRF7;TBK1;CD300LF;CD14;RIPK1;UBC;UBA52;BIRC2
prerank,negative regulation of reproductive process (GO:2000242),-0.54714799089333,-1.6129489780541582,0.03571428571428571,0.36443387511186814,1.0,7/17,20.52%,PAEP;IGF1;ARHGDIB;DUSP1;GJA1;HYAL3;TIMP1
prerank,regulation of embryonic development (GO:0045995),-0.4492366409592183,-1.6117047537460658,0.008064516129032258,0.36367215250791446,1.0,15/34,21.08%,PHLDB1;B4GALT5;RPS6KA6;BAG6;DAG1;RACGAP1;WDPCP;TRIP12;CDK1;EHMT1;CCSAP;LHX1;NIBAN2;NPHP3;POGLUT1
prerank,error-prone translesion synthesis (GO:0042276),-0.515677117476546,-1.610468965650439,0.041343669250646,0.3634131429066329,1.0,7/21,16.99%,PCNA;POLI;UBC;UBA52;MAD2L2;RPA1;RPA2
prerank,pentose-phosphate shunt (GO:0006098),-0.6393602066046572,-1.6092348652406052,0.045346062052505964,0.3626771190644281,1.0,4/11,12.60%,RBKS;TALDO1;TKT;SHPK
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.634599964131827,-1.6087075806176552,0.019230769230769232,0.36067359046161845,1.0,5/11,12.35%,DAB2;PTPN23;MTMR2;MSN;RAB21
prerank,neurotransmitter biosynthetic process (GO:0042136),0.6258542773829657,1.6077820079476297,0.03333333333333333,0.5219804703387745,1.0,6/14,22.70%,ALDH9A1;ACHE;CHAT;MOXD1;DAGLA;DAGLB
prerank,regulation of exocytosis (GO:0017157),0.4702356124225225,1.6067567327955345,0.010526315789473684,0.5168725047323903,1.0,15/46,14.91%,LGI3;RAB3A;CADPS2;SYTL4;SYT1;RAB26;RAB8A;CLASP2;CFTR;IL1RAPL1;RAB5A;RAB3D;CPLX2;RAB12;HAP1
prerank,negative regulation of cell development (GO:0010721),-0.4887975248096783,-1.6049387217274778,0.014742014742014743,0.3675829396213676,1.0,14/25,24.07%,IGF1;PCM1;FBXW7;IL1B;NOTCH1;B2M;LILRB1;TNF;PTHLH;RFLNA;APPL2;LTF;PAX6;HOOK3
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.519839335422769,-1.6044568077330736,0.03,0.365543853154299,1.0,7/21,14.83%,RBKS;TALDO1;TKT;HK1;SHPK;GPI;PGM2L1
prerank,regulation of interleukin-12 production (GO:0032655),-0.4270020176668339,-1.6028307138537294,0.0,0.3661400654798158,1.0,16/47,16.40%,CD47;TLR2;PIBF1;LILRA5;IL16;THBS1;HSPD1;SYK;TLR8;LTB;SLAMF1;FOXP1;AGER;LILRB1;SCIMP;TLR4
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.5554564426950412,-1.6018566527503906,0.02030456852791878,0.365282046470519,1.0,10/17,14.14%,BUB3;MIS12;BOD1;ZWILCH;CENPA;HASPIN;CTCF;CDK1;RB1;SPDL1
prerank,clathrin coat assembly (GO:0048268),-0.5627976996221226,-1.6018484899434866,0.0327455919395466,0.36180316983746647,1.0,8/15,18.22%,HIP1;FCHO2;HIP1R;PICALM;EPS15;CLTA;CLTB;FCHO1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6363843459983569,-1.6016785940515776,0.029953917050691243,0.35887893839804297,1.0,5/11,17.14%,SP100;RPS6KA6;MAD2L2;KAT5;HIPK2
prerank,spermatid development (GO:0007286),0.5067250095841684,1.6015465135831057,0.013114754098360656,0.530054938749749,1.0,7/32,6.07%,YTHDC2;TDRD5;ACRBP;DDX25;JAM2;NME5;ZMYND15
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.3605716244980259,-1.6003887312748408,0.0,0.3589287289757399,1.0,49/112,24.91%,GAS6;PTPN22;OAS2;IGF1;PTPRC;CD47;IFIH1;TLR2;LILRA5;RARA;CCR2;MAPKAPK2;TYROBP;CD14;THBS1;PF4;NOD2;SYK;RIPK1;PSEN1;ZC3H12A;LPL;CYBA;CD2;OAS3;SLAMF1;SPHK2;FOXP1;LBP;AGER;LILRB1;HSPB1;WNT5A;SPN;TLR4;MMP8;ARHGEF2;TLR1;CD33;LTF;NLRC3;ISL1;NR1H4;TWIST1;APP;TNFRSF8;GSTP1;FADD;TLR9
prerank,protein heterotetramerization (GO:0051290),0.6356578523418615,1.5999833856501842,0.01559792027729636,0.5276495761168074,1.0,7/13,14.28%,CPSF6;CBR4;PKD2;GRIN1;GRIN2B;PKD1;NUDT21
prerank,clathrin-dependent endocytosis (GO:0072583),-0.4848017557069333,-1.5995718162155133,0.022613065326633167,0.35786613354888996,1.0,8/26,6.28%,ITSN1;AP2A2;DNAJC6;SIGLEC1;GAK;FCHO2;AP2B1;PICALM
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.5984355379943453,-1.5995350858287685,0.029055690072639227,0.3546330156044613,1.0,6/13,16.29%,PPARG;CD36;SYK;LDLR;LPL;FCER1G
prerank,endothelial cell migration (GO:0043542),-0.4433701605995411,-1.5993163782653639,0.0,0.35184310118127493,1.0,13/37,15.73%,NRP1;PXN;DPP4;PLEKHG5;PIK3CA;STAT1;EGR3;ADGRA2;ID1;EMP2;CCN3;PRKX;MYH9
prerank,axonal fasciculation (GO:0007413),0.6405123336591054,1.599270483018919,0.026833631484794274,0.521307511149814,1.0,5/12,14.93%,MEGF8;ARHGAP35;NRCAM;EPHA4;EPHB2
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4409626200175445,-1.596486865730356,0.010723860589812333,0.35594838032119713,1.0,16/34,23.83%,IGF1;CUL3;NSMCE2;IL1B;NUSAP1;CD28;CDC27;IGF2;ESPL1;RB1;NUP62;RGCC;DRD3;TGFA;ANAPC7;EGF
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.46542591989768534,1.5952707269894826,0.015723270440251572,0.5299873825776175,1.0,15/44,19.01%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ATP1B1;ATP1B3;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2;WNK1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5742808838711653,-1.594345651127459,0.034031413612565446,0.35799514275816274,1.0,4/14,11.91%,IGF1;PTPRC;LDLR;TNFRSF1B
prerank,negative regulation of transport (GO:0051051),-0.40390211762991024,-1.5936291179581012,0.006349206349206349,0.35687918395731244,1.0,21/51,24.76%,FCGR2B;MCTP1;ARL6IP5;PIP4P2;TLR2;MTMR2;RAB7A;BST2;NR1H2;DYSF;NR1H3;RACK1;LILRB1;YRDC;RSC1A1;PPM1F;ITGB3;NDFIP1;PLSCR1;EGF;PRTN3
prerank,phagosome acidification (GO:0090383),-0.4783313691368707,-1.5926890912830582,0.016574585635359115,0.35601014828129535,1.0,6/26,4.12%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.4237610300524329,-1.591781654888176,0.01358695652173913,0.3552985639458916,1.0,18/47,15.85%,FBXW7;PROX1;NFKB1;CAV1;FYN;ERLIN2;BRCA1;WDTC1;ZC3H12A;EP300;PTGIS;C1QTNF3;CRY1;CEACAM1;APOC1;GLA;SIK1;ACADL
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6674575516136936,1.5909380190189106,0.03041144901610018,0.5401469361175337,1.0,3/10,5.53%,VSIR;NCKAP1L;PRNP
prerank,retrograde axonal transport (GO:0008090),0.5924979424009355,1.5900751429799067,0.03304347826086956,0.5347031729215412,1.0,5/16,14.91%,ACTR10;DLG2;DST;KIF1C;HAP1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.5494397578356979,-1.588699180449481,0.033419023136246784,0.35983210075149497,1.0,9/16,25.48%,ULBP1;LYST;SLAMF7;CEBPG;RAET1E;TUBB4B;KLRK1;PLEKHM2;VAMP7
prerank,dendritic spine morphogenesis (GO:0060997),0.6050364982423796,1.5884780272469192,0.02348993288590604,0.5327620988111677,1.0,11/15,28.40%,SHANK3;CTNND2;DOCK10;EPHB2;WNT7A;SHANK1;CDC42;WASL;DLG4;DIP2A;PTEN
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5157539456255921,-1.5877526058861704,0.01728395061728395,0.3591116727032891,1.0,12/22,20.53%,FLOT2;GCNT2;CD44;IL1B;LCK;SKAP1;AGER;TNF;MAPK7;MYADM;BMP7;KLF4
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.4318121818141574,-1.587752468703157,0.014245014245014245,0.35606835344309173,1.0,10/38,12.17%,UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;BAG4;ARIH2;PARL;UBE2L3;LRRK2
prerank,calcium ion import (GO:0070509),0.51703259788658,1.5873197101818675,0.017054263565891473,0.5289865746356293,1.0,11/28,16.42%,ATP2A2;CACNB2;CACNA1S;MICU2;SMDT1;CACNA1G;SLC8A1;CACNA1D;CACNA1B;SLC25A23;CACNA1A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.6109604705485422,-1.5867754024185383,0.02912621359223301,0.35548336370259304,1.0,3/11,1.54%,BCL2;CD74;CD44
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5924433138506492,-1.5858857802114068,0.029556650246305417,0.3547035133808713,1.0,6/14,14.97%,PIBF1;LILRA5;THBS1;TLR8;SLAMF1;LILRB1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5895424315278974,1.5857868059939508,0.03820598006644518,0.5268573129541774,1.0,9/16,20.36%,SH3BP1;STMN3;ARHGAP44;PIK3CG;OGT;RASGRF1;CADM4;ALS2;GABARAP
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.637617766602687,1.5857555611643008,0.031088082901554404,0.5186445258061464,1.0,5/12,11.37%,AAAS;BMP4;TGFB1;NEDD4;IFI27
prerank,regulation of T cell proliferation (GO:0042129),-0.39574107246175566,-1.585740803742255,0.009174311926605505,0.35204263860612856,1.0,16/61,11.91%,IL15;CD274;CCDC88B;TNFSF8;SLC7A1;PTPRC;DLG5;IL6ST;NCK1;IL27;TFRC;CEBPB;ANXA1;IL1B;CD28;TNFRSF1B
prerank,mitotic sister chromatid segregation (GO:0000070),-0.3563143986099787,-1.5830372619491608,0.0,0.3566817867096644,1.0,37/98,19.82%,DIS3L2;KPNB1;CHMP4B;CHMP4A;MIS12;CUL3;PDS5B;PIBF1;KIF23;PRC1;NCAPD2;NCAPH;BOD1;CDCA8;TEX14;NCAPG2;KIFC1;PDS5A;HASPIN;NUSAP1;SMC2;CDK1;ESPL1;PDCD6IP;CHMP1B;RAD21;RB1;SPDL1;NUP62;NDC80;PLK1;DCTN2;KIF18B;MCPH1;ZWINT;REC8;TENT4A
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.6176543318544799,1.5825146971642883,0.024271844660194174,0.5235983583567677,1.0,7/13,22.48%,KCNJ3;KCNA5;CACNB2;KCNJ5;ANK2;SCN3B;KCNN2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5786662153249811,-1.582152659459825,0.047961630695443645,0.3560775637780339,1.0,7/13,22.58%,PTPN1;NCK1;DNAJB9;RACK1;WFS1;PPP1R15A;BFAR
prerank,peptidyl-proline modification (GO:0018208),0.5230380128248178,1.5821195532033006,0.012698412698412698,0.5172031092539293,1.0,6/25,7.31%,P3H2;PPIC;PPIB;PPWD1;PPIL1;PPIG
prerank,inner dynein arm assembly (GO:0036159),0.657463005460553,1.5817746684445633,0.02434782608695652,0.5107152397412308,1.0,4/11,8.60%,DNAAF1;CCDC39;DNAI3;CFAP100
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5139684132796586,-1.5791265553817118,0.01951219512195122,0.3576480845289991,1.0,10/21,16.17%,BCL2;BCL2L1;MCL1;PF4;IL1B;EYA1;EYA3;EYA2;TNF;MAPK7
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5139684132796586,-1.5791265553817118,0.01951219512195122,0.3576480845289991,1.0,10/21,16.17%,BCL2;BCL2L1;MCL1;PF4;IL1B;EYA1;EYA3;EYA2;TNF;MAPK7
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.5944549102118519,-1.5783768420957076,0.0430622009569378,0.35667167066023847,1.0,7/13,24.91%,PIK3C3;PIK3R4;TLR7;EPG5;IRAK4;MYD88;TLR9
prerank,positive regulation of binding (GO:0051099),-0.3710765562790784,-1.5762995337265582,0.0,0.35878247471729213,1.0,36/84,21.17%,STK3;APOE;IGF1;HMGB2;PPARG;DTX3L;RARA;MET;NCBP1;CEBPG;TAF1;HIP1R;CAV1;PLAUR;STMN1;CLN5;TXN;PSEN1;AKTIP;SPPL3;LRRK2;PARP9;LRP1;B2M;RALB;BMP2;CDT1;NMD3;HIPK2;MMP8;HES1;DPH3;BAMBI;RPL11;TRIM21;SIRT2
prerank,negative regulation of axonogenesis (GO:0050771),0.5163332083731225,1.576197254962698,0.024077046548956663,0.5266513955497828,1.0,18/27,29.90%,DIP2B;DCC;THY1;OMG;EFNB3;ARHGDIA;FGF13;GDI1;MAG;PTPRS;ULK2;MAP2;ULK1;RHOA;NGFR;LINGO1;PTEN;RTN4R
prerank,regulation of cytokinesis (GO:0032465),-0.36680892122201925,-1.5761479098858284,0.013201320132013201,0.3565336398279396,1.0,26/78,16.22%,SVIL;PIK3C3;BCL2L1;PRKCE;CUL3;PIK3R4;GIT1;KIF23;BIRC6;CDC14B;SH3GLB1;PRC1;KIF20B;CIT;UVRAG;RACGAP1;DRD2;KLHL21;CALM3;AHCTF1;CALM2;E2F8;PRPF40A;E2F7;PLK1;KIF20A
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4100000043613512,-1.5738920077291625,0.014970059880239521,0.3594692969411411,1.0,14/45,17.07%,IQGAP1;KIF16B;REPS2;BRAF;GAB1;PIK3CA;GRB2;CBL;EGFR;SHC1;PTK2B;BCAR1;AAMP;ADAM17
prerank,organophosphate ester transport (GO:0015748),-0.497796269134391,-1.5730656198644615,0.015463917525773196,0.358561381457539,1.0,8/24,10.10%,OSBPL8;NPC2;PLTP;LDLR;EPG5;PCTP;OSBPL2;SLC25A19
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5713035008781719,1.5716376882692196,0.027210884353741496,0.5388292707629645,1.0,8/17,24.33%,KCNH2;NOS1AP;KCNE2;GJA5;CACNA2D1;ANK2;SCN1B;SNTA1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6516562659552365,1.569603229096153,0.034545454545454546,0.5400152685671781,1.0,2/11,0.86%,P3H2;P4HA3
prerank,anterograde trans-synaptic signaling (GO:0098916),0.36417224854403446,1.5694451962950453,0.0,0.5330546521306128,1.0,59/224,18.42%,PLP1;SNAP25;GABRQ;PCDHB9;CACNB4;GLRA3;PCDHB4;DLG2;HTR1F;KCND2;GABRG1;CACNB2;MPZ;GABRD;GIPC1;SYT1;PCDHB5;GRIA2;NRXN1;GABRG2;SLC1A1;GLRB;GRM3;KCNK3;NPTX1;GRIK2;GRIA1;RIT2;GABRA2;CPNE6;GRIN1;SST;GRIA4;GRIN2B;SLC12A6;GLRA2;ASIC2;UNC13B;SLC1A3;PCDHB3;MINK1;CACNA1B;GAD2;GABBR2;SLC6A1;DLGAP1;GABRB1;NOVA1;HAP1;GABRR2;SPG11;CACNA1A;HTR6;PRKAR1A;MTNR1B;MBP;SNCB;CHRNA7;CHRFAM7A
prerank,regulation of cholesterol storage (GO:0010885),-0.5427028658819246,-1.5693922234512887,0.03953488372093023,0.365435233947351,1.0,7/15,13.27%,MSR1;PPARG;PPARD;NR1H2;ABCG1;LPL;NR1H3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.43717165034064365,-1.5678106722963456,0.014619883040935672,0.3665006469323857,1.0,10/35,9.96%,APOE;ALOX5;XDH;PPARG;AIMP1;THBS1;FLT1;CAV1;PDCD10;STAT1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.44609315838370356,-1.5673333883217075,0.014534883720930232,0.36507830388928814,1.0,9/33,10.70%,ITSN1;SYNJ2;DNAJC6;GAK;FCHO2;PICALM;AMPH;SNCG;DNM2
prerank,keratinocyte differentiation (GO:0030216),-0.4520661549954842,-1.5660166981949557,0.01662049861495845,0.36565203659234935,1.0,17/29,36.48%,ST14;ADAM9;CLIC4;ANXA1;TXNIP;WNT5A;EPHA2;OPN3;BCR;DSP;EVPL;SCEL;KRT10;ASAH1;UGCG;EXPH5;SPRR1A
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6279980159756088,-1.5651717011534803,0.04035874439461883,0.3651058055948498,1.0,5/10,14.97%,BTLA;CD24;LYN;BAG6;LILRB1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5738265577512197,-1.5646831380542952,0.026634382566585957,0.3634843758225597,1.0,3/12,1.54%,BCL2;CD74;CD44
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.5624124337173585,1.5646046422181668,0.027777777777777776,0.5464360346228518,1.0,7/19,11.81%,MAF1;PRDX5;RPTOR;TENM1;AR;ZC3H8;POLR3F
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.6070994075943403,-1.5644026190669447,0.032036613272311214,0.3614883481194881,1.0,8/12,20.01%,GCNT2;CD44;IL1B;LCK;SKAP1;AGER;TNF;BMP7
prerank,purine-containing compound salvage (GO:0043101),0.6400947897139957,1.5637949140341718,0.026929982046678635,0.5420409774376304,1.0,6/12,15.26%,ADA;PNP;AMPD3;HPRT1;DCK;GMPR
prerank,establishment of protein localization to extracellular region (GO:0035592),0.46844960899252225,1.5634834638191497,0.01746031746031746,0.535802618716002,1.0,15/39,19.25%,LTBP2;RAB3A;TVP23A;RAB8A;COPG1;PPY;TANGO2;ARL4D;RAB3D;MTTP;RAB12;MIA3;COPG2;PREB;OLFM2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3868870503136868,-1.562769212071064,0.006191950464396285,0.3628721144927118,1.0,19/55,16.34%,IL15;CD274;IGF1;CCDC88B;SLC7A1;PTPRC;CCR2;IL6ST;NCK1;SYK;TFRC;CD24;ANXA1;IL1B;CD28;IGF2;EBI3;AGER;IL27RA
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3912913415389087,-1.560092500714802,0.0060790273556231,0.36679728072964707,1.0,27/57,28.91%,RPL5;RPS24;CUL4A;URB2;RPS16;MALSU1;RPL35A;RPS7;RPF2;BYSL;METTL17;XPO1;RPL14;NPM1;GTF3A;EMG1;RPL26;SDAD1;RPL11;NAF1;RPS15;RPS6;RPS17;LTO1;BOP1;RPS19;WDR74
prerank,protein localization to cilium (GO:0061512),0.4936075757346945,1.5594465009385867,0.01910828025477707,0.546273378883548,1.0,8/32,11.02%,IFT20;WDR19;ODAD4;ROPN1;MAPK15;TMEM107;BBS9;EHD1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3799692123811375,-1.5593616400033696,0.006430868167202572,0.365833670140593,1.0,15/63,8.08%,VAV3;IL15;BCL2;CD74;CD38;CD274;CCDC88B;SLC7A1;PTPRC;IL6ST;NCK1;GPR183;TFRC;ANXA1;IL1B
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.5241701042991054,-1.5593004750149762,0.03935185185185185,0.36340356737240587,1.0,12/17,30.86%,CEBPB;CAV1;CD24;CEACAM1;PRKX;AJAP1;MAFG;GATA3;DSPP;FOXN1;APOLD1;DLL1
prerank,regulation of catabolic process (GO:0009894),0.561362394489253,1.559264924080351,0.025477707006369428,0.5398613926963707,1.0,8/18,20.13%,RARRES2;FAF1;CENATAC;ZDHHC2;TMEM9;NEDD4L;HPGD;SNF8
prerank,positive regulation of cellular protein localization (GO:1903829),-0.3819136340639825,-1.5589395348681876,0.003134796238244514,0.3616705138594493,1.0,24/69,16.66%,DTX3L;GNL3L;LAMTOR5;TYROBP;CEP250;TRAPPC12;TFRC;FYN;YAP1;GPR137B;TM9SF4;CDK1;PARP9;SLC5A3;NUMA1;CDT1;ORMDL3;TNF;KAT7;NUP62;NDC80;PARD6A;PLK1;SESN2
prerank,negative regulation of B cell activation (GO:0050869),-0.5013463140755368,-1.558545241021204,0.03258145363408521,0.36016201674130593,1.0,7/21,12.05%,FCGR2B;CD300A;TYROBP;LYN;BANK1;RC3H1;FOXJ1
prerank,inositol phosphate metabolic process (GO:0043647),0.4677086959975452,1.5579240570691602,0.0074962518740629685,0.5383958229566778,1.0,14/46,12.25%,PLCH1;INPP4B;ITPK1;IP6K1;INPP5D;NUDT10;PLCD1;INPP5B;PLCG1;NUDT3;PLD4;OCRL;FGF2;IPMK
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5033359188231158,-1.5553527197480406,0.025280898876404494,0.36543798175466957,1.0,9/21,28.40%,OSBPL8;PLA2G4E;PLAAT3;LPCAT4;PLA1A;PLA2G4F;PLA2G2D;MBOAT1;PLA2G12A
prerank,sulfur amino acid metabolic process (GO:0000096),-0.46782803391138855,-1.5552984308968052,0.029333333333333333,0.36299297881299836,1.0,12/24,24.23%,MSRA;MTHFR;MTHFD1;GCLC;MTRR;MPST;ADI1;CBS;GADL1;CTH;ADO;NOX4
prerank,chemical synaptic transmission (GO:0007268),0.3517631555757117,1.5527451443742162,0.0,0.5541430410595702,1.0,74/284,18.42%,PLP1;SNAP25;GABRQ;PCDHB9;CACNB4;GLRA3;PCDHB4;DLG2;HTR1F;KCND2;GABRG1;TSPOAP1;CACNB2;RAB3A;MPZ;GABRD;GIPC1;SYT1;SNAPIN;PCDHB5;NAPB;ERC2;GRIA2;NRXN1;CBLN2;GABRG2;SLC1A1;GLRB;GRM3;KCNK3;FCHSD2;NPTX1;GRIK5;GRIK2;GRIA1;RIT2;GABRA2;GRID2;CPNE6;GRIN1;SST;CHAT;GRIA4;GRIN2B;SLC12A6;GLRA2;ASIC2;UNC13B;SLC1A3;RIMS1;PCDHB3;MINK1;SLC1A4;CRHBP;CACNA1B;GAD2;GABBR2;STXBP2;SLC6A1;DLGAP1;GABRB1;NOVA1;HAP1;GABRR2;SPG11;CACNA1A;HTR6;DLGAP2;PRKAR1A;MTNR1B;MBP;SNCB;CHRNA7;CHRFAM7A
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.6196706285914932,-1.5502730210526134,0.05,0.3730449524983123,1.0,5/10,16.40%,TLR2;NAMPT;NOD2;KDR;TLR4
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6144425147393575,-1.5493167781661727,0.03728070175438596,0.37291987149084643,1.0,3/10,9.39%,DIS3L2;UBC;UBA52
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5344937894107036,1.5483908663379773,0.02694136291600634,0.5660329703020741,1.0,9/22,19.76%,FGF10;FGF7;SRSF6;AREG;SNAI2;TGM1;PRKD1;STXBP4;EPB41L4B
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.376821442889128,-1.5454801323467517,0.006920415224913495,0.38000392855108633,1.0,35/73,24.91%,OAS2;PTPRC;IFIH1;TLR2;LILRA5;CCR2;TYROBP;CD14;THBS1;PF4;NOD2;SYK;RIPK1;PSEN1;LPL;ADAM8;CYBA;CD2;OAS3;SPHK2;LBP;AGER;HSPB1;WNT5A;SPN;TLR4;MMP8;ARHGEF2;TLR1;ISL1;TWIST1;APP;TNFRSF8;FADD;TLR9
prerank,endocytic recycling (GO:0032456),-0.40258518897514484,-1.5444976604732228,0.008902077151335312,0.37994367988443023,1.0,11/50,8.48%,DENND1A;EHD4;STX6;VPS26A;PTPN23;DENND1B;RAB7A;VPS35;LMTK2;EPS15;CCDC22
prerank,intracellular sterol transport (GO:0032366),-0.5594983314993744,-1.5443573996554658,0.050359712230215826,0.37760169173474983,1.0,5/13,9.43%,NPC2;OSBP;SERAC1;OSBPL2;ABCG1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.40219389824366136,-1.5434332291337027,0.0033444816053511705,0.37726004203431074,1.0,23/56,19.81%,ALPK1;SFTPA2;SFTPA1;TLR2;CD36;MAPKAPK2;TLR7;CD14;NOD2;CTSL;UBC;TLR8;CTSB;TAB1;UBA52;S100A1;MAPKAPK3;IRAK4;LBP;TLR4;CLEC4E;TLR1;MYD88
prerank,regulation of p38MAPK cascade (GO:1900744),-0.4469870605208369,-1.5431336359509478,0.026595744680851064,0.3755139476191272,1.0,11/35,14.85%,SASH1;PTPN22;XDH;PJA2;RELL1;IL1B;ZC3H12A;GADD45G;BMP2;DUSP1;AGER
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4690983182054404,1.5422928616393525,0.02388535031847134,0.586226146724263,1.0,13/38,17.90%,YWHAE;KCNJ3;KCNH2;BIN1;KCNA5;CACNB2;KCNE2;CACNA1G;CACNA1D;CACNA2D1;KCNJ5;CTNNA3;ANK2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.563710583818668,1.5418571586686818,0.028428093645484948,0.58079850996026,1.0,11/18,32.94%,HHEX;MCM3AP;DDX25;NUP133;SARNP;NXF1;DDX19A;PCID2;ZC3H11A;POLDIP3;NUP93
prerank,regulation of viral genome replication (GO:0045069),-0.39207521048457733,-1.5418243131017104,0.006172839506172839,0.3763583380175015,1.0,23/56,23.52%,OAS2;IFIH1;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;CD28;PPIH;BANF1;OAS3;LARP1;TNF;ZC3HAV1;STAU1;LTF;TNIP1;IFITM1;VAPB;ILF3;EIF2AK2;PLSCR1
prerank,lipid droplet organization (GO:0034389),0.5286177380143396,1.5400341975416472,0.03889789303079417,0.5815337654923864,1.0,4/22,15.23%,PLA2G4C;HILPDA;PNPLA3;FITM2
prerank,positive regulation of transport (GO:0051050),-0.36045572692711403,-1.5382186773994657,0.01020408163265306,0.3831263499628637,1.0,22/85,16.29%,DAB2;FCGR2B;IL15;APOE;GAS6;CD47;DOCK2;BAX;HIP1R;ANXA1;IL1B;KCTD7;CYBA;SLC11A1;NR1H3;LRP1;INPP5K;NUMA1;TNF;TUB;CHP1;FCER1G
prerank,regulation of response to biotic stimulus (GO:0002831),-0.4563755701293315,-1.5365543621699587,0.019553072625698324,0.38486118108527684,1.0,12/28,25.11%,FCGR2B;PTPN22;CD36;ERAP1;BIRC2;TRIM5;CD55;FOXP1;APPL2;XIAP;APPL1;DHX58
prerank,regulation of cell motility (GO:2000145),0.3853078346462669,1.5351553578681345,0.003865979381443299,0.5973027641400248,1.0,39/121,19.02%,CCDC25;FGF10;SPOCK3;ABI3;FRMD5;FGF16;PLXNB2;FGF9;LDB2;LDB1;PKN1;PARD6B;ROBO4;NRG4;BEX4;SPOCK2;FGF7;SPINT2;PRAG1;SRCIN1;ENPP2;ERBB4;SST;TGFB1;INPP5F;CAMSAP3;FGF2;MINK1;DOCK10;HACE1;KIF2A;RCC2;SERPINE2;CADM4;KIF14;ROCK1;FES;PIN1;PLXNB1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5896483502888215,-1.5351279921168817,0.056433408577878104,0.38600540853240123,1.0,5/11,21.17%,BCL2L1;ZC3H12A;PTGIS;DFFA;SIRT2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.567744651292055,-1.5323388620163507,0.04316546762589928,0.39068859094982034,1.0,7/13,20.95%,SOX11;TAF1;PSEN1;MAD2L2;HEY2;PER2;TMSB4X
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.4110312620009322,-1.5319393435803605,0.0113314447592068,0.389131013516995,1.0,12/41,15.14%,PTPN23;ADAM19;GCNT2;CD44;CD47;AFDN;PLAUR;IL1B;LCK;SKAP1;AGER;TNF
prerank,regulation of autophagy (GO:0010506),-0.30634677219676754,-1.5316689965104342,0.0,0.38726702424522036,1.0,57/216,15.83%,BCL2;ATP6V0D1;PTPN22;ABL2;VPS26A;TRIM65;ATP6V0D2;TPCN2;PSAP;CAPN1;TRIM14;ATP6V1B2;ATG13;PRKAB1;ATP6V0A1;RRAGC;DRAM2;MCL1;FBXW7;PRKACA;MET;EEF1A1;LAMTOR5;SH3GLB1;VPS35;ATP6V0B;EXOC4;ERN1;TPCN1;MTMR4;ITPR1;UBQLN1;GPR137B;PRKAG2;CISD2;DRAM1;CTSA;SMCR8;ZC3H12A;DCAF12;EP300;FOXO1;VPS26B;DAPK1;LRRK2;RRAGA;EXOC8;KAT5;ATP6V1A;TRIM5;GPR137;ORMDL3;PRKAB2;HSPB1;OPTN;FOXK2;MTMR3
prerank,neurotransmitter uptake (GO:0001504),0.6213052429284021,1.5314712301793445,0.03873239436619718,0.607225730456937,1.0,3/12,11.08%,SNAP25;SLC29A2;SLC1A3
prerank,regulation of interleukin-6 production (GO:0032675),-0.3498730577918035,-1.528900998793026,0.003676470588235294,0.3920591223043391,1.0,39/96,22.59%,CD74;GAS6;PTPN22;CD47;IFIH1;TLR2;LILRA5;IL16;RAB7B;MAPKAPK2;TYROBP;TLR7;NOD2;HSPD1;SYK;TLR8;IL1B;ZC3H12A;LPL;C1QTNF3;CYBA;FOXJ1;SLAMF1;SPHK2;LBP;AGER;TNF;SCIMP;WNT5A;TLR4;MMP8;ARHGEF2;TLR1;AFAP1L2;MYD88;NLRC3;ISL1;TWIST1;APP
prerank,protein localization to chromosome (GO:0034502),-0.4247579706501725,-1.5277211170102174,0.02865329512893983,0.39273337291341626,1.0,14/34,16.99%,ESR1;IFFO1;BOD1;CENPA;HASPIN;CTCF;RPA1;RAD21;RB1;TERF2;MCM9;MCM8;PLK1;RPA2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4764843253841487,-1.5262604795566486,0.031791907514450865,0.3941486955935987,1.0,10/27,13.27%,PRKCH;MSR1;PPARG;CD36;NFKB1;PF4;NR1H2;ABCG1;LPL;NR1H3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4728942083716257,-1.5262435266937895,0.031746031746031744,0.39178918510413363,1.0,12/26,17.28%,NR1H2;PRKAG2;ERLIN2;BRCA1;WDTC1;CEACAM1;APOC1;NR1H3;MID1IP1;PRKAB2;ACADL;ADIPOR2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.43319261824208866,-1.526207142041701,0.01871657754010695,0.3894917191182362,1.0,7/30,9.26%,UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;ARIH2;UBE2L3
prerank,determination of heart left/right asymmetry (GO:0061371),0.457937262245122,1.526016088736153,0.026033690658499236,0.6249107684110252,1.0,11/43,13.33%,DNAAF1;VANGL2;CCDC39;MEGF8;MEF2C;DAND5;BBS5;PKD2;TBX2;TBX6;NDRG4
prerank,negative regulation of defense response (GO:0031348),-0.3656363266815979,-1.5250152462830888,0.01048951048951049,0.3899254387461322,1.0,34/77,25.11%,AOAH;ITCH;APOE;ALOX5;PPARG;METRNL;PTGER4;VPS35;PPARD;ENPP3;PTGIS;ACOD1;C1QTNF3;NR1H3;CCN3;RB1;CXCL17;OTULIN;MAPK7;MUL1;GATA3;TRAF3IP1;KLF4;NLRC3;TRIM21;MVK;SIRT2;FFAR4;ISL1;NR1H4;MEFV;SMPDL3B;FEM1A;DHX58
prerank,translesion synthesis (GO:0019985),-0.40983256617684405,-1.5249052859303291,0.011594202898550725,0.38774905331653126,1.0,16/42,19.91%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;UBA52;MAD2L2;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43;NPLOC4
prerank,regulation of mast cell activation (GO:0033003),-0.6010359004208963,-1.523950910835688,0.05353319057815846,0.38798381181572883,1.0,5/10,26.45%,CD300LF;LYN;CD226;PLSCR1;TSLP
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.5531473119717787,-1.5229575361183962,0.04060913705583756,0.38822389503161175,1.0,8/15,15.14%,APOE;ADAM9;NRDC;SNX9;IL1B;ADAM8;TNFRSF1B;TNF
prerank,regulation of potassium ion transport (GO:0043266),0.4868099622922206,1.5227863270833462,0.0304,0.633404412012338,1.0,9/31,11.88%,KCNH2;KCNA5;KCNE2;KCNIP3;KCNIP4;ADRA2A;FHL1;ACTN2;CACNA1D
prerank,N-glycan processing (GO:0006491),-0.5161586495176522,-1.5221779137214269,0.030732860520094562,0.3878719236158716,1.0,8/18,14.94%,MAN2A1;GANAB;ST8SIA6;FUT8;ST8SIA4;GNPTAB;PRKCSH;ST8SIA2
prerank,negative regulation of receptor binding (GO:1900121),0.6571677407869284,1.5221254894307137,0.03780718336483932,0.6291806599942512,1.0,3/10,10.35%,ATP2A3;ATP2A2;ADAM15
prerank,natural killer cell activation (GO:0030101),-0.4699925915017096,-1.5205821601144338,0.043478260869565216,0.3897386998334078,1.0,8/23,15.38%,AXL;PTPRC;ULBP1;SLAMF7;TOX;BAG6;CD2;KAT7
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.5631010146637752,1.5194383175663864,0.05518394648829431,0.6350398774276688,1.0,7/16,23.78%,SRSF12;CWC15;CACTIN;SRSF1;PSIP1;SART1;WBP4
prerank,regulation of inflammatory response (GO:0050727),-0.31003314073198707,-1.5194008960998069,0.0,0.39043495238862186,1.0,66/190,23.96%,AOAH;IL15;APOE;PSMA6;ALOX5;CELF1;CD47;TLR2;LILRA5;PPARG;METRNL;ZBP1;CCR2;IL16;PTGER4;VPS35;TLR7;NFKBIZ;PPARD;USP18;NOD2;RIPK1;ANXA1;ENPP3;IL1B;HCK;LPL;GPSM3;GPRC5B;PTGIS;ACOD1;C1QTNF3;BIRC2;TNFRSF1B;SHPK;NR1H3;CCN3;RB1;CXCL17;FOXP1;TNF;WNT5A;OTULIN;BST1;PDE2A;MAPK7;TLR4;GATA3;MMP8;ADAMTS12;MYD88;KLF4;CASP1;NLRC3;TMSB4X;MVK;TNIP1;FFAR4;ISL1;NR1H4;APP;MEFV;PLA2G7;XIAP;SMPDL3B;BCL6
prerank,tryptophan catabolic process (GO:0006569),0.6225178697528065,1.5192057886857113,0.043402777777777776,0.6289333765533963,1.0,4/11,11.66%,IL4I1;IDO2;AFMID;KYAT1
prerank,negative regulation of neuron projection development (GO:0010977),0.4372677800001569,1.5181823834533832,0.016591251885369532,0.6268315187591975,1.0,17/56,13.80%,DCC;THY1;STMN2;CRMP1;PTPRO;OMG;EFNB3;ITM2C;RTN4RL1;PRAG1;MINAR1;ARHGDIA;GDI1;EFNA1;MAG;MYLIP;EPHA4
prerank,DNA packaging (GO:0006323),-0.5320991447426707,-1.5177767739750028,0.05515587529976019,0.39225718993982456,1.0,8/16,29.72%,NAA10;H1-0;HAT1;BANF1;PRM1;M1AP;AIFM1;BANF2
prerank,peptide biosynthetic process (GO:0043043),-0.3195785272697784,-1.5170873407124459,0.0,0.3918742731596431,1.0,41/153,14.02%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;EEF1A1;RPS29;RPS14;RPS20;GGTA1;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;DHPS;RPL37A;EIF4EBP2;IGHMBP2;RHD;RPL10;RPL15;YARS2;RPS10;RPL14;RPL9;RPL32;RPL36;RPL31;RPL23A;AGO2;MRPL35;RPL41;RPL3
prerank,positive regulation of cell division (GO:0051781),-0.41787515549178966,-1.5170133952615754,0.01529051987767584,0.3897553933128992,1.0,16/38,22.33%,SVIL;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;FGF1;RACGAP1;DRD2;ECT2;DRD3;MAP10;SIRT2;CDC14A;SHH
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.40954393222588376,-1.5169865136258889,0.024128686327077747,0.38759057709518174,1.0,15/42,15.58%,NRP1;CDK6;CD36;LIMS1;CCL25;UTRN;CIB1;S100A10;EFEMP2;SKAP1;KDR;EMP2;MYOC;PTK2B;CCL28
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.4877228919735419,1.516868001357589,0.03328050713153724,0.6260628533848231,1.0,13/30,24.33%,KCNH2;FGF12;KCNA5;KCNE2;CACNA1G;CACNA1D;NEDD4L;CACNA2D1;ANK2;ATP1A1;SCN1B;SCN3B;SNTA1
prerank,regulation of endocytic recycling (GO:2001135),0.6219937219330742,1.5167722833513029,0.05319148936170213,0.6196244684154293,1.0,6/11,11.38%,ATP9A;PLA2G3;ACTN2;INPP5F;EHD1;EHD2
prerank,central nervous system myelination (GO:0022010),0.6201661836016479,1.5158782768223515,0.03893805309734513,0.6174098089287623,1.0,6/11,13.97%,PLP1;CNTNAP1;SOX10;CLU;MYRF;ABCA2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6032420684136423,-1.5156987094101673,0.05542168674698795,0.3885815203698406,1.0,6/10,21.41%,TYROBP;CD24;LILRB1;FN1;LAPTM4B;CDH3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5388649443128873,-1.5155369971143944,0.03508771929824561,0.3867098220336536,1.0,6/15,9.52%,PRKCH;MSR1;CD36;NFKB1;PF4;LPL
prerank,motile cilium assembly (GO:0044458),0.6011037559735193,1.5108177351619942,0.051070840197693576,0.635077843190296,1.0,4/12,16.66%,DNAAF1;CCDC39;BBS5;DNAAF3
prerank,potassium ion import across plasma membrane (GO:1990573),0.4541718301933127,1.5102471380576152,0.0182370820668693,0.6308354519404601,1.0,14/41,19.85%,KCNJ3;KCNH2;ATP1B1;KCNE2;KCNJ8;SLC12A2;ATP1B3;KCNJ13;SLC12A6;KCNJ5;KCNK9;ATP1A3;ATP1A4;ATP1A1
prerank,potassium ion transport (GO:0006813),0.3773844042171704,1.5101272994727246,0.011795543905635648,0.6248251936040216,1.0,32/120,19.85%,HCN1;KCNMA1;KCNK12;KCNJ3;KCNH2;KCND2;KCNA5;KCNE2;KCNJ8;KCNH7;KCNC1;KCNK3;ATP1B3;KCNJ13;SLC9A4;PKD2;KCNK6;SLC1A3;KCNN4;SLC9A5;ABCC8;HPN;KCNJ5;KCNC3;SLC24A3;KCNMB3;KCNN3;KCNK9;KCNQ4;SLC24A4;KCNK2;ATP1A4
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6043001059678146,-1.5093104697856274,0.05733944954128441,0.4002470829950393,1.0,8/10,28.26%,SOX11;BMP5;NOTCH1;LRP6;BMP7;LIN7C;DLL4;PHACTR4
prerank,neuron projection fasciculation (GO:0106030),0.6422081122522287,1.5087084095249734,0.04436229205175601,0.6247654294221983,1.0,4/10,14.93%,ARHGAP35;NRCAM;EPHA4;EPHB2
prerank,regulation of amyloid-beta formation (GO:1902003),0.46950718345163295,1.5083989264840685,0.023411371237458192,0.6198754757013437,1.0,17/34,18.62%,RTN1;GGA3;BIN1;RELA;PRNP;CLU;LRRTM3;EFNA1;CASP3;EPHA4;ABCA2;HAP1;NTRK2;IFNGR1;ROCK1;CHRNA7;PIN1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5027378626073445,-1.5081720001613408,0.05025125628140704,0.4008839940642357,1.0,9/18,17.07%,APOE;ADAM19;LDLRAP1;PSEN1;ABCG1;TMCC2;APH1B;CLN3;ADAM17
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5016731384601716,-1.5055741082590683,0.04390243902439024,0.40527259736135574,1.0,5/18,11.81%,OS9;UGGT1;UBC;UBA52;RNF103
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5878520020594991,1.5055280843688004,0.03231292517006803,0.6265865202545504,1.0,6/14,21.62%,CARD14;COPS8;ZFP91;MAP3K7;TLR3;TIRAP
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5669397630770444,-1.5053130130606374,0.07177033492822966,0.39926982236927105,1.0,5/12,13.37%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5669397630770444,-1.5053130130606374,0.07177033492822966,0.39926982236927105,1.0,5/12,13.37%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5669397630770444,-1.5053130130606374,0.07177033492822966,0.39926982236927105,1.0,5/12,13.37%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,regulation of histone methylation (GO:0031060),0.5888480713347927,1.5047901667197605,0.059336823734729496,0.6237102655218878,1.0,6/13,18.33%,TET1;CTR9;NSD1;TTLL12;PAF1;CHTOP
prerank,potassium ion export across plasma membrane (GO:0097623),0.5973708148832909,1.5042956232834128,0.06140350877192982,0.6196155533290675,1.0,3/13,3.06%,KCNH2;KCNA5;KCNE2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.5975402296351917,-1.504179243407055,0.05069124423963134,0.39999852516075746,1.0,4/11,16.87%,NOL11;SMARCA4;IPPK;NOP53
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5865853540245209,-1.5040734793817472,0.06444444444444444,0.3981755449840556,1.0,4/11,14.11%,EP300;C1QTNF3;CRY1;SIK1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6091497342489813,-1.5027920205125653,0.060674157303370786,0.39917364261241994,1.0,4/10,17.14%,SP100;RPS6KA6;KAT5;HIPK2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.4649771178342844,-1.5018877528705434,0.04699738903394256,0.399227370836217,1.0,11/26,23.05%,CUL3;CDK5RAP2;NSMCE2;CDC27;ESPL1;RB1;DUSP1;PLK1;UBE2C;ANAPC7;CCNB1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4506269515870443,1.501703373994695,0.02403846153846154,0.6255293526860516,1.0,17/41,24.56%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2;CTSS;KCNN2;PDZK1;ANK3;GNG2
prerank,membrane repolarization (GO:0086009),0.5773225825854347,1.5016863893615242,0.04655172413793104,0.619443043947111,1.0,4/15,7.03%,KCNH2;ATP1B1;KCNE2;ATP1B3
prerank,vascular transport (GO:0010232),0.3980464218945691,1.501320238243526,0.01813110181311018,0.6152566727341511,1.0,28/81,21.84%,SLC4A8;ATP2A3;SLC2A3;SLCO2B1;ABCC3;SLC29A2;AVPR1A;KCNJ8;SLC38A2;SLC22A8;LRP2;SLC12A2;SLC1A1;SLC1A3;SLC1A4;ABCA2;SLC6A1;SLC19A1;INSR;SLC24A3;ATP8A1;SLC16A12;SLC13A3;ATP1A4;ABCG2;SLC6A9;SLC22A5;SLC38A3
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6193588880696136,1.5001882317539215,0.03684210526315789,0.6146952046454875,1.0,4/11,11.98%,UQCRC1;CYC1;UQCC3;UQCR11
prerank,negative regulation of blood pressure (GO:0045776),-0.5489074356600211,-1.4998769274752874,0.04176334106728538,0.4024149848313885,1.0,8/13,40.52%,DRD2;PRCP;DRD3;BMPR2;NOS1;NOS2;NPPA;SCPEP1
prerank,negative regulation of programmed cell death (GO:0043069),-0.28607580547202244,-1.4997090660064933,0.0,0.40070440832587545,1.0,90/355,16.18%,DAB2;ARHGAP10;BCL2;ITCH;CD74;CD38;GAS6;IGF1;AXL;BCL2L1;KLHL20;RAF1;CD44;TNFAIP8;ATAD3A;YME1L1;BRAF;KANK2;BIRC6;MCL1;MET;NUAK2;SIAH2;RAB7A;IL6ST;BCL3;PIM1;NFKB1;CIAPIN1;RASA1;BAG4;THBS1;VHL;FAS;HSPD1;RIPK1;TFRC;PRDM9;PDCD10;PLAUR;IFIT3;ANXA1;HNRNPK;UBC;CIB1;NAA16;PSEN1;RPL10;HCK;TPT1;RNF157;PIDD1;UBA52;HYPK;GCLC;SH3RF1;ANXA4;CD28;BIRC5;SPRY2;EGR3;CTNNB1;FOXO1;ATF5;BARD1;MIEN1;CDK1;MAD2L1;HDAC2;BIRC2;SMAD6;CBL;FHL2;HDAC1;KDR;CCND2;PSMD10;SCX;PTMA;GREM1;NPM1;EGFR;SHC1;PTK2B;HSPB1;WNT5A;TM7SF3;NUP62;CLN3;PLK1
prerank,negative regulation of TOR signaling (GO:0032007),0.4620746024576185,1.4994179307846565,0.024922118380062305,0.612411615371909,1.0,11/36,16.81%,TSC2;STK11;MINAR1;ITFG2;DDIT4;PDCD6;EPM2A;FLCN;SH3BP4;RNF152;MAPKAPK5
prerank,diterpenoid metabolic process (GO:0016101),0.4221676915313985,1.498583048687313,0.014992503748125937,0.6102528492834535,1.0,14/55,15.46%,AGRN;RDH10;AKR1C1;BCO2;RARRES2;LRP2;AWAT2;GPC1;AKR1B1;GPC2;GPC5;RDH5;GPC4;NAPEPLD
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.5045476403903841,-1.4969994575648333,0.03783783783783784,0.4056527020805572,1.0,7/16,11.91%,PTPN22;TNFSF8;SOX11;AHR;IL27;IKZF3;TNFRSF1B
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.45251594431877684,-1.4963312128272936,0.041884816753926704,0.40525002157632145,1.0,14/26,29.84%,APOE;ATP7A;HIF1A;IL1B;S100A1;TERF2;TNF;NUS1;POR;DHFR;CDH3;TERT;GCH1;AGTR2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5029179825252259,1.4957931374515705,0.03278688524590164,0.6169162915140011,1.0,15/28,26.62%,STMN4;STMN3;STMN2;MAP1S;CLASP2;MAPRE2;CAMSAP3;CAMSAP1;MAP2;MAPRE3;GBA2;GAS2L1;FKBP4;MAPT;MAP1B
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.37263507092715453,1.4953677019352678,0.005305039787798408,0.612910664659709,1.0,35/124,17.40%,CTTN;PLP1;STMN4;STMN3;ARMC2;CFAP126;PQBP1;BLOC1S2;ROPN1;CATIP;STMN2;SNAPIN;IL6;LGI1;RYK;MANF;SAMD14;ADCYAP1;SH3GL2;PKD2;GPRIN1;NEDD4;RASGRF1;BTG2;STX3;EHD1;CAMSAP1;MICALL1;CYFIP1;HMGB1;ERCC6;CFAP61;PPP1R9A;ROCK1;HDGFL3
prerank,prostanoid metabolic process (GO:0006692),0.5942322006347847,1.4947696833833497,0.06307977736549165,0.6100046399902118,1.0,7/13,21.82%,CYP2S1;PTGS1;AKR1C1;ACOX1;HPGD;PTGR2;HPGDS
prerank,inflammatory response (GO:0006954),-0.3014538811025524,-1.494307982367582,0.0,0.408368277086521,1.0,81/195,29.50%,FCGR2B;ADGRE5;CYBB;ITCH;NRROS;PARP4;HRH1;CD44;TLR2;PJA2;C3AR1;CIITA;SIGLEC1;TBK1;CCR2;MAPKAPK2;PTGER4;NLRC4;NFKB1;CD14;CCL25;C5AR1;THBS1;PF4;CEBPB;GPR68;ITGAL;TUSC2;SCUBE1;ANXA1;BLNK;IL1B;ADAM8;ADCY1;OLR1;CYBA;SLC11A1;CCRL2;BMP2;FOS;TNF;RELB;LIAS;TLR4;HYAL3;TRAF3IP2;LY75;PTX3;TLR1;AFAP1L2;NFATC3;PIK3CD;LTB4R;HDAC4;HPR;HP;MMP25;TLR5;MEFV;PLA2G2D;FPR3;CRH;CCL7;TAC4;CD96;NOX4;NFX1;RAC1;ADORA2A;ALOX15;IL36G;CCL24;FPR2;XCR1;IL10RB;PTGDR;LAT;PTGIR;FOLR2;TBXA2R;MFHAS1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.47764728136171,-1.4936652135857158,0.0275,0.40787088649515574,1.0,6/22,12.91%,OS9;UGGT1;UBC;UBA52;RNF103;EDEM1
prerank,regulation of AMPA receptor activity (GO:2000311),0.49756417312256274,1.4922289369314907,0.043973941368078175,0.6155434361634056,1.0,9/25,17.85%,CACNG5;CACNG2;CNIH2;MEF2C;SHANK3;CACNG7;MINK1;CACNG3;SHANK1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.43169954090542667,1.491363728487588,0.02365930599369085,0.6139007381240399,1.0,10/47,16.82%,GAPDH;SPOCK3;ANXA8;ANXA8L1;BIN1;SPOCK2;SERPINH1;VTN;SERPINE2;AGT
prerank,regulation of keratinocyte migration (GO:0051547),0.6045658863716759,1.490774341621737,0.05281090289608177,0.6110215182690967,1.0,5/12,10.49%,FGF10;FGF7;MAPRE2;MAP4K4;IQSEC1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.5232407739832359,-1.49022560524208,0.05289672544080604,0.41483178635129997,1.0,6/16,14.77%,KPNB1;DNASE2;HMGB2;H1-0;ENDOG;DFFA
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.4130809186386264,-1.4893893927320248,0.03804347826086957,0.414907940582758,1.0,21/36,26.45%,CD74;GAS6;AXL;PARP14;UBE2K;ZBP1;CD300LF;RIPK1;HIF1A;TRIM44;NLRC5;PARP9;WNT5A;ADAM17;AGPAT2;HSPA1B;CASP1;TICAM2;FADD;CSF1;TSLP
prerank,positive regulation of cytokinesis (GO:0032467),-0.42376443829499055,-1.4888896264762954,0.034482758620689655,0.41420384950076916,1.0,9/32,9.18%,SVIL;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;RACGAP1;DRD2
prerank,excitatory postsynaptic potential (GO:0060079),0.5263679370806627,1.4881639480565239,0.047787610619469026,0.6171779707919598,1.0,6/19,9.58%,MPP2;MEF2C;ARRB2;GRID2;GRIN1;GRIN2B
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.45683944464533927,1.4878545504710596,0.030560271646859084,0.6130975956587322,1.0,9/34,9.58%,MPP2;GABRG1;GABRG2;MEF2C;ARRB2;GABRA2;GRID2;GRIN1;GRIN2B
prerank,response to molecule of bacterial origin (GO:0002237),-0.35719694030990445,-1.487761853375969,0.0189873417721519,0.41488482437345425,1.0,20/69,17.07%,FCGR2B;IFNAR1;PTPN22;NOCT;HMGB2;MAPKAPK2;CD14;CD24;IL1B;C4B;ACOD1;MAPKAPK3;SMAD6;SLC11A1;PELI1;FOXP1;LBP;LIAS;TLR4;ADAM17
prerank,regulation of regulated secretory pathway (GO:1903305),0.4600925019273135,1.4849528948292001,0.03889789303079417,0.6208617424103763,1.0,9/34,11.17%,SYT4;RAB3A;SYT13;SYT1;SNAPIN;SYT6;RAB5A;RAB3D;RIMS1
prerank,neutrophil degranulation (GO:0043312),-0.2809818705221704,-1.4841844822144963,0.0,0.42191079944046256,1.0,125/425,20.25%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;KPNB1;AP2A2;ERP44;ALOX5;CD300A;RNASE3;FUCA1;CD44;VCP;GMFG;HGSNAT;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;CD36;MAGT1;ATP6V0A1;DNASE1L1;DOCK2;EEF1A1;RAB7A;GYG1;TYROBP;IDH1;NFKB1;PLEKHO2;ATG7;CD14;C5AR1;TMEM30A;AGL;PSMD11;MOSPD2;BST2;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;RAB6A;PSEN1;SLC2A5;CTSA;SNAP23;LAMP2;HPSE;ARPC5;PRCP;GDI2;RAB10;ADAM8;SNAP29;PGAM1;DOK3;IGF2R;STOM;PTGES2;GLIPR1;OLR1;TNFRSF1B;CYBA;CD53;LTA4H;TBC1D10C;PLD1;CEACAM1;SLC11A1;LAMP1;FRK;LCN2;B2M;GLA;CD55;GPI;IMPDH1;CPPED1;VCL;GCA;DNAJC13;GAA;ORMDL3;LILRB3;RAB4B;RAP1B;RAP1A;BST1;FCER1G;FTL;NRAS;PFKL;CRACR2A;GSN;RAB31;GM2A;PTX3;AGPAT2;PLAC8;MMP8;TOM1;MCEMP1;HVCN1;PSMD1;CFP;CD33;CAMP;HSPA1B;PA2G4;LTF;OSCAR
prerank,polyol metabolic process (GO:0019751),0.4450557894821576,1.483090955616742,0.025297619047619048,0.6240513445349363,1.0,13/46,12.25%,PLCH1;INPP4B;ITPK1;IP6K1;INPP5D;NUDT10;PLCD1;INPP5B;PLCG1;NUDT3;PLD4;OCRL;IPMK
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5366356612536826,-1.4828492850848995,0.05200945626477541,0.4232248093436378,1.0,5/15,12.58%,PLIN2;OSBPL8;PPARG;LPL;PNPLA2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5012739650172752,-1.482537710556036,0.05612244897959184,0.4219134862438292,1.0,10/18,30.10%,THBS1;HSPD1;CD226;CD2;LBP;WNT5A;TLR4;CEBPA;TSLP;IL33
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.36247976619743005,-1.4820686648742376,0.019867549668874173,0.4209002405622512,1.0,28/66,23.68%,IGF1;GIT1;LILRA5;CD36;TYROBP;NLRC4;NOD2;TLR8;ZC3H12A;LPL;FOXP1;AGER;TNF;HSPB1;WNT5A;TLR4;FFAR1;PYDC1;TRIM16;CD33;MYD88;CASP1;AIM2;FFAR4;ISL1;APP;MEFV;GSTP1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.49848341617953257,-1.4819939927394288,0.05868544600938967,0.4189786436566807,1.0,8/17,17.84%,RARA;IRF4;SYK;CEBPB;PRKCQ;CD28;FCER1G;GATA3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4559507103471386,1.4818809861104008,0.03379416282642089,0.623793497474584,1.0,15/37,16.53%,PTPRD;DCHS1;CADM1;TENM1;IGSF21;GRID2;NECTIN3;TENM3;IL1RAPL1;CRTAM;ICAM1;CADM3;FAT4;HMCN1;CXADR
prerank,microtubule depolymerization (GO:0007019),0.544299987896906,1.4806402718928864,0.042105263157894736,0.6241207409496161,1.0,8/17,16.39%,STMN4;STMN3;STMN2;NCKAP5;CKAP5;NCKAP5L;KIF2A;KIF14
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2801118841999703,-1.480165014874194,0.0,0.4216183970429982,1.0,126/428,20.25%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;KPNB1;AP2A2;ERP44;ALOX5;CD300A;RNASE3;FUCA1;CD44;VCP;GMFG;HGSNAT;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;CD36;MAGT1;ATP6V0A1;DNASE1L1;DOCK2;EEF1A1;RAB7A;GYG1;TYROBP;IDH1;NFKB1;PLEKHO2;ATG7;CD14;C5AR1;TMEM30A;AGL;PSMD11;MOSPD2;BST2;SYK;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;RAB6A;PSEN1;SLC2A5;CTSA;SNAP23;LAMP2;HPSE;ARPC5;PRCP;GDI2;RAB10;ADAM8;SNAP29;PGAM1;DOK3;IGF2R;STOM;PTGES2;GLIPR1;OLR1;TNFRSF1B;CYBA;CD53;LTA4H;TBC1D10C;PLD1;CEACAM1;SLC11A1;LAMP1;FRK;LCN2;B2M;GLA;CD55;GPI;IMPDH1;CPPED1;VCL;GCA;DNAJC13;GAA;ORMDL3;LILRB3;RAB4B;RAP1B;RAP1A;BST1;FCER1G;FTL;NRAS;PFKL;CRACR2A;GSN;RAB31;GM2A;PTX3;AGPAT2;PLAC8;MMP8;TOM1;MCEMP1;HVCN1;PSMD1;CFP;CD33;CAMP;HSPA1B;PA2G4;LTF;OSCAR
prerank,carbohydrate derivative transport (GO:1901264),-0.49830652835540856,-1.4798939457652363,0.059431524547803614,0.42020692843666524,1.0,13/18,27.18%,NPC2;SLC15A3;PLTP;ABCG1;SLC25A19;LBP;CLN3;MFSD2A;SLC15A4;SLC15A2;VLDLR;SLC28A1;CPTP
prerank,neutrophil mediated immunity (GO:0002446),-0.27945936969815327,-1.479247961071897,0.0,0.4198672157915898,1.0,127/432,20.25%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;KPNB1;AP2A2;ERP44;ALOX5;CD300A;RNASE3;FUCA1;CD44;VCP;GMFG;HGSNAT;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;CD36;MAGT1;ATP6V0A1;DNASE1L1;DOCK2;EEF1A1;RAB7A;GYG1;TYROBP;IDH1;NFKB1;PLEKHO2;ATG7;CD14;C5AR1;TMEM30A;AGL;PSMD11;MOSPD2;BST2;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;RAB6A;PSEN1;SLC2A5;CTSA;SNAP23;LAMP2;HPSE;ARPC5;PRCP;GDI2;RAB10;ADAM8;SNAP29;PGAM1;DOK3;IGF2R;STOM;PTGES2;GLIPR1;OLR1;TNFRSF1B;CYBA;CD53;LTA4H;TBC1D10C;PLD1;CEACAM1;SLC11A1;LAMP1;IRAK4;FRK;LCN2;B2M;GLA;CD55;GPI;IMPDH1;CPPED1;VCL;GCA;DNAJC13;GAA;ORMDL3;LILRB3;RAB4B;RAP1B;RAP1A;BST1;FCER1G;FTL;NRAS;ADAM17;PFKL;CRACR2A;GSN;RAB31;GM2A;PTX3;AGPAT2;PLAC8;MMP8;TOM1;MCEMP1;HVCN1;PSMD1;CFP;CD33;CAMP;HSPA1B;PA2G4;LTF;OSCAR
prerank,ganglion development (GO:0061548),-0.5722713593317326,-1.4786052942025063,0.06542056074766354,0.41951093623916247,1.0,3/11,10.74%,NRP1;NRP2;CTNNB1
prerank,positive regulation of chemotaxis (GO:0050921),0.44163199103285,1.4785152605613987,0.0219435736677116,0.6284799850967903,1.0,15/43,12.83%,F3;P2RY12;PRSS56;MEGF8;RARRES2;SMOC2;IL6;NTRK3;DSCAM;LGMN;PRKD2;TGFB1;FGF2;STX3;PDGFB
prerank,regulation of macroautophagy (GO:0016241),-0.3309572395481092,-1.4774695484761426,0.0036363636363636364,0.42044309191574714,1.0,34/105,16.66%,ATP6V0D1;VPS26A;ATP6V0D2;CAPN1;PAFAH1B2;ATP6V1B2;ATG13;PRKAB1;ATP6V0A1;RRAGC;PRKACA;TBK1;LAMTOR5;SH3GLB1;VPS35;ATP6V0B;EXOC4;ERN1;UBQLN1;PRKAG2;SMCR8;PIK3CA;VPS26B;LRRK2;RRAGA;EXOC8;ATP6V1A;KDR;LARP1;PRKAB2;WAC;CLN3;MAPK8;SESN2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6306350704583322,1.4772661085552243,0.06206896551724138,0.6287824115391956,1.0,5/10,10.49%,FGF10;FGF7;MAPRE2;MAP4K4;IQSEC1
prerank,neuron development (GO:0048666),0.3579294393681019,1.4765106258271492,0.0078125,0.6267103990895259,1.0,55/141,26.15%,ATP8A2;PLP1;STMN4;STMN3;PQBP1;BLOC1S2;TENM1;STMN2;SNAPIN;PBX2;IL6;LGI1;MEF2C;RYK;MANF;SAMD14;ADCYAP1;SH3GL2;GPRIN1;TENM3;NEDD4;RASGRF1;BTG2;STX3;EHD1;PBX3;CAMSAP1;HS6ST1;MICALL1;HMGB1;ERCC6;NTRK2;PPP1R9A;ROCK1;HDGFL3;XBP1;WNK1;SRF;SRRM4;EPHA5;MAP2;GPM6A;ZFYVE27;ULK1;OPHN1;GBA2;PTPRM;VAPA;RUNX1;TBCD;RAPGEF2;FLRT3;CNTNAP2;LGI4;MAPT
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5337360357254908,1.4763162873068552,0.045936395759717315,0.6225547549982803,1.0,11/17,21.35%,RTN1;GGA3;BIN1;PRNP;CLU;HAP1;NTRK2;ROCK1;CHRNA7;PIN1;ABCA7
prerank,axonemal dynein complex assembly (GO:0070286),0.4732295644816899,1.4761642446799763,0.04361370716510903,0.6181721164743053,1.0,10/28,16.66%,DNAAF1;ODAD4;CCDC39;DNAI3;CCDC65;CFAP100;SPAG1;DNAL1;DNAAF2;DNAAF3
prerank,potassium ion transmembrane transport (GO:0071805),0.36316571133572095,1.4755756310849086,0.01032258064516129,0.6154926204503506,1.0,36/135,19.85%,HCN1;KCNK12;KCNJ3;KCNH2;KCND2;KCNA5;ATP1B1;KCNE2;KCNJ8;KCNH7;KCNC1;SLC12A2;KCNK3;ATP1B3;KCNJ13;SLC9A4;PKD2;SLC12A6;KCNK6;SLC1A3;KCNN4;SLC9A5;ABCC8;HPN;KCNJ5;KCNC3;SLC24A3;KCNT2;KCNN3;KCNK9;KCNQ4;SLC24A4;KCNK2;ATP1A3;ATP1A4;ATP1A1
prerank,cGMP biosynthetic process (GO:0006182),0.6314797747056404,1.4738804740684068,0.06140350877192982,0.6182182736671943,1.0,3/10,10.32%,GUCY2F;GUCY2C;GUCY2D
prerank,mammary gland epithelium development (GO:0061180),0.5706417121232652,1.473315655913215,0.06688963210702341,0.6157934817355809,1.0,4/14,8.93%,WNT4;SCRIB;WNT3;ERBB4
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.41205853288871486,-1.4732737908873954,0.02702702702702703,0.42943921452475753,1.0,12/40,15.61%,PID1;BCL2;ARL6IP5;BCL2L1;VCP;BAX;MTLN;TUSC2;LRRK2;STOML2;PMAIP1;SLC25A33
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5688820928396575,-1.4716305143846475,0.07256235827664399,0.43158764265905436,1.0,7/11,35.19%,NFKBIZ;PRKCQ;CLEC6A;IL12RB1;MALT1;IL23R;IL12B
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.520370787195213,-1.4715751390373142,0.06443914081145585,0.42965587921129367,1.0,5/14,12.43%,TFRC;CD226;MAD2L2;PAXIP1;SHLD1
prerank,protein heterooligomerization (GO:0051291),0.5433281329169699,1.4715131767843375,0.044905008635578586,0.6190072072184357,1.0,8/17,14.28%,CPSF6;MAT2A;CBR4;PKD2;GRIN1;GRIN2B;PKD1;NUDT21
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.570081256908788,-1.471471760845882,0.06323185011709602,0.42790404591487907,1.0,5/11,20.61%,LIMD1;PUM2;AJUBA;WTIP;PUM1
prerank,defense response to protozoan (GO:0042832),-0.572629655551281,-1.4708334278093464,0.0675,0.42751350588032794,1.0,9/12,22.82%,LYST;IRF4;PF4;SLC11A1;GBP4;BATF2;MYD88;GBP6;GBP7
prerank,positive regulation of synaptic transmission (GO:0050806),0.4006572038759714,1.4699235538509499,0.02442528735632184,0.6209277182595646,1.0,26/72,18.78%,ADCY8;CACNG5;CACNG2;MPP2;SYT1;PRKCZ;NRXN1;LGI1;LGMN;GRIK2;SHANK3;CLSTN2;GRIN2B;CACNG7;ZDHHC2;RIMS1;KCTD13;BAIAP3;HAP1;EPHB2;SLC8A3;EIF2AK4;PLK2;CACNG3;CHRNA7;RIMS3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6068047456470911,1.4688560299077407,0.06837606837606838,0.62088903252065,1.0,4/11,9.35%,DDX5;IL6;BMP4;TGFB1
prerank,potassium ion homeostasis (GO:0055075),0.5026008005562678,1.4679377439744006,0.046104928457869634,0.620105709970493,1.0,9/23,19.85%,KCNMA1;KCNH2;ATP1B1;SLC12A2;ATP1B3;SLC12A6;ATP1A3;ATP1A4;ATP1A1
prerank,myoblast fusion (GO:0007520),0.5789985878368606,1.4670312281168172,0.05190311418685121,0.6193163089046356,1.0,4/12,11.81%,JAM2;CD81;ADAMTS15;ADAM12
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5879365303600137,-1.4663948034573022,0.05263157894736842,0.4367519676795146,1.0,6/10,21.39%,MTRR;MPST;CBS;GADL1;CTH;ADO
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.4248260791248875,-1.4637989378128915,0.04935064935064935,0.4414166828325158,1.0,11/31,15.81%,FCGR2B;CD274;CD300A;DLG5;SOX11;TYROBP;CEBPB;LYN;RC3H1;LILRB1;SPN
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.5953765247836712,-1.4634409439341862,0.08295964125560538,0.44033429183532213,1.0,6/10,25.04%,GAS6;AXL;LYN;LILRB1;CXCL12;BLK
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6024007874770281,1.4620006298312136,0.0528169014084507,0.6373110397920538,1.0,5/11,15.11%,KCNH2;BIN1;ACTN2;STK39;NEDD4L
prerank,defense response to fungus (GO:0050832),0.5375096238755966,1.4617143915313866,0.0706713780918728,0.6336325882736343,1.0,5/17,13.78%,GAPDH;RARRES2;CX3CR1;RNASE7;FAM3A
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3445838933831269,-1.4616735096486146,0.018726591760299626,0.44316467709806867,1.0,25/84,17.96%,ITCH;APOE;WWP1;VCP;STX5;RAB7A;SMURF2;VPS35;ADAM9;ATG7;MSN;HECW1;NRDC;SNX9;IL1B;PTTG1IP;ADAM8;FOXO1;BARD1;TNFRSF1B;TNF;WNT5A;TIPARP;DTL;RILP
prerank,primary neural tube formation (GO:0014020),0.47382013895546116,1.461366207926866,0.042488619119878605,0.6303734711080707,1.0,9/30,10.48%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3
prerank,oligodendrocyte development (GO:0014003),0.5531752942321384,1.4610593890238,0.0642361111111111,0.62712763077967,1.0,7/15,15.19%,TPPP;PLP1;CNTNAP1;SOX10;EIF2B3;MYRF;EIF2B1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5562421898406819,-1.4608874033026176,0.08009153318077804,0.4431528325800957,1.0,7/11,30.00%,PJA2;LYN;ACOD1;CYBA;TLR1;MFHAS1;TNFAIP3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.5919738908956748,-1.4608508461102552,0.08018867924528301,0.44119510781054705,1.0,6/10,24.19%,RWDD3;UBA2;MUL1;HDAC4;PIAS4;PIAS3
prerank,receptor metabolic process (GO:0043112),-0.37644028561659004,-1.460698831714333,0.021341463414634148,0.43957292180363644,1.0,21/53,17.40%,KIF16B;PIK3R4;CD36;SNX1;SH3GLB1;LMTK2;LDLRAP1;SYK;TFRC;PICALM;CAV1;UVRAG;SNX25;GRB2;DNM2;LRP1;LILRB1;RAMP2;CALCRL;FCER1G;RAB31
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.35733117378727514,-1.4606659528217296,0.026402640264026403,0.43765546716916565,1.0,29/68,22.59%,CD74;IFIH1;TLR2;LILRA5;IL16;RAB7B;TYROBP;TLR7;NOD2;HSPD1;SYK;TLR8;IL1B;LPL;CYBA;SPHK2;LBP;AGER;TNF;SCIMP;WNT5A;TLR4;MMP8;ARHGEF2;TLR1;MYD88;ISL1;TWIST1;APP
prerank,positive regulation of locomotion (GO:0040017),0.48025423080662,1.458310013327258,0.05128205128205128,0.6345974603342837,1.0,7/27,12.83%,CCDC25;P2RY12;SPOCK2;RARRES2;TGFB1;STX3;PDGFB
prerank,neurotransmitter transport (GO:0006836),0.40124902609267177,1.4579018149656677,0.020833333333333332,0.6317246243246891,1.0,17/73,14.15%,SNAP25;TSPOAP1;RAB3A;SLC29A2;SYT1;SNAPIN;SLC38A2;NRXN1;SLC1A1;GABRA2;CHAT;PPFIA4;UNC13B;SLC1A3;RIMS1;GAD2;STXBP2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.5005488132136321,-1.4576997676699146,0.06633906633906633,0.44381016402012796,1.0,9/16,21.83%,HFM1;TOP2A;RMI1;MSH4;EME1;CENPX;SLX4;FANCM;TOP2B
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.5942304007049201,-1.4563840444045661,0.08597285067873303,0.4453317928627551,1.0,4/10,15.41%,NFKBIZ;ZC3H12A;RC3H1;RC3H2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4810337444234863,-1.4561989964763062,0.06313131313131314,0.44386084297786643,1.0,10/19,28.33%,ADAM19;AFDN;MAD2L2;NOTCH1;NOTCH4;RGCC;PPM1F;SERPINF2;TJP1;PLG
prerank,synaptic vesicle exocytosis (GO:0016079),0.4372743234362793,1.455831445486943,0.04711246200607903,0.6361991029457487,1.0,10/40,11.91%,SNAP25;RAB3A;SYT1;SNAPIN;DOC2B;OTOF;UNC13B;STX3;RIMS1;CPLX2
prerank,lipoprotein localization (GO:0044872),-0.5692986692214482,-1.4547097028057474,0.09027777777777778,0.4458801856289154,1.0,5/11,13.37%,ZDHHC3;PPARG;CD36;ZDHHC17;LRP1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4652622398743734,-1.454417791183194,0.059278350515463915,0.44261637797898784,1.0,9/23,17.73%,ZEB2;DAB2;SDCBP;THBS1;SNW1;EP300;ADAM17;HIPK2;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4652622398743734,-1.454417791183194,0.059278350515463915,0.44261637797898784,1.0,9/23,17.73%,ZEB2;DAB2;SDCBP;THBS1;SNW1;EP300;ADAM17;HIPK2;SMAD4
prerank,activation of phospholipase C activity (GO:0007202),0.4680824054220123,1.454280107864201,0.032520325203252036,0.6383482669291772,1.0,8/29,7.24%,P2RY12;ANG;TXK;NMUR1;AVPR1A;CD86;PLCG1;GNA15
prerank,positive regulation of inflammatory response (GO:0050729),-0.3335766760058591,-1.4539834434609502,0.0035211267605633804,0.4418803675875007,1.0,32/86,26.45%,IL15;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;IL6ST;PTGER4;TLR7;NFKBIZ;RIPK1;IL1B;LPL;GPSM3;GPRC5B;ADAM8;LBP;TNF;WNT5A;PDE2A;TLR4;MMP8;OSMR;TNIP1;APP;PLA2G7;FEM1A;TLR9;VAMP7;CEBPA;TSLP
prerank,T cell activation involved in immune response (GO:0002286),-0.5474497120949423,-1.453425105036537,0.09498680738786279,0.44140208936990705,1.0,6/12,16.29%,CD74;ITGAL;LCP1;SLC11A1;LILRB1;FCER1G
prerank,positive regulation of cholesterol transport (GO:0032376),-0.4359208703774984,-1.4529368552865922,0.05994550408719346,0.4407314193015899,1.0,8/27,13.37%,APOE;EEPD1;PPARG;PLTP;CAV1;NR1H2;NR1H3;LRP1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3883781690493238,-1.4515143202342475,0.037383177570093455,0.4429133346805624,1.0,12/45,11.56%,CD74;GAS6;IGF1;CD300A;CDK6;CDC73;NDUFS4;S100A6;BMI1;PDGFC;CTNNB1;LIG4
prerank,eye photoreceptor cell development (GO:0042462),0.5431039710959842,1.4514774372795596,0.06701940035273368,0.6460364936901916,1.0,3/15,12.45%,NRL;THY1;RPGRIP1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.5311699030539535,-1.4509420264684643,0.054373522458628844,0.44246632146109616,1.0,9/13,32.58%,SYK;GAB2;LAMP1;SPHK2;CD177;KLRC2;FGR;ITGB2;STX4
prerank,Golgi to endosome transport (GO:0006895),-0.5058667684997826,-1.4494551443258794,0.08232445520581114,0.4442985706762658,1.0,9/16,24.59%,KIF16B;KLHL20;GBF1;EPS15;AP4M1;CORO7;DOP1B;VPS13C;AP2A1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.4161138169175389,-1.44884364957869,0.04582210242587601,0.44391384738753,1.0,8/31,10.02%,CHST11;IGF1;EXT1;XYLT1;CHST9;FAM20B;UGDH;NDST3
prerank,tube closure (GO:0060606),0.4645810554452469,1.4486034409379538,0.04633781763826607,0.653582150842439,1.0,9/31,10.48%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.34370683953164716,-1.4484447657231947,0.030821917808219176,0.4431476748085195,1.0,20/72,13.52%,ARHGEF3;APOE;NRP1;STARD8;EPS8;ABL2;RAF1;RIPOR2;CUL3;KANK2;MET;CCDC125;ARHGEF18;PDCD10;STMN1;ARHGDIB;GPR65;GPR18;ARHGEF28;MYOC
prerank,iron ion transport (GO:0006826),-0.3841443660458636,-1.4481459316718086,0.025157232704402517,0.44204555435915616,1.0,17/47,22.08%,ATP6V0D1;ATP6V0D2;STEAP3;ATP6V1B2;ATP6V0A1;ATP6V0B;LMTK2;TFRC;DNM2;CP;SLC11A1;ATP6V1A;MCOLN1;ATP6V0A4;LTF;HEPH;ATP6V1G2
prerank,sensory perception of sound (GO:0007605),0.380594380970858,1.4475936465930037,0.023676880222841225,0.6534889963158197,1.0,19/88,15.48%,LHFPL3;LHFPL4;WHRN;LHFPL5;CDH23;LRTOMT;COL2A1;PJVK;LRP2;MARVELD2;GSDME;SLC26A4;SNAI2;HOMER2;POU3F4;CACNA1D;TIMM13;EPS8L2;HPN
prerank,negative regulation of gene expression (GO:0010629),-0.28524849545105885,-1.4474031970468015,0.0,0.4419238063689356,1.0,98/302,22.94%,FCGR2B;APOE;FLOT2;PTPN22;MECP2;IGF1;EPC1;DIS3L2;CELF1;SETDB2;PARP14;NOCT;MSR1;RPS26;XDH;ZC3H12D;RBBP7;CNOT9;PPHLN1;MALSU1;FBXW7;NPTN;SOX11;PTGER4;ESR1;NFKB1;SAMD4A;ERN1;TAF1;RPS13;YY1;VHL;CRKL;PICALM;PDCD10;YAP1;SRGN;DNMT1;EIF4ENIF1;HIF1A;BMI1;PSEN1;DDX6;CAPRIN1;H3-3A;SMCR8;HINFP;ZC3H12A;CD28;NOTCH1;ZNF148;DAPK1;SLC11A1;PARP9;AGO2;HDAC1;LSM2;KDR;PAIP2B;SYNCRIP;TYMS;RB1;LARP1;RACK1;LSM5;BMP2;CREB3L1;FOXP1;TERF2;TRIM71;TNF;FXR2;TIPARP;RGCC;HEY2;IGFBP5;MMP8;PHF19;MYADM;RNH1;EED;HSPA1B;NCOR1;NOTCH2;KLF4;PTBP3;DHFR;NDFIP1;CPEB3;FFAR4;ID2;ANXA7;CD3E;APLNR;KAT2B;APP;ILF3;TASOR
prerank,regulation of interleukin-10 production (GO:0032653),-0.38001789803084923,-1.4472930078661097,0.023255813953488372,0.4403526828799469,1.0,10/44,6.17%,FCGR2B;CD274;CD47;PIBF1;LILRA5;TYROBP;IRF4;NOD2;HSPD1;SYK
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.42772073200175453,-1.4471407337619842,0.040697674418604654,0.43885207594975406,1.0,9/29,10.76%,IL15;IFNAR1;STAT5B;STAT4;CCR2;IFNAR2;STAT2;STAT1;GHR
prerank,regulation of anoikis (GO:2000209),-0.47980125124937545,-1.4468100666328039,0.059431524547803614,0.4378605704915046,1.0,7/19,14.11%,BCL2;MCL1;CAV1;PIK3CA;NOTCH1;BRMS1;SIK1
prerank,early endosome to late endosome transport (GO:0045022),-0.46478932387396354,-1.4465351374582265,0.053164556962025315,0.43668408441352236,1.0,10/20,13.63%,PIK3C3;KIF16B;PTPN23;RAB7A;LMTK2;WDR91;AKTIP;WDR81;EMP2;EEA1
prerank,regulation of synapse maturation (GO:0090128),0.6092623467361941,1.4464148691570375,0.06505576208178439,0.654063612270934,1.0,6/10,22.93%,NEUROD2;NRXN1;DAB2IP;ANAPC2;ADGRL1;CAMK2B
prerank,positive regulation of protein polymerization (GO:0032273),0.3975665759674531,1.446177453975298,0.03757225433526012,0.6505279372803916,1.0,12/65,7.35%,TPPP;CTTN;BIN1;PAK1;LMOD1;PSRC1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;NAV3;FCHSD2
prerank,mammary gland development (GO:0030879),0.5039308899463003,1.4459833589048048,0.05564924114671164,0.6469541178287697,1.0,5/21,12.58%,WNT4;PRLR;WNT3;ERBB4;ARHGAP35
prerank,regulation of ion transmembrane transport (GO:0034765),0.446756372348631,1.4453158531541288,0.05745341614906832,0.6454684963339452,1.0,9/33,15.91%,YWHAE;KCNJ3;KCNH2;KCNE2;KCNJ8;KCNJ13;NEDD4;NEDD4L;KCNJ5
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3864541000952356,-1.445081254930489,0.041884816753926704,0.438556802654145,1.0,12/44,15.23%,APOE;PTPN22;CD300A;STK38;PTPN1;LYN;IL1B;SPRY2;SPRY1;INPP5K;DUSP1;SPRY4
prerank,synaptic vesicle cycle (GO:0099504),0.47199221780433526,1.4436423346570906,0.04732824427480916,0.648552130750256,1.0,8/30,15.54%,SNAP25;RAB3A;SNAPIN;OTOF;RAB5A;RIMS1;CPLX2;WNT7A
prerank,myofibril assembly (GO:0030239),0.43105464114025843,1.4434422908447873,0.040123456790123455,0.6449683091428411,1.0,8/42,12.95%,CAPN3;OBSL1;LMOD1;SIX4;MYPN;TMOD2;ACTN2;LMOD3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.5298796533011892,-1.4421329552168822,0.07785888077858881,0.44268823516203637,1.0,4/13,14.97%,IL15;STAT5B;GRB2;SHC1
prerank,cellular response to interleukin-15 (GO:0071350),-0.5298796533011892,-1.4421329552168822,0.07785888077858881,0.44268823516203637,1.0,4/13,14.97%,IL15;STAT5B;GRB2;SHC1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.5679561115857121,-1.4420957062407533,0.08684863523573201,0.44100810987709765,1.0,2/10,8.06%,DNMT1;BRCA1
prerank,myelination (GO:0042552),0.4247149128290564,1.4409859111028944,0.0315955766192733,0.6512490628369917,1.0,20/46,22.68%,TPPP;PLP1;CNTNAP1;MPZ;SOX10;GPC1;NFASC;CMTM8;CXCR4;MYRF;GAL3ST1;SCN2A;MAL2;SLC8A3;ACSBG1;MBP;ABCD2;MAL;EIF2B5;SCN8A
prerank,regulation of mast cell degranulation (GO:0043304),-0.5072016369216157,-1.4409127054837751,0.07710280373831775,0.4421422178964256,1.0,5/14,14.05%,CD300A;SYK;LYN;GAB2;SPHK2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.45084517396285184,1.4405115500004257,0.0423861852433281,0.6490182871383828,1.0,20/37,26.97%,TPPP;STMN4;STMN3;MAP6;STMN2;CLASP2;MAPRE2;CAMSAP3;BICD2;PHLDB2;ROCK1;TAOK1;BICD1;CYLD;CDK2AP2;MAPRE3;GAS2L1;MAPT;PRKAA2;EPHA3
prerank,regulation of interleukin-1 production (GO:0032652),-0.5175301467884955,-1.440441095938522,0.07633587786259542,0.44154261128194006,1.0,6/15,16.40%,GAS6;ANXA1;TMED10;CEACAM1;FOXP1;TLR4
prerank,transport across blood-brain barrier (GO:0150104),0.3798364705896202,1.4400918969131462,0.03212290502793296,0.6464414930002232,1.0,28/83,21.84%,SLC4A8;ATP2A3;SLC2A3;SLCO2B1;ABCC3;SLC29A2;AVPR1A;KCNJ8;SLC38A2;SLC22A8;LRP2;SLC12A2;SLC1A1;SLC1A3;SLC1A4;ABCA2;SLC6A1;SLC19A1;INSR;SLC24A3;ATP8A1;SLC16A12;SLC13A3;ATP1A4;ABCG2;SLC6A9;SLC22A5;SLC38A3
prerank,regulation of glucose metabolic process (GO:0010906),0.44909284415366196,1.4397330238217123,0.04692556634304207,0.6439141496445202,1.0,13/34,24.41%,SELENOS;GNB3;SLC45A3;DGKQ;OGT;PRKN;IRS1;KHK;RORA;RUBCNL;PDK1;GPLD1;USP7
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4916462500173318,1.4397174559364059,0.06581059390048154,0.6397827803872703,1.0,5/22,4.86%,CACNB4;CBARP;NOS1AP;CACNB2;DMD
prerank,response to fatty acid (GO:0070542),-0.4845532491993684,-1.439621365597843,0.08816120906801007,0.4416381783047893,1.0,7/17,22.70%,PID1;CD36;LPL;FOXO1;FFAR1;NR1H4;GLDC
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5892021029559004,1.4392459871587922,0.0831858407079646,0.6376792887256212,1.0,4/11,10.97%,PRDX5;PRDX2;PXDN;PRDX4
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3541485092773281,-1.4385288879548472,0.02564102564102564,0.44261301940102943,1.0,19/64,15.95%,PEAK1;SLK;PLAU;CDK6;CD36;CORO1C;RASA1;CCL25;UTRN;THBS1;CIB1;SKAP1;EMP2;MYOC;VCL;AJAP1;PTK2B;CCL28;BST1
prerank,receptor catabolic process (GO:0032801),-0.44180299153734004,-1.4374381292426828,0.06132075471698113,0.4440456766295529,1.0,9/24,11.18%,AP2A2;KIF16B;PIK3R4;SH3GLB1;AP2B1;ZNRF3;UVRAG;SNX25;CLTA
prerank,cellular response to alcohol (GO:0097306),-0.38934315824687465,-1.4371155408749692,0.028409090909090908,0.4431043043967782,1.0,19/42,21.48%,PTGER4;CTNNA1;AHR;BRCA1;ADCY5;ADCY6;KLF9;CTNNB1;ADCY1;ADCY3;LARP1;GRAMD1C;SPHK2;GRAMD1B;MAP4K1;LRP6;CDH1;MLC1;PTCH1
prerank,regulation of mitochondrial translation (GO:0070129),-0.4602519676325187,-1.4369612848923772,0.07506053268765134,0.441605241035339,1.0,13/21,30.75%,RCC1L;MALSU1;TRUB2;TRMT10C;MTG2;UQCC2;MTG1;MRPS27;RPUSD3;TSFM;C1QBP;SHMT2;MPV17L2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.46716877150785197,-1.4356448853413661,0.05811138014527845,0.4433983371344439,1.0,5/20,5.95%,BCL2;BCL2L1;MCL1;BAX;FAS
prerank,body fluid secretion (GO:0007589),0.5419634698214353,1.4352875466513695,0.06796116504854369,0.6504157192473952,1.0,6/15,22.66%,PRLR;ERBB4;SLC22A4;ZBTB7B;GUCA1B;NPR1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5095589383690495,-1.4348862505398814,0.08490566037735849,0.4435112607542026,1.0,5/15,11.37%,RPL5;DTX3L;RPS7;MAD2L2;MAD2L1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5834727775760382,-1.4344449782593787,0.0784313725490196,0.4430271861424233,1.0,5/10,13.83%,NBR1;FAS;LYN;RNF13;GREM1
prerank,mitochondrial transport (GO:0006839),0.4058855537159872,1.4339635111972648,0.03458646616541353,0.6520476854166612,1.0,27/53,26.74%,SLC25A4;STARD3;FIS1;TMEM14C;FBXO7;TMEM14A;FLVCR1;SLC25A31;BAK1;TOMM34;SLC25A5;PITRM1;TIMM13;TSPO;TIMM22;TOMM70;OXA1L;MFF;BCS1L;MTX2;TIMM23;COX18;TIMM44;TOMM22;TIMM10;SLC25A16;TIMM10B
prerank,macroautophagy (GO:0016236),-0.32039739536507805,-1.433310980844894,0.011494252873563218,0.4442479829773649,1.0,31/118,17.72%,VIPAS39;VPS37C;PIK3C3;CHMP4B;CHMP4A;MAP1LC3B;NBR1;VCP;PIK3R4;ATG13;PRKAB1;LIX1;MTMR14;TOMM7;ATG7;UBQLN1;EPG5;PRKAG2;UVRAG;LAMP2;SNAP29;TOMM20;ATG3;STAM;PRKAB2;MTMR3;AMBRA1;CLN3;SQSTM1;MAP1LC3A;PGAM5
prerank,glial cell differentiation (GO:0010001),0.46616591165724613,1.4328687232782586,0.056818181818181816,0.6527457977077957,1.0,6/28,5.19%,TPPP;FGF10;NFIB;SOX10;SOX4;GPC1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.2996797166925296,-1.4310234073932848,0.010256410256410256,0.44865627999689656,1.0,48/182,15.56%,APOBEC1;APOE;FLOT2;PTPN22;MECP2;IGF1;CELF1;SETDB2;PARP14;NOCT;MSR1;SDCBP;XDH;FBXW7;MTMR2;SOX11;ESR1;NFKB1;ANKRD13A;TAF1;YY1;VHL;CRKL;PICALM;PDCD10;LDLR;YAP1;DNMT1;HIF1A;PSEN1;SMCR8;HINFP;ZC3H12A;CD28;NOTCH1;ZNF148;PARP9;AGO2;HDAC1;KDR;RB1;RACK1;BMP2;CREB3L1;FOXP1;TERF2;TNF;OPTN
prerank,Golgi inheritance (GO:0048313),-0.5633554341924873,-1.4308562475718407,0.07317073170731707,0.44737230240132153,1.0,5/11,11.27%,VCPIP1;STX5;GBF1;PDCD10;CDK1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3412113232622123,-1.4307684456128573,0.016233766233766232,0.44582334940385115,1.0,20/72,16.07%,CD74;GAS6;AXL;PTPRC;LIFR;ZBP1;PTPN1;IFNAR2;USP18;SYK;RIPK1;CD24;STAT1;HIPK1;TRIM44;BIRC2;RACK1;TNF;OTULIN;TRAF1
prerank,retinoid metabolic process (GO:0001523),0.38799330533856663,1.4306664668661557,0.024853801169590642,0.6578119784443931,1.0,12/71,8.57%,AGRN;CYP2S1;RDH10;AKR1C1;BCO2;RARRES2;LRP2;AWAT2;GPC1;AKR1B1;GPC2;GPC5
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.5094691543482133,1.4301752710313729,0.06587837837837837,0.6559584671185446,1.0,6/19,10.17%,FBXW8;OBSL1;PTPRD;CDKL5;IL1RAPL1;SS18L1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3849259889036659,1.4288291781225988,0.0345821325648415,0.658017114724009,1.0,24/75,19.85%,KCNJ3;KCNH2;ATP1B1;KCNE2;SLC39A4;KCNJ8;SLC12A2;TRPM2;ATP1B3;KCNJ13;SLC9A4;SLC12A6;SLC8A1;SLC39A8;SLC9A5;SLC6A1;SLC8A3;CACNA2D1;KCNJ5;KCNK9;TRPV6;ATP1A3;ATP1A4;ATP1A1
prerank,anterior/posterior pattern specification (GO:0009952),0.40916712455985627,1.4286965284072177,0.03918722786647315,0.6546149593364644,1.0,9/53,9.05%,HOXA5;HHEX;HOXD4;CYP26C1;HOXB9;HOXC6;HOXB7;TGFBR1;HEY1
prerank,regulation of pseudopodium assembly (GO:0031272),0.6044633972847024,1.4286314951173396,0.08274647887323944,0.6468583075807046,1.0,4/10,20.78%,CDC42EP5;CDC42EP4;CDC42EP1;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6044633972847024,1.4286314951173396,0.08274647887323944,0.6468583075807046,1.0,4/10,20.78%,CDC42EP5;CDC42EP4;CDC42EP1;CDC42
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.41736582451241117,-1.4279916290610277,0.06497175141242938,0.45122257134006893,1.0,6/33,5.53%,SP100;APOE;PTPN23;MCC;CORO1C;THBS1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5568346249648626,-1.4273352687544096,0.0798004987531172,0.4510715189859363,1.0,5/11,16.17%,LDLR;NR1H2;CTDNEP1;NR1H3;MFSD2A
prerank,filopodium assembly (GO:0046847),-0.48669658729998944,-1.4273223925694902,0.07058823529411765,0.4493746335354509,1.0,5/16,7.77%,FGD4;FGD6;S1PR2;SPEF1;FGD1
prerank,regulation of interferon-gamma production (GO:0032649),-0.34843055828135466,-1.4270485889688802,0.019543973941368076,0.4483206723921697,1.0,23/71,16.79%,GAS6;PTPN22;CD274;AXL;CD47;IL12RB2;RARA;CCR2;TLR7;CEBPG;CD14;IL27;HSPD1;TLR8;IL1B;CD226;ZC3H12A;CD2;SLC11A1;EBI3;LILRB1;TLR4;IL18R1
prerank,neuron projection extension (GO:1990138),-0.4081509514825006,-1.4269114700608885,0.0425531914893617,0.4469583450465788,1.0,8/32,12.37%,IQGAP1;ALCAM;NRP1;NRP2;CDKL3;USP9X;CTNNB1;SEMA5B
prerank,diacylglycerol metabolic process (GO:0046339),0.48316190385521934,1.426702385617463,0.06115702479338843,0.6512083204302894,1.0,11/23,21.81%,DGKI;ANG;DGAT2;DGKQ;DGKZ;DGKE;DAGLA;PGS1;PLA2G15;DGKH;LIPE
prerank,positive regulation of cell cycle process (GO:0090068),-0.3323841299088972,-1.4263262620171442,0.03557312252964427,0.4468774030323151,1.0,35/91,23.83%,SVIL;IGF1;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;IL1B;RACGAP1;DRD2;NUSAP1;CD28;RHNO1;MAD2L1;IGF2;RAD21;E2F8;NUMA1;UBXN2B;NUP62;E2F7;NDC80;RGCC;ECT2;CEP295;DRD3;MAP10;SIRT2;MAP3K20;TGFA;CDC14A;CCNB1;PLSCR1;EGF
prerank,negative regulation of viral process (GO:0048525),-0.35983562516308265,-1.4261173358876025,0.043333333333333335,0.44575729069698405,1.0,34/57,33.16%,OAS2;IFIH1;TRIM14;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;TRIM62;STAT1;BANF1;TRIM5;OAS3;TNF;ZC3HAV1;PTX3;LTF;TRIM21;TNIP1;IFITM1;ILF3;EIF2AK2;PLSCR1;TRIM13;LARP7;ISG20;BTBD17;SLPI;SRPK1;TRIM11;TRIM32;ISG15;PPIA
prerank,dendritic spine organization (GO:0097061),0.47054110432965485,1.4261059714933426,0.07120253164556962,0.6499109498310488,1.0,16/26,28.40%,PRNP;LGMN;SHANK3;CTNND2;DOCK10;INSR;EPHB2;WNT7A;SHANK1;CHRNA7;CDC42;ARF1;WASL;DLG4;DIP2A;PTEN
prerank,regulation of viral life cycle (GO:1903900),-0.45152897541114434,-1.4256619589676864,0.06830601092896176,0.4452404575919142,1.0,5/21,6.61%,AXL;TRIM25;TRIM14;KPNA2;TRIM62
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.3374642813331935,-1.424221196631847,0.015723270440251572,0.4474403080764651,1.0,26/80,17.86%,STX6;RIC1;VPS26A;SNX8;STX5;TMEM87B;RAB7A;RAB7B;SNX1;VPS35;GBF1;CLN5;RAB6A;TMED9;DENND2A;VPS26B;TBC1D10C;TBC1D10A;DENND5A;VPS54;YKT6;RBSN;RGP1;VPS52;GCC2;ERC1
prerank,positive regulation of synapse assembly (GO:0051965),0.4752127277364172,1.423973119155493,0.058823529411764705,0.6550964280453914,1.0,10/27,15.54%,AGRN;PTPRD;SRPX2;IL1RAP;NRXN1;GRID2;CLSTN2;IL1RAPL1;EPHB2;WNT7A
prerank,regulation of protein localization (GO:0032880),-0.3600305965854861,-1.4239427416991552,0.026143790849673203,0.4464171607104925,1.0,20/58,20.87%,STX6;TRIM25;TRIM14;DVL3;AFDN;FBXW7;BORA;TRIM17;PICALM;USP8;TMEM231;WDPCP;TRIM5;RACK1;DNAJB6;MAPK8;PPM1F;ITGB3;ZDHHC7;TRIM21
prerank,cellular response to cytokine stimulus (GO:0071345),-0.26751853393099,-1.4231342818681965,0.0,0.44654764152102655,1.0,105/416,16.94%,F13A1;PID1;BCL2;IFNAR1;GAS6;POU2F1;ITGAX;AXL;BCL2L1;ALOX5;ABL2;CSK;CRK;PTPN23;RIPOR2;CD47;STAT5B;LIFR;TEC;TLR2;STAT4;UBE2K;CD36;IL12RB2;MCL1;PRKACA;TBK1;CCR2;IL16;IFNAR2;STAT2;IL6ST;JUNB;IFIT1;PIM1;GRAP2;NFKB1;CCL25;IRF4;BAG4;PF4;SMAD3;LDLRAP1;CRKL;SYK;RIPK1;CDC34;CCND1;FYN;RO60;ANXA1;GBP3;UBC;CIB1;GAB2;HIF1A;BRCA1;IL1B;HCK;PTPN7;SOCS5;PIK3CA;UBA52;ZC3H12A;VIM;STAT1;BIRC5;PTGIS;LCK;RC3H1;GRB2;GHR;FOXO1;ACOD1;TNFRSF1B;DAPK1;CBL;IRAK4;TCF7;SHPK;ASAH2;SYNCRIP;LCN2;GBP4;INPP5K;HAS2;FOS;DUSP1;IFNLR1;LBP;EBI3;SHC1;TNF;BCL2L11;WNT5A;RBMX;PDE2A;IL27RA;SDC1;TLR4;HMOX1;MAPK8;CRNN;IL18R1;HYAL3
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.45299502358122506,-1.4225735917730564,0.06930693069306931,0.4462780392043651,1.0,11/23,23.68%,GAS6;IGF1;GIT1;ZC3H12A;CEACAM1;FFAR1;PYDC1;CD33;FFAR4;MEFV;GSTP1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.37622674695366765,1.4224562498768214,0.02937062937062937,0.65763048550123,1.0,18/85,14.35%,LHFPL3;LHFPL4;WHRN;LHFPL5;CDH23;LRTOMT;COL2A1;PJVK;LRP2;MARVELD2;GSDME;SLC26A4;SNAI2;HOMER2;POU3F4;CACNA1D;TIMM13;EPS8L2
prerank,energy reserve metabolic process (GO:0006112),-0.47858514778417,-1.4217682662577262,0.07088607594936709,0.44668994454025485,1.0,4/19,11.71%,PID1;PHKB;PRKAG2;PPP1R3C
prerank,negative regulation of endocytosis (GO:0045806),-0.44815300630365534,-1.421415678196241,0.05291005291005291,0.44586514074581013,1.0,9/24,14.97%,MCTP1;CD300A;MTMR2;PICALM;CAV1;NR1H2;APOC1;NR1H3;LILRB1
prerank,neuron projection morphogenesis (GO:0048812),0.3511263513259821,1.4211416853103171,0.023591087811271297,0.6591545095204417,1.0,67/137,28.40%,CTTN;MAP6;CNTNAP1;SRGAP2;DCC;NYAP2;RAB3A;CTNNA2;PAK1;PARD6B;NCKAP1;NCKAP1L;ATL1;LRP2;MAP1S;RYK;RAB8A;DAB2IP;SHANK3;APBB1;MAP4K4;KLF7;CTNND2;BTBD3;MINK1;DOCK10;SLITRK4;ANKRD27;NRCAM;EPHB2;DSCAML1;EIF2AK4;WNT7A;PLPPR4;ROCK1;TAOK1;NTNG2;NTNG1;ALS2;SHANK1;ACTB;PLXNB1;SDC2;CDC42;MAP2;GPM6A;FARP1;IMPACT;WASL;CCK;MEF2A;BDNF;ANK3;TAOK2;DCLK1;FLRT3;CNTNAP2;MYO16;LLGL1;DLG4;MAP1B;DIP2A;BRSK2;EPB41L3;SLITRK1;CELSR2;PTEN
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.5557142353512434,-1.4211331748059108,0.10739856801909307,0.4448165362741419,1.0,5/11,36.40%,RTP4;PKD1L3;LPO;RTP2;TAS1R3
prerank,sodium ion export across plasma membrane (GO:0036376),0.5699436873832235,1.4210850433570608,0.05518394648829431,0.6555291631303135,1.0,7/13,28.03%,ATP1B1;ATP1B3;ATP1A3;ATP1A4;ATP1A1;SLC9A1;ATP1B2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5157171057489377,1.4204959060059037,0.0851063829787234,0.6542676997549431,1.0,7/17,24.33%,KCNH2;KCNE2;KCNJ8;NEDD4L;ANK2;SCN3B;SNTA1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.522907797536581,1.4202595389168622,0.07560137457044673,0.6514687337457014,1.0,8/17,22.35%,CACNB2;CACNA1G;SLC8A1;CACNA1D;CACNA2D1;ANK2;SCN1B;SCN3B
prerank,cAMP metabolic process (GO:0046058),-0.5316580841114832,-1.4200916476404788,0.08037825059101655,0.44572212284242285,1.0,8/13,17.38%,ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;ADCY10;EPHA2;PTHLH
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.4601355605132643,-1.419895352334103,0.08395061728395062,0.4446072608646586,1.0,12/21,29.66%,RPL5;RAB1A;CDC14B;RPS7;MAD2L2;MAD2L1;PLK1;UBE2C;RPL11;GORASP1;CDC20;RPL23
prerank,regulation of cholesterol efflux (GO:0010874),-0.4172741871605612,-1.4196777184901677,0.053475935828877004,0.44353013127952035,1.0,9/30,13.37%,APOE;EEPD1;PPARG;PLTP;CAV1;NAXE;NR1H2;NR1H3;LRP1
prerank,negative regulation of insulin secretion (GO:0046676),0.5252641776126488,1.4186108477138155,0.08094435075885328,0.654522633358892,1.0,9/17,27.13%,ADRA2A;PRKN;KLF7;IRS1;SFRP1;REST;MIDN;CHGA;KCNB1
prerank,negative regulation of catalytic activity (GO:0043086),-0.4402952378034785,-1.4185963601460223,0.05555555555555555,0.4447998869828389,1.0,16/24,34.50%,IFIT1;PPP1R12A;NOSIP;NOTCH1;PHPT1;PARP9;CLN3;NES;TIMP1;HP;APBA3;TMBIM1;CAND1;NOS1;HDAC6;GZMA
prerank,innate immune response (GO:0045087),-0.28804553893903806,-1.4182868728605589,0.0,0.443945709508204,1.0,65/217,20.87%,SP100;CYBB;CD74;NRROS;ANKRD17;RNASE3;ALPK1;TRIM25;RPL39;ATAD3A;IFIH1;TLR2;PJA2;TRIM14;PPARG;CIITA;IRF7;TBK1;IFITM3;TYROBP;CXCL16;IFIT1;TRIM17;SHFL;BST2;NOD2;SYK;TRIM62;LYN;FYN;TLR8;CLEC6A;HCK;LCK;CYBA;SLC11A1;IRAK4;NLRC5;FRK;KLRD1;TRIM5;LCN2;B2M;IFNLR1;LBP;AGER;PTK2B;OTULIN;RELB;FCER1G;TLR4;ANKHD1;PYDC1;ZAP70;MSRB1;PTX3;CLEC4E;CFP;CAMP;MYD88;CD300E;LTF;SETD2;PIK3CD;TRIM21
prerank,kinetochore organization (GO:0051383),-0.5284463214205523,-1.417974966237735,0.08,0.4431465465459873,1.0,6/13,17.04%,MIS12;CENPA;CDT1;CENPW;NDC80;NUF2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.49817749161371233,1.4169513808239758,0.08387096774193549,0.6576140734207027,1.0,5/20,7.31%,PPIC;PPIB;PPWD1;PPIL1;PPIG
prerank,retinal metabolic process (GO:0042574),0.5693373097480953,1.4167969781439926,0.07560137457044673,0.6544774717598597,1.0,3/12,4.32%,RDH10;AKR1C1;BCO2
prerank,inositol lipid-mediated signaling (GO:0048017),0.40684426608702684,1.4165479866963824,0.04899135446685879,0.6518222981847573,1.0,12/50,11.47%,PLCH1;PIK3C2G;PLCL1;ADAP2;NTRK1;PLCD1;PIK3CG;RPS6KB1;TNFAIP8L3;OGT;INPP5F;IRS1
prerank,negative regulation of anoikis (GO:2000811),-0.5128851955109412,-1.416140670923816,0.07804878048780488,0.4461578711856578,1.0,5/14,10.93%,BCL2;MCL1;CAV1;PIK3CA;NOTCH1
prerank,positive regulation of response to external stimulus (GO:0032103),-0.307882350222806,-1.4155532114603973,0.008298755186721992,0.4460118595880499,1.0,46/128,25.11%,SASH1;IL15;DDX60;ANKRD17;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;PTGER4;TLR7;NFKBIZ;PUM2;OASL;THBS1;RIPK1;TLR8;IL1B;LPL;GPSM3;GPRC5B;ADAM8;ACOD1;CYBA;PTN;TNF;SCIMP;WNT5A;OPTN;PDE2A;TLR4;POLR3G;PPM1F;USP15;PUM1;SLC15A4;TNIP1;APOH;SERPINF2;APP;PLA2G7;PLSCR1;FEM1A;TLR9;DHX58
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4258970616837371,-1.4149353367829935,0.05526315789473684,0.4459394404167483,1.0,14/26,24.91%,PTPN22;TLR2;PJA2;CAV1;CYBA;NR1H3;LBP;TLR1;LTF;SLC15A4;TLR5;TICAM2;TREML4;TLR9
prerank,positive regulation of B cell proliferation (GO:0030890),-0.4124827941172734,-1.4146241073012877,0.05929919137466307,0.4450770475934671,1.0,7/29,6.20%,VAV3;BCL2;CD74;CD38;PTPRC;GPR183;TFRC
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.37573931808989397,1.4145667135554731,0.03248587570621469,0.6563308414823819,1.0,37/75,28.99%,MAP6;DCC;RAB3A;CTNNA2;PARD6B;ATL1;MEF2C;MAP1S;RYK;RAB8A;APBB1;KLF7;BTBD3;MINK1;SLITRK4;NRCAM;DSCAML1;WNT7A;PLPPR4;NTNG2;NTNG1;ACTB;SDC2;MAP2;FARP1;OPHN1;CCK;MEF2A;ANK3;TBCD;TAOK2;LLGL1;MAP1B;BRSK2;SLITRK1;CELSR2;DCDC2
prerank,primary alcohol metabolic process (GO:0034308),-0.4334104152666418,-1.414544458496401,0.0681265206812652,0.4436683759126833,1.0,11/25,24.41%,IGF1;GPD2;RDH11;GDPD3;GDE1;CYP1A1;ALDH3A2;DHRS9;DHRS3;CYP1B1;RDH12
prerank,neuron differentiation (GO:0030182),0.33948657054336867,1.414051867677561,0.005221932114882507,0.6548610893092229,1.0,49/165,26.23%,ATP8A2;WNT4;LDB1;PTPRD;NEUROG2;ATOH7;NEUROD2;TENM1;SOX4;PBX2;WNT3;MEF2C;ITM2C;RYK;TGFBR1;MANF;NRBP2;LHX3;TENM3;WNT8B;IL1RAPL1;DDIT4;CASP3;PBX3;HS6ST1;LHX5;LMX1B;ERCC6;NTRK2;WNT7A;LHX2;EN2;XBP1;PIN1;WNK1;SRF;IRX5;EPHA5;LHX4;OPHN1;ACSL3;ERCC2;NIF3L1;RUNX1;RNF112;VXN;WNT5B;FZD5;PHOX2A
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3940297203028831,-1.4140079541240995,0.051630434782608696,0.4432794796251867,1.0,14/33,23.83%,HIP1;CNOT9;FBXW7;HIP1R;BCAR3;ARAP1;PLAUR;CBL;NUP62;ADAM17;PDE6H;AFAP1L2;TGFA;EGF
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5278676508964407,-1.4133170221723355,0.08958837772397095,0.44348948707114355,1.0,7/13,18.13%,CD74;GAS6;AXL;IFIH1;TRIM44;WNT5A;AGPAT2
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.36941625796322225,-1.4130668153496044,0.04216867469879518,0.44254308727157254,1.0,19/49,19.86%,CD74;TLR2;RAB1A;LAMTOR5;TLR7;CD14;NOD2;SYK;RIPK1;TLR8;IL1B;CD2;LBP;TNF;TLR4;TLR1;AFAP1L2;MYD88;HSPA1B
prerank,metanephros development (GO:0001656),0.4709006757401199,1.4130126378014463,0.06774193548387097,0.6551689867887751,1.0,6/26,12.51%,FGF10;SIX4;FOXD1;BMP4;PKD2;PKD1
prerank,aminoglycan biosynthetic process (GO:0006023),0.4064275560439716,1.4122877275847783,0.046583850931677016,0.6545889951678696,1.0,13/49,13.22%,AGRN;B3GNT9;HS3ST6;HS3ST5;B3GNT6;B4GAT1;B3GALT2;GPC1;GPC2;GPC5;B3GALNT1;HS6ST1;GPC4
prerank,regulation of immune response (GO:0050776),-0.30432239430675034,-1.4116873149036524,0.0041841004184100415,0.4444450709460434,1.0,53/135,25.11%,ITGA4;FCGR2B;IL15;PTPN22;CD300A;CSK;ULBP1;DENND1B;IRF7;SLAMF7;CD300LF;TYROBP;AHR;IRF4;SYK;ITGB7;LYN;ITGAL;PDCD1;CD226;ERAP1;HCST;JAML;RAET1E;BIRC2;KLRD1;B2M;FOXP1;LILRB1;SPN;GPR108;CLEC2D;TREML2;CD247;COL3A1;CD33;PILRA;APPL2;CD300E;OSCAR;CD300LG;IFITM1;CD3E;KLRK1;TREML4;PLSCR1;XIAP;BCL6;CD96;FCRLB;CD300C;APPL1;DHX58
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.391710721680516,-1.4116722873640266,0.060941828254847646,0.44293551850819995,1.0,22/36,31.50%,APOE;CAV1;HIF1A;IL1B;NOSIP;DNM2;S100A1;GLA;TERF2;EGFR;TNF;NUS1;DHFR;NOSTRIN;TERT;CYGB;HSP90AA1;ZDHHC21;GCH1;AGTR2;CALM1;DDAH1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5215728246647617,1.4112135712944527,0.08983050847457627,0.6554813400651855,1.0,4/18,4.81%,PAG1;ADTRP;IL4I1;PPARA
prerank,regulation of cell aging (GO:0090342),0.5865910338104785,1.4106526764124776,0.08199643493761141,0.6540444103591951,1.0,4/11,21.73%,VASH1;NEK4;NUAK1;ING2
prerank,cellular response to zinc ion (GO:0071294),0.5294972671657603,1.410492751713305,0.0847457627118644,0.6510782779676122,1.0,10/15,18.07%,GLRA2;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.34300020742402865,-1.4102841119619556,0.032467532467532464,0.4449076982193681,1.0,20/67,16.70%,VAV3;CYBB;NRP1;NRP2;PXN;AXL;CRK;MAPKAPK2;NCK1;FLT1;FYN;PIK3CA;MAPKAPK3;CYBA;KDR;PTK2B;HSPB1;ELMO2;BCAR1;AAMP
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5072826543833804,1.4102099201396603,0.0829103214890017,0.6486481377094083,1.0,7/19,15.26%,POLD3;ADA;PNP;AMPD3;HPRT1;DCK;GMPR
prerank,regulation of receptor binding (GO:1900120),0.6028000989761481,1.4100963404798532,0.08103130755064457,0.6455680659253609,1.0,4/10,12.50%,ATP2A3;ATP2A2;ADAM15;GREM2
prerank,nervous system development (GO:0007399),0.3088039179257094,1.409353290353319,0.0022346368715083797,0.6451907652272215,1.0,98/429,15.60%,NAV2;ROGDI;STMN3;PCDHB9;FUT10;PCDHB4;GDF11;LSAMP;MERTK;OBSL1;ECRG4;LDB2;LDB1;FGF12;WWTR1;FGF11;DCHS1;ACAN;MPZ;CNTFR;NEUROD2;SOX10;CYP26C1;TENM1;MAB21L2;NCKAP1;PCDHB5;CRMP1;SPOCK2;NFASC;LY6H;EFNB3;GSS;NRXN1;NAV3;DSCAM;TMOD2;LGI1;GLRB;MEF2C;MAP1S;RYK;DPF2;SEMA6B;NDP;NPTX1;TGFBR1;ADAM22;SHANK3;LIMK1;ADGRL3;CPNE6;COX7B;ACHE;ERBB4;SH3GL2;PKD2;RAPGEFL1;SDK1;PCDHA5;TGFB1;RAPGEF5;APLP1;WNT8B;PRKN;ASIC2;PCDH1;FGF13;FGF2;BTBD3;FEZ2;PCDHB3;CXCR4;LRCH4;ACVR1B;HAPLN2;SH3GL3;SEMA4F;PKD1;VCAN;DCTN1;NRCAM;MYLIP;TBX6;GFRA1;EVL;RBFOX2;RBFOX3;ALDH5A1;HAPLN1;SCN2A;DPYSL2;HAP1;EPHB2;DSCAML1;ERCC6;FAT4;APC2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.5387067153727945,-1.409168313556595,0.07857142857142857,0.4462241326816237,1.0,4/13,12.25%,GAS6;AXL;TYROBP;LAMP1
prerank,calcium-mediated signaling (GO:0019722),0.36523955373134265,1.409064855052511,0.026499302649930265,0.6429119322862743,1.0,27/93,16.32%,ACKR4;P2RY12;ATP2A2;ACKR3;KSR2;ATP1B1;NMUR1;TNNI3;FIS1;PRNP;TRPM2;PLCG1;CCR1;SAMD14;RCAN3;CXCR6;CX3CR1;SLC8A1;BTK;CXCR4;PPP3CC;CCR6;RCAN2;ACKR2;CCR9;DMPK;PPP1R9A
prerank,cellular response to purine-containing compound (GO:0071415),0.5944340348511312,1.4088316643360552,0.0979020979020979,0.640425812021811,1.0,4/10,12.16%,CACNA1S;TRPM2;SLC8A1;P2RY1
prerank,neural tube closure (GO:0001843),0.44042910770691684,1.4084772040496356,0.06323529411764706,0.6384898390157148,1.0,10/34,11.15%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3;KDM2B
prerank,heart contraction (GO:0060047),0.4189804785663106,1.4078721806383965,0.0390625,0.6375953719161714,1.0,9/41,12.28%,KCNH2;ATP1B1;TNNI3;TNNC1;DMD;MYBPC3;SLC8A1;SGCZ;SGCG
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.511240089845233,-1.4075211033839625,0.09302325581395349,0.4488021904599574,1.0,9/14,32.08%,XDH;CAV1;SPRY2;SPRY1;NOTCH4;GDF3;SPRED1;DLL1;MMP9
prerank,cellular protein metabolic process (GO:0044267),-0.2653951926768123,-1.4068607639788835,0.0,0.4488067662689976,1.0,111/396,19.55%,MSRA;APOE;PARP4;GAS6;UBE2D3;IGF1;ABL2;STK38;RPN2;RPS26;RPL39;SFTPA2;SFTPA1;RPS23;YME1L1;RPL5;RPS24;IGFBP4;RPS16;LGALS1;RPL28;EEF1A1;SIAH2;RPS29;NAGPA;RPS14;SHISA5;RPS20;RPL35A;RPS12;RPL18A;RPS13;RPL27;RPL21;RPS7;UBL4A;RPS5;PADI4;RIPK1;CDC34;RPL30;PARL;RPL6;DHPS;RPL37A;CPE;EIF4EBP2;CLN5;IGHMBP2;ST8SIA4;PSEN1;RPL10;RPL15;CDKL3;MBTPS1;SERPINC1;GOLM1;UBE2L3;UBA52;LOX;SERPIND1;YARS2;RPS10;PPP4R2;RPL14;ICMT;RPL9;RPL32;RPL36;CP;CCN1;SPPL3;RPL31;IGF2;RPL23A;LTA4H;RPN1;PRKCSH;AGO2;ATG3;MRPL35;PNPLA2;STOML2;FAM20C;APH1B;FBXO2;RPL41;MXRA8;RPL3;UBE2L6;ST8SIA2;MAGEC2;CDH2;RPL8;ADPRH;ADAM17;WFS1;CCDC59;IGFBP7;GNMT;MSRB1;ANO8;MFGE8;RPL37;IGFBP5;FN1;SRBD1;NAPSA;MRPS33;RPL36A;RPL26
prerank,magnesium ion transport (GO:0015693),-0.5371618355556618,-1.4048937871115992,0.11347517730496454,0.4523281973663047,1.0,7/12,28.00%,MAGT1;MRS2;NIPAL4;NIPAL3;MMGT1;SLC41A1;NIPAL1
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.46532461090168487,-1.4042576123661556,0.07692307692307693,0.4524363886889521,1.0,7/19,9.96%,IFIH1;IRF7;TBK1;TLR7;HSPD1;TLR8;STAT1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4687816990381682,1.4032371442720835,0.08427876823338736,0.6532964352753706,1.0,6/23,9.60%,KCNH2;SCNN1A;OTC;SLC12A2;SLC26A4;SLC12A6
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3835011828754325,1.402246574236982,0.04387291981845688,0.6541482796992539,1.0,13/62,6.89%,POLR2L;CDK7;CTR9;RTF1;POLR2F;NELFB;ELP2;GTF2H2;NELFCD;ELOC;SSRP1;GTF2H4;GTF2F1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4466242424149477,-1.4017320356534364,0.07086614173228346,0.45733652526483576,1.0,7/22,14.21%,NOL11;WDR43;SMARCA4;DHX33;IPPK;UTP15;UBTF
prerank,organic anion transport (GO:0015711),0.37491869274183576,1.400553111091812,0.040059347181008904,0.6574526368448231,1.0,16/76,14.50%,SLC25A4;SLC4A8;SLC35A1;SLCO2B1;CA1;CA3;CA4;SLC2A2;CFTR;CYB5R2;SLC26A7;MFSD10;SLC39A8;SLC4A10;SLC4A7;SLC19A1
prerank,neuropeptide signaling pathway (GO:0007218),0.39176928686330365,1.4002654038964846,0.03265940902021773,0.6552051660262908,1.0,14/58,18.98%,GLRA3;NMUR1;NXPH3;LTB4R2;GLRB;PPY;SORCS1;NXPH2;ADCYAP1;GLRA2;SORT1;GAL;OPRM1;OPRD1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5054834846868441,-1.4002432415135377,0.08536585365853659,0.459622495925507,1.0,5/14,19.69%,IL6ST;IL1B;ADAM8;TNF;OSMR
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2603513257401882,-1.39867930513751,0.0,0.4620670662369742,1.0,132/532,18.00%,F13A1;SP100;IL15;BCL2;IFNAR1;PSMA6;POU2F1;ITGAX;OAS2;BCL2L1;ALOX5;ABL2;CSK;CRK;TNFSF8;CD44;TRIM25;STAT5B;LIFR;TEC;TALDO1;MAP3K8;STAT4;IFIT2;IRF9;CIITA;IRF7;CD36;PSMB2;IL12RB2;MCL1;PRKACA;SMARCA4;CCR2;IL16;IFITM3;CD300LF;IFNAR2;STAT2;IL6ST;PSME2;JUNB;IFIT1;PIM1;LIMS1;GRAP2;NFKB1;MSN;CCL25;IL27;OASL;IRF4;LMNB1;BAG4;PF4;PSMD11;BST2;CRKL;NOD2;SYK;RIPK1;CCND1;PSMC6;TRIM62;IFIT3;MID1;FYN;YAP1;ANXA1;UBC;GAB2;HIF1A;PSMA3;IL1B;HCK;IL1RL1;TAB1;SOCS5;PIK3CA;UBA52;LCP1;CAMK2D;VIM;STAT1;BIRC5;LCK;GRB2;LTB;GHR;FOXO1;BIRC2;HNRNPA2B1;TNFRSF1B;CBL;CEACAM1;IRAK4;PELI1;TRIM5;OAS3;PSMD10;LCN2;EDA;B2M;TNFRSF17;FOS;IRF2;AIP;IFNLR1;LBP;EBI3;SHC1;PSMB5;TNF;BCL2L11;PTK2B;RAP1B;TRAF1;FCER1G;IL27RA;SDC1;HMOX1;IL18R1;SQSTM1;ADAM17;TRAF3IP2;ADIPOR2;PYDC1;TNFRSF9;TNFRSF25;SMAD4;GATA3;PSMD5
prerank,actomyosin structure organization (GO:0031032),0.37397576173296926,1.3984738722815377,0.03281027104136947,0.6594241140697189,1.0,14/75,9.01%,EPB41L2;FRMD5;CAPN3;F11R;LMOD1;SIX4;MYPN;MYH10;ITGB5;TMOD2;FRMD3;EPB41;CDC42BPA;ACTN2
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5134335003883195,-1.3983758722333206,0.0982367758186398,0.4612425040269629,1.0,4/13,4.02%,CBLB;KPNB1;RANBP2;KPNA2
prerank,mRNA splice site selection (GO:0006376),0.44944693652335915,1.3968748529720594,0.07313195548489666,0.6627555985309496,1.0,12/30,18.37%,SRSF12;SRSF5;ISY1;SRSF6;SF3A1;SRSF1;YTHDC1;CELF6;SETX;SRSF9;PUF60;PSIP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.5276825656688261,-1.3960061097723708,0.08314087759815242,0.4655659805421634,1.0,5/13,13.89%,APOE;NFKB1;ERLIN2;BMP5;BMP2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4548730912047473,1.3939890394808268,0.06220839813374806,0.671429961074451,1.0,14/29,19.42%,P2RY12;TNFAIP8L3;CD81;TGFB1;FGF2;IRS1;EEF1A2;PDGFB;TEK;DGKZ;PRKD1;PTK2;FLT3;PDGFRB
prerank,positive chemotaxis (GO:0050918),0.5196395177739329,1.3933568418284294,0.096,0.670760447735806,1.0,4/17,5.56%,FGF10;TSC2;SCRIB;FGF7
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5198192512287608,-1.3928839362947738,0.09803921568627451,0.47197254472543043,1.0,5/13,15.76%,MDFIC;SP100;NUP153;BARD1;CHP1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5422270207067905,1.3912650647682778,0.09540034071550256,0.6760288917872355,1.0,4/14,6.03%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,mismatch repair (GO:0006298),-0.41338975494315017,-1.3909572727772221,0.05630026809651475,0.47559047538385035,1.0,12/27,20.71%,PCNA;MSH5;POLD4;RPA1;MSH4;MCM9;RNASEH2A;PMS1;RPA2;MUTYH;XPC;SETD2
prerank,regulation of endocytosis (GO:0030100),-0.34184408720788645,-1.3907538097719632,0.03254437869822485,0.47456109536009167,1.0,10/61,6.28%,DAB2;MCTP1;APOE;HIP1;ABL2;PTPN1;MTMR2;ZFYVE16;HIP1R;PICALM
prerank,protein polyglutamylation (GO:0018095),0.5774699534525074,1.3903464547885436,0.09298245614035087,0.6761939686984411,1.0,8/11,30.23%,TTLL6;TTLL7;TPGS1;TTLL1;TTLL5;TTLL11;CFAP20;CEP41
prerank,chromatin assembly (GO:0031497),-0.39001695173838014,-1.389801449883427,0.0423728813559322,0.47536921229645324,1.0,10/38,10.49%,LIN54;HMGB2;KAT6B;PADI4;PRDM9;ANP32B;H3-3A;H1-0;CTCF;GRWD1
prerank,cholesterol transport (GO:0030301),-0.36683867692024535,-1.38979633941062,0.05847953216374269,0.4738240417912341,1.0,13/45,9.43%,APOE;NPC2;MSR1;OSBP;CD36;STX12;LDLRAP1;CAV1;LDLR;SERAC1;OSBPL2;ABCG4;ABCG1
prerank,cellular response to interferon-beta (GO:0035458),-0.5009028631903542,-1.389201141733117,0.08120649651972157,0.4739160466865807,1.0,7/14,27.77%,UBE2K;CDC34;STAT1;ACOD1;AIM2;NDUFA13;IRGC
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.4743777498005597,-1.3884604544438455,0.10643564356435643,0.4742562726786559,1.0,8/16,32.73%,VCP;ATP7A;UQCC2;SLC25A33;PPIF;ABCD1;SHMT2;PDE12
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5295317337164687,-1.3884347881396288,0.09927360774818401,0.4727563387563676,1.0,5/11,21.88%,P2RX4;FOXO1;NOTCH1;SMAD4;LMNA
prerank,maintenance of blood-brain barrier (GO:0035633),0.45004685046284104,1.3883202219467226,0.07766990291262135,0.6815361511972519,1.0,6/30,5.93%,F11R;JAM2;DMD;IL6;SLC12A2;SLC1A1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5847322905649438,1.3871035118232626,0.10825688073394496,0.683298415476586,1.0,3/10,8.76%,SELENOS;DGKQ;OGT
prerank,cytosolic calcium ion transport (GO:0060401),0.4473797033071131,1.3869676254488121,0.08466453674121406,0.6804967346539321,1.0,10/28,15.59%,ATP2A3;ATP2A2;MICU2;SMDT1;SLC8A1;ITPR3;JPH1;ATP2B3;CACNA2D1;SLC25A23
prerank,immunoglobulin mediated immune response (GO:0016064),-0.559877402667428,-1.3867135577051404,0.10476190476190476,0.4756629193705843,1.0,3/10,7.52%,FCGR2B;CD74;TLR8
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.3572021626430664,-1.386317581544334,0.025210084033613446,0.4750569700943092,1.0,17/47,21.94%,NOCT;PPARG;METRNL;ASXL2;PIM1;PPARD;CEBPB;ZC3H12A;LPL;AAMDC;TRPM4;BMP2;GDF3;BMP7;HNRNPU;ID2;RREB1
prerank,positive regulation of secretion by cell (GO:1903532),0.3769940305068539,1.3855873262645857,0.0350140056022409,0.683069320712002,1.0,21/70,18.11%,FRMD4A;MYOM1;ANG;RAB3A;CADPS2;SYTL4;MYH10;SLC12A2;CLASP2;APBB1;ACHE;TGFB1;CFTR;RAB5A;UNC13B;DNM1L;BAIAP3;APBB3;IER3IP1;STXBP5;IL1A
prerank,heart development (GO:0007507),0.33882765617886684,1.385201472604955,0.02284263959390863,0.6813348387716653,1.0,36/150,16.68%,TSC2;ZFPM1;FGF12;KDM6B;ADAP2;TNNI3;SOX4;MEGF8;MYBPC3;TCF25;ZFPM2;NTRK3;MEF2C;DAND5;TGFBR3;TGFBR1;BMP4;ERBB4;PKD2;FOXC1;TGFB1;LDB3;TBX2;SGCZ;CRELD1;SGCG;PKD1;AKAP13;PDGFB;TEK;NDRG4;INSR;BORCS8;CXADR;PTK2;SGCD
prerank,response to iron ion (GO:0010039),-0.5219840765220984,-1.3851419910139995,0.11084905660377359,0.4764549679101739,1.0,3/12,13.38%,BCL2;HIF1A;B2M
prerank,regulation of interleukin-8 production (GO:0032677),-0.3319961918379609,-1.384842579399839,0.029900332225913623,0.47565799554526134,1.0,27/69,20.95%,CD74;PTPN22;PTPRC;TLR2;RAB1A;LAMTOR5;BCL3;TLR7;CD14;NOD2;SYK;RIPK1;ANXA1;TLR8;IL1B;ANXA4;CD2;LBP;TNF;TLR4;TLR1;CD33;AFAP1L2;MYD88;HSPA1B;KLF4;TMSB4X
prerank,steroid metabolic process (GO:0008202),0.3751466491456658,1.384733411868045,0.044096728307254626,0.6799553890093173,1.0,16/72,17.86%,STARD3;STAR;NR1I2;AKR1C1;CYP26C1;PRLR;LRP2;FDX2;LGMN;CYP39A1;LSS;RDH5;TSPO;CYP27A1;AMACR;HSD17B10
prerank,protein secretion (GO:0009306),0.38453354415295393,1.3846164393780398,0.04874446085672083,0.6771899264283465,1.0,18/56,19.25%,LTBP2;PTPRN;RAB3A;TVP23A;RAB8A;COPG1;PPY;ADCYAP1;TANGO2;ARL4D;RAB3D;MTTP;RAB12;GAL;MIA3;COPG2;PREB;OLFM2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3644136682371481,-1.3844970582161205,0.036923076923076927,0.47502736347615343,1.0,17/48,16.79%,PTPN22;IL12RB2;CCR2;TLR7;CEBPG;CD14;IL27;HSPD1;TLR8;IL1B;CD226;CD2;SLC11A1;EBI3;LILRB1;TLR4;IL18R1
prerank,alpha-amino acid catabolic process (GO:1901606),0.44182059639658905,1.3840891203785863,0.07967479674796749,0.6761368165954629,1.0,9/29,17.86%,HOGA1;IL4I1;IDO2;OTC;ACADSB;KYAT1;ALDH4A1;DAO;HSD17B10
prerank,monoacylglycerol metabolic process (GO:0046462),0.535022330621953,1.384045623838755,0.1286231884057971,0.6730868564593053,1.0,3/13,7.16%,DGAT2;AWAT2;ABHD12
prerank,sensory perception of chemical stimulus (GO:0007606),-0.485812571101071,-1.3839499385599388,0.0989010989010989,0.47498286696100983,1.0,4/15,12.72%,CD36;C5AR1;DRD2;ADCY3
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.45003338292191186,1.3834335027029778,0.07973421926910298,0.6725458407141534,1.0,6/29,9.35%,ZFPM1;TNNI3;TNNC1;MYBPC3;TGFBR3;TGFB1
prerank,heterochromatin organization (GO:0070828),-0.5001114268951907,-1.382822563929638,0.09722222222222222,0.47661450965674534,1.0,7/14,22.27%,SETDB2;SETD7;SMCHD1;HP1BP3;HMGA2;POLE3;MECOM
prerank,cell junction assembly (GO:0034329),0.3547749220320837,1.3820194109912574,0.045706371191135735,0.6750555325690037,1.0,41/100,28.44%,SH3BP1;PCDHB9;PCDHB4;FSCN1;OBSL1;DCHS1;PARD6B;PCDHB5;SPOCK2;PKP4;NRXN1;DSCAM;RYK;CDH18;SHANK3;ADGRL3;ACHE;SDK1;CTNND2;PCDHB3;NRCAM;FLCN;ITGA6;ACTB;CDC42;GRHL2;GPM6A;FARP1;VMP1;OPHN1;LIMS2;BDNF;RHOA;FLRT3;FZD5;CDH10;CDHR3;MYO9A;SLITRK1;PTEN;CLDN5
prerank,megakaryocyte differentiation (GO:0030219),0.569242149940376,1.3813432390173699,0.10877192982456141,0.674581239965441,1.0,3/11,14.65%,ZFPM1;SH2B3;THPO
prerank,mitotic metaphase plate congression (GO:0007080),-0.35283305608168014,-1.38107055113412,0.04573170731707317,0.479643061654731,1.0,17/51,17.42%,KPNB1;CHMP4B;CHMP4A;MIS12;CUL3;PIBF1;BOD1;CDCA8;KIFC1;PDCD6IP;CHMP1B;SPDL1;CDT1;NUP62;NDC80;NUF2;DCTN2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3698899445301278,-1.3810644431658334,0.05322128851540616,0.47814290123375275,1.0,15/43,17.92%,CLSPN;CDC14B;TOPBP1;NBN;BRCA1;ABRAXAS1;TAOK3;CDK1;TICRR;PLK1;NOP53;UIMC1;BRCC3;DTL;HMGA2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3589159923782526,-1.379985279202116,0.05828220858895705,0.4794918422739773,1.0,13/47,14.00%,PID1;XDH;CD36;TYROBP;THBS1;DHRS4;SYK;RIPK1;ZC3H12A;GRB2;ACOD1;CYBA;SLC5A3
prerank,regulation of NMDA receptor activity (GO:2000310),0.4335739213319603,1.3799440669288139,0.08426073131955485,0.6771579676361051,1.0,14/32,22.93%,DLG2;GRIA2;MEF2C;GRIA1;ACTN2;GRIN1;GRIA4;GRIN2B;CRHBP;EPHB2;OPRM1;SLC6A9;NEFL;CAMK2B
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.44147680547434653,-1.3791034280355752,0.08009708737864078,0.48031064428890874,1.0,9/21,23.05%,RAD51B;MECP2;CCND1;CDK1;NPM1;CDC25A;DTL;CDC25C;CCNB1
prerank,regulation of chemokine production (GO:0032642),-0.37978291258346253,-1.3785000262484974,0.057534246575342465,0.48042098050607696,1.0,19/36,30.41%,CD74;TLR2;TLR7;HIF1A;LPL;FOXP1;AGER;TNF;WNT5A;TLR4;HMOX1;ADAM17;APP;EIF2AK2;TLR9;TSLP;SIGIRR;IL33;EGR1
prerank,fat cell differentiation (GO:0045444),-0.3550650775641895,-1.37844257519531,0.05329153605015674,0.4790560744965496,1.0,21/57,22.09%,PID1;OSBPL8;PPARG;METRNL;BBS7;EGR2;ERAP1;EP300;TMEM120B;FOXO1;ATF5;C1QTNF3;SMAD6;ALOXE3;TMEM120A;HMGA2;PER2;TFAP2B;KLF4;FFAR4;CLIP3
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2676840934727467,-1.3781783802132297,0.0,0.47822917621128236,1.0,79/306,15.59%,APOE;B4GALT5;EPC1;EXT1;RBBP8;RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RRAGC;CLSPN;RPL28;EEF1A1;POLR2E;RPS29;TOPBP1;RPS14;BCL3;RPS20;RPL35A;RPS12;EEFSEC;ORC5;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;DHPS;RPL37A;NBN;EIF4EBP2;IGHMBP2;PCLAF;BRCA1;RPL10;RPL15;RMI1;ATRIP;EEF1D;ORC2;ALAS1;YARS2;RPS10;RPL14;GRWD1;RPL9;RHNO1;BARD1;RPL32;RPL36;RPA1;CDK1;RPL31;RPL23A;RMI2;MCM2;AGO2;MRPL35;KAT5;TICRR;ORC4;POLR2B;TYMS;SCX;PTMA;RPL41;RPL3;POLR2H;POLR2J;MCM9;MCM8;KAT7;RPL8
prerank,sodium ion transport (GO:0006814),0.3674497096702973,1.377997664534514,0.029577464788732393,0.6818478620575597,1.0,34/85,29.35%,HCN1;SLC4A8;ATP1B1;SCNN1A;SLC5A12;SLC12A2;ATP1B3;SLC38A7;PKD2;SLC8A1;ASIC1;ASIC2;FGF13;SCN2A;SLC6A1;SLC8A3;NEDD4L;SLC24A3;ASIC3;SLC24A4;ATP1A4;SLC6A9;SCN1B;SCN3B;SCN8A;SLC6A7;SCN7A;SLC6A2;SLC6A5;KCNK1;SCN1A;NALCN;SLC6A15;NDUFA9
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.43910458689745824,-1.3776774889678125,0.09511568123393316,0.4780239743012336,1.0,8/21,14.21%,STAP1;PRKCH;SLC39A10;PTPRC;TESPA1;CD226;LCK;FOXP1
prerank,response to lipid (GO:0033993),-0.31143532619265596,-1.3765794639041984,0.02074688796680498,0.4792598901046027,1.0,30/105,18.57%,IFNAR1;PTPN22;NOCT;STAT5B;HMGB2;PPARG;CD36;RARA;MAPKAPK2;ESR1;PPARD;ANXA1;IL1B;ABCG1;CTNNB1;FOXO1;MAPKAPK3;OVCA2;SMAD6;SLC11A1;RXRB;PELI1;FOXP1;LBP;LIAS;TLR4;ADAM17;FFAR1;PAQR7;TRIM16
prerank,nucleosome assembly (GO:0006334),-0.39627985983213343,-1.3763587417515606,0.056,0.47841901191853564,1.0,9/31,14.13%,HMGB2;KAT6B;CABIN1;PADI4;ANP32B;H3-3A;GRWD1;HAT1;NPM1
prerank,regulation of hippo signaling (GO:0035330),-0.4727137185262434,-1.3763424668968611,0.08591885441527446,0.4769807587709658,1.0,8/17,19.60%,LIMD1;DLG5;SOX11;CIT;MOB3B;AJUBA;NEK8;WTIP
prerank,positive regulation of immune effector process (GO:0002699),-0.4114874308088011,-1.3762154007628045,0.08333333333333333,0.47580576170837824,1.0,11/27,26.05%,DDX60;ANKRD17;PTPRC;CCR2;IL1B;LBP;LILRB1;APPL2;DHX58;IL12RB1;MYB
prerank,negative regulation of nervous system development (GO:0051961),-0.46600171088884274,-1.375925696670334,0.10679611650485436,0.47507875656862164,1.0,10/17,24.07%,PCM1;TLR2;SLIT1;IL1B;NOTCH1;B2M;TNF;APPL2;PAX6;HOOK3
prerank,cellular response to leucine (GO:0071233),0.589786829439508,1.375764524184067,0.099644128113879,0.684671064122074,1.0,2/10,2.41%,KLHL22;RPTOR
prerank,response to leucine (GO:0043201),0.589786829439508,1.375764524184067,0.099644128113879,0.684671064122074,1.0,2/10,2.41%,KLHL22;RPTOR
prerank,positive regulation of defense response (GO:0031349),-0.3171611098645367,-1.3755252973996808,0.02127659574468085,0.47463810623003344,1.0,24/89,17.45%,IL15;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;PTGER4;TLR7;NFKBIZ;RIPK1;TLR8;IL1B;LPL;GPSM3;GPRC5B;ADAM8;CYBA;TNF;WNT5A;OPTN;PDE2A;TLR4;POLR3G
prerank,regulation of cation transmembrane transport (GO:1904062),0.4370392286907686,1.3754700859446132,0.07666666666666666,0.6827593324620718,1.0,11/29,25.04%,KCNH2;FGF12;KCNE2;KCNIP3;KCNIP4;CACNA1D;WNK1;KCNN2;PDZK1;SNTA1;CD63
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.3506107897116653,-1.3753902857563645,0.054878048780487805,0.47354289306063324,1.0,20/57,17.92%,CLSPN;CDC14B;TOPBP1;MDC1;CCND1;NBN;BRCA1;ABRAXAS1;TAOK3;CDK1;TICRR;EME1;WAC;PLK1;NOP53;RPA2;UIMC1;BRCC3;DTL;HMGA2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.503905066686662,-1.375001213692279,0.09976798143851508,0.4731631190555954,1.0,5/13,12.17%,CHMP4B;CHMP4A;SMCR8;MTM1;LRRK2
prerank,protein-containing complex disassembly (GO:0032984),-0.3539723860906736,-1.3739897652758604,0.04560260586319218,0.474227766460049,1.0,21/54,25.50%,VIPAS39;MAP1LC3B;VCP;DVL3;LIX1;CAV1;UBQLN1;EPG5;UVRAG;LAMP2;SNAP29;CTNNB1;FZD2;CLN3;MAP1LC3A;LRP6;LIX1L;PYM1;GABARAPL2;VAMP7;FZD1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.37428876039668674,1.373969162859652,0.0581039755351682,0.6860810904244216,1.0,13/64,6.89%,POLR2L;CDK7;CTR9;RTF1;POLR2F;NELFB;ELP2;GTF2H2;NELFCD;ELOC;SSRP1;GTF2H4;GTF2F1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.36147654945118424,1.373399654843055,0.0403899721448468,0.6852571166342297,1.0,38/84,25.49%,SRSF12;RNPS1;PRDX6;SMU1;DDX5;TRA2B;CWC22;ZC3H10;SRSF6;PTBP1;CIRBP;RBM5;SON;YTHDC1;METTL16;KHDRBS2;CELF6;QKI;RBFOX2;RBFOX3;NOVA1;HNRNPA1;RBMXL1;REST;RBM3;SRSF9;PUF60;TRA2A;SRRM4;TIA1;RBFOX1;FXR1;RBM39;RBM15B;CELF4;SRSF3;ZBTB7A;SF1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5777627704950667,1.3731209473719999,0.09859154929577464,0.68330415921407,1.0,3/10,13.64%,WHRN;STRC;IFT88
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5091657047796274,-1.3730209695184636,0.13,0.4753146937173612,1.0,3/13,3.64%,PID1;VCP;ENO1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3623041384882927,-1.372778277451022,0.0668693009118541,0.4745368741716313,1.0,19/45,22.59%,LILRA5;CD36;TYROBP;NLRC4;NOD2;TLR8;LPL;AGER;TNF;HSPB1;WNT5A;TLR4;PYDC1;TRIM16;MYD88;CASP1;AIM2;ISL1;APP
prerank,cilium-dependent cell motility (GO:0060285),0.4743558155123784,1.3725850648159195,0.11037891268533773,0.6824967183113252,1.0,8/22,21.60%,CCDC39;DNAH3;DNAI3;CCDC65;DNAAF2;CFAP44;CFAP54;DNAH2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5854818432227638,1.3720513489984383,0.1056338028169014,0.6815718446369659,1.0,5/10,21.22%,ALOX12;SH2B3;PRKG1;SERPINE2;RDX
prerank,regulation of cilium movement (GO:0003352),0.5872207532589998,1.3717468266677872,0.11363636363636363,0.6796938103529725,1.0,4/10,6.86%,DNAAF1;CFAP43;CCDC39;CCDC65
prerank,membrane raft organization (GO:0031579),-0.4959683934526011,-1.3716995895268171,0.09948979591836735,0.47586884423691184,1.0,7/15,18.83%,RFTN1;FLOT2;NAXE;S100A10;EMP2;CLN3;MYADM
prerank,regulation of defense response (GO:0031347),-0.32799444728570537,-1.3715689437043392,0.02877697841726619,0.47483824229914257,1.0,23/76,20.95%,FCGR2B;APOE;PSMA6;PTPN22;ALOX5;CELF1;ZBP1;CCR2;USP18;NOD2;ANXA1;HCK;ERAP1;BIRC2;SHPK;FOXP1;WNT5A;BST1;ADAMTS12;MYD88;APPL2;CASP1;TMSB4X
prerank,regulation of cardiac conduction (GO:1903779),0.39014727619425466,1.371272141806476,0.05701754385964912,0.6786273270458726,1.0,20/54,22.82%,ATP2A3;ATP2A2;ITPR2;ATP1B1;ASPH;ATP1B3;SLC8A1;GJA5;ITPR3;ATP2B3;SLC8A3;DMPK;AGT;ANK2;TMEM65;ATP1A3;ATP1A4;ATP1A1;NPR1;RYR3
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5395395233358073,1.3706374037669544,0.1256544502617801,0.6782771353487594,1.0,3/13,5.81%,GCHFR;FPGS;MTHFD1L
prerank,axon development (GO:0061564),0.3658285436291223,1.370190086246706,0.058823529411764705,0.6770829020682015,1.0,25/78,19.69%,PLP1;DCC;RAB3A;CTNNA2;PARD6B;ATL1;MAP1S;RYK;RAB8A;RTN4RL1;APBB1;KLF7;SLITRK4;ARHGAP35;NRCAM;VASH2;EPHB2;DSCAML1;WNT7A;PLPPR4;MTR;NTNG2;NTNG1;ACTB;NREP
prerank,cAMP biosynthetic process (GO:0006171),-0.550563734663587,-1.3697556640087865,0.11764705882352941,0.4780435861432325,1.0,6/10,14.26%,ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;ADCY10
prerank,membrane protein proteolysis (GO:0033619),-0.37944753829189604,-1.3692083313010701,0.07162534435261708,0.47804982532429585,1.0,16/37,17.07%,ADAM19;NFKB1;ADAM9;PARL;PRKCQ;PSEN1;DAG1;ERAP1;MBTPS1;RET;CLPP;SPPL3;APH1B;MYH9;RBMX;ADAM17
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.46210776245673896,-1.368576749333487,0.08068459657701711,0.47825319406970557,1.0,8/17,22.57%,RBPJ;SNW1;STAT1;EP300;NOTCH1;NOTCH4;HEYL;KAT2B
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4097473926880451,-1.3683656116387088,0.0891891891891892,0.4774002187265969,1.0,10/27,15.14%,CCDC88B;CD44;CD47;CCR2;HSPD1;PRKCQ;LCK;SKAP1;HAS2;TNF
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4930751536191038,1.3682038783628867,0.09133858267716535,0.682057494555643,1.0,7/19,15.29%,DNAAF1;ODAD4;CCDC39;ROPN1L;SPA17;SPEF2;DNAAF2
prerank,mitotic cytokinesis (GO:0000281),-0.3626027426530261,-1.367359791505137,0.048859934853420196,0.4785923499684513,1.0,18/47,17.83%,CHMP4B;KIF23;RASA1;SNX9;STMN1;CIT;RACGAP1;USP8;CENPA;NUSAP1;ESPL1;PDCD6IP;KIF4A;CKAP2;INCENP;PLK1;KIF20A;ECT2
prerank,response to glucagon (GO:0033762),-0.46199762159915947,-1.3670822401141125,0.08549222797927461,0.4778470722839027,1.0,8/19,15.04%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;CRY1;ADCY3;PRKACB
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3391121939757988,-1.366479940335912,0.03908794788273615,0.47794923853082905,1.0,15/59,11.27%,MED13;MECP2;MITF;MED26;MED7;CDK8;BAX;MED16;NFKB1;CEBPB;CCND1;MED10;MED15;CTNNB1;CDK1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5576548022873079,1.3653974497892833,0.1079646017699115,0.6907425766407514,1.0,3/11,2.39%,BIN1;NOS1AP;CACNB2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.3372408941549266,-1.3650767390228693,0.04,0.48009294957223236,1.0,16/60,12.10%,MED13;MECP2;MED26;MED7;CDK8;BAX;MED16;NFKB1;CEBPB;CCND1;MED10;MED15;CTNNB1;PAXIP1;CDK1;ATF7IP
prerank,positive regulation of exosomal secretion (GO:1903543),-0.4772827682652577,-1.36414965530406,0.08396946564885496,0.4808087641851294,1.0,7/15,25.35%,SDCBP;RAB7A;PDCD6IP;STAM;SDC1;SDC4;ATP13A2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5195795286202307,-1.3641018419650903,0.11961722488038277,0.47953741539282047,1.0,7/12,21.64%,DAB2;SMARCA4;PIAS2;HDAC1;FOXP1;NCOR1;HEYL
prerank,negative regulation of ossification (GO:0030279),-0.4272409969611751,-1.363914620215809,0.08977556109725686,0.47867042886892747,1.0,8/23,15.28%,RBPJ;BCOR;SRGN;NOTCH1;TRPM4;SMAD6;GREM1;PTK2B
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3957456997247711,-1.3636543889772625,0.0889487870619946,0.4779534553936115,1.0,10/29,16.27%,UBE2K;ZBP1;PTPN1;IFNAR2;STAT2;USP18;NLRC5;OAS3;WNT5A;MUL1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5712900959557816,1.3633670220853542,0.13066202090592335,0.696149080931119,1.0,6/10,17.41%,CACNG5;NPTXR;NPTX1;DLGAP1;DLGAP2;DLGAP3
prerank,cGMP-mediated signaling (GO:0019934),-0.49891061247622337,-1.363004204338919,0.11809045226130653,0.47826852833536176,1.0,8/13,35.50%,APOE;CD36;IRAG1;PDE2A;AQP1;HTR2C;PDE3A;NPPA
prerank,circulatory system development (GO:0072359),0.3422479309694184,1.3627102398088293,0.030303030303030304,0.6958194479106936,1.0,25/118,12.98%,TSC2;ZFPM1;FGF12;KDM6B;ADAP2;FLT4;TNNI3;SOX4;STK11;TCF25;ZFPM2;NTRK3;NXN;MEF2C;TGFBR1;ERBB4;PKD2;FOXC1;HEY1;TGFB1;LDB3;PKD1;AKAP13;PDGFB;TEK
prerank,nucleotide catabolic process (GO:0009166),-0.4730358277739169,-1.3623338512060228,0.1076555023923445,0.47857010883686024,1.0,4/16,5.65%,GDA;VCP;XDH;NT5E
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.32096173457825117,-1.3622089520937466,0.04180064308681672,0.47747481162851124,1.0,10/70,6.29%,PEAK1;ITGA4;NRP1;PXN;ATRNL1;RILPL2;ACTN1;PROX1;ARL13B;ITGB7
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.44636406056574457,-1.3617049534424814,0.11137440758293839,0.4773119098218246,1.0,9/19,24.03%,GNL3L;EXOSC10;TERF2;TENT4B;NAT10;HNRNPC;HNRNPU;TINF2;PIF1
prerank,insulin receptor signaling pathway (GO:0008286),-0.3286364699448278,-1.360452034018407,0.04983388704318937,0.47903180575497967,1.0,15/69,12.82%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;NAMPT;ATP6V0B;GAB1;BCAR3;AP3S1;PIK3CA;GRB2;FOXO1;IGF2;SORBS1;ATP6V1A
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.45132702607844233,-1.36021256182095,0.11682242990654206,0.478167978094643,1.0,6/18,15.07%,RIC1;VPS35;MSN;PTTG1IP;WDR91;RGP1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3502172036487975,-1.3588690660996559,0.05714285714285714,0.4802523330171276,1.0,21/51,22.59%,LILRA5;CD36;IL16;TYROBP;NLRC4;NOD2;TLR8;LPL;TMED10;AGER;TNF;HSPB1;WNT5A;TLR4;PYDC1;TRIM16;MYD88;CASP1;AIM2;ISL1;APP
prerank,intracellular pH reduction (GO:0051452),-0.38838644084888696,-1.3582320501741894,0.07536231884057971,0.4805394265605015,1.0,6/33,4.12%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B
prerank,icosanoid biosynthetic process (GO:0046456),-0.5411058714069986,-1.3580099295488477,0.10101010101010101,0.479808546300243,1.0,4/10,18.56%,ALOX5;MGST3;LTA4H;LTC4S
prerank,cGMP metabolic process (GO:0046068),0.5531804850880973,1.3576861646066607,0.13036020583190394,0.7139988802074563,1.0,3/12,10.32%,GUCY2F;GUCY2C;GUCY2D
prerank,purine-containing compound biosynthetic process (GO:0072522),0.45757078962417735,1.3574080297401574,0.10032894736842106,0.712057049025358,1.0,10/25,15.26%,ADA;PNP;GART;PRPSAP2;AMPD3;HPRT1;DCK;ADSL;PRPSAP1;GMPR
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5080998540361796,-1.3569819696768697,0.1234866828087167,0.4810821302755427,1.0,6/13,17.51%,FCGR2B;ALOX5;NR1H2;NR1H3;AQP11;WFS1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.30882652456656645,-1.356852006865443,0.022304832713754646,0.48007643661832855,1.0,30/88,20.62%,FNIP2;VCP;SDCBP;GNL3L;RAB7A;BAX;SH3GLB1;SYNPO2;MTLN;SMAD3;SYK;TFRC;AJUBA;PDCD6IP;SYNPO;STAM;RACK1;CDT1;TNF;BCL2L11;ICE1;PFN2;SDC1;STX18;RGCC;SLX4;HAS3;BMP7;SDC4;WARS1
prerank,thymus development (GO:0048538),0.536228961586559,1.3566506600581398,0.10385259631490787,0.712060326464382,1.0,3/13,7.63%,FGF10;RIPK3;TGFBR1
prerank,defense response to bacterium (GO:0042742),-0.3027303001601261,-1.3554911534080556,0.017241379310344827,0.48210759548485815,1.0,32/105,20.24%,ANKRD17;OAS2;MPEG1;RNASE3;RPL39;TLR2;HMGB2;LYST;RAB1A;NLRC4;NOD2;SYK;CEBPB;RPL30;LYZL4;STAB2;SLC11A1;OAS3;LCN2;GBP4;LBP;SHC1;OPTN;SPN;FCER1G;TLR4;ADAM17;CFP;CAMP;MYD88;GBP6;LTF
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.4608688915757094,-1.355431261786618,0.1044776119402985,0.48092703939061526,1.0,6/16,16.17%,LDLR;NR1H2;CTDNEP1;PNPLA2;NR1H3;MFSD2A
prerank,positive regulation of developmental growth (GO:0048639),0.3903660919284638,1.3550475460330635,0.07407407407407407,0.7158564344221243,1.0,13/49,15.11%,AGRN;SYT4;SEMA7A;PPIB;SYT1;LIMK1;TWF2;CPNE6;CDKL5;RIMS1;MAP3K13;INSR;NEDD4L
prerank,protein autoubiquitination (GO:0051865),-0.33358959578654296,-1.3550082623960777,0.06896551724137931,0.4806762018476603,1.0,14/61,10.60%,ITCH;UBE2D3;CUL3;DTX3L;RNF213;OBI1;TRIM17;UHRF2;RNF146;RNF13;BRCA1;RNF157;SH3RF1;RNF220
prerank,collagen fibril organization (GO:0030199),0.3516864699475678,1.3531831105631407,0.04700854700854701,0.7208284903259309,1.0,27/88,23.86%,P3H2;PLOD3;P4HA3;COL5A1;DST;PPIB;LAMB3;COL2A1;TGFBR1;SERPINH1;PXDN;COL4A5;COL28A1;ADAMTS14;COL4A2;COL15A1;COL18A1;PLOD1;ITGA6;ADAMTS3;P4HA2;COL4A4;LAMC2;COL6A1;COL20A1;COL13A1;COL27A1
prerank,negative regulation of potassium ion transport (GO:0043267),0.528062233739877,1.3530657932287073,0.12478632478632479,0.7182437762034322,1.0,5/13,15.11%,KCNH2;BIN1;ACTN2;STK39;NEDD4L
prerank,regulation of establishment of cell polarity (GO:2000114),-0.4634771558681412,-1.3524106265419904,0.12345679012345678,0.48590181277063377,1.0,8/16,20.16%,RIPOR2;KIF20B;SHTN1;RACK1;PTK2B;RAP1B;GSN;BCAS3
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.297315516857799,-1.3521452583286806,0.028,0.4852452049379646,1.0,44/125,23.72%,MECP2;KPNB1;BUB3;MIS12;TACC3;KIF11;PMF1;RANBP2;PTPA;ZWILCH;CDCA8;STMN1;CENPA;NUP43;MAPRE1;NUSAP1;XPO1;BIRC5;MAD2L1;AHCTF1;ESPL1;BUB1;DYNC1LI2;BUB1B;KNTC1;SPDL1;KIF4A;INCENP;NDC80;PLK1;WDR62;NUF2;DCTN2;ERCC6L;PAFAH1B1;ZWINT;SETD2;MAP4;B9D2;RCC1;NUP98;CCNB1;NDE1;SPC24
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.4542204678514986,-1.3521082664108757,0.07637231503579953,0.48400545825494823,1.0,3/18,3.58%,AOAH;FUCA1;BPGM
prerank,ether lipid biosynthetic process (GO:0008611),0.574677751642779,1.35182306338855,0.127208480565371,0.7202833412628784,1.0,3/10,11.35%,PLA2G4C;DHRS7B;LPCAT2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.39120261183892857,-1.351699733267182,0.06162464985994398,0.4837154084351997,1.0,8/30,12.15%,RPN2;MAGT1;UGGT1;MGAT2;MCFD2;ST6GAL1;FUT8;RPN1
prerank,myotube differentiation (GO:0014902),0.4951308501887394,1.3516178277459916,0.09859154929577464,0.7181082525808055,1.0,6/17,13.98%,SIX4;JAM2;MEF2C;ADAMTS15;ADAM12;SORT1
prerank,regulation of interferon-alpha production (GO:0032647),-0.4225469194853225,-1.3512142399640132,0.09438775510204081,0.4835533108206065,1.0,10/23,20.73%,IFIH1;IRF7;TBK1;TLR7;HSPD1;TLR8;STAT1;TLR4;SETD2;NLRC3
prerank,error-free translesion synthesis (GO:0070987),-0.4383162984944441,-1.3509289708890313,0.10427807486631016,0.4829584090626675,1.0,7/22,19.91%,VCP;PCNA;UBC;UBA52;RPA1;RPA2;NPLOC4
prerank,protein tetramerization (GO:0051262),0.3702225185090559,1.3508917912585616,0.05621301775147929,0.7181124975838179,1.0,20/67,20.89%,HCN1;CPSF6;KCNC1;TRPM2;ALDH9A1;CBR4;PKD2;GRIN1;ACOT13;GRIN2B;HPRT1;PKD1;NUDT21;OXA1L;KCNC3;ACACB;TK1;HSD17B10;ALDOA;SSBP1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.39236407677662277,-1.3507371340742904,0.07541899441340782,0.4821449318018109,1.0,10/29,16.17%,APOE;LDLR;NR1H2;CTDNEP1;SORBS1;NR1H3;ZBTB20;MID1IP1;CHP1;MFSD2A
prerank,B cell mediated immunity (GO:0019724),-0.5490411293993754,-1.3506205071313198,0.13752913752913754,0.4811478313383681,1.0,3/10,7.52%,FCGR2B;CD74;TLR8
prerank,metanephric mesenchyme development (GO:0072075),0.5609078874444766,1.3500376188023029,0.14,0.7188417346015228,1.0,3/10,8.99%,WNT4;SIX4;PKD2
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3299849893705598,-1.3498701871191348,0.0379746835443038,0.48170033559075903,1.0,22/66,19.89%,CCT6A;DTX3L;ZPR1;LAMTOR5;SMAD3;TFRC;YAP1;PSEN1;ZC3H12A;CDK1;CCT3;PARP9;NMD3;ORMDL3;KAT7;PLK1;SESN2;FLNA;ECT2;CDH1;DKC1;CHP2
prerank,chromosome condensation (GO:0030261),-0.372538702951115,-1.3494843398179222,0.06470588235294118,0.481446828532821,1.0,20/36,27.05%,TOP2A;NCAPD2;NCAPH;NCAPG2;H1-0;NUSAP1;SMC2;CDK1;BANF1;RB1;INCENP;PLK1;MCPH1;TENT4A;ACIN1;NCAPH2;CCNB1;ERN2;AIFM1;CDCA5
prerank,protein modification process (GO:0036211),-0.32283831519280926,-1.3487804337638472,0.02857142857142857,0.48188951504166255,1.0,24/76,15.71%,MSRA;PARP4;UBE2D3;ABL2;STK38;RPN2;NAGPA;UBL4A;PADI4;CDC34;CPE;ST8SIA4;CDKL3;UBE2L3;UBA52;LOX;PPP4R2;ICMT;RPN1;ATG3;FBXO2;UBE2L6;ST8SIA2;ADPRH
prerank,negative regulation of coagulation (GO:0050819),0.5312744430868118,1.3485217816522026,0.12345679012345678,0.7220065896563724,1.0,6/14,15.41%,ADTRP;HS3ST5;CD34;THBD;VTN;SERPINE2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5326375050259416,1.3476531022145115,0.10843373493975904,0.7227724450053403,1.0,5/13,15.54%,HHEX;DAB2IP;NEDD4;PDCD6;CADM4
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.4854535345248844,1.347451521081288,0.12295081967213115,0.7205929539143405,1.0,6/19,14.62%,FSCN1;DLG2;SCRIB;PRKCI;MTCL1;PATJ
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.44208033516147427,-1.3474162201281799,0.0891089108910891,0.4826695920782933,1.0,6/20,13.89%,MGST3;GSTA3;GSTO2;GSTZ1;GSTM1;GSTM5
prerank,glutathione derivative metabolic process (GO:1901685),-0.44208033516147427,-1.3474162201281799,0.0891089108910891,0.4826695920782933,1.0,6/20,13.89%,MGST3;GSTA3;GSTO2;GSTZ1;GSTM1;GSTM5
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4894851420964229,1.347396307353643,0.11837455830388692,0.7178836159996143,1.0,9/18,18.41%,RELA;CLU;LRRTM3;EFNA1;CASP3;EPHA4;ABCA2;IFNGR1;CHRNA7
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5116847000844157,-1.3472052405342083,0.1353211009174312,0.481911933756871,1.0,6/12,13.37%,CTCF;CTNNB1;ESPL1;BUB1;RAD21;RB1
prerank,positive regulation of protein processing (GO:0010954),-0.4445281828959271,-1.3464701250136817,0.10160427807486631,0.4824789455898401,1.0,11/19,31.10%,CCBE1;ENO1;NLRC4;ADAM8;MYH9;GSN;NKD2;KLKB1;RHBDD1;CLEC3B;F12
prerank,sodium ion transmembrane transport (GO:0035725),0.35471773075768015,1.345547583146689,0.057534246575342465,0.7228727823608038,1.0,35/84,29.35%,HCN1;SLC4A8;ATP1B1;SCNN1A;SLC12A2;ATP1B3;SLC9A4;PKD2;SLC8A1;ASIC1;ASIC2;SLC9A5;SCN2A;SLC6A1;SLC8A3;SLC24A3;ASIC3;SLC24A4;ATP1A3;ATP1A4;ATP1A1;SLC6A9;SCN1B;SCN3B;SCN8A;SLC6A7;SLC9A1;SCN7A;SLC6A2;SLC6A5;KCNK1;ATP1B2;SCN1A;NALCN;SLC6A15
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4877092099065489,-1.3453965851371854,0.11421911421911422,0.4838296428880741,1.0,8/13,28.83%,NRP1;CTNNB1;KDR;NOTCH4;SHH;SEMA3E;DLL4;NRARP
prerank,negative regulation of hippo signaling (GO:0035331),-0.5106939123737045,-1.3439980750069975,0.10478359908883828,0.4860981883171781,1.0,6/12,24.26%,LIMD1;DLG5;CIT;AJUBA;WTIP;MAP2K3
prerank,positive regulation of endocytosis (GO:0045807),-0.35700133067631656,-1.3434003263665772,0.06340057636887608,0.48633381752542393,1.0,16/45,22.09%,DAB2;APOE;HIP1;STAP1;AXL;LDLRAP1;HNRNPK;CBL;RAB21;LRP1;B2M;CLN3;RAB31;APPL2;ABCA13;CLIP3
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3517736255935022,-1.3428559083712042,0.07396449704142012,0.4863426550520066,1.0,19/48,23.25%,APOE;FLOT2;NFKB1;LDLR;PFDN5;EDNRB;MAD2L2;AGAP2;MAD2L1;EGFR;FLNA;RILP;PTX3;ITGB3;FMN2;PFDN2;SIRT2;ADGRB1;EIF2AK1
prerank,renal filtration (GO:0097205),0.5611675803478242,1.3427264918537536,0.13427561837455831,0.7318462401294334,1.0,3/10,6.44%,TMEM63C;CD34;XPNPEP3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.40233580237800887,1.3426576376297341,0.08307692307692308,0.7291818303101194,1.0,10/44,13.33%,DNAAF1;VANGL2;CCDC39;MEGF8;MEF2C;BBS5;PKD2;TBX2;TBX6;NDRG4
prerank,heart looping (GO:0001947),0.4094431803968098,1.342315849567499,0.09627329192546584,0.7277890200542093,1.0,9/40,13.33%,DNAAF1;VANGL2;CCDC39;MEF2C;BBS5;PKD2;TBX2;TBX6;NDRG4
prerank,indolalkylamine catabolic process (GO:0046218),0.5652977907339938,1.3415575062445815,0.12299465240641712,0.7281065925443491,1.0,3/10,11.66%,IL4I1;IDO2;KYAT1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.5053797477373018,-1.3409202506296471,0.11286681715575621,0.48997944241344044,1.0,6/12,20.05%,PCGF3;SMCHD1;CDYL;BRCA1;PCGF5;HNRNPU
prerank,fluid transport (GO:0042044),-0.5182284325723546,-1.340814557556984,0.13365155131264916,0.4889351842883446,1.0,5/12,36.42%,AQP11;SLC26A6;PDPN;AQP1;SLC4A11
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.4667575389244608,1.3406360299364755,0.08972267536704731,0.7290163009495971,1.0,5/23,9.35%,TNNI3;TNNC1;MYBPC3;TGFBR3;TGFB1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.42755211650579894,1.3406145044250708,0.08103975535168195,0.726194752972081,1.0,9/31,13.80%,ABI3;TANC2;ARHGAP44;SHANK3;SRCIN1;EFNA1;CFL1;LZTS3;EPHA4
prerank,autophagosome maturation (GO:0097352),-0.39219313817181356,-1.34030166388519,0.10451977401129943,0.4889655964916712,1.0,9/32,10.26%,VIPAS39;MAP1LC3B;VCP;LIX1;UBQLN1;EPG5;UVRAG;LAMP2;SNAP29
prerank,regulation of macrophage migration (GO:1905521),0.5669874912790529,1.340175058520408,0.12078152753108348,0.7251278756593201,1.0,3/10,9.54%,P2RY12;CD81;CX3CR1
prerank,translation (GO:0006412),-0.27305961663170986,-1.339691765122592,0.005208333333333333,0.48922614814095516,1.0,49/208,14.32%,RPS26;RPL39;RPS23;RPL5;RPS24;RPS16;RPL28;EEF1A1;ETF1;RPS29;AIMP1;RPS14;RPS20;RPL35A;RPS12;EEFSEC;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;FARS2;RPL30;RPL6;DHPS;RPL37A;TMA7;EIF4EBP2;IGHMBP2;IARS2;RPL10;RPL15;EEF1D;UBA52;YARS2;RPS10;RPL14;RPL9;RPL32;RPL36;RPL31;RPL23A;AGO2;MRPL35;RPL41;RPL3;QARS1;NARS1
prerank,prostaglandin metabolic process (GO:0006693),0.43965754180285854,1.339585868446426,0.10666666666666667,0.7246758261393446,1.0,11/26,22.70%,CYP2S1;PTGS1;PTGDS;AKR1C1;PRXL2B;ACOX1;HPGD;PTGR2;HPGDS;PNPLA8;DAGLB
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.4690533710141247,-1.3391649659431382,0.1375,0.489199107238883,1.0,7/14,17.07%,ADAM19;DYRK1A;PSEN1;ABCG1;APH1B;CLN3;ADAM17
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.43070757078463323,-1.339064266621168,0.09399477806788512,0.4881570846679741,1.0,6/21,12.05%,FCGR2B;PTPN22;PIBF1;SOX11;BANK1;FOXJ1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.5235863544204895,-1.3378827716722115,0.13202933985330073,0.48997865093365056,1.0,3/11,8.25%,VCP;UGGT1;BAG6
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5411798859786976,-1.3378318487687961,0.13729977116704806,0.48884179689282875,1.0,5/10,14.97%,FCGR2B;PTPRC;CEACAM1;KLRD1;LILRB1
prerank,histone modification (GO:0016570),-0.3017953247709534,-1.3378270677043262,0.02834008097165992,0.4876023468433758,1.0,26/109,14.93%,BAZ1B;KAT6B;SIN3B;ATXN7;RCOR1;PADI4;PHF20;HLCS;TBL1X;EYA1;TRRAP;EYA3;EP300;EYA2;PRMT2;BRMS1;BRMS1L;CCNA2;HDAC2;RCOR3;EHMT1;KAT5;HDAC1;MIDEAS;MSL3;INCENP
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.49284566982104927,-1.3376937650980858,0.13615023474178403,0.4866448415070192,1.0,7/14,19.13%,PPP2R2A;NCK1;PPP2R2C;PPP3CA;DUSP1;PPP2CB;PPM1F
prerank,regulation of protein secretion (GO:0050708),0.33847246905170975,1.3374715491797697,0.03337783711615487,0.7305596307083996,1.0,35/119,19.97%,FRMD4A;MYOM1;SNAP25;ADTRP;ANG;ITPR2;KCNA5;SYTL4;DISP1;MYH10;IL6;SLC12A2;RFX6;SLC2A2;ADRA2A;APBB1;RAPGEF3;PRKCA;ACHE;TGFB1;CACNA2D2;UNC13B;ITPR3;CACNA1D;DNM1L;ABCC8;APBB3;IER3IP1;CACNA1A;MTNR1B;STXBP5;IL1A;CCL5;LLGL2;ERP29
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.45844642912601485,-1.3361568715565557,0.13513513513513514,0.4892207070477951,1.0,7/17,8.70%,ARL6IP5;NOD2;PDCD10;LYN;MID1;RNF13;TAOK3
prerank,negative regulation of fat cell differentiation (GO:0045599),0.41659375083664635,1.3360312163524077,0.09455128205128205,0.7336558584687236,1.0,8/34,9.35%,ZFPM1;WWTR1;E2F1;IL6;ZFPM2;TRIB2;ZFP36L2;TGFB1
prerank,transepithelial transport (GO:0070633),0.5024673839033177,1.3353692960163324,0.12794612794612795,0.7335772278803416,1.0,6/15,23.61%,SLC12A2;SLC1A1;SLC1A3;CXADR;ABCG2;GPLD1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.4535545218665955,-1.335264518641795,0.11959287531806616,0.4902944415342632,1.0,8/18,18.30%,FCGR2B;BAX;NCK1;ERN1;BAG6;PMAIP1;BCL2L11;RNFT1
prerank,lung development (GO:0030324),0.42198959384968493,1.3351558413030824,0.09119496855345911,0.731594714097704,1.0,8/33,12.51%,FGF10;DNAAF1;FGF9;CCDC39;FGF7;BMP4;FGF2;PKD1
prerank,regulation of membrane repolarization (GO:0060306),0.528207854947361,1.3349793745396559,0.13924050632911392,0.7295203618062454,1.0,5/13,15.58%,YWHAE;KCNH2;KCNE2;NEDD4L;CACNA2D1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4208591000231543,-1.3348043865546462,0.12690355329949238,0.4902375414408483,1.0,10/21,17.07%,ADAM19;ADAM9;PRKCQ;PSEN1;DAG1;ERAP1;SPPL3;MYH9;RBMX;ADAM17
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.48731319804426815,-1.3346083509146398,0.1396508728179551,0.4894729946964733,1.0,7/14,13.60%,CPSF1;NCBP1;ERN1;FIP1L1;CPSF4;CSTF2;CPSF2
prerank,regulation of microtubule depolymerization (GO:0031114),0.4441136093855806,1.3344140611289013,0.12751677852348994,0.7290068480499542,1.0,10/25,17.40%,STMN2;NAV3;MAP1S;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.49169328845140936,-1.3342551576281014,0.11463414634146342,0.4891807775786095,1.0,3/13,0.72%,PLXNC1;NRP1;NRP2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3125162231353876,-1.3342392163135925,0.02702702702702703,0.4879657638995896,1.0,34/88,26.00%,MYO5A;RABEP1;DNAJC6;KIF16B;KLHL20;GOLGB1;EXOC4;GBF1;AP1S3;CLINT1;EPS15;CCDC22;AP4M1;SNAP23;RAB10;DNM2;CLTA;EXOC8;STXBP6;CORO7;FTL;DOP1B;EXOC6;GOPC;CCDC93;NAPA;DTNBP1;PUM1;VPS13C;APP;AP2A1;BLOC1S3;VAMP7;EXOC1
prerank,regulation of T cell activation (GO:0050863),-0.3556334116157118,-1.3341335132478847,0.07784431137724551,0.4869693490403024,1.0,11/42,12.09%,PTPN22;CCDC88B;TNFSF8;CD47;CCR2;IL27;HSPD1;PRKCQ;LCK;TNFRSF1B;CD2
prerank,regulation of protein sumoylation (GO:0033233),-0.4574843288162214,-1.3340744511567597,0.12213740458015267,0.4859061356153165,1.0,9/17,24.19%,RWDD3;GNL3L;ZMIZ1;UBA2;CTNNB1;MUL1;HDAC4;PIAS4;PIAS3
prerank,cellular metal ion homeostasis (GO:0006875),0.3441248650733215,1.3331483541464653,0.052917232021709636,0.7313832986129487,1.0,28/102,19.85%,ATP2A3;KCNMA1;ATP13A4;ATP2A2;ATP1B1;SLC24A5;CLDN16;TNNI3;ATP13A5;SLC12A2;ATP1B3;CCR1;SLC8A1;RMDN3;ATP2C1;ATP2B3;SLC8A3;NEDD4L;SLC24A3;DMPK;ANK2;CHRNA7;SLC24A4;CCL15;CCL5;ATP1A3;ATP1A4;ATP1A1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.41999464030679245,-1.3328681271996479,0.1111111111111111,0.48777757729726606,1.0,5/23,5.92%,CD74;DPP4;RIPOR2;MPP1;MOSPD2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4508243199466445,-1.3320502701886394,0.10344827586206896,0.4885817659436961,1.0,8/18,23.05%,RAD51B;MECP2;CCND1;CDK1;CDC25A;DTL;CDC25C;CCNB1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4314319411688614,-1.3319952298197701,0.12276214833759591,0.48748515067780124,1.0,9/21,17.31%,GAS6;BCOR;SRGN;NOTCH1;TRPM4;GREM1;PTK2B;ASPN;HEY2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4475768624087135,-1.3307233015809583,0.10565110565110565,0.48935566681855824,1.0,10/20,15.85%,FBXW7;ERLIN2;BRCA1;WDTC1;BMP5;CEACAM1;APOC1;BMP2;SIK1;ACADL
prerank,positive regulation of histone modification (GO:0031058),0.4123801173763392,1.3304678750641987,0.10923076923076923,0.7398245005297805,1.0,14/33,21.92%,TET1;PPARGC1A;CTBP1;AKAP8L;UBE2N;AKAP8;SAP30BP;MAPK3;PAF1;CHTOP;ZBTB7B;ARRB1;ING2;BRD7
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.5113255085561992,-1.3299534522210719,0.1411764705882353,0.490362691397752,1.0,4/11,12.10%,SETDB2;PPHLN1;DNMT1;ATF7IP
prerank,sphingolipid catabolic process (GO:0030149),-0.4653277664053552,-1.3292383829092542,0.11724137931034483,0.49092689357852903,1.0,5/15,13.45%,ACER3;SGPL1;SMPDL3A;ASAH2;GLA
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5382119586072788,1.3290637267697734,0.12020905923344948,0.7430858625038114,1.0,6/12,19.11%,SYT1;DOC2B;UNC13B;RIMS1;RIMS3;UNC13C
prerank,heterocycle biosynthetic process (GO:0018130),-0.4740551524546802,-1.3288814989018627,0.11734693877551021,0.4906954091013617,1.0,4/14,7.09%,ALOX5;MOCS2;MOCS1;PYCR2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.47995054250843683,1.3283071416434555,0.12745098039215685,0.743310042938128,1.0,8/17,22.29%,CTNNA2;NCKAP1;DNAI3;FCHSD2;WASF3;CYFIP1;WASF2;ARF1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.44113654847353034,-1.328301384955926,0.10669975186104218,0.49096108737697697,1.0,6/18,6.95%,ABL2;RIPOR2;CUL3;MET;CCDC125;STMN1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.44544794949572863,-1.3269192401083798,0.12628865979381443,0.49336518001640445,1.0,12/18,28.08%,C3AR1;C5AR1;LYN;BAG6;SPG21;FCER1G;BCAR1;LAX1;FPR3;BLK;FPR2;CD19
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.4803173922208442,-1.325591280386905,0.14218009478672985,0.49563745191320524,1.0,5/14,14.71%,PTPN22;CCR2;SYK;CD55;EBI3
prerank,regulation of exit from mitosis (GO:0007096),-0.3628355840480957,-1.3253167836057154,0.08991825613079019,0.49513390376982386,1.0,15/38,22.34%,BUB3;CDC14B;UBC;UBA52;CDC27;MAD2L1;BUB1B;KNTC1;UBE2C;MAD2L1BP;RGCC;SIRT2;ANAPC10;CDC14A;ANAPC7
prerank,regulation of cellular respiration (GO:0043457),-0.4588969712268894,-1.3250367981865854,0.1393643031784841,0.4945697468129569,1.0,10/17,34.75%,IFNAR1;VCP;CBFA2T3;IFNLR1;NOP53;NOA1;IL10RB;SHMT2;TRAP1;NOS2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.426915535797401,-1.3243842163249167,0.12129380053908356,0.4950048937487545,1.0,6/22,14.01%,APOE;PPARG;PPARD;IL1B;SORBS1;ZBTB20
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.5150636334114319,-1.3243775393159871,0.15311004784688995,0.49382615167287186,1.0,4/11,19.33%,CIITA;PF4;HDAC2;TAF7
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.37918030576084716,1.324000838866851,0.08172362555720654,0.7584019111160227,1.0,17/52,15.67%,SRSF12;RNPS1;SMU1;DDX5;TRA2B;ZC3H10;SRSF6;PTBP1;RBM5;YTHDC1;KHDRBS2;CELF6;RBFOX2;RBFOX3;NOVA1;HNRNPA1;REST
prerank,cardiac muscle contraction (GO:0060048),0.41192655444586745,1.3237134458642419,0.10048622366288493,0.756815064373401,1.0,7/34,9.64%,KCNH2;ATP1B1;TNNI3;TNNC1;DMD;MYBPC3;SLC8A1
prerank,mitochondrial protein processing (GO:0034982),-0.5174178663271897,-1.3234264932172113,0.17225950782997762,0.495091295687068,1.0,3/11,15.36%,YME1L1;STOML2;IMMP2L
prerank,bile acid and bile salt transport (GO:0015721),0.4464362445046637,1.3229093542202985,0.1271585557299843,0.7573207617067489,1.0,7/24,17.79%,SLCO2B1;ABCC3;AKR1C1;SLC10A2;STARD5;ATP8B1;SLC10A1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3968791372092084,-1.3228492954048128,0.13101604278074866,0.4952919562426501,1.0,4/26,3.75%,IQGAP1;STAT5B;EEF1A1;ZPR1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.4574185705401099,-1.3225877728770206,0.12,0.49476043218848476,1.0,7/17,15.04%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB
prerank,purine nucleotide biosynthetic process (GO:0006164),0.529215503632403,1.322385482567596,0.14028776978417265,0.7566263861460475,1.0,6/12,14.22%,ADA;GART;PRPSAP2;HPRT1;ADSL;PRPSAP1
prerank,microtubule polymerization (GO:0046785),0.418301868808416,1.3223279565987751,0.1181959564541213,0.7540551273071461,1.0,13/29,26.15%,TPPP;CLASP2;CCDC57;CKAP5;FGF13;TUBGCP2;HDGFL3;PIN1;TUBGCP6;MAP7D3;TPPP3;TUBGCP5;MAPT
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4945634086608065,1.3220834936362054,0.140893470790378,0.7522231042443794,1.0,9/16,31.75%,C3;MRAP;PRKCA;PRMT5;GRP;CHGA;NECAB2;SLC39A14;PDE6G
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4957874723032198,1.3218772588541519,0.13915857605177995,0.7502553719807042,1.0,5/15,9.35%,FSCN1;CST3;IL6;CLASP2;TGFB1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.522713813695087,1.3218628640271008,0.125,0.7475408267443007,1.0,7/13,18.41%,ADCY8;LGMN;SHANK3;ZDHHC2;EPHB2;EIF2AK4;CHRNA7
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.36623600723067334,-1.321270807352651,0.09090909090909091,0.49693015586664596,1.0,14/38,21.08%,SASH1;DDX60;ANKRD17;PUM2;OASL;TLR8;ADAM8;ACOD1;CYBA;SCIMP;POLR3G;USP15;PUM1;SLC15A4
prerank,negative regulation of inflammatory response (GO:0050728),-0.27511734848677566,-1.320591462370139,0.013452914798206279,0.4975916324092474,1.0,74/182,30.00%,AOAH;CD163;APOE;IGF1;ALOX5;GIT1;PPARG;METRNL;PRKACA;ADCY9;PTGER4;VPS35;PPARD;SYK;LYN;FYN;ENPP3;HCK;ADCY5;VIPR1;ADCY6;PTGIS;ACOD1;ADCY1;C1QTNF3;TNFRSF1B;ADCY3;NR1H3;CCN3;RB1;CXCL17;NPSR1;PRKACB;RAMP2;CALCRL;GPR27;MYH9;OTULIN;MAPK7;ADAM17;PTHLH;GATA3;CD247;KLF4;NLRC3;MVK;FFAR4;ISL1;VIPR2;NR1H4;MEFV;RXFP2;PTH1R;CRH;CALCA;GSTP1;SMPDL3B;GLP1R;FEM1A;RAMP3;SCTR;ADORA2A;VIP;FPR2;CREB1;GPR83;PTGDR;RPS19;PTGIR;MFHAS1;GPR15;RHBDF2;FGR;TNFAIP3
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.40831548301500514,-1.3204045796789157,0.1346704871060172,0.4968533267887308,1.0,12/24,33.17%,RTEL1;ZRANB3;H1-0;TERF2;DFFA;DACH1;NIBAN2;KMT2A;BMPR2;RPS3;MSH6;MSH3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.48458629801420067,1.3199914334996903,0.14067796610169492,0.7528302886251845,1.0,6/18,20.52%,ADCY8;CRTC1;PRKD2;PRKD1;OPRD1;EPHA5
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.28801833596920134,-1.3189172895616301,0.024390243902439025,0.4995644360403014,1.0,35/132,15.91%,ITCH;APOE;IGF1;TRIM65;TRIM14;DTX3L;PTPN1;SH3GLB1;VPS35;ADAM9;MSN;MTLN;TPCN1;NRDC;SNX9;HIF1A;IL1B;PSEN1;ZC3H12A;PTTG1IP;ADAM8;RC3H1;FOXO1;TNFRSF1B;DAPK1;LRRK2;KAT5;PNPLA2;TRIM5;ENTPD5;ZBTB20;ORMDL3;TNF;OPTN;ZC3H18
prerank,arachidonic acid secretion (GO:0050482),-0.522801282027399,-1.3182185042066352,0.16930022573363432,0.4988873730661916,1.0,3/10,19.72%,ANXA1;DRD2;DRD3
prerank,arachidonate transport (GO:1903963),-0.522801282027399,-1.3182185042066352,0.16930022573363432,0.4988873730661916,1.0,3/10,19.72%,ANXA1;DRD2;DRD3
prerank,positive regulation of cellular respiration (GO:1901857),-0.5067013954353947,-1.317629409555644,0.12971698113207547,0.49927842371745534,1.0,2/11,1.55%,IFNAR1;VCP
prerank,basement membrane organization (GO:0071711),0.5097227194507437,1.3175992241974057,0.14049586776859505,0.7603279581268907,1.0,8/14,23.48%,LAMB3;PXDN;HPN;NTNG2;NTNG1;CTSS;FLRT2;LAMB2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.3917632120344953,1.3170095159684274,0.08513931888544891,0.7599721629362455,1.0,15/40,19.68%,P2RY12;ANG;TXK;NMUR1;AVPR1A;CD86;NTRK3;PLCG1;GNA15;FGF2;NTRK2;HRAS;ITK;PDGFRB;PLCB2
prerank,protein homooligomerization (GO:0051260),0.3312797964458562,1.3168659511455927,0.06149732620320856,0.7578165833771926,1.0,35/114,23.06%,HCN1;ADCY8;GLRA3;MPP2;IKZF4;NACC2;FUS;C9;DISP1;ATL1;TRPM2;TRMT61B;ALDH9A1;CBR4;PKD2;ACOT13;SIGMAR1;HPRT1;ASIC1;EHD1;CHMP2A;RNF135;ACACB;TK1;EHD3;ALS2;HSD17B10;ALAD;ALDOA;SSBP1;ALOX5AP;STEAP4;SPAST;RYR3;ATL2
prerank,activation of protein kinase A activity (GO:0034199),-0.4594614559402722,-1.3166460355855583,0.12807881773399016,0.5006359903794774,1.0,7/16,15.04%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB
prerank,positive regulation of immune response (GO:0050778),-0.3226882669344491,-1.3160943410968855,0.0761904761904762,0.5008477693453316,1.0,14/64,14.97%,FCGR2B;IL15;CD74;PTPRC;IL6ST;NOD2;TLR8;CD226;ADAM8;SKAP1;CYBA;SASH3;SPHK2;LILRB1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5309985064508941,-1.3158295588188287,0.1489841986455982,0.5002612458724169,1.0,5/10,13.53%,BCL2;LRRK2;KDR;MYOC;RACK1
prerank,cell projection assembly (GO:0030031),0.449697402738246,1.3156618073103454,0.12687813021702837,0.7600960771286774,1.0,8/22,20.78%,RHOV;NCKAP1;NCKAP1L;CYFIP1;RHOQ;RHOU;CAPG;CDC42
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.33054705171230553,-1.3153382979538149,0.06086956521739131,0.500332350676462,1.0,14/55,15.95%,PID1;ALOX5;XDH;THBS1;DHRS4;RIPK1;PARL;BRCA1;ZC3H12A;GRB2;ACOD1;SPHK2;SLC25A33;BST1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5085114639894743,-1.3144574773868416,0.14460784313725492,0.5014548589685928,1.0,7/12,35.19%,CCR2;IL1B;SLC11A1;IL18R1;IL12RB1;IL23R;IL12B
prerank,peptidyl-asparagine modification (GO:0018196),-0.3772616177777104,-1.314005979449371,0.09141274238227147,0.5014211012002519,1.0,7/31,7.74%,RPN2;MAGT1;UGGT1;MGAT2;MCFD2;ST6GAL1;FUT8
prerank,regulation of T cell cytokine production (GO:0002724),-0.468236413683511,-1.3128327671188695,0.1485148514851485,0.5031893409565908,1.0,5/15,13.46%,CCR2;TRPM4;TNFRSF1B;B2M;CD55
prerank,negative regulation of mRNA processing (GO:0050686),0.5048209769214744,1.3125336485317676,0.13322091062394603,0.7709432260177459,1.0,4/15,6.03%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,pinocytosis (GO:0006907),-0.5349751202736965,-1.3121667851377459,0.13921113689095127,0.5036391092239485,1.0,4/10,11.24%,DOCK2;MAPKAPK2;CARMIL1;MAPKAPK3
prerank,transport along microtubule (GO:0010970),0.5114523725478354,1.3113232365239251,0.13822525597269625,0.7736138292935372,1.0,8/13,26.77%,COPG1;CAMSAP3;BORCS5;SPG11;COPG2;CDC42;APBA1;DYNC1I1
prerank,regulation of nervous system process (GO:0031644),0.47524213655178843,1.3112252013105816,0.14770797962648557,0.7711908685088437,1.0,8/18,18.41%,CACNG5;NPTXR;NPTX1;DLGAP1;SLC8A3;DLGAP2;DLGAP3;CHRNA7
prerank,DNA methylation or demethylation (GO:0044728),-0.42708722800138427,-1.310418495928899,0.11274509803921569,0.5056507612966388,1.0,6/19,14.04%,DNMT1;ATF7IP;EHMT1;MTRR;GATAD2A;FOS
prerank,DNA alkylation (GO:0006305),-0.42708722800138427,-1.310418495928899,0.11274509803921569,0.5056507612966388,1.0,6/19,14.04%,DNMT1;ATF7IP;EHMT1;MTRR;GATAD2A;FOS
prerank,regulation of nervous system development (GO:0051960),-0.361055350739543,-1.3102806057396919,0.09883720930232558,0.5048125411502418,1.0,16/37,21.64%,HMGB2;DOCK7;ZPR1;YAP1;IL1B;CTNNB1;TNFRSF1B;PTN;HEY2;PER2;NPHP3;HES1;PTPRZ1;BHLHE40;SIRT2;HEYL
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5187957728976942,-1.3101262221534666,0.16990291262135923,0.5040941991834996,1.0,4/10,10.76%,STAT5B;PTPN1;LYN;GHR
prerank,negative regulation of apoptotic process (GO:0043066),-0.24482284564339235,-1.310013205032776,0.0,0.5031820505920701,1.0,106/444,16.18%,DAB2;ARHGAP10;BCL2;ITCH;CD74;APOE;CD38;GAS6;IGF1;AXL;PRKCH;BCL2L1;KLHL20;RAF1;CD44;TNFAIP8;ATAD3A;YME1L1;BRAF;BIRC6;MCL1;NUAK2;SIAH2;RNF213;IL6ST;LAMTOR5;BCL3;PIM1;NFKB1;CIAPIN1;RASA1;BAG4;THBS1;VHL;FAS;HSPD1;RIPK1;TFRC;PRDM9;CAV1;PDCD10;PLAUR;IFIT3;YAP1;ANXA1;HNRNPK;UBC;CIB1;NAA16;PSEN1;RPL10;HCK;TPT1;CPEB4;RNF157;PIK3CA;PIDD1;UBA52;HYPK;ZC3H12A;GCLC;SH3RF1;ANXA4;ADAM8;CD28;BIRC5;SPRY2;EGR3;AGAP2;CTNNB1;FOXO1;ATF5;BARD1;NOTCH1;MIEN1;CDK1;MAD2L1;HDAC2;LIG4;BIRC2;SMAD6;CBL;FHL2;HDAC1;KDR;CCND2;ASAH2;PSMD10;RB1;SCX;PTMA;GREM1;NPM1;QARS1;EGFR;DFFA;SHC1;TNF;PTK2B;HSPB1;WNT5A;DNAJB6;NUP62;GPX1;CLN3;PLK1
prerank,B cell proliferation (GO:0042100),-0.44017489806221155,-1.3098537392100136,0.10779816513761468,0.5024239057270865,1.0,3/17,6.06%,BCL2;PTPRC;HSPD1
prerank,negative regulation of lipid storage (GO:0010888),-0.4347223367109918,-1.3089093584707956,0.13917525773195877,0.5036841836760924,1.0,8/19,15.14%,OSBPL8;PPARG;PPARD;NR1H2;ABCG1;PNPLA2;NR1H3;TNF
prerank,regulation of adaptive immune response (GO:0002819),-0.4421407633982216,-1.3085489853272783,0.10152284263959391,0.5033882174627582,1.0,6/18,13.73%,FCGR2B;IRF7;IL6ST;AHR;SKAP1;SASH3
prerank,protein deacetylation (GO:0006476),-0.35876727719628876,-1.3082806765324813,0.09631728045325778,0.502910687244278,1.0,14/41,22.85%,SIN3B;RCOR1;TBL1X;BRMS1;BRMS1L;HDAC2;RCOR3;HDAC1;MIDEAS;MSL3;FLNA;SIRT2;HDAC4;TBL1XR1
prerank,protein oxidation (GO:0018158),-0.5137006776185482,-1.308275816501895,0.14285714285714285,0.5017826727099512,1.0,5/11,35.38%,SUMF1;LOX;LOXL1;PRDX3;APOA2
prerank,regulation of cellular catabolic process (GO:0031329),-0.32238922857674335,-1.3076040841006242,0.06666666666666667,0.5023077556631625,1.0,20/62,15.83%,ABL2;TPCN2;PSAP;RRAGC;DRAM2;MTMR4;ITPR1;GPR137B;CISD2;DRAM1;SMCR8;DCAF12;EP300;WDR91;DAPK1;LRRK2;RRAGA;GPR137;HSPB1;MTMR3
prerank,ion transport (GO:0006811),0.3276067462965583,1.3074384593400283,0.04854368932038835,0.7846284867111434,1.0,37/111,23.42%,TMEM63C;SLC24A5;SLC5A12;TRPM3;VDAC1;SLC12A2;SLC1A1;GLRB;SLC20A1;CNGB1;SLC25A18;SLC9A4;SLC26A4;GRIN1;SLC12A6;SLC8A1;SLC26A7;SLC1A3;CTNS;TRPC6;PANX1;TSPO;KCNN4;SLC9A5;GABRB1;SLC8A3;SLC24A3;KCNN3;CHRNA7;SLC24A4;WNK1;ATP1A4;PANX2;SLC25A10;KCNN2;SLC9A1;SLC25A26
prerank,cellular response to misfolded protein (GO:0071218),-0.4254364673713913,-1.3072364971642942,0.11528150134048257,0.5021130229584381,1.0,5/20,8.29%,VCP;CUL3;UGGT1;BAG6;KLHL15
prerank,negative regulation of phosphatase activity (GO:0010923),-0.39925572917796054,-1.3069737643447479,0.12121212121212122,0.5016641724723656,1.0,13/25,30.91%,PTPA;BOD1;CRY2;PPP1R35;CHP1;PPP1R15A;BOD1L1;SEMA4D;SH2D4A;MASTL;PPP1R26;TGFB2;FKBP1A
prerank,response to nutrient levels (GO:0031667),0.4783362029796421,1.3069186753511033,0.13179571663920922,0.783843172212306,1.0,8/17,30.39%,RPTOR;RPS6KB1;ULK1;MEAK7;ATF4;PRKAA2;KCNB1;FAM107A
prerank,lymphocyte differentiation (GO:0030098),-0.316028118836929,-1.3066580529666967,0.05211726384364821,0.5013184950002774,1.0,25/68,22.45%,ITGA4;PTPN22;AXL;PTPRC;KLF6;CEBPG;LYL1;TOX;DNAJB9;BLNK;LFNG;LCK;CD79B;NHEJ1;KAT7;RELB;IKZF1;ADAM17;ZAP70;GATA3;CD79A;PIK3CD;HDAC4;GPR89A;GPR89B
prerank,negative regulation of cytokine production (GO:0001818),-0.27360348961605707,-1.3065782135613422,0.0196078431372549,0.5004574893355516,1.0,49/163,20.95%,FCGR2B;ITCH;GAS6;PTPN22;CD274;AXL;TRIM25;PTPRC;IFIH1;PIBF1;LILRA5;RARA;TBK1;NPTN;PTGER4;TYROBP;BCL3;RNF216;THBS1;HOMER3;ANXA1;TLR8;SRGN;ZC3H12A;ANXA4;ACOD1;C1QTNF3;FOXJ1;CEACAM1;SLC11A1;NLRC5;KAT5;SLAMF1;AGER;UBE2L6;LILRB1;TNF;TLR4;RGCC;FN1;MMP8;TRAF3IP1;CD33;NPLOC4;APPL2;KLF4;NLRC3;RNF125;TMSB4X
prerank,lipid droplet formation (GO:0140042),0.5526335273944676,1.3065510279785308,0.16696588868940754,0.7826542088535192,1.0,2/10,15.23%,PLA2G4C;FITM2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4082754727544877,-1.3063183922024195,0.12655086848635236,0.5000702838926756,1.0,8/23,21.35%,GIT1;CBFA2T3;EP300;C1QTNF3;CRY1;SIK1;NCOR1;HDAC4
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.474368056503466,1.3062561914219066,0.13810316139767054,0.7810575115848639,1.0,6/18,9.35%,DDX5;ZC3H10;IL6;NCOR2;BMP4;TGFB1
prerank,regulation of monocyte differentiation (GO:0045655),-0.4761210945179389,-1.3045363562131367,0.16279069767441862,0.5033964155287393,1.0,3/14,2.83%,CD74;CDK6;IRF7
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5327327833838956,-1.3039530287456325,0.15473441108545036,0.5036909810645737,1.0,5/10,19.18%,THBS1;IL1B;INPP5K;RSC1A1;IRS2
prerank,vacuolar acidification (GO:0007035),-0.41710443792122676,-1.3036101093935621,0.12307692307692308,0.503453765986316,1.0,7/21,19.82%,ATP6V0D1;ATP6V0D2;ATP6V0A1;CLN5;SLC11A1;CLN3;ATP6V0A4
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.44592611743390737,1.303576637283233,0.15358361774744028,0.7897086813836626,1.0,9/21,17.40%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4570491077075469,-1.3025908889547906,0.13267813267813267,0.504914372115201,1.0,3/15,1.54%,BCL2;CD74;CD44
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.4414052016780923,-1.3021112232250394,0.13506493506493505,0.5050165173942002,1.0,8/18,16.29%,DOCK2;TYROBP;SYK;ENPP3;DYSF;SLAMF1;LBP;FCER1G
prerank,brain morphogenesis (GO:0048854),0.5110590999064175,1.3018473492926856,0.1651705565529623,0.7943302023690318,1.0,3/12,12.89%,CTNNA2;SHANK3;SPEF2
prerank,zinc ion homeostasis (GO:0055069),0.425844531272035,1.3012330806658452,0.12135922330097088,0.7941077568048704,1.0,13/28,18.07%,SLC39A4;TMC8;PRKN;SLC39A8;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,apical protein localization (GO:0045176),0.5511068732398033,1.3009591617044882,0.16493055555555555,0.7925456695663479,1.0,6/10,21.63%,VANGL2;INSC;JAM3;ATP8B1;ACTB;MAL
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.44723519954894597,1.3008169087442372,0.15577889447236182,0.7903220893109288,1.0,4/22,6.81%,IL2RA;IL4I1;VSIR;IL2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.31045353340324106,-1.2997699368380977,0.05245901639344262,0.5097614678092239,1.0,20/71,16.67%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2;MYO10;WIPF3;ELMO2;FCER1G;PLD2
prerank,establishment of protein localization to membrane (GO:0090150),-0.31910299597891206,-1.2989689986515334,0.053691275167785234,0.5107448404582801,1.0,19/66,17.09%,RFTN1;VPS37C;SDCBP;ZDHHC14;ZDHHC3;AFDN;BRAF;ZDHHC4;RABGEF1;RAB10;ICMT;SEC63;ATG3;REEP1;NACAD;EGFR;RTP4;RAB3GAP2;AQP11
prerank,skeletal muscle contraction (GO:0003009),0.46726665234350684,1.2984100979992386,0.14162348877374784,0.7977871979623892,1.0,2/19,4.01%,TNNI3;TNNC1
prerank,epithelial tube morphogenesis (GO:0060562),0.41450702550737245,1.2981357627099248,0.12695924764890282,0.796184987968574,1.0,9/32,12.51%,FGF10;SCRIB;PAK1;MEGF8;MEF2C;BMP4;PRKD2;PKD2;PKD1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4254296361368732,1.2979192159782647,0.1299342105263158,0.7915601166831759,1.0,9/29,15.56%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACLY
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4254296361368732,1.2979192159782647,0.1299342105263158,0.7915601166831759,1.0,9/29,15.56%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACLY
prerank,regulation of neuron migration (GO:2001222),0.4285738569954967,1.2977288623501835,0.12755905511811025,0.7896881886972116,1.0,13/26,26.70%,SRGAP2;PLXNB2;CTNNA2;DAB2IP;IGSF10;ULK4;NTNG2;NTNG1;NSMF;CAMK2B;SEMA3A;RAPGEF2;PHACTR1
prerank,action potential (GO:0001508),0.38256080123764247,1.2976271437288909,0.13178294573643412,0.7875279596126413,1.0,17/44,28.45%,KCNH2;KCND2;KCNE2;DMD;GNA15;CACNA1G;SCN2A;GNA11;KCNMB3;SCN3B;SCN8A;SCN7A;ANK3;GNAQ;KCNB1;CACNA1H;SCN1A
prerank,positive regulation of cell projection organization (GO:0031346),0.3253847721832959,1.2973989334896512,0.07103825136612021,0.7857896430387061,1.0,55/115,29.11%,MAP6;FBXW8;PLXNB2;OBSL1;PTPRD;NTRK1;ARSB;STMN2;PLA2G3;NTRK3;PTK7;PRKCI;GPC2;RIT2;DAB2IP;TWF2;ARHGDIA;CDKL5;TENM3;IL1RAPL1;SS18L1;ARHGAP35;NDRG4;MAP3K13;NDNF;STYXL1;NTRK2;PRKD1;TWF1;SETX;ITGA6;SCARB2;FES;PLXNB1;DVL2;MAGI2;ROR1;SCN1B;CAMK2B;SERPINI1;BDNF;TIAM1;RHOA;RAPGEF2;CAMK1;DLG4;NGFR;EPHA3;CUX1;SLITRK1;ATP1B2;ROR2;ROBO1;MDK;CUL7
prerank,mitochondrial genome maintenance (GO:0000002),0.5363034987752928,1.2972400776236632,0.16262975778546712,0.7837987838256691,1.0,2/11,0.37%,TOP3A;SLC25A4
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3457791017252423,-1.297000815975518,0.08985507246376812,0.5142991337021189,1.0,17/40,22.14%,SUCO;APOE;CD36;LARP6;VIM;HDAC2;SORBS1;CYBA;SCX;CREB3L1;SLC5A3;ZBTB20;TLR4;RGCC;MMP8;SERPINF2;ADGRB1
prerank,lung epithelium development (GO:0060428),0.5585999013359325,1.2961871754508631,0.1570945945945946,0.7856159023966883,1.0,3/10,12.51%,FGF10;BMP4;PKD1
prerank,regulation of GTPase activity (GO:0043087),0.3084802846873737,1.2958145450774285,0.04326328800988875,0.7845539741083304,1.0,58/177,20.52%,AGRN;SH3BP1;STMN3;SRGAP2;PLXNB2;ARHGAP44;CHN1;F11R;SGSM2;CHN2;NTRK1;SGSM3;THY1;FGD2;PKP4;TMED2;DAB2IP;MAPRE2;RAPGEF3;ADCYAP1;EPHA1;CDKL5;MAP4K4;RGS10;ITGB1BP1;OCRL;RASGRF1;RAP1GAP;SFRP1;DOCK10;RAP1GDS1;VAV1;PRKG1;DOCK9;RALBP1;ARFGEF1;EPHA4;FLCN;RCC2;NTRK2;SH3BP4;RSU1;RRP1B;HRAS;PTK2;ITGA6;ALS2;ZC3H15;ARHGAP12;ASAP3;PIN1;CCL15;WNK1;PLXNB1;CCL5;CAV2;GMIP;EPHA5
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.2463146979731198,-1.2956356653497474,0.01834862385321101,0.5166622254957524,1.0,85/336,18.84%,VAV3;BCL2;VCPIP1;FNIP2;RAD51B;PARP4;BCL2L1;RBBP8;VCP;SETD7;ETAA1;BAZ1B;PDS5B;CUL4A;IRF7;UBA6;DTX3L;MCL1;BAX;TOP2A;MAPKAPK2;TOPBP1;USP28;DOT1L;BCL3;RTEL1;ZBTB40;ZRANB3;TAF1;YY1;CHD1L;CCND1;POLI;LYN;YAP1;NBN;IGHMBP2;CIB1;USP45;PCLAF;BRCA1;UVRAG;PSEN1;PDS5A;TAOK3;ATRIP;HINFP;PIDD1;ZC3H12A;TRRAP;ALKBH8;GRB2;FOXO1;BARD1;TRIP12;RPA1;CDK1;AKTIP;CRY1;TNFRSF1B;RMI2;BRAT1;ALKBH7;TICRR;NPM1;FOXP1;FAAP20;MNAT1;MCM9;BCL2L11;MCM8;CRIP1;EPHA2;WAC;NOP53;MUTYH;NUPR2;DTL;PPP1R15A;SLX4;MAPK12;XPC;WDHD1;HPF1;RBBP5
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4473767353129742,1.2955709835218796,0.15091210613598674,0.7829811254183472,1.0,6/23,17.90%,CBARP;NOS1AP;PRNP;UBASH3B;CACNA2D1;ANK2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.41728578423793167,-1.2951210192502862,0.13730569948186527,0.516797243440518,1.0,9/22,15.14%,APOE;ADAM9;NRDC;SNX9;IL1B;ADAM8;TNFRSF1B;TIMP4;TNF
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.44033266859499953,-1.2945075589095596,0.12530712530712532,0.5172890698837455,1.0,3/17,5.94%,PLBD1;PLA2G4E;PLAAT3
prerank,synaptic membrane adhesion (GO:0099560),0.5089652709343382,1.2944685274845493,0.1514629948364888,0.7851910568766869,1.0,9/14,32.02%,PTPRD;GPC4;PTPRS;NTNG1;LRRC4C;LRRC4B;SLITRK1;LRFN5;PTPRF
prerank,proteoglycan metabolic process (GO:0006029),-0.3954692195294723,-1.294307205514966,0.116751269035533,0.5166256837328886,1.0,6/26,9.54%,CHST11;IGF1;XYLT1;CHST9;FAM20B;HPSE
prerank,cellular response to ketone (GO:1901655),-0.36887822272320114,-1.2942546653484241,0.11263736263736264,0.5156982987258645,1.0,12/35,14.05%,NR3C1;PTGER4;AHR;MSN;ADCY5;ADCY6;KLF9;ACOD1;ADCY1;ADCY3;LARP1;SPHK2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.4454576167790534,-1.2942513965800087,0.14805825242718446,0.5145855651902401,1.0,6/17,13.19%,CD74;CD44;DYRK1A;YJU2;PTTG1IP;PSMD10
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.42383320766246013,-1.2938940326108737,0.12562814070351758,0.5143604555033868,1.0,6/20,6.28%,DAB2;PID1;BCL2L1;CSK;PPP2R5A;PICALM
prerank,DNA damage checkpoint signaling (GO:0000077),-0.37949582508250856,-1.291625061994557,0.11794871794871795,0.5189238188119523,1.0,8/28,10.72%,PRPF19;CLSPN;USP28;DOT1L;NBN;ATRIP;HINFP;RHNO1
prerank,positive regulation of axon extension (GO:0045773),0.4481382134527907,1.2906387176883405,0.14513556618819776,0.7989777430707575,1.0,7/22,13.98%,SEMA7A;MEGF8;DSCAM;LIMK1;TWF2;CDKL5;MAP3K13
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.37570399277771643,-1.2902246644725897,0.11173184357541899,0.521330274401686,1.0,8/32,14.01%,PID1;IGF1;VCP;ENO1;HIF1A;PSEN1;ENTPD5;ZBTB20
prerank,negative regulation of developmental growth (GO:0048640),0.41349602851991185,1.2896346648323718,0.13782051282051283,0.8007430328277424,1.0,14/30,30.40%,DIP2B;DCC;FGF13;MAG;WWC1;PTPRS;ULK2;MAP2;ULK1;NKD1;PTEN;DUSP10;RTN4R;FGFR3
prerank,response to organonitrogen compound (GO:0010243),0.39418300682878027,1.2893772357591382,0.1253968253968254,0.7991348023248059,1.0,11/38,15.21%,UBXN6;GLRA3;IL6;INAVA;TRPM2;GLRB;PRKN;GLRA2;CCDC47;DERL1;IRF5
prerank,determination of left/right symmetry (GO:0007368),0.3975568882103412,1.2893684770774358,0.11773700305810397,0.7965363859913422,1.0,7/37,8.99%,DNAAF1;ODAD4;CCDC39;PKD1L1;MEGF8;DAND5;PKD2
prerank,positive regulation of cytokine production (GO:0001819),-0.2500306461624338,-1.2891102837228106,0.014598540145985401,0.5230751465111579,1.0,84/292,18.58%,IL15;RFTN1;PAEP;CD74;PTPN22;CD274;CCDC88B;PTPRC;CCBE1;IFIH1;TLR2;PIBF1;LILRA5;IRF7;IL12RB2;RAB1A;RARA;ZBP1;TBK1;CCR2;IL16;POLR2E;RAB7B;IL6ST;LAMTOR5;PTGER4;TYROBP;DHX33;TLR7;NFKB1;CEBPG;CD14;IL27;IRF4;NOD2;HSPD1;SYK;RIPK1;CEBPB;DDX41;ANXA1;TLR8;PRKCQ;HIF1A;CLEC6A;BRCA1;IL1B;CD226;DRD2;LPL;HPSE;TMED10;EP300;CD28;CTNNB1;LTB;C1QTNF3;CYBA;CD2;SLC11A1;STOML2;LRRFIP1;CXCL17;SPHK2;POLR2H;FOXP1;LBP;EBI3;AGER;LILRB1;TNF;SCIMP;WNT5A;FCER1G;TLR4;HMOX1;IL18R1;ADAM17;RGCC;POLR3G;GATA3;AGPAT2;MMP8;ARHGEF2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4462745807376063,-1.289093904634541,0.1491442542787286,0.5219790123439964,1.0,10/16,29.84%,APOE;HIF1A;S100A1;TERF2;TNF;NUS1;DHFR;TERT;GCH1;AGTR2
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4051085785729955,-1.28876866265871,0.11979166666666667,0.5217141927570718,1.0,7/22,15.76%,MDFIC;SP100;BAG4;BARD1;LRRK2;INPP5K;CHP1
prerank,acyl-CoA metabolic process (GO:0006637),0.3972652351395914,1.2885710025383312,0.13771517996870108,0.7973854594472913,1.0,9/35,16.36%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACACB
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4271873316144408,1.288399983223467,0.14211438474870017,0.7955251527516836,1.0,6/25,9.58%,MPP2;MEF2C;ARRB2;GRID2;GRIN1;GRIN2B
prerank,negative regulation of bone mineralization (GO:0030502),-0.47981865094684606,-1.2882763976465998,0.15865384615384615,0.5218702185397962,1.0,6/13,19.84%,BCOR;SRGN;TRPM4;GREM1;PTK2B;RFLNA
prerank,photoreceptor cell development (GO:0042461),-0.46474801604992794,-1.2882608137782954,0.13267813267813267,0.5207807565710809,1.0,10/14,44.83%,MFSD2A;RP1;DCX;TH;CDHR1;AHI1;CEP290;MYO7A;TOPORS;VEGFA
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5231712759245457,1.287892970503672,0.17896678966789667,0.7951055741114573,1.0,4/11,20.43%,GTF2H2;ARRB2;ADM;ARRB1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.5332213936316689,1.2876089124109846,0.1794425087108014,0.7937599765504785,1.0,6/11,26.74%,TIMM29;TIMM13;TIMM22;TOMM70;TIMM10;TIMM10B
prerank,cell projection organization (GO:0030030),0.4110534316109119,1.2872568908210889,0.13848631239935588,0.7927044179046966,1.0,10/30,21.34%,P2RY12;RHOV;NCKAP1;NCKAP1L;CYFIP1;RHOQ;RHOU;CAPG;CDC42;KIF17
prerank,metal ion export (GO:0070839),0.41173392999664826,1.2872283410192908,0.1419656786271451,0.7902333447446072,1.0,9/31,19.85%,KCNH2;KCNA5;ATP1B1;KCNE2;ATP1B3;KCNT2;ATP1A3;ATP1A4;ATP1A1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3395196989816835,-1.286719687063123,0.07453416149068323,0.5234050384728074,1.0,19/46,24.60%,MAP3K1;PTGER4;TLR7;NFKB1;FAS;TLR8;IL1B;PIEZO2;PDE2A;TLR4;MAPK8;MAP2K4;TMEM150C;MYD88;CASP1;MAP3K2;TLR5;TNFRSF8;FADD
prerank,muscle cell differentiation (GO:0042692),0.4086182621913049,1.2865331701037834,0.13564668769716087,0.7907001174926642,1.0,13/32,27.69%,NEBL;DUSP29;LBX2;DMD;MEF2C;SGCZ;RORA;NRAP;MRTFA;POPDC3;TMEM204;WNT5B;SEMA4C
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.3461559548961738,-1.286074608835922,0.10204081632653061,0.5241096382101614,1.0,14/42,18.45%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;UBA52;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43
prerank,development of primary male sexual characteristics (GO:0046546),0.4004664026265596,1.285945014534464,0.14378029079159935,0.7906041803675188,1.0,6/34,9.13%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,regulation of apoptotic process (GO:0042981),-0.23475090899358245,-1.2858201773632907,0.0,0.5236870510901547,1.0,149/676,16.52%,VAV3;DAB2;ARHGEF3;FGD4;ITSN1;ARHGAP10;BCL2;STK3;ITCH;CD74;ARL6IP5;SLK;DDX42;CD38;GAS6;HIP1;IGF1;AXL;BCL2L1;KLHL20;RAF1;STK17B;CD44;VCP;TNFAIP8;STEAP3;ATAD3A;YME1L1;IFIT2;ACTN1;BRAF;BIRC6;MCL1;NUAK2;LGALS1;ZBP1;SIAH2;BAX;TOP2A;IL6ST;PTPA;NLRC4;BCL3;PIM1;NFKB1;CIAPIN1;ARHGEF18;RASA1;ATG7;ARHGEF6;SLC27A4;HIP1R;BAG4;THBS1;VHL;FAS;HSPD1;RIPK1;TFRC;PRDM9;PDCD10;PLAUR;IFIT3;PLEKHG5;ANXA1;TMEM219;HNRNPK;UBC;ANP32B;CIB1;NAA16;FGD1;CTSB;PSEN1;RPL10;HCK;TPT1;IKZF3;RNF157;PIDD1;PNMA2;ABR;UBA52;HYPK;GNA13;GCLC;SH3RF1;UTP11;MAP3K11;STAT1;ANXA4;CD28;BIRC5;SPRY2;EGR3;DNM2;CTNNB1;FOXO1;PRMT2;ATF5;BARD1;MIEN1;CDK1;BRMS1;STPG1;MAD2L1;HDAC2;BIRC2;SMAD6;GRM4;DAPK1;CBL;ARHGEF26;GADD45G;FHL2;RPS6KA2;HDAC1;KDR;CCND2;APH1B;PSMD10;RYBP;RACK1;SCX;PTMA;GREM1;BMP2;SPHK2;NPM1;HS1BP3;PMAIP1;EGFR;DFFA;SHC1;LILRB1;TNF;BCL2L11;PTK2B;HSPB1;WNT5A;NUP62;SAP18;DDX20;CLN3;ARHGEF5;PLK1;KLF11;BCAR1;MAPK8
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4722432599072795,1.2857874026865888,0.14593698175787728,0.7887366602311516,1.0,6/18,15.11%,CBARP;KCNH2;BIN1;COMMD1;STK39;NEDD4L
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.4620992233633149,-1.2856518673341653,0.14213197969543148,0.5229951672481501,1.0,5/14,10.76%,PXN;STAT5B;PTPN1;LYN;GHR
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.32242233447683666,-1.2854528658076236,0.08787878787878788,0.5224644808423665,1.0,18/56,17.76%,RAD51B;ANKRD17;MECP2;CUL3;NSMCE2;CCND1;ANXA1;CDC27;CDK1;ESPL1;CCND2;RB1;EGFR;CDC25A;UBE2C;ADAM17;RGCC;DTL
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.48019304246368744,1.2851100973423066,0.1644518272425249,0.7891861258271411,1.0,4/16,13.56%,DDX5;AR;TADA3;RBFOX2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.46261799264646747,1.284771856889516,0.15754560530679934,0.7881502529816266,1.0,8/18,18.41%,PRKCZ;NRXN1;SHANK3;GRIN1;RIMS1;WNT7A;SHANK1;CHRNA7
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.3077988621333165,-1.2847417154118441,0.05806451612903226,0.5231392817040724,1.0,15/70,10.70%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2
prerank,sulfur compound transport (GO:0072348),-0.39459509704662205,-1.284568704809851,0.11940298507462686,0.5224930289388194,1.0,7/27,12.72%,LRRC8D;SLC26A11;SLC6A6;RACGAP1;SLC25A19;SLC13A4;SLC25A11
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2426122432278503,-1.2840659218792077,0.0,0.5226702152171154,1.0,126/417,21.84%,RBPJ;MDFIC;NR3C1;WWP1;CD38;GAS6;MECP2;POU2F1;EPC1;SETDB2;SP3;LIMD1;ZHX2;HMGB2;KAT6B;PPARG;CIITA;CBFA2T3;SMARCA4;RARA;ENO1;SMURF2;PATZ1;BCL3;AHR;PROX1;LIMS1;NAB1;PPARD;ATXN1;MBD2;RCOR1;CIART;BCL7A;DPF3;BCOR;PFDN5;KDM8;NR1H2;ID4;BRCA1;FOXE1;CRY2;HINFP;SNW1;ID3;GCLC;MBD1;L3MBTL4;CTCF;BIRC5;ZBTB18;CTNNB1;FOXO1;PRMT2;ATF5;SPEN;NOTCH1;L3MBTL3;BRMS1;HDAC2;ID1;RCOR3;ZNF148;CRY1;ATF7IP;DEPDC1;EHMT1;KAT5;HDAC1;MIDEAS;RB1;GATAD2A;INPP5K;BMP2;FOXP2;CREB3L1;L3MBTL2;QARS1;FOXP1;ZNF318;RIOX1;THAP7;LHX1;DACH1;SHC1;TNF;KDM5C;KAT7;WNT5A;FOXK2;DEAF1;SAP18;IKZF1;ARID5B;UIMC1;HEY2;SMAD4;GATA3;HMGA2;GLIS2;PER2;NIBAN2;LANCL2;HES1;TFAP2B;PPM1F;CDKN2A;TAF7;EED;YEATS2;PA2G4;BMP7;NCOR1;HMGA1;BHLHE40;KLF4;SCMH1;RBAK;BASP1;SIRT2;TRIM33;HDAC4;HEYL;ID2;PSPC1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.49292183430509917,-1.2835527157665247,0.15473441108545036,0.5228723434453221,1.0,5/12,12.10%,APOBEC1;SETDB2;PPHLN1;DNMT1;ATF7IP
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3943496391076724,-1.28338354353042,0.13881748071979436,0.5221680451053727,1.0,10/25,18.41%,IGF1;SOX11;DOT1L;H1-0;MAD2L2;RB1;HEY2;GATA3;PER2;NIBAN2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.27723647247312305,-1.2833040482453983,0.014563106796116505,0.5212961726666475,1.0,48/136,21.75%,SP100;ITCH;GAS6;RWDD3;ESR1;PROX1;PIM1;CEBPG;TAF1;ID3;ZC3H12A;MAD2L2;ANXA4;PTGIS;PAXIP1;NFKBIE;PRMT2;ACOD1;BRMS1;HDAC2;ID1;FOXJ1;NLRC5;PSMD10;RB1;SIK1;SFRP5;CHP1;OTULIN;PYDC1;WFS1;FLNA;GLIS2;NWD1;HES1;TRIM37;CDKN2A;BMP7;BHLHE40;KLF4;NLRC3;TRIM21;TMSB4X;HDAC4;AIM2;PTCH1;HEYL;ID2
prerank,negative regulation of protein transport (GO:0051224),-0.39690284032984746,-1.2831018450839826,0.14360313315926893,0.5208136083016998,1.0,10/25,21.29%,APOE;CSK;DRD2;RSC1A1;PKDCC;DPH3;PPM1F;DRD3;SERGEF;NDFIP1
prerank,positive regulation of B cell activation (GO:0050871),-0.3288587855084433,-1.2826487807944429,0.08982035928143713,0.5208622599260014,1.0,15/50,16.53%,VAV3;BCL2;CD74;CD38;PTPRC;NOD2;GPR183;SYK;TFRC;MAD2L2;PAXIP1;SHLD1;SASH3;BST1;CHRNB2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.40921211151972264,1.282603573001874,0.1306532663316583,0.7947973561723436,1.0,12/32,19.82%,FBXW8;OBSL1;PTPRD;CDKL5;HECW2;IL1RAPL1;SS18L1;NEDD4;NEDD4L;SARM1;NSMF;SDC2
prerank,neuron projection organization (GO:0106027),0.47390037773145405,1.282270379853445,0.17699115044247787,0.7937353271687014,1.0,8/15,22.29%,PRNP;LGMN;DCTN1;INSR;ABCD2;CHRNA7;ATP1A3;ARF1
prerank,protein deneddylation (GO:0000338),0.5344882435726419,1.2822571458816403,0.1541095890410959,0.7912836085170631,1.0,4/10,20.14%,COPS8;COPS3;COPS6;COPS5
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3038443729539948,-1.2821123733453421,0.06007067137809187,0.5211168737926716,1.0,19/73,16.10%,FNIP2;GAS6;RAF1;CD44;CNOT9;BRAF;DOCK7;TBK1;TFRC;BCAR3;CAV1;PDCD10;TXN;MAD2L2;SPRY2;MTCP1;EGFR;TNF;PFN2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3550805915193628,-1.2813087772457767,0.1348973607038123,0.5221257466921511,1.0,11/39,14.73%,NOL11;RPS24;RPS16;RPS14;RPS7;DDX52;RPS5;UTP4;METTL17;NPM1;WDR3
prerank,response to ATP (GO:0033198),0.4701975213902321,1.2804865784514206,0.1610738255033557,0.7963274463604173,1.0,6/18,16.10%,P2RY12;TRPC3;DGKQ;HSP90B1;P2RY1;SSH1
prerank,positive regulation of nervous system development (GO:0051962),0.38938367427447146,1.27982369582556,0.1299093655589124,0.7966458984084466,1.0,17/42,23.81%,PTPRD;SRPX2;NUMB;LRP2;IL1RAP;NRXN1;GRID2;CLSTN2;CX3CR1;IL1RAPL1;EPHB2;WNT7A;OPRM1;GHRL;NAP1L1;BDNF;LRRC4B
prerank,actin nucleation (GO:0045010),-0.4143834258111211,-1.2797830538671455,0.15733333333333333,0.5249164058270532,1.0,4/21,9.55%,IQGAP2;ACTR3;ARPC2;ARPC5
prerank,membrane depolarization during action potential (GO:0086010),0.42245062644331594,1.2792903613155933,0.14814814814814814,0.7964626987526521,1.0,14/26,34.04%,KCNH2;CACNA1G;SLC8A1;CACNA1D;SCN2A;SCN1B;SCN3B;SCN8A;SCN7A;CACNA1H;SCN1A;CACNA1I;SCN4B;KCNJ2
prerank,regulation of cell cycle process (GO:0010564),-0.2893521505028884,-1.2790079624365334,0.040740740740740744,0.5257757793880373,1.0,29/104,17.92%,PIK3C3;BCL2L1;PIK3R4;GIT1;BIRC6;KIF11;MKI67;SH3GLB1;BORA;PRC1;CEP250;KIF20B;UVRAG;RACGAP1;KLHL21;CTNNB1;ATF5;CALM3;AHCTF1;RMI2;BUB1;CALM2;PRPF40A;NUMA1;PLK1;KIF20A;CUL9;ECT2;HMGA2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4310505498810625,1.2786715712747103,0.12460567823343849,0.7965505495332138,1.0,4/25,5.88%,CAPN3;CACNB2;THY1;PLCG1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5039765809387733,1.2786520789615385,0.16782006920415224,0.794179526178138,1.0,3/13,7.53%,DDX5;HIC1;EEF1E1
prerank,axon extension (GO:0048675),-0.40423750861881363,-1.2779937866900073,0.13756613756613756,0.5273010540575355,1.0,6/23,12.37%,ALCAM;NRP1;NRP2;SLIT1;USP9X;SEMA5B
prerank,myelin maintenance (GO:0043217),0.5319551329013614,1.2776792609020302,0.17876106194690267,0.7958955207151324,1.0,6/10,28.40%,CLU;CXCR4;MYRF;ABCD2;EPB41L3;PTEN
prerank,regulation of viral entry into host cell (GO:0046596),-0.37406695807287077,-1.2776255952307474,0.13440860215053763,0.527148533539614,1.0,7/30,6.61%,CD74;TRIM25;TRIM14;CIITA;LGALS1;IFITM3;TRIM62
prerank,signal release from synapse (GO:0099643),0.3847404198256443,1.27716694470713,0.13529411764705881,0.7956050728275733,1.0,10/43,14.15%,SNAP25;RAB3A;SYT1;SNAPIN;NRXN1;OTOF;RIMS1;CPLX2;GAD2;STXBP2
prerank,protein stabilization (GO:0050821),-0.2631371839027895,-1.2769098604246987,0.023474178403755867,0.527908805936498,1.0,44/168,17.77%,STK3;FLOT2;HIP1;IGF1;RPL5;CCT6A;DVL3;STX12;FBXW7;TYROBP;TAF1;HIP1R;BAG4;VHL;SEC16A;RPS7;HSPD1;PDCD10;TBL1X;NAA16;BAG6;LAMP2;HYPK;EP300;USP9X;CCNH;TRIM44;CCT3;WDR81;ATF7IP;LAMP1;RAB21;NLK;GET1;TESC;MCM8;CHP1;PFN2;MUL1;NAPG;NOP53;DNLZ;WFS1;FLNA
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4959800700968954,1.2764011511078022,0.19425675675675674,0.7964312308780365,1.0,9/14,27.16%,SH3BP1;FSCN1;SCRIB;CAMSAP3;PATJ;CDC42;OPHN1;RHOA;MYO9A
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.35717544405412066,-1.2761117698499131,0.14245014245014245,0.5287467058187922,1.0,12/36,24.31%,ITCH;PTPN22;TAOK3;FOXO1;DUSP1;QARS1;NCOR1;DUSP19;MECOM;GSTP1;DUSP3;FKTN
prerank,respiratory system development (GO:0060541),0.40022771731406964,1.2759417294875732,0.13709677419354838,0.7958968970604916,1.0,8/32,12.89%,DNAAF1;FGF9;CCDC39;DISP1;FGF7;BMP4;FGF2;SPEF2
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.2627876124818485,-1.27531676665352,0.025252525252525252,0.5296950966291895,1.0,32/170,9.88%,APOE;NOVA2;IGF1;KIF16B;AFF1;CDK6;PTPRC;ZUP1;TRIM14;PEG3;MTMR2;AHR;PROX1;NFKBIZ;TRIM17;RASA1;TAPBP;MTMR4;PRDM9;ZFP64;HNRNPAB;LDLR;SLC8A2;RO60;HNRNPK;HIF1A;BMI1;PSEN1;KDM6A;HINFP;ZC3H12A;CTCF
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.29797174379360686,-1.2742991839110451,0.0708955223880597,0.5313687993724823,1.0,27/93,18.72%,FCGR2B;SASH1;ARL6IP5;SDCBP;XDH;PJA2;NOD2;RIPK1;PDCD10;MID1;RELL1;IL1B;TAOK3;ZC3H12A;SH3RF1;MAP3K11;TNFRSF19;GADD45G;SLAMF1;BMP2;AGER;PTK2B;SCIMP;TRAF1;HIPK2;MMP8;TRAF4
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.33458369259784393,-1.2731355803185365,0.09943181818181818,0.5334701116300865,1.0,5/46,1.66%,PEAK1;ITGA4;NRP1;PXN;ATRNL1
prerank,mitochondrion localization (GO:0051646),-0.4202054453159993,-1.273084784738674,0.15186915887850466,0.532484095937824,1.0,6/19,16.27%,TRAK1;MARK2;MTM1;BRAT1;LRRK2;MUL1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3553648133570206,-1.2729333291127523,0.11782477341389729,0.5318134577683064,1.0,12/39,14.82%,RBPJ;IL6ST;NOD2;PDCD10;ZMIZ1;YAP1;SNW1;EP300;NOTCH1;TSPAN5;CCN3;NOTCH4
prerank,mucosal immune response (GO:0002385),-0.45185714938493104,-1.2729249731093142,0.1738095238095238,0.5307605041958114,1.0,5/15,20.24%,RNASE3;RPL39;IFNLR1;CAMP;LTF
prerank,negative regulation of cell projection organization (GO:0031345),0.37059159162055644,1.2727828397207506,0.13561847988077497,0.8066433454440142,1.0,13/48,13.80%,DCC;STMN2;CRMP1;PTPRO;PRNP;ITM2C;RTN4RL1;PRAG1;MINAR1;GRIN2B;MAG;MYLIP;EPHA4
prerank,positive regulation of signaling (GO:0023056),0.39198280861109824,1.2726615562580028,0.13853503184713375,0.804666738762852,1.0,10/37,14.45%,CD80;SCRIB;SYT1;LGI1;GRIK2;CLSTN2;INPP5F;RIMS1;KCTD13;VAMP3
prerank,calcium ion transport into cytosol (GO:0060402),0.44021298918967633,1.272428224653098,0.16803953871499178,0.8032647504651705,1.0,7/21,15.58%,TRPM2;GRIN1;GRIN2B;SLC8A1;ITPR3;JPH1;CACNA2D1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3033670286781412,-1.2722994028580774,0.07308970099667775,0.5313942316098154,1.0,20/73,16.67%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2;MYO10;WIPF3;ELMO2;FCER1G;PLD2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4432459477758672,-1.2721040778539485,0.15346534653465346,0.5307325610070409,1.0,2/16,1.02%,MCTP1;MCTP2
prerank,mitochondrion transport along microtubule (GO:0047497),0.4927644800049012,1.2720318290988526,0.16869565217391305,0.802453637935275,1.0,8/13,26.15%,MAP1S;RHOT1;LRPPRC;SYBU;UXT;NEFL;SPAST;MAPT
prerank,epithelial cell migration (GO:0010631),-0.35144914050552867,-1.271020996764453,0.11506849315068493,0.5323971075034968,1.0,10/37,13.74%,ZEB2;NRP1;PXN;DPP4;KANK2;PLEKHG5;PIK3CA;STAT1;ADGRA2;PRKX
prerank,regulation of cell division (GO:0051302),-0.30439787645696276,-1.2697841249012916,0.07876712328767123,0.5345515170761281,1.0,25/72,22.33%,PIK3C3;BCL2L1;PIK3R4;GIT1;BIRC6;SH3GLB1;PRC1;MLLT3;CIB1;TXNIP;FGF1;UVRAG;KLHL21;CALM3;AHCTF1;CALM2;RACK1;PRPF40A;PLK1;KIF20A;KIF18B;ESRRB;SETD2;SIRT2;SHH
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5211232475666849,1.2697795199635373,0.16202090592334495,0.8093525315914123,1.0,2/12,0.46%,IDH3B;IREB2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3693806319107621,-1.2697320206335998,0.10695187165775401,0.5336315734246452,1.0,8/30,10.22%,CD274;PIBF1;LILRA5;IRF4;NOD2;HSPD1;SYK;CD28
prerank,histone H2A ubiquitination (GO:0033522),0.4579111242849666,1.2686755082261187,0.17271157167530224,0.8116666806991546,1.0,6/17,14.08%,UBE2B;KDM2B;RNF168;RNF8;DDB2;RNF2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3706582596304604,-1.268531660146152,0.15404699738903394,0.5358646104976439,1.0,12/30,25.38%,GNL3L;EXOSC10;TERF2;DACH1;NIBAN2;TENT4B;NAT10;HNRNPC;HNRNPU;TINF2;PIF1;BMPR2
prerank,inorganic ion transmembrane transport (GO:0098660),0.5123720128053667,1.2682950460389502,0.17491166077738515,0.8108494709473897,1.0,4/12,14.41%,KCNJ8;PKD2;ASIC2;ABCC8
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4916818794165764,-1.2676757118002406,0.1766109785202864,0.5371667337124515,1.0,2/11,4.12%,STAP1;TYROBP
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.319425283662004,-1.266988179123083,0.08917197452229299,0.5378439042697537,1.0,16/66,13.38%,MTSS1;APOE;ALOX5;CDK6;MCC;CDC73;XDH;RUNX3;FBXW7;AIMP1;THBS1;CAV1;STAT1;KLF9;CEACAM1;B2M
prerank,cation transport (GO:0006812),0.30551631096813897,1.2668690510353886,0.08375,0.8145908663426187,1.0,33/167,16.27%,KCNMA1;TMEM63C;KCNJ3;KCNA5;ATP1B1;SLC5A12;KCNJ8;LRP2;TRPM3;KCNC1;SLC12A2;TRPM2;SLC1A1;KCNK3;CNGB1;KCNJ13;SLC38A7;GRIN1;SLC8A1;ASIC1;KCNK6;FGF13;TRPC6;PANX1;SLC66A1;KCNN4;SCN2A;ABCC8;SLC22A4;SLC8A3;NEDD4L;KCNJ5;KCNMB3
prerank,thyroid hormone generation (GO:0006590),-0.5018325432285157,-1.2667697897184371,0.19158878504672897,0.5373380002338118,1.0,7/10,37.09%,CPQ;FOXE1;TG;SLC5A5;TPO;DUOX1;DIO2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.4885841541315111,-1.2661052224865526,0.17511520737327188,0.5380121557562606,1.0,5/12,10.07%,APOE;FLOT2;RANBP9;PICALM;TMED10
prerank,negative regulation of peptidase activity (GO:0010466),0.36787299006151636,1.265359637891061,0.1294851794071763,0.8188365882003446,1.0,14/47,26.07%,GAPDH;SPOCK3;CST3;SPOCK2;SERPINH1;VTN;SERPINE2;UBXN1;AGT;TIMP2;SERPINI1;CST7;SERPINF1;SERPINB8
prerank,mRNA processing (GO:0006397),0.2879586057139687,1.2650841105894877,0.045828437132784956,0.8175107145563407,1.0,80/287,20.24%,POLR2L;SRSF12;DHX35;RNPS1;CDK7;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;DDX5;TRA2B;BCAS2;HNRNPH1;CWC22;CASC3;XAB2;PPARGC1A;PPWD1;CTNNBL1;GTF2H2;CPSF6;SF3B2;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;PTBP1;SRSF11;GTF2H4;RBM5;GTF2F1;CACTIN;DDX46;AKAP8L;PRMT9;SNRNP70;SON;SF3B5;SF3A1;SRSF1;SNRPD2;YTHDC1;CPSF3;GPKOW;POLR2G;LSM8;RAMAC;TBRG4;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;DDX39B;HNRNPA1;THOC5;SARNP;GEMIN5;GEMIN6;SRSF9;ELAVL2;PUF60;CHTOP;UBL5;GCFC2;TRA2A;SNRPD3;SNRNP27;ALYREF;SRSF2;SRRM4;RBM10
prerank,negative regulation of type I interferon production (GO:0032480),-0.34186544440690403,-1.2650115479045998,0.11484593837535013,0.5398943643746634,1.0,15/40,20.89%,ITCH;TRIM25;IFIH1;TBK1;RNF216;YY1;ACOD1;NLRC5;UBE2L6;LILRB1;RELB;TRAF3IP1;NPLOC4;NLRC3;RNF125
prerank,protein K48-linked ubiquitination (GO:0070936),-0.31785060503113,-1.2649774609283184,0.10714285714285714,0.5388987095925056,1.0,14/54,12.78%,ITCH;UBE2D3;CUL3;UBE2K;DTX3L;RNF216;RNF146;CDC34;ARIH2;TTC3;RNF6;UBE2Q2;PELI1;UBE2E3
prerank,regulation of lymphocyte differentiation (GO:0045619),0.45537440777996885,1.2645923094762004,0.1912479740680713,0.817090202548513,1.0,7/18,16.94%,IL4I1;NCKAP1L;XRCC6;ZFP36L2;CRTAM;PRDM1;PRELID1
prerank,negative regulation of hemostasis (GO:1900047),0.5193460878433878,1.2640293965032428,0.20106761565836298,0.8170590096344904,1.0,5/12,15.41%,ADTRP;CD34;THBD;VTN;SERPINE2
prerank,T cell activation (GO:0042110),-0.30268320086608835,-1.2638723388153685,0.08227848101265822,0.5405868676023045,1.0,26/69,22.45%,CD74;PTPN22;CD44;DPP4;PTPRC;NCK1;MSN;IRF4;HSPD1;KIF13B;JAML;LFNG;LCP1;CD28;LCK;PPP3CA;CD2;NHEJ1;ZAP70;GATA3;TREML2;NLRC3;PIK3CD;CD3E;GPR89A;GPR89B
prerank,positive regulation of insulin secretion (GO:0032024),0.3888578725624118,1.2633717539298122,0.15160796324655437,0.8175066278048708,1.0,7/36,9.94%,ADCY8;NNAT;SOX4;RFX6;DOC2B;TCF7L2;CFTR
prerank,striated muscle contraction (GO:0006941),0.36132380404686515,1.2630616440865132,0.10973724884080371,0.816468989769821,1.0,9/53,12.95%,KCNH2;ATP1B1;TNNI3;TNNC1;DMD;MYBPC3;PGAM2;SLC8A1;LMOD3
prerank,negative regulation of immune response (GO:0050777),-0.26553086865618575,-1.2630514785848532,0.03125,0.5416585861227484,1.0,61/154,30.00%,FCGR2B;ITCH;CD163;CD300A;PRKACA;ADCY9;CCR2;PTGER4;SYK;LYN;FYN;ENPP3;PDCD1;HCK;ADCY5;VIPR1;ADCY6;RC3H1;ACOD1;ADCY1;ADCY3;NPSR1;LILRB1;PRKACB;RAMP2;CALCRL;GPR27;MYH9;MUL1;ADAM17;PTHLH;CD247;TRAF3IP1;COL3A1;NLRC3;TRIM21;SIRT2;VIPR2;RXFP2;PTH1R;CRH;CALCA;GLP1R;RAMP3;FCRLB;DHX58;SCTR;ADORA2A;VIP;ALOX15;RNF26;SPINK5;CREB1;GPR83;PTGDR;PTGIR;C1QBP;GPR15;RHBDF2;FGR;TNFAIP3
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5159965858833958,1.2630165166988314,0.1971326164874552,0.814254817357251,1.0,9/12,32.39%,ATP1B1;DMD;ATP1B3;WNK1;GLRX;ANK3;ATP1B2;WNK4;WNK3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4996470509657399,1.26282633992047,0.20469798657718122,0.8127122659996457,1.0,7/13,20.17%,NFIB;RELA;PPARA;BMP4;PDGFB;REST;SRF
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.41706163618106107,-1.2626091678430253,0.15691489361702127,0.541759782998576,1.0,9/18,20.91%,TCTA;FBXW7;GPR137B;GPR137;LILRB1;LILRB3;TLR4;LTF;TMEM178A
prerank,membrane fusion (GO:0061025),-0.35637929789497963,-1.2625401962605234,0.11621621621621622,0.5408988090780984,1.0,12/33,19.28%,MYOF;RABEP1;SNAP23;DYSF;SNAP29;DNM2;GCA;UBXN2B;CHP1;NAPG;USO1;NAPA
prerank,acylglycerol biosynthetic process (GO:0046463),0.425966589416947,1.2619422824643893,0.18319327731092436,0.8141708360747824,1.0,4/23,6.61%,ANG;DGAT2;AWAT2;PNPLA3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.23670677878472124,-1.2612151714774968,0.0,0.5434154687217482,1.0,152/476,22.47%,MDFIC;SP100;MED13;CD74;CREB5;APOE;CD38;IGF1;EPC1;MITF;SP3;ARID1B;CDK5RAP2;HMGB2;KAT6B;RUNX3;PPARG;DVL3;CIITA;IRF7;DTX3L;SMARCA4;RARA;SOX11;MED16;BCL3;ESR1;AHR;NFKB1;SETD3;KLF6;IRF4;LYL1;VHL;PPARD;NCOA1;SMAD3;SP1;MLLT3;DYRK1A;JMJD6;CEBPB;HNRNPAB;PICALM;EGR2;ZMIZ1;PCBD2;ILF2;KDM8;NR1H2;YAP1;TBL1X;NAA16;HIF1A;SMARCA1;BRCA1;IL1B;FOXE1;PSEN1;RNF14;HINFP;RNF6;RET;MAD2L2;CTCF;STAT1;PBX4;EP300;DNM2;CTNNB1;FOXO1;PRMT2;ATF5;NOTCH1;TRIM44;HDAC2;SKAP1;NFE2;ATF7IP;FZD2;RXRB;PARP9;KAT5;HDAC1;NR1H3;RYBP;SCX;INPP5K;BMP2;FOS;NPM1;TESC;ZNF318;EGFR;NOTCH4;LHX1;BICRAL;SHC1;TNF;TRIM45;ING1;WNT5A;PHF5A;NUP62;FOXK2;WAC;DEAF1;EDRF1;TNNI2;HIPK2;KLF2;MAP2K7;HEY2;NAT14;SMAD4;GATA3;HMGA2;HNRNPD;GLIS2;RNF20;NIBAN2;LRP6;TRIM16;XPC;HAS3;CDH1;HES1;TFAP2B;AFAP1L2;ACVR1;BMP7;EHF;ESRRB;BAMBI;HMGA1;ELF2;NFATC2;EPO;KLF4;KMT2B;POU3F1;MAP3K2;ZFP90;HDAC4;ID2;RREB1;HMGN5;FZD4;MECOM;NR1H4;SHH;CAND2
prerank,mesonephric tubule development (GO:0072164),0.47008405086801747,1.2608336031382543,0.17869415807560138,0.8166077701932722,1.0,5/15,12.51%,BMP4;PKD2;FOXC1;NPNT;PKD1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.4655549563760998,-1.2606417515412118,0.17206982543640897,0.5437939630359743,1.0,4/13,8.99%,UBA5;UBA6;ATG7;UBA2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3837349266009409,-1.2603973397637458,0.14323607427055704,0.5433710865775907,1.0,7/26,9.39%,ITCH;ALPK1;IFIH1;NOD2;UBC;TAB1;UBA52
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.43649501054600814,-1.2602485772506626,0.17798594847775176,0.5427198607296387,1.0,6/16,18.52%,FCGR2B;CD274;TYROBP;AGER;LILRB1;MMP8
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3355787718530915,-1.2599314792061111,0.1132596685082873,0.5424959417005341,1.0,13/48,13.52%,NEDD9;NRP1;CASS4;CRK;LIMS1;CRKL;CARMIL1;CIB1;CDKL3;CAPRIN1;S100A10;CUX2;MYOC
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4456991684659687,1.2596672265041757,0.16091954022988506,0.819162992595239,1.0,6/20,12.55%,ATP2A2;ATP1B1;TNNI3;DMD;SLC8A1;GSTO1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3703522248162113,1.2595937449464525,0.1471927162367223,0.8171278277572281,1.0,10/44,13.24%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;FCHSD2;LMOD3;EVL
prerank,cholesterol efflux (GO:0033344),-0.41870803314054594,-1.259572556739852,0.15079365079365079,0.5423782207681858,1.0,6/20,12.97%,APOE;NPC2;STX12;ABCG4;ABCG1;APOC1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3426245299411276,1.259184011922477,0.11673699015471167,0.8164617729306949,1.0,12/69,11.47%,PLCH1;TPTE;PIK3C2G;PLCL1;NYAP2;NTRK1;PLCD1;PIK3CG;RPS6KB1;OGT;INPP5F;IRS1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.40310584933159843,-1.2586650673010278,0.16183574879227053,0.5435829706467049,1.0,8/20,17.73%,RBPJ;SMAD9;HIF1A;EP300;NOTCH1;BMP2;SESN2;SMAD4
prerank,modification-dependent protein catabolic process (GO:0019941),-0.2598967819891581,-1.2577136408757887,0.015957446808510637,0.5449876972820765,1.0,42/193,12.04%,ITCH;RNF149;BUB3;TRIM25;CUL3;ARIH1;UBE2K;UBA6;DTX3L;BIRC6;FBXL14;SIAH2;RNF213;OS9;SMURF2;TAF1;RNF146;PSMD11;CDC34;UBL7;ARIH2;UBQLN1;RNF13;UBC;ZNRF3;FBXW4;BAG6;KLHL15;RNF14;TTC3;RNF150;RNF6;UBE2L3;UBA52;CDC27;SPSB2;RC3H1;TRIP12;WDR91;MAD2L1;WDR81;CBL
prerank,purine nucleotide catabolic process (GO:0006195),-0.467572189138422,-1.257647288380288,0.16704805491990846,0.5441144552153195,1.0,3/13,5.65%,GDA;XDH;NT5E
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.4342008643889138,-1.257584216476658,0.1717171717171717,0.5432262667851963,1.0,11/16,35.19%,PTPRC;CEACAM1;KLRD1;AGER;LILRB1;FADD;IL12RB1;KLRC1;IL12A;IL23R;IL12B
prerank,central nervous system development (GO:0007417),0.28810061991359226,1.2574246897932304,0.06553398058252427,0.8214895916681474,1.0,58/250,18.14%,TPPP;ZFHX3;ROGDI;PLXNB2;C3;DNAJC30;ECRG4;BPTF;NNAT;ACAN;NFIB;SOX10;CYP26C1;ABCB6;NCKAP1;SOX4;PBX2;MAP1S;UBE3A;SEMA6B;NPTX1;ADAM22;ADGRL3;COX7B;SH3GL2;PKD2;GRIN1;CX3CR1;GRIN2B;PRKN;ASIC2;DDIT4;CTNS;CXCR4;PBX3;HAPLN2;SH3GL3;PKD1;PHF8;VCAN;NRCAM;TBX6;NDRG4;MYRF;ALDH5A1;HAPLN1;APOD;NKX2-2;HAP1;DSCAML1;SLC8A3;IER3IP1;TUBGCP2;AATK;ZIC5;IL1RAPL2;POU3F3;MBP
prerank,apoptotic nuclear changes (GO:0030262),-0.3861404443667932,-1.2566343622589151,0.1452513966480447,0.5445531973404795,1.0,7/24,14.77%,KPNB1;DNASE2;HMGB2;TOP2A;H1-0;ENDOG;DFFA
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4458898264045001,1.2563502696507818,0.16006600660066006,0.8236133601959382,1.0,5/19,13.93%,PRDX5;PRDX2;PXDN;PRDX4;ACOX1
prerank,DNA replication initiation (GO:0006270),-0.34481301765265926,-1.2558966137116259,0.12885154061624648,0.5455496650402218,1.0,16/37,26.28%,POLE4;TOPBP1;ORC5;CDC34;ORC2;RPA1;MCM2;ORC4;CDT1;PRIM2;MCM8;RPA2;POLE3;CDC45;PURA;POLE
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.3996863503970936,1.2556488350551471,0.15141955835962145,0.8241744603105109,1.0,5/31,7.63%,HOXD4;COL2A1;MEGF8;HOXB9;TGFBR1
prerank,maturation of SSU-rRNA (GO:0030490),-0.34856543097479376,-1.255209375922698,0.143646408839779,0.5463656572071941,1.0,8/34,14.73%,UTP6;NOL11;RPS16;RPS14;DDX52;UTP4;TSR1;WDR3
prerank,innate immune response in mucosa (GO:0002227),-0.5028379338427853,-1.2549963289382335,0.2058165548098434,0.5458974625515516,1.0,4/10,20.24%,RNASE3;RPL39;CAMP;LTF
prerank,regulation of protein polymerization (GO:0032271),0.3961464435650342,1.2547181541549344,0.1536050156739812,0.8257960186689179,1.0,11/35,23.08%,TPPP;CTTN;FCHSD2;CAMSAP3;CAMSAP1;PLEKHG2;MAP2;LATS1;MAPRE3;TPPP3;GBA2
prerank,nucleoside salvage (GO:0043174),0.5272741159710296,1.2536918414673872,0.2037351443123939,0.8276052745156496,1.0,5/10,19.74%,HPRT1;DCK;TK1;TK2;UCK1
prerank,Notch signaling pathway (GO:0007219),-0.3124394545153327,-1.2535306471788434,0.13043478260869565,0.5487260358987054,1.0,19/59,22.57%,RBPJ;ITCH;DTX3L;PSEN1;SNW1;STAT1;EP300;NOTCH1;APH1B;GMDS;BMP2;NOTCH4;ADAM17;DTX4;HEY2;HES1;NOTCH2;HEYL;KAT2B
prerank,positive regulation of hydrolase activity (GO:0051345),0.3090752579597876,1.2535293758815653,0.07493540051679587,0.8259368629628085,1.0,38/137,19.55%,AGRN;SH3BP1;SRGAP2;F11R;SGSM2;NTRK1;SGSM3;THY1;MTMR9;PKP4;RIPK3;MAPRE2;RAPGEF3;ADCYAP1;CDKL5;MAP4K4;RGS10;RASGRF1;RAP1GAP;SFRP1;DOCK10;MTCL1;RAP1GDS1;DOCK9;RALBP1;FLCN;RSU1;HRAS;ITGA6;ALS2;ZC3H15;WRN;ASAP3;PIN1;CCL15;PLXNB1;CCL5;CAV2
prerank,arachidonic acid metabolic process (GO:0019369),0.3927182315687279,1.2534079222519254,0.1456953642384106,0.8241510535021189,1.0,6/35,5.39%,CYP2S1;CYP2U1;PTGS1;PTGDS;ALOX12;PLA2G4C
prerank,inorganic anion transport (GO:0015698),-0.32381539669881093,-1.2534026646985121,0.12389380530973451,0.5479890474215873,1.0,21/53,28.54%,SLC26A11;CLIC4;CLCN1;ENPP3;RACGAP1;FXYD1;SLC13A4;SLC11A1;SLC25A11;ANO5;ANO8;ANO1;CLIC5;PACC1;SLC26A6;CLIC1;GLRA1;ANO10;ANO4;SLC4A1;SLC5A5
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.44070522662455697,-1.2526913542097355,0.18734177215189873,0.5487710509767201,1.0,5/15,23.83%,RBPJ;CEACAM1;EGFR;WDR54;EGF
prerank,signal transduction by p53 class mediator (GO:0072331),0.3934714079712314,1.2525122581634802,0.16155088852988692,0.8256656581458236,1.0,8/30,15.32%,FHIT;USP10;DDX5;STK11;MYO6;PPP1R13B;NDRG1;BATF
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2649473628999828,-1.2523243123915377,0.05555555555555555,0.5487033510597445,1.0,52/163,21.10%,VAV3;RFTN1;BCL2;CD38;PSMA6;PTPN22;CSK;PTPRC;DENND1B;TEC;PSMB2;PSME2;GRAP2;NFKBIZ;NFKB1;NCK1;PSMD11;SYK;PSMC6;FYN;BLNK;PRKCQ;THEMIS;PSMA3;EIF2B2;PIK3CA;ZC3H12A;CD28;LCP2;LCK;RC3H1;SPPL3;SKAP1;STOML2;PSMD10;CD79B;PSMB5;EIF2B4;RC3H2;SPG21;BCAR1;ZAP70;GATA3;PSMD5;CD247;THEMIS2;PSMD1;CD79A;NFATC2;PRAM1;PIK3CD;LAX1
prerank,positive regulation of leukocyte migration (GO:0002687),0.4062180663624535,1.2517504100141557,0.165625,0.8266850077591775,1.0,7/27,15.93%,PRSS56;THY1;NCKAP1L;IL6;ICAM1;MIA3;JAM3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5010703568929553,1.2513696052278243,0.19546247818499127,0.8259490631533655,1.0,4/12,12.24%,NELFB;NELFCD;RNF168;RNF8
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5222939770357472,1.2511939698895012,0.2063758389261745,0.8243415815513955,1.0,5/10,25.34%,ENPP2;LIPC;PLA2G15;PNPLA8;PLA2G4A
prerank,regulation of biosynthetic process (GO:0009889),-0.49734571352664236,-1.2510092498194045,0.21462264150943397,0.5512176194071442,1.0,6/11,24.20%,ALOX5;SPHK2;MID1IP1;SLC25A33;GSTP1;CCN6
prerank,protein polyubiquitination (GO:0000209),-0.24481163887009097,-1.250586949081553,0.0,0.5512712131594901,1.0,76/297,18.10%,SASH1;BCL2;ITCH;WWP1;HECTD2;PSMA6;UBE2D3;HERC6;KLHL20;FBXL17;UNKL;CUL3;ARIH1;PRPF19;TRIM14;UBE2K;PSMB2;DTX3L;FBXL14;FBXO30;FBXW7;SIAH2;RNF213;FBXL8;SMURF2;PSME2;TAF1;RNF216;UBE2Q1;RNF146;HECW1;PSMD11;CDC34;ARIH2;PSMC6;TRIM62;UBC;NHLRC3;PSMA3;FBXW4;BRCA1;RNF14;TTC3;LMO7;RNF6;UBE2L3;UBA52;CDC27;RC3H1;UBE2Q2;CTNNB1;BARD1;TRIP12;AKTIP;BIRC2;PELI1;UBE2E3;TRIM5;FBXO32;PSMD10;FBXO2;UBE2L6;PSMB5;TRIM71;RC3H2;MKRN1;TRAF1;MUL1;UBE2C;LONRF1;TRAF3IP2;TRIM3;DTL;PSMD5;RNF20;RNF144A
prerank,acute inflammatory response (GO:0002526),0.4184357906636311,1.2497236733134744,0.16965742251223492,0.8281358905201388,1.0,3/23,5.65%,F3;MBL2;IL6
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4624410602002874,-1.2497056746176463,0.18944844124700239,0.5524583445429397,1.0,3/13,12.04%,CBLB;SOCS5;CBL
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5140850656809036,1.2496341606387467,0.19387755102040816,0.8262074558350827,1.0,3/11,8.32%,SOX4;ZFPM2;BMP4
prerank,regulation of defense response to virus by host (GO:0050691),-0.3587602351728837,-1.2494776218220525,0.16573033707865167,0.5520061900092479,1.0,11/30,17.17%,PTPN22;DTX3L;RNF216;ZC3H12A;STAT1;TRIM44;PARP9;IFNLR1;LILRB1;MUL1;TRAF3IP2
prerank,response to exogenous dsRNA (GO:0043330),-0.42720466067097806,-1.2491628832832995,0.1989795918367347,0.5518285396531866,1.0,7/18,17.50%,RFTN1;IFIH1;IFIT1;CAV1;RALB;MUL1;SLC3A2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4974086892573499,-1.2485521397306478,0.20227272727272727,0.5524073891347558,1.0,5/10,22.57%,BAG6;EP300;KAT5;KAT7;KAT2B
prerank,hemidesmosome assembly (GO:0031581),0.5125053086963097,1.2482130069462434,0.1857638888888889,0.8299057562556365,1.0,6/11,25.03%,DST;LAMB3;ITGA6;LAMC2;LAMC1;ITGB4
prerank,respiratory tube development (GO:0030323),0.4026704284853912,1.2482025472217328,0.16558441558441558,0.8276414844598491,1.0,6/28,10.75%,DNAAF1;FGF9;CCDC39;FGF7;BMP4;FGF2
prerank,response to zinc ion (GO:0010043),0.4068093485764277,1.2478445742477287,0.17619783616692428,0.8268304464446499,1.0,12/25,18.07%,GLRA2;SLC30A3;KHK;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.36567506754092816,1.2461738853945856,0.15292353823088456,0.8313404586606603,1.0,10/46,7.90%,DGKI;CACNG5;CACNG2;SYT1;NRXN1;MEF2C;ATAD1;GRM3;TPRG1L;SHANK3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.29675151316339643,-1.2459664245619213,0.09120521172638436,0.5581990445425854,1.0,25/76,20.95%,SASH1;PTPN22;TLR2;BCL3;TLR7;LIMS1;CD14;UACA;NOD2;IL1B;ZC3H12A;EP300;TRIM44;C1QTNF3;CCN3;EGFR;AGER;TNF;TLR4;NR3C2;MMP8;PTP4A3;BMP7;NLRC3;TMSB4X
prerank,cellular response to glucose starvation (GO:0042149),-0.33818383671347796,-1.2458344949846747,0.14114114114114115,0.5575088558129732,1.0,13/41,16.66%,PIK3C3;PIK3R4;NUAK2;SH3GLB1;PRKAG2;CPEB4;ZC3H12A;SZT2;SIK2;SIK1;PMAIP1;MTMR3;SESN2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.3353633093125678,-1.2454710267569233,0.13730569948186527,0.5574235444396245,1.0,7/41,3.44%,NEDD9;GAS6;STAP1;CASS4;LILRA5;FBXW7;PTPN1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.36897801820090703,-1.2453994676345141,0.15706806282722513,0.5565302116111898,1.0,13/28,19.14%,KPNB1;CDK5RAP2;CENPA;NUSAP1;MAD2L1;ESPL1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1
prerank,sodium-independent organic anion transport (GO:0043252),0.5331688642477489,1.2451488536671569,0.1857638888888889,0.8334563540412874,1.0,2/10,10.41%,SLCO2B1;MFSD10
prerank,regulation of oxidoreductase activity (GO:0051341),-0.45713116753320604,-1.2450671400214344,0.18660287081339713,0.5564470245760084,1.0,4/13,11.69%,ABL2;ATP7A;NOD2;SZT2
prerank,regulation of B cell differentiation (GO:0045577),0.44959717184922704,1.2445031690860102,0.19801980198019803,0.8339703358264233,1.0,7/17,17.88%,IL4I1;NCKAP1L;ZFP36L2;BTK;SFRP1;INHA;XBP1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4343382254483564,1.2444636371063527,0.16828478964401294,0.8318739228440432,1.0,5/20,10.24%,GATM;FPGS;GSS;GGCT;PTDSS2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4281054518276832,1.2440489102867767,0.18360655737704917,0.8313513485007445,1.0,10/22,26.15%,NTRK1;STMN2;NTRK3;SH3GL2;EHD1;NTRK2;MAGI2;BDNF;RAPGEF2;MAPT
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4109407251680307,1.2440286654669381,0.1685214626391097,0.8291880143020943,1.0,12/26,20.38%,VSIR;USP50;GRIN1;GRIN2B;EFNA1;PSME3;PSENEN;EFNA3;EPHA4;PRELID1;MBP;PSME1
prerank,calcium ion transport (GO:0006816),0.31243846448325574,1.243966665065032,0.10273972602739725,0.8272002888113588,1.0,33/113,19.32%,ATP2A3;TRPC3;ATP2A2;CDH23;CACNB2;SLC24A5;NMUR1;CACNA1S;TRPM3;TRPM2;CCR1;PKD2;CACNA1G;SLC8A1;CACNG7;ATP2C1;TRPC6;PANX1;CACNA1D;PKD1;CACNA1B;KCNN4;SLC8A3;CACNA2D1;SLC24A3;CACNA1A;CACNG3;ANK2;CHRNA7;SELENOK;SLC24A4;TRPV6;CCL5
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.358115874777628,1.2437413555823023,0.1465648854961832,0.8259727078622994,1.0,12/51,12.11%,CTTN;CNTNAP1;SRGAP2;NYAP2;PAK1;NCKAP1;NCKAP1L;MAP1S;DAB2IP;MAP4K4;MINK1;ANKRD27
prerank,intestinal lipid absorption (GO:0098856),0.5141311944782482,1.243619484224699,0.19152542372881357,0.8242710948581704,1.0,3/11,5.58%,ABCG8;AKR1C1;SOAT2
prerank,regulation of cell cycle (GO:0051726),-0.24506377166431814,-1.2427173808494845,0.022222222222222223,0.5615964328542503,1.0,87/271,24.47%,IQGAP1;ANKRD17;FBXL17;CDK6;BRINP1;LIN54;PTPRC;SDCBP;RUNX3;PRCC;PRKACA;RARA;FBXL8;CDC14B;JUNB;PROX1;GBF1;ERN1;UHRF2;THBS1;SMAD3;CCND1;KIF20B;LIN52;NBN;PCLAF;BRCA1;MYBL2;CDKN2C;LIN37;EP300;UHMK1;BIRC5;CDKN3;BARD1;NOTCH1;BIRC2;GADD45G;RPS6KA2;ASAH2;RB1;RACK1;BMP2;PRR11;DUSP1;SIK1;LILRB1;CDC25A;PLK1;MLF1;NOP53;NUDT6;HIPK2;RGCC;NUPR2;DTL;PPP1R15A;GATA3;HMGA2;RNF20;PER2;LRP6;MAPK12;CDKN2A;FBXL12;AFAP1L2;BMP7;HNRNPU;NOTCH2;CDK9;PUM1;TRIM21;SIRT2;DHCR24;MAP3K20;ID2;CDC14A;MECOM;RPRM;KAT2B;CCNB1;XIAP;MASTL;DDIAS;RPRD1B;PLAGL1;PIM2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4244645493245925,-1.2425784465744707,0.1932367149758454,0.5609766815069209,1.0,9/15,27.18%,CD36;DHX33;TLR4;PYDC1;MYD88;NLRC3;MEFV;EIF2AK2;CPTP
prerank,sensory perception of pain (GO:0019233),-0.3982795407228618,-1.242537364838524,0.17941952506596306,0.5600808783197451,1.0,8/21,24.57%,P2RX4;CCR2;KCNA2;ALOXE3;CHRNB2;OPRK1;CHRNA4;SCN9A
prerank,regulation of axonogenesis (GO:0050770),0.35955528871078324,1.2420477462175168,0.15022761760242792,0.8287699486677291,1.0,23/51,28.40%,MAP6;PLXNB2;CHN1;PAK1;THY1;OMG;EFNB3;ARHGDIA;GDI1;MAG;ARHGAP35;EPHA4;NTRK2;PLXNB1;LRRC4C;TIAM1;RHOA;NGFR;LINGO1;BRSK2;SLITRK1;PTEN;ROBO1
prerank,regulation of microtubule-based process (GO:0032886),0.38657740482485126,1.2419141713330009,0.1777434312210201,0.8270510019556635,1.0,17/36,26.97%,TPPP;MAP6;CLASP2;CAMSAP3;BICD2;PHLDB2;ROCK1;TAOK1;BICD1;KLHL42;CYLD;CDK2AP2;MEMO1;AURKA;MAPT;PRKAA2;EPHA3
prerank,neurotransmitter secretion (GO:0007269),0.3707259540229809,1.2417088096319322,0.15451895043731778,0.8256814849740117,1.0,10/44,14.15%,SNAP25;RAB3A;SYT1;SNAPIN;NRXN1;OTOF;RIMS1;CPLX2;GAD2;STXBP2
prerank,lipoprotein transport (GO:0042953),-0.5067747758084516,-1.2416134617389476,0.20554272517321015,0.5615285549432403,1.0,4/10,13.37%,PPARG;CD36;ZDHHC17;LRP1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.3514946548720211,-1.2415463444032344,0.15083798882681565,0.5606400189204255,1.0,10/35,16.17%,APOE;ADGRG6;PDE7B;CD36;AHR;ADCY1;IRAG1;RIMS2;PDE2A;MAPK7
prerank,positive regulation of lipid storage (GO:0010884),-0.4063097277450898,-1.2414366379964765,0.18052256532066507,0.5598993679018794,1.0,5/21,9.52%,PLIN2;MSR1;NFKB1;ZC3H12A;LPL
prerank,negative regulation of dephosphorylation (GO:0035305),-0.42545210927878674,-1.2413820024998123,0.1806930693069307,0.5590518961686787,1.0,10/18,29.50%,ENSA;PTPA;PPP1R35;INPP5K;ARPP19;CHP1;PPP1R15A;SH2D4A;PPP1R26;MFHAS1
prerank,covalent chromatin modification (GO:0016569),-0.4584496067067615,-1.2399282433435377,0.2,0.5618276376622767,1.0,3/14,12.76%,MBD2;HLCS;HDAC1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.39515240114391365,-1.2397920007735395,0.17616580310880828,0.5611756716680357,1.0,3/21,3.17%,PEAK1;SLK;CORO1C
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2831871548764135,-1.2397391346339501,0.07936507936507936,0.5603131684023899,1.0,42/105,25.11%,AOAH;ITCH;APOE;ALOX5;CRK;PPARG;METRNL;PTGER4;VPS35;PPARD;ENPP3;DRD2;PTGIS;ACOD1;C1QTNF3;NR1H3;CCN3;RB1;CXCL17;AJAP1;OTULIN;MAPK7;MUL1;CERS2;KLK8;GATA3;TRAF3IP1;DRD3;LTF;KLF4;NLRC3;TRIM21;MVK;SIRT2;FFAR4;ISL1;NR1H4;MEFV;SMPDL3B;DUSP3;FEM1A;DHX58
prerank,negative regulation of defense response to virus (GO:0050687),-0.4918726106308461,-1.2393358063353908,0.20134228187919462,0.560340929487622,1.0,5/10,29.63%,ITCH;MUL1;TRAF3IP1;RNF26;C1QBP
prerank,regulation of mitochondrial fusion (GO:0010635),-0.4972033323732642,-1.2392481320231847,0.20279720279720279,0.5595817219268104,1.0,2/11,6.20%,PID1;TFRC
prerank,triglyceride metabolic process (GO:0006641),-0.32673041653918744,-1.2389669341217866,0.1282051282051282,0.5592980012616985,1.0,11/48,16.51%,APOE;FABP4;PLAAT3;CAV1;LPL;FABP7;PNPLA2;APOC1;GK;GK5;GPAM
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.34721787311565266,-1.2387326287042746,0.16939890710382513,0.5588948716608291,1.0,12/35,17.80%,CD300A;PPP6R1;PTPA;PPP6R3;PPP1R12A;BOD1;CRY2;CALM3;CALM2;PPP1R2;ITGA1;PPP1R15A
prerank,phagosome maturation (GO:0090382),-0.34634005841296245,-1.2384451302214334,0.15339233038348082,0.5586943678695429,1.0,6/35,4.12%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3841430269523694,1.238371177887598,0.16585365853658537,0.8350964648313988,1.0,8/31,12.30%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;GTF2F1;POLR2G;RAMAC
prerank,7-methylguanosine RNA capping (GO:0009452),0.3841430269523694,1.238371177887598,0.16585365853658537,0.8350964648313988,1.0,8/31,12.30%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;GTF2F1;POLR2G;RAMAC
prerank,brain development (GO:0007420),0.30372075185112085,1.2381506013242312,0.09668874172185431,0.833766541853254,1.0,30/136,16.00%,ZFHX3;ROGDI;PLXNB2;DNAJC30;BPTF;CTNNA2;NNAT;NFIB;ABCB6;PBX2;MAP1S;UBE3A;SHANK3;ADGRL3;GRIN1;CX3CR1;GRIN2B;DDIT4;CTNS;CXCR4;PBX3;PHF8;SPEF2;NDRG4;APOD;NKX2-2;HAP1;DSCAML1;IER3IP1;TUBGCP2
prerank,muscle filament sliding (GO:0030049),0.3802509239817037,1.238020101944031,0.15705128205128205,0.8299607385756345,1.0,6/38,9.16%,TNNI3;TNNC1;DMD;MYBPC3;ACTN2;MYL6
prerank,actin-myosin filament sliding (GO:0033275),0.3802509239817037,1.238020101944031,0.15705128205128205,0.8299607385756345,1.0,6/38,9.16%,TNNI3;TNNC1;DMD;MYBPC3;ACTN2;MYL6
prerank,male gonad development (GO:0008584),0.38867200839050353,1.237974960919561,0.17932148626817448,0.8279932291366956,1.0,6/34,9.13%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,regulation of astrocyte differentiation (GO:0048710),0.49477363341696934,1.2377038603309614,0.18804920913884007,0.826935006628918,1.0,5/12,15.41%,BIN1;IL6;CLCF1;EPHA4;SERPINE2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.24913442296404614,-1.23770385501721,0.03164556962025317,0.5596480430651662,1.0,53/260,12.92%,FGD4;EHD4;MTSS1;ATP6V0D1;FGD6;RAB8B;NRP1;ACTR3;KIF3A;PTPN23;EMP1;PCM1;FXYD5;SDCBP;RILPL2;FAM161A;PIBF1;RAB1A;MKS1;RPGR;SCLT1;CDC14B;EXOC4;CPLANE1;GBF1;CEP250;ARL13B;S1PR2;ARHGEF6;TCTN1;SSX2IP;SPEF1;BBS7;FHDC1;ASAP1;CARMIL1;DNAH5;FGD1;TMEM231;KIF24;CEP164;WDPCP;CENPJ;SNAP29;CCDC28B;TMEM138;NOTCH1;SHTN1;FOXJ1;IFT52;EXOC8;PMP22;EMP2
prerank,peptide metabolic process (GO:0006518),-0.29483756549423235,-1.2376167261398958,0.08745247148288973,0.5588479887950277,1.0,17/75,13.89%,NLN;ANPEP;CPQ;CPD;PARL;GSTA3;CPE;CLN5;RHD;PSEN1;ERAP1;CPM;GSTZ1;SPPL3;LTA4H;GSTM1;GSTM5
prerank,determination of bilateral symmetry (GO:0009855),-0.3859442540310087,-1.2373924260207554,0.16991643454038996,0.5584143861337802,1.0,14/25,35.83%,BBS7;DNAH5;ODAD2;NOTCH1;FOXJ1;ODAD3;NPHP3;GALNT11;KIF3B;DLL1;TBX1;DNAAF4;LEFTY1;PITX2
prerank,negative regulation of developmental process (GO:0051093),0.3387997693007451,1.2371889113211725,0.1452991452991453,0.8269023393351933,1.0,15/69,11.54%,DCC;CST3;NEUROD2;NFIB;THY1;BMP4;RAPGEF3;FOXC1;VASH1;HEY1;TGFB1;TBX2;PRKN;KLF7;SFRP1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.42226185743839917,1.2371354664124055,0.15959252971137522,0.8249807283510282,1.0,8/24,15.54%,HHEX;DAB2IP;PRKD2;NEDD4;ITGA5;PDCD6;VTN;CADM4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.27210886480493796,-1.2369016993567439,0.07258064516129033,0.558696032651058,1.0,40/122,19.55%,IGF1;UPF3A;NIBAN1;TLR2;RPL5;CIITA;NAMPT;PCNA;BCL3;NFKB1;SAMD4A;THBS1;NOD2;BCAR3;IL1B;LARP6;VIM;CD28;PIWIL2;IGF2;SORBS1;PLD1;NLRC5;PPP1R3E;KDR;NPM1;CDT1;NMD3;ZCCHC4;EGFR;KAT7;LARP4B;FXR2;TLR4;UPF3B;RGCC;HNRNPD;IRS2;NAT10;RPL26
prerank,regulation of cellular metabolic process (GO:0031323),0.3602272607889195,1.2365579929880595,0.1559633027522936,0.8252970058096687,1.0,15/45,16.36%,MKLN1;GNB3;BCO2;PPARA;CNDP1;NCOR2;EIF6;PRKN;TBC1D16;COQ7;AGPAT1;ABCA2;ACLY;SSH1;ACACB
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.36834099420676414,-1.2364403827584232,0.1432225063938619,0.558913456178185,1.0,12/27,24.65%,CHST11;XYLT1;CHST9;UGDH;CSPG4;CHST7;CHPF;XYLT2;PXYLP1;CHST12;CHSY3;CHST3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.48362658543216236,1.2358342304460515,0.21217391304347827,0.8260258715745533,1.0,4/13,12.24%,NELFB;NELFCD;RNF168;RNF8
prerank,negative regulation of GTPase activity (GO:0034260),0.43028908276327515,1.2358276237895132,0.1956521739130435,0.8239097550897901,1.0,12/22,23.16%,F11R;TMED2;DAB2IP;ARFGEF1;RCC2;SH3BP4;RRP1B;HRAS;WNK1;GMIP;RDX;GPSM1
prerank,regulation of DNA binding (GO:0051101),-0.32195500048941655,-1.2356486227202106,0.11849710982658959,0.5600014598976591,1.0,9/44,8.19%,SP100;IGF1;HMGB2;PPARG;DOT1L;BCL3;CEBPG;PLAUR;TXN
prerank,V(D)J recombination (GO:0033151),0.5019685860809612,1.2355987919251856,0.1905564924114671,0.8227322606060437,1.0,5/11,21.44%,DCAF1;LIG3;HMGB1;TCF3;XRCC4
prerank,apoptotic cell clearance (GO:0043277),-0.3616458142105631,-1.2353691385277115,0.16348773841961853,0.5597191063348805,1.0,13/30,27.83%,GAS6;RARA;TYROBP;THBS1;ANXA1;NR1H3;LRP1;ITGB3;ADGRB1;XKR7;RAC1;ALOX15;XKR9
prerank,eye morphogenesis (GO:0048592),0.4391175837089145,1.235213376941469,0.1912751677852349,0.8222856951215509,1.0,4/19,9.37%,COL5A1;MFAP2;FBN2;TENM3
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2864373267379257,-1.2347232319844486,0.0812720848056537,0.5605309443973188,1.0,31/87,25.51%,APOE;CD300A;STK38;PTPRC;PTPN1;RANBP9;RPS6KA6;CAV1;LYN;IL1B;DAG1;SPRY2;FOXO1;SEMA6A;SPRY1;PSMD10;INPP5K;DUSP1;QARS1;SPRY4;PEBP1;TLR4;SMAD4;BMP7;TNIP1;GSTP1;DUSP3;TIMP3;DUSP7;FBLN1;PIK3R2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.26886916867504984,-1.234487876681757,0.04597701149425287,0.5601713961474188,1.0,48/129,23.78%,PPP2R2A;PCM1;FBXL17;ENSA;PPP1R12B;CDK5RAP2;PRKACA;FBXL8;BORA;TUBA4A;CEP250;PPP1R12A;KDM8;YWHAG;HAUS2;CEP164;MAPRE1;CENPJ;WEE1;CCNH;DNM2;CDK1;CCNA2;AJUBA;HAUS8;MNAT1;ARPP19;CDK14;CDC25A;OPTN;PLK1;DCTN2;ODF2;FBXL15;PAFAH1B1;NES;FBXL12;MELK;AKAP9;CDC25C;CEP78;CCNY;OFD1;TUBB4B;CCNB1;NDE1;BRSK1;MASTL
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4112676726386724,-1.2343065641022708,0.195852534562212,0.5597046676385622,1.0,11/19,30.00%,IGF1;GIT1;ZC3H12A;FFAR1;PYDC1;CD33;FFAR4;MEFV;GSTP1;CPTP;TNFAIP3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4036520505720072,1.2341439983137077,0.1891891891891892,0.824670877708378,1.0,10/27,23.97%,SYT4;SYT13;SYT1;SYT6;DOC2B;RIMS1;SDF4;RIMS3;SYT11;SYT12
prerank,monosaccharide transmembrane transport (GO:0015749),0.46059553286758836,1.234075463597142,0.1939799331103679,0.8228679389417519,1.0,3/16,6.70%,SLC50A1;SLC45A3;SLC2A2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.32052226500892134,-1.2337938356975076,0.11267605633802817,0.5602018918944928,1.0,16/46,17.72%,RBPJ;IL15;NOVA2;DOCK7;NRDC;NR1H2;PCTP;NOTCH1;ID1;ALDH1A1;NR1H3;RB1;TLR4;IL18R1;ADAM17;PGAM5
prerank,organic cation transport (GO:0015695),0.4376619593616025,1.233186169195137,0.17636986301369864,0.8244578512457756,1.0,10/20,29.51%,SLC44A2;RALBP1;SLC22A4;SEC14L1;SLC22A18;SLC22A5;SLC25A26;PDZK1;SLC5A7;SLC25A29
prerank,response to glucocorticoid (GO:0051384),-0.37865703186169597,-1.2322185796040497,0.16539440203562342,0.5632525939580437,1.0,12/26,29.14%,NR3C1;ADAM9;GOT1;ANXA1;UBE2L3;TNF;BCL2L11;HNRNPU;ISL1;HSD3B2;SLIT2;SLIT3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.43048203411339897,1.2320600884013337,0.20103986135181975,0.8269515752335456,1.0,11/19,21.35%,RTN1;GGA3;BIN1;PRNP;CLU;HAP1;NTRK2;ROCK1;CHRNA7;PIN1;ABCA7
prerank,embryonic eye morphogenesis (GO:0048048),0.5065337700463921,1.2316275186651695,0.21025641025641026,0.8266538982422663,1.0,6/11,24.90%,MFAP2;FBN2;TBX2;KDM2B;MFAP5;FBN1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.3864063308948241,-1.2311493311467703,0.17287234042553193,0.5649428874500744,1.0,6/24,11.52%,ITGA4;MSN;NT5E;SYK;ITGAL;OLR1
prerank,negative regulation of histone methylation (GO:0031061),-0.48686177223343297,-1.2305016940884086,0.21728395061728395,0.5656460773603226,1.0,5/10,24.47%,BCOR;DNMT1;BRCA1;AASS;MTF2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.39871551321447285,-1.2296920968739238,0.1744186046511628,0.5668245868861359,1.0,9/20,23.63%,IGF1;LAMTOR5;H1-0;EP300;RB1;GATA3;NIBAN2;TWIST1;PAX6
prerank,defense response to tumor cell (GO:0002357),0.5183373978736922,1.2293794377248237,0.21241830065359477,0.8337914883830183,1.0,3/10,8.90%,ABI3;DLEC1;PRDX2
prerank,regulation of ossification (GO:0030278),-0.34269565735054086,-1.2292312780400174,0.13066666666666665,0.5671023147440625,1.0,18/36,31.15%,RBPJ;NBR1;SOX11;ANKH;NOTCH1;SMAD6;PTN;BMP2;WNT5A;LRP6;ACVR1;TWIST1;BMPR2;KREMEN2;NOTUM;LRP4;TGFB2;DDR2
prerank,regulation of interferon-beta production (GO:0032648),-0.3233227448560935,-1.228933541946668,0.146875,0.5669220028449004,1.0,14/46,17.45%,OAS2;IFIH1;TLR2;IRF7;TBK1;TLR7;RNF216;YY1;TLR8;OAS3;LILRB1;RELB;TLR4;POLR3G
prerank,autophagy of peroxisome (GO:0030242),-0.46107036352652614,-1.228832645907498,0.18140589569160998,0.5661981173060958,1.0,4/12,2.33%,PIK3C3;MAP1LC3B;NBR1;PIK3R4
prerank,purine-containing compound catabolic process (GO:0072523),-0.45837256173160495,-1.228514807738129,0.1963470319634703,0.5660105159175948,1.0,3/13,5.65%,GDA;XDH;NT5E
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2711960157675076,-1.2281118340892887,0.05603448275862069,0.5660651198793267,1.0,23/121,12.49%,NEDD9;IL15;CD74;NRP1;GAS6;IGF1;CASS4;PARP14;CD44;PTPRC;TEC;PIBF1;LILRA5;PTPN1;IL6ST;LYN;CLEC6A;BANK1;GPRC5B;GHR;CSPG4;IGF2;PARP9
prerank,superoxide metabolic process (GO:0006801),-0.36315847089942166,-1.2280946309511738,0.16753926701570682,0.565138444795022,1.0,10/29,24.23%,CYBB;NRROS;ATP7A;SH3PXD2B;CYBA;CYB5R4;SOD3;TAFA4;NOXO1;NOX4
prerank,positive regulation of glucose metabolic process (GO:0010907),0.46825549360118224,1.2279667521249518,0.20918367346938777,0.8375057650138267,1.0,4/14,15.05%,SLC45A3;PPARGC1A;IRS1;PTPN2
prerank,regulation of Golgi organization (GO:1903358),-0.4022724533842011,-1.2274524981379995,0.20098039215686275,0.5658834832350399,1.0,8/17,20.29%,MYO5A;STX5;PDCD10;USP6NL;RBSN;RAB33B;STX18;AKAP9
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2349806388815723,-1.2272213633670919,0.023622047244094488,0.5655375197054684,1.0,70/341,13.26%,PPP2R5C;ITCH;WWP1;VPS37C;PSMA6;RNF149;UBE2D3;KLHL20;PTPN23;BUB3;FBXL17;VCP;TRIM25;CUL3;ARIH1;CUL4A;UBE2K;UBA6;PSMB2;DTX3L;BIRC6;FBXL14;FBXW7;SIAH2;RNF213;OS9;SMURF2;PSME2;TAF1;RNF216;RNF146;HECW1;RMND5B;PSMD11;CDC34;UBL7;ARIH2;PSMC6;UBQLN1;RNF13;NHLRC3;TBL1X;ZNRF3;PSMA3;FBXW4;BAG6;KLHL15;RNF14;TTC3;RNF150;SPOPL;RNF6;UBE2L3;KCTD17;RAD23B;CDC27;USP9X;SPSB2;RC3H1;CTNNB1;TRIP12;WDR91;MAD2L1;BIRC2;WDR81;CBL;KAT5;PELI1;PSMD10;BUB1B
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.42517240369790155,-1.226770625566898,0.19911504424778761,0.5657689508835466,1.0,5/16,6.59%,PARP14;PIBF1;BCL3;VHL;CAV1
prerank,response to estrogen (GO:0043627),-0.35161268989339234,-1.2264710017098341,0.17403314917127072,0.5654995048759373,1.0,11/31,20.16%,TRIM25;RARA;ESR1;CAV1;CD24;BRCA1;EP300;KMT2D;GATA3;RBBP5;BCAS3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5288895803637627,1.2261731284745294,0.22357019064124783,0.8428043928714338,1.0,5/10,30.09%,DIP2B;FLCN;PRKAA2;DIP2A;SETD5
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4628053565237785,-1.226022759240998,0.22072072072072071,0.5646475207626697,1.0,7/12,20.56%,IGF1;CIB1;SPPL3;TNF;CAMTA1;CHP2;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4628053565237785,-1.226022759240998,0.22072072072072071,0.5646475207626697,1.0,7/12,20.56%,IGF1;CIB1;SPPL3;TNF;CAMTA1;CHP2;STIMATE
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.44460842094341435,1.225769808336573,0.22564935064935066,0.8423986322682012,1.0,9/18,27.13%,ADRA2A;PRKN;IRS1;SFRP1;CRHBP;REST;MIDN;CHGA;KCNB1
prerank,multivesicular body assembly (GO:0036258),-0.3565547028518283,-1.2257304498067894,0.15675675675675677,0.5644164151817157,1.0,6/30,13.39%,VPS37C;CHMP4B;CHMP4A;PDCD6IP;CHMP1B;STAM
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.39715496129825195,-1.2256966638530533,0.17839195979899497,0.5635308800440588,1.0,10/20,22.88%,C3AR1;P2RX4;NT5E;TXNIP;IL1B;TXN;ENTPD5;CASP1;APP;MEFV
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3508289784084703,-1.2256745101695907,0.13972602739726028,0.5626669893184968,1.0,15/34,16.73%,NRP1;MAPKAPK2;GAB1;ERN1;FLT1;ANXA1;PIK3CA;SPRY2;EGR3;NOTCH1;SEMA6A;KDR;RAMP2;HSPB1;NUS1
prerank,glycerolipid metabolic process (GO:0046486),0.5023350493276836,1.2256600997748117,0.21557971014492755,0.8407216471786004,1.0,5/11,20.35%,PNPLA3;DGKQ;GAL3ST1;DGKZ;PLA2G15
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.42998695568167933,-1.2255019507102274,0.19902912621359223,0.562203411453437,1.0,7/15,16.17%,FBXW7;LDLR;NR1H2;CTDNEP1;NR1H3;SIK1;MFSD2A
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.31412225609473504,1.2248644775480202,0.11201079622132254,0.8420480616222679,1.0,31/107,19.32%,ATP2A3;ATP13A4;ATP2A2;ATP1B1;SLC24A5;SLC39A4;TNNI3;ATP13A5;CCR1;SLC8A1;RMDN3;SLC39A8;ATP2C1;ATP2B3;SLC8A3;SLC24A3;DMPK;MT2A;ANK2;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;CHRNA7;SLC24A4;CCL15;CCL5
prerank,cyclooxygenase pathway (GO:0019371),0.5159424564793359,1.2245443758231662,0.22014925373134328,0.8411856361269056,1.0,2/10,2.13%,PTGS1;PTGDS
prerank,regulation of defense response to virus (GO:0050688),-0.4427823454580673,-1.2242874466904115,0.18427518427518427,0.5644556301113939,1.0,7/14,30.00%,ITCH;RNF216;IFNLR1;TRAF3IP1;RNF26;C1QBP;TNFAIP3
prerank,cellular response to interleukin-6 (GO:0071354),0.4025690207484578,1.2240169995745538,0.183739837398374,0.8412150697862856,1.0,6/26,5.65%,SELPLG;CTR9;RELA;PTPRT;SOCS3;IL6
prerank,protein localization to cell junction (GO:1902414),-0.3849963708716256,-1.2239984208307533,0.18581907090464547,0.5642291280753595,1.0,10/22,29.90%,KIF3A;CGNL1;ARHGEF18;NECTIN1;MPP4;NLGN2;DSP;TJP1;NPHS1;MARVELD3
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.4782185370191411,-1.2235439214938904,0.23227383863080683,0.56450509394476,1.0,4/11,13.17%,CDC73;NCBP1;BARD1;AHCYL1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.4452909506952544,1.2234223332409935,0.1857638888888889,0.8415512061017464,1.0,5/18,16.91%,AGRN;GNA15;RGS10;GNA11;OPRM1
prerank,positive regulation of protein secretion (GO:0050714),0.3331878993997062,1.223026928225978,0.15988779803646563,0.8410629417941289,1.0,19/69,19.57%,FRMD4A;MYOM1;ANG;NNAT;SYTL4;SOX4;MYH10;DOC2B;APBB1;TCF7L2;ACHE;TGFB1;UNC13B;DNM1L;APBB3;IER3IP1;IL1A;GHRL;HCAR2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.22903547353061957,-1.2229583071965422,0.0,0.5650524781858071,1.0,144/497,21.84%,RBPJ;MDFIC;NR3C1;WWP1;CD38;GAS6;MECP2;POU2F1;EPC1;SETDB2;SP3;LIMD1;ZHX2;HMGB2;CNOT9;KAT6B;PPARG;CIITA;CBFA2T3;MALSU1;SMARCA4;RARA;ENO1;SMURF2;PATZ1;BCL3;AHR;PROX1;LIMS1;SAMD4A;NAB1;PPARD;ATXN1;MBD2;RCOR1;CIART;BCL7A;DPF3;BCOR;PFDN5;KDM8;NR1H2;EIF4ENIF1;ID4;BRCA1;FOXE1;CRY2;DDX6;PDS5A;CAPRIN1;HINFP;SNW1;ID3;GCLC;MBD1;L3MBTL4;CTCF;BIRC5;ZBTB18;CTNNB1;FOXO1;PRMT2;ATF5;SPEN;NOTCH1;L3MBTL3;BRMS1;HDAC2;ID1;RCOR3;ZNF148;CRY1;DAPK1;ATF7IP;DEPDC1;EHMT1;KAT5;HDAC1;MIDEAS;PAIP2B;SYNCRIP;TYMS;RB1;LARP1;RACK1;GATAD2A;INPP5K;BMP2;FOXP2;CREB3L1;L3MBTL2;QARS1;FOXP1;ZNF318;RIOX1;THAP7;LHX1;DACH1;SHC1;TRIM71;TNF;KDM5C;KAT7;WNT5A;FOXK2;DEAF1;SAP18;IKZF1;FXR2;ARID5B;UIMC1;HEY2;SMAD4;GATA3;HMGA2;GLIS2;PER2;IGFBP5;NIBAN2;LANCL2;HES1;TFAP2B;PPM1F;CDKN2A;TAF7;EED;YEATS2;PA2G4;BMP7;NCOR1;HMGA1;BHLHE40;KLF4;SCMH1;RBAK;DHFR;BASP1;SIRT2;TRIM33;HDAC4;CPEB3;HEYL;ID2;PSPC1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3929762262411585,1.2227396765622778,0.19376026272577998,0.8400694961567614,1.0,14/30,25.24%,FHIT;GIPC1;SGTA;OGT;STYX;TAF9;CCAR2;UBXN1;HSP90AB1;TLK2;CAMLG;USP7;TRIM39;HFE
prerank,multivesicular body organization (GO:0036257),-0.35192827924397607,-1.2224299562222185,0.14824797843665768,0.565505846304314,1.0,6/31,13.39%,VPS37C;CHMP4B;CHMP4A;PDCD6IP;CHMP1B;STAM
prerank,positive regulation of neurogenesis (GO:0050769),0.3292853156939855,1.2221875168875316,0.16242937853107345,0.8403438900362808,1.0,14/68,11.23%,MAP6;FBXW8;PLXNB2;OBSL1;PTPRD;NUMB;LRP2;SHANK3;ARHGDIA;CDKL5;CX3CR1;IL1RAPL1;SS18L1;SMARCD3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4618155201228127,-1.2217216160543367,0.229064039408867,0.5663763373483582,1.0,3/11,6.64%,ARL6IP5;STK24;PDCD10
prerank,lymphocyte proliferation (GO:0046651),-0.38390611526520535,-1.221427362366213,0.16786570743405277,0.5661140621842432,1.0,4/22,6.06%,BCL2;PTPRC;MSN;HSPD1
prerank,glycerol metabolic process (GO:0006071),-0.4853141251098181,-1.221372821017256,0.22146118721461186,0.5652887004277735,1.0,4/10,14.06%,GOT1;COQ3;GK;GK5
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.42033930168755074,-1.2211335309505484,0.18295739348370926,0.5649581803572843,1.0,7/18,22.22%,NR3C1;ANXA1;UBE2L3;KLF9;BCL2L11;HNRNPU;ISL1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2818369505457013,1.2205134992403823,0.08414634146341464,0.8453273149198955,1.0,86/241,26.08%,POLR2L;SRSF12;DHX35;RNPS1;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;DDX5;TRA2B;BCAS2;HNRNPH1;CWC22;CASC3;XAB2;PPWD1;CTNNBL1;SF3B2;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;PTBP1;SRSF11;RBM5;GTF2F1;CACTIN;DDX46;SNRNP70;SF3B5;SF3A1;SRSF1;SNRPD2;YTHDC1;CPSF3;GPKOW;POLR2G;LSM8;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;DDX39B;HNRNPA1;GEMIN5;GEMIN6;SRSF9;ELAVL2;PUF60;UBL5;GCFC2;TRA2A;SNRPD3;SNRNP27;ALYREF;SRSF2;RBM10;USP49;POLR2C;LSM4;LSM3;SART1;SNRPB2;RBM15B;POLR2D;SNU13;WBP4;PRPF38A;PNN;ESS2;SRSF3;HNRNPH3;SF1;METTL14;DHX16;NONO;USP39
prerank,positive regulation of interferon-beta production (GO:0032728),-0.34458284844962167,-1.220447454869931,0.17888563049853373,0.5657986227218543,1.0,7/33,7.52%,OAS2;IFIH1;TLR2;IRF7;TBK1;TLR7;TLR8
prerank,histone deacetylation (GO:0016575),-0.3273762129281829,-1.219171296657559,0.15041782729805014,0.568118938374506,1.0,15/43,22.85%,SIN3B;RCOR1;TBL1X;BRMS1;BRMS1L;HDAC2;RCOR3;HDAC1;MIDEAS;MSL3;ELK4;PER2;SIRT2;HDAC4;TBL1XR1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.45294088601676324,-1.219066140151799,0.20603015075376885,0.5674688117521812,1.0,7/12,20.53%,CD74;LPL;OAS3;FOXP1;TNF;TLR4;KLF4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.37986321363271425,1.2186610120451988,0.19298245614035087,0.8510469278178721,1.0,15/32,27.54%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;RRN3;MAPK3;POLR1F;POLR1G;GTF2H3;ERCC2;TAF1A;POLR1A;GTF2H1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.31648632078703665,-1.2181192987899707,0.15588235294117647,0.5690670198331361,1.0,13/48,17.34%,GAS6;STAP1;PARP14;PTPRC;PPARG;STAT2;USP18;NR1H2;NLRC5;OAS3;NR1H3;MUL1;PYDC1
prerank,regulation of receptor internalization (GO:0002090),0.37810768447355153,1.2180535410126956,0.18181818181818182,0.8514234223043852,1.0,14/35,26.40%,MKLN1;RIN3;ANKRD13D;ATAD1;ARRB2;INSR;ATXN2;RSPO1;MAGI2;ARRB1;ARF1;CD63;SCYL2;DLG4
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.27384041159062367,-1.2176201156344444,0.09124087591240876,0.5693435030071756,1.0,29/101,16.52%,PTPN22;STAP1;CD274;AXL;PRKCE;CDC73;HMGB2;GIT1;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;LYN;IL1B;HCK;ZC3H12A;VIM;ACOD1;TNFRSF1B;SHPK;NR1H3;LBP;LILRB1;TNF;WNT5A;TLR4;MAPK8
prerank,hexose transmembrane transport (GO:0008645),0.42284634228197304,1.2175821300951897,0.20563847429519072,0.8512813092188107,1.0,5/21,13.04%,SLC2A3;SLC50A1;SLC45A3;SLC2A2;SLC45A1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.49423900359010947,-1.2175513780685125,0.20353982300884957,0.5685608941930623,1.0,3/10,7.41%,ATP5MG;ATP5PO;ATP5MC1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.481705934543197,-1.2173554282087624,0.2422062350119904,0.5681292503963051,1.0,3/11,13.98%,ATF3;CEBPB;CREB3L1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4410213996965101,1.2172290046231122,0.1969178082191781,0.850639705279239,1.0,5/16,11.07%,FOXD1;BMP4;PKD2;FGF2;NPNT
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.2910797014063936,-1.2170992118811776,0.10542168674698796,0.5678774489345069,1.0,23/79,17.96%,FCGR2B;CD74;KIF3A;AP2A2;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;DCTN4;CLTA;MFSD6;DYNC1LI2;KIF4A;CAPZB;FCER1G;DCTN2;RILP
prerank,protein localization to chromatin (GO:0071168),-0.40142013000527393,-1.2169537598531235,0.21409921671018275,0.5673581753142626,1.0,11/18,33.22%,PPHLN1;ESR1;RAD21;MCM9;MCM8;PLK1;TASOR;FAM47E;RUVBL2;WAPL;SGF29
prerank,regulation of histone deacetylation (GO:0031063),0.4718981662442788,1.2167738936145172,0.21232876712328766,0.850484890239241,1.0,6/13,21.73%,CTBP1;AKAP8L;AKAP8;SAP30BP;ZBTB7B;ING2
prerank,regulation of centriole replication (GO:0046599),-0.4061144869497235,-1.2164594945007894,0.16957605985037408,0.5676824668811753,1.0,8/18,22.57%,CDK5RAP2;BRCA1;CENPJ;NPM1;NUP62;CEP295;TRIM37;KAT2B
prerank,epithelial cell morphogenesis (GO:0003382),-0.4057877930182092,-1.2163177369093812,0.1970074812967581,0.5671427531213568,1.0,3/17,4.18%,RILPL2;MET;CCDC88C
prerank,protein modification by small protein conjugation (GO:0032446),-0.23055177287514575,-1.216104649057473,0.02702702702702703,0.566748400988542,1.0,79/361,13.71%,ITCH;VCPIP1;WWP1;UBE2D3;MSL2;KLHL20;FBXL17;VCP;CDC73;CUL3;TRIM7;IFIH1;ARIH1;NSMCE2;UBA5;PJA2;TRIM14;CUL4A;UBE2K;UBA6;DTX3L;PEX10;BIRC6;FBXW7;RNF213;RANBP2;OS9;PCNA;SMURF2;TRIM17;UHRF2;ATG7;HECW1;VHL;EGR2;CDC34;ARIH2;TRIM62;UBC;ZNRF3;HIF1A;BRCA1;EYA1;NUP153;NDC1;RNF14;CCDC22;LMO7;UBA2;NUP43;RNF6;RNF157;UBE2L3;UBA52;PEX13;NUP210;CDC27;USP9X;SPSB2;RNF220;UFC1;KLHL21;UBE2Q2;BARD1;TRIM44;PIAS2;TRPM4;DCUN1D1;RNF103;CBL;RRAGA;RNF38;ATG3;UBE2E3;TRIM5;FBXO32;RACK1;FBXO2;UCHL3
prerank,protein mannosylation (GO:0035268),0.4202464574292026,1.2158858647849413,0.19402985074626866,0.8520090968848366,1.0,6/22,10.09%,B4GAT1;TMTC4;DPY19L4;FKRP;DPY19L3;SDF2L1
prerank,ribosome assembly (GO:0042255),-0.31723330161568164,-1.2156950553937935,0.12568306010928962,0.566812273588371,1.0,16/47,22.19%,EIF2A;RPL5;DHX29;RPS14;RPS5;RPF2;RPL6;RPL10;RPL23A;MDN1;RPL3;NPM1;NOP53;EFL1;RPL11;RPS15
prerank,regulation of axon extension (GO:0030516),0.3748069261987749,1.2151406820810486,0.18209876543209877,0.8530693352554181,1.0,9/37,13.98%,CTTN;DIP2B;SEMA7A;LIMK1;TWF2;CDKL5;MAG;NRCAM;MAP3K13
prerank,protein sumoylation (GO:0016925),-0.3106846680902978,-1.2147621694662842,0.1640378548895899,0.5681505589975102,1.0,12/49,11.39%,IFIH1;NSMCE2;RANBP2;EGR2;EYA1;NUP153;NDC1;UBA2;NUP43;NUP210;PIAS2;TRPM4
prerank,base conversion or substitution editing (GO:0016553),0.5015074445803611,1.2147563828181256,0.2534965034965035,0.8526137067719908,1.0,3/11,6.36%,ADARB2;APOBEC2;ADAR
prerank,DNA geometric change (GO:0032392),-0.37974883537716986,-1.2140861749335663,0.19948186528497408,0.5689441940531446,1.0,8/24,15.20%,ASCC3;HMGB2;RTEL1;ZRANB3;NBN;ANXA1;HNRNPA2B1;MCM9
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.49244734463626244,1.2140197169896931,0.2167235494880546,0.8537601697758342,1.0,4/12,14.59%,ADCY8;RFX6;CFTR;BAIAP3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.45736411392508924,-1.213758643623731,0.22572815533980584,0.5688258559291379,1.0,3/12,12.68%,CLSPN;TOPBP1;TICRR
prerank,detection of mechanical stimulus (GO:0050982),0.4383177494392394,1.2134958898992974,0.21829855537720708,0.8539246072579176,1.0,6/19,18.79%,LHFPL5;PKD1L1;PKD2;PKD1;PTK2;PKD2L2
prerank,regulation of glucose import (GO:0046324),-0.3472510474823516,-1.2132102551667125,0.17922077922077922,0.5692886903827015,1.0,3/30,0.97%,PID1;OSBPL8;IGF1
prerank,positive regulation of nuclear division (GO:0051785),-0.3648442253397313,-1.213196018268462,0.17647058823529413,0.5683992774990589,1.0,11/25,23.83%,IGF1;IL1B;NUSAP1;CD28;IGF2;NUP62;RGCC;DRD3;SIRT2;TGFA;EGF
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.39907439991114924,-1.2130452833241876,0.17321016166281755,0.5678343668739381,1.0,4/18,9.94%,APOE;VPS35;MSN;PTTG1IP
prerank,regulation of postsynapse organization (GO:0099175),0.3952811684055818,1.213014947851853,0.19319938176197837,0.8538602558768462,1.0,12/28,18.86%,ABI3;TANC2;ARHGAP44;SHANK3;SRCIN1;CDKL5;IL1RAPL1;CFL1;LZTS3;EPHA4;ARHGAP22;ABHD17C
prerank,regulation of protein targeting to membrane (GO:0090313),0.40225272048600397,1.2128491865569884,0.19122257053291536,0.8525329742704317,1.0,14/28,27.58%,FIS1;PRNP;MYO1C;ITGB1BP1;GDI1;MTCL1;HRAS;MFF;ITGAM;PDZK1;ANK3;DMTN;KCNB1;CEMIP
prerank,response to sterol (GO:0036314),0.4957712880877685,1.212628951963257,0.2189239332096475,0.8513957965481683,1.0,5/11,20.59%,TGFBR1;TGFB1;ABCA2;RORA;SMAD2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.27678612237053524,1.2123299258530185,0.08581644815256258,0.8506026516962617,1.0,91/264,26.08%,POLR2L;SRSF12;DHX35;RNPS1;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;DDX5;TRA2B;BCAS2;HNRNPH1;CWC22;CASC3;XAB2;PPWD1;CTNNBL1;SF3B2;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;PTBP1;DDX1;SRSF11;RBM5;GTF2F1;CACTIN;DDX46;SNRNP70;SF3B5;SF3A1;SNUPN;SRSF1;SNRPD2;YTHDC1;CPSF3;GPKOW;POLR2G;LSM8;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;DDX39B;HNRNPA1;GEMIN5;GEMIN6;SRSF9;ELAVL2;PUF60;UBL5;GCFC2;TRA2A;SNRPD3;SNRNP27;ALYREF;SRSF2;RBM10;PRMT5;USP49;POLR2C;LSM4;LSM3;SART1;SNRPB2;RBM15B;POLR2D;SNU13;WBP4;PRPF38A;PNN;ESS2;COIL;CELF4;SRSF3;HNRNPH3;SF1;METTL14;DHX16;NONO;USP39
prerank,protein N-linked glycosylation (GO:0006487),-0.2979659071513222,-1.2122579153446356,0.15015015015015015,0.5689409467520844,1.0,12/66,8.49%,TMEM165;RPN2;MPDU1;MAGT1;UGGT1;MGAT2;MCFD2;ALG12;ST6GAL1;MGAT4C;FUT8;ALG13
prerank,epiboly involved in wound healing (GO:0090505),-0.4220007342190268,-1.2117455574437115,0.20147420147420148,0.5693254266055027,1.0,7/16,17.77%,CD44;PDCD10;LCP1;CCN1;CEACAM1;CARMIL2;FLNA
prerank,cellular response to alkaloid (GO:0071312),0.4574754130428941,1.2117427526577274,0.21305841924398625,0.8509797995219005,1.0,5/17,12.73%,CACNA1S;SLC8A1;CASP3;CASP7;CRHBP
prerank,regulation of erythrocyte differentiation (GO:0045646),0.37561749192447463,1.2115489346148762,0.19339622641509435,0.8497631186645307,1.0,7/35,11.72%,HOXA5;ANKRD54;ZFPM1;LDB1;NCKAP1L;HSPA9;ACVR1B
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.49858365433959695,1.2109076070334728,0.2222222222222222,0.8504822751010497,1.0,5/11,19.92%,DONSON;TIMELESS;LIG3;SMARCAL1;FBXO5
prerank,regulation of interleukin-13 production (GO:0032656),-0.4438754146483721,-1.2105204103290415,0.24519230769230768,0.5716598553120857,1.0,7/13,26.45%,LILRA5;RARA;IRF4;SPHK2;GATA3;LEF1;TSLP
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.45464320186130497,1.210512895145379,0.2184873949579832,0.8481238533876165,1.0,4/15,20.28%,NANOS1;ZFP36L2;TOB1;DHX36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.45464320186130497,1.210512895145379,0.2184873949579832,0.8481238533876165,1.0,4/15,20.28%,NANOS1;ZFP36L2;TOB1;DHX36
prerank,mitotic spindle organization (GO:0007052),-0.260333840112471,-1.2103174758289665,0.07109004739336493,0.5713070832921944,1.0,51/153,23.72%,MECP2;KPNB1;BUB3;VCP;MIS12;PIBF1;KIF23;KIF11;PMF1;RANBP2;PTPA;PRC1;KIFC2;ZWILCH;CDCA8;STMN1;KIFC1;ABRAXAS1;CENPA;NUP43;MAPRE1;XPO1;BIRC5;MAD2L1;AHCTF1;BUB1;DYNC1LI2;BUB1B;KNTC1;SPDL1;KIF4A;INCENP;NDC80;PLK1;WDR62;NUF2;MZT1;DCTN2;FLNA;TPX2;ERCC6L;PAFAH1B1;ZWINT;MAP4;B9D2;RCC1;OFD1;NUP98;CCNB1;NDE1;SPC24
prerank,regulation of mRNA metabolic process (GO:1903311),-0.462018832839301,-1.2101248421748811,0.21040723981900453,0.5708784453287317,1.0,2/11,4.76%,NCBP1;SLTM
prerank,blood vessel morphogenesis (GO:0048514),-0.3041209724127346,-1.2101035376742153,0.12933753943217666,0.5700118740248802,1.0,21/54,23.51%,RBPJ;NRP1;CCBE1;PROX1;RASA1;FLT1;SYK;AGGF1;CAV1;LOX;ID1;KDR;HAS2;CDH2;RAMP2;HEY2;HES1;SERPINF2;SHH;APLNR;CYP1B1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.42791723832166517,1.2089498258226523,0.19289340101522842,0.8524166280921129,1.0,7/19,10.75%,ZFPM2;MEF2C;TGFBR3;TGFBR1;ERBB4;TBX2;FGF2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.30952432614979175,1.2089497439459391,0.13568521031207598,0.8504250004563837,1.0,31/107,19.51%,DGKI;SLC4A8;CACNG5;NPTXR;SYT1;SLC12A2;LGI1;MEF2C;GRM3;NPTX1;TPRG1L;GRIK5;GRIK2;GRID2;CLSTN2;CX3CR1;NRG3;RIMS1;KCTD13;CPLX2;CACNA1B;DLGAP1;BAIAP3;SLC8A3;DGKZ;CACNA1A;DLGAP2;DLGAP3;CHRNA7;RIMS3;LRRC4C
prerank,mitotic cell cycle phase transition (GO:0044772),-0.24745764318760788,-1.208845111304923,0.05025125628140704,0.5722578164734302,1.0,71/204,23.79%,CHMP4B;EPS8;PPP2R2A;PCM1;FBXL17;CDK6;ENSA;PPP1R12B;CUL3;CDK5RAP2;CUL4A;TACC3;PRKACA;FBXL8;GPR132;BORA;TUBA4A;CEP250;PPP1R12A;CDC34;CCND1;KDM8;YWHAG;CDKN2C;HAUS2;HINFP;CEP164;MAPRE1;CENPJ;WEE1;CDC27;CCNH;DNM2;CDKN3;CDK1;CCNA2;AJUBA;HAUS8;CCND2;RB1;MNAT1;ARPP19;TRIM71;CDK14;CDC25A;OPTN;PLK1;UBE2C;DCTN2;ODF2;FBXL15;PAFAH1B1;CDKN2A;NES;FBXL12;ACVR1;CUL5;MELK;AKAP9;CDC25C;CEP78;CCNY;RCC1;OFD1;ANAPC7;TUBB4B;CCNB1;NDE1;BRSK1;MASTL;CTDP1
prerank,negative regulation of platelet activation (GO:0010544),0.4526343445202236,1.208820236093591,0.2141623488773748,0.8489530655078933,1.0,6/16,15.41%,ALOX12;THBD;SH2B3;PRKG1;PDGFB;SERPINE2
prerank,positive regulation of DNA binding (GO:0043388),-0.35799454460160507,-1.208607353830097,0.16422287390029325,0.5719720351581367,1.0,15/31,23.83%,IGF1;HMGB2;PPARG;CEBPG;PLAUR;TXN;H1-0;RB1;GATA3;NIBAN2;MMP8;HES1;SIRT2;TWIST1;EGF
prerank,response to ionizing radiation (GO:0010212),-0.2896886832728855,-1.2085837986932326,0.1461794019933555,0.5711166215492985,1.0,28/70,25.73%,AEN;TOPBP1;USP28;ANXA1;BRCA1;EYA1;ABRAXAS1;EEF1D;EYA3;GRB2;RHNO1;PAXIP1;LIG4;BRAT1;KAT5;TICRR;SWI5;NHEJ1;UIMC1;BRCC3;ECT2;XRRA1;BABAM2;BRSK1;NET1;RAD51AP1;TRIM13;TNKS1BP1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4375573925856274,1.20851442146978,0.2179930795847751,0.8482701251332434,1.0,7/18,11.61%,NAPB;GRIA2;GRIK5;GRIK2;GRID2;UNC13B;SLC1A4
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3987558579962979,1.2077672513697917,0.19516129032258064,0.8493867659481797,1.0,10/25,22.17%,LDB1;HTATSF1;EAF2;CCNK;ERCC6;DDX39B;CCAR2;THOC5;ALYREF;SCAF8
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.48487141114739785,-1.2073504651460514,0.2324455205811138,0.5735027916510291,1.0,4/10,12.45%,PPARG;RARA;SNW1;RXRB
prerank,bile acid biosynthetic process (GO:0006699),-0.3709609193359285,-1.2071211788861336,0.1827956989247312,0.573161915501438,1.0,5/24,9.14%,ACOT8;OSBP;OSBPL9;OSBPL1A;OSBPL2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3502235977637722,-1.2068374311481551,0.18232044198895028,0.5730527349002722,1.0,10/30,14.21%,DAB2;SMARCA4;RNF14;H3-3A;RNF6;EP300;PRMT2;PIAS2;HDAC1;FOXP1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4964590278335111,1.2067103505311347,0.24864864864864866,0.8518747900973667,1.0,4/10,19.01%,PDE3B;SNAI2;JAM3;WNK1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4499546520979856,1.206432639933405,0.22664359861591696,0.8510625011034785,1.0,6/17,19.85%,ATP1B1;GJC3;SLC8A1;GJA5;ATP1A3;ATP1A1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.29354752863683664,-1.2063801721665466,0.15358361774744028,0.5733718027597846,1.0,22/65,24.00%,HIP1;CNOT9;HIP1R;BCAR3;ARAP1;PLAUR;EPS15;SPRY2;GRB2;CBL;CEACAM1;SPRY1;STAM;EGFR;ITGA1;NUP62;PDE6H;AFAP1L2;TGFA;WDR54;EGF;DUSP3
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.47626112163175205,1.206236863177861,0.23013245033112584,0.8499545056391978,1.0,8/14,30.58%,ATP1B1;ATP1B3;ACTN2;GAL;ANK2;LRRC55;ATP1B2;KCNIP2
prerank,cellular response to interleukin-12 (GO:0071349),-0.3192524809779225,-1.2061668233824696,0.1518624641833811,0.573013242973828,1.0,11/48,15.33%,CD47;TALDO1;STAT4;IL12RB2;PSME2;MSN;LMNB1;LCP1;HNRNPA2B1;AIP;RAP1B
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.42870928083620263,-1.2061021087573918,0.23040380047505937,0.5722595917896014,1.0,5/15,9.47%,VCP;ATF3;GSTO2;HSF1;ZC3H12A
prerank,ventricular septum morphogenesis (GO:0060412),0.39665202892432616,1.2059384907425315,0.21753246753246752,0.8492662489436923,1.0,7/27,9.05%,ZFPM1;SOX4;ZFPM2;TGFBR3;TGFBR1;BMP4;HEY1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.30665088586062406,-1.2058935639064285,0.15757575757575756,0.5718455636307453,1.0,10/52,9.26%,BCL2;UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;PPP3R1;ARIH2;YWHAG;UBE2L3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.25277944439671374,-1.2058929703236148,0.06511627906976744,0.5709407447009498,1.0,52/166,19.73%,ZEB2;IGF1;UPF3A;NIBAN1;RPL5;ATP7A;P2RX4;CD36;PCNA;BCL3;SAMD4A;THBS1;SMAD3;SP1;BCAR3;LDLR;NR1H2;CTDNEP1;HIF1A;IL1B;LARP6;VIM;CD28;PIWIL2;IGF2;SORBS1;PLD1;PPP1R3E;NR1H3;NPM1;CDT1;NMD3;MID1IP1;ARPP19;ZCCHC4;EGFR;TNF;KAT7;CHP1;LARP4B;MFSD2A;FXR2;TLR4;UPF3B;KLF2;RGCC;HNRNPD;MMP8;IRS2;NAT10;RPL26;OPN3
prerank,negative regulation of phosphorylation (GO:0042326),-0.28258673564157355,-1.2056278262071007,0.12624584717607973,0.5707736150346383,1.0,27/85,21.35%,PID1;STAP1;NIBAN1;XDH;GIT1;CBFA2T3;CORO1C;CRKL;LYN;CIB1;CDKN2C;ZC3H12A;DNAJC10;LRRK2;INPP5K;PRKRIP1;CHP1;LRP6;TRAF3IP1;MYADM;CDKN2A;IRS2;BMP7;HNRNPU;NCOR1;WARS1;HDAC4
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.41664225691281204,-1.2055356342103956,0.20151133501259447,0.5701143124446352,1.0,6/16,10.80%,BCOR;DNMT1;BRCA1;SNW1;CTNNB1;PAXIP1
prerank,regulation of gastrulation (GO:0010470),-0.44118011381650485,-1.2054393683352032,0.22650602409638554,0.5694678271021717,1.0,6/14,21.08%,PHLDB1;DAG1;RACK1;SCX;LHX1;POGLUT1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.39700726153131527,1.2053788805188073,0.19874804381846636,0.8495873820923412,1.0,8/27,17.90%,YWHAE;CACNB4;CACNB2;DMD;ADRA2A;JPH1;HPCA;ANK2
prerank,positive regulation of protein deacetylation (GO:0090312),0.46227319184118587,1.2053773230729492,0.24394463667820068,0.8476540605344963,1.0,6/14,21.73%,CTBP1;AKAP8L;AKAP8;SAP30BP;ZBTB7B;ING2
prerank,granulocyte differentiation (GO:0030851),-0.39954385981493123,-1.2047871262320653,0.21,0.5704362366663815,1.0,4/18,10.18%,CBFA2T3;RARA;DEK;EP300
prerank,regulation of steroid biosynthetic process (GO:0050810),0.4892033679309465,1.2041048149616498,0.23519458544839256,0.8510398669520222,1.0,3/11,8.51%,WNT4;STAR;DGKQ
prerank,external encapsulating structure organization (GO:0045229),0.2835208310451807,1.2040082698363583,0.09813664596273292,0.8494888217136533,1.0,55/205,19.80%,AGRN;COL5A1;MMP16;F11R;LAMB3;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ADAMTS20;SMOC2;ITGB5;MFAP2;FBN2;ADAMTSL1;ADAMTS15;APLP1;BSG;PXDN;ADAM15;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;THSD4;VCAN;PDGFB;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;TGM1;COL15A1;COL18A1;JAM3;ADAMTS4;LAMA1;ITGA6;POSTN;MMP17;ADAMTS3;DCN;MFAP5;COL4A4;ITGAD
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3689743910719012,1.2039141649272442,0.19391025641025642,0.8479645177697223,1.0,16/36,25.24%,FHIT;GIPC1;PSMF1;OGT;TAF9;CCAR2;UBXN1;PRKCG;ALAD;HSP90AB1;TLK2;CAMLG;OPHN1;USP7;TRIM39;HFE
prerank,endodermal cell fate commitment (GO:0001711),0.5097834372971083,1.2038644859350371,0.23217550274223034,0.8462542344703122,1.0,2/10,1.94%,CTR9;RTF1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.30764508701112353,-1.2036057711255839,0.14240506329113925,0.572724988571289,1.0,18/56,17.83%,CHMP4B;KIF23;RASA1;SNX9;STMN1;CIT;RACGAP1;USP8;CENPA;NUSAP1;ESPL1;PDCD6IP;KIF4A;CKAP2;INCENP;PLK1;KIF20A;ECT2
prerank,axon guidance (GO:0007411),0.28113148953220046,1.2034774923150937,0.1220125786163522,0.8458596772659827,1.0,50/201,16.84%,SEMA7A;PLXNB2;DCC;CHN1;EFNA4;ROBO4;NFIB;SEMA6C;MYPN;CNTN2;PTPRO;GPC1;EFNB3;NRXN1;DOK4;DSCAM;PLCG1;LGI1;RYK;SEMA6B;SHANK3;SEMA3D;PRKCA;EPHA1;BSG;KLF7;EFNA1;RAP1GAP;FEZ2;SPTAN1;CXCR4;SEMA4F;USP33;EFNA3;ARHGAP35;SPTBN2;GFRA1;EVL;EPHA4;CYFIP1;SPTBN1;ENAH;EPHB2;DSCAML1;MAPK3;SEMA4B;SIAH1;SEMA3C;PTK2;LAMA1
prerank,regulation of response to external stimulus (GO:0032101),-0.26714362977420714,-1.2034763258691394,0.11440677966101695,0.5721971813893069,1.0,34/121,20.95%,FCGR2B;PSMA6;PTPN22;ALOX5;CELF1;P2RX4;CD36;ZBP1;CCR2;CAMKMT;STK24;USP18;NOD2;CAV1;ANXA1;HCK;ERAP1;FNTB;ADGRA2;BIRC2;SHPK;TRIM5;CD55;FOXP1;WNT5A;BST1;PDE6B;PDGFRA;ADAMTS12;PPEF1;MYD88;APPL2;CASP1;TMSB4X
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3938067169827385,1.203379444615866,0.21680672268907564,0.8443378863340342,1.0,4/25,1.74%,B3GNT9;B3GNT6;B4GAT1;B3GALT2
prerank,endothelial cell proliferation (GO:0001935),0.4470843227513399,1.2032018474503035,0.2222222222222222,0.8432043542886165,1.0,5/17,12.98%,CD34;BMP4;ITGB1BP1;THAP1;TEK
prerank,regulation of muscle contraction (GO:0006937),-0.35867123408024626,-1.2031513754548335,0.18765432098765433,0.5721641404766832,1.0,4/26,6.59%,PPP1R12B;ENO1;CHRM2;CAV1
prerank,glycoprotein metabolic process (GO:0009100),-0.3056235140411625,-1.202877277147675,0.17681159420289855,0.5719841390845579,1.0,12/53,14.94%,B4GALT5;ERP44;MAN2A1;GANAB;ST8SIA6;FUT8;HIF1A;ST8SIA4;HPSE;PRKCSH;FBXO2;ST8SIA2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4293509439878539,1.2028162414844432,0.22093023255813954,0.8429272797999907,1.0,5/18,11.12%,CACNG5;CACNG2;NRXN1;SHANK3;CACNG7
prerank,positive regulation of chemokine production (GO:0032722),-0.3126814412865794,-1.2026408591740614,0.14450867052023122,0.571649352881936,1.0,14/44,17.07%,CD74;TLR2;TLR7;SYK;HIF1A;IL1B;LPL;OAS3;AGER;TNF;WNT5A;TLR4;HMOX1;ADAM17
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3839470884382117,-1.202482846682473,0.19559228650137742,0.5711392579753846,1.0,9/22,21.75%,PROX1;TOX;LRRK2;TRIM71;NES;SHCBP1;PTPRZ1;APPL2;ID2
prerank,cellular response to insulin stimulus (GO:0032869),-0.2632160891485072,-1.2022622953766609,0.08870967741935484,0.5709107763671484,1.0,36/124,22.57%,ATP6V0D1;MYO5A;RAB8B;ATP6V0D2;DENND4C;PPARG;ATP6V1B2;ATP6V0A1;NAMPT;ATP6V0B;GAB1;SLC27A4;BCAR3;GOT1;AP3S1;RAB15;RAB10;GRB2;FOXO1;IGF2;SORBS1;CEACAM1;ATP6V1A;INPP5K;SHC1;SLC25A33;BCAR1;CPEB2;RAB31;IRS2;ATP6V0A4;ZDHHC7;INSIG1;ATP6V1G2;CAPN10;KAT2B
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4225594311978026,-1.2013506519002133,0.21445783132530122,0.5723457286772763,1.0,4/15,8.21%,APOE;LDLR;PFDN5;PSEN1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4214517525968471,1.2009688058620984,0.22110552763819097,0.8481773147828624,1.0,7/20,15.11%,YWHAE;ADRA2A;ACTN2;HECW2;NEDD4;STK39;NEDD4L
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.36361135129504557,-1.2008792377344069,0.20718232044198895,0.5727209282184283,1.0,11/26,25.07%,FLOT2;TLR2;IRF7;CD36;BIRC2;GPR108;APPL2;TLR5;SMPDL3B;TLR9;APPL1
prerank,protein K63-linked ubiquitination (GO:0070534),0.36156941813282956,1.2006225845319638,0.19197707736389685,0.847668334479665,1.0,13/41,15.88%,UBE2B;UBE2V1;RNF126;UBE2G1;ZFP91;PRKN;PELI3;NEDD4;UBE2N;RNF168;RNF8;RNF135;RNF152
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4216892222944552,1.200375780315785,0.20797227036395147,0.846787144096011,1.0,10/20,27.55%,NCKAP1;NCKAP1L;FMNL3;FMNL1;RHOQ;ROCK1;LLGL2;FHOD1;LLGL1;RAB13
prerank,neutrophil activation (GO:0042119),-0.449024264951957,-1.2003522523979622,0.22505800464037123,0.5732596680292985,1.0,3/12,6.17%,IL15;TYROBP;SYK
prerank,regulation of insulin secretion (GO:0050796),0.3067013275865406,1.1992151353891698,0.14673913043478262,0.8496375905264242,1.0,26/101,19.32%,SNAP25;ITPR2;KCNA5;NNAT;SOX4;IL6;RFX6;SLC2A2;DOC2B;ADRA2A;TCF7L2;RAPGEF3;PRKCA;PRKN;CACNA2D2;IRS1;SFRP1;ITPR3;CACNA1D;ABCC8;REST;CACNA1A;STXBP4;MTNR1B;GHRL;CCL5
prerank,regulation of programmed cell death (GO:0043067),-0.2536360179213931,-1.199074879998762,0.05263157894736842,0.5757848683749941,1.0,38/161,17.62%,SLK;DDX42;HIP1;ACER3;RAF1;VCP;STEAP3;ACTN1;KANK2;LGALS1;BAX;NLRC4;BCL3;FAS;RIPK1;TMEM219;ANP32B;CTSB;TPT1;IKZF3;PIDD1;STAT1;BIRC5;BRMS1;BIRC2;DAPK1;LRRK2;HS1BP3;PMAIP1;DFFA;TNF;BCL2L11;TM7SF3;NUP62;BCAR1;NOP53;WFS1;TNFRSF25
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4183426011172472,1.198161530113116,0.23115577889447236,0.8519397706904358,1.0,8/20,25.83%,DGAT2;CBR4;PPT2;FITM2;ACLY;ACSL3;SLC25A1;FASN
prerank,ceramide transport (GO:0035627),-0.46093824058882643,-1.1976531820990854,0.24824355971896955,0.5784348927509455,1.0,8/12,28.67%,PSAP;PLEKHA3;PLTP;SGPP1;ABCA13;CERT1;CPTP;GLTP
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.2919081799428246,-1.1975350563094642,0.1492063492063492,0.5778483829982067,1.0,17/74,10.45%,BCL2;IGF1;BCL2L1;BIRC6;MCL1;SIAH2;THBS1;PF4;FAS;RIPK1;BRCA1;IL1B;EYA1;BMP5;SH3RF1;EYA3;EYA2
prerank,epithelium development (GO:0060429),0.30249192997249147,1.1967896620764515,0.1527027027027027,0.8557948036682554,1.0,19/107,13.33%,FGF10;WNT4;CD34;AKR1C1;CDHR2;SOX10;MEOX2;WNT3;VDAC1;TIMELESS;ALDOC;PKD2;TGFB1;TBX2;SNAI2;UPK1B;PPP2R3A;PKD1;NDRG4
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.47493163246349557,-1.1966432566134328,0.25598086124401914,0.5792720077635924,1.0,5/11,14.97%,PTPRC;AHR;CEACAM1;KLRD1;LILRB1
prerank,heart process (GO:0003015),0.4567938519029383,1.1961695465705053,0.2429078014184397,0.856520541401701,1.0,5/14,16.68%,TNNI3;SGCZ;SGCG;PPCS;SGCD
prerank,protein K48-linked deubiquitination (GO:0071108),0.40960767047016633,1.1958033156255636,0.21753246753246752,0.856104208489986,1.0,7/23,15.27%,OTUD7A;USP50;USP33;OTUB1;BAP1;OTUD7B;OTUD5
prerank,axonogenesis (GO:0007409),0.27528915173067,1.1956025351288682,0.11138310893512852,0.8550148344416155,1.0,59/237,16.84%,SEMA7A;DCC;RAB3A;CTNNA2;EFNA4;PARD6B;ROBO4;SEMA6C;MYPN;ATL1;CNTN2;PTPRO;GPC1;EFNB3;NRXN1;DOK4;DSCAM;PLCG1;LGI1;MAP1S;RYK;RAB8A;SEMA6B;SHANK3;APBB1;SEMA3D;PRKCA;EPHA1;BSG;KLF7;EFNA1;RAP1GAP;FEZ2;SPTAN1;CXCR4;SLITRK4;SEMA4F;USP33;EFNA3;ARHGAP35;NRCAM;SPTBN2;GFRA1;EVL;EPHA4;CYFIP1;SPTBN1;ENAH;EPHB2;DSCAML1;SPG11;WNT7A;MAPK3;SEMA4B;SIAH1;SEMA3C;PLPPR4;PTK2;LAMA1
prerank,regulation of MAP kinase activity (GO:0043405),-0.27640503074132516,-1.1952223213339608,0.13602941176470587,0.5819945632789444,1.0,25/92,15.23%,APOE;CD300A;STK38;PTPN1;NOD2;PDGFD;FLT1;PDCD10;CD24;LYN;IL1B;FGF1;PDGFC;ADAM8;SPRY2;LRRK2;PIK3R6;SPRY1;PIK3R5;INPP5K;DUSP1;CDK12;EGFR;TNF;SPRY4
prerank,cell cycle G2/M phase transition (GO:0044839),-0.26006697177363014,-1.1949220719581604,0.08235294117647059,0.5818990354855523,1.0,48/130,23.78%,PPP2R2A;PCM1;FBXL17;ENSA;PPP1R12B;CDK5RAP2;PRKACA;FBXL8;BORA;TUBA4A;CEP250;PPP1R12A;KDM8;YWHAG;HAUS2;CEP164;MAPRE1;CENPJ;WEE1;CCNH;DNM2;CDK1;CCNA2;AJUBA;HAUS8;MNAT1;ARPP19;CDK14;CDC25A;OPTN;PLK1;DCTN2;ODF2;FBXL15;PAFAH1B1;NES;FBXL12;MELK;AKAP9;CDC25C;CEP78;CCNY;OFD1;TUBB4B;CCNB1;NDE1;BRSK1;MASTL
prerank,copper ion transport (GO:0006825),-0.4640335008622496,-1.1949171241492644,0.25240384615384615,0.581014185826623,1.0,3/11,3.73%,STEAP3;ATP7A;SLC31A2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.4485409827706228,-1.1948468759067,0.2350230414746544,0.5803197581026425,1.0,6/11,25.88%,CDK5RAP2;BRCA1;NPM1;TRIM37;KAT2B;CCNF
prerank,aorta morphogenesis (GO:0035909),-0.4054716224263034,-1.1946693909561048,0.22994652406417113,0.5799294203308321,1.0,7/17,19.19%,RBPJ;PROX1;EFEMP2;LRP1;HEY2;TFAP2B;MYLK
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.3907683468777738,-1.1945066861507618,0.21212121212121213,0.5795236376205024,1.0,5/20,6.28%,DAB2;PID1;BCL2L1;PPP2R5A;PICALM
prerank,extracellular structure organization (GO:0043062),0.2816219634260721,1.1943843406173764,0.10875,0.8580173398991807,1.0,55/204,19.80%,AGRN;COL5A1;MMP16;F11R;LAMB3;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ADAMTS20;SMOC2;ITGB5;MFAP2;TGFBR1;FBN2;ADAMTSL1;ADAMTS15;APLP1;BSG;PXDN;ADAM15;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;THSD4;VCAN;PDGFB;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;COL15A1;COL18A1;JAM3;ADAMTS4;LAMA1;ITGA6;POSTN;MMP17;ADAMTS3;DCN;MFAP5;COL4A4;ITGAD
prerank,mononuclear cell differentiation (GO:1903131),-0.3634079178514755,-1.193804948637161,0.1927710843373494,0.5803751966960988,1.0,8/24,16.08%,GAS6;AXL;PPARG;LYN;LILRB1;MYH9;RELB;IKZF1
prerank,positive regulation of type I interferon production (GO:0032481),-0.28829472760733466,-1.1937727510721283,0.15034965034965034,0.5795740166200563,1.0,21/73,14.18%,PTPN22;OAS2;IFIH1;TLR2;IRF7;ZBP1;TBK1;POLR2E;DHX33;TLR7;NFKB1;CD14;HSPD1;DDX41;TLR8;STAT1;EP300;CTNNB1;OAS3;LRRFIP1;POLR2H
prerank,negative regulation of immune system process (GO:0002683),-0.41500628941781575,-1.1935191727454844,0.23671497584541062,0.5793693316553863,1.0,8/16,28.01%,FCGR2B;LYN;PDCD1;HMOX1;COL3A1;FADD;FCRLB;SPINK5
prerank,negative regulation of T cell differentiation (GO:0045581),0.5014420604152303,1.1933570790103991,0.2427843803056027,0.8602639424215998,1.0,6/10,28.92%,BMP4;ZC3H8;LAG3;GLI3;IRF1;MDK
prerank,cytoplasmic translational initiation (GO:0002183),-0.407135999404718,-1.1922303631873148,0.20187793427230047,0.5818851386639863,1.0,4/17,5.90%,EIF4B;DHX29;EIF2S2;EIF3I
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4526344086405026,1.1921338623038065,0.23842195540308747,0.8632711214491756,1.0,4/15,12.27%,SELENOS;HSP90B1;HERPUD1;DERL1
prerank,organic hydroxy compound transport (GO:0015850),0.3671265183819037,1.1908418677292734,0.19672131147540983,0.8667552962286408,1.0,10/36,18.81%,SLCO2B1;ABCC3;ABCG8;AKR1C1;SLC10A2;STARD5;RALBP1;ATP8B1;SLC10A1;GHRL
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.38190970398734914,-1.190535184387874,0.2077922077922078,0.5853034010312286,1.0,8/21,18.29%,IGF1;MEF2D;ERN1;LDLRAP1;DNMT1;HTR1B;GJA1;IGFBP5
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4411399113498334,-1.1904240767364052,0.22632794457274827,0.5846685807843333,1.0,5/13,19.48%,MET;TXN;LRRK2;RACK1;GPR37
prerank,phasic smooth muscle contraction (GO:0014821),-0.4788050525433093,-1.1902697233627109,0.2340909090909091,0.5841776375045574,1.0,7/10,37.77%,EDNRB;DRD2;HTR1D;EDN3;EDN2;EDN1;GDNF
prerank,neuromuscular synaptic transmission (GO:0007274),0.4290543305351969,1.190073524517235,0.2287145242070117,0.8680003546825991,1.0,4/18,9.33%,TSPOAP1;ERC2;FCHSD2;CHAT
prerank,metal ion transport (GO:0030001),0.31320167958303025,1.1899217343477113,0.1754636233951498,0.866752073574653,1.0,26/86,19.87%,ATP2A3;TRPC3;CDH23;NMUR1;CACNA1S;LRP2;TRPM2;CCR1;PKD2;SLC8A1;CACNG7;SLC39A8;ATP2C1;PANX1;CACNA1D;CACNA1B;KCNN4;SLC8A3;CACNA2D1;CACNA1A;CACNG3;CHRNA7;SELENOK;TRPV6;CCL5;CNNM4
prerank,negative regulation of myoblast differentiation (GO:0045662),0.46043082629584076,1.1891794968313854,0.23378839590443687,0.8677713339537579,1.0,3/13,9.35%,PRICKLE1;BMP4;TGFB1
prerank,positive regulation of cellular component movement (GO:0051272),0.3961616554043717,1.1891203878636718,0.24879614767255218,0.8661129674695582,1.0,4/24,7.63%,CCDC25;SPOCK2;STK11;TGFBR1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3765859785606551,1.1887290692076318,0.20193861066235863,0.8657631626495441,1.0,13/30,27.54%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;POLR1F;POLR1G;GTF2H3;ERCC2;TAF1A;POLR1A;GTF2H1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.47656097479469894,1.1884050621139202,0.2603978300180832,0.86528415751942,1.0,3/11,9.35%,TGFBR3;TGFBR1;TGFB1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4551409496012436,1.1883836925996671,0.24781849912739964,0.8616668342735943,1.0,4/15,9.77%,BLOC1S2;SNAPIN;AP3M1;AP3B2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4551409496012436,1.1883836925996671,0.24781849912739964,0.8616668342735943,1.0,4/15,9.77%,BLOC1S2;SNAPIN;AP3M1;AP3B2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.44633735777234995,-1.1880107244086588,0.24754901960784315,0.5891937542890753,1.0,6/13,13.60%,CPSF1;NCBP1;FIP1L1;CPSF4;CSTF2;CPSF2
prerank,amyloid fibril formation (GO:1990000),-0.3074469651873176,-1.187973074473659,0.15988372093023256,0.5884226176457628,1.0,20/51,23.38%,TGFBI;ITM2B;CD36;SIAH2;RIPK1;GGA2;UBC;H3-3A;UBA52;USP9X;TSPAN5;APH1B;B2M;UBE2L6;GSN;MFGE8;LTF;SERF1A;APP;CALCA
prerank,postreplication repair (GO:0006301),-0.31090187628205873,-1.1862638517788764,0.17134831460674158,0.5921167204908075,1.0,15/45,18.45%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;BRCA1;UBA52;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.39392956308912697,-1.186174732849914,0.22391857506361323,0.5914498580843244,1.0,3/19,5.92%,CD74;RIPOR2;MOSPD2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.37934795066306287,1.1860120183498442,0.22755417956656346,0.8693729554785152,1.0,8/31,9.35%,TNNI3;TNNC1;LRP2;MYBPC3;ZFPM2;TGFBR3;TGFBR1;TGFB1
prerank,Fc receptor signaling pathway (GO:0038093),-0.26472768919855455,-1.185795365259635,0.12043795620437957,0.591593632216499,1.0,30/110,18.00%,VAV3;MAP3K1;PSMA6;TEC;PSMB2;PSME2;GRAP2;NFKB1;PPP3R1;PSMD11;SYK;PSMC6;LYN;GAB2;PRKCQ;PSMA3;TAB1;PIK3CA;LCP2;GRB2;PPP3CA;PSMD10;FOS;SHC1;PSMB5;FCER1G;MAPK8;MAP2K4;MAP2K7;PSMD5
prerank,receptor signaling pathway via STAT (GO:0097696),-0.36201979859523753,-1.1854786718921997,0.21774193548387097,0.5915290018236786,1.0,8/25,10.76%,IFNAR1;STAT5B;STAT4;CCR2;IFNAR2;STAT2;STAT1;GHR
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4047274542679326,1.185406620794679,0.22932917316692666,0.8698866666105368,1.0,12/24,27.58%,FIS1;PRNP;MYO1C;ITGB1BP1;MTCL1;HRAS;MFF;ITGAM;PDZK1;ANK3;KCNB1;CEMIP
prerank,Golgi to lysosome transport (GO:0090160),-0.4628487559071963,-1.185082416526457,0.2340909090909091,0.5917780967273106,1.0,5/11,16.03%,GAK;AP4M1;LAMP1;RBSN;CLN3
prerank,epithelial cell-cell adhesion (GO:0090136),0.48659421248341256,1.1848563143857356,0.2754385964912281,0.8701529931350794,1.0,3/11,10.48%,PLEKHA7;ITGB5;CAMSAP3
prerank,negative regulation of wound healing (GO:0061045),0.3880081425052684,1.1848229909408978,0.23052464228934816,0.8684373466129635,1.0,9/28,15.95%,ADTRP;CD34;SLC12A2;CLASP2;THBD;FGF2;VTN;SERPINE2;PHLDB2
prerank,heme biosynthetic process (GO:0006783),0.41329395222482546,1.1846541441836895,0.2441077441077441,0.8672189630502604,1.0,10/22,25.44%,ABCB6;FLVCR1;TSPO;PGRMC1;UROD;ALAD;ABCG2;SLC25A38;COX10;CPOX
prerank,tRNA processing (GO:0008033),0.3356851909781773,1.1845423570729148,0.19264705882352942,0.8658355310231197,1.0,13/61,10.21%,ZBTB8OS;TYW5;ADAT2;RPP40;TSEN54;ELP5;CTU1;DDX1;METTL1;ELAC2;ADAT1;DTWD2;FTSJ1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4554419214620048,-1.184212603782583,0.2512315270935961,0.5932665122645241,1.0,3/12,6.88%,APOE;LDLR;PFDN5
prerank,protein ubiquitination (GO:0016567),-0.21875448251589727,-1.1835433558088144,0.021505376344086023,0.5941821357429486,1.0,111/471,16.57%,SASH1;BCL2;ITCH;VCPIP1;WWP1;HECTD2;PSMA6;UBE2D3;MSL2;HERC6;KLHL20;FBXL17;VCP;UNKL;TRIM25;CDC73;CUL3;TRIM7;ARIH1;PRPF19;PJA2;TRIM14;CUL4A;UBE2K;UBA6;PSMB2;DTX3L;PEX10;BIRC6;FBXL14;FBXO30;FBXW7;SIAH2;RNF213;OBI1;FBXL8;OS9;PCNA;SMURF2;PSME2;TRIM17;UHRF2;TAF1;UBE2Q1;RNF146;HECW1;VHL;PSMD11;CDC34;ARIH2;PSMC6;TRIM62;RNF13;UBC;NHLRC3;ZNRF3;HIF1A;PSMA3;FBXW4;BRCA1;RNF14;CCDC22;LMO7;RNF6;RNF157;UBE2L3;UBA52;SH3RF1;PEX13;CDC27;USP9X;SPSB2;RNF220;RC3H1;KLHL21;UBE2Q2;CTNNB1;KBTBD8;BARD1;TRIM44;TRIP12;AKTIP;BIRC2;RNF103;CBL;RRAGA;RNF38;ATG3;PELI1;UBE2E3;TRIM5;FBXO32;PSMD10;RACK1;FBXO2;UCHL3;UBE2L6;PSMB5;TRIM71;RC3H2;KLHL41;WAC;OTULIN;MKRN1;PLK1;MUL1;UBE2C;LONRF1;ASB4;USP5;CUL9
prerank,cellular response to estrogen stimulus (GO:0071391),0.4504030618253918,1.1833772920209376,0.23857868020304568,0.8688307857455174,1.0,4/14,12.73%,WBP2;AR;SFRP1;CRHBP
prerank,methylguanosine-cap decapping (GO:0110156),0.493707140457663,1.18330368498553,0.2673611111111111,0.867268665731357,1.0,2/10,5.34%,PATL1;LSM1
prerank,regulation of cell development (GO:0060284),-0.32685204213618724,-1.1831074845419363,0.18209876543209877,0.5944849566406588,1.0,13/36,21.64%,HMGB2;DOCK7;YAP1;IL1B;CTNNB1;FOXO1;ADGRA2;HEY2;PER2;HES1;BHLHE40;NOTCH2;HEYL
prerank,phosphate ion transport (GO:0006817),0.44064242416863125,1.182976599495307,0.23943661971830985,0.866827431416584,1.0,6/16,25.31%,SLC37A4;SLC20A1;SLC37A1;SLC25A10;XPR1;SLC37A3
prerank,bicellular tight junction assembly (GO:0070830),0.34528687229945937,1.1824671447247719,0.21688500727802038,0.8670879947725564,1.0,6/46,6.81%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2982669928208235,1.1824447675913297,0.16037735849056603,0.8653643211618887,1.0,30/113,17.95%,FGF10;F3;ANG;FGF9;PTPRN;FLT4;FGF7;SRSF6;AREG;TGFBR1;EGFL7;NME1;BMP4;TCF7L2;PRKCA;PRKD2;FGF2;PDCD6;SFRP1;PDGFB;VASH2;TEK;TGM1;HPN;WNT7A;PRKD1;HRAS;STXBP4;XBP1;AKT3
prerank,positive regulation of cell population proliferation (GO:0008284),-0.22655901479472962,-1.1824216283960358,0.022727272727272728,0.5954102222473888,1.0,91/423,15.61%,PID1;RBPJ;IL15;BCL2;CD74;GAS6;MECP2;ITGAX;ACER3;IGF1;PRKCH;GCNT2;CDK6;DPP4;PTPRC;SDCBP;NDUFS4;CUL3;CD47;LIFR;CAPN1;FAM98B;IL12RB2;MEIS1;RARA;FAM98A;NAMPT;CDCA7L;SOX11;IL6ST;DOT1L;KITLG;PROX1;S100A6;PIM1;PRC1;S1PR2;C5AR1;THBS1;TOX;BST2;CRKL;NOD2;PDGFD;FLT1;KIF20B;PDCD10;LYN;DHPS;YAP1;CIB1;GAB2;IL1B;FGF1;BMI1;HSF1;HCK;BMP5;VIPR1;KRAS;HPSE;PDGFC;STAT1;BIRC5;NOTCH1;TRPM4;CCN1;HDAC2;LIG4;IGF2;HDAC1;KDR;EMP2;CCND2;PTN;SLAMF1;SCX;GREM1;BMP2;HAS2;NPM1;KMT2D;FOXP1;CIAO1;EGFR;SHC1;TNF;PTK2B;GJA1;WNT5A;SLC25A33
prerank,DNA dealkylation (GO:0035510),-0.4670878441763157,-1.1818264189506227,0.25112107623318386,0.5952609190038043,1.0,2/10,3.91%,ASCC3;ASCC1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.4670878441763157,-1.1818264189506227,0.25112107623318386,0.5952609190038043,1.0,2/10,3.91%,ASCC3;ASCC1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.43540016311451163,1.181761031577315,0.24496644295302014,0.8663255180947231,1.0,6/17,15.48%,THY1;SLA2;PRNP;PVRIG;PTPN2;DGKZ
prerank,inorganic cation transmembrane transport (GO:0098662),0.270391681098689,1.1814362918387193,0.11033681765389082,0.8658011425128702,1.0,67/268,23.15%,HCN1;SLC4A8;ATP2A3;KCNK12;TRPC3;ATP2A2;KCNH2;KCND2;KCNA5;ATP1B1;SLC24A5;SCNN1A;KCNE2;SLC39A4;KCNJ8;TRPM3;KCNH7;KCNC1;SLC12A2;TRPM2;KCNK3;ATP1B3;SLC9A4;PKD2;CACNA1G;SLC8A1;ASIC1;ASIC2;KCNK6;SLC1A3;SLC39A8;ATP2C1;TRPC6;CACNA1D;SLC30A3;PKD1;KCNN4;SLC9A5;SCN2A;SLC6A1;ABCC8;ATP6V0E1;SLC8A3;HPN;KCNC3;SLC24A3;CACNA1A;KCNN3;ASIC3;SLC39A3;KCNK9;KCNQ4;SLC24A4;TRPV6;KCNK2;ATP1A3;ATP1A4;ATP1A1;ABCB7;SLC6A9;SCN1B;SCN3B;KCNN2;SCN8A;RYR3;SLC6A7;SLC9A1
prerank,cardiac muscle tissue development (GO:0048738),0.3414458963109215,1.1814221938539846,0.20417287630402384,0.8640564633990616,1.0,10/50,12.52%,ZFPM1;KDM6B;BMP4;HEY1;CACNA1G;TBX2;SGCZ;GJA5;SGCG;AKAP13
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4642274693781804,-1.181120582338021,0.23529411764705882,0.596285711714961,1.0,2/11,4.74%,NOVA2;RASA1
prerank,receptor internalization (GO:0031623),-0.3148003739794184,-1.1808079523426565,0.17563739376770537,0.5962089830711559,1.0,16/44,17.40%,CD36;SNX1;LDLRAP1;SYK;TFRC;PICALM;CAV1;GRB2;DNM2;CEACAM1;LRP1;LILRB1;RAMP2;CALCRL;FCER1G;RAB31
prerank,protein hydroxylation (GO:0018126),0.44202529948714075,1.1805856434849384,0.24829931972789115,0.8654319500882663,1.0,3/15,5.44%,P3H2;PLOD3;ASPH
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3287975544714046,-1.1805285798558653,0.21763085399449036,0.5960923016574786,1.0,7/38,6.59%,NEDD9;GAS6;CASS4;PTPRC;LILRA5;PTPN1;CAV1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.26308473085700745,-1.180508250529819,0.12454212454212454,0.5952658449418625,1.0,30/109,18.00%,VAV3;MAP3K1;PSMA6;TEC;PSMB2;PSME2;GRAP2;NFKB1;PPP3R1;PSMD11;SYK;PSMC6;LYN;GAB2;PRKCQ;PSMA3;TAB1;PIK3CA;LCP2;GRB2;PPP3CA;PSMD10;FOS;SHC1;PSMB5;FCER1G;MAPK8;MAP2K4;MAP2K7;PSMD5
prerank,regulation of vacuole organization (GO:0044088),0.416539643774332,1.1803782033891532,0.23688663282571912,0.8644747492423506,1.0,7/20,20.73%,IFT20;RAB1B;RAB5A;IFT88;UBQLN2;SCARB2;ENO3
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4589619302168748,-1.1803345910926866,0.25970873786407767,0.5948163836616642,1.0,5/12,19.21%,PPARG;NR1H2;ABCG1;NR1H3;ITGB3
prerank,T cell differentiation (GO:0030217),-0.318829084820392,-1.1802842315786102,0.17857142857142858,0.594084225999562,1.0,17/40,22.45%,PTPN22;PTPRC;ANXA1;LFNG;CD28;LCK;LIG4;TCF7;NHEJ1;FCER1G;ADAM17;ZAP70;GATA3;PIK3CD;SHH;GPR89A;GPR89B
prerank,protein localization to centrosome (GO:0071539),-0.4098839273204606,-1.1800813848139333,0.23897911832946636,0.5937556441281392,1.0,4/17,5.75%,PCM1;GOLGB1;PIBF1;CCDC14
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3886718128160884,1.179741367044122,0.24918032786885247,0.8652337805530843,1.0,9/24,16.54%,SEMA7A;SEMA6C;MEGF8;DSCAM;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,sphingoid biosynthetic process (GO:0046520),-0.4684407128435334,-1.1794231367143355,0.2330316742081448,0.5937983282418893,1.0,5/11,20.32%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,sphingosine biosynthetic process (GO:0046512),-0.4684407128435334,-1.1794231367143355,0.2330316742081448,0.5937983282418893,1.0,5/11,20.32%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4582520587680213,-1.1789528020354352,0.26773455377574373,0.5941059122341161,1.0,4/11,7.83%,SYK;PLAUR;LYN;PRKCQ
prerank,regulation of microglial cell activation (GO:1903978),-0.42156437972751526,-1.178754260862064,0.24494949494949494,0.5937375154919783,1.0,3/15,6.67%,STAP1;PTPRC;LDLR
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.4548579368491017,1.1787075385137316,0.2470389170896785,0.8674477923602776,1.0,4/14,13.33%,TRIB1;MEF2C;PRKG1;NDRG4
prerank,regulation of mitotic nuclear division (GO:0007088),-0.29813500622042016,-1.1786873729306466,0.14324324324324325,0.5930529642283835,1.0,21/55,23.83%,IGF1;CDK5RAP2;MKI67;BORA;KIF20B;IL1B;NUSAP1;CD28;IGF2;DUSP1;NUP62;CUL9;RGCC;NME6;DRD3;BMP7;CDC25C;TGFA;RCC1;CCNB1;EGF
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.28346190252655123,-1.178472994190534,0.15060240963855423,0.5918914593628444,1.0,22/78,17.96%,FCGR2B;CD74;KIF3A;AP2A2;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;DCTN4;CLTA;DYNC1LI2;KIF4A;CAPZB;FCER1G;DCTN2;RILP
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.28346190252655123,-1.178472994190534,0.15060240963855423,0.5918914593628444,1.0,22/78,17.96%,FCGR2B;CD74;KIF3A;AP2A2;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;DCTN4;CLTA;DYNC1LI2;KIF4A;CAPZB;FCER1G;DCTN2;RILP
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.26805310764888646,-1.178228686824977,0.12,0.5916665834570998,1.0,26/95,16.52%,FCGR2B;STAP1;CD274;AXL;CDC73;TLR2;HMGB2;GIT1;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;IL1B;ZC3H12A;VIM;ACOD1;TNFRSF1B;SHPK;NR1H3;LBP;LILRB1;WNT5A;TLR4;MAPK8
prerank,peptidyl-methionine modification (GO:0018206),0.4803663716069069,1.1767934713310795,0.26929982046678635,0.873212498277042,1.0,4/12,21.27%,NAA30;METAP1D;NAA60;METAP2
prerank,cilium movement (GO:0003341),0.34388841545171184,1.176503298217511,0.2230320699708455,0.8725599547578727,1.0,12/48,15.89%,DNAAF1;ODAD4;CCDC39;ROPN1L;DNAH9;DNAI3;CFAP100;CAMSAP3;SPA17;SPEF2;DNAAF2;CFAP61
prerank,vasodilation (GO:0042311),0.4628396286335281,1.1762227774246958,0.24315068493150685,0.871877744331088,1.0,1/13,0.54%,KCNMA1
prerank,positive regulation of actin nucleation (GO:0051127),0.4802917937715583,1.1761906974079037,0.2578397212543554,0.8702283016212907,1.0,5/11,17.93%,NCKAP1;FCHSD2;WASF3;CYFIP1;WASF2
prerank,calcium ion transmembrane transport (GO:0070588),0.30515799676591326,1.175987440346748,0.17768595041322313,0.8691847940585172,1.0,23/86,16.42%,ATP2A3;TRPC3;ATP2A2;SLC24A5;TRPM3;TRPM2;MICU2;SMDT1;PKD2;GRIN1;CACNA1G;GRIN2B;SLC8A1;ATP2C1;TRPC6;CACNA1D;PKD1;ATP2B3;SLC8A3;CACNA2D1;SLC25A23;SLC24A3;CACNA1A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4455435754796697,-1.1758196159880574,0.25635103926096997,0.5971765740844418,1.0,4/11,23.22%,FAS;PLAUR;GSN;CAAP1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.4174698985539203,1.1752586843896624,0.2613065326633166,0.8703702368867259,1.0,6/18,11.14%,SELPLG;ADD2;JAM2;PODXL2;CX3CR1;SLC39A8
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4763346037002249,1.1752495733313986,0.27563025210084036,0.8686376927969541,1.0,5/12,16.06%,FGF9;MEF2C;PRKG1;PDGFB;DOCK4
prerank,response to unfolded protein (GO:0006986),-0.3041581640072111,-1.1750369461060137,0.17592592592592593,0.598515467326634,1.0,18/48,19.86%,ERP44;HSPA4;PTPN1;BAX;ERN1;HSPD1;HSF1;PACRG;TOR1B;HSPB3;HSPB1;HSPB8;TM7SF3;OPTN;DNAJB5;DNAJB1;HSPA13;HSPA1B
prerank,negative regulation of metabolic process (GO:0009892),-0.2954358949456298,-1.174786224141857,0.15406976744186046,0.5982643291660472,1.0,18/54,17.72%,RBPJ;IL15;NOVA2;DOCK7;NRDC;NR1H2;IL1B;PCTP;NOTCH1;ID1;APOC1;ALDH1A1;NR1H3;RB1;TLR4;IL18R1;ADAM17;PGAM5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.363219600730411,-1.1744205088468638,0.23096446700507614,0.5982808395161523,1.0,4/24,1.54%,BCL2;CD74;BCL2L1;CD44
prerank,autophagy of nucleus (GO:0044804),-0.4050138860628577,-1.1744158062558308,0.23857868020304568,0.5974388794372697,1.0,5/16,16.23%,ATG13;ATG7;ATG2B;ATG3;ATG9B
prerank,positive regulation of myoblast differentiation (GO:0045663),0.44419362058379575,1.1744079633061137,0.2521440823327616,0.870141209953675,1.0,7/16,27.68%,BOC;MEF2C;SMYD1;BTG1;RANBP3L;HIF1AN;PLCB1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4647025287277669,-1.1741878507949453,0.2553191489361702,0.5971257839052629,1.0,2/11,3.17%,CD44;CORO1C
prerank,vitamin D metabolic process (GO:0042359),0.46832904538422154,1.1740863629479128,0.27175843694493784,0.8695920325366091,1.0,2/13,6.71%,LRP2;LGMN
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.28173513339912604,-1.1730722787367258,0.1624203821656051,0.5991293766710941,1.0,14/71,10.40%,PSMA6;CHMP4B;FBXL17;VCP;YME1L1;PRPF19;CAPN2;CTSL;UBC;CTSB;BAG6;UBA52;CLPP;USP9X
prerank,response to lipopolysaccharide (GO:0032496),-0.25181272704987107,-1.173016561131242,0.12552301255230125,0.5984166610187951,1.0,35/138,17.07%,IFNAR1;PTPN22;STAP1;CD274;AXL;NOCT;CDC73;HMGB2;GIT1;MAPKAPK2;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;IL1B;ZC3H12A;VIM;ACOD1;MAPKAPK3;SMAD6;TNFRSF1B;SLC11A1;SHPK;PELI1;NR1H3;FOXP1;LBP;LILRB1;WNT5A;LIAS;TLR4;MAPK8;ADAM17
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3436657206164033,-1.17280903793013,0.21012658227848102,0.5981385865642773,1.0,9/30,13.19%,CD74;BCL2L1;CD44;RTEL1;DYRK1A;YJU2;TPT1;PTTG1IP;PSMD10
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2736498111887442,-1.1727499258811276,0.16071428571428573,0.5974254259513624,1.0,23/88,16.37%,APOE;RIC1;DNAJC1;CNOT9;MALSU1;NFKB1;SAMD4A;CLN8;EIF4ENIF1;EDNRB;BAG6;DDX6;CAPRIN1;DAPK1;PAIP2B;SYNCRIP;TYMS;LARP1;RACK1;RGP1;TRIM71;CLN3;FXR2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3142107855418029,1.1726588693146078,0.20815752461322082,0.8736768690353689,1.0,26/72,26.13%,FGF10;POLR2L;FGF16;FGF9;POLR2F;KLB;HNRNPH1;FGF7;PTBP1;GTF2F1;FGF2;POLR2G;RBFOX2;HNRNPA1;MAPK3;SETX;CEP57;TIA1;POLR2C;FLRT2;POLR2D;ESRP1;MAPK1;FRS3;FLRT3;GALNT3
prerank,positive regulation of catalytic activity (GO:0043085),-0.3227982210226854,-1.1723291079219322,0.20224719101123595,0.5977227757951797,1.0,11/37,16.52%,ABL2;ATP7A;NOD2;CAV1;CIB1;PSEN1;IGF2;SLC5A3;MID1IP1;NHEJ1;MAPK8
prerank,cellular response to oxygen levels (GO:0071453),-0.47654847924308674,-1.1714562246767062,0.2469733656174334,0.5992824506471278,1.0,3/10,12.82%,ATP6V0D1;CPEB4;ATP6V1A
prerank,regulation of organelle organization (GO:0033043),-0.27299397866382313,-1.1711886627288506,0.14965986394557823,0.5991151694654475,1.0,24/80,16.83%,ZEB2;MYO5A;MARK2;STX5;VPS35;CAPN2;CLIC4;MSN;SPEF1;PARL;PDCD10;TMED9;EP300;MTM1;USP6NL;CDT1;RBSN;CLN3;ARHGEF5;PDE2A;MUL1;RAB33B;STX18;SQSTM1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3758991512208062,1.1710366068999156,0.24165341812400637,0.8783625863933512,1.0,5/32,9.09%,TRPC3;CAPN3;THY1;PLCG1;GRIN1
prerank,regulation of interleukin-2 production (GO:0032663),0.3499687481010605,1.1705736104009232,0.21362229102167182,0.8784099438148234,1.0,11/43,14.32%,CD80;CD34;IL17F;CD86;PRNP;NAV3;PNP;PRKD2;HOMER2;MAP3K7;SPTBN1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.43880420429268374,-1.1702259351978235,0.26865671641791045,0.6007884053947309,1.0,7/12,30.84%,MBNL1;FBXW4;LRP6;PTCH1;SHH;CYP26B1;TGFB2
prerank,positive regulation of neuron projection development (GO:0010976),0.30537444679511294,1.170222395977308,0.19382022471910113,0.8781052859778141,1.0,32/85,23.80%,PLXNB2;NTRK1;ARSB;STMN2;PLA2G3;NTRK3;PTK7;PRKCI;GPC2;RIT2;DAB2IP;TWF2;TENM3;ARHGAP35;NDRG4;NDNF;STYXL1;NTRK2;PRKD1;TWF1;SETX;ITGA6;SCARB2;FES;MAGI2;ROR1;DHX36;SCN1B;ZDHHC15;CAMK2B;SERPINI1;BDNF
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.27697977945951724,-1.169808054030632,0.14634146341463414,0.6010831713291778,1.0,23/86,20.01%,ZEB2;DAB2;RBPJ;SDCBP;SOX11;THBS1;BMP5;SNW1;EP300;NOTCH1;CCN1;RBPMS;BMP2;NUMA1;BMP3;ADAM17;HIPK2;SMAD4;FBXL15;ACVR1;ACVR2A;GDF3;BMP7
prerank,neuromuscular process controlling balance (GO:0050885),0.46679520518479767,1.1694593503064201,0.27380952380952384,0.8794056078150206,1.0,5/12,25.51%,CDH23;NRXN1;SHANK1;CLRN1;TPP1
prerank,regulation of cellular senescence (GO:2000772),0.3842568004211663,1.169150155642196,0.24873949579831933,0.8788460462500456,1.0,11/28,21.73%,ABI3;EEF1E1;VASH1;NEK4;CGAS;RBL1;AKT3;ARG2;FBXO5;NUAK1;ING2
prerank,regulation of leukocyte migration (GO:0002685),0.4315039955416982,1.1690823059568978,0.27017543859649124,0.877379782271916,1.0,4/16,15.74%,ADTRP;NCKAP1L;CD81;MIA3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.21289285106433453,-1.1689372150694717,0.0,0.6025231532362509,1.0,239/807,22.97%,ZEB2;DAB2;RBPJ;TRPS1;MDFIC;SP100;FNIP2;NR3C1;WWP1;CD38;GAS6;UBE2D3;MECP2;POU2F1;EPC1;GATAD2B;SETDB2;MITF;SP3;IRF2BP2;TGIF1;SDCBP;LIMD1;CDC73;ZHX2;ATF3;HMGB2;KAT6B;SIN3B;RUNX3;PPARG;CIITA;PEG3;CBFA2T3;ETV6;IRF7;KANK2;TFEC;MNT;SMARCA4;RARA;ERF;ENO1;SOX11;SMURF2;N4BP2L2;RPS14;PATZ1;BCL3;ESR1;AHR;PROX1;LIMS1;NFKB1;ETV5;NAB1;TAF1;ZNF8;LCOR;YY1;VHL;PPARD;ATXN1;MBD2;SMAD3;RCOR1;CIART;BCL7A;CEBPB;DPF3;CCND1;CAV1;BCOR;PFDN5;KDM8;NR1H2;WWOX;YAP1;UBC;TBL1X;ID4;ZMYM5;BRCA1;FOXE1;BMI1;EDNRB;PSEN1;HSF1;RPL10;CRY2;HINFP;LIN37;SNW1;UBA52;ID3;H1-0;GCLC;ORC2;MAD2L2;MBD1;MZF1;L3MBTL4;CTCF;STAT1;EP300;NFIC;FOXP4;BIRC5;ZBTB18;USP9X;CTNNB1;FOXO1;PRMT2;ATF5;SPEN;NOTCH1;L3MBTL3;BRMS1;BRMS1L;HDAC2;ID1;CUX2;RCOR3;ZNF148;IGF2;CRY1;ZBTB5;FOXJ1;ATF7IP;DEPDC1;EHMT1;FHL2;PARP9;KAT5;FRK;HDAC1;MIDEAS;CBX8;PSMD10;NR1H3;LRRFIP1;RB1;GATAD2A;E2F8;INPP5K;BMP2;MOSPD1;FOXP2;CREB3L1;L3MBTL2;QARS1;FOXP1;IRF2;ELK4;ZNF318;RIOX1;THAP7;NOTCH4;LHX1;DACH1;SHC1;TNF;KDM5C;KAT7;WNT5A;ZBTB2;FOXK2;DEAF1;SAP18;DDX20;E2F7;IKZF1;PDE2A;PLK1;KLF11;ARID5B;NOP53;UIMC1;KLF2;DNAJB1;HEY2;SATB1;WFS1;NUPR2;SMAD4;NRIP1;FLNA;GATA3;HMGA2;HIVEP1;GLIS2;PER2;NIBAN2;MCPH1;LANCL2;HES1;TFAP2B;TRIM37;MYT1L;PPM1F;CDKN2A;TAF7;EED;MXI1;YEATS2;PA2G4;BMP7;HNRNPU;NCOR1;HMGA1;BHLHE40;EPO;KLF4;SCMH1;RBAK;BASP1;SIRT2;TRIM33;ZFP90;HDAC4;PTCH1;CPEB3;HEYL;ID2;PSPC1;RREB1;SEMA4D;ISL1;MECOM;NR1H4;SHH;TWIST1;HOXD9;AASS;ILF3;NDUFA13;TBL1XR1;TFAP2C;ZNF3
prerank,positive regulation of protein transport (GO:0051222),0.3241731670144043,1.1686724901503616,0.1900709219858156,0.8771535037559677,1.0,19/67,18.62%,FRMD4A;MYOM1;ANG;SYTL4;TENM1;MYH10;APBB1;ACHE;OAZ1;TGFB1;PLK3;UNC13B;ATP2C1;DNM1L;APBB3;IER3IP1;B3GAT3;IL1A;RIPOR1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3682980088979298,-1.1685710552300137,0.2756892230576441,0.6026816973226514,1.0,12/22,30.00%,PTPN22;RAB7B;LYN;ACOD1;NR1H3;LBP;APPL2;LTF;TICAM2;APPL1;MFHAS1;TNFAIP3
prerank,regulation of cartilage development (GO:0061035),-0.39093087245546326,-1.1682137009064304,0.22458628841607564,0.6028186308990523,1.0,5/18,17.38%,TRPS1;SOX6;SCX;BMP2;PTHLH
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4153283834904793,-1.1674405868859652,0.23058252427184467,0.6040560403908483,1.0,6/15,22.22%,NR3C1;ANXA1;UBE2L3;BCL2L11;HNRNPU;ISL1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.4299634150728729,1.1669342847111872,0.26744186046511625,0.8822392291877182,1.0,5/17,15.40%,SELENOS;HSP90B1;HERPUD1;DERL1;HM13
prerank,sensory perception of light stimulus (GO:0050953),0.3062223560830933,1.1668376860636986,0.17146776406035666,0.8808986698808261,1.0,10/87,8.46%,GUCY2F;WHRN;ROM1;RDH10;CDH23;COL2A1;CRYGN;CNGB1;CRYBA4;CABP1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.22317820280101444,-1.1664924977101294,0.02564102564102564,0.6057446589250939,1.0,75/348,16.37%,IQGAP1;DAB2;IL15;CD74;FNIP2;NRP1;GAS6;IGF1;RAF1;CD44;PTPRC;SDCBP;TEC;NIBAN1;CNOT9;DVL3;UBE2K;FAM20A;BRAF;DOCK7;TBK1;NPTN;S1PR2;FAS;CRKL;PDGFD;RIPK1;TFRC;BCAR3;CCND1;CAV1;PDCD10;PLAUR;SNX9;LYN;NBN;PRKAG2;CIB1;CLEC6A;IL1B;FGF1;TXN;BANK1;BMP5;KRAS;MAD2L2;PDGFC;SPRY2;LCP2;AGAP2;GHR;CALM3;AKTIP;CCN1;CSPG4;IGF2;RBPMS;BRAT1;LRRK2;KDR;CCND2;CALM2;RACK1;RALB;MTCP1;BMP2;EGFR;AGER;TNF;PTK2B;RAP1A;BMP3;PFN2;PLK1;FXR2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.36777959071791216,1.1656808700944001,0.23565891472868217,0.883995488020532,1.0,13/34,19.42%,P2RY12;TNFAIP8L3;DAB2IP;TGFB1;FGF2;IRS1;PDGFB;TEK;PIK3IP1;PRKD1;PTK2;FLT3;PDGFRB
prerank,histone H3-K4 methylation (GO:0051568),-0.3494539403831594,-1.1656793872373064,0.23333333333333334,0.6070300419641301,1.0,14/26,25.76%,TET2;PRDM9;WDR82;KMT2C;KDM6A;PAXIP1;TET3;DPY30;KMT2D;RBBP5;KMT2B;SETD1A;KMT2A;DYDC2
prerank,dendritic cell differentiation (GO:0097028),-0.35753527941103347,-1.164519928953293,0.21578947368421053,0.6093487417627141,1.0,5/22,14.97%,GAS6;AXL;LYN;BATF2;LILRB1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.389049325138454,1.1637391898221774,0.24758842443729903,0.8899124389420048,1.0,12/26,30.49%,ADCY8;RFX6;ADRA2A;CFTR;KLF7;BAIAP3;STXBP4;EPHA5;GPLD1;BRSK2;CDK16;LRP5
prerank,regulation of cell adhesion (GO:0030155),0.2914636736866043,1.1632984118561855,0.18857901726427623,0.8898224022803048,1.0,34/129,19.76%,ZFHX3;FRMD5;PLXNB2;ARHGDIG;SIPA1;PKP4;DSCAM;PIK3CG;PDE3B;ADAM22;ARHGDIA;PRKCA;PRKD2;ITGB1BP1;EFNA1;STX3;ZDHHC2;MINK1;CXCR4;EPHA4;FLCN;CBLL1;EPHB2;RSU1;MIA3;KIF14;PTK2;ROCK1;PPP2R1A;IL18;FES;PLXNB1;CCL5;EPB41L4B
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.43562785562082973,-1.1629202641016767,0.24523809523809523,0.6127632828009232,1.0,2/12,6.73%,IQGAP1;CD24
prerank,cellular response to lectin (GO:1990858),-0.2605856965987244,-1.1625304507739604,0.11627906976744186,0.6120346979484003,1.0,28/104,19.15%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;NRAS;PSMD5;CLEC4E;PSMD1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2605856965987244,-1.1625304507739604,0.11627906976744186,0.6120346979484003,1.0,28/104,19.15%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;NRAS;PSMD5;CLEC4E;PSMD1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2605736389291878,-1.162050806587195,0.12624584717607973,0.6124215020653553,1.0,28/105,19.15%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;NRAS;PSMD5;CLEC4E;PSMD1
prerank,positive regulation of receptor internalization (GO:0002092),0.3989039155578607,1.1620407133097024,0.24587458745874588,0.8932996430732882,1.0,7/22,25.14%,ATAD1;ARRB2;INSR;MAGI2;ARRB1;CD63;SCYL2
prerank,pyruvate metabolic process (GO:0006090),0.3302279108354766,1.1616191452932723,0.2361963190184049,0.8932094950797015,1.0,15/52,20.73%,HOGA1;GAPDH;VDAC1;PGAM2;ALDOC;BSG;PFKM;HK2;DLD;DLAT;PDHX;PFKFB2;PGM1;ALDOA;ENO3
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.40019080754834435,-1.1614907357494275,0.26436781609195403,0.6130675038143121,1.0,3/17,2.80%,PID1;GIT1;CBFA2T3
prerank,extracellular matrix organization (GO:0030198),0.2638600766856414,1.1612434558026075,0.14631197097944376,0.8930825629028744,1.0,75/276,21.54%,P3H2;AGRN;PLOD3;P4HA3;COL5A1;DST;MMP16;PPIB;F11R;LAMB3;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ADAMTS20;SMOC2;ITGB5;MFAP2;TGFBR1;SERPINH1;FBN2;TGFB1;ADAMTSL1;ADAMTS15;APLP1;BSG;CAPNS1;PXDN;ADAM15;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;THSD4;VCAN;PDGFB;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;KLK2;COL15A1;COL18A1;JAM3;PLOD1;ADAMTS4;LAMA1;ITGA6;POSTN;TMPRSS6;MMP17;QSOX1;ADAMTS3;P4HA2;DCN;CTSK;MFAP5;COL4A4;ITGAD;CAPG;ITGAM;KIF9;LAMC2;COL6A1;CTSS
prerank,protein dephosphorylation (GO:0006470),-0.24963115950650613,-1.161113814482223,0.12448132780082988,0.6131937796242998,1.0,35/135,15.83%,PPP2R5C;PTPN22;DUSP16;PPP2R1B;PPP2R2A;PTPRC;PPP2R5A;PPP4R1;PTPN1;MTMR2;CDC14B;PTPN21;NCK1;PPM1H;PPP1R12A;MTMR4;CTDNEP1;EYA1;PTPN7;TAB1;DUSP18;EYA3;PPP2R2C;PPP4R2;EYA2;PHPT1;PPP3CA;MTM1;CTDSP1;DUSP1;TIMM50;PPP2CB;RPAP2;TNS2;MTMR3
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2460531303761238,-1.1609080485437628,0.11914893617021277,0.6128839602759895,1.0,27/160,9.32%,HIP1;PXN;CHMP4B;CHMP4A;MIS12;OTUD6B;HSPA4;EIF4B;PSMG1;FCHO2;NCK1;HIP1R;SMAD3;PSMD11;HSPD1;TBCA;PICALM;SNX9;EPS15;UVRAG;TESPA1;NUP153;HSF1;NDC1;CENPA;TBCEL;CCDC40
prerank,regulation of protein binding (GO:0043393),-0.25678735504990485,-1.1607986776260009,0.11702127659574468,0.6123404031092402,1.0,29/114,17.14%,DAB2;STK3;CRK;MARK2;BTBD1;IFIT2;DTX3L;GNL3L;PRKACA;BAX;IFIT1;TAF1;HIP1R;LDLRAP1;CAV1;PSEN1;AKTIP;SPPL3;LRRK2;LRP1;B2M;RACK1;RALB;BMP2;NMD3;CFHR2;PLK1;MAPK8;HIPK2
prerank,ethanol metabolic process (GO:0006067),-0.4424940964294114,-1.1604084524615055,0.28888888888888886,0.6125956332025796,1.0,4/12,22.41%,ACSS2;ALDH1A1;ALDH2;ALDH1B1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2671663835168329,-1.1602990943316858,0.18439716312056736,0.6120822786394681,1.0,14/82,9.55%,VAV3;ITSN1;ACTR3;AP2A2;CRK;SDCBP;GIT1;RASA1;AP2B1;ARPC2;LYN;FYN;PSEN1;ARPC5
prerank,regulation of cholesterol esterification (GO:0010872),-0.47180438426147275,-1.1601471120901745,0.2706422018348624,0.6116325166169325,1.0,3/10,12.97%,APOE;ABCG1;APOC1
prerank,snRNA processing (GO:0016180),0.4345888056989181,1.1595621623104915,0.2591362126245847,0.8980989775764144,1.0,6/16,20.66%,INTS6L;INTS10;INTS8;INTS5;INTS9;INTS11
prerank,lipid phosphorylation (GO:0046834),0.493192265934088,1.1593522869279012,0.2815198618307427,0.8971398785207237,1.0,5/10,20.70%,DGKI;DGKQ;DGKZ;DGKE;DGKH
prerank,negative regulation of axon extension (GO:0030517),0.3670400231722995,1.1593485317850474,0.25241157556270094,0.8954014974923067,1.0,10/30,17.32%,DIP2B;SEMA7A;SEMA6C;SEMA6B;SEMA3D;MAG;SEMA4F;SEMA4B;SEMA3C;PTPRS
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4144520164316533,1.159286230197981,0.2646566164154104,0.8939692904497873,1.0,4/18,10.36%,CD34;PRNP;NAV3;HOMER2
prerank,response to alcohol (GO:0097305),0.3758953608181467,1.1591232052381852,0.25,0.8928843770381234,1.0,8/27,20.59%,TGFBR3;TGFBR1;GRIN1;TGFB1;GRIN2B;ABCA2;SDF4;SMAD2
prerank,amino acid transport (GO:0006865),-0.3073843173506727,-1.1590239303625522,0.17971014492753623,0.6138575713442392,1.0,12/49,17.50%,SLC38A6;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11;SLC6A17;SLC25A47;SLC16A10;SLC7A6;SLC38A11;SLC3A2
prerank,cardiac muscle cell contraction (GO:0086003),0.41119690955318255,1.1588357508290228,0.25951557093425603,0.89225638074941,1.0,8/19,22.35%,FGF12;KCNE2;CACNA1G;CACNA1D;CACNA2D1;ATP1A1;SCN1B;SCN3B
prerank,selective autophagy (GO:0061912),-0.29072014764799414,-1.1587915029904121,0.196875,0.6136320690455677,1.0,15/56,13.01%,MAP1LC3B;NBR1;UBA5;ATG13;RAB7A;ARL13B;UBQLN1;UBC;WDFY3;UBA52;VIM;UFC1;ATG2B;WDR81;DYNC1LI2
prerank,positive regulation of protein binding (GO:0032092),-0.29514026854638176,-1.1586594235679915,0.1983695652173913,0.6131313711520829,1.0,20/56,20.87%,STK3;APOE;DTX3L;TAF1;HIP1R;CAV1;PSEN1;AKTIP;SPPL3;LRRK2;LRP1;B2M;RALB;BMP2;NMD3;PPP2CB;HIPK2;BAMBI;RPL11;TRIM21
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.25587519534794434,-1.1586543501864088,0.14285714285714285,0.6122985263386977,1.0,55/110,36.93%,ADGRE5;ADGRG6;ADCY9;PTGER4;S1PR2;PF4;ADCY5;DRD2;GNA13;ADCY6;ADCY1;GPR65;ADCY3;RAMP2;CALCRL;PTHLH;ADRA1A;ADGRG5;S1PR3;DRD3;LPAR2;ADGRL2;ADGRB1;GPR101;RXFP2;PTH1R;CALCA;GLP1R;RAMP3;S1PR4;ADORA2A;VIP;LPAR3;ADGRG7;GPR4;PTGIR;TBXA2R;ADGRG1;GPR26;ADGRG2;LGR4;PTGFR;MC2R;CXCL9;ADGRD1;DRD1;GPER1;GPR3;CALCR;FSHR;LHCGR;ADRA2C;GHRH;CALCB;ADCY4
prerank,cellular response to lipid (GO:0071396),-0.23990074049088234,-1.1584876098042896,0.10606060606060606,0.6119451100397433,1.0,50/191,17.75%,PID1;NR3C1;STAP1;CD274;AXL;ABL2;BRINP1;CDC73;HMGB2;GIT1;ESR1;AHR;NFKB1;ADAM9;CD14;MSN;LCOR;PF4;NOD2;TNIP3;LYN;IL1B;ADCY5;RET;UBE2L3;SNW1;ZC3H12A;LPL;ADCY6;VIM;ACOD1;ADCY1;TNFRSF1B;KAT5;SHPK;ADCY3;NR1H3;SPHK2;TESC;LBP;EGFR;LILRB1;PTK2B;WNT5A;FAM210B;TLR4;MAPK8;ADNP2;MAP4K1;NRIP1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.38420614131873254,-1.1580090094788977,0.2390745501285347,0.6123849434104485,1.0,4/18,6.08%,ITGA4;PPARG;SP1;FLT1
prerank,mesenchyme development (GO:0060485),0.43339217140688224,1.1579699290184011,0.2857142857142857,0.8939250593672144,1.0,4/15,10.45%,TGFBR1;BMP4;PKD2;CRELD1
prerank,chemical homeostasis (GO:0048878),0.3214987288261797,1.1578950335019538,0.20689655172413793,0.8925281178489274,1.0,24/61,25.79%,TLCD3A;SLC4A8;USF2;TLCD3B;PNPLA3;ABCB4;TLCD2;SLC66A1;USF1;SLC4A10;SLC4A7;ACOX1;ABHD5;NEDD4L;FITM2;ANGPTL3;ABHD8;WNK1;EIF5A2;PNPLA8;THADA;VGF;DDX3X;KLHL3
prerank,camera-type eye morphogenesis (GO:0048593),0.49586537971565625,1.1578795193905136,0.27404718693284935,0.8908963234382947,1.0,3/10,11.15%,TENM3;TBX2;KDM2B
prerank,regulation of dopamine secretion (GO:0014059),0.38083255365897,1.156632244993353,0.25442834138486314,0.8942061098004389,1.0,5/25,9.79%,SYT4;SYT13;SYT1;SYT6;PRKN
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3043844424594642,1.1565134830253416,0.22048364153627312,0.8929863333821233,1.0,31/87,26.13%,FGF10;POLR2L;FGF16;FGF9;POLR2F;KLB;HNRNPH1;FGF7;PTBP1;GTF2F1;ZFP36L2;ITGB1BP1;FGF2;SFRP1;POLR2G;RBFOX2;NDNF;HNRNPA1;MAPK3;SETX;CCL5;CEP57;TIA1;POLR2C;FLRT2;POLR2D;ESRP1;MAPK1;FRS3;FLRT3;GALNT3
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.36045866884961525,-1.1559610932773234,0.2376237623762376,0.6169736286037076,1.0,3/24,5.50%,PID1;NDUFS4;MTLN
prerank,positive regulation of catabolic process (GO:0009896),-0.2818705519612099,-1.1559489851235611,0.21337579617834396,0.6161605841799658,1.0,16/65,17.96%,ITCH;WWP1;VCP;STX5;RAB7A;SMURF2;ATG7;HECW1;IL1B;FOXO1;BARD1;TNF;WNT5A;TIPARP;DTL;RILP
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3982192307182918,1.1547245915814284,0.27303754266211605,0.8984155645749888,1.0,10/22,18.41%,RELA;CLU;LRRTM3;EFNA1;CASP3;EFNA3;EPHA4;ABCA2;IFNGR1;CHRNA7
prerank,negative regulation of viral release from host cell (GO:1902187),0.44616435331337406,1.1543388543044037,0.27879799666110183,0.8982471156301529,1.0,3/13,13.45%,MID2;TRIM26;TRIM8
prerank,gene expression (GO:0010467),-0.22068811884830433,-1.1527071784825027,0.02830188679245283,0.6241129270696032,1.0,76/348,14.18%,APOBEC1;SRSF4;EPC1;RPS26;RPL39;CPSF1;RPS23;RPL5;RPS24;LMF2;RPS16;RRAGC;AGFG1;NCBP1;RPL28;EEF1A1;POLR2E;RANBP2;RPS29;RBM8A;RPS14;BCL3;SNRNP40;RPS20;RPL35A;FIP1L1;RPS12;RPL18A;RPS13;RPL27;RPL21;ATXN1;RPS7;RPS5;HSPD1;RPL30;RPL6;DHX38;DHPS;RPL37A;HNRNPK;RNGTT;EIF4EBP2;IGHMBP2;NUP153;RPL10;RPL15;NDC1;NUP43;NUP210;YARS2;RPS10;RPL14;XRN2;RPL9;RPL32;RPL36;RPL31;RBPMS;HNRNPA2B1;RPL23A;CPSF4;PRPF4;TSPAN5;AGO2;MRPL35;NXT1;POLR2B;SYNCRIP;SCX;CPSF2;PTMA;RPL41;RPL3;POLR2H;TESC
prerank,negative regulation of protein depolymerization (GO:1901880),0.3842870034176996,1.1524670551720275,0.252991452991453,0.904110883368034,1.0,9/24,17.40%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.30483207385486,-1.1523747111282023,0.19879518072289157,0.6241992731885505,1.0,14/47,15.37%,ARL6IP5;NBR1;FAS;NOD2;PDCD10;MID1;TAOK3;FOXO1;MAPK8IP3;GREM1;QARS1;EGFR;AGER;SCIMP
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3628831193365409,-1.1521891028258626,0.24296675191815856,0.6239272001418715,1.0,7/23,16.40%,GAS6;CD274;AXL;RARA;ZC3H12A;LILRB1;TLR4
prerank,Rho protein signal transduction (GO:0007266),0.32599273545654794,1.1519849856716304,0.23665223665223664,0.9043470741169881,1.0,22/53,24.68%,RHOV;EPS8L3;ARHGDIG;CDC42EP5;ADRA2A;CTNNAL1;LIMK1;ARHGDIA;ARHGAP5;CFL1;EPS8L2;ROCK1;RIPOR1;RHOU;CDC42EP4;CDC42EP1;CDC42;ARHGAP1;ARHGAP4;EPS8L1;ARHGEF1;RHOA
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3541704471642597,1.1511411057011451,0.24357034795763993,0.9061141442668064,1.0,8/35,11.93%,GGT7;HMGCLL1;ALOX12;AWAT2;GGT5;CBR4;PPT2;ACSS3
prerank,positive regulation of MAPK cascade (GO:0043410),-0.22878410307863778,-1.151097573654445,0.08433734939759036,0.6260763482697939,1.0,52/245,15.66%,IQGAP1;CD74;ARL6IP5;APOE;NRP1;GAS6;PTPN22;IGF1;GCNT2;CD44;PTPRC;LILRA5;BRAF;CD36;FBXW7;DHX33;CCL25;C5AR1;CRKL;NOD2;GPR183;PDGFD;FLT1;BCAR3;PDCD10;CD24;MID1;GLIPR2;CIB1;FGF1;TAOK3;RET;PDGFC;ADAM8;SPRY2;NOTCH1;IGF2;GRM4;LRRK2;PIK3R6;KDR;TRIM5;PIK3R5;SLAMF1;BMP2;EGFR;AGER;SHC1;TNF;PTK2B;SCIMP;RAP1A
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4011853535352853,1.1508598730190576,0.2565359477124183,0.9055055751768512,1.0,3/22,6.71%,LRP2;VKORC1L1;LGMN
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3449687489902439,-1.1507633088647808,0.24293785310734464,0.6260911977436747,1.0,8/29,15.14%,PPP2R1B;THBS1;RIPK1;CAV1;WWOX;RET;PMAIP1;TNF
prerank,iron ion transmembrane transport (GO:0034755),0.4903218164885889,1.1506400788143998,0.28776978417266186,0.9046601828796915,1.0,5/10,31.31%,ABCB6;SLC39A8;ABCB7;ABCC5;SLC39A14
prerank,xenobiotic transport (GO:0042908),0.4225812182424196,1.1506246284158117,0.3048780487804878,0.9030213987788164,1.0,7/17,27.08%,ABCC3;NR1I2;SLC22A4;ABCG2;SLC22A18;ABCC5;ABCA3
prerank,regulation of T cell mediated immunity (GO:0002709),-0.45164197451008303,-1.1502949681964447,0.2709832134292566,0.626499701802353,1.0,5/10,14.85%,CCR2;IL1B;TRPM4;TNFRSF1B;AGER
prerank,tight junction assembly (GO:0120192),0.3349384857577914,1.1502739901165535,0.2481962481962482,0.9028152046426962,1.0,6/49,6.81%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,RNA export from nucleus (GO:0006405),0.29971965390718586,1.1500273950683333,0.20481927710843373,0.9020614103508291,1.0,35/100,24.22%,HHEX;RNPS1;AAAS;SRSF5;MCM3AP;CASC3;DDX25;SRSF6;SRSF11;NUP54;SRSF1;YTHDC1;CPSF3;NUP88;RAE1;FYTTD1;UPF1;CDC40;DDX39B;HNRNPA1;THOC5;NUP133;SARNP;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,ventricular septum development (GO:0003281),0.35012100379420513,1.1500133027304136,0.2749615975422427,0.9004100792459788,1.0,8/37,9.91%,ZFPM1;SOX4;ZFPM2;DAND5;TGFBR3;TGFBR1;HEY1;GJA5
prerank,protein methylation (GO:0006479),-0.3142845430761885,-1.1499994008804348,0.20448179271708683,0.6264733299239819,1.0,13/40,14.03%,FAM98B;FAM98A;ETF1;CAMKMT;SETD3;RAB6A;SNRPB;VCPKMT;ICMT;PRMT2;EEF2KMT;EHMT1;ETFBKMT
prerank,establishment of melanosome localization (GO:0032401),-0.3744430090238132,-1.149898317063219,0.2589073634204275,0.6258940282122245,1.0,6/19,26.38%,MYO5A;BBS7;MLPH;SHROOM2;BLOC1S3;MREG
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.36998402165798455,-1.1497822956302866,0.2524271844660194,0.6236826390499479,1.0,10/20,19.39%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;PLK1;TRIP13;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.36998402165798455,-1.1497822956302866,0.2524271844660194,0.6236826390499479,1.0,10/20,19.39%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;PLK1;TRIP13;ZWINT
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.36998402165798455,-1.1497822956302866,0.2524271844660194,0.6236826390499479,1.0,10/20,19.39%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;PLK1;TRIP13;ZWINT
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3802273497250263,-1.1487093230735554,0.25757575757575757,0.6255834952957183,1.0,13/19,30.61%,NFKB1;TNF;MAPK7;MAPK8;KLF2;WFS1;GATA3;KLF4;APP;EGF;MTPN;TMEM106A;PAX8
prerank,histone H3 deacetylation (GO:0070932),-0.40602336412216145,-1.148627123270037,0.25907990314769974,0.6249781495079353,1.0,6/15,21.35%,HDAC2;HDAC1;ELK4;PER2;SIRT2;HDAC4
prerank,positive regulation of cell killing (GO:0031343),-0.4241497321206267,-1.1484257327365857,0.25853658536585367,0.6246980731245066,1.0,8/13,34.75%,SYK;CYBA;WNT5A;MAPK8;NOXO1;RAC1;FZD7;NOS2
prerank,positive regulation of proteolysis (GO:0045862),-0.2930070882238646,-1.1481589289424097,0.22530864197530864,0.6245611795604717,1.0,21/55,24.60%,APOE;CCBE1;NLRC4;ADAM9;NRDC;SNX9;IL1B;ZC3H12A;ADAM8;HDAC2;TNFRSF1B;TBC1D10A;TNF;PLK1;MAPK12;NKD2;TNIP1;NDUFA13;PERP;FGFR4;FADD
prerank,negative regulation of protein kinase activity (GO:0006469),0.3038729686766342,1.1479929454028512,0.23281907433380084,0.9069182513460428,1.0,16/88,10.23%,TSC2;PPM1E;WWTR1;THY1;PTPRT;PTPRO;TRIB1;ADAR;TRIB2;UBASH3B;DAB2IP;SRCIN1;EPHA1;MVP;SLC8A1;ITGB1BP1
prerank,peptidyl-arginine modification (GO:0018195),-0.4070759810959556,-1.147691032296007,0.26108374384236455,0.6250392127015807,1.0,2/15,6.12%,NDUFAF5;PADI4
prerank,positive regulation of neutrophil migration (GO:1902624),-0.3939741357584411,-1.1472603118438252,0.28607594936708863,0.6253939498264206,1.0,4/18,10.17%,CD74;RIPOR2;MOSPD2;ADAM8
prerank,monocarboxylic acid transport (GO:0015718),0.3251051279114292,1.147148252521017,0.22943722943722944,0.9086170310132412,1.0,7/51,8.67%,SLC16A6;SLCO2B1;ABCC3;AKR1C1;SLC10A2;ABCB4;STARD5
prerank,regulation of synapse assembly (GO:0051963),0.34603587363221233,1.1468431792657199,0.2285276073619632,0.9081603908019532,1.0,14/46,18.81%,LHFPL4;PTPRD;SRPX2;IL1RAP;NRXN1;MEF2C;GRID2;CLSTN2;IL1RAPL1;GPC4;EPHB2;WNT7A;IL1RAPL2;GHRL
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4105362637351175,-1.1466771036037013,0.2645631067961165,0.6261424117324403,1.0,4/14,5.98%,CD74;DENND1B;RARA;NOD2
prerank,muscle contraction (GO:0006936),0.28550066797689355,1.1463620672556003,0.21941489361702127,0.9084415731263639,1.0,17/126,9.80%,MYOM1;LMOD1;NMUR1;CACNA1S;TNNI3;TNNC1;DMD;MYBPC3;ITGB5;ASPH;TMOD2;MYL12B;PGAM2;ACTN2;MYL6;SLC8A1;EMD
prerank,cellular calcium ion homeostasis (GO:0006874),0.283057291420583,1.1462134134374706,0.19220779220779222,0.9074109263213955,1.0,32/133,19.55%,ATP2A3;YWHAE;ATP13A4;ADCY8;TRPC3;ATP2A2;CDH23;ATP1B1;SLC24A5;TNNI3;ATP13A5;CCR1;MICU2;SMDT1;BAK1;SLC8A1;CCDC47;HERPUD1;RMDN3;ATP2C1;TRPC6;ATP2B3;SLC8A3;SLC24A3;DMPK;ANK2;CHRNA7;SELENOK;SLC24A4;CCL15;CCL5;CAV2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3004591171351107,1.1461688661844542,0.2194787379972565,0.9059176922612349,1.0,14/86,8.08%,CTTN;BIN1;PAK1;LMOD1;PSRC1;TENM1;STMN2;NCKAP1;NCKAP1L;CDC42EP5;NAV3;CLU;FCHSD2;LIMK1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4097439029345083,1.1460301783841642,0.2966666666666667,0.9047769823461077,1.0,4/18,9.64%,POLD3;GINS3;MCM3;LIG3
prerank,prostanoid biosynthetic process (GO:0046457),0.4325458385838255,1.1455623878535754,0.2979452054794521,0.904999519042331,1.0,3/15,4.38%,PTGS1;PTGDS;PRXL2B
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.39429633099329675,-1.1452482118083318,0.2924281984334204,0.6291919962447753,1.0,7/16,21.73%,SMCHD1;KLHL15;MAD2L2;RMI2;SHLD1;PARPBP;FBH1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.3345796980644291,-1.1451808319828582,0.24040920716112532,0.6285348830459825,1.0,10/31,17.63%,RAB1A;FBXW7;CDC14B;BMI1;UBE2L3;DCUN1D1;MAGEC2;PLK1;UBE2C;ARRDC4
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3889453506412216,-1.144916702981636,0.2648401826484018,0.6283957964153664,1.0,9/18,27.63%,BRAF;PRKAG2;IL1B;INPP5K;RSC1A1;FFAR4;CLIP3;APPL1;TRIB3
prerank,mRNA export from nucleus (GO:0006406),0.2957962390959888,1.1449110840745018,0.20789473684210527,0.9059651171057901,1.0,50/102,31.41%,HHEX;RNPS1;AAAS;SRSF5;MCM3AP;CASC3;DDX25;SRSF6;SRSF11;NUP54;SRSF1;YTHDC1;CPSF3;NUP88;RAE1;FYTTD1;UPF1;CDC40;DDX39B;THOC5;NUP133;SARNP;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;DDX19A;ALKBH5;RBM15B;POLR2D;GLE1;EIF4E;SRSF3;PCID2;NUP107;NUP155;THOC7;SRRM1;NUP85;ZC3H11A;TPR;SRSF7;SEC13;POLDIP3;U2AF1;U2AF2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.21073276831557974,-1.1446353626866657,0.013888888888888888,0.6283185884756171,1.0,168/572,22.51%,ZEB2;DAB2;RBPJ;TRPS1;SP100;FNIP2;NR3C1;UBE2D3;MECP2;EPC1;GATAD2B;MITF;IRF2BP2;TGIF1;SDCBP;CDC73;ZHX2;ATF3;SIN3B;RUNX3;PPARG;CIITA;PEG3;ETV6;IRF7;KANK2;TFEC;MNT;SMARCA4;RARA;ERF;ENO1;SOX11;SMURF2;N4BP2L2;RPS14;ESR1;PROX1;NFKB1;ETV5;TAF1;ZNF8;LCOR;YY1;VHL;PPARD;ATXN1;MBD2;SMAD3;CEBPB;CCND1;CAV1;BCOR;NR1H2;WWOX;YAP1;UBC;TBL1X;ID4;ZMYM5;FOXE1;BMI1;EDNRB;PSEN1;HSF1;RPL10;CRY2;LIN37;SNW1;UBA52;ID3;H1-0;ORC2;MAD2L2;MZF1;CTCF;STAT1;EP300;NFIC;FOXP4;ZBTB18;USP9X;SPEN;NOTCH1;BRMS1;BRMS1L;HDAC2;ID1;CUX2;ZNF148;IGF2;CRY1;ZBTB5;FOXJ1;FHL2;PARP9;KAT5;FRK;HDAC1;CBX8;PSMD10;NR1H3;LRRFIP1;RB1;GATAD2A;E2F8;BMP2;MOSPD1;FOXP2;FOXP1;IRF2;ELK4;THAP7;NOTCH4;DACH1;TNF;ZBTB2;DEAF1;DDX20;E2F7;PDE2A;PLK1;KLF11;ARID5B;NOP53;KLF2;DNAJB1;HEY2;SATB1;WFS1;NUPR2;SMAD4;NRIP1;GATA3;HMGA2;HIVEP1;GLIS2;PER2;MCPH1;HES1;TFAP2B;TRIM37;MYT1L;TAF7;EED;MXI1;YEATS2;HNRNPU;NCOR1;BHLHE40;NFATC3;EPO;KLF4;SIRT2;TRIM33;ZFP90;HDAC4;PTCH1;CPEB3;ID2;RREB1;SEMA4D;ISL1;NR1H4;SHH;TWIST1;HOXD9;AASS
prerank,L-amino acid transport (GO:0015807),0.3738061630256867,1.144378095581285,0.24394184168012925,0.9063899172636205,1.0,7/28,11.61%,SLC38A2;SLC1A1;SLC25A18;SFXN1;SLC1A3;CTNS;SLC1A4
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3707909223554534,-1.1443014215454335,0.24812030075187969,0.6283698617853894,1.0,5/20,11.64%,APOE;DLG5;PSEN1;CAPRIN1;CUX2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3479257339332847,-1.1442950515397574,0.2613333333333333,0.6275459020179566,1.0,3/25,6.29%,ITGA4;ITGAX;ITGB7
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.43192305953173527,-1.1442626257345614,0.2785714285714286,0.6268052065075967,1.0,5/12,20.46%,FCGR2B;GPR183;LFNG;PTK2B;NOTCH2
prerank,heart morphogenesis (GO:0003007),0.3315406039726871,1.1442133241160144,0.24624624624624625,0.905384637694001,1.0,12/50,22.13%,ZFPM1;MEGF8;MYBPC3;TGFBR3;TGFBR1;HEY1;TBX2;INSR;PTK2;ENG;MDM4;FLRT2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.42764386262308984,1.143952032280215,0.2906574394463668,0.9047848605611046,1.0,6/16,18.27%,PQBP1;DDX5;SRSF6;SRSF1;SRSF9;PUF60
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.41853217262050235,1.1430035467653115,0.27986906710310966,0.9069425930502536,1.0,7/17,23.98%,NDUFA4;COX7B;COX6C;COX7C;COX4I1;COX6B1;COX10
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.32783929824176383,-1.142919426183149,0.24233983286908078,0.629600808748752,1.0,14/32,22.43%,CDK17;ZPR1;PCNA;HINFP;TYMS;RB1;CDT1;CDK14;E2F7;KLF11;ESRRB;DHFR;ID2;CDC45
prerank,stress fiber assembly (GO:0043149),-0.4094588484704223,-1.142637834568056,0.29850746268656714,0.6287265095929292,1.0,5/15,11.84%,PDLIM1;CUL3;FHDC1;PDCD10;SORBS1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4094588484704223,-1.142637834568056,0.29850746268656714,0.6287265095929292,1.0,5/15,11.84%,PDLIM1;CUL3;FHDC1;PDCD10;SORBS1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.41361838696718545,-1.1421057157870103,0.26869158878504673,0.6293038286886113,1.0,8/14,30.75%,RCC1L;TRUB2;TRMT10C;UQCC2;MRPS27;RPUSD3;C1QBP;MPV17L2
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.23186747862784035,-1.142019723927994,0.10674157303370786,0.6286963649593456,1.0,47/199,17.84%,RBPJ;FCGR2B;IL15;PAEP;GAS6;NOVA2;PTPN23;MCC;DOCK7;CORO1C;NPTN;PTGER4;RPS6KA6;NRDC;NR1H2;SRGN;IL1B;PCTP;BMP5;RAB11FIP1;MAD2L2;SPRY2;ARHGDIB;NOTCH1;ID1;SMAD6;SLC11A1;PROCR;SPRY1;ALDH1A1;NR1H3;RB1;BMP2;RAB11FIP5;EGFR;AGER;TNF;TRPV3;GJA1;PFN2;TLR4;IL18R1;ADAM17;RGCC;HEY2;PGAM5;GATA3
prerank,atrial septum morphogenesis (GO:0060413),0.4825011900451747,1.141972797841218,0.2867256637168142,0.9092773950985266,1.0,2/10,4.45%,ZFPM1;SOX4
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.27138157089467985,-1.141855766646754,0.20679012345679013,0.6283479325816925,1.0,29/76,25.18%,CUL3;RWDD3;FBXW7;CAV1;UBQLN1;BRCA1;UBA2;UBE2L3;ZC3H12A;PTTG1IP;PAXIP1;DCUN1D1;BIRC2;CRY1;LRRK2;PSMD10;FANCI;MUL1;WFS1;CENPX;NDFIP1;TNIP1;HDAC4;PHF23;XIAP;PIAS4;PIAS3;ANGPT1;DCUN1D4
prerank,cellular response to sterol (GO:0036315),-0.41905191615611986,-1.1409578819495427,0.2981651376146789,0.6300054515164564,1.0,8/13,31.15%,GRAMD1C;GRAMD1B;LRP6;MLC1;INSIG1;PTCH1;RORC;INSIG2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3054056647624585,1.140657589155991,0.2136627906976744,0.9128096337872212,1.0,23/75,23.21%,GUCY2F;C3;MRAP;RGS11;CNGB1;GNG4;DGKQ;ADCYAP1;MGRN1;GUCY2D;USP33;RIC8B;RGS2;RGS20;NMT1;ROCK1;CCL5;YWHAB;METAP2;GUCA1B;GIT2;TULP3;RGS5
prerank,gonad development (GO:0008406),0.3433319976544509,1.1405667238538069,0.274294670846395,0.9115325394772624,1.0,6/41,9.13%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,protein catabolic process (GO:0030163),-0.28590430759558716,-1.140374079786831,0.20795107033639143,0.630781353217981,1.0,14/59,14.96%,APOE;VCP;PRPF19;SIAH2;RIPK1;CLN8;CLN5;BAG6;LAMP2;CEACAM1;FBXO2;UCHL3;PMAIP1;MAGEC2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.44351616702241464,1.139096911669998,0.2887323943661972,0.9156830606995038,1.0,6/13,10.75%,ZFPM2;MEF2C;TGFBR3;ERBB4;TBX2;FGF2
prerank,glycogen metabolic process (GO:0005977),-0.3403082903911402,-1.1390312506548421,0.2627551020408163,0.6336796870247747,1.0,8/27,18.14%,PHKB;GYG1;AGL;PRKAG2;PPP1R3C;GAA;PGM2L1;PER2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4175673089705132,-1.1389712805667431,0.27702702702702703,0.6330189031490494,1.0,8/13,31.00%,CAV1;CAMK2D;CALM3;CALM2;PDE4D;CASQ2;CALM1;SRI
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3977642696998786,-1.138908277028155,0.28217821782178215,0.6323403026123011,1.0,5/16,14.83%,AOAH;PHKB;AGL;GAA;PGM2L1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.43854003386654405,-1.1389000362332573,0.2989010989010989,0.6315339779334995,1.0,3/11,11.98%,DAB2;MLLT3;PLEKHA4
prerank,positive regulation of reproductive process (GO:2000243),-0.33684689805185264,-1.1386391915167522,0.2572944297082228,0.6314170968613938,1.0,14/31,34.51%,SMURF2;PRDM9;PGAM4;AGO2;HYAL3;SIRT2;TAC4;VIP;GLRA1;INHBB;C1QBP;SYDE1;PDE3A;PLA2G10
prerank,DNA replication (GO:0006260),-0.2559247035223595,-1.138623285068601,0.16141732283464566,0.6306299842185485,1.0,28/105,16.99%,BAZ1A;RBBP8;CLSPN;TOPBP1;ORC5;NBN;IGHMBP2;PCLAF;BRCA1;RMI1;ATRIP;ORC2;POLD4;GRWD1;RHNO1;BARD1;RPA1;CDK1;RMI2;MCM2;KAT5;TICRR;ORC4;MCM9;MCM8;KAT7;RNASEH2A;RPA2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.43838181374232676,1.1384936537095025,0.28620689655172415,0.9165932836555652,1.0,2/14,3.31%,AVPR2;AVPR1A
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.311481371986974,-1.1383490779979513,0.23824451410658307,0.6305499155089944,1.0,10/39,17.84%,ITGA4;GAS6;THBS1;KDR;TNF;RAMP2;MAPK7;ECSCR;RGCC;GATA3
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.46271875092343867,-1.1381753067852582,0.2973568281938326,0.630214180659978,1.0,2/10,3.29%,APOE;PRKACA
prerank,negative regulation of T cell activation (GO:0050868),-0.32648696952174544,-1.1381563884269237,0.25333333333333335,0.6294528213594437,1.0,6/35,6.21%,FCGR2B;PTPN22;CD274;RIPOR2;DLG5;CEBPB
prerank,regulation of platelet aggregation (GO:0090330),0.41118589578845477,1.1380982298247329,0.3265993265993266,0.9165535923679594,1.0,6/17,15.41%,F11R;ALOX12;PRKCA;SH2B3;PRKG1;SERPINE2
prerank,dendrite self-avoidance (GO:0070593),0.42439969570913433,1.138010652160511,0.29553264604810997,0.9152503847142839,1.0,6/16,14.96%,ROBO4;MYPN;CNTN2;DSCAM;BSG;DSCAML1
prerank,cellular response to amyloid-beta (GO:1904646),-0.31965365979457394,-1.137930776797347,0.256198347107438,0.6292038528267131,1.0,10/35,16.40%,ITGA4;FCGR2B;IGF1;CD36;FYN;PSEN1;LRP1;AGER;GJA1;TLR4
prerank,protein insertion into ER membrane (GO:0045048),0.34473305103572893,1.1377624549639203,0.271889400921659,0.9146068415639367,1.0,10/37,15.22%,SGTA;PRNP;EMC6;EMC2;OTOF;EMD;TRAM2;CCDC47;GET3;TRAM1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.39519017325618505,-1.1376990886545433,0.2706185567010309,0.6290504483207205,1.0,9/16,19.58%,PDS5B;BOD1;PDS5A;HASPIN;MAU2;RAD21;RB1;DSCC1;REC8
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3883832272338713,-1.1375255519606053,0.25882352941176473,0.6286762382348283,1.0,4/16,12.83%,ATP5MG;ATP5PO;ATP5MC1;STOML2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4452204190886555,-1.1374700154214863,0.27522935779816515,0.6280101885989542,1.0,5/11,22.65%,PARP4;PARP14;PARP9;TIPARP;PARP16
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2975531835572324,1.1371370076872067,0.22696929238985314,0.9155166997061978,1.0,34/96,24.22%,HHEX;RNPS1;AAAS;SRSF5;MCM3AP;CASC3;DDX25;SRSF6;SRSF11;NUP54;SRSF1;YTHDC1;CPSF3;NUP88;RAE1;FYTTD1;UPF1;CDC40;DDX39B;THOC5;NUP133;SARNP;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3939369780362909,-1.1361503956172385,0.2864321608040201,0.6307744085234015,1.0,3/17,5.92%,CD74;RIPOR2;MOSPD2
prerank,positive regulation of chromosome organization (GO:2001252),-0.39338498087688745,-1.1358967013571408,0.28708133971291866,0.630621525981164,1.0,4/15,13.24%,RTEL1;NBN;LIG4;RAD21
prerank,oligodendrocyte differentiation (GO:0048709),0.40334017370730113,1.1354893194917222,0.2878535773710483,0.9205605344207712,1.0,6/19,15.19%,TPPP;SOX10;EIF2B3;MYRF;SLC8A3;EIF2B1
prerank,platelet degranulation (GO:0002576),-0.2504868431455732,-1.1352930237286378,0.16666666666666666,0.6314942702043418,1.0,54/118,32.54%,F13A1;GAS6;IGF1;OLA1;PSAP;ACTN1;CD36;TUBA4A;THBS1;PF4;LYN;SRGN;LAMP2;SERPING1;IGF2;FAM3C;TAGLN2;VCL;FLNA;FN1;F8;ITGB3;F5;TIMP1;TLN1;PHACTR2;TMSB4X;APOH;SERPINF2;APP;VEGFB;ANXA5;EGF;TIMP3;BLK;PDGFA;CTSW;TOR4A;CLEC3B;ITIH3;PLG;ACTN4;PLEK;VEGFC;CD109;CALM1;TGFB2;VWF;PROS1;HGF;RAB27B;BRPF3;ABCC4;TTN
prerank,regulation of interleukin-17 production (GO:0032660),0.3597212506123164,1.135253985675127,0.2805872756933116,0.9198271705680017,1.0,7/31,9.35%,VSIR;NCKAP1L;SLAMF6;PRNP;IL6;IL2;TGFB1
prerank,organelle assembly (GO:0070925),-0.21597660462708246,-1.1351263247982986,0.11570247933884298,0.6311210720084076,1.0,73/385,13.39%,EHD4;ATP6V0D1;RAB8B;VPS37C;ACTR3;EIF2A;PIK3C3;KIF3A;CHMP4B;CHMP4A;PTPN23;PCM1;MAP1LC3B;MIS12;LIMD1;RILPL2;FAM161A;RPS23;PIBF1;ATG13;STX12;RAB1A;DHX29;TMOD1;MKS1;RAB7A;RPGR;SCLT1;CDC14B;SH3PXD2B;EXOC4;CPLANE1;GBF1;CEP250;ARL13B;ATG7;TCTN1;SSX2IP;BBS7;UBAP2L;FHDC1;ASAP1;UBQLN1;HPS1;DNAH5;EIF4ENIF1;DDX6;HAUS2;TMEM231;KIF24;CEP164;CENPA;WDPCP;MAPRE1;CENPJ;TUBGCP4;EIF2S1;SNAP29;CCDC28B;TMEM138;RC3H1;NOTCH1;ATG2B;HAUS8;FOXJ1;IFT52;ATG3;EXOC8;PGM5;PDCD6IP;CHMP1B;SYNPO;STAM
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.38388821732200196,-1.13442536970202,0.24824355971896955,0.6322296176026424,1.0,4/17,12.83%,ATP5MG;ATP5PO;ATP5MC1;STOML2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.2820844114458909,1.133829806107378,0.21823204419889503,0.9236962263954371,1.0,33/118,19.82%,BCL9L;ABI3;TANC2;ARHGAP44;CHN1;PAK1;FLT4;IL6;MEF2C;CLASP2;SHANK3;SRCIN1;VASH1;HECW2;TGFB1;NEDD4;FGF2;CFL1;SFRP1;CAMSAP1;ARHGAP35;VASH2;LZTS3;EPHA4;NEDD4L;FITM2;SARM1;PHLDB2;ZMYM6;NSMF;ZMYM3;LRRC4C;SDC2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38558626501709914,1.1337973622564164,0.2809364548494983,0.9221566677455306,1.0,10/24,25.44%,ABCB6;FLVCR1;TSPO;PGRMC1;UROD;ALAD;ABCG2;SLC25A38;COX10;CPOX
prerank,Notch signaling involved in heart development (GO:0061314),-0.4388234166934083,-1.1334852028461073,0.2894736842105263,0.6338764393355137,1.0,7/11,27.04%,RBPJ;NOTCH1;HEY2;NOTCH2;HEYL;GALNT11;DLL4
prerank,ribosomal large subunit assembly (GO:0000027),-0.34413597605909796,-1.1333333852612828,0.28217821782178215,0.6334720924078986,1.0,9/24,20.35%,RPL5;RPF2;RPL6;RPL10;RPL23A;MDN1;RPL3;NOP53;RPL11
prerank,positive regulation of protein maturation (GO:1903319),-0.4437165504916557,-1.1330181520185163,0.30227272727272725,0.633492225922817,1.0,4/11,19.35%,CCBE1;NLRC4;ADAM8;NKD2
prerank,regulation of RNA metabolic process (GO:0051252),-0.28413815860859665,-1.13299589787701,0.23103448275862068,0.6327756761306389,1.0,10/59,6.91%,AHNAK;HNRNPLL;OAS2;NOVA2;CELF1;MITF;MBNL1;RASA1;OASL;MBNL3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4285274596900108,1.1329535632290157,0.3021702838063439,0.9237153279854164,1.0,2/15,1.44%,WHRN;LHFPL5
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3584637192535267,1.1329343515403494,0.2903225806451613,0.9221572900427012,1.0,13/30,22.05%,THY1;SOCS3;PRKCZ;SRCIN1;MVP;INPP5F;SH2B3;SFRP1;PTPN2;CADM4;PPP2R1A;SH3BP5L;SFRP2
prerank,B cell activation (GO:0042113),-0.27398770982946896,-1.1327909092064747,0.22641509433962265,0.6325075565480827,1.0,22/68,21.35%,ITGA4;BCL2;PTPRC;KLF6;CEBPG;LYL1;GPR183;HSPD1;DNAJB9;BLNK;BANK1;FCRL1;CD79B;NHEJ1;CHRNB2;ADAM17;ZAP70;CD79A;PIK3CD;CHRNA4;LAX1;HDAC4
prerank,positive regulation of exocytosis (GO:0045921),0.3463851350882303,1.1323631788346946,0.26497005988023953,0.9227595842394313,1.0,11/35,21.97%,RAB3A;CADPS2;SYTL4;CLASP2;CFTR;RAB5A;RAB3D;CHMP2A;STXBP5;SNF8;RAB2B
prerank,myeloid leukocyte differentiation (GO:0002573),-0.27010323557424465,-1.1322187267831076,0.19795221843003413,0.6331771579475298,1.0,13/65,15.75%,IL15;PPARG;CBFA2T3;RARA;TYROBP;GPR183;GAB2;DEK;EP300;FOXP1;BATF2;MYH9;EPHA2
prerank,nuclear migration (GO:0007097),-0.4146408901949385,-1.1319810268829793,0.26666666666666666,0.6329661890581371,1.0,6/13,24.07%,PCM1;DOCK7;TMEM201;PAFAH1B1;SYNE2;HOOK3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3037073109972439,1.1318031918773452,0.24679029957203993,0.923272683269246,1.0,22/72,21.81%,PSMB1;CARD14;RELA;COPS8;PSMF1;BTRC;PSMA1;PSMD7;ZFP91;PSMA8;PSME3;MAP3K7;PSMD14;PSMC4;TLR3;PSMB4;REL;PSME1;PSMD2;PSMD4;TIRAP;PSMD8
prerank,T cell receptor signaling pathway (GO:0050852),-0.24366725911418988,-1.131761723029698,0.16091954022988506,0.6327057434622134,1.0,40/138,19.15%,RFTN1;PSMA6;PTPN22;CSK;PTPRC;DENND1B;TEC;PSMB2;PSME2;GRAP2;NFKBIZ;NFKB1;NCK1;PSMD11;PSMC6;FYN;PRKCQ;THEMIS;PSMA3;EIF2B2;PIK3CA;ZC3H12A;CD28;LCP2;LCK;RC3H1;SPPL3;SKAP1;STOML2;PSMD10;PSMB5;EIF2B4;RC3H2;BCAR1;ZAP70;GATA3;PSMD5;CD247;THEMIS2;PSMD1
prerank,nuclear export (GO:0051168),0.3028675944870033,1.1317274894447196,0.24417009602194786,0.9219087480088349,1.0,38/80,31.41%,RNPS1;STRADB;SRSF5;CASC3;SRSF6;SRSF11;TGFB1;SRSF1;RAE1;PKD1;CDC40;DDX39B;HNRNPA1;THOC5;XPO6;SARNP;SRSF9;NXF1;CHTOP;STRADA;ALYREF;SRSF2;RANBP3L;POM121;RANBP17;EIF4E;CCHCR1;SRSF3;NUP155;THOC7;SRRM1;ZC3H11A;TPR;SRSF7;POLDIP3;RITA1;U2AF1;U2AF2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3639204201777166,-1.1317137451516697,0.27989821882951654,0.6320343235029354,1.0,10/21,27.70%,CHST11;CHST9;UGDH;CSPG4;CHST7;CHPF;CHST12;CHSY3;CHST3;NCAN
prerank,cellular lipid catabolic process (GO:0044242),-0.34359957357939225,-1.1315048783948245,0.2904040404040404,0.6317137849162067,1.0,4/27,5.55%,AOAH;ACOT8;PLBD1;PPARD
prerank,positive regulation of programmed cell death (GO:0043068),-0.2184039898625556,-1.1313491467691494,0.08450704225352113,0.6313442325568441,1.0,60/272,16.83%,VAV3;ARHGEF3;FGD4;ITSN1;STK3;ARL6IP5;STK17B;TNFAIP8;IFIT2;ZBP1;BAX;TOP2A;PTPA;NLRC4;ARHGEF18;ATG7;ARHGEF6;SLC27A4;HIP1R;FAS;HSPD1;SYK;RIPK1;PLEKHG5;UBC;FGD1;PSEN1;PIDD1;PNMA2;ABR;UBA52;GNA13;UTP11;MAP3K11;DNM2;CTNNB1;FOXO1;PRMT2;BARD1;STPG1;DAPK1;ARHGEF26;LRRK2;GADD45G;RPS6KA2;APH1B;RYBP;RACK1;BMP2;SPHK2;PMAIP1;LILRB1;TNF;BCL2L11;SAP18;DDX20;ARHGEF5;KLF11;MAPK8;SQSTM1
prerank,peptide cross-linking (GO:0018149),-0.346143282683561,-1.1309752923873941,0.2727272727272727,0.6315401115658161,1.0,15/25,36.48%,F13A1;THBS1;ANXA1;CD247;FN1;COL3A1;DSP;EVPL;KRT10;TGM6;TGM5;EPB42;TGM7;CD3G;SPRR1A
prerank,regulation of neuron apoptotic process (GO:0043523),0.29247495786202937,1.1308096099618983,0.2538569424964937,0.9239562513283507,1.0,22/96,16.74%,FAIM2;NTRK1;SIX4;PPARGC1A;PLA2G3;PRNP;BACE1;MEF2C;LGMN;PRKCI;NRBP2;GRID2;SIGMAR1;PRKN;CLCF1;KDM2B;MAG;NDNF;SNX6;NTRK2;KIF14;PRKCG
prerank,double-strand break repair via break-induced replication (GO:0000727),0.44858349643527917,1.1306172589342738,0.29636048526863085,0.9230386410831124,1.0,2/12,7.47%,MCM5;MCM3
prerank,regulation of innate immune response (GO:0045088),-0.2904474103922354,-1.1300727623119777,0.26851851851851855,0.6331321272635297,1.0,21/57,25.11%,FCGR2B;PTPN22;PTPN1;IFNAR2;USP18;TLR8;ERAP1;ADAM8;ACOD1;BIRC2;PARP9;MUL1;POLR3G;APPL2;NLRC3;TRIM21;SLC15A4;PLSCR1;XIAP;APPL1;DHX58
prerank,cellular response to starvation (GO:0009267),-0.24154495174430696,-1.129933494204225,0.1509433962264151,0.6327348022621422,1.0,35/147,17.55%,ATP6V0D1;PIK3C3;ATP6V0D2;MAP1LC3B;PIK3R4;ATP6V1B2;RRAGC;NUAK2;LAMTOR5;SH3GLB1;ATP6V0B;STK24;ATG7;FAS;CEBPB;PRKAG2;CPEB4;LAMP2;ZC3H12A;EIF2S1;FOXO1;SZT2;LRRK2;RRAGA;ATP6V1A;SIK2;RALB;SIK1;PMAIP1;MTMR3;MFSD2A;MAPK8;SESN2;MAP1LC3A;NUPR2
prerank,regulation of isotype switching (GO:0045191),-0.4050931747062695,-1.1294378907115168,0.2772511848341232,0.6332495620239431,1.0,4/14,12.43%,TFRC;MAD2L2;PAXIP1;SHLD1
prerank,regulation of protein localization to membrane (GO:1905475),0.36711012610365146,1.128819297929734,0.29093799682034976,0.9285216175320962,1.0,11/28,23.64%,GPC1;AR;GPC2;GPC5;PRKN;ZDHHC2;GPC4;SPTBN1;ACTB;VTI1B;PDZK1
prerank,organic substance transport (GO:0071702),0.28429035216492476,1.1285253093513055,0.2324621733149931,0.9279888306948885,1.0,34/121,22.66%,SCAMP5;SLCO2B1;ABCA9;SLC48A1;SLC50A1;ABCG8;DISP1;ABCB6;LRP2;FLVCR1;LRP1B;SLC18A1;HSP90B1;SCAMP2;RAB38;CHMP1A;ARRDC1;ABCA2;CHMP2A;SPNS2;SLC19A1;SLC22A4;MIA3;ATP8A1;VPS33B;ABCD2;LMAN2L;ABCG2;SLC22A18;SCAMP3;ABCA7;SLC22A5;SLC19A2;PEX3
prerank,second-messenger-mediated signaling (GO:0019932),0.29488250794663406,1.128203684772159,0.2430167597765363,0.9276121179458385,1.0,23/82,18.40%,ACKR4;P2RY12;ACKR3;KSR2;NMUR1;PLCG1;CCR1;SAMD14;RCAN3;CXCR6;CX3CR1;BTK;CXCR4;CCR6;NDNF;RCAN2;ACKR2;CCR9;DDAH2;PPP1R9A;AGT;PPP2R1A;INPP5A
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.33770577400507673,-1.1276463468608733,0.2641975308641975,0.6372508853249506,1.0,8/27,15.38%,KAT6B;PHF20;BAG6;TRRAP;EP300;KAT5;MSL3;KAT7
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.41742634932630124,1.1268459592358266,0.3017241379310345,0.9313787937819556,1.0,2/17,3.06%,NOS1AP;KCNE2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.21442513071892186,-1.1262094831627183,0.10743801652892562,0.640367495813967,1.0,110/348,25.35%,PID1;RBPJ;ITCH;CD74;GAS6;PTPN22;STAP1;ITGAX;IGF1;CELF1;SETDB2;ADAM19;MITF;MED26;TLR2;RPL5;FAM98B;PPHLN1;AFDN;BRAF;CD36;PRKAB1;DTX3L;FAM98A;PTPN1;ZPR1;SOX11;LAMTOR5;VPS35;TYROBP;LIMS1;MSN;RPS7;PF4;SMAD3;SP1;TFRC;PDCD10;YAP1;DNMT1;HIF1A;BRCA1;IL1B;FGF1;PSEN1;HINFP;ZC3H12A;KRAS;CTCF;CD28;SPRY2;NOTCH1;CUX2;ATF7IP;SLC11A1;AGO2;SCX;GREM1;BMP2;TESC;RIMS2;TERF2;LILRB1;TNF;RAMP2;GJA1;WNT5A;PDE2A;MAPK7;TLR4;MAPK8;KLF2;GSN;RGCC;HEY2;WFS1;HMGA2;FN1;NWD1;MMP8;PPM1F;MYD88;HSPA1B;BMP7;DTNBP1;RPL11;KLF4;WARS1;PIK3CD;POU3F1;CDH3;ID2;HMGN5;CD3E;FGF18;TWIST1;APP;TASOR;PLSCR1;MAPK11;PAX6;EGF;FGFR4;TMEM119;RAMP3;ANGPT1;TLR9;RNF207;MTPN;ATP13A2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4333936154881238,1.1262048646527074,0.3016949152542373,0.9323014196774171,1.0,6/14,16.67%,SEC31A;SEC24D;SEC24B;MIA3;SEC24C;SCAP
prerank,protein alkylation (GO:0008213),-0.35835077359373274,-1.12619298358781,0.2725118483412322,0.6396106097206143,1.0,9/22,14.03%,FAM98B;FAM98A;ETF1;CAMKMT;SNRPB;VCPKMT;PRMT2;EEF2KMT;ETFBKMT
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.44112868309694997,-1.125992738554932,0.29550827423167847,0.6393845707046509,1.0,4/10,21.17%,NCK1;VHL;DNAJB1;SIRT2
prerank,regulation of spindle assembly (GO:0090169),-0.3373129393986452,-1.125692810370658,0.2603092783505155,0.6394122034431852,1.0,8/25,20.05%,CHMP4B;PDCD6IP;CHMP1B;CCSAP;NUMA1;PLK1;HSPA1B;HNRNPU
prerank,B cell differentiation (GO:0030183),-0.2974009411578674,-1.1256603152158857,0.22865013774104684,0.6386966550083958,1.0,8/46,7.82%,ITGA4;IRF2BP2;PTPRC;KLF6;CEBPG;LYL1;DNAJB9;BLNK
prerank,digestive tract development (GO:0048565),0.35151109887291443,1.1255507246657015,0.2932454695222405,0.9333175364445871,1.0,4/33,4.97%,DNAAF1;CCDC39;MEGF8;RARRES2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4239106750222136,-1.1252066702714558,0.2926267281105991,0.6390876958241339,1.0,5/12,19.18%,IGF1;IGF2;SORBS1;PPP1R3E;IRS2
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.3166569457104609,-1.1249155576755612,0.24932249322493225,0.6390766689850371,1.0,13/37,22.31%,APOE;SDCBP;MTMR2;NFKB1;ANKRD13A;BRCA1;EDNRB;OPTN;PTX3;ITGB3;NCOR1;SIRT2;WDR54
prerank,amide biosynthetic process (GO:0043604),0.3337076072401181,1.124846116154658,0.2786144578313253,0.9345590763223631,1.0,12/47,18.94%,OTC;SLC25A2;PM20D1;DMD;TLCD3B;CERS4;SPTSSA;CERS5;CERS6;CERS1;ASMT;ARG2
prerank,cell-cell junction organization (GO:0045216),0.300274304280403,1.1246670644566903,0.23837209302325582,0.9336743193576034,1.0,18/79,16.53%,FSCN1;ANG;DCHS1;PARD6B;CADM1;PKP4;MARVELD2;PRKCI;CDH18;SDK1;NECTIN3;TGFB1;CTNND2;CDH4;CADM3;FLCN;CADM2;CXADR
prerank,cellular protein catabolic process (GO:0044257),-0.28345156685172596,-1.124569233422024,0.25,0.6391789193498829,1.0,12/59,11.18%,PSMA6;AP2A2;YME1L1;SIAH2;RAB7A;CAPN2;AP2B1;RIPK1;CTSL;CTSB;CLPP;CLTA
prerank,sympathetic nervous system development (GO:0048485),-0.39320700177910106,-1.1245521701837218,0.2938388625592417,0.6384317496532124,1.0,6/15,19.00%,NRP1;NRP2;SOX11;CTNNB1;GATA3;TFAP2B
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4256250845937854,1.1243404220432198,0.3118466898954704,0.9333369905964404,1.0,6/15,15.94%,FGF16;SMOC2;LGMN;PRKD2;FGF2;PRKD1
prerank,cortical cytoskeleton organization (GO:0030865),0.3374205867106865,1.1240229219656965,0.28417818740399386,0.9329500657483182,1.0,15/41,27.76%,NCKAP1;NCKAP1L;RHOBTB1;FMNL3;FMNL1;RHOQ;ROCK1;RHOBTB2;LLGL2;RHOBTB3;RHOA;FHOD1;LLGL1;RAB13;EPB41L3
prerank,negative regulation of cell growth (GO:0030308),0.28091175914118593,1.1236948910816789,0.2327469553450609,0.9325836641339855,1.0,39/121,24.48%,WFDC1;DIP2B;DCC;CDHR2;PSRC1;SIPA1;STK11;MINAR1;APBB1;FHL1;GNG4;TGFB1;ADAM15;FGF13;MAG;SFRP1;CGRRF1;ACVR1B;DCBLD2;FLCN;EI24;CCAR2;SH3BP4;NDRG3;PTPRS;PPP2R1A;BTG1;TCHP;ULK2;MAP2;FRZB;SFRP2;ULK1;NPR1;JADE1;PRDM11;SMARCA2;CDKN2AIP;CRLF3
prerank,positive regulation of cell adhesion (GO:0045785),0.30457394667862975,1.1235615983399947,0.27206946454413894,0.9314787514804277,1.0,15/74,15.63%,ZFHX3;FRMD5;P2RY12;NCKAP1L;MAGI1;PRKCA;PRKD2;STX3;NPNT;PDGFB;EPHA4;FLCN;NDNF;FBLN2;RSU1
prerank,histone methylation (GO:0016571),0.3667417489820318,1.1234616559028565,0.2797319932998325,0.9302643681344289,1.0,7/26,17.01%,SMYD2;NSD1;SETD6;SUV39H2;SMYD1;FBLL1;N6AMT1
prerank,negative regulation of autophagy (GO:0010507),-0.28973163323704004,-1.1231228936836348,0.22935779816513763,0.6414262366586588,1.0,10/54,12.26%,BCL2;PTPN22;MCL1;MET;ATG7;CTSA;SMCR8;PIK3CA;LRRK2;RRAGA
prerank,positive regulation of axonogenesis (GO:0050772),0.3329531356128065,1.1229782791628486,0.2874074074074074,0.9305817792328578,1.0,18/43,28.40%,MAP6;SEMA7A;PLXNB2;LIMK1;TWF2;ARHGDIA;CDKL5;MAP3K13;NTRK2;PLXNB1;ZFYVE27;BDNF;TIAM1;RHOA;MAPT;NGFR;SLITRK1;ROBO1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.24789460295426505,-1.1224787380411385,0.1839080459770115,0.6423554375126304,1.0,26/103,16.67%,IGF1;RRAGC;SIAH2;USP28;CCDC88C;SHOC2;GRAP2;ARHGEF18;ARHGAP18;CRKL;ARHGAP30;DNMT1;USP8;RASGRP2;ABR;KRAS;GRB2;CCNA2;SHTN1;PLD1;RB1;RALB;SHC1;CHP1;NRAS;PLD2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.39326959204440803,-1.122389409898005,0.3107476635514019,0.6418156779228875,1.0,10/15,39.08%,TACC3;CDC27;PLK1;UBE2C;ANAPC7;CDC23;CENPE;ANAPC1;PTTG1;CDC16
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.44744361716066494,-1.1219525515066893,0.31910112359550563,0.6422280646391202,1.0,4/10,16.06%,STOML2;E2F8;CDT1;E2F7
prerank,positive regulation of signal transduction (GO:0009967),-0.22566557663887177,-1.1217298114718046,0.11695906432748537,0.6420136092148762,1.0,51/238,15.37%,RBPJ;SASH1;CD74;NRP1;GAS6;IGF1;AXL;PTPRC;CDC73;CCBE1;RWDD3;DLG5;TLR2;SMARCA4;ASXL2;BAX;NPTN;IL6ST;VPS35;LIMS1;ERN1;TUBD1;FAS;NOD2;PDCD10;ZMIZ1;YAP1;TEDC2;HIF1A;CLEC6A;IL1B;FGF1;CD226;SNW1;EP300;PTGIS;NOTCH1;TRIM44;CUX2;F7;IGF2;SORBS1;LRRK2;TSPAN5;EMP2;CCN3;BMP2;RIMS2;NOTCH4;PTK2B;SCIMP
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.29021065405690016,-1.1206705190498887,0.25,0.6441256368866867,1.0,11/49,15.24%,BCL2;BCL2L1;MCL1;BAX;CAV1;UBQLN1;PLAUR;LCK;RACK1;PMAIP1;BCL2L11
prerank,regulation of interleukin-4 production (GO:0032673),-0.35805905688002065,-1.119994829570348,0.2740740740740741,0.6451747002430148,1.0,8/21,17.84%,RARA;IRF4;SYK;CEBPB;PRKCQ;CD28;FCER1G;GATA3
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.2414446560980936,-1.1198935240185177,0.18222222222222223,0.6446799276741788,1.0,26/140,12.13%,VAV3;ARHGAP15;ARHGEF3;FGD4;ITSN1;ARHGAP10;STARD8;ARHGAP17;ARHGAP19;CGNL1;ARHGEF18;ARHGEF6;ARHGAP18;ARAP1;ARHGAP30;PLEKHG5;FGD1;RACGAP1;ARHGAP24;ABR;GNA13;RHOJ;ARHGDIB;ARHGAP39;ARHGEF26;ARHGAP28
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.34718479100472466,-1.1197102888486758,0.2804878048780488,0.6443817103870051,1.0,7/23,14.77%,KPNB1;DNASE2;HMGB2;DNASE1L1;H1-0;ENDOG;DFFA
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4106475286982828,-1.1194320610635513,0.31527093596059114,0.644344362612319,1.0,4/14,17.30%,ITGA4;THBS1;ECSCR;RGCC
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.44982382454584724,1.119042933684795,0.32066115702479336,0.9444676007156015,1.0,4/12,14.82%,IFT20;F3;NDRG4;APOD
prerank,mRNA transport (GO:0051028),0.28881199937768626,1.1190114993478442,0.2633637548891786,0.9429464907844297,1.0,34/101,24.22%,HHEX;RNPS1;AAAS;SRSF5;MCM3AP;CASC3;DDX25;SRSF6;SRSF11;NUP54;SRSF1;YTHDC1;CPSF3;NUP88;RAE1;FYTTD1;UPF1;CDC40;DDX39B;THOC5;NUP133;SARNP;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,regulation of endothelial cell migration (GO:0010594),-0.25964021940598125,-1.1189283955642915,0.1950354609929078,0.6449116935779368,1.0,33/85,25.63%,SASH1;SP100;APOE;NRP1;NRP2;PROX1;THBS1;FGF1;ZC3H12A;PRCP;RHOJ;CEACAM1;KDR;EMP2;PTN;GPI;FOXP1;PTK2B;WNT5A;EPHA2;BCAR1;AAMP;GATA3;ITGB3;BCAS3;PIK3CD;APOH;ADGRB1;EGF;ANXA3;ANGPT1;BMPR2;RAC1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.40438549548360125,-1.1187273392182462,0.3140096618357488,0.6446591991685672,1.0,10/14,38.91%,ETNPPL;PISD;ETNK2;ALOX15;LPIN3;CHKA;LPIN1;ETNK1;CEPT1;SLC27A1
prerank,mRNA polyadenylation (GO:0006378),-0.3362032856016658,-1.118334222964899,0.2706766917293233,0.6441643506338474,1.0,11/26,26.20%,CDC73;CPSF1;FIP1L1;TENT2;AHCYL1;CPSF2;PCF11;TENT4B;APP;LEO1;WDR33
prerank,RNA polyadenylation (GO:0043631),-0.3362032856016658,-1.118334222964899,0.2706766917293233,0.6441643506338474,1.0,11/26,26.20%,CDC73;CPSF1;FIP1L1;TENT2;AHCYL1;CPSF2;PCF11;TENT4B;APP;LEO1;WDR33
prerank,negative regulation of double-strand break repair (GO:2000780),-0.32611059648259977,-1.1176003634595084,0.2798913043478261,0.6453556535580298,1.0,12/30,22.48%,SMCHD1;CYREN;HSF1;KLHL15;MAD2L2;TRIP12;RMI2;SHLD1;PARPBP;HMGA2;FBH1;TWIST1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3050093312016527,1.1175717543291745,0.27116212338593976,0.9469088745106043,1.0,15/68,16.94%,ACSF2;GTPBP1;ACSL6;ACOT13;AMPD3;HPRT1;OXSM;DBI;ACOT4;ACBD6;TPST2;ACOT11;ACLY;GNAI3;RHOQ
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.38528047475350446,-1.1170211942627362,0.3014705882352941,0.6461434523547593,1.0,7/18,24.68%,CCT6A;EXOSC10;CCT3;NOP10;DKC1;NAF1;NHP2
prerank,protein localization to organelle (GO:0033365),0.2728160948722437,1.1169886507640925,0.25394736842105264,0.9476786474602702,1.0,23/133,13.35%,IFT20;HHEX;YWHAE;LAMP5;OBSL1;ROPN1;SIX4;SGTA;PRNP;SYS1;DDX1;MTCH2;BMP4;OTOF;ARFRP1;BBS9;EMD;TRAM2;CCDC47;EHD1;SCG3;BICD2;MICALL1
prerank,embryonic heart tube development (GO:0035050),0.4345217083103251,1.1169835606437926,0.32167832167832167,0.9460747429137476,1.0,3/14,13.33%,MEGF8;TBX2;NDRG4
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.41805293497319307,1.1169799920030057,0.29528985507246375,0.9444749824863017,1.0,5/16,20.75%,GNB3;PRKN;SCARB2;RORA;PDK1
prerank,leukocyte tethering or rolling (GO:0050901),0.40609954087089345,1.1166746236616025,0.30390492359932086,0.9440359018687244,1.0,5/17,9.54%,SELPLG;ADD2;JAM2;PODXL2;CX3CR1
prerank,positive regulation of rRNA processing (GO:2000234),0.4763475732677603,1.116536340208149,0.3344768439108062,0.9430082592063563,1.0,3/10,8.16%,RIOK1;WDR75;DIMT1
prerank,phosphorylation (GO:0016310),-0.21611454248200912,-1.11597016215763,0.14285714285714285,0.6482471150489858,1.0,90/385,18.05%,PEAK1;MAP3K1;STK3;FNIP2;GAS6;PRKCH;CSK;STK38;PRKCE;STK17B;CDK6;GMFG;MARK2;LIMD1;TEC;CDK17;PIK3R4;CDK8;RUNX3;FAM20A;BRAF;PRKAB1;PPP4R1;BIRC6;PRKACA;RARA;NUAK2;TBK1;MKNK1;MAPKAPK2;DGKK;NADK;PIM1;LMTK2;ERN1;STK24;TAF1;TESK2;DYRK1A;SYK;FAM20B;CERKL;LYN;FYN;PRKAG2;CDKL3;HCK;TAOK3;HCST;PIK3CA;RET;HASPIN;CAMK2D;MAP3K11;GNPTAB;BIRC5;HIPK1;LCK;CERK;CDK1;DAPK1;HK1;LRRK2;PANK3;SHPK;FRK;FAM20C;SIK2;NLK;GK;BMP2;SPHK2;GK5;SIK1;CDK12;PRKACB;CDK14;PTK2B;DGKA;PI4KA;POMK;PLK1;MAPK8;HIPK2;ZAP70;MAP4K1;TBCK;PKN3;SGK3;SGK2
prerank,nuclear membrane reassembly (GO:0031468),-0.2828346540160615,-1.115797130424981,0.2532051282051282,0.6478834232600561,1.0,15/54,23.05%,KPNB1;CHMP4B;CHMP4A;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1;UBXN2B;SIRT2;LMNA;RCC1;NUP98;CCNB1
prerank,RNA stabilization (GO:0043489),-0.31827078548306365,-1.1156608634195044,0.28608923884514437,0.647477726125465,1.0,16/33,28.81%,NOCT;ZCCHC17;EIF4ENIF1;TENT2;TRDMT1;TENT5A;SLC11A1;NSUN2;LARP1;DKC1;HNRNPU;NAF1;TENT5C;VIP;PAIP1;PHAX
prerank,lipid translocation (GO:0034204),0.3889085485351042,1.115297987325778,0.3099510603588907,0.9462188760611071,1.0,6/21,16.69%,ATP8A2;ATP9A;ABCB4;ATP11A;ATP8B1;ATP8A1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.23945477674470916,-1.1150492722274932,0.18421052631578946,0.6483580018501387,1.0,43/149,20.24%,PSMA6;FLOT2;PRKCH;TRIM25;TLR2;TRIM14;CD36;RAB7B;LAMTOR5;NLRC4;DHX33;NFKB1;NOD2;RIPK1;TFRC;CAV1;TRIM62;UBC;CIB1;PRKCQ;IL1B;TAB1;PIDD1;UBA52;ADAM8;EP300;TRIM5;EDA;NPM1;RIPK4;AGER;TNF;WNT5A;TRAF1;TLR4;CRNN;IL18R1;ERC1;ARHGEF2;TRIM37;MYD88;HSPA1B;LTF
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.384624874077408,1.114965295725303,0.3142857142857143,0.9459599063752401,1.0,6/20,18.41%,AGRN;LY6H;RGS10;LY6G6D;GNA11;CHRNA7
prerank,cellular response to cadmium ion (GO:0071276),0.37477842153488733,1.1145871298303478,0.2942122186495177,0.9458342043482091,1.0,10/24,18.07%,MAPK3;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,acyl-CoA biosynthetic process (GO:0071616),0.41451498857336144,1.114584038705661,0.3242320819112628,0.9442431104289262,1.0,11/16,32.63%,CBR4;PPT2;ACLY;PPCS;ACSS1;SLC25A1;FASN;DIP2A;ACAT1;MLYCD;GCDH
prerank,translational termination (GO:0006415),0.28894338801045094,1.1143493693869477,0.2602739726027397,0.943608970290046,1.0,33/95,26.26%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;GSPT1;N6AMT1;DAP3;MRPS5;MRPL58;APEH;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;TRMT112;MRPS25;MRPS9
prerank,negative regulation of T cell proliferation (GO:0042130),0.36060357939436855,1.1140863384523823,0.29421487603305785,0.9431552566989582,1.0,5/28,5.53%,CD80;IL4I1;SCRIB;CD86;PRNP
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.33194608182741425,-1.1140550340065005,0.29974811083123426,0.6503402438196679,1.0,12/26,27.88%,ALOX5;CD36;CYBA;SLC5A3;SPHK2;SLC25A33;TLR4;MMP8;ADGRB1;CCN6;ABCD1;SLC30A10
prerank,nucleotide biosynthetic process (GO:0009165),0.40833213762645715,1.1138027351352806,0.31596638655462184,0.9427389356931917,1.0,8/18,18.89%,PNP;GART;PRPSAP2;HPRT1;ADSL;PRPSAP1;NMNAT2;RRM2B
prerank,histone ubiquitination (GO:0016574),0.3854029862810134,1.1137208973926653,0.31433224755700323,0.9414634429307501,1.0,6/21,16.18%,CTR9;UBE2B;PHC1;UBE2N;RNF8;PAF1
prerank,RNA processing (GO:0006396),0.26678996754700113,1.113611502547526,0.24133504492939667,0.9403047580464173,1.0,41/176,17.49%,ADARB2;RNPS1;IVNS1ABP;SMU1;SRSF5;FUS;DHX15;TSEN54;BCAS2;HNRNPH1;PPARGC1A;CPSF6;SF3B2;LSM1;PTBP1;SRSF11;MTPAP;ADAR;RBM5;PPIG;AKAP8L;PRMT9;SON;RNASEL;SF3A1;SRSF1;SNRPD2;MPHOSPH10;DROSHA;SF3B3;NUDT21;NOVA1;RP9;DDX39B;DDX47;CCAR2;RBM3;SETX;BICD1;SRSF9;PPP2R1A
prerank,positive regulation of glucose import (GO:0046326),-0.35171629438531815,-1.1135031577742034,0.30412371134020616,0.6511031944980187,1.0,7/21,25.07%,OSBPL8;IGF1;SORBS1;ARPP19;IRS2;CAPN10;APPL1
prerank,dendritic cell chemotaxis (GO:0002407),0.433609891439823,1.1134424437460702,0.31438127090301005,0.9393733032461723,1.0,7/14,19.32%,TRPM2;PIK3CG;CCR1;CXCR4;CCR6;HMGB1;CCL5
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.430488308881557,-1.1134344432615588,0.3310344827586207,0.650528144701987,1.0,4/12,9.48%,EML2;DYRK1A;STMN1;MAPRE1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.29870165660447795,1.113084502248616,0.2785923753665689,0.93917324233286,1.0,15/72,15.17%,POLR2L;CDK7;POLR2F;COPS8;XAB2;GTF2H2;ISY1;POLD3;GTF2H4;XRCC1;LIG3;COPS3;POLR2G;COPS6;ERCC6
prerank,protein complex oligomerization (GO:0051259),0.292819242142429,1.1128464102594031,0.2714486638537271,0.9385418319825164,1.0,23/85,18.88%,ADCY8;GLRA3;MPP2;IKZF4;NACC2;FUS;C9;CPSF6;ATL1;KCNC1;TRMT61B;MAT2A;PKD2;EHD1;DNM1L;CHMP2A;NUDT21;RNF135;OXA1L;KCNC3;EHD3;ALS2;ALAD
prerank,DNA metabolic process (GO:0006259),-0.21777317815270159,-1.1128009739243259,0.11486486486486487,0.6515185664307905,1.0,62/270,17.03%,SP100;RAD51B;PARP4;RBBP8;VCP;DNASE2;HMGB2;PDS5B;DNASE1L1;POLE4;TOP2A;PCNA;KPNA2;TOPBP1;DOT1L;RTEL1;UHRF2;ORC5;ZRANB3;NT5E;CDC34;CHD1L;POLI;NBN;UBC;IGHMBP2;DNMT1;USP45;BRCA1;UVRAG;PDS5A;ATRIP;HINFP;UBA52;TRRAP;ORC2;POLD4;BARD1;RPA1;CDK1;LIG4;RMI2;MCM2;KAT5;TICRR;ORC4;RAD21;TYMS;ENDOG;NPM1;CDT1;PRIM2;MNAT1;TERF2;DDX21;MCM8;RNASEH2A;NTHL1;CBS;NOP53;RPA2;MUTYH
prerank,macromolecule catabolic process (GO:0009057),-0.334533199688293,-1.1125964835792603,0.29894179894179895,0.6513783463095102,1.0,7/26,8.34%,KIF16B;PIK3R4;SH3GLB1;CLN8;CLN5;UVRAG;SNX25
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.45762659704551034,1.1125816480181965,0.3178694158075601,0.9380216691038686,1.0,3/10,7.88%,GABRG1;GABRG2;GABRA2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.4262255161167242,-1.1125634766647594,0.3235955056179775,0.6506987227562562,1.0,6/12,19.39%,PRCC;ZWILCH;WEE1;BUB1;BUB1B;ZWINT
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.26216070787071244,-1.1124920879260571,0.24742268041237114,0.6501089423105347,1.0,19/78,17.20%,DAB2;PID1;PRKCH;BCL2L1;PRKCE;PPP2R5A;LDLRAP1;PICALM;CIB1;SORBS1;LRP1;EGFR;TNF;EPHA2;PLS1;CLN3;SQSTM1;RSC1A1;AKAP5
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.21040828858448368,-1.111851820892426,0.06578947368421052,0.6510624933783876,1.0,107/509,15.43%,IQGAP1;OSBPL8;SASH1;BCL2;CD74;DDX60;GAS6;HIP1;ANKRD17;IGF1;AXL;BCL2L1;CASS4;GCNT2;ALPK1;TRIM25;PTPRC;DLG5;TLR2;TRIM14;LILRA5;P2RX4;FRS2;RRAGC;MET;LGALS1;TBK1;BAX;SOX11;LAMTOR5;SHISA5;DHX33;TLR7;ESR1;KITLG;GAB1;RPS20;LIMS1;PUM2;CD14;OASL;THBS1;BST2;NOD2;PDGFD;FLT1;RIPK1;TFRC;BCAR3;LITAF;CAV1;TRIM62;LYN;FYN;PLEKHG5;RNF13;GAB2;CLEC6A;IL1B;FGF1;TXN;CCDC22;NRG2;S100A4;SMCR8;EEF1D;HCST;PIK3CA;RET;HPSE;GPRC5B;PDGFC;ADAM8;EP300;CD28;SPRY2;TNFRSF19;LCK;GRB2;TRIM44;F7;GPR61;BIRC2;IGF2;GRM4;CBL;RRAGA;IRAK4;PELI1;KDR;TRIM5;ZDHHC17;PIK3R5;MYOC;RACK1;BMP2;SPHK2;CHD5;PMAIP1;EGFR;AGER;SHC1;DDX21;TNF;BCL2L11;GJA1;WNT5A
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.4360022184043596,1.1117739678516332,0.3288364249578415,0.9398320395379383,1.0,4/13,14.65%,GTPBP1;CNOT8;NUDT21;UPF1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.379072605527645,-1.1116883140079041,0.28398058252427183,0.650736071312496,1.0,6/18,13.89%,SOX6;FRS2;NOTCH1;HDAC1;CCN3;BMP2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.4401933432667307,1.111597992125642,0.32212389380530976,0.9389602321437688,1.0,3/12,9.35%,SELENOS;AR;TGFB1
prerank,cellular response to dsRNA (GO:0071359),-0.39242098297742656,-1.1111007524002803,0.30663615560640733,0.6514473163741864,1.0,6/15,16.27%,IFIH1;IFIT1;CAV1;RALB;NPM1;MUL1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3064162300316224,-1.1109620509496068,0.28535353535353536,0.6510301674127639,1.0,10/37,15.24%,BCL2;BCL2L1;BAX;NCK1;RPS7;CAV1;LCK;RACK1;PMAIP1;BCL2L11
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.30487528246396356,-1.1107889930682309,0.24285714285714285,0.6506984540546783,1.0,8/37,11.78%,IGF1;PPARG;MEF2D;ERN1;LDLRAP1;DNMT1;EFEMP2;HTR1B
prerank,regulation of protein transport (GO:0051223),-0.33150001507941385,-1.1101560140467825,0.30434782608695654,0.6516407691233779,1.0,13/27,30.19%,DNAJC1;PTPN1;GAPVD1;LCP1;TNF;CHP1;PPM1F;NDFIP1;ATP13A2;SNX3;RHBDF2;SCFD1;NDFIP2
prerank,digestive tract morphogenesis (GO:0048546),-0.4082165294405946,-1.1099960553407704,0.3137254901960784,0.651317218677422,1.0,7/14,37.49%,SOX11;BBS7;PDGFRA;ID2;GLI1;SOX17;STRA6
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3434124659757131,-1.1099191435123246,0.31362467866323906,0.6507517188728192,1.0,8/25,19.90%,RBPJ;SOX11;NOTCH1;CCN1;NUMA1;SMAD4;FBXL15;ACVR2A
prerank,tryptophan metabolic process (GO:0006568),0.4499547053231611,1.1094247203147525,0.3373287671232877,0.9458905623415611,1.0,3/11,11.66%,IL4I1;IDO2;KYAT1
prerank,proton transmembrane transport (GO:1902600),-0.30979183072809546,-1.1091976805899215,0.2753623188405797,0.6519459803341958,1.0,8/36,19.82%,ATP6V0D1;ATP5PO;SLC46A1;UCP2;ATP6V1A;HVCN1;SLC25A27;ATP6V0A4
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.31276680326385176,1.1091495338698127,0.2962962962962963,0.9452793718963418,1.0,12/53,15.47%,FGF10;WRAP53;NACC2;DDX5;HIC1;NSMCE4A;EEF1E1;UBE2N;RNF168;RNF8;ERCC6;CCAR2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.33642256401948567,-1.108913957682924,0.2826086956521739,0.6520235596535765,1.0,12/24,30.08%,GNL3L;EXOSC10;TERF2;SLX4;TENT4B;NAT10;HNRNPC;HNRNPU;TINF2;PIF1;TNKS;PINX1
prerank,negative regulation of RNA splicing (GO:0033119),0.39645150801181045,1.1087983437863047,0.3070739549839228,0.9450418582612399,1.0,4/19,6.03%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,gluconeogenesis (GO:0006094),0.3327321589653936,1.107916966033684,0.29199372056514916,0.9469493429038149,1.0,15/39,27.24%,GAPDH;PPARGC1A;SLC37A4;PGAM2;ALDOC;MDH1;PGM1;ALDOA;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1
prerank,positive regulation of growth (GO:0045927),-0.2757179867524323,-1.1078375714533952,0.2347560975609756,0.6541148121690409,1.0,18/64,17.51%,RFTN1;BCL2;SDCBP;NCBP1;ZPR1;CXCL16;DDX49;CIB1;H3-3A;BRAT1;PSMD10;EXOSC9;EGFR;SLC25A33;MFSD2A;ADAM17;ADNP2;WFS1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.2645166193416866,-1.1072944594001233,0.22653721682847897,0.654830615374301,1.0,18/73,16.27%,HIP1;VCP;XDH;PPARG;BAX;NLRC4;HIP1R;SMAD3;FAS;HSPD1;RIPK1;ANP32B;PIDD1;LCK;SENP1;RACK1;TNF;MUL1
prerank,regulation of vasculogenesis (GO:2001212),-0.3959133482703554,-1.1072784718125743,0.2927400468384075,0.6541050580597614,1.0,7/14,17.31%,XDH;CEACAM1;KDR;EMP2;RAP1A;ASB4;HEY2
prerank,signal transduction in response to DNA damage (GO:0042770),-0.2876178889431898,-1.1072607317210301,0.26740947075208915,0.6533828166274722,1.0,12/49,10.80%,PRPF19;CLSPN;USP28;DOT1L;BCL3;NBN;ATRIP;HINFP;MAD2L2;GRB2;RHNO1;PAXIP1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.41393300420775897,1.1070375227889775,0.3333333333333333,0.9487751471910738,1.0,5/16,31.43%,CLDN16;CLDN14;CLDN18;CLDN5;CLDN10
prerank,hexose biosynthetic process (GO:0019319),0.3284551056269045,1.1069450166174388,0.29750778816199375,0.9475624430921348,1.0,16/42,27.24%,GAPDH;PPARGC1A;SLC37A4;AKR1B1;PGAM2;ALDOC;MDH1;PGM1;ALDOA;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1
prerank,regulation of B cell activation (GO:0050864),-0.3414896072397414,-1.106762599383735,0.28165374677002586,0.6539782003623933,1.0,6/25,12.05%,FCGR2B;AHR;NOD2;BANK1;IKZF3;FOXJ1
prerank,cell-cell junction assembly (GO:0007043),0.3048745985498141,1.106437159911122,0.2985714285714286,0.9480728120230801,1.0,12/63,15.93%,CNTNAP1;FSCN1;DCHS1;PARD6B;PKP4;CDH18;PRKCA;GJA5;CTNND2;FLCN;PATJ;JAM3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.41290968439025516,-1.1060962870212039,0.3392405063291139,0.655001762513464,1.0,9/13,27.14%,PRPF19;PRPF6;LSM2;CD2BP2;DDX20;PRPF3;USP4;PRPF31;AAR2
prerank,response to progesterone (GO:0032570),-0.37443751416395354,-1.1059382910111235,0.2972972972972973,0.6546444433511197,1.0,7/18,13.27%,THBS1;CATSPER3;CAV1;YAP1;CATSPER2;ACOD1;NR1H3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.30514948513757895,-1.1058716476536488,0.2924791086350975,0.6540384955975495,1.0,14/38,20.53%,CD47;P2RX4;CD36;SMAD3;CAV1;IL1B;ZC3H12A;PTGIS;GLA;TNF;TLR4;KLF2;MMP8;KLF4
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3757268576956177,1.1055147262351344,0.3294701986754967,0.9502149922327758,1.0,7/22,23.15%,ATP1B1;PKD2;GSTO1;HAP1;ANK2;VMP1;SLC9A1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3566587901930582,1.1054998764022304,0.31309904153354634,0.9487218236842266,1.0,12/31,27.16%,SH3BP1;DLG2;SCRIB;PRKCI;CAMSAP3;MTCL1;LIN7A;CDC42;OPHN1;RHOA;PARD3B;MYO9A
prerank,ESCRT III complex disassembly (GO:1904903),0.4674233902580487,1.104930307032531,0.3274336283185841,0.9477565573541353,1.0,6/10,28.97%,CHMP1A;CHMP2A;CHMP5;VTA1;CHMP7;CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.4674233902580487,1.104930307032531,0.3274336283185841,0.9477565573541353,1.0,6/10,28.97%,CHMP1A;CHMP2A;CHMP5;VTA1;CHMP7;CHMP2B
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.2834053482963115,-1.10491980465939,0.2553846153846154,0.6550516530652246,1.0,9/51,12.77%,KPNB1;CHMP4B;CHMP4A;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.2834053482963115,-1.10491980465939,0.2553846153846154,0.6550516530652246,1.0,9/51,12.77%,KPNB1;CHMP4B;CHMP4A;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1
prerank,icosanoid secretion (GO:0032309),-0.4172088156444015,-1.1042507737955745,0.3144208037825059,0.6560934790562094,1.0,5/12,34.75%,ANXA1;DRD2;DRD3;ABCC4;NOS2
prerank,protein import into peroxisome matrix (GO:0016558),0.44105091033812616,1.104154735884217,0.3381294964028777,0.9493057853480388,1.0,5/12,18.23%,PEX5;PEX26;PEX14;PEX2;PEX6
prerank,kidney development (GO:0001822),0.3032027526657193,1.1039421103379918,0.30158730158730157,0.9486435388044278,1.0,13/65,17.16%,FGF10;WNT4;VANGL2;SOX4;TGFBR1;BMP4;FOXC1;C1GALT1;PKD1;IFT27;IFT88;AGT;PYGO2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3958263769880407,-1.1037470582291684,0.3044496487119438,0.6567540539742083,1.0,3/14,7.75%,ACOT8;ACOX3;CROT
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.280826212314138,-1.1035723699082909,0.27384615384615385,0.6564114996698213,1.0,14/49,14.20%,HMGB2;RAB7B;THBS1;PF4;KMT2C;CIB1;PRKCQ;H3-3A;EP300;NFE2;HDAC1;DPY30;TESC;KMT2D
prerank,positive regulation of cellular senescence (GO:2000774),0.46568856245401297,1.1035507931741806,0.3493761140819964,0.9486340522895681,1.0,4/10,18.94%,ABI3;EEF1E1;CGAS;ARG2
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.445328448853592,-1.103541701054145,0.3292079207920792,0.6557315045343286,1.0,2/10,2.62%,ZEB2;ATP7A
prerank,peptidyl-lysine methylation (GO:0018022),0.37009039072410854,1.1034493037581232,0.3140096618357488,0.9475172924901186,1.0,9/26,17.01%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4;SUV39H2;SMYD1;N6AMT1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.2600949904334219,-1.1033038573763845,0.25,0.6555939601618556,1.0,34/73,30.54%,DAB2;NEDD9;NRP1;CUL3;CD47;TEC;ADAM9;SYK;ITGB7;HCK;ADAM11;CEACAM1;PTN;PTK2B;MYH9;BCAR1;FN1;ITGB3;COL3A1;PRAM1;DOCK1;LAMA5;ITGA11;ITGA2;LAMA3;FBLN1;ILK;FYB2;PLEK;LAT;ITGB8;PLPP3;FGR;ITGB2
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2505872966346265,-1.1032383066796463,0.2226027397260274,0.6550305626183373,1.0,20/98,14.55%,PID1;APOE;IFNAR1;CHCHD2;XDH;PPARG;RAB1A;THBS1;PPARD;DHRS4;RIPK1;NR1H2;ZC3H12A;GRB2;ACOD1;CDK1;APOC1;NR1H3;GREM1;IFNLR1
prerank,phospholipid transport (GO:0015914),-0.2873312127950395,-1.103180840712645,0.27246376811594203,0.6543925148008204,1.0,12/52,12.97%,OSBPL8;ATP8B4;APOE;NPC2;TMEM30A;PLTP;LDLR;PCTP;OSBPL2;ABCG1;ATP11C;APOC1
prerank,negative regulation of histone modification (GO:0031057),-0.3951573978607425,-1.1031594364310677,0.3349282296650718,0.6537132690943037,1.0,6/14,22.51%,BRCA1;SPHK2;THAP7;TAF7;TWIST1;AASS
prerank,midbody abscission (GO:0061952),-0.37745382422983353,-1.103034299654941,0.32678132678132676,0.6533434586015763,1.0,5/17,16.22%,CHMP4B;CHMP4A;PDCD6IP;CHMP1B;KIF20A
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.4507149810845631,1.1029087645026636,0.3462214411247803,0.9481530532519684,1.0,3/11,11.47%,TSC2;GIGYF1;IRS1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3956190365999791,-1.102765742659245,0.29901960784313725,0.6532425861657822,1.0,6/14,10.80%,PRDM9;DNMT1;BRCA1;SNW1;CTNNB1;PAXIP1
prerank,endochondral bone morphogenesis (GO:0060350),0.4617892861051165,1.102528164424054,0.3339160839160839,0.9480743087269434,1.0,6/11,23.76%,MEF2C;BMP4;FOXC1;BMPR1B;INPPL1;COL13A1
prerank,transcription by RNA polymerase I (GO:0006360),0.34043564770205303,1.102434343554909,0.31528662420382164,0.9469015157916224,1.0,15/34,27.54%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;RRN3;MAPK3;POLR1F;POLR1G;GTF2H3;ERCC2;TAF1A;POLR1A;GTF2H1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2976690779374381,-1.1024204535436668,0.28651685393258425,0.653447523439885,1.0,15/43,23.68%,GAS6;PTPN22;CD274;IGF1;RARA;ZC3H12A;SLAMF1;LBP;LILRB1;TLR4;CD33;LTF;NLRC3;NR1H4;GSTP1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.24632106897195374,-1.1023745803937173,0.24907063197026022,0.6528118344914142,1.0,30/101,17.92%,ETAA1;PROX1;NOD2;PDGFD;FLT1;CCND1;PDCD10;CD24;SLC8A2;CIB1;IL1B;FGF1;PDGFC;ADAM8;CALM3;LRRK2;PIK3R6;CCND2;PSMD10;CALM2;PIK3R5;RALB;MTCP1;EGFR;INCENP;TNF;WNT5A;ADAM17;RGCC;HMGA2
prerank,limb morphogenesis (GO:0035108),-0.3544866325176153,-1.1022847222965184,0.2979274611398964,0.6522734722841772,1.0,7/20,22.33%,MBNL1;FBXW4;IQCE;LRP6;TFAP2B;PTCH1;SHH
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3481641432791839,-1.1022497437547019,0.29048843187660667,0.6515935064047585,1.0,9/22,15.43%,CCR2;NOD2;TRPM4;TNFRSF1B;SPHK2;LILRB1;TNF;SCIMP;WNT5A
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3761763507588871,1.101950556823038,0.31751227495908346,0.9473306602348985,1.0,12/24,26.77%,VKORC1L1;TTLL6;PARP1;AGBL4;TTLL7;TPGS1;TTLL1;TTLL10;TTLL5;TTLL8;TTLL11;CFAP20
prerank,proteasome assembly (GO:0043248),-0.42587458303024506,-1.1017319373625418,0.30303030303030304,0.6521490377101353,1.0,5/11,18.00%,OTUD6B;PSMG1;PSMD11;PSMD10;PSMD5
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3763866747167643,-1.1013565072107228,0.31026252983293556,0.6524401893116435,1.0,11/16,31.47%,RTEL1;HNRNPA2B1;TERF2;SLX4;SMG6;NAF1;TINF2;TNKS;PINX1;SMG5;ATM
prerank,negative regulation of organelle assembly (GO:1902116),-0.3132974699263868,-1.1013534340125382,0.2947976878612717,0.6516966709846858,1.0,16/35,29.82%,CHMP4B;CHMP4A;CDK5RAP2;YAP1;BRCA1;SMCR8;MTM1;LRRK2;SMAD4;TRIM37;KAT2B;PHF23;CEP97;TESK1;CCP110;SCFD1
prerank,nuclear pore complex assembly (GO:0051292),-0.4390713059735377,-1.1013189624633224,0.3204819277108434,0.651057981543359,1.0,3/10,11.62%,NUP153;NDC1;AHCTF1
prerank,cardiac myofibril assembly (GO:0055003),0.4163274653603108,1.100622154319148,0.3413793103448276,0.9509521205814542,1.0,2/15,1.81%,NEBL;OBSL1
prerank,cellular amino acid catabolic process (GO:0009063),0.2864878222614169,1.1002846539615359,0.3131868131868132,0.9508123984855527,1.0,22/87,20.91%,HOGA1;HMGCLL1;IL4I1;IDO2;OTC;ACADSB;BCAT1;KYAT1;BCKDHB;AMT;ALDH6A1;ALDH5A1;ALDH4A1;SLC25A44;DAO;DLD;HSD17B10;BCKDHA;ABAT;ECHS1;QDPR;ASPA
prerank,mesenchymal cell differentiation (GO:0048762),-0.28591884903766024,-1.1001602548147256,0.27714285714285714,0.6533018430106461,1.0,18/51,22.22%,RBPJ;FBXL17;DLG5;LIMS1;HNRNPAB;HIF1A;S100A4;CTNNB1;NOTCH1;BMP2;NOTCH4;WNT5A;HEY2;HMGA2;LRP6;BMP7;HEYL;ISL1
prerank,amino acid import (GO:0043090),0.38492105904650664,1.0999792917761462,0.3316151202749141,0.9504796908048706,1.0,7/21,15.55%,SLC1A1;SFXN1;SLC1A3;SFXN2;SLC6A1;SLC22A4;SH3BP4
prerank,regulation of osteoblast differentiation (GO:0045667),-0.26085110814157664,-1.0995716795625858,0.26755852842809363,0.6541219434741188,1.0,32/82,24.56%,SUCO;IGF1;NBR1;NOCT;CDK6;LIMD1;PPARG;PRKACA;SOX11;IL6ST;YAP1;NOTCH1;TRPM4;CCN1;SMAD6;GREM1;BMP2;SMOC1;RIOX1;ACVR1;ACVR2A;BMP7;LTF;BAMBI;PTCH1;IFITM1;FFAR4;SEMA4D;TWIST1;TNN;GDF10;TMEM119
prerank,protein targeting to peroxisome (GO:0006625),0.35755561243841183,1.099294405698276,0.3162251655629139,0.9515642931900552,1.0,16/29,27.86%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;PEX6;ABCD2;PEX11B;PEX3;ZFAND6;HACL1;PXMP4;ABCD3;ACBD5;LONP2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3997680772259895,-1.0987420585729444,0.33101851851851855,0.6556206491060238,1.0,5/13,23.05%,CDK5RAP2;MAD2L1;DUSP1;NDC80;CCNB1
prerank,mesonephros development (GO:0001823),0.45529796197699945,1.0986951872987334,0.35294117647058826,0.9522849991580508,1.0,2/11,8.32%,FGF10;BMP4
prerank,negative regulation of DNA recombination (GO:0045910),-0.29555575225468755,-1.0986411235684206,0.2891566265060241,0.655151490353196,1.0,14/43,17.14%,POLR2E;SMCHD1;RTEL1;ZRANB3;KLHL15;H1-0;MAD2L2;RMI2;SHLD1;POLR2B;POLR2H;TERF2;POLR2J;PARPBP
prerank,RNA catabolic process (GO:0006401),-0.2849279858493108,-1.0986299224854643,0.2978723404255319,0.6544301619022522,1.0,14/46,19.86%,DIS3L2;RNASE3;ZC3H12D;NCBP1;ZPR1;ERN1;XRN2;LSM2;LSM5;RNASEH2A;HNRNPD;RNH1;RNASEH1;HSPA1B
prerank,osteoclast differentiation (GO:0030316),-0.3467421978546791,-1.098611784277209,0.31909547738693467,0.653729096807077,1.0,9/22,31.52%,TYROBP;GPR183;GAB2;FOXP1;EPHA2;OSCAR;CSF1;GLO1;DCSTAMP
prerank,pre-miRNA processing (GO:0031054),0.42368850582008377,1.09805699062429,0.3467600700525394,0.9532412054766191,1.0,4/14,21.33%,ADAR;DROSHA;AGO4;LIN28B
prerank,histone H4-K8 acetylation (GO:0043982),0.42332980038335943,1.0979618567475489,0.3473861720067454,0.9505728888363101,1.0,9/15,30.69%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MCRS1;ING4;KANSL3
prerank,histone H4-K5 acetylation (GO:0043981),0.42332980038335943,1.0979618567475489,0.3473861720067454,0.9505728888363101,1.0,9/15,30.69%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MCRS1;ING4;KANSL3
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.35710345346041467,-1.0973001073787123,0.3065326633165829,0.6565219527253832,1.0,6/20,13.04%,FLOT2;SDCBP;RIPK1;BIRC2;PELI1;PDCD6IP
prerank,pancreas development (GO:0031016),0.44209031877259874,1.0971431727951555,0.34554973821989526,0.9521809130017691,1.0,3/12,8.65%,DNAAF1;CCDC39;TCF7L2
prerank,myoblast differentiation (GO:0045445),-0.3877435118481867,-1.0968994521962798,0.3493670886075949,0.6569163149578567,1.0,7/14,18.63%,IGF1;MBNL1;HINFP;RB1;PLEKHM3;SDC1;MAPK12
prerank,positive regulation of vasoconstriction (GO:0045907),0.43385805732601235,1.0968342304439553,0.3448844884488449,0.9518434786885263,1.0,2/13,3.31%,AVPR2;AVPR1A
prerank,blood vessel diameter maintenance (GO:0097746),-0.30854441275399697,-1.0966076371145408,0.2913165266106443,0.6569633526207042,1.0,20/34,40.52%,EDNRB;GCLC;ADCY6;EDNRA;KLF2;PER2;SERPINF2;ACE2;AGTR2;KEL;NOS1;EDN3;CRP;EDN2;GPER1;AGTR1;EDN1;KCNMB4;ECE1;SCPEP1
prerank,striated muscle cell development (GO:0055002),0.42664658357433394,1.0962438427170307,0.3482758620689655,0.9526080673258405,1.0,4/14,12.95%,CAPN3;LMOD1;TMOD2;LMOD3
prerank,negative regulation of response to stimulus (GO:0048585),-0.2722709457237081,-1.096130246173534,0.2645161290322581,0.6575277959168367,1.0,21/60,22.48%,FCGR2B;MCTP1;ALOX5;CDK6;PTPN1;LYN;NR1H2;PDCD1;SOCS5;NR1H3;TERF2;MAPK7;AQP11;WFS1;HMGA2;COL3A1;ACVR1;APPL2;KLF4;VPS13C;TWIST1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.4589276389995651,1.0960741824718148,0.3397212543554007,0.951765038759508,1.0,4/10,10.50%,SMYD2;EEF1AKMT2;SETD6;SETD4
prerank,regulation of BMP signaling pathway (GO:0030510),-0.262437143851016,-1.0959959923778344,0.26605504587155965,0.6571466064524084,1.0,26/73,26.47%,RBPJ;UBE2D3;PPARG;SOX11;SMURF2;SMAD9;LEMD3;NOTCH1;CCN1;SMAD6;GREM1;BMP2;NUMA1;HIPK2;SMAD4;FBXL15;TFAP2B;ACVR2A;GDF3;BAMBI;TRIM33;SKIL;XIAP;BMPR2;FST;UBE2O
prerank,mitochondrial translational elongation (GO:0070125),0.28686577671751834,1.0959488993608435,0.31163434903047094,0.9507741131746893,1.0,29/88,26.26%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,positive regulation of protein kinase activity (GO:0045860),-0.23149603661412246,-1.09589766839745,0.23829787234042554,0.6566815057584255,1.0,32/148,15.66%,IQGAP1;NEDD9;STK3;GAS6;CASS4;PTPRC;MARK2;ETAA1;LILRA5;CLSPN;PTPN1;BORA;PDCD10;SLC8A2;SNX9;PRKAG2;CIB1;TAOK3;GPRC5B;LCP2;AGAP2;CALM3;CCN1;SLC11A1;EMP2;CALM2;RALB;MTCP1;INCENP;TNF;PTK2B;RAP1A
prerank,regulation of peptide hormone secretion (GO:0090276),0.30004711603082523,1.0956812510763176,0.29929078014184396,0.9503391548327197,1.0,16/67,17.28%,SNAP25;ITPR2;KCNA5;IL6;RFX6;SLC2A2;ADRA2A;RAPGEF3;PRKCA;CACNA2D2;ITPR3;CACNA1D;CRHBP;ABCC8;CACNA1A;MTNR1B
prerank,response to cadmium ion (GO:0046686),0.36217899069585496,1.0954095624131415,0.3186119873817035,0.9498621530141386,1.0,15/26,31.57%,MAPK3;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MAPK1;SUMO1;CHUK;HAAO;NCF1
prerank,sulfation (GO:0051923),0.44991661819343315,1.0952907899098872,0.34501845018450183,0.9488107797361128,1.0,1/11,1.10%,HS3ST5
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.39224791273672094,1.095158305467148,0.32698961937716264,0.9478603901114497,1.0,4/18,11.17%,SLC4A8;SNAPIN;RAB5A;RIMS1
prerank,lymphocyte chemotaxis (GO:0048247),-0.30859302749318357,-1.0951029633710885,0.2840909090909091,0.6580803488310941,1.0,5/34,10.17%,GAS6;CXCL16;CCL25;GPR183;ADAM8
prerank,protein O-linked glycosylation (GO:0006493),0.27964212685326656,1.0950888020515703,0.27346938775510204,0.9466240948253426,1.0,28/96,23.51%,PLOD3;TET1;B3GNT6;B4GAT1;TMTC4;ST6GALNAC2;GALNTL6;POFUT1;GXYLT1;OGT;FKRP;SDF2L1;C1GALT1;SLC35C1;MGAT5B;POMGNT1;PLOD1;DPM3;GCNT4;ST3GAL3;GALNT4;GALNT2;GCNT1;OGA;LARGE1;ST6GALNAC4;GALNT9;PGM3
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3411068632097888,1.094937107793719,0.3156297420333839,0.945738034952042,1.0,12/35,22.97%,POLG;POLD3;OGG1;XRCC1;LIG3;ADPRS;PARP1;APEX1;FEN1;UNG;MPG;RFC4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.20768131071016502,-1.0946311391951717,0.11,0.6585979277386832,1.0,83/390,16.73%,VAV3;NEDD9;ITSN1;MTSS1;CYBB;ATP6V0D1;NRP1;NRP2;ACTR3;PXN;STAP1;IGF1;AXL;AP2A2;CASS4;KIF16B;CRK;ATP6V0D2;SDCBP;HNRNPM;GIT1;ATP6V1B2;ATP6V0A1;FRS2;MET;NCBP1;NAMPT;POLR2E;MAPKAPK2;ATP6V0B;SHOC2;GAB1;LMTK2;NCK1;RASA1;AP2B1;RASGRP4;ARPC2;PDGFD;FLT1;SYK;BCAR3;LYN;STMN1;FYN;AP3S1;BLNK;FGF1;PSEN1;HCK;PIK3CA;RET;ARPC5;PDGFC;LCP2;LCK;GRB2;GHR;FOXO1;MAPKAPK3;IGF2;SORBS1;CYBA;CBL;FRK;ATP6V1A;KDR;APH1B;POLR2B;ARHGEF28;POLR2H;EGFR;SHC1;POLR2J;TRIM71;PTK2B;ELMO2;EPHA2;GFRA2;BCAR1;AAMP;EPHB4;NUS1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3277935755168156,1.0945323133105218,0.3114241001564945,0.9457642261802023,1.0,9/41,9.35%,TNNI3;TNNC1;SOX4;MYBPC3;MEF2C;TGFBR3;BMP4;HEY1;TGFB1
prerank,regulation of pH (GO:0006885),0.44999471307483674,1.0945241335629827,0.36589698046181174,0.9443305532544609,1.0,4/11,23.15%,LACC1;SLC26A4;ATP1A4;SLC9A1
prerank,protein localization to condensed chromosome (GO:1903083),-0.4196607601077106,-1.0944738616167782,0.33980582524271846,0.6582771586939576,1.0,5/12,14.14%,BUB3;MIS12;ZWILCH;CDK1;SPDL1
prerank,membrane depolarization (GO:0051899),0.3484509970965155,1.0944016717100848,0.3328050713153724,0.943363872486178,1.0,17/32,32.39%,CACNB4;CACNG2;KCNH2;CACNA1G;CACNA1B;SCN2A;CACNA1A;SCN1B;SCN3B;SCN8A;SCN7A;CACNA1H;SCN1A;ATP5IF1;CACNA1I;P2RX7;CACNA1E
prerank,cellular response to peptide (GO:1901653),-0.27621795132089993,-1.0943558939385103,0.28169014084507044,0.6578727200440629,1.0,14/56,16.40%,ITGA4;FCGR2B;PTPN22;IGF1;CD36;NOD2;CAV1;FYN;PSEN1;VIM;LRP1;AGER;GJA1;TLR4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.3309242596680452,-1.0942514958843406,0.33002481389578164,0.6573956224571187,1.0,6/27,8.08%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B
prerank,positive regulation of cell communication (GO:0010647),0.35872150670857217,1.0941865865961553,0.3137254901960784,0.942744409757938,1.0,7/28,11.22%,CD80;SYT1;LGI1;GRIK2;CLSTN2;RIMS1;KCTD13
prerank,protein homotetramerization (GO:0051289),0.31489445995443177,1.0940779521606916,0.29742033383915023,0.9417024728259561,1.0,13/49,22.82%,HCN1;TRPM2;ALDH9A1;CBR4;PKD2;ACOT13;HPRT1;ACACB;TK1;HSD17B10;ALDOA;SSBP1;RYR3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.43517338108078957,1.0940397071376218,0.342512908777969,0.9403914496330276,1.0,4/12,14.93%,MYCBP2;NFIB;EPHA4;EPHB2
prerank,cellular glucan metabolic process (GO:0006073),-0.4380504611030014,-1.0938802698529948,0.31742243436754175,0.6576575098833247,1.0,5/11,25.78%,PHKB;PRKAG2;PPP1R3C;GBE1;PHKA1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4610977849601565,1.0934782257053526,0.3506944444444444,0.9410901720902622,1.0,2/10,2.39%,NOS1AP;CACNB2
prerank,regulation of neurogenesis (GO:0050767),-0.2752717505006169,-1.09312457304667,0.26875,0.6589097484276322,1.0,21/55,24.07%,PCM1;HMGB2;DOCK7;SOX11;YAP1;IL1B;SNW1;CTNNB1;SPEN;NOTCH1;LIG4;B2M;TNF;HEY2;PER2;HES1;APPL2;BHLHE40;HEYL;PAX6;HOOK3
prerank,regulation of RNA splicing (GO:0043484),0.2983365536003054,1.092862789992823,0.31053351573187415,0.9420314276373092,1.0,29/69,25.49%,PQBP1;FUS;FAM50A;TRA2B;HNRNPH1;CWC22;SLC38A2;PTBP1;SNRNP70;SON;YTHDC1;METTL16;KHDRBS2;METTL4;QKI;SETX;RRP1B;SRRM4;RBM20;TIA1;RBM38;CLK3;FASTK;RBM39;TMBIM6;ESRP1;SRSF3;HNRNPH3;SF1
prerank,amino acid transmembrane transport (GO:0003333),-0.289881611356215,-1.092696847334477,0.2988165680473373,0.6593144675361714,1.0,10/45,17.50%,SLC38A6;LRRC8D;SLC7A1;SLC6A6;SLC7A11;SFXN3;SLC7A6;SLC38A11;SLC3A2;SLC25A22
prerank,protein acetylation (GO:0006473),-0.32146900517614746,-1.0922094711743717,0.2755681818181818,0.6598891713592023,1.0,12/30,26.14%,NAA10;NAA16;EP300;HAT1;FOXO1;KAT5;DSCC1;NAT10;ESCO2;KAT2B;NAA40;NAT9
prerank,regulation of cell migration (GO:0030334),0.2422379634504489,1.0920449317061287,0.2303370786516854,0.9437051551567002,1.0,86/382,17.88%,FGF10;ABI3;FRMD5;SEMA7A;F3;FGF16;SRGAP3;SRGAP2;PLXNB2;FGF9;LDB2;LDB1;STK26;LDLRAD4;CTNNA2;PAK1;ELP5;PARD6B;LRRC15;ROBO4;VSIR;SLURP1;ARSB;THY1;NUMB;SEMA6C;BEX4;PTPRT;DNAI3;PTPRU;FGF7;NTRK3;NAV3;MAPK15;TRIP6;SEMA6B;ADRA2A;CCR1;MAZ;TGFBR1;SEMA3D;SRCIN1;ENPP2;PRKCA;EPHA1;ERBB4;MAP4K4;SST;IGSF10;TGFB1;MYO1C;SNAI2;ADAM15;CAMSAP3;FGF2;MINK1;SFRP1;DOCK10;SCAI;SEMA4F;PDGFB;HACE1;EPHA4;FLCN;RFFL;KIF2A;CBLL1;INSR;EPHB2;RCC2;SERPINE2;ADORA3;MIA3;SEMA4B;KIF14;HRAS;SEMA3C;PTK2;ITGA6;ANGPTL3;ROCK1;ENG;ULK4;NTNG2;NTNG1;XBP1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.47163227590216084,1.0918025768785724,0.37185929648241206,0.9431746337209275,1.0,4/10,13.31%,ADTRP;CST3;TGFB1;CHADL
prerank,artery morphogenesis (GO:0048844),0.3486916574921945,1.0916678674834124,0.3317901234567901,0.942232534733646,1.0,10/30,19.42%,LRP2;TGFBR1;BMP4;PKD2;TBX2;GJA5;ANGPTL3;ENG;HPGD;PDGFRB
prerank,regulation of gluconeogenesis (GO:0006111),0.3520275027228801,1.0916642066633118,0.342668863261944,0.940802111500158,1.0,4/27,8.76%,SELENOS;PPARGC1A;DGKQ;OGT
prerank,phosphate ion transmembrane transport (GO:0035435),0.440705939928765,1.0914327053596378,0.3460837887067395,0.9402289539022953,1.0,6/12,25.31%,SLC37A4;SLC20A1;SLC37A1;SLC25A10;XPR1;SLC37A3
prerank,positive regulation of cell death (GO:0010942),-0.27271148383737853,-1.0913389234762314,0.2980769230769231,0.6614075328596742,1.0,15/59,15.43%,FCGR2B;CELF1;CD36;SLC6A6;TYROBP;RIPK1;PICALM;FYN;ZC3H12A;EIF2S1;LRRK2;LRP1;FOS;TNF;WNT5A
prerank,nucleotide metabolic process (GO:0009117),0.3687123811687485,1.0912466687208786,0.3338842975206612,0.9394874786540716,1.0,8/23,23.34%,FHIT;REXO2;PNP;DCK;NMNAT2;AK5;AK1;AK4
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.34291756248705907,-1.091238265135635,0.3177083333333333,0.6609342522157107,1.0,12/23,24.25%,CDK5RAP2;CENPA;MAD2L1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1;NDE1;PKHD1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4380174987782021,1.090950670636138,0.3447098976109215,0.9391336622548524,1.0,4/13,12.84%,RAB3A;GRIK2;SYNGR1;SLC4A10
prerank,cell junction organization (GO:0034330),0.2943874652686142,1.0908817047340977,0.31187410586552217,0.9379704349831339,1.0,22/71,23.04%,AGRN;SH3BP1;CBLN2;MARVELD2;PPFIBP1;PRKCI;SDK1;TGFB1;CTNND2;PPFIA4;SLC6A1;SLC8A3;CXADR;SNCB;CHRNA7;PIN1;ACTB;CDC42;GRHL2;VMP1;OPHN1;LIMS2
prerank,lipid transport (GO:0006869),-0.245519140438395,-1.0905399068414785,0.2482758620689655,0.662072449896742,1.0,17/97,9.43%,OSBPL8;APOE;NPC2;OSBP;CD36;ABCA6;SLC27A4;PPARD;PLEKHA3;NCOA1;PLTP;CLN8;LDLR;PCTP;OSBPL2;ABCG4;ABCG1
prerank,nucleotide-excision repair (GO:0006289),0.2779190605430597,1.090351483890553,0.3080168776371308,0.938586554157258,1.0,31/101,24.41%,POLR2L;CDK7;POLR2F;COPS8;XAB2;GTF2H2;ISY1;POLD3;GTF2H4;COMMD1;OGG1;XRCC1;LIG3;COPS3;FAN1;POLR2G;PARP1;DDB2;COPS6;ERCC6;BRIP1;HUS1;COPS5;POLR2C;GTF2H3;POLA1;RFC4;POLR2D;ERCC2;ERCC4;USP7
prerank,B cell activation involved in immune response (GO:0002312),-0.38622572210167827,-1.0900781241367767,0.34146341463414637,0.662594433286476,1.0,3/13,11.56%,FCGR2B;GPR183;LIG4
prerank,chordate embryonic development (GO:0043009),-0.2771476501056252,-1.0889942331112266,0.2804878048780488,0.664800996362899,1.0,19/55,22.22%,XYLT1;MBNL1;PROX1;FUT8;BRCA1;BMP5;HINFP;LIG4;IGF2;BMP2;TRIM71;WNT5A;DEAF1;EGFL8;GATA3;BMP7;ALDH1A2;PTCH1;ISL1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.3895587540116897,-1.0888208424018009,0.33753148614609574,0.664515502757008,1.0,5/15,13.37%,RIC1;NOTCH1;EFEMP2;LRP1;RB1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.27222491664036086,-1.0885655889338097,0.3076923076923077,0.664451679650381,1.0,18/58,17.30%,NSD2;HMGB2;PRPF19;NSMCE2;IFFO1;MDC1;NBN;BRCA1;UVRAG;CYREN;ABRAXAS1;PAXIP1;BARD1;LIG4;KAT5;NHEJ1;UIMC1;BRCC3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.28962521432309096,-1.0883311295089317,0.27793696275071633,0.6643320439920423,1.0,10/46,15.33%,TALDO1;STAT4;IL12RB2;PSME2;MSN;LMNB1;LCP1;HNRNPA2B1;AIP;RAP1B
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3032874173309663,-1.0882360204912824,0.3047091412742382,0.663854661736972,1.0,9/36,17.07%,NRP1;FBXW7;CCR2;TAF1;HIF1A;HDAC2;HDAC1;GREM1;ADAM17
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3280619481313256,1.0873773603797572,0.32961783439490444,0.9485038631759886,1.0,8/37,15.71%,IFT20;WDR19;IFT81;DYNC2I2;IFT27;IFT88;CLUAP1;DYNLRB1
prerank,sodium ion import across plasma membrane (GO:0098719),0.39619588209436435,1.087362828028993,0.32578397212543553,0.9471150371169117,1.0,5/17,14.20%,SLC12A2;SLC9A4;SLC8A1;SLC9A5;SLC6A1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3553637774244016,-1.0873127703709722,0.31343283582089554,0.6656009841201551,1.0,7/20,18.73%,MCUB;YME1L1;PARL;MICU3;STOML2;MICU1;SLC8B1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.389090792311819,-1.0869758818845952,0.3309002433090024,0.6657457526796912,1.0,5/16,13.02%,TRIM25;TRIM14;CAV1;TRIM62;TRIM5
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.3965843630143947,-1.0868402108773252,0.3182897862232779,0.6653707712605839,1.0,4/15,12.97%,APOE;PLTP;ABCG1;APOC1
prerank,regulation of cytokine production (GO:0001817),-0.2349025746414324,-1.0867773313187963,0.270042194092827,0.6648176483905999,1.0,18/126,8.04%,FCGR2B;IL15;CCDC88B;ALOX5;PTPRC;CD47;IFIH1;IRF7;ZBP1;TBK1;CCR2;MAPKAPK2;NPTN;PTGER4;LYN;ANXA1;SRGN;CLEC6A
prerank,regulation of urine volume (GO:0035809),-0.43788678053775737,-1.0866124454072028,0.34210526315789475,0.6645316472494843,1.0,4/10,19.00%,ADCY6;INPP5K;HAS2;TFAP2B
prerank,regulation of intracellular signal transduction (GO:1902531),-0.2054524001661468,-1.0864843462484295,0.1346153846153846,0.6640977133597767,1.0,92/420,17.20%,VAV3;ARHGAP15;ARHGEF3;FGD4;ITSN1;PPP2R5C;ARHGAP10;STK3;PTPN22;STARD8;CRK;RBBP8;AKAP12;RBBP7;RPL5;PJA2;PRKAB1;ARHGAP17;RRAGC;ARHGAP19;TTI1;TOPBP1;BCL3;ARHGEF18;TAF1;ARHGEF6;ARHGAP18;PHF20;ARAP1;RPF2;CD24;LYN;TAF12;ARHGAP30;GNA12;NBN;PLEKHG5;PRKAG2;FGD1;MOB3B;CLEC6A;BRCA1;IL1B;FGF1;RACGAP1;RMI1;ARHGAP24;TAOK3;ATRIP;PIDD1;ABR;GNA13;RHOJ;EP300;HIPK1;RHNO1;ARHGDIB;BARD1;ARHGAP39;RPA1;CDK1;HDAC2;BIRC2;RMI2;ARHGEF26;ARHGAP28;LRRK2;CEACAM1;EHMT1;KAT5;HDAC1;MYOC;ENTPD5;SPHK2;EGFR;AGER;TNF;PRKAB2;ARAP2;HSPB1;WNT5A;OPTN;BST1;ARHGEF5;TRAF1;PDE2A;CRNN;SQSTM1;NOP53;RPA2;HIPK2;AKAP5
prerank,neutral amino acid transport (GO:0015804),-0.3249846279212171,-1.0863481964163777,0.2928759894459103,0.6637082035144913,1.0,4/28,3.14%,SLC38A6;SLC1A5;SLC43A2;SLC6A6
prerank,regulation of protein catabolic process (GO:0042176),-0.2453147003264127,-1.0862649813035847,0.2563176895306859,0.6631997622395319,1.0,24/99,17.96%,ITCH;WWP1;VCP;STX5;EEF1A1;RAB7A;SMURF2;ATG7;HECW1;CTSA;MAD2L2;AGAP2;FOXO1;BARD1;WDR91;MAD2L1;EGFR;TNF;WNT5A;ODC1;TIPARP;DTL;FLNA;RILP
prerank,regulation of synapse organization (GO:0050807),0.3592456822437264,1.0861049220602554,0.3247588424437299,0.9504754106859947,1.0,9/26,18.86%,CTNNA2;MEF2C;CDKL5;IL1RAPL1;NEDD4;SLITRK4;EPHA4;ARHGAP22;ABHD17C
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.3527632846274814,-1.0856743771818838,0.3407960199004975,0.6641238114249075,1.0,8/19,22.77%,PRKCE;CD14;TNIP3;LBP;SCIMP;TLR4;NR1H4;TICAM2
prerank,positive regulation of cell junction assembly (GO:1901890),0.3119399367149779,1.0856521699753536,0.3215339233038348,0.9506941214846065,1.0,16/56,18.81%,PTPRD;SRPX2;THY1;IL1RAP;NRXN1;GRID2;MAP4K4;CLSTN2;IL1RAPL1;SFRP1;TEK;EPHB2;WNT7A;AGT;ROCK1;GHRL
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3448967569831725,1.0854669858696455,0.3187702265372168,0.9499970264287497,1.0,6/32,14.91%,CAPN3;THY1;PLCG1;PKD2;GSTO1;HAP1
prerank,response to peptide (GO:1901652),-0.307774365054456,-1.0854544759750224,0.29508196721311475,0.6639686249729528,1.0,11/33,15.38%,STAT5B;STAT4;STAT2;NOD2;FYN;ANXA1;EIF2B2;STAT1;AGER;EIF2B4;KAT7
prerank,neuron fate commitment (GO:0048663),-0.389257658997866,-1.0851114841393543,0.360381861575179,0.6641286781453193,1.0,8/14,30.86%,MYT1L;ID2;ISL1;SHH;PAX6;DLL4;EPOP;DLL1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.42199551184334183,1.084994337905911,0.34982935153583616,0.950366902927979,1.0,7/14,24.38%,SELENOS;PRKN;HERPUD1;TXNDC12;XBP1;CREB3;TMBIM6
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2948871824060709,1.0848770072193934,0.31213872832369943,0.9493362004563644,1.0,18/69,16.74%,NTRK1;SIX4;PPARGC1A;PLA2G3;MEF2C;LGMN;PRKCI;NRBP2;CX3CR1;PRKN;CLCF1;KDM2B;MAG;NDNF;SNX6;NTRK2;KIF14;PRKCG
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3635582580389899,1.0846474893176639,0.3549920760697306,0.9487534313237187,1.0,11/27,19.42%,P2RY12;TNFAIP8L3;TGFB1;FGF2;IRS1;PDGFB;TEK;PRKD1;PTK2;FLT3;PDGFRB
prerank,substantia nigra development (GO:0021762),0.33170158452525317,1.0845500166270323,0.30654761904761907,0.9477270705558563,1.0,5/37,6.86%,PLP1;YWHAE;FGF9;NDRG2;SYNGR3
prerank,atrial septum development (GO:0003283),0.42625143572028235,1.0845140440629644,0.3672787979966611,0.9464093126063118,1.0,5/13,21.45%,ZFPM1;DAND5;GJA5;ANK2;MDM4
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.34535266673675974,1.0845043654028328,0.35596026490066224,0.9450305578359576,1.0,10/33,15.48%,RELA;THY1;SLA2;PRNP;CD81;PRKD2;KCNN4;PVRIG;PTPN2;DGKZ
prerank,regulation of protein localization to cell periphery (GO:1904375),0.39276191470718147,1.0841670235513328,0.35584843492586493,0.9448845606869982,1.0,7/18,21.43%,MISP;AR;ZDHHC2;ABCA2;SPTBN1;ACTB;VTI1B
prerank,glycoprotein biosynthetic process (GO:0009101),0.28505948391965147,1.0841160082780341,0.2978723404255319,0.9436511335708109,1.0,19/79,19.53%,ST3GAL5;B3GNT9;FUT10;B3GNT6;B3GALT2;DDOST;ALG1;SERP2;CHST10;ST6GALNAC2;B3GALNT1;GAL3ST4;CSGALNACT1;ST3GAL6;ALG5;CANT1;ALG3;BMPR1B;ST3GAL3
prerank,calcium ion homeostasis (GO:0055074),0.2813735641588512,1.0840412597707763,0.3219645293315143,0.942538947065769,1.0,22/95,19.32%,ATP2A3;ATP13A4;ATP2A2;ATP1B1;SLC24A5;TNNI3;ATP13A5;CCR1;GRIN1;SLC8A1;RMDN3;ATP2C1;ATP2B3;SLC8A3;SLC24A3;DMPK;ANK2;CHRNA7;SLC24A4;CCL15;TRPV6;CCL5
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2478088321273943,-1.083847486201509,0.2872727272727273,0.6668480614336442,1.0,22/93,16.10%,FNIP2;GAS6;RAF1;CD44;CNOT9;BRAF;DOCK7;TBK1;NCK1;TFRC;BCAR3;CAV1;PDCD10;TXN;MAD2L2;SPRY2;RACK1;MTCP1;INPP5K;EGFR;TNF;PFN2
prerank,ketone body metabolic process (GO:1902224),0.45511385128157145,1.0838365258962899,0.3516295025728988,0.9419090004152277,1.0,3/10,14.64%,HMGCLL1;ACSS3;OXCT1
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.36002876859970795,-1.0838267046639838,0.3155339805825243,0.6661855843509303,1.0,7/19,20.05%,CHMP4B;PDCD6IP;CHMP1B;CCSAP;PLK1;HSPA1B;HNRNPU
prerank,cellular zinc ion homeostasis (GO:0006882),0.36332827070270807,1.0837858587839682,0.343801652892562,0.9406937122075028,1.0,11/26,18.07%,SLC39A4;SLC39A8;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.24623354783744986,-1.0834484295639033,0.26436781609195403,0.6664483112513386,1.0,34/112,21.53%,NR3C1;NRROS;PXN;SOX6;GCNT2;LIMS1;ARHGEF18;ADAM9;SMAD3;CRKL;SMAD9;ZMIZ1;WWOX;UBC;UBA52;USP9X;ID1;SMAD6;CBL;NLK;FOS;WNT5A;PDE2A;PARD6A;MAPK7;SMAD4;COL3A1;ACVR1;APPL2;USP15;CGN;BAMBI;USP9Y;ZMIZ2
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.3608979278910063,-1.0833683855579412,0.33495145631067963,0.6659422480271303,1.0,3/18,5.98%,ABL2;ATP7A;NOD2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.3746049851494619,1.08323372971361,0.3434343434343434,0.941424811627297,1.0,7/20,16.54%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,cognition (GO:0050890),-0.2943216386261865,-1.082954721932364,0.3157894736842105,0.6662863043068722,1.0,14/42,22.59%,MAGT1;C5AR1;SLC8A2;SHROOM4;CBR3;CUX2;TNF;DGCR2;MFSD2A;CHRNB2;DOP1B;CHRNA4;SOBP;APP
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3465726667234111,-1.0827325510666308,0.32160804020100503,0.6661670151889614,1.0,10/21,19.39%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;PLK1;TRIP13;ZWINT
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.31974876015408976,-1.0827083717752226,0.32904884318766064,0.6655059119312804,1.0,6/29,8.06%,UBA5;CNOT9;KANK2;ESR1;YAP1;BRCA1
prerank,positive regulation of viral transcription (GO:0050434),0.35766804725335605,1.0826432939847495,0.32432432432432434,0.942264759620732,1.0,5/25,6.89%,POLR2L;POLR2F;NELFB;NELFCD;GTF2F1
prerank,long-chain fatty acid transport (GO:0015909),-0.3202958603399609,-1.0820184890536582,0.34540389972144847,0.6666260426178184,1.0,10/30,16.26%,APOE;PPARG;CD36;FABP4;SLC27A4;PRKAG2;MID1IP1;PRKAB2;MFSD2A;ACACA
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3967715470276202,-1.0819353638507074,0.34834123222748814,0.6661328732945476,1.0,5/13,19.18%,IGF1;IGF2;SORBS1;PPP1R3E;IRS2
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.39958306539056504,-1.0818863384777844,0.3310344827586207,0.6655669581580405,1.0,4/13,12.05%,TOX;TESPA1;ADAM8;FOXJ1
prerank,extracellular transport (GO:0006858),0.4230621230145698,1.0816706116387222,0.3481848184818482,0.9445993250685097,1.0,5/13,15.29%,ROPN1L;SPA17;SPEF2;ARRDC1;DNAAF2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3573050698084101,1.0814669387286662,0.3411371237458194,0.9439302095287933,1.0,5/26,8.96%,SMOC2;LGMN;RPS6KB1;PRKCA;CCDC57
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3166315511450044,-1.0809344800464271,0.30446927374301674,0.6676080078461787,1.0,11/31,24.91%,TLR2;IL16;HSPD1;SYK;LTB;AGER;SCIMP;TLR4;ISL1;MAPK11;TLR9
prerank,positive regulation of gene expression (GO:0010628),-0.20330124399433935,-1.080830194463132,0.1326530612244898,0.6671742989103843,1.0,128/442,22.59%,PID1;RBPJ;IL15;CD74;HNRNPLL;GAS6;PTPN22;STAP1;ITGAX;IGF1;CCDC88B;CELF1;ADAM19;MITF;MED26;UPF3A;NIBAN1;TLR2;RPL5;BAZ1B;FAM98B;AFDN;BRAF;CD36;PRKAB1;FAM98A;POLR2E;ZPR1;SOX11;LAMTOR5;PTGER4;VPS35;TYROBP;BCL3;LIMS1;SAMD4A;ERN1;MSN;THBS1;RPS7;PF4;SMAD3;SP1;DYRK1A;RIPK1;TFRC;PDCD10;YAP1;DNMT1;HIF1A;CLEC6A;BRCA1;IL1B;FGF1;PSEN1;DEK;HINFP;LARP6;ZC3H12A;KRAS;VIM;CTCF;EP300;CD28;SPRY2;NOTCH1;C1QTNF3;PIWIL2;CUX2;PLD1;SLC11A1;AGO2;SCX;BMP2;SPHK2;NPM1;POLR2H;TESC;RIMS2;TERF2;ZCCHC4;EGFR;LILRB1;DDX21;TNF;RAMP2;GJA1;WNT5A;LARP4B;PDE2A;FXR2;TLR4;UPF3B;MAPK8;GSN;RGCC;HEY2;HMGA2;HNRNPD;AGPAT2;FN1;NWD1;MMP8;TENT4B;PPM1F;NAT10;RPL26;MYD88;TENT4A;HSPA1B;BMP7;DTNBP1;RPL11;KLF4;WARS1;PIK3CD;POU3F1;POLR1B;CDH3;CPEB3;ID2;HMGN5;CD3E;FGF18;EIF3E;TWIST1;KAT2B;APP
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3350181728095372,-1.0805327444895627,0.34584450402144773,0.6672639039502306,1.0,5/24,6.28%,DAB2;PID1;BCL2L1;PPP2R5A;PICALM
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.43877175419208136,-1.0805170399130284,0.35667396061269147,0.6658714327706244,1.0,5/10,25.48%,AP2A2;AP2B1;CLTA;AP2A1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.43877175419208136,-1.0805170399130284,0.35667396061269147,0.6658714327706244,1.0,5/10,25.48%,AP2A2;AP2B1;CLTA;AP2A1;VLDLR
prerank,tRNA modification (GO:0006400),0.30504511469922224,1.0797072654204651,0.3522388059701492,0.9490430015210803,1.0,11/62,10.21%,TYW5;ADAT2;ELP5;CTU1;METTL2A;METTL2B;TRMT44;METTL1;TRMT61B;DTWD2;FTSJ1
prerank,mitochondrial translational termination (GO:0070126),0.28273329944892234,1.0796092049734185,0.3324022346368715,0.9480114971030487,1.0,29/88,26.26%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.3238833558924965,-1.0795669940640802,0.3467741935483871,0.6677603745172559,1.0,10/27,20.61%,LIMD1;PUM2;RIPK1;EIF4ENIF1;DDX6;AJUBA;AGO2;EGFR;WTIP;PUM1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.42112863698190356,1.0795303483418288,0.34904013961605584,0.9468844305449378,1.0,6/14,16.22%,PELI3;CCDC3;RFFL;TRAIP;PTPN2;CARD16
prerank,membrane assembly (GO:0071709),-0.31202399962619054,-1.0794423671974716,0.29775280898876405,0.6674328579611795,1.0,9/34,14.84%,RFTN1;FLOT2;CHMP4B;GAK;PICALM;NRXN2;S100A10;EMP2;UBXN2B
prerank,cellular response to calcium ion (GO:0071277),0.29639696825858164,1.0794291952985813,0.3475699558173785,0.9458510262371206,1.0,12/67,8.99%,SYT4;ADCY8;CAPN3;NEUROD2;SYT13;SYT1;SYT6;TRPM2;MEF2C;LGMN;CPNE6;PKD2
prerank,regulation of lymphocyte migration (GO:2000401),0.45693921177082636,1.078464949444825,0.3688811188811189,0.9480325308184345,1.0,4/10,15.74%,ADTRP;JAM2;CCR6;MIA3
prerank,receptor clustering (GO:0043113),0.35493212913046146,1.0781280710501302,0.3523654159869494,0.9478539465891079,1.0,6/27,10.23%,AGRN;DLG2;SCRIB;THY1;NRXN1;ITGB1BP1
prerank,lipid catabolic process (GO:0016042),-0.36052654457631045,-1.0776196922914265,0.3120567375886525,0.6718407701037074,1.0,6/18,22.02%,PLAAT3;LPL;ACADL;HSD11B1;SIRT2;PLA1A
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.2515531676851657,-1.0770877934967191,0.2793103448275862,0.672519841536903,1.0,33/84,25.63%,SASH1;NRP1;NRP2;P2RX4;MET;PROX1;THBS1;SP1;HIF1A;FGF1;ZC3H12A;KDR;GPI;FOXP1;PTK2B;HSPB1;WNT5A;BCAR1;AAMP;NUS1;ADAM17;GATA3;ITGB3;BCAS3;PIK3CD;TMSB4X;FGF18;EGF;MAP2K3;ANXA3;ANGPT1;BMPR2;RAC1
prerank,regulation of cellular component size (GO:0032535),-0.30863655662051637,-1.07674494151954,0.3193717277486911,0.6728016742648695,1.0,13/30,25.63%,VAV3;EPS8;LAMTOR5;MSN;PICALM;NEB;HP1BP3;PPP1R15A;LARS1;LAMTOR4;MTPN;ATP13A2;RAC1
prerank,protein transport (GO:0015031),-0.20568907393470184,-1.0767277507296822,0.1935483870967742,0.6721302439076352,1.0,79/332,18.64%,ATP6V0D1;VIPAS39;CD74;STX6;ARL6IP5;APOE;RAB8B;RIC1;TBC1D1;KIF3A;VPS26A;GOLPH3L;ATP6V0D2;STEAP3;SNX8;PPARG;ATP6V1B2;CD36;ATP6V0A1;STX12;STX5;RAB1A;RAB7A;SNX1;RPGR;AP3B1;VPS35;ATP6V0B;AP3D1;LMTK2;DNAJC27;ARF3;RABGAP1;TBC1D2;TFRC;GGA2;SNX9;TXNIP;RAB6A;NDC1;CTSA;AP4M1;TMED9;LAMP2;RAB15;VPS45;ABCG1;RAB10;TMED10;HIKESHI;DNM2;VPS26B;TBC1D10C;RAB21;TBC1D10A;ATP6V1A;CHMP1B;ZDHHC17;LRP1;USP6NL;NPM1;RAMP2;CALCRL;OPTN;ADPRH;MYH9;NAPG;SEC23IP;USO1;RAB3GAP2;RAB31;MCOLN1;ARRDC4;GCC2;TBCK;RILP;STX19;ARHGEF2;TOM1
prerank,supramolecular fiber organization (GO:0097435),0.24264885713214646,1.0766812213570538,0.2930011862396204,0.9517478756128047,1.0,79/334,21.50%,TPPP;P3H2;STMN4;SH3BP1;LTBP3;LTBP2;PLOD3;STMN3;P4HA3;COL5A1;DST;GGA3;CAPN3;PPIB;LAMB3;CST3;COL2A1;LMOD1;STMN2;BFSP2;RHOBTB1;NCKAP5;TMOD2;BACE1;TSPAN15;RIPK3;TGFBR1;SERPINH1;MYO6;SAMD14;FSD1;CKAP5;PLK3;MYO1C;PRKN;PXDN;COL4A5;CAMSAP3;FGF13;MYO1H;CAMSAP1;COL28A1;PSENEN;NCKAP5L;DCTN1;ADAMTS14;COL4A2;CORO1A;LMOD3;EVL;HOOK2;KIF2A;TCHH;COL15A1;COL18A1;TUBGCP2;SIAH1;PPP1R9A;CLIP1;KIF14;PLOD1;ITGA6;RHOBTB2;HDGFL3;ARHGAP12;ADAMTS3;PIN1;HOOK1;P4HA2;COL4A4;INPPL1;ALDOA;CCDC13;CALB1;HSP90AB1;CDC42;TUBGCP6;LAMC2;COL6A1
prerank,regulation of dendrite development (GO:0050773),0.3319404941842607,1.0763991065265242,0.34838709677419355,0.9513824407144613,1.0,10/37,19.82%,CSMD3;DCC;DAB2IP;CDKL5;HECW2;NEDD4;NEDD4L;SARM1;NSMF;SDC2
prerank,embryonic limb morphogenesis (GO:0030326),-0.3063872234780622,-1.0762021678843046,0.32590529247910865,0.6729234166912794,1.0,11/34,22.48%,MBNL1;FBXW4;WDPCP;CTNNB1;HDAC2;HDAC1;LRP6;MAP3K20;PTCH1;SHH;TWIST1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23350039673999623,-1.0760393067277545,0.25,0.6726055892299484,1.0,25/144,9.47%,BCL2;GAS6;UBE2D3;PCM1;ATG13;FBXW7;ZPR1;TOMM7;SH3GLB1;PPP3R1;SEC16A;TMEM30A;SMAD3;ARIH2;KIF20B;PDCD10;FYN;ANP32B;CIB1;YWHAG;IL1B;PSEN1;TM9SF4;UBE2L3;ZC3H12A
prerank,DNA conformation change (GO:0071103),0.39327353997479075,1.0755772452162846,0.3624161073825503,0.9530866432182767,1.0,5/17,15.28%,TOP3A;HHEX;TOP1MT;HMGB1;HMGB3
prerank,regulation of chromosome organization (GO:0033044),-0.33917696008691367,-1.0754852089636309,0.335978835978836,0.6734314656114043,1.0,9/22,18.11%,LIG4;RMI2;BUB1;YLPM1;RB1;CDT1;TERF2;HNRNPD;SMG6
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4171631192912129,1.0753166990134069,0.3649122807017544,0.9526962106342072,1.0,6/13,24.16%,NCKAP1L;PNP;NKAP;ZBTB7B;GLI3;RUNX1
prerank,RNA splicing (GO:0008380),0.2795421593254238,1.0750360546619235,0.33959537572254334,0.952334430612619,1.0,21/95,15.47%,RNPS1;IVNS1ABP;SMU1;FUS;DHX15;TRA2B;BCAS2;PPARGC1A;SF3B2;LSM1;PTBP1;SRSF11;PPIG;SNRPD2;MPHOSPH10;SF3B3;NOVA1;RP9;DDX39B;DDX47;CCAR2
prerank,carbohydrate catabolic process (GO:0016052),0.32624587962552787,1.074634799272741,0.34822804314329736,0.9524430828824662,1.0,14/38,24.43%,GAPDH;PGAM2;NEU1;NAGA;ALDOC;MAN2B2;PFKM;HK2;PFKFB2;PGM1;ALDOA;ENO3;MANBA;PKM
prerank,regulation of trophoblast cell migration (GO:1901163),-0.3909103464926321,-1.0744967968626467,0.3654320987654321,0.6752971566980172,1.0,7/14,29.70%,SMURF2;ARHGDIB;AGO2;GJA1;TIMP1;C1QBP;SYDE1
prerank,regulation of cytoskeleton organization (GO:0051493),0.27594230885496757,1.0744120746370205,0.3154929577464789,0.9518918111548578,1.0,30/108,20.54%,TPPP;SH3BP1;STMN3;MAP6;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TWF2;CAMSAP3;GRHL3;BICD2;ARHGAP35;CORO1A;MAPK3;PHLDB2;PTK2;RHOQ;CDK10;ROCK1;TAOK1;RHOBTB2;BICD1;PLXNB1;PDGFRB;CYLD;EPHA5;IQGAP3
prerank,cellular protein localization (GO:0034613),-0.20805920669025393,-1.0742369822766162,0.18309859154929578,0.6752883617838215,1.0,75/285,19.28%,ITSN1;VIPAS39;CD74;STX6;RIC1;TBC1D1;VPS26A;SNX8;PRPF19;ATG13;STX12;RRAGC;STX5;TM9SF3;RAB1A;SNX1;RPGR;AP3B1;VPS35;SH3PXD2B;AP3D1;CEP250;DNAJC27;ARF3;RABGAP1;TBC1D2;GGA2;SNX9;TM9SF2;CPE;TM9SF1;RAB6A;CTSA;AP4M1;TMED9;TM9SF4;VPS45;TMED10;CTNNB1;VPS26B;ID1;FOXJ1;TBC1D10C;LRRK2;RRAGA;RAB21;TBC1D10A;EMP2;REEP1;CEP68;USP6NL;NPM1;VCL;EGFR;GJA1;WNT5A;ADPRH;RTP4;ATG9B;NAPG;SEC23IP;USO1;RAB3GAP2;HEY2;RAB31;FLNA;TBCK;STX19;ARHGEF2;RAP2A;USP4;TBC1D22A;FBLN5;HPS6;NAPA
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.29909111990991094,-1.0741706638305404,0.31976744186046513,0.6747548319774579,1.0,9/34,16.64%,CD300A;RAB7B;CD300LF;CD14;GRAMD4;LYN;ACOD1;TLR4;GPR108
prerank,actin filament organization (GO:0007015),-0.23131305008898995,-1.0738105575064263,0.27802690582959644,0.6750594116973192,1.0,33/151,18.89%,NEDD9;MYO5A;SVIL;HIP1;EPS8;CASS4;ACTN1;ARHGAP17;CORO1C;TMOD1;CGNL1;MYO1F;PROX1;HIP1R;MYO15A;CARMIL1;SHROOM4;GAS2L3;LCP1;MAD2L2;NEB;COBL;EMP2;VILL;CORO7;ELMO2;PLS1;BCAR1;GSN;CARMIL2;FLNA;ARHGEF2;TPM4
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.32152819289046286,-1.073513478644419,0.3236842105263158,0.675134795102352,1.0,9/26,23.83%,CBLB;FBXW7;SOCS5;CBL;SHC1;ADAM17;TGFA;APP;EGF
prerank,cell part morphogenesis (GO:0032990),-0.39179981260151053,-1.0734819798936717,0.3640661938534279,0.674504864275645,1.0,4/13,15.01%,PID1;MTM1;PACSIN2;WASF1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.3979765002437448,-1.0732847690897591,0.3810623556581986,0.674248679234389,1.0,4/12,15.38%,NBN;TICRR;CDT1;KAT7
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3999421998390854,1.0731355165972403,0.37608318890814557,0.955378525144022,1.0,3/17,4.82%,CTR9;CPSF6;ZC3H14
prerank,regulation of actin filament polymerization (GO:0030833),0.2914154793862818,1.0730034458966287,0.34950071326676174,0.9544359084813073,1.0,19/69,21.56%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;FCHSD2;TWF2;EVL;ARFGEF1;TWF1;SSH1;PLEKHG2;SSH2;SSH3;CDC42EP4;CDC42EP1;LATS1
prerank,mRNA destabilization (GO:0061157),-0.2963023289751022,-1.0728011389863568,0.335149863760218,0.6749288508651023,1.0,12/38,25.85%,DIS3L2;CELF1;ZC3H12D;ZC3H12A;RC3H1;TRIM71;RC3H2;MEX3D;PUM1;CPEB3;RIDA;GIGYF2
prerank,cellular response to metal ion (GO:0071248),0.2684783939643637,1.072704894142757,0.324,0.9541277244846054,1.0,48/123,28.39%,SYT4;ADCY8;DLG2;CAPN3;NEUROD2;SYT13;SYT1;SYT6;PRNP;SLC12A2;TRPM2;MEF2C;LGMN;CPNE6;PKD2;PRKN;GLRA2;CRHBP;AOC1;MAPK3;HPCA;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;ALOX5AP;RYR3;GPLD1;CPNE5;MEF2A;SYT11;SYT12;ANK3;MAPK1;HFE;PLCG2;DLG4;ADD1;PRKAA2;DMTN;CACNA1H;KCNH1;SUMO1
prerank,mRNA metabolic process (GO:0016071),0.28408248075552534,1.0726850887657813,0.3425414364640884,0.9528361596100625,1.0,20/90,14.29%,NUDT12;SRSF5;DHX15;DDX5;PPARGC1A;CPSF6;SF3B2;PTBP1;SRSF11;AKAP8L;PRMT9;ZFP36L2;SON;SF3A1;SRSF1;CPSF3;METTL16;TBRG4;NUDT21;AGO4
prerank,UV-damage excision repair (GO:0070914),0.4262904956204946,1.0726789209608476,0.38003502626970226,0.9514881653716499,1.0,4/12,23.37%,POLD3;DDB2;POLA1;ACTR5
prerank,regulation of protein kinase activity (GO:0045859),-0.2419491638262225,-1.0723562447805868,0.25,0.6753612757049761,1.0,36/106,21.49%,IQGAP1;GAS6;PTPRC;C5AR1;SNX9;PRKAG2;YWHAG;UVRAG;SMCR8;TAB1;LCP2;AGAP2;CCN1;CEACAM1;RB1;INPP5K;QARS1;DEPTOR;PRKRIP1;TNF;PTK2B;HSPB1;RAP1A;CHP1;PYDC1;ECT2;LRP6;TRAF4;PPM1F;TAF7;DBNDD1;DTNBP1;PLCE1;WARS1;GSKIP;DUSP19
prerank,response to amino acid starvation (GO:1990928),-0.2516276475224427,-1.071999721075682,0.3217993079584775,0.6755899045160555,1.0,14/72,13.47%,ATP6V0D1;ATP6V0D2;ATP6V1B2;RRAGC;LAMTOR5;SH3GLB1;ATP6V0B;FAS;CEBPB;EIF2S1;SZT2;RRAGA;ATP6V1A;LARP1
prerank,ncRNA metabolic process (GO:0034660),0.32313309580244864,1.071075806146178,0.3648854961832061,0.9560553434462546,1.0,7/37,17.31%,NIFK;DTD1;MEPCE;EXD1;DROSHA;TDRKH;DTD2
prerank,regulation of TOR signaling (GO:0032006),0.29456790604370997,1.0708831760197197,0.3473227206946454,0.9553878638962858,1.0,18/67,18.76%,TSC2;RPTOR;SLC38A9;MINAR1;DGKQ;ITFG2;DDIT4;PDCD6;EPM2A;FLCN;RFFL;WDR59;SH3BP4;HTR6;WDR24;MAPKAPK5;FBXO9;HDAC3
prerank,regulation of cell differentiation (GO:0045595),-0.22669088135630208,-1.0707041711088077,0.27488151658767773,0.6783348960926536,1.0,41/148,22.33%,TRPS1;PHLDB1;MOSMO;FLOT2;ALOX5;RAF1;CDK6;CDK5RAP2;RUNX3;SLC6A6;PRKACA;PURB;VHL;CEBPB;CD24;ST7;ANP32B;YWHAG;DAG1;BIRC2;IGF2;UQCC2;NSUN2;EMP2;GREM1;SMOC1;SIK1;NOTCH4;TNF;KLHL41;HEY2;PTHLH;GATA3;TFAP2B;PA2G4;KLF4;CDK9;ID2;SERPINF2;ISL1;SHH
prerank,positive regulation of cell migration (GO:0030335),-0.21511448734981395,-1.0706992817029901,0.24705882352941178,0.6776309103976199,1.0,75/253,22.36%,DAB2;NEDD9;NRP1;PLAU;ITGAX;IGF1;CASS4;PRKCE;GCNT2;PTPRC;SDCBP;CCR2;SMURF2;CXCL16;GAB1;ADAM9;THBS1;CRKL;PDGFD;FLT1;KIF20B;CAV1;PDCD10;CARMIL1;GLIPR2;CIB1;HIF1A;IL1B;FGF1;SEMA6D;RET;MAPRE1;PDGFC;SPRY2;ELP6;NOTCH1;MIEN1;SEMA6A;CCN1;PPP3CA;F7;SHTN1;SEMA3B;SEMA5B;AGO2;FAM83H;KDR;MYOC;RACK1;BMP2;HAS2;FAM89B;EGFR;PTK2B;BCAR1;ADAM17;SEMA4A;CLDN1;CARMIL2;FN1;ARHGEF2;PDGFRA;MYADM;PPM1F;MYLK;F10;ACVR1;SYNE2;DOCK1;PIK3CD;CXCL12;RREB1;SEMA4D;SEMA4G;CCAR1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.319827594567872,-1.0705991817196379,0.3566084788029925,0.6771880230549199,1.0,6/28,8.08%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3554550596425604,1.0700993523179732,0.34782608695652173,0.956832099513235,1.0,5/26,12.55%,YWHAE;CBARP;ADRA2A;PKD2;GSTO1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.37625162252487065,1.0695769719895865,0.36981757877280264,0.9573739673094012,1.0,3/21,2.74%,GUCY2F;ADCY8;GUCY2C
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.34791597283638687,1.0689108262784148,0.3259493670886076,0.9584754384724905,1.0,10/29,17.85%,SHANK3;TWF2;PRKN;CORO1A;ARFGEF1;TWF1;SSH1;SSH2;SSH3;SHANK1
prerank,regulation of hemopoiesis (GO:1903706),-0.43369802645305405,-1.0688907895712947,0.36199095022624433,0.6809987531055611,1.0,3/10,13.42%,PURB;MYSM1;PTN
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.24043883018592901,-1.0687096960291622,0.31800766283524906,0.6807679626591974,1.0,23/108,15.14%,ARL6IP5;HIP1;VCP;XDH;PPARG;BAX;NLRC4;GRAMD4;HIP1R;UACA;SMAD3;FAS;HSPD1;SYK;RIPK1;ANP32B;PIDD1;LCK;DAPK1;SENP1;RACK1;PMAIP1;TNF
prerank,lipid homeostasis (GO:0055088),0.30399825952191034,1.0682689194292108,0.3333333333333333,0.959503999860477,1.0,17/57,18.16%,TLCD3A;DGAT2;USF2;TLCD3B;PNPLA3;ABCB4;ORMDL2;TLCD2;USF1;ACOX1;ABCA2;ABHD5;FITM2;ANGPTL3;FABP3;XBP1;ABHD8
prerank,positive regulation of GTPase activity (GO:0043547),0.2532407707913892,1.0682000539541905,0.325,0.9584015284225984,1.0,48/188,20.58%,AGRN;SH3BP1;SRGAP2;F11R;SGSM2;SCRIB;NTRK1;SGSM3;THY1;SIPA1;PKP4;NTRK3;MAPRE2;RAPGEF3;ADCYAP1;EPHA1;CDKL5;MAP4K4;RGS10;RASGRF1;RAP1GAP;TBC1D16;SFRP1;DOCK10;RAP1GDS1;TBC1D8;DOCK9;RALBP1;FLCN;SYDE2;APC2;RSU1;TBC1D25;HRAS;ITGA6;ARHGAP22;ALS2;ZC3H15;ASAP3;PIN1;CCL15;PLXNB1;CCL5;CAV2;SIPA1L2;GMIP;ARHGAP45;GARNL3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.33888719494980285,1.0679674653012794,0.3705501618122977,0.957915931580179,1.0,13/31,21.39%,YWHAE;E2F1;ZNF205;BAK1;PPP3CC;PPP1R13B;CHCHD10;BBC3;YWHAQ;NMT1;CASP8;YWHAB;TFDP2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.33049851563274546,-1.0677407671995274,0.3215962441314554,0.6827696396307575,1.0,7/23,13.27%,PARP14;PPARG;NR1H2;STAT1;NLRC5;PARP9;NR1H3
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.22553007232743347,-1.0674500155055564,0.25396825396825395,0.6828502857218861,1.0,36/153,18.63%,CSNK1G1;GAS6;PRKCH;STK38;PRKCE;MARK2;PRKACA;CLSPN;TBK1;MKNK1;MAPKAPK2;LMTK2;ERN1;TAF1;RPS6KA6;DYRK1A;RIPK1;PRKCQ;CAMK2D;UHMK1;HIPK1;MAPKAPK3;CDK1;LRRK2;RPS6KA2;NLK;PRKX;PLK1;MAPK8;HIPK2;MAP4K1;CAMK1G;PKN3;SGK3;SGK2;MAPK12
prerank,DNA duplex unwinding (GO:0032508),-0.28319707637175295,-1.0674348774232525,0.3342696629213483,0.6821745321529739,1.0,11/50,12.46%,ASCC3;CUL4A;RTEL1;CHD1L;NBN;ANXA1;UBC;UBA52;RAD23B;RPA1;MCM2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.25592879433332966,-1.067067975413253,0.33444816053511706,0.6824979427305787,1.0,18/66,16.03%,SASH1;DVL3;NOD2;PDGFD;FLT1;PDCD10;CD24;FGF1;TAOK3;MAP3K11;PDGFC;ADAM8;LRRK2;PIK3R6;PIK3R5;EGFR;TNF;ARHGEF5
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.23283688015302617,-1.0666039681783401,0.2572463768115942,0.6830043576209638,1.0,27/113,16.99%,FNIP2;VCP;CUL4A;CD36;GNL3L;BAX;SH3GLB1;DHX33;ESR1;MTLN;SYK;TFRC;CHD1L;ASAP1;PSMC6;LCP1;RPA1;AJUBA;SKAP1;RACK1;CDT1;TNF;BCL2L11;ICE1;RAP1B;TLR4;RPA2
prerank,positive regulation of apoptotic process (GO:0043065),-0.20712897912140255,-1.0662537572942852,0.21428571428571427,0.6832650657680269,1.0,62/293,16.83%,VAV3;ARHGEF3;FGD4;ITSN1;STK3;ARL6IP5;STK17B;TNFAIP8;IFIT2;ZBP1;BAX;TOP2A;PTPA;NLRC4;ARHGEF18;ATG7;ARHGEF6;SLC27A4;HIP1R;FAS;HSPD1;RIPK1;PLEKHG5;UBC;FGD1;PSEN1;PIDD1;PNMA2;ABR;UBA52;GNA13;ZC3H12A;UTP11;MAP3K11;PTGIS;DNM2;CTNNB1;FOXO1;PRMT2;BARD1;BRMS1;STPG1;DAPK1;ARHGEF26;GADD45G;RPS6KA2;APH1B;RYBP;RACK1;BMP2;SPHK2;SIK1;PMAIP1;LILRB1;TNF;BCL2L11;SAP18;DDX20;ARHGEF5;KLF11;MAPK8;SQSTM1
prerank,embryonic organ morphogenesis (GO:0048562),0.32275229082121515,1.0658659107234993,0.35993975903614456,0.9642516114046928,1.0,13/42,26.03%,HOXD4;MEGF8;HOXB9;MFAP2;FBN2;RBPMS2;DSCAML1;MFAP5;HOXB3;RBP4;HOXC9;FBN1;FUZ
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.3925638888734439,-1.065706587767342,0.3462414578587699,0.6840452822324548,1.0,7/13,39.81%,IDH1;GOT1;PHYH;GPT2;TAT;GOT2;ADHFE1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.31406672621198306,1.0656351752987363,0.3603053435114504,0.9637691536285717,1.0,13/46,19.47%,TOMM40L;TIMM21;FIS1;FBXO7;TOMM34;PITRM1;TIMM13;TSPO;TIMM22;TOMM70;HK2;MFF;TIMM23
prerank,regulation of platelet activation (GO:0010543),-0.34054910073350037,-1.0652565855389131,0.3788659793814433,0.6846223162952718,1.0,8/21,18.71%,APOE;TEC;SYK;LYN;PRKCQ;FCER1G;TLR4;PDGFRA
prerank,negative regulation of secretion (GO:0051048),-0.4202366460984054,-1.0651247197738272,0.37303370786516854,0.6842367795448139,1.0,4/10,26.52%,CD74;NR1H3;EGF;SPX
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.39768505179713726,1.0647968191357042,0.39273356401384085,0.9655426243690457,1.0,3/15,16.82%,SIX4;BMP4;AGT
prerank,regulation of chemotaxis (GO:0050920),0.3478278163905176,1.0645804337985298,0.3625,0.964965990734837,1.0,8/30,15.05%,P2RY12;MYCBP2;RARRES2;TGFB1;STX3;CXCR4;PDGFB;PTPN2
prerank,negative regulation of cell adhesion (GO:0007162),0.28931508325126376,1.0644769746531384,0.36079545454545453,0.9639999516980724,1.0,18/72,16.65%,PLXNB2;ARHGDIG;CORO2B;PTPRO;SIPA1;DSCAM;PDE3B;SPINT2;ADAM22;ARHGDIA;TGFB1;SNAI2;ITGB1BP1;CBLL1;EPHB2;MIA3;JAM3;PTK2
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3626399423031964,-1.0644129379571186,0.35308056872037913,0.6854639967429075,1.0,7/17,20.05%,PTPRC;SOX11;N4BP2L2;KAT7;GJA1;HMGA2;HNRNPU
prerank,negative regulation of locomotion (GO:0040013),0.41691770462066224,1.064342854812375,0.37005163511187605,0.9631601280742802,1.0,5/12,18.62%,SPOCK3;FRMD5;SPINT2;PTPN2;PIN1
prerank,cellular response to hydroxyurea (GO:0072711),0.43978814496488555,1.0642728115628635,0.3707052441229656,0.9620316119773306,1.0,2/10,14.44%,TIMELESS;NSMCE3
prerank,ncRNA catabolic process (GO:0034661),-0.3182081952924387,-1.0639538686766103,0.34153005464480873,0.686057573497553,1.0,10/28,25.45%,DIS3L2;EXOSC8;EXOSC10;EXOSC9;RBM7;POP1;TRIR;TENT4B;EXOSC7;ERN2
prerank,cellular response to radiation (GO:0071478),-0.28973998031154147,-1.0637063274676664,0.34408602150537637,0.6860731943254235,1.0,21/40,35.07%,EEF1D;GRB2;RHNO1;LIG4;SWI5;GPR88;ECT2;OPN3;TRPM1;RRH;NET1;RAD51AP1;TNKS1BP1;GPR52;FIGNL1;CLOCK;SPIDR;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,positive regulation of epithelial cell migration (GO:0010634),0.2764095927642158,1.0632375369876077,0.3622377622377622,0.9644051871427941,1.0,18/92,10.78%,FGF10;INSL3;FLT4;SMOC2;FGF7;PLCG1;PIK3CG;CLASP2;MAPRE2;BMP4;ENPP2;PRKCA;PRKD2;MAP4K4;ITGB1BP1;IQSEC1;FGF2;PDCD6
prerank,protein kinase A signaling (GO:0010737),0.42548519196008533,1.0631692889944977,0.3954305799648506,0.9633080048700905,1.0,2/12,3.22%,MYOM1;TCP11
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.27168999541706584,-1.062986584412062,0.3652694610778443,0.6873596549252727,1.0,17/51,24.03%,CCT6A;GNL3L;PKIB;PRKCQ;EXOSC10;CTNNB1;CCT3;TERF2;MAP2K7;SMG6;TENT4B;NAT10;HNRNPC;HNRNPU;NAF1;TINF2;PIF1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.37242968543154586,-1.0629770812063584,0.3853658536585366,0.686667176380593,1.0,3/15,8.06%,CELF1;STOX2;BRCA1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3255188330061074,1.0628126942675653,0.3784219001610306,0.9633179330324892,1.0,11/35,16.54%,SH3BP1;SEMA7A;PLXNB2;SEMA6C;SEMA6B;SEMA3D;ARHGDIA;FARP2;SEMA4F;SEMA4B;SEMA3C
prerank,protein ADP-ribosylation (GO:0006471),-0.31416355804581236,-1.0623353568185347,0.34574468085106386,0.6877488551336703,1.0,8/28,22.65%,PARP4;PARP14;PARP9;TIPARP;ZC3HAV1;HPF1;SIRT2;PARP16
prerank,regulation of intracellular transport (GO:0032386),0.3224971199411773,1.0622693893130217,0.3674418604651163,0.9639332031449085,1.0,8/38,14.91%,DNAJC30;AAAS;ATP9A;PLA2G3;MYBPC3;INPP5F;WWC1;HAP1
prerank,negative regulation of blood coagulation (GO:0030195),0.3214428819002813,1.0622116620365796,0.3549382716049383,0.9627706908210358,1.0,8/38,15.41%,ADTRP;F3;PLAT;CD34;THBD;PDGFB;VTN;SERPINE2
prerank,hyaluronan metabolic process (GO:0030212),-0.33075910999935676,-1.0620533116179132,0.3491271820448878,0.6878175667166619,1.0,10/23,18.71%,LYVE1;CD44;IL1B;HMMR;CEMIP2;STAB2;HAS2;CHP1;HYAL3;HAS3
prerank,pigment granule transport (GO:0051904),-0.35168400375332287,-1.0620445832056506,0.3581395348837209,0.6864275380711377,1.0,2/18,5.65%,MYO5A;BBS7
prerank,melanosome transport (GO:0032402),-0.35168400375332287,-1.0620445832056506,0.3581395348837209,0.6864275380711377,1.0,2/18,5.65%,MYO5A;BBS7
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.34159591633566266,-1.0619959465198574,0.37105263157894736,0.6858672867127933,1.0,4/22,7.83%,IL15;RFTN1;NOD2;PRKCQ
prerank,nucleic acid-templated transcription (GO:0097659),0.31529355541951887,1.0610270971745452,0.37202380952380953,0.9658283526832512,1.0,9/42,13.50%,POLR2L;RNPS1;POLR2F;XAB2;E2F1;FUBP3;POLR2G;THAP1;PPP5C
prerank,response to interleukin-4 (GO:0070670),-0.432093442600422,-1.0610230337283812,0.38609112709832133,0.6878330471683163,1.0,7/10,36.28%,TCF7;SHPK;GATA3;LEF1;DCSTAMP;CITED1;RUFY4
prerank,negative regulation of hormone secretion (GO:0046888),-0.43903414610743385,-1.0608764655312837,0.3795620437956204,0.6875119856059505,1.0,4/10,15.39%,IL1B;RAB11FIP1;RAB11FIP5;GJA1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.30532451296917656,1.0608325087856034,0.3724340175953079,0.9652065706098176,1.0,17/49,25.30%,LDLRAD4;TMC8;PEX5;PRKCZ;CLU;PPM1A;ANKRD27;HMGB1;JAM3;KIF14;OPRD1;CDC42;ULK1;IMPACT;AIDA;CRYAB;DDX3X
prerank,regulation of epithelial cell proliferation (GO:0050678),0.2797357450035446,1.0608169863400179,0.36962750716332377,0.9639120276200698,1.0,19/85,16.50%,FGF10;MAGED1;FGF16;FGF9;SIX4;FGF7;SRSF6;TGFBR3;DAB2IP;NME1;BMP4;TCF7L2;TGFB1;FGF2;SFRP1;HPN;PRKD1;PEX2;HRAS
prerank,lamellipodium assembly (GO:0030032),0.34886372449523806,1.0607064181626091,0.35618729096989965,0.9629359286212754,1.0,4/26,8.02%,P2RY12;SRGAP2;PTPRO;ABLIM2
prerank,protein neddylation (GO:0045116),0.41346555563319964,1.0603437059603473,0.37261698440207974,0.9629758553303024,1.0,7/13,32.71%,UBE2M;DCUN1D2;UBA3;NAE1;RBX1;RNF7;NEDD8
prerank,tyrosine metabolic process (GO:0006570),0.4312562905103452,1.060236072712091,0.3843478260869565,0.9620136135013114,1.0,2/11,13.17%,IL4I1;DCT
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3501362931174623,-1.059962007719089,0.37965260545905705,0.6894524402241138,1.0,6/18,17.75%,ESR1;LCOR;KAT5;EGFR;FAM210B;NRIP1
prerank,establishment of spindle orientation (GO:0051294),-0.3124530002363343,-1.0598574490012402,0.35218508997429304,0.6890437254109009,1.0,13/28,24.25%,CDK5RAP2;CENPA;MAD2L1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1;MAP4;NDE1;PKHD1
prerank,amide transport (GO:0042886),-0.32563049237702596,-1.0592005030676954,0.3685636856368564,0.6901562890090548,1.0,12/26,29.21%,PLEKHA3;PLTP;SLC46A1;SLC14A2;AQP11;ABCA13;PDPN;CERT1;CPTP;GLTP;FOLR2;FOLR1
prerank,female gamete generation (GO:0007292),-0.3032887710816623,-1.0589706056023727,0.34986945169712796,0.6901131158768697,1.0,10/29,20.22%,PRDM9;DIAPH2;USP9X;PIWIL2;PTN;KMT2D;MCM9;MCM8;TRIP13;FMN2
prerank,sphingosine metabolic process (GO:0006670),-0.36219189089432846,-1.0582829181251716,0.3546099290780142,0.6912808341197657,1.0,6/17,20.32%,ACER3;SGPP1;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,protein-DNA complex assembly (GO:0065004),-0.23721878731414134,-1.058098668969886,0.2569444444444444,0.6910361669134296,1.0,29/116,15.34%,PSMA6;HMGB2;KAT6B;CUL4A;PSMB2;PSME2;ORC5;PSMD11;PADI4;CHD1L;PSMC6;UBC;ANP32B;PSMA3;H3-3A;UBA52;ORC2;RAD23B;CCNH;GRWD1;RPA1;MCM2;ORC4;PSMD10;NPM1;CDT1;MNAT1;PSMB5;MCM8
prerank,cation transmembrane transport (GO:0098655),0.30861944273510566,1.0580515328383004,0.36324167872648333,0.9686966959107609,1.0,9/44,14.41%,ATP1B1;KCNJ8;TRPM3;TRPM2;PKD2;SFXN1;ASIC2;SFXN2;ABCC8
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3406701512692394,-1.0577702473154125,0.33980582524271846,0.6912842315139825,1.0,6/20,24.57%,SP100;BCL3;BARD1;HNRNPU;SYNE1;ARL2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.41202249176202865,1.0577339651638162,0.39019963702359345,0.9684961120601374,1.0,6/13,29.45%,ALDH4A1;DAO;PRODH;GLUL;GLS2;GAD1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3144695795148454,1.0572970438998066,0.3563748079877112,0.9688331622883674,1.0,9/40,11.56%,ANG;MBL2;RARRES2;DEFA6;IL6;MR1;PGLYRP2;RNASE7;DROSHA
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3224102062856757,-1.0572801047707419,0.3870967741935484,0.691991573958435,1.0,8/24,13.79%,MET;CGNL1;ARHGEF18;ARAP1;STMN1;ARHGAP28;MYOC;INPP5K
prerank,aminoglycan metabolic process (GO:0006022),-0.42110437718459576,-1.0571664242611678,0.3922018348623853,0.6915651470066039,1.0,2/10,4.06%,XYLT1;CHST9
prerank,substrate-dependent cell migration (GO:0006929),-0.3771116538511841,-1.0570602297000786,0.38010204081632654,0.6911465180231784,1.0,3/14,1.93%,NRP1;PTPRC;SDCBP
prerank,phagosome-lysosome fusion (GO:0090385),-0.4277400367551053,-1.0570510247126368,0.3645083932853717,0.6904711584298852,1.0,3/10,16.03%,RAB7A;RAB7B;CLN3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.40523054010240667,1.0568695421433785,0.3799654576856649,0.9690158867688925,1.0,9/15,26.79%,NTRK1;DDIT4;CASP3;SORT1;HAP1;NTRK2;ZFYVE27;BDNF;NGFR
prerank,intraciliary retrograde transport (GO:0035721),0.42955796044558203,1.0568112120965976,0.38070175438596493,0.9679063717560276,1.0,2/12,6.48%,WDR19;DYNC2I2
prerank,vesicle organization (GO:0016050),0.3080275996659619,1.0565882372832243,0.3441358024691358,0.9673770845666847,1.0,14/46,20.46%,ANXA8;ANXA8L1;CD34;USP50;PI4K2A;CORO1A;SORT1;HOOK2;VPS33B;ALS2;SNX33;HOOK1;CAV2;SNX11
prerank,sprouting angiogenesis (GO:0002040),-0.2750078520542874,-1.0565361818975842,0.35365853658536583,0.6911709221985771,1.0,16/51,16.71%,NRP1;CCBE1;RNF213;THBS1;JMJD6;NAXE;EGR3;ADGRA2;KDR;E2F8;GREM1;PTK2B;RAMP2;OTULIN;E2F7;EPHB4
prerank,nuclear envelope organization (GO:0006998),-0.33739484088267074,-1.0563459155707018,0.37626262626262624,0.6910248440909981,1.0,5/20,12.42%,TOR1AIP1;CTDNEP1;LEMD3;TOR1B;NEMP1
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.25594987593998,-1.0563009370078378,0.3396825396825397,0.690449683566755,1.0,17/62,15.65%,LIMD1;PPARG;POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;AJUBA;AGO2;POLR2B;POLR2H;POLR2J;TRIM71;NUP62
prerank,ERBB signaling pathway (GO:0038127),-0.25758419729397325,-1.0561752546467222,0.33783783783783783,0.6900949854852758,1.0,15/64,17.07%,IQGAP1;KIF16B;REPS2;BRAF;GAB1;NRG2;PIK3CA;GRB2;CBL;EGFR;SHC1;PTK2B;BCAR1;AAMP;ADAM17
prerank,double-strand break repair (GO:0006302),-0.222238581475171,-1.0560986514466493,0.2767857142857143,0.6896128641127053,1.0,42/158,18.68%,NSD2;RAD51B;RBBP8;VCP;BAZ1B;HMGB2;PRPF19;NSMCE2;DTX3L;KPNA2;IFFO1;YY1;MDC1;NBN;CIB1;BRCA1;EYA1;CYREN;ABRAXAS1;RMI1;MAD2L2;EYA3;PAXIP1;BARD1;RPA1;LIG4;PARP9;KAT5;RAD21;SWI5;NHEJ1;MCM9;MCM8;EME1;MMS22L;MAPK8;RPA2;UIMC1;BRCC3;SLX4;TRIP13;HPF1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3191859508068671,1.0558171172995638,0.3891472868217054,0.9689272456686632,1.0,16/40,26.96%,SMYD2;UBE2V1;NSMCE4A;USP51;NEK4;UBE2N;WRNIP1;RFWD3;SMG1;FBXO5;ING2;NPAS2;FXR1;MAPT;FEM1B;RADX
prerank,positive regulation of ion transport (GO:0043270),0.3071708681757669,1.055632022382747,0.37025796661608495,0.96833093073237,1.0,9/48,11.88%,CACNB2;PLA2G3;CNKSR3;ADRA2A;CCR1;FHL1;ACTN2;TRPC6;CACNA1D
prerank,cellular response to pH (GO:0071467),-0.36674459801976195,-1.0556027286372727,0.38563829787234044,0.690243893415403,1.0,6/17,18.98%,GPR68;RAB11FIP5;CHP1;PKD1L3;MCOLN1;HVCN1
prerank,positive regulation of ERAD pathway (GO:1904294),0.41346570762256235,1.0555281161500067,0.37456445993031356,0.9674186012905639,1.0,5/13,16.99%,TMEM259;SGTA;NFE2L2;HERPUD1;UBQLN2
prerank,protein targeting to lysosome (GO:0006622),-0.3399531024993532,-1.0552345175594313,0.36220472440944884,0.69056838495021,1.0,7/20,10.26%,RAB7A;NAGPA;M6PR;ZFYVE16;AP4M1;LAMP2;GNPTAB
prerank,neurotrophin signaling pathway (GO:0038179),0.3691475353825535,1.0550036692707117,0.3896321070234114,0.9679869517468487,1.0,11/21,26.79%,NTRK1;DDIT4;CASP3;SORT1;HAP1;NTRK2;MAGI2;ZFYVE27;BDNF;RAPGEF2;NGFR
prerank,positive regulation of protein metabolic process (GO:0051247),-0.23479699262239678,-1.05493621321892,0.2748091603053435,0.6906490806470083,1.0,27/110,17.96%,PAEP;ITCH;APOE;WWP1;VCP;STX5;RAB1A;RAB7A;SMURF2;RANBP9;ATG7;HECW1;NR1H2;IL1B;PSEN1;FOXO1;BARD1;NR1H3;TNF;WNT5A;MAPK7;MAPK8;TIPARP;KLF2;WFS1;DTL;RILP
prerank,mitotic chromosome condensation (GO:0007076),-0.3207377596477843,-1.0548316891247407,0.3675675675675676,0.6902136279671738,1.0,12/26,23.05%,NCAPD2;NCAPH;NCAPG2;NUSAP1;SMC2;CDK1;RB1;PLK1;MCPH1;TENT4A;NCAPH2;CCNB1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.31704260164767106,-1.054818712625913,0.33156498673740054,0.6895610736496651,1.0,3/26,2.77%,OSBPL8;IGF1;BRAF
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.31393347542305744,-1.05474701448885,0.3399014778325123,0.6890604799173019,1.0,10/26,20.56%,IGF1;HOMER3;CIB1;SPPL3;FHL2;TNF;CHP1;CAMTA1;CHP2;STIMATE
prerank,folic acid-containing compound metabolic process (GO:0006760),0.37630651575917545,1.054697471771486,0.38870967741935486,0.9677822659727684,1.0,6/19,14.50%,FPGS;MTHFD1L;MTHFD2L;GGH;ALDH1L1;SLC19A1
prerank,synaptonemal complex organization (GO:0070193),-0.38206689378770664,-1.0546749305655214,0.3891625615763547,0.687854547976984,1.0,6/15,19.58%,STAG3;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,synaptonemal complex assembly (GO:0007130),-0.38206689378770664,-1.0546749305655214,0.3891625615763547,0.687854547976984,1.0,6/15,19.58%,STAG3;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,regulation of MAPK cascade (GO:0043408),-0.22001480201686868,-1.054628789166308,0.32701421800947866,0.6872929903256991,1.0,36/157,16.34%,IQGAP1;STK3;CD74;IGF1;NBR1;PTPRC;LILRA5;DHX33;FAS;FLT1;SYK;BCAR3;CAV1;CD24;LYN;IL1B;DAG1;TAOK3;RET;CCN1;IGF2;GRM4;CEACAM1;KDR;TRIM5;PSMD10;ZDHHC17;MYOC;GREM1;BMP2;DUSP1;EGFR;SHC1;EPHA2;ARHGEF5;PEBP1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.26483491267133163,-1.0546161582592382,0.34534534534534533,0.6866438912786166,1.0,14/51,17.30%,NRP1;PXN;ARHGEF10L;CD47;SYNPO2;CARMIL1;SORBS3;S100A10;GPR65;SYNPO;MYOC;ARHGEF5;PFN2;RGCC
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.30685555373596973,-1.0537734140985284,0.38227146814404434,0.6881845960846509,1.0,9/26,14.20%,TET2;SETD3;PRDM9;WDR82;VCPKMT;EEF2KMT;TET3;ETFBKMT;KMT2D
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3628960717665798,-1.0535927219599448,0.3878504672897196,0.6879851472320235,1.0,10/16,37.70%,SLC2A5;DRD2;PRCP;KLK3;KLK1;BMPR2;SPX;DDAH1;NPPA;GSK3A
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3226173333724816,-1.053565933377493,0.35405405405405405,0.6873712993068487,1.0,6/24,11.56%,PCNA;UBC;UBA52;POLD4;RPA1;LIG4
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.44698785400652963,1.0532369046900147,0.40625,0.9719177110978485,1.0,3/10,15.05%,NDRG4;APOD;PTPN2
prerank,presynapse assembly (GO:0099054),0.4016663026707111,1.0531413154362637,0.41196581196581195,0.9709345468169516,1.0,9/16,32.26%,PTPRD;LRRTM3;IL1RAPL1;WNT7A;PCLO;PTEN;CEL;NLGN3;NLGN1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.333952222895069,-1.0530331262723225,0.3627450980392157,0.688178447617193,1.0,3/22,1.21%,FCGR2B;PTPN22;CD300A
prerank,liver development (GO:0001889),0.33180635069918435,1.052686715329224,0.38283828382838286,0.9712417620883499,1.0,6/32,8.99%,WNT4;DNAAF1;CCDC39;IL6;TGFBR3;PKD2
prerank,regulation of blood coagulation (GO:0030193),0.3503313434439782,1.052447290377514,0.38752052545155996,0.9707615694713544,1.0,7/27,15.41%,ADTRP;CD34;THBD;ENPP4;VTN;EPHB2;SERPINE2
prerank,in utero embryonic development (GO:0001701),-0.3211129306268497,-1.0523108757381379,0.38613861386138615,0.6894848270843019,1.0,7/25,16.22%,MBNL1;FUT8;HINFP;LIG4;IGF2;BMP2;EGFL8
prerank,negative regulation of cell motility (GO:2000146),0.2670403613838005,1.0522011921644379,0.3655629139072848,0.970340470790583,1.0,43/108,29.25%,SPOCK3;FRMD5;SRGAP3;SRGAP2;STK26;LDLRAD4;SLURP1;THY1;PTPRT;DNAI3;PTPRU;NAV3;MAPK15;SPINT2;EPHA1;ADAM15;SFRP1;SCAI;EPHA4;FLCN;ADORA3;MIA3;ENG;PIN1;MAGI2;ARHGAP4;RAP2C;SFRP2;SINHCAF;TMIGD3;TMEFF2;ARID2;FUZ;NGFR;SULF1;CHRD;PTEN;ROBO1;CLDN5;DUSP10;KANK1;DLC1;NKX2-1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3423502205203914,1.051793755576709,0.38087774294670845,0.9705232705642057,1.0,5/28,5.97%,FGF10;THY1;NCKAP1L;IL6;XRCC6
prerank,sulfate transport (GO:0008272),-0.3915450531305874,-1.051784575218097,0.3738095238095238,0.6902570833264221,1.0,4/14,12.72%,SLC26A11;RACGAP1;SLC13A4;SLC25A11
prerank,cellular response to amino acid starvation (GO:0034198),-0.24693281800927572,-1.0517380156648668,0.3424657534246575,0.6896948918986305,1.0,13/71,12.82%,ATP6V0D1;ATP6V0D2;ATP6V1B2;RRAGC;LAMTOR5;SH3GLB1;ATP6V0B;FAS;CEBPB;EIF2S1;SZT2;RRAGA;ATP6V1A
prerank,regulation of secretion by cell (GO:1903530),0.2996348336231752,1.0516768466262356,0.3569364161849711,0.9696500472039207,1.0,13/54,14.91%,LGI3;RAB3A;DISP1;SYT1;RAB26;MEF2C;RAB8A;RAB3D;RIMS1;CPLX2;RAB12;VAMP3;HAP1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.24704386828986954,-1.0516144121850204,0.36363636363636365,0.6893841659689945,1.0,26/87,21.53%,NRROS;PXN;GCNT2;ARHGEF18;ADAM9;SMAD3;SMAD9;ZMIZ1;UBC;UBA52;USP9X;ID1;SMAD6;CBL;NLK;FOS;PARD6A;SMAD4;COL3A1;ACVR1;APPL2;USP15;CGN;BAMBI;USP9Y;ZMIZ2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.31362290607302,1.0515427745916701,0.36281859070464767,0.9688250175100387,1.0,10/42,17.13%,WRAP53;PPP4C;FUS;USP51;TIMELESS;CGAS;PARP1;ERCC6;SHLD3;MRNIP
prerank,protein import into peroxisome membrane (GO:0045046),0.3644217947499818,1.0509678231002468,0.41408934707903783,0.9696179512916411,1.0,12/22,27.71%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;ABCD2;PEX11B;PEX3;PXMP4;ABCD3;ACBD5
prerank,peroxisome organization (GO:0007031),0.3510543204303361,1.0508301807071678,0.38220757825370677,0.9688377095834462,1.0,12/25,22.95%,SEC16B;FIS1;PEX11G;PEX14;DNM1L;PEX2;MFF;PEX6;ABCD2;PEX11B;PEX3;PEX11A
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3171537917927967,1.0503898122261675,0.375,0.969121085174131,1.0,7/38,10.19%,OTUD7A;USP10;MAPKBP1;CACTIN;DAB2IP;PPM1A;PPM1N
prerank,plasma membrane organization (GO:0007009),0.29095850219994646,1.0500583422865102,0.350354609929078,0.969032668040045,1.0,21/61,24.89%,COL5A1;BIN1;RAB3A;SYTL4;OTOF;BIN2;EHD2;CXCR4;TLCD2;MICALL1;SPTBN1;ANK2;ABCD2;SNX33;ABCA7;PACSIN3;PLSCR4;FA2H;SYT11;ANK3;FNBP1L
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.41644297060145286,1.0498764916167587,0.38524590163934425,0.9683526972614739,1.0,4/12,19.01%,ADTRP;PPARA;MIA3;WNK1
prerank,response to calcium ion (GO:0051592),0.27022764258551185,1.0492298473466075,0.3819444444444444,0.9693703643346215,1.0,19/102,12.73%,KCNMA1;SYT4;ADCY8;TRPC3;CAPN3;NEUROD2;SYT13;SYT1;SYT6;TRPM2;MEF2C;LGMN;SEC31A;CPNE6;PKD2;NEDD4;PDCD6;ITPR3;CRHBP
prerank,RNA transport (GO:0050658),0.28544205077934165,1.0489345597681587,0.3807471264367816,0.9691119811955932,1.0,33/71,31.94%,RNPS1;SRSF5;CASC3;SRSF6;SRSF11;CKAP5;SRSF1;RAE1;CDC40;DDX39B;HNRNPA1;THOC5;SARNP;SRSF9;NXF1;ATXN2;CHTOP;ALYREF;SRSF2;POM121;RBFOX1;EIF4E;SRSF3;NUP155;THOC7;SRRM1;ZC3H11A;TPR;SRSF7;POLDIP3;U2AF1;U2AF2;YBX1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.41412260688674457,-1.0485609315388902,0.360381861575179,0.6969637576600286,1.0,4/11,16.32%,ATG7;AGTPBP1;ICMT;AGBL1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3337579184995502,1.048533828470396,0.3786259541984733,0.9692686725978669,1.0,6/32,15.02%,GAPDH;ANG;DEFA6;RNASE7;FAM3A;GALP
prerank,NAD biosynthetic process (GO:0009435),-0.3492074387728825,-1.048426027401689,0.3493670886075949,0.6965964792732052,1.0,9/20,24.61%,NAMPT;NAXE;PTGIS;PARP9;NMNAT3;NAXD;PARP16;KYNU;NMNAT1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.35280847579887675,1.048158898528844,0.389351081530782,0.969302797108593,1.0,12/25,27.65%,HSPA2;SDF2;SDF2L1;HSPA9;DNAJC7;HSPE1;HSPA14;DNAJB4;DNAJB13;ST13;HSPA8;PTGES3
prerank,axoneme assembly (GO:0035082),0.33520240657653183,1.0479685460792303,0.3644859813084112,0.9686532947060342,1.0,8/31,16.66%,DNAAF1;CCDC39;CCDC65;SPAG1;LRGUK;SPAG16;DNAAF2;DNAAF3
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.24925289237346182,-1.0477012069638039,0.3519163763066202,0.6978692393430057,1.0,30/86,20.53%,DENND1A;STARD8;IGF1;EPS8;RAF1;DENND4C;KANK2;ARHGAP17;SHOC2;ARHGEF18;RASGRP4;CRKL;PDCD10;LYN;SPRY2;GRB2;ARHGDIB;NOTCH1;SPRY1;ARHGEF28;SHC1;SPRY4;NUP62;SQSTM1;ARHGEF2;IRS2;MYO9B;PLCE1;NOTCH2;EPO
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.388349375821746,1.0476353931135145,0.38358458961474035,0.9685148671404035,1.0,5/16,13.85%,PFAS;NUDT2;GART;AMPD3;ADSL
prerank,negative regulation of kinase activity (GO:0033673),-0.2621742916567286,-1.0473765856868096,0.35347432024169184,0.698036906240276,1.0,25/62,21.49%,PTPRC;PPP2R5A;PRKAG2;YWHAG;SMCR8;TAB1;CEACAM1;RB1;INPP5K;QARS1;DEPTOR;PRKRIP1;HSPB1;CHP1;PYDC1;LRP6;PPM1F;IRS2;TAF7;DBNDD1;HNRNPU;DTNBP1;WARS1;GSKIP;DUSP19
prerank,microtubule bundle formation (GO:0001578),0.31762549483861546,1.0473497740351518,0.3858858858858859,0.9682394163387849,1.0,10/42,16.37%,TPPP;AAAS;PSRC1;NCKAP5;MAP1S;NCKAP5L;LRGUK;MTCL1;SPAG16;CLIP1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3391845803174983,1.0471742668513524,0.39067524115755625,0.9675268856125915,1.0,7/28,11.83%,LACC1;RELA;UBE2V1;INAVA;NOD1;UBE2N;MAP3K7
prerank,epithelial to mesenchymal transition (GO:0001837),-0.2759735218328835,-1.0468900448536547,0.3863013698630137,0.6986014785073983,1.0,16/47,22.94%,RBPJ;DLG5;LIMS1;HNRNPAB;HIF1A;S100A4;CTNNB1;NOTCH1;BMP2;NOTCH4;WNT5A;HEY2;HMGA2;BMP7;HEYL;TASOR
prerank,regulation of protein kinase B signaling (GO:0051896),0.24914053131673808,1.0468336719576008,0.3690621193666261,0.9674658179773189,1.0,38/193,15.21%,FGF10;TPTE;TSC2;F3;FGF16;P2RY12;CD80;FGF9;NTRK1;KLB;NRG4;PPARA;LRP2;CD86;FGF7;NTRK3;AREG;PIK3CG;ARRB2;TNFAIP8L3;MAZ;TGFBR1;TCF7L2;ERBB4;TGFB1;CX3CR1;ITGB1BP1;SH2B3;FGF2;PDCD6;IRS1;VAV1;PDGFB;TEK;FLCN;THPO;INSR;NTRK2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.2974859797765077,1.046784945323198,0.3823088455772114,0.9663623814693976,1.0,13/57,14.37%,PPARGC1A;FIS1;MLLT11;PDCD5;FBXO7;ZNF205;BAK1;PRKN;DNM1L;RALBP1;CHCHD10;BIK;BBC3
prerank,regulation of DNA replication (GO:0006275),-0.2717472120396198,-1.0466635882862285,0.3595166163141994,0.6985299857823491,1.0,10/49,15.38%,ANKRD17;OBI1;PCNA;ORC5;BCAR3;PDS5A;CCNA2;CDT1;EGFR;KAT7
prerank,epithelial cell differentiation (GO:0030855),-0.24136385007003366,-1.0464830813601536,0.3515625,0.6984089092322685,1.0,25/88,21.77%,DAB2;PPARG;PCNA;PROX1;SCUBE1;ANXA1;CTSB;ANXA4;RAB10;CDK1;HDAC2;MAF;HDAC1;KDR;TAGLN2;E2F8;E2F7;TAGLN;GATA3;CASP6;ZDHHC7;EHF;DHRS9;BASP1;ANXA7
prerank,endothelial tube morphogenesis (GO:0061154),-0.4248626868831407,-1.0463707619779512,0.42757009345794394,0.6980088127191757,1.0,2/10,10.74%,RBPJ;CTNNB1
prerank,regulation of phosphorylation (GO:0042325),-0.22506029717402207,-1.0459615302346283,0.3305084745762712,0.6984075573928513,1.0,32/120,16.87%,FNIP2;NRP1;STAP1;SDCBP;NDUFS4;CORO1C;RANBP2;STAT2;CCDC88C;KCTD20;THBS1;CD24;LYN;PRKAG2;HIF1A;PSEN1;NUP153;NDC1;CDKN2C;NUP43;NUP210;EP300;PGAM1;BARD1;NLRC5;EMP2;PRKRIP1;EGFR;HSPB1;NUP62;SESN2;NOP53
prerank,positive regulation of organelle assembly (GO:1902117),-0.2815154623088548,-1.0457763312662698,0.36176470588235293,0.6982494393052426,1.0,17/44,23.41%,SDCBP;SH3GLB1;ASAP1;KCTD17;LCP1;PDCD6IP;RALB;NUMA1;TNF;NUP62;SDC1;STX18;RAB3GAP2;SDC4;CNOT6L;G3BP1;MARK4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.33270515606039597,1.0457618253583085,0.3974358974358974,0.9687181104740052,1.0,9/31,19.47%,TOMM40L;PEX5;TIMM21;PEX26;PEX14;TOMM70;PEX2;PEX6;TIMM23
prerank,regulation of cellular component movement (GO:0051270),-0.2752317124349295,-1.0457282126527523,0.3475609756097561,0.6976900409582747,1.0,9/49,8.61%,SP100;ABL2;RAF1;CDK6;ACTN1;ARHGAP18;ARAP1;LYN;NRG2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.25059869053415185,-1.045699561894839,0.3322784810126582,0.6970983063972436,1.0,14/74,10.93%,RBPJ;PSMA6;LIMD1;PSMB2;PSME2;VHL;PSMD11;PSMC6;UBC;HIF1A;PSMA3;UBA52;EP300;NOTCH1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.37318715682687364,1.045495642647696,0.39579967689822293,0.9684265010351967,1.0,4/19,12.43%,VDAC1;FBXO7;PRKN;DNM1L
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.38023043389920597,1.0454301116373106,0.40371621621621623,0.9673813138466155,1.0,4/18,12.55%,POLR2L;MAF1;WDR75;PHF8
prerank,activation of protein kinase activity (GO:0032147),0.2695568935221403,1.045108512033609,0.3817204301075269,0.9673322712628181,1.0,29/106,19.01%,ADCY8;STRADB;ANG;PAK1;CARD14;COPS8;PRLR;STK11;CD86;NTRK3;ADRA2A;RIPK3;MAP4K4;ZFP91;PRR5;ITGB1BP1;MINK1;MAP3K7;PAK5;PDGFB;TOM1L1;INSR;KIF14;PAK6;PRKAR1A;TAOK1;TLR3;IL18;STRADA
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3967236534989783,1.0450041265293053,0.4,0.9664334500436994,1.0,5/15,28.15%,SAT2;MOXD1;ASMT;AANAT;SRM
prerank,positive regulation of developmental process (GO:0051094),-0.21972531808090293,-1.0449908007916444,0.3275862068965517,0.6983340609067601,1.0,47/164,22.33%,APOE;PHLDB1;DDHD1;B4GALT5;SOX6;DLG5;DVL3;SLC6A6;CORO1C;SMURF2;VPS35;VHL;TFRC;CEBPB;PSEN1;DAG1;BMP5;MAD2L2;PAXIP1;TRPM4;COBL;SHLD1;AGO2;KDR;PTN;SCX;BMP2;NUMA1;LHX1;TNF;GJA1;WNT5A;MUL1;MIEF1;NIBAN2;ACVR1;PA2G4;BMP7;ESRRB;BASP1;CPEB3;LMNA;RREB1;SERPINF2;FZD4;ISL1;SHH
prerank,regulation of cell size (GO:0008361),-0.3267865878763335,-1.0449736161054495,0.36623376623376624,0.6976974741828338,1.0,3/23,5.05%,VAV3;LAMTOR5;MSN
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.28406090540932877,1.0449165464051726,0.37052341597796146,0.9654737753847707,1.0,17/69,17.21%,NDUFA6;UQCRC1;COA6;NDUFA4;CYC1;SDHC;COX7B;UQCC3;COX6C;NDUFS1;UQCR11;NDUFA8;NDUFS6;SDHAF2;COX7C;NDUFAB1;NDUFS2
prerank,chromatin remodeling (GO:0006338),-0.23501258240356904,-1.0447584527006033,0.3237410071942446,0.6976208270998593,1.0,30/100,22.63%,BAZ1A;GATAD2B;ARID1B;BAZ1B;SMARCA4;ESR1;INO80C;MBD2;PADI4;CHD1L;INO80B;SMARCA1;SATB2;KDM6A;MYSM1;HDAC2;NUDT5;HDAC1;RB1;NPM1;TADA2B;KDM5C;SATB1;HMGA2;TADA2A;POLE3;HNRNPC;HDAC4;KAT2B;TAF6L
prerank,spliceosomal complex assembly (GO:0000245),0.31216502154065634,1.0444388464130467,0.4169230769230769,0.9658797326677162,1.0,15/46,18.71%,SRSF5;SRSF6;DDX1;RBM5;SF3A1;SRSF1;SNRPD2;YTHDC1;CELF6;CRNKL1;DDX39B;SETX;SRSF9;PUF60;GCFC2
prerank,metal ion homeostasis (GO:0055065),0.31263290934968957,1.0444264602555835,0.39631336405529954,0.9646545537346173,1.0,7/40,9.64%,KCNH2;SCNN1A;CLDN16;SLC12A2;GRIN1;SLC12A6;SLC8A1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4099911113319659,-1.0444225310923174,0.39198218262806234,0.6978214063154067,1.0,3/10,8.28%,CDC73;NCBP1;HSF1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.25982821080163704,-1.0443928164902039,0.3651315789473684,0.6972377533007699,1.0,20/59,25.12%,TLR2;TBK1;BCL3;TLR7;CD14;RIPK1;UBC;TLR8;TAB1;UBA52;BIRC2;TNF;RELB;TLR4;ERC1;NKIRAS1;NLRC3;TICAM2;TLR9;TAB3
prerank,establishment of endothelial barrier (GO:0061028),0.3324852993340657,1.0439605933918337,0.3993231810490694,0.9650605205943443,1.0,6/29,11.31%,RAB1B;F11R;ROBO4;MARVELD2;RAPGEF3;ICAM1
prerank,positive regulation of protein modification process (GO:0031401),-0.21167005786774531,-1.0438843616827096,0.3089005235602094,0.6979062997138912,1.0,48/203,17.07%,DAB2;CD74;GAS6;NIBAN1;FAM161A;PPP2R5A;DVL3;FAM20A;NPTN;PTPA;ATG7;FAS;CRKL;DYRK1A;RIPK1;TFRC;CCND1;PLAUR;LYN;CIB1;IL1B;FGF1;TXN;KRAS;CDCA2;BRMS1;CALM3;AKTIP;CCN1;SPPL3;IGF2;BRAT1;LRRK2;KAT5;KDR;CCND2;CALM2;RACK1;RALB;BMP2;EGFR;AGER;TNF;CHP1;FXR2;CAMTA1;RAB3GAP2;ADAM17
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.3501039999247682,1.0437912809983783,0.397708674304419,0.9644076730320383,1.0,7/25,17.90%,ATP2A2;NOS1AP;GJA5;FGF13;CXADR;CTNNA3;ANK2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3711372068887415,1.043765441954653,0.39669421487603307,0.9632468805503994,1.0,4/21,9.58%,BEX3;USP50;GRIN1;GRIN2B
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3051342953854868,1.0434757984902814,0.39821693907875183,0.9630207181515208,1.0,12/48,17.43%,GUCY2F;ADCY8;NUDT2;GUCY2C;PPCDC;AMPD3;GUCY2D;COASY;DCAKD;ADSL;PPCS;AK5
prerank,phosphate-containing compound metabolic process (GO:0006796),0.24651951618306908,1.0434156272821382,0.36318407960199006,0.9619890174686803,1.0,52/198,21.51%,PLCH1;INPP4B;TPTE;ITPK1;IP6K1;PTPRD;PAK1;INPP5D;PLA2G3;NUDT10;PLCD1;INPP5B;PFKFB4;PLA2G4C;PLCG1;PIK3CG;TNFAIP8L3;SLC20A1;NUDT3;LIMK2;PLD4;ALDOC;PPM1A;TGFB1;ALPL;PPA1;OCRL;IPMK;AGPAT1;COQ8A;PFKM;HK2;EPHB2;MAPK3;PLPPR4;PRKCG;ANGPTL3;TAOK1;INPP5A;PFKFB2;PLCB2;FRA10AC1;NT5C;INPPL1;ALDOA;PFKP;PLA2G15;PLPP1;PSPH;PIP4P1;INPP5J;TOP1
prerank,DNA strand elongation (GO:0022616),0.38153633337937876,1.0433051941748817,0.40404040404040403,0.9610912774317599,1.0,3/18,7.47%,POLD3;GINS3;MCM3
prerank,polyamine metabolic process (GO:0006595),0.40548376839586514,1.0429318517846586,0.3976510067114094,0.9611740251355034,1.0,3/13,14.71%,SMS;SAT2;AOC1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.32817623667458945,1.042905653795416,0.37777777777777777,0.9600208781552868,1.0,9/33,16.87%,MN1;SUSD2;E2F1;TCIM;PSME3;PKD1;PAF1;KIF14;STXBP4
prerank,neural crest cell development (GO:0014032),0.30808358693680804,1.0427120344867427,0.4006024096385542,0.9594213578529931,1.0,12/44,16.54%,SEMA7A;SOX10;CYP26C1;SEMA6C;SEMA6B;SEMA3D;ERBB4;SNAI2;PDCD6;SEMA4F;SEMA4B;SEMA3C
prerank,organophosphate biosynthetic process (GO:0090407),-0.28831249154149474,-1.042488947297098,0.33532934131736525,0.7010493235093369,1.0,11/37,18.86%,MOCS2;MOCS1;AGPAT4;AGPAT5;TKT;IPPK;GK;GK5;ITPKA;GPAM;IP6K3
prerank,cell differentiation in spinal cord (GO:0021515),0.4416162128737272,1.0423342371103064,0.43214285714285716,0.9595528792353321,1.0,2/10,4.45%,MDGA2;SOX4
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.3900731985414877,1.042201631518591,0.38945578231292516,0.9588026739481375,1.0,6/16,18.85%,PRDX6;TRA2B;CIRBP;RBMXL1;RBM3;TRA2A
prerank,hippo signaling (GO:0035329),0.3434804072726214,1.0419690620037212,0.42536115569823435,0.9583963299583131,1.0,12/26,22.76%,YWHAE;WWTR1;DCHS1;CASP3;WWC1;FAT4;TEAD3;DVL2;YWHAB;TEAD2;LATS1;AMOT
prerank,protein deubiquitination (GO:0016579),-0.20851090794871352,-1.0416213579867701,0.3202247191011236,0.7025939335601905,1.0,62/242,18.66%,VCPIP1;PSMA6;VCP;OTUD6B;IFIH1;PSMB2;ASXL2;CLSPN;SIAH2;ATXN7;SMURF2;PSME2;USP28;ESR1;YY1;INO80C;USP18;SMAD3;PSMD11;TNIP3;RIPK1;INO80B;PSMC6;UBC;USP45;HIF1A;PSMA3;BRCA1;ABRAXAS1;USP8;TAB1;UBA52;ZC3H12A;TRRAP;MYSM1;RAD23B;EP300;USP9X;USP38;NFRKB;BARD1;JOSD1;TOMM20;CDK1;CCNA2;BIRC2;PSMD10;STAM;UCHL3;TADA2B;PSMB5;CDC25A;FOXK2;OTULIN;USP5;UIMC1;BRCC3;SMAD4;GATA3;PSMD5;INO80E;USP4
prerank,protein monoubiquitination (GO:0006513),-0.28734100504789073,-1.041606429307926,0.34594594594594597,0.7019694681764274,1.0,6/36,3.75%,UBE2D3;TRIM25;CDC73;CUL3;DTX3L;OBI1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3709208538821053,-1.0413812382863887,0.3946731234866828,0.7019262759272686,1.0,4/15,16.77%,CDC73;CUL3;NPM1;CRNN
prerank,sister chromatid segregation (GO:0000819),-0.30086094090735066,-1.0413037826299352,0.3869209809264305,0.7014478824670443,1.0,13/31,21.83%,MIS12;TOP2A;CDCA8;NCAPG2;KIFC1;NUSAP1;ESPL1;RB1;NDC80;PLK1;KIF18B;ZWINT;TOP2B
prerank,microtubule nucleation (GO:0007020),0.36240627404540715,1.0412644287800723,0.3926174496644295,0.9597299482988823,1.0,3/20,8.96%,TPPP;CLASP2;CCDC57
prerank,regulation of catecholamine secretion (GO:0050433),0.334232254544037,1.0409907503326699,0.3951612903225806,0.9594310471314527,1.0,5/29,9.79%,SYT4;SYT13;SYT1;SYT6;PRKN
prerank,positive regulation of autophagy (GO:0010508),0.2776027418028305,1.0408866659084972,0.3986013986013986,0.9585753812903309,1.0,22/81,17.74%,TSC2;MID2;STK11;FBXO7;SCOC;PLK3;PRKN;EPM2A;MAP3K7;TFEB;TRIM8;FLCN;HMGB1;EIF2AK4;SH3BP4;GNAI3;RNF152;PRKD1;PLK2;ROCK1;TRIM68;TMEM59
prerank,entry into host (GO:0044409),-0.3873676650330749,-1.040541389192268,0.39856801909307876,0.7027904971006602,1.0,5/13,18.74%,MET;GRB2;CTNNB1;CBL;CDH1
prerank,P-body assembly (GO:0033962),-0.386421385414892,-1.040511351112481,0.40298507462686567,0.7021880668950361,1.0,4/12,10.65%,LIMD1;EIF4ENIF1;DDX6;RC3H1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.36987296455502083,-1.0402158524208334,0.3976470588235294,0.7023268821388086,1.0,3/14,7.92%,CMPK1;ENPP3;SMPDL3A
prerank,regulation of protein export from nucleus (GO:0046825),-0.3240391127738691,-1.0401359623128597,0.39851485148514854,0.7018802631364245,1.0,6/23,10.93%,SP100;GAS6;ANP32B;IL1B;UHMK1;BARD1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.2971695980303445,-1.0400021581136767,0.3682795698924731,0.701554323239779,1.0,12/33,22.23%,ALOX5;THBS1;FGF1;CEMIP2;RHOJ;S100A1;SEMA6A;CEACAM1;CREB3L1;KLF2;KLF4;FGF18
prerank,neuron apoptotic process (GO:0051402),-0.34139221863289687,-1.0399086173734327,0.37681159420289856,0.7011145721973853,1.0,5/19,11.56%,BCL2;TRPC5;FAS;CIT;LIG4
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3266852906121336,1.03986675908787,0.40816326530612246,0.9609666420777073,1.0,4/33,6.58%,TPTE;PIK3C2G;NYAP2;PIK3CG
prerank,nitric oxide metabolic process (GO:0046209),0.4015770281074979,1.0398450372528305,0.4,0.959831128319685,1.0,4/14,18.94%,GCHFR;DDAH2;CYB5B;ARG2
prerank,regulation of ion transport (GO:0043269),0.27910895938582464,1.039810698680806,0.39633286318758815,0.9587116535279401,1.0,15/76,15.91%,SYT4;KCNJ3;KCNA5;KCNJ8;SYT13;SYT1;SYT6;KCNJ13;PRKN;NKAIN2;NEDD4;VAMP3;SNX6;NEDD4L;KCNJ5
prerank,peptidyl-lysine modification (GO:0018205),-0.23483343297153242,-1.0393379842960664,0.3686274509803922,0.7019898008309321,1.0,21/99,14.03%,VIPAS39;IFIH1;NSMCE2;ATP7A;RANBP2;EGR2;EYA1;NUP153;NDC1;UBA2;NUP43;NUP210;LOX;USPL1;EP300;VCPKMT;PIAS2;TRPM4;KAT5;SENP1;ETFBKMT
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3738073797725665,-1.0389265842254078,0.39344262295081966,0.7023513263616222,1.0,5/15,15.14%,ORMDL1;RACK1;SPHK2;ORMDL3;TNF
prerank,triglyceride catabolic process (GO:0019433),-0.35062804665958847,-1.0386609894362657,0.3975,0.7023973714043974,1.0,4/19,12.58%,FABP4;LPL;FABP7;PNPLA2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.26562442825104704,-1.038255087508235,0.36728395061728397,0.7028207074150482,1.0,18/57,19.72%,AKAP12;PSAP;ADCY9;CHRM2;ADCY5;DRD2;NPY1R;ADCY6;ADCY1;HTR1B;GRM4;ADCY3;PDE2A;AKAP5;FLNA;OPRK1;GPR37;DRD3
prerank,cellular response to unfolded protein (GO:0034620),-0.312265570287277,-1.0376721570877143,0.37055837563451777,0.7036425026343831,1.0,11/26,19.86%,PTPN1;BAX;ERN1;HSPD1;HSF1;PACRG;HSPB8;TM7SF3;OPTN;HSPA13;HSPA1B
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3903023065762311,-1.0374996418775024,0.42105263157894735,0.7034713849133469,1.0,6/13,22.65%,NAMPT;NAXE;PTGIS;PARP9;NAXD;PARP16
prerank,generation of neurons (GO:0048699),0.24301500516939223,1.037437285085067,0.3843283582089552,0.9659717002412179,1.0,36/190,16.62%,WNT4;PLXNB2;LDB1;PTPRD;NEUROG2;SIX4;ATOH7;NEUROD2;WNT3;MEF2C;ITM2C;RYK;NRBP2;LHX3;ADGRL3;CDKL5;HEY1;CX3CR1;WNT8B;IL1RAPL1;FGF13;DDIT4;CASP3;NRCAM;LHX5;TUBB2A;NDNF;LMX1B;ERCC6;NTRK2;TAFA1;WNT7A;TUBGCP2;LHX2;BHLHE41;EN2
prerank,negative regulation of catabolic process (GO:0009895),-0.2711118976901162,-1.0372602098382544,0.4221556886227545,0.7034639174898534,1.0,17/47,22.14%,GIT1;CBFA2T3;IL1B;MAD2L2;AGAP2;MAD2L1;APOC1;EGFR;TNF;FLNA;RILP;ZDHHC7;FMN2;NCOR1;SIRT2;HDAC4;ADGRB1
prerank,glycogen catabolic process (GO:0005980),-0.3679846071450466,-1.037204264172341,0.41421568627450983,0.7029630497802971,1.0,4/15,14.83%,PHKB;AGL;GAA;PGM2L1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3247752106842009,-1.0371391478009708,0.3954659949622166,0.7024970458755776,1.0,7/24,19.00%,MCL1;FBXW7;BAX;TYROBP;CTNNB1;TNF;TFAP2B
prerank,positive regulation of cell aging (GO:0090343),0.4296721531167874,1.0368057190131172,0.4126984126984127,0.9669996585045103,1.0,3/11,10.41%,ABI3;EEF1E1;CGAS
prerank,regulation of rRNA processing (GO:2000232),0.39051100923804566,1.0359907827879025,0.4080645161290323,0.9685410334036012,1.0,3/16,8.16%,RIOK1;WDR75;DIMT1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2475099102302753,-1.03535157923417,0.3554006968641115,0.7066999939035542,1.0,27/73,24.73%,MECP2;EPC1;RBBP7;BAZ1B;PPHLN1;POLR2E;DNMT1;BMI1;H3-3A;DEK;CTCF;EP300;IGF2;SPHK2;POLR2H;DDX21;GPX1;PHF19;EED;POLR1B;HDAC4;KAT2B;TFAP2C;TASOR;EZH2;MTF2;TDG
prerank,intracellular protein transmembrane transport (GO:0065002),0.30809178699141143,1.034714653779272,0.3932411674347158,0.9717924046681448,1.0,11/42,19.47%,TOMM40L;PEX5;TIMM21;SEC62;PEX26;PEX14;SEC61A2;TOMM70;PEX2;PEX6;TIMM23
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.24609878788878056,-1.0344051894583293,0.35580524344569286,0.7086223397644054,1.0,27/76,24.91%,ITCH;RWDD3;CCDC22;ZC3H12A;ANXA4;PTGIS;PRMT2;ACOD1;BRMS1;FOXJ1;NLRC5;PSMD10;CHP1;OTULIN;PYDC1;NWD1;TRIM37;CDKN2A;BMP7;KLF4;NLRC3;TRIM21;TMSB4X;AIM2;CYP1B1;PKHD1;TLR9
prerank,protein localization to plasma membrane (GO:0072659),0.256506039811091,1.034216460895033,0.38838709677419353,0.9723494771655848,1.0,29/129,14.32%,F11R;CACNB2;ATP1B1;RAB3A;RAB40B;KCNIP3;MRAP;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;CD81;ACTN2;NECTIN3;BSG;ITGB1BP1;FGF13;RAB3D;EHD1;ZDHHC2;EHD2;P2RY1;RAB34;RAB12;SPTBN1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.32969369011759,-1.0341235509873605,0.39753086419753086,0.7087049232928462,1.0,6/19,16.65%,GNPDA1;UAP1L1;UGDH;GNPNAT1;GMPPB;NAGK
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.3084951362065759,-1.0340882636183815,0.3838383838383838,0.7081144086145673,1.0,9/26,16.40%,CDK6;TCTA;RARA;GPR137B;CEACAM1;GPR137;LILRB3;C1QC;TLR4
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3910815402158656,-1.0340034266380242,0.40048543689320387,0.7076625926859746,1.0,4/12,16.03%,TMEM165;CLN5;LRRK2;CLN3
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.43142222294989385,1.0338749490046317,0.4270833333333333,0.972268804369464,1.0,4/11,24.40%,MEF2C;TGFB1;DHX36;EFNB2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3905550915748573,-1.033851647566464,0.40145985401459855,0.7073776061445062,1.0,3/12,4.76%,PTPN1;BAX;ERN1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.3510152115179045,-1.0335656073235233,0.38609112709832133,0.7075154653751033,1.0,7/17,20.22%,PPARG;PPARD;CAV1;PRKAG2;PRKAB2;ADIPOR2;NCOR1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.3665972951151453,-1.033407638609232,0.39402173913043476,0.7072609254148768,1.0,11/16,36.46%,THBS1;PDCD10;HMOX1;FGFBP1;APLNR;DLL4;JCAD;GATA2;IL12A;IL12B;AGTR1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.29453306234090987,-1.03335600127845,0.37681159420289856,0.7067521555094529,1.0,10/32,17.80%,CD300A;PPP2R5A;PTPA;CDCA2;CALM3;SPPL3;CALM2;ITGA1;CAMTA1;PPP1R15A
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3183640100749099,-1.0332071686317048,0.3948051948051948,0.7065233633791653,1.0,5/23,12.04%,CBLB;PTPRC;CAV1;SOCS5;CBL
prerank,histone H3-K36 demethylation (GO:0070544),-0.42729470586085183,-1.0332048493498833,0.4034229828850856,0.705858811671337,1.0,4/10,14.60%,RIOX2;KDM7A;KDM8;RIOX1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.23929314262945736,-1.0327800341454687,0.3614864864864865,0.7063597455712665,1.0,15/94,8.25%,BCL2;ARL6IP5;FNIP2;BCL2L1;CUL3;CUL4A;MCL1;BAX;ERN1;STK24;CEBPB;ITPR1;CD24;BRCA1;BAG6
prerank,protein prenylation (GO:0018342),0.4342630333256333,1.0327352166830994,0.4336917562724014,0.9750076401280687,1.0,6/10,30.98%,CHM;PGGT1B;RABGGTB;RCE1;FNTA;RABGGTA
prerank,nitric oxide biosynthetic process (GO:0006809),0.40158891685518294,1.0327329615835754,0.3983050847457627,0.973779316716702,1.0,4/13,18.94%,GCHFR;DDAH2;CYB5B;ARG2
prerank,protein localization to membrane (GO:0072657),0.2448014350774818,1.0327068283130008,0.3661800486618005,0.972659924691105,1.0,37/187,12.65%,AGRN;WDR19;DLG2;CAPN3;F11R;CACNB2;SCRIB;ATP1B1;RAB3A;RAB40B;KCNIP3;THY1;ARL5A;MRAP;NRXN1;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;SHANK3;NUP54;CD81;ACTN2;BSG;ITGB1BP1;RAB38;FGF13;RAB3D;EHD1;ZDHHC2;EHD2;P2RY1;RAB34
prerank,negative regulation of cellular component movement (GO:0051271),-0.36678550729698933,-1.032540325821984,0.405152224824356,0.7063818583042727,1.0,4/15,3.71%,SP100;CRK;ACTN1;CCDC125
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2615602912943632,1.032402060169556,0.3855755894590846,0.9725094761924452,1.0,18/107,12.42%,SELENOS;TMEM117;ATP2A3;SCAMP5;TMEM259;UBXN6;ATP2A2;DAB2IP;BAK1;PRKN;CFTR;HSP90B1;RASGRF1;CCDC47;HERPUD1;CASP4;DERL1;ERP27
prerank,organelle transport along microtubule (GO:0072384),0.327382691432806,1.03198209417,0.4220032840722496,0.9727467574521453,1.0,11/31,17.35%,MAP1S;COPG1;RHOT1;LRPPRC;PEX14;BICD2;BORCS5;HAP1;UXT;COPG2;BICD1
prerank,apical junction assembly (GO:0043297),0.2932050168546404,1.0319674920436734,0.4057971014492754,0.971578211815389,1.0,6/53,6.81%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,regulation of gene expression (GO:0010468),-0.1835118746338518,-1.0316420773602615,0.15151515151515152,0.7081450480889956,1.0,235/903,22.63%,PID1;RBPJ;AHNAK;CD74;NR3C1;APOE;NSD2;HNRNPLL;NFXL1;FLOT2;GAS6;PTPN22;MECP2;STAP1;ITGAX;NOVA2;IGF1;CELF1;SETDB2;AFF1;ADAM19;SOX6;PARP14;MITF;GCNT2;NOCT;CDK6;SP3;LIN54;MED26;MSR1;MBNL1;PTPRC;LIMD1;XDH;TLR2;RPL5;ZUP1;FAM98B;TRIM14;KAT6B;RUNX3;AFDN;PEG3;BRAF;CD36;PRKAB1;FBXW7;FAM98A;ZPR1;SOX11;ASCC1;LAMTOR5;VPS35;TYROBP;PATZ1;ESR1;AHR;PROX1;LIMS1;NFKBIZ;NFKB1;TRIM17;PUM2;NAB1;MSN;TAF1;LYL1;YY1;VHL;ATXN1;RPS7;PF4;TAPBP;SMAD3;SP1;CRKL;TFRC;CEBPB;PRDM9;ZFP64;HNRNPAB;PICALM;PDCD10;RPL6;SLC8A2;LYN;PFDN5;MBNL3;YAP1;RO60;SRRT;HNRNPK;DNMT1;PRKCQ;HIF1A;BRCA1;IL1B;FGF1;BMI1;PSEN1;UTP4;MYBL2;RNF14;KDM6A;SMCR8;HINFP;RNF6;UBE2L3;ZC3H12A;KRAS;TRRAP;MZF1;CTCF;EP300;CD28;SPRY2;RC3H1;DNM2;ATF5;NOTCH1;TRIM44;AJUBA;CUX2;ZNF148;IGF2;CPSF4;ZNHIT3;SLC11A1;PARP9;AGO2;TCF7;HDAC1;KDR;TRIM5;RYBP;ZBTB11;PRDM4;RB1;LARP1;RACK1;SCX;NLK;BMP2;CREB3L1;TESC;KMT2D;FOXP1;IRF2;MSL3;RIMS2;TERF2;THAP7;LHX1;LILRB1;TRIM71;TNF;RAMP2;KAT7;GJA1;CRIP1;WNT5A;FOXK2;GPX1;PDE2A;HP1BP3;ZKSCAN5;TLR4;MAPK8;TIPARP;MLF1;CRNN;ADNP2;TESMIN;GSN;RGCC;HEY2;PTHLH;RFXANK;CLK4;GATA3;ERC1;HMGA2;HNRNPD;RNF20;TRAPPC2;FN1;NWD1;FOXN2;MMP8;PHF19;SBNO1;CDH1;MYADM;PPM1F;PTP4A3;WTIP;MYD88;HSPA1B;BMP7;ESRRB;LTF;DTNBP1;HMGA1;BHLHE40;RPL11;NFATC2;NOTCH2;KLF4;PUM1;WARS1;PTBP3;PIK3CD;TRIM21;RBAK;ZC3H7A;POU3F1;NDFIP1;HDAC4;CDH3;ID2;ANXA7;PSPC1;RREB1;HMGN5;SPIN4;CD3E;FGF18;SHH;CCAR1;TWIST1;APLNR;APP;PRDM8;TAF6L
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.2793777479436435,1.0314638874027204,0.41863699582753827,0.9721041101394519,1.0,14/75,12.98%,WNT4;HOXA5;HHEX;IL17F;YJEFN3;PDE3B;GTF2I;MINAR1;DAB2IP;FOXC1;VASH1;EFNA3;COL4A2;TEK
prerank,protein modification by small protein removal (GO:0070646),-0.20377866201262398,-1.0308108358778114,0.3448275862068966,0.7096323574847493,1.0,64/252,18.66%,VCPIP1;PSMA6;VCP;OTUD6B;IFIH1;PSMB2;ASXL2;CLSPN;SIAH2;ATXN7;SMURF2;PSME2;USP28;ESR1;YY1;INO80C;USP18;SMAD3;PSMD11;TNIP3;RIPK1;INO80B;PSMC6;UBC;USP45;HIF1A;PSMA3;BRCA1;ABRAXAS1;USP8;TAB1;UBA52;ZC3H12A;TRRAP;MYSM1;USPL1;RAD23B;EP300;USP9X;USP38;NFRKB;BARD1;JOSD1;TOMM20;CDK1;CCNA2;BIRC2;SENP1;PSMD10;STAM;UCHL3;TADA2B;PSMB5;CDC25A;FOXK2;USP5;UIMC1;BRCC3;SMAD4;GATA3;PSMD5;COPS4;INO80E;USP4
prerank,glutamate receptor signaling pathway (GO:0007215),0.3162044823202349,1.0302406034234477,0.41294298921417566,0.9752148131793014,1.0,19/37,29.64%,GRIA2;GRM3;GRIK2;GRID2;GRIN1;GRIA4;GRIN2B;HOMER2;DAGLA;DAGLB;GRIK3;GRIK4;GRM8;GNAQ;GRM7;KCNB1;PLCB1;GRM1;GRIN2A
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.3434085423660058,-1.0302099795174553,0.4154228855721393,0.7106840115065756,1.0,4/20,8.85%,APOE;KPNB1;LDLRAP1;MBTPS1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.4085330567538659,-1.0297661058659997,0.41025641025641024,0.7111408363924132,1.0,4/11,5.98%,GAS6;AXL;IRF7;NOD2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.314358749826121,-1.0296702220180005,0.42077922077922075,0.7107545153698067,1.0,10/27,23.54%,MAP3K8;CCDC88C;NFKB1;UBC;UBA52;KAT7;MAPK8;MAP2K7;MAP3K20;MAPK11
prerank,response to ethanol (GO:0045471),0.38846024355590736,1.0293797741031077,0.4063047285464098,0.9770534978809354,1.0,4/14,17.45%,GRIN1;GRIN2B;GLRA2;SDF4
prerank,Golgi ribbon formation (GO:0090161),-0.38226233818998634,-1.0292602026571107,0.41445783132530123,0.7112245051474585,1.0,4/13,17.70%,STX6;FHDC1;OPTN;GCC2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3506547528467714,-1.0291364293477043,0.4041994750656168,0.7109245646344146,1.0,6/16,18.71%,NRP1;PTPN1;PDGFD;PDGFC;BCAR1;PDGFRA
prerank,aromatic amino acid family catabolic process (GO:0009074),0.38656670641659263,1.0289070070901127,0.4075342465753425,0.9775378821117001,1.0,3/15,11.66%,IL4I1;IDO2;KYAT1
prerank,cell-substrate junction assembly (GO:0007044),0.3243581468374033,1.0288224057088515,0.40031645569620256,0.9765979558232065,1.0,6/33,9.01%,CTTN;DST;LAMB3;THY1;TRIP6;ACTN2
prerank,protein localization to cell surface (GO:0034394),0.34663488954585797,1.0287071514672192,0.419672131147541,0.9757946202310748,1.0,7/26,17.90%,FGF10;GGA3;PTPRU;FGF7;UNC50;JAM3;ANK2
prerank,positive regulation of cell motility (GO:2000147),-0.20957438894803143,-1.0284480791960149,0.375,0.712014824046864,1.0,71/205,25.85%,DAB2;NEDD9;PLAU;ITGAX;IGF1;CASS4;GCNT2;SDCBP;CXCL16;ADAM9;THBS1;PDGFD;FLT1;CAV1;PDCD10;CARMIL1;CIB1;IL1B;FGF1;SEMA6D;RET;MAPRE1;PDGFC;SPRY2;ELP6;NOTCH1;MIEN1;SEMA6A;PHPT1;CCN1;PPP3CA;F7;SEMA3B;SEMA5B;FAM83H;KDR;MYOC;RACK1;BMP2;HAS2;FAM89B;EGFR;PTK2B;BCAR1;ADAM17;SEMA4A;CLDN1;CARMIL2;PDGFRA;MYADM;PPM1F;MYLK;F10;ACVR1;SYNE2;PIK3CD;CXCL12;SEMA4D;SEMA4G;CCAR1;TWIST1;GTSE1;EGF;CCL7;SEMA3F;SEMA3E;TJP1;PDPN;GPNMB;CSF1;PDGFA
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3602569642232526,1.0281321742825025,0.41368078175895767,0.9752632001860708,1.0,9/20,19.94%,ACADSB;BCAT1;BCKDHB;ALDH6A1;SLC25A44;DLD;HSD17B10;BCKDHA;ECHS1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3602569642232526,1.0281321742825025,0.41368078175895767,0.9752632001860708,1.0,9/20,19.94%,ACADSB;BCAT1;BCKDHB;ALDH6A1;SLC25A44;DLD;HSD17B10;BCKDHA;ECHS1
prerank,DNA repair (GO:0006281),-0.20217296583887406,-1.0280483128239049,0.36054421768707484,0.7124107893259238,1.0,70/284,18.68%,ASCC3;VCPIP1;NSD2;RAD51B;PARP4;RBBP8;VCP;BAZ1B;PDS5B;DTX3L;PCNA;ASCC1;KPNA2;TOPBP1;DOT1L;ZRANB3;APEX2;MDC1;ERCC6L2;CHD1L;POLI;NBN;UBC;IGHMBP2;CIB1;USP45;BRCA1;UVRAG;EYA1;ABRAXAS1;PDS5A;ATRIP;HINFP;UBA52;TRRAP;MAD2L2;EYA3;RAD23B;POLD4;RHNO1;BARD1;RPA1;CDK1;LIG4;RMI2;PARP9;KAT5;TICRR;RAD21;NPM1;FAAP20;MNAT1;FANCI;EME1;RNASEH2A;MAPK8;PMS1;NOP53;RPA2;MUTYH;UIMC1;BRCC3;CENPX;HMGA2;SLX4;TRIP13;FANCM;XPC;WDHD1;HPF1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.39393020019158154,-1.0277898901873361,0.41007194244604317,0.7124793517075535,1.0,4/12,18.52%,STAP1;IL1B;TNF;MMP8
prerank,skeletal muscle organ development (GO:0060538),0.338253714097159,1.0277887472104728,0.3913764510779436,0.9752335000750291,1.0,9/26,23.99%,SIX4;DISP1;MEF2C;MYL6;IGSF8;LARGE1;FXR1;CFLAR;POPDC3
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3039048120185327,1.0277471877729876,0.3858858858858859,0.9741716877778275,1.0,15/46,20.70%,ANG;IL6;XRCC6;TRIB1;CCN4;BMP4;TCF7L2;RBPMS2;PDGFB;NDRG4;APOD;IL18;CCL5;PDGFRB;XRCC5
prerank,positive regulation of calcium ion transport (GO:0051928),0.3191761022521261,1.0276347001990136,0.4267515923566879,0.9733577391327835,1.0,10/36,19.42%,TRPC3;CACNB2;CCR1;GRIN1;TRPC6;CACNA1D;PDGFB;ANK2;CCL5;PDGFRB
prerank,renal water homeostasis (GO:0003091),-0.3193937174869034,-1.0273857612869277,0.42077922077922075,0.7128996393509234,1.0,9/23,19.00%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB;WFS1;TFAP2B
prerank,mRNA 3'-end processing (GO:0031124),0.27560502343507026,1.0272769615868327,0.4096728307254623,0.9733697060658717,1.0,22/78,20.12%,RNPS1;SRSF5;CPSF4L;CASC3;CPSF6;SRSF6;SRSF11;MTPAP;SRSF1;CPSF3;CSTF1;NUDT21;CDC40;DDX39B;THOC5;PAF1;SARNP;SRSF9;CHTOP;ALYREF;SSU72;SRSF2
prerank,carboxylic acid metabolic process (GO:0019752),0.3196723793168121,1.0271045330882935,0.37598736176935227,0.9727348949592445,1.0,7/33,16.81%,SLC2A3;CYP2S1;GSTO1;CSGALNACT1;ACOT4;DAO;AGXT
prerank,glucose homeostasis (GO:0042593),0.2750740599425751,1.027041372380845,0.40772532188841204,0.971743994624394,1.0,15/83,15.05%,NUCKS1;ADCY8;PPARGC1A;SOX4;STK11;IL6;RFX6;ADRA2A;TCF7L2;KLF7;IRS1;USF1;HK2;INSR;PTPN2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3262129610151605,-1.026896715652766,0.4,0.7135751439638761,1.0,9/23,23.83%,IGF1;NFKB1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP;EGF
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.35723899124587766,-1.0268841431534632,0.3930232558139535,0.7129476690926844,1.0,6/16,21.41%,IGF1;IGFBP4;BMP5;BMP2;IGFBP5;CDH3
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4272895262241978,1.0267131464513097,0.42857142857142855,0.9717237562531167,1.0,3/10,20.14%,IL4I1;KYAT1;QDPR
prerank,ncRNA 3'-end processing (GO:0043628),0.39851918062449554,1.0266290766408197,0.4075993091537133,0.9708213682059278,1.0,6/14,22.14%,INTS6L;ELAC2;PTCD1;INTS8;INTS5;TRNT1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3166487577328737,1.0261765919007495,0.4214501510574018,0.9711498960291507,1.0,18/33,32.26%,SLC4A8;GRIK5;GRIK2;GRID2;CX3CR1;NRG3;CACNA1B;CACNA1A;LRRC4C;GRIK3;BDNF;GRIK4;PSMC5;FABP5;CEL;GRID1;NLGN3;NLGN1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.31604749761422224,-1.0259825488755043,0.40931372549019607,0.7147672813401397,1.0,8/22,16.71%,NRP1;EGR3;ID1;KDR;EMP2;GREM1;MYH9;EPHB4
prerank,outer dynein arm assembly (GO:0036158),0.3827735752511512,1.0257549681212643,0.43094841930116473,0.9713725935322496,1.0,2/15,2.02%,DNAAF1;ODAD4
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.33142489700320743,-1.0257314909131703,0.3888888888888889,0.7147812569904979,1.0,3/20,0.97%,NRP1;PLAU;IGF1
prerank,prostaglandin biosynthetic process (GO:0001516),0.36902447098966,1.0255629717635473,0.43005181347150256,0.9708352631032329,1.0,3/18,4.38%,PTGS1;PTGDS;PRXL2B
prerank,positive regulation of translation (GO:0045727),-0.23654460743715444,-1.0251133889179525,0.36454849498327757,0.7157430762609963,1.0,27/94,19.55%,RCC1L;UPF3A;NIBAN1;RPL5;TRUB2;BCL3;SAMD4A;TRMT10C;THBS1;LARP6;VIM;UHMK1;CD28;PIWIL2;JMJD4;PLD1;UQCC2;AGO2;LARP1;NPM1;ZCCHC4;LARP4B;FXR2;UPF3B;HNRNPD;NAT10;RPL26
prerank,amino acid import across plasma membrane (GO:0089718),-0.3139697386467083,-1.0249132657683306,0.39901477832512317,0.7155951183052044,1.0,3/24,3.14%,SLC1A5;SLC7A1;SLC6A6
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.353305649132455,1.0246145675997933,0.4174603174603175,0.9729347580345602,1.0,8/24,25.47%,BOC;CTNNA2;MEF2C;TCF3;OLFM2;CDC42;MEF2A;CAMK1
prerank,MAPK cascade (GO:0000165),0.23040035319701224,1.0245755025926087,0.389082462253194,0.9718794827585564,1.0,72/295,21.40%,FGF10;YWHAE;IL5RA;FGF16;PSMB1;DLG2;FGF9;IL2RA;PAK1;KLB;RGL2;NRG4;FGF7;MEF2C;AREG;IL2;PSMF1;BTRC;LYPLA1;RIT2;DAB2IP;SHANK3;RASGEF1A;PPP1CC;PSMA1;ZFP36L2;PSMD7;ERBB4;ACTN2;GRIN1;MAP4K4;TGFB1;GRIN2B;PTPN3;PSMA8;RASGRF1;FGF13;FGF2;SPTAN1;PSME3;IRS1;MINK1;MAP3K7;PSMD14;PDGFB;TEK;SPTBN2;GFRA1;PPP5C;PSMC4;SPTBN1;RASAL3;MAPK3;SETX;HRAS;PTK2;TAOK1;FLT3;IL18;MBP;PSMB4;GOLGA7;ABHD17C;IL17RD;CCL5;PDGFRB;TNIP2;PSME1;YWHAB;PSMD2;PSMD4;SHC3
prerank,regulation of biomineral tissue development (GO:0070167),-0.31165405652086275,-1.0245201957367094,0.42650602409638555,0.7159173234542257,1.0,5/26,10.93%,GAS6;NBR1;CEBPB;ANKH;NOTCH1
prerank,regulation of muscle cell differentiation (GO:0051147),0.32737955569276833,1.0244293071748454,0.4228395061728395,0.9712032048933843,1.0,4/31,6.22%,BOC;CTNNA2;PTBP1;MEF2C
prerank,regulation of telomere capping (GO:1904353),-0.32246365616455885,-1.024393263469282,0.37530266343825663,0.7156151031623764,1.0,8/23,18.11%,RTEL1;PKIB;NBN;PRKCQ;TERF2;MAP2K7;HNRNPD;SMG6
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.24569110835329883,1.0239133645393512,0.4046692607003891,0.9717578904077493,1.0,39/173,18.47%,ACTR10;RAB1B;KDELR3;CNIH2;CNIH4;SEC16B;TMED2;AREG;COPG1;COG4;SEC31A;GRIA1;NRBP2;TRAPPC3;MPPE1;ZW10;BGLAP;PDCD6;CNIH1;SPTAN1;BET1L;DCTN1;SPTBN2;TMED5;SEC24D;SEC24B;SPTBN1;COPE;IER3IP1;KDELR2;MIA3;SEC24C;TMED3;COPG2;ANK2;PREB;STX17;LMAN2L;DCTN3
prerank,positive regulation of DNA replication (GO:0045740),-0.3616719420851955,-1.0238618162518003,0.4289340101522843,0.7164107667269888,1.0,5/16,15.38%,PCNA;BCAR3;CDT1;EGFR;KAT7
prerank,renal absorption (GO:0070293),-0.410702068542784,-1.0237214002377388,0.4075829383886256,0.7160947559109674,1.0,4/10,24.70%,HAS2;GSN;KCNQ1;SLC15A2
prerank,regulation of lipid catabolic process (GO:0050994),0.36539625585832497,1.0236043084948616,0.42424242424242425,0.9716200977915834,1.0,6/19,20.22%,RARRES2;PDE3B;ADRA2A;ANGPTL3;HCAR2;TYSND1
prerank,negative regulation of growth (GO:0045926),0.2563956332071488,1.0235619588019857,0.3942701227830832,0.9705822029812136,1.0,39/121,24.48%,WFDC1;PSRC1;SIPA1;STK11;MINAR1;APBB1;FHL1;GNG4;TGFB1;ADAM15;SFRP1;CGRRF1;ACVR1B;DCBLD2;FLCN;EI24;CCAR2;SH3BP4;NDRG3;MT2A;PPP2R1A;BTG1;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;TCHP;FRZB;SFRP2;NPR1;JADE1;PRDM11;SMARCA2;CDKN2AIP;CRLF3
prerank,erythrocyte differentiation (GO:0030218),0.305383604921916,1.0233376317393061,0.4074074074074074,0.9701592434873679,1.0,11/44,17.40%,ZFPM1;NCKAP1L;TGFBR3;FLVCR1;SH2B3;HSPA9;CASP3;SLC25A5;INHA;PTPN2;KMT2E
prerank,cardiac muscle cell differentiation (GO:0055007),0.35841373645816177,1.0232436955959159,0.42197452229299365,0.9692824262630277,1.0,5/21,16.53%,KDM6B;MEF2C;SLC8A1;AKAP13;CXADR
prerank,negative regulation of JNK cascade (GO:0046329),-0.2938973093945412,-1.0232006818028105,0.39617486338797814,0.7168392911809099,1.0,9/31,24.31%,ITCH;PTPN22;TAOK3;NCOR1;DUSP19;MECOM;GSTP1;DUSP3;FKTN
prerank,skeletal system development (GO:0001501),-0.21588130182968251,-1.0231428695869382,0.35658914728682173,0.7163255397005043,1.0,36/148,20.01%,TRPS1;IGF1;EXT1;XYLT1;SOX6;CD44;PAPSS2;ATP7A;SOX11;PTGER4;SH3PXD2B;TCOF1;COL11A2;DYM;WWOX;ANKH;BMP5;IGF2;MYOC;BMP2;GJA1;WNT5A;DEAF1;BMP3;ANKRD11;RAB33B;HYAL3;PTHLH;COL9A2;TRAPPC2;BPNT2;TEAD4;PKDCC;RFLNA;GDF3;BMP7
prerank,positive regulation of histone acetylation (GO:0035066),-0.31464406926618604,-1.023111568624136,0.4049382716049383,0.7157434629069647,1.0,9/23,18.49%,BRCA1;IL1B;PAXIP1;GLYR1;SPHK2;TADA2B;KAT7;SMAD4;TADA2A
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3590966461952515,1.0229606583380968,0.4574829931972789,0.9691243111417406,1.0,6/21,15.23%,NUDT10;PNP;NUDT3;AMPD3;HPRT1;FITM2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3093189603231471,1.022946973020416,0.40476190476190477,0.9679909009382371,1.0,9/39,11.28%,FGF14;FGF12;FGF11;DMD;HECW2;PTPN3;NEDD4;FGF13;STK39
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.21281031185006272,-1.0227035895587475,0.36683417085427134,0.7162522055371539,1.0,40/175,19.15%,PID1;PSMA6;TNFSF8;PSMB2;PSME2;LIMS1;CCL25;BAG4;PSMD11;RIPK1;PSMC6;GBP3;CIB1;PSMA3;BRCA1;ZC3H12A;STAT1;LTB;ACOD1;BIRC2;TNFRSF1B;PSMD10;EDA;INPP5K;TNFRSF17;HAS2;PSMB5;TNF;PTK2B;TRAF1;HYAL3;ADAM17;PYDC1;TNFRSF9;TNFRSF25;GATA3;PSMD5;ARHGEF2;ADAMTS12;PSMD1
prerank,protein targeting to membrane (GO:0006612),0.267230990354865,1.022018349639703,0.4167832167832168,0.9699638706452887,1.0,29/83,22.66%,CHM;PEX5;FIS1;SGTA;ATAD1;PRKCI;SEC62;ZDHHC22;SSR1;PEX26;MYO1C;ZDHHC1;PEX14;ZDHHC2;SGTB;SRP14;GET3;MICALL1;TRAM1;SRP19;ZDHHC23;PEX2;SRPRA;ABCD2;GOLGA7;SSR2;PEX11B;ZDHHC15;PEX3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.29550433615000404,-1.0219357452321345,0.410958904109589,0.7176161682384856,1.0,8/32,10.41%,AEN;USP28;BCL3;BAG6;TMEM109;SNW1;EP300;HIPK1
prerank,vesicle transport along microtubule (GO:0047496),-0.3205513546951547,-1.0217554029116527,0.4137055837563452,0.7174414708997731,1.0,12/23,33.51%,TRAK1;KIF3A;RAB1A;CLN3;PAFAH1B1;NDE1;TRAK2;KIF3B;BICDL2;KIF5A;DYNC1H1;HTT
prerank,diol biosynthetic process (GO:0034312),-0.36670204226048986,-1.0213006690486093,0.4358974358974359,0.7179936784167825,1.0,6/15,20.95%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3;DHFR
prerank,regulation of transport (GO:0051049),-0.2826044042624003,-1.0211476957225636,0.4143646408839779,0.717726178457468,1.0,9/36,17.13%,ARL6IP5;NRP1;GAPVD1;ICA1;MBTPS1;LRRK2;YRDC;MUL1;RSC1A1
prerank,positive regulation of secretion (GO:0051047),0.4232473587415421,1.021131316426974,0.43456375838926176,0.9718105017489834,1.0,4/11,23.61%,XBP1;NPR1;ACSL3;GPLD1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.3547785718103245,-1.0211143618062695,0.42744063324538256,0.7171485277069104,1.0,3/16,3.64%,PID1;VCP;ENO1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.34663813431574153,1.0207458106222504,0.43399339933993397,0.9707978877788767,1.0,10/23,21.39%,YWHAE;E2F1;PPP3CC;PPP1R13B;BBC3;YWHAQ;NMT1;CASP8;YWHAB;TFDP2
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.34663813431574153,1.0207458106222504,0.43399339933993397,0.9707978877788767,1.0,10/23,21.39%,YWHAE;E2F1;PPP3CC;PPP1R13B;BBC3;YWHAQ;NMT1;CASP8;YWHAB;TFDP2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.3242505866287514,-1.0205741017124323,0.40591397849462363,0.7179510235453436,1.0,10/22,25.85%,PDGFD;NBN;PDGFC;CALM3;CALM2;GREM1;RAP2A;GPNMB;TNKS1BP1;PDGFA
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4121849283978868,-1.0204093769329667,0.44075829383886256,0.7177093041018678,1.0,5/10,19.02%,XYLT1;DSEL;DSE;XYLT2;PXYLP1
prerank,positive regulation of metabolic process (GO:0009893),0.25698881295211956,1.0203732736883775,0.4100817438692098,0.9708774774000833,1.0,25/103,18.81%,KSR2;G0S2;ESRRG;KDM6B;PPARGC1A;GATM;PRLR;MFAP2;ADCYAP1;OGT;ACHE;CXCR4;ELOVL6;EPAS1;AGPAT1;PRDM16;INSR;ACLY;ACACB;GNAS;ALMS1;IL18;ZBTB7B;HDAC3;GHRL
prerank,regulation of type I interferon production (GO:0032479),-0.23723966728770635,-1.0201055615735677,0.40492957746478875,0.7178727512563652,1.0,29/84,22.58%,ITCH;PTPN22;TRIM25;IFIH1;IRF7;ZBP1;TBK1;POLR2E;DHX33;NFKB1;CD14;RNF216;DDX41;EP300;CTNNB1;ACOD1;NLRC5;LRRFIP1;POLR2H;UBE2L6;DTX4;POLR3G;TRAF3IP1;MYD88;NPLOC4;TRIM21;RNF125;G3BP1;CRCP
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.21696085254164452,-1.0198962551966144,0.36086956521739133,0.7177763143030584,1.0,23/161,7.94%,DAB2;STK3;APOE;PSMA6;MCC;LIMD1;CUL3;DVL3;IGFBP4;PSMB2;SIAH2;PSME2;CCDC88C;DKK2;HECW1;PSMD11;MLLT3;TMEM131L;PSMC6;CAV1;PFDN5;ZNRF3;PSMA3
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.4042845953478822,-1.0196718386823183,0.42105263157894735,0.7177748153282013,1.0,4/11,13.89%,SOX6;FRS2;GREM1;BMP2
prerank,tRNA transport (GO:0051031),-0.2780929732102835,-1.0195224804433467,0.4323529411764706,0.7175241739950257,1.0,8/35,11.14%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB;TOMM20
prerank,T cell homeostasis (GO:0043029),0.43445454698243735,1.0194819693494315,0.4355400696864111,0.9727512160822208,1.0,3/10,9.81%,NCKAP1L;RIPK3;ZC3H8
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.3419644173876227,-1.0192627060474175,0.41798941798941797,0.7175453104102101,1.0,7/19,20.53%,LIFR;IFIH1;CD24;PARP9;WNT5A;MAPK7;KLF4
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3583305568438483,1.019162433321431,0.41710296684118675,0.9726636863289074,1.0,12/22,27.34%,MAP1S;AEBP1;CAMSAP3;CAMSAP1;AKAP13;CHRNA7;MAP2;MAPRE3;GBA2;MAPT;MAP1B;HSPA8
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.27270621018309826,1.0190345979069189,0.41531664212076586,0.9719502433771702,1.0,22/72,24.18%,DNASE1;RNASE1;GTF2H2;DNASE1L2;POLD3;DDX1;GTF2H4;OGG1;FAN1;PARP1;DDB2;FEN1;PNRC2;DXO;REXO4;HORMAD1;IHO1;EXD2;GTF2H3;RFC4;ERCC2;ERCC4
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3064255145517335,-1.0190032252605257,0.42091152815013405,0.7175328350235058,1.0,8/24,17.17%,PTPN22;DTX3L;ZC3H12A;STAT1;TRIM44;PARP9;LILRB1;TRAF3IP2
prerank,actin filament capping (GO:0051693),-0.33757806361396053,-1.0188119595114213,0.39285714285714285,0.7167421372360561,1.0,6/18,17.28%,SVIL;EPS8;ADD3;VILL;CAPZB;GSN
prerank,barbed-end actin filament capping (GO:0051016),-0.33757806361396053,-1.0188119595114213,0.39285714285714285,0.7167421372360561,1.0,6/18,17.28%,SVIL;EPS8;ADD3;VILL;CAPZB;GSN
prerank,telomere organization (GO:0032200),-0.2738940406038297,-1.0185227950468752,0.43023255813953487,0.716911475242042,1.0,8/43,11.08%,SP100;PCNA;DOT1L;RTEL1;NBN;H3-3A;POLD4;RPA1
prerank,positive regulation of neuron death (GO:1901216),-0.2702079911275543,-1.0185075326874538,0.3732193732193732,0.7163074090858353,1.0,11/46,16.40%,FCGR2B;BAX;TYROBP;PICALM;FYN;EIF2S1;CTNNB1;FOS;TNF;WNT5A;TLR4
prerank,alcohol catabolic process (GO:0046164),-0.4236193397989867,-1.0183669439459337,0.4376417233560091,0.716037410807421,1.0,1/10,0.52%,APOE
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.19996374829399513,-1.0182064619108222,0.3680555555555556,0.7158470502790117,1.0,59/314,13.86%,PPP2R5C;ITCH;WWP1;PSMA6;UBE2D3;KLHL20;BUB3;FBXL17;VCP;TRIM25;CUL3;CUL4A;UBE2K;PSMB2;FBXL14;FBXW7;SIAH2;FBXL8;OS9;SMURF2;PSME2;TAF1;RNF216;HECW1;RMND5B;PSMD11;CDC34;PSMC6;UBQLN1;DNAJB9;UBC;NHLRC3;TBL1X;PSMA3;ERLIN2;FBXW4;BAG6;KLHL15;SPOPL;KCTD17;UBA52;DCAF12;DNAJC10;RAD23B;CDC27;SPSB2;CTNNB1;CDK1;MAD2L1;BIRC2;RNF103;KAT5;PELI1;EDEM1;PSMD10;BUB1B;RB1;FBXO2;KCTD2
prerank,regulation of presynapse organization (GO:0099174),0.3709786571515609,1.0182009474352216,0.43934426229508194,0.9724753436520854,1.0,9/18,30.71%,PTPRD;IL1RAPL1;GPC4;WNT7A;IL1RAPL2;LRRC4B;SLITRK1;LRFN5;MDGA1
prerank,regulation of presynapse assembly (GO:1905606),0.3709786571515609,1.0182009474352216,0.43934426229508194,0.9724753436520854,1.0,9/18,30.71%,PTPRD;IL1RAPL1;GPC4;WNT7A;IL1RAPL2;LRRC4B;SLITRK1;LRFN5;MDGA1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.41757992543874456,-1.018149121116683,0.4406392694063927,0.7147266916857636,1.0,8/10,37.81%,PPP3R1;PPP3CA;NFATC3;NFATC2;NFAT5;PPP3CB;NFATC4;NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),-0.41757992543874456,-1.018149121116683,0.4406392694063927,0.7147266916857636,1.0,8/10,37.81%,PPP3R1;PPP3CA;NFATC3;NFATC2;NFAT5;PPP3CB;NFATC4;NFATC1
prerank,ureteric bud morphogenesis (GO:0060675),0.3731703115354728,1.018101977069778,0.4189655172413793,0.9716226965401066,1.0,4/16,11.07%,BMP4;PKD2;FGF2;NPNT
prerank,neuron remodeling (GO:0016322),0.42353322361113366,1.0180588783128273,0.4318181818181818,0.9706170263208507,1.0,2/10,12.15%,C3;FARP2
prerank,positive regulation of translational initiation (GO:0045948),0.3639715210709815,1.0179698137843431,0.44839255499153974,0.9697667632909467,1.0,7/18,25.30%,RPS6KB1;CDC123;POLR2G;CCL5;EIF2B5;POLR2D;DDX3X
prerank,positive regulation of bone mineralization (GO:0030501),0.31428754025791117,1.0177249464305815,0.4201550387596899,0.969466585805925,1.0,6/35,9.64%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.28105608796573256,-1.0175330779126217,0.42118863049095606,0.7157195683068877,1.0,9/38,14.00%,EPC1;RBBP8;RBBP7;BRCA1;BMI1;RHNO1;EHMT1;RYBP;L3MBTL2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3865252901725048,-1.017491227286726,0.41232227488151657,0.7151814640061005,1.0,5/12,17.04%,MIS12;BOD1;CDT1;NDC80;NUF2
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2795699619233539,-1.0172182898073219,0.3942857142857143,0.7153029746316911,1.0,12/38,16.87%,PPP2R5C;XDH;CIB1;DAG1;BANK1;DRD2;RACK1;INPP5K;SFRP5;EPHA2;MUL1;NOP53
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.24861888509354374,1.0172105760184054,0.4295125164690382,0.9701017465492567,1.0,21/138,9.70%,POLR2L;CDK7;WWTR1;POLR2F;ESRRG;NR1I2;NR1I3;PPARGC1A;GTF2H2;PPARA;NR2F6;AR;GTF2H4;RXRG;GTF2F1;MAZ;NCOR2;GTF2E2;HDAC5;TAF9;MAML3
prerank,regulation of necroptotic process (GO:0060544),-0.3163412052131698,-1.0171808130312354,0.46296296296296297,0.7147735964072667,1.0,7/23,13.04%,FLOT2;SDCBP;ZBP1;RIPK1;BIRC2;PELI1;PDCD6IP
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.20404485209909184,-1.0169901804421406,0.39263803680981596,0.7146445617071212,1.0,53/234,17.30%,STK3;PSMA6;FLOT2;PRKCH;TRIM25;TLR2;TRIM14;PPARG;CD36;SMARCA4;RAB7B;LAMTOR5;NLRC4;DHX33;ESR1;NFKB1;CEBPG;TAF1;SMAD3;NOD2;RIPK1;TFRC;CAV1;TRIM62;TAF12;UBC;CIB1;PRKCQ;IL1B;HSF1;TAB1;PIDD1;UBA52;ADAM8;EP300;CTNNB1;ADCY1;FZD2;TRIM5;EDA;NPM1;RIPK4;AGER;TNF;WNT5A;ARHGEF5;TRAF1;TLR4;ARID5B;CRNN;IL18R1;HIPK2;RGCC
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.34119604831319306,-1.016830072766489,0.3847926267281106,0.7144666478830684,1.0,7/16,17.30%,SUCO;LARP6;VIM;HDAC2;SCX;CREB3L1;RGCC
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3732395606013602,1.0166082597513153,0.4050632911392405,0.9709932322768872,1.0,5/16,15.47%,NACC2;ACKR3;CLU;SNAI2;CCAR2
prerank,negative regulation of cell population proliferation (GO:0008285),0.22692300360797152,1.0165663022117264,0.42390078917700114,0.9699642365465145,1.0,69/351,18.11%,ATP8A2;P3H2;MN1;TPTE;TSC2;MAGED1;SMYD2;AVPR2;ANG;NACC2;PAK1;NTRK1;SLURP1;COPS8;TENM1;SOX4;IGFBP6;PTPRU;STK11;E2F1;IL6;PDCD5;CTBP1;TRIB1;GSDME;AR;RBM5;EEF1E1;TGFBR3;MINAR1;DAB2IP;NME1;BMP4;ERBB4;PKD2;SST;TGFB1;NMI;EMD;BTG3;ITGB1BP1;SH2B3;THAP12;BTG2;KDM2B;SFRP1;CGRRF1;NDRG4;FLCN;BAP1;ZBTB49;APOD;PTPN2;IFI35;HPN;SH3BP4;ADORA3;REST;COL18A1;MED25;PEX2;DNAJA3;HRAS;OPRM1;CDK10;BTG1;FABP3;UTP20;IL1A
prerank,microtubule anchoring at centrosome (GO:0034454),-0.4240026957271237,-1.0165461324894998,0.4331065759637188,0.7145908176025652,1.0,2/10,1.48%,KIF3A;PCM1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.43770251563520585,1.0163039963285674,0.4392857142857143,0.9697037451429361,1.0,6/10,27.16%,SH3BP1;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,macrophage migration (GO:1905517),-0.3691142586128132,-1.0162954570018765,0.4413145539906103,0.7146473573521394,1.0,4/13,13.58%,P2RX4;CCR2;EDNRB;CXCL17
prerank,positive regulation of innate immune response (GO:0045089),-0.30225485164385985,-1.0160840387714372,0.41595441595441596,0.7145923680217859,1.0,14/30,28.77%,UBE2K;ZBP1;TRIM62;TLR8;ADAM8;NLRC5;LBP;WNT5A;POLR3G;SLC15A4;PLSCR1;FADD;FPR2;RPS19
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.307137565203051,1.0160621747663698,0.43440233236151604,0.9693576082345847,1.0,7/39,9.66%,RNF126;AREG;LGMN;DAB2IP;SH3GL2;MVP;PTPN3
prerank,ion homeostasis (GO:0050801),0.328410589992021,1.0158513236452515,0.4578512396694215,0.9689233216667128,1.0,8/30,19.01%,SLC4A8;FHL1;SLC30A3;UNC80;SLC4A10;SLC4A7;NEDD4L;WNK1
prerank,regulation of multicellular organism growth (GO:0040014),-0.3597915902949021,-1.0157809353014984,0.4337899543378995,0.7147662495046603,1.0,6/15,22.59%,IGF1;STAT5B;GHR;MFSD2A;PTCH1;APP
prerank,protein glycosylation (GO:0006486),0.24985300208954064,1.0157798750035625,0.44161073825503355,0.9679933460808321,1.0,29/125,20.17%,PLOD3;ST3GAL5;TET1;B3GNT9;FUT10;B3GNT6;B4GAT1;B3GALT2;DDOST;ALG1;SERP2;ST6GALNAC2;POFUT1;OGT;B3GALNT1;SLC39A8;MGAT5B;ST3GAL6;GAL3ST1;MGAT4B;TMEM258;POMGNT1;PLOD1;ALG5;DPM3;GCNT4;ALG3;ST3GAL3;GALNT2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.2858675965269508,-1.0157594345806251,0.42105263157894735,0.7141710024780943,1.0,17/33,37.33%,CD74;PF4;RIPK1;HSF1;TESC;TNF;ACIN1;ID2;FADD;CSF1;LEF1;CD4;DCSTAMP;IL23R;IL12B;POU4F2;POU4F1
prerank,protein localization to cell-cell junction (GO:0150105),0.38424403874741375,1.0151194700637998,0.43676222596964587,0.9690874755939578,1.0,2/15,2.48%,F11R;SCRIB
prerank,positive regulation of RNA metabolic process (GO:0051254),0.30028102608791507,1.0148084531690806,0.4277016742770167,0.9690078125511254,1.0,9/45,9.35%,DDX5;RELA;SLC38A2;RIOK1;IL6;WDR75;DIMT1;BMP4;TGFB1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3291150317220686,-1.0147302664855076,0.4188861985472155,0.7162548912542445,1.0,8/19,17.30%,SUCO;CIITA;LARP6;VIM;HDAC2;SCX;CREB3L1;RGCC
prerank,negative regulation of protein binding (GO:0032091),0.2744746817647888,1.0144883287771211,0.42334739803094235,0.9689507090010058,1.0,24/71,25.47%,ATP2A3;ZFPM1;ATP2A2;TMC8;EFHB;ARRB2;GTF2F1;STYX;ITGB1BP1;ADAM15;PEX14;USP33;PDGFB;MITD1;CARD16;ROCK1;PIN1;ACTB;MAP2;PPP1CA;AURKA;TMBIM6;HFE;CAMK1
prerank,negative regulation of proteolysis (GO:0045861),0.31824487546738617,1.0142699999971811,0.4526813880126183,0.9685278492937061,1.0,12/34,24.13%,PLAT;CST3;PRNP;PTPN3;EFNA1;EPHA4;SERPINE2;ROCK1;TMEM59;TIMP2;CST7;ACP4
prerank,aggrephagy (GO:0035973),-0.3070578626760097,-1.0138961704676464,0.43717277486910994,0.7177969889895788,1.0,9/27,16.83%,ARL13B;UBQLN1;UBC;WDFY3;UBA52;VIM;WDR81;DYNC1LI2;SQSTM1
prerank,glycerophospholipid metabolic process (GO:0006650),0.27228170489021847,1.0135873681265914,0.45043731778425655,0.9696840649438522,1.0,11/75,8.84%,PRDX6;PLA2G3;PLCD1;PLA2G4C;PIGQ;PLCG1;PNPLA3;ABHD12;PIGB;PIGP;CPNE6
prerank,positive regulation of T cell differentiation (GO:0045582),0.3133581212510747,1.0132541085449598,0.44227642276422763,0.9697006719390696,1.0,6/36,10.56%,IL4I1;VSIR;NCKAP1L;SOX4;PNP;NKAP
prerank,protein localization to kinetochore (GO:0034501),-0.37481367197616544,-1.0130197212226892,0.4260204081632653,0.7195569708770205,1.0,5/14,14.14%,BUB3;MIS12;ZWILCH;CDK1;SPDL1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.26242542157569876,-1.0130144103453358,0.4319526627218935,0.7189327780825082,1.0,16/50,19.56%,SASH1;TLR2;TLR7;LIMS1;CD14;NOD2;IL1B;EP300;TRIM44;EGFR;AGER;TNF;TLR4;NR3C2;MMP8;PTP4A3
prerank,positive regulation of nervous system process (GO:0031646),0.36000959968068436,1.0129647059782785,0.43485342019543977,0.9695177776648568,1.0,4/18,13.57%,TPPP;UNC13B;RIMS1;MYRF
prerank,erythrocyte development (GO:0048821),0.4251173065393915,1.0129220625551818,0.437609841827768,0.968510604598826,1.0,5/10,27.09%,NCKAP1L;SH2B3;ZBTB7A;LYAR;DMTN
prerank,response to UV-B (GO:0010224),0.40887786554675987,1.0128303735285522,0.4735099337748344,0.9676575888638387,1.0,2/12,5.04%,RELA;STK11
prerank,response to amyloid-beta (GO:1904645),-0.2663128979357059,-1.012431804153855,0.42857142857142855,0.7199463388389881,1.0,10/44,16.40%,ITGA4;FCGR2B;IGF1;CD36;FYN;PSEN1;LRP1;AGER;GJA1;TLR4
prerank,protein localization to cell periphery (GO:1990778),0.2513256619774148,1.0124140235655776,0.42277486910994766,0.9679270262003548,1.0,29/133,14.32%,WDR19;F11R;CACNB2;ATP1B1;RAB3A;RAB40B;KCNIP3;MRAP;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;CD81;ACTN2;BSG;ITGB1BP1;FGF13;RAB3D;EHD1;ZDHHC2;EHD2;P2RY1;RAB34;RAB12;SPTBN1
prerank,regulation of response to oxidative stress (GO:1902882),-0.3969521160906859,-1.0122314617812744,0.4278728606356968,0.7198554093381497,1.0,2/11,1.17%,MCTP1;ALOX5
prerank,regulation of lamellipodium organization (GO:1902743),-0.36192198116454627,-1.0119967657071134,0.42857142857142855,0.7198472390343787,1.0,7/14,25.63%,CD44;CARMIL1;EPHA2;CAPZB;CARMIL2;PDPN;RAC1
prerank,protein O-linked mannosylation (GO:0035269),0.369397790496196,1.0117882796440574,0.4444444444444444,0.9689197620953368,1.0,8/18,27.31%,B4GAT1;TMTC4;FKRP;SDF2L1;DPM3;LARGE1;DPM1;DPM2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.41474569103625153,-1.0117090144167444,0.41247002398081534,0.7200053443966384,1.0,3/10,18.57%,PRKCH;NUMA1;TRIM16
prerank,mitotic spindle assembly (GO:0090307),-0.27185524313020726,-1.011571973249683,0.4444444444444444,0.7197739542134588,1.0,9/42,8.48%,KPNB1;PIBF1;KIF23;KIF11;PRC1;KIFC2;KIFC1;RACGAP1;ABRAXAS1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.40651423399295095,1.0114708584240004,0.4226086956521739,0.9687969578972515,1.0,4/12,9.35%,ZC3H10;IL6;NCOR2;TGFB1
prerank,positive regulation of integrin activation (GO:0033625),0.4193207058867611,1.0112716196254345,0.4525043177892919,0.9683483288931587,1.0,1/11,1.15%,P2RY12
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.23177408434427998,-1.0112291400336915,0.42765273311897106,0.7200432953297491,1.0,23/95,17.73%,ZEB2;DAB2;SDCBP;SOX11;SMURF2;THBS1;SMAD3;MTMR4;CAV1;UBC;LEMD3;SNX25;SNW1;UBA52;EP300;SPRY2;SMAD6;SPRY1;FAM89B;ASPN;ADAM17;HIPK2;SMAD4
prerank,acute-phase response (GO:0006953),0.4044379097143718,1.0111863707929336,0.4577205882352941,0.9675078464558341,1.0,2/12,5.65%,MBL2;IL6
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3133235513962367,1.0110951980128522,0.4431137724550898,0.9666877068842292,1.0,8/35,16.17%,DDX5;WBP2;AR;UBE3A;TADA3;NEDD4;RBFOX2;CALCOCO1
prerank,regulation of chromatin organization (GO:1902275),-0.3486399992697566,-1.0108752845930347,0.441588785046729,0.7203097377583412,1.0,7/14,21.05%,MKI67;MLLT3;IGF2;HPF1;HNRNPU;CDK9;SETD1A
prerank,response to interleukin-6 (GO:0070741),0.4251411135826562,1.0107730492314233,0.4566787003610108,0.9665965346466642,1.0,3/10,4.59%,SELPLG;RELA;PTPRT
prerank,GPI anchor metabolic process (GO:0006505),0.3346565916600304,1.0105294269716227,0.438871473354232,0.9663304409026685,1.0,11/26,28.05%,PIGQ;PIGB;PIGP;MPPE1;DPM3;PGAP2;GPLD1;PGAP3;DPM1;DPM2;PIGZ
prerank,regulation of protein localization to nucleus (GO:1900180),-0.2688055781292695,-1.0104399051322313,0.4144927536231884,0.7208018433901524,1.0,12/43,16.66%,DTX3L;LAMTOR5;CTNNA1;TFRC;YAP1;BYSL;CDK1;PARP9;ORMDL3;KAT7;PLK1;SESN2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.2864732208907227,-1.010128368609032,0.43103448275862066,0.7209608194411953,1.0,5/36,5.53%,SP100;APOE;MECP2;PPARG;THBS1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3008931323388577,1.0098626785575866,0.43373493975903615,0.9674012124265449,1.0,9/39,13.79%,PIK3C2G;IP6K1;SLA2;SOCS3;PIK3CG;PI4K2A;SOCS2;SOCS6;SOCS4
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3510536811716073,1.0095220678681025,0.43470790378006874,0.9673991796539055,1.0,6/21,20.35%,HOGA1;CYP26C1;ACOX1;LDHD;AGXT;PLA2G15
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3169422843409381,-1.0094393930938448,0.4476439790575916,0.7221419625993208,1.0,7/24,20.64%,TRPS1;SOX6;GREM1;PTHLH;ADAMTS12;PKDCC;WNT9A
prerank,regulation of microtubule nucleation (GO:0010968),-0.42131857282801083,-1.0091975861748967,0.4377880184331797,0.7221812774013254,1.0,3/10,4.83%,MECP2;GIT1;EML2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3556295405268958,1.0091480323341366,0.4372937293729373,0.9674556309333494,1.0,3/20,1.96%,HOXA5;CTR9;LDB1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.40281195435067163,-1.0091475301697284,0.45739910313901344,0.7216903190882396,1.0,7/10,43.69%,SOX6;PKDCC;SOX5;GDF6;ZBTB16;SOX9;ACVRL1
prerank,camera-type eye development (GO:0043010),0.3367598199958005,1.0090727087295839,0.4555921052631579,0.966585580349298,1.0,4/25,9.37%,PRSS56;FBN2;CRYBA4;TENM3
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2795421261748881,-1.0083879809261254,0.4617737003058104,0.7230711575682884,1.0,9/36,18.62%,PPP2R5C;PPP2R5A;PDGFD;NBN;PDGFC;CALM3;CALM2;CHP1;RAP2A
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.36232549522997787,-1.0082025856715093,0.4148148148148148,0.7229050588450397,1.0,5/14,15.24%,PTPN1;BAX;DNAJB9;FICD;BCL2L11
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.27242472567918663,1.008111679885184,0.4458689458689459,0.9687204348145716,1.0,20/67,19.42%,ABI3;TXK;NTRK1;FLT4;PRLR;EPHA1;ERBB4;BTK;PDGFB;TEK;EPHA4;INSR;EPHB2;MAPK3;PTK2;ITK;AATK;FLT3;FES;PDGFRB
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.35381629400612313,-1.0080679137724733,0.4300254452926209,0.7226611342947834,1.0,4/15,5.83%,PRKCE;PPARG;PPARD;LDLRAP1
prerank,positive regulation of myelination (GO:0031643),0.40373091222916685,1.0077769577069353,0.4489795918367347,0.9686731789415735,1.0,1/11,0.01%,TPPP
prerank,organelle disassembly (GO:1903008),-0.28831679822955614,-1.0077305130460004,0.4472934472934473,0.7229423736332368,1.0,7/33,11.32%,VCP;UBA5;STX5;GBF1;UFC1;CDK1;ATG2B
prerank,positive regulation of response to stimulus (GO:0048584),-0.28002075999536097,-1.0077265841562004,0.4247787610619469,0.7223137386664611,1.0,14/40,21.54%,FCGR2B;IL15;IFIH1;IER5;B2M;WNT5A;ECHDC3;FXR2;GATA3;HMGA2;CDKN2A;HMGA1;HOMER1;SELENON
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.21554292420112936,-1.0075423941260646,0.43601895734597157,0.7221920409205852,1.0,32/151,15.66%,CD74;APOE;NRP1;GAS6;PTPN22;GCNT2;CD44;PTPRC;BRAF;CD36;FBXW7;CCL25;C5AR1;CRKL;NOD2;GPR183;PDGFD;GLIPR2;CIB1;PDGFC;SPRY2;NOTCH1;KDR;SLAMF1;BMP2;EGFR;AGER;SHC1;TNF;PTK2B;SCIMP;RAP1A
prerank,regulation of protein dephosphorylation (GO:0035304),-0.27596777198056444,-1.0075263016751415,0.4301994301994302,0.7215927134155143,1.0,13/37,17.80%,ENSA;PPP2R5A;PPP6R1;PTPA;PPP6R3;CDCA2;CALM3;SPPL3;CALM2;ARPP19;PPP1R2;CAMTA1;PPP1R15A
prerank,regulation of activated T cell proliferation (GO:0046006),0.3181915945095017,1.0074735025375259,0.4522691705790297,0.9685787372106348,1.0,10/30,18.30%,SCRIB;PRNP;IGFBP2;IL2;RIPK3;CRTAM;HMGB1;PRKAR1A;IL18;ICOSLG
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.33833967719592734,1.0073125531207052,0.4498432601880878,0.9680048411403882,1.0,10/24,25.09%,UBE2B;TCP11;PDE3B;MGRN1;CGAS;PRKAR1A;PRKAR2B;PDE11A;GNAI1;RAPGEF2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3568503208342421,-1.0071336479363842,0.4502262443438914,0.7219684307769916,1.0,4/15,11.98%,RIPOR2;TYROBP;ADAM9;CD53
prerank,regulation of chromosome segregation (GO:0051983),-0.34735135132807327,-1.0067964388432011,0.4431818181818182,0.7222765413714142,1.0,5/16,14.23%,MKI67;PUM2;RMI2;BUB1;NUMA1
prerank,protein K63-linked deubiquitination (GO:0070536),0.32402348931102265,1.0066094271932495,0.44290123456790126,0.9692933929019563,1.0,11/31,25.02%,OTUD7A;USP50;USP33;PSMD14;OTUD7B;OTUD5;ABRAXAS2;STAMBP;CYLD;USP7;BABAM1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.42956451854541766,1.0065080929709682,0.45027124773960214,0.9684816175246677,1.0,5/10,15.11%,COMMD1;HECW2;NEDD4;STK39;NEDD4L
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3609776677845665,-1.0061724726299925,0.4617283950617284,0.7233437867453392,1.0,2/15,5.30%,DAB2;HIP1R
prerank,double-strand break repair via homologous recombination (GO:0000724),0.26075935723458743,1.0060348476285002,0.4361111111111111,0.969011607674087,1.0,22/95,19.42%,NUCKS1;MCM5;RNF138;RAD21L1;SMC5;MCM3;XRCC1;LIG3;UBE2N;RECQL;FAN1;RAD52;PSMD14;PARP1;FEN1;XRCC3;RFWD3;TONSL;HUS1;WRN;SEM1;RECQL4
prerank,lipid oxidation (GO:0034440),0.40237958916587946,1.0060276990332004,0.44308231173380036,0.9679189745517881,1.0,3/12,13.93%,ALOX12;PPARGC1A;ACOX1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.30915822583698105,1.0058485051058854,0.43837753510140404,0.967411450784434,1.0,10/34,20.23%,LACC1;CD86;IL6;INAVA;IL2;CLCF1;VAMP3;EPHB2;XBP1;TNFRSF4
prerank,regulation of receptor recycling (GO:0001919),0.36812328337936184,1.0057064467107675,0.44540727902946275,0.9667796802745344,1.0,4/16,14.45%,SCRIB;INPP5F;TBC1D16;VAMP3
prerank,response to growth factor (GO:0070848),0.3068784179073456,1.005014932322028,0.45038167938931295,0.9679238064415246,1.0,10/41,14.72%,LRP2;RPS6KB1;TGFBR1;TWF2;MAP2K5;EMD;SFRP1;ACVR1B;PDGFB;AMHR2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3786281800229069,1.0047314440262314,0.4365482233502538,0.9677600795762349,1.0,4/14,13.61%,RELA;CD81;PRKD2;KCNN4
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.23804731674083768,-1.0046399311487177,0.44891640866873067,0.7268031482424003,1.0,20/76,19.86%,DAB2;VCP;ARIH1;CBFA2T3;FBXW7;TAF1;BBS7;ARIH2;RNF14;CCDC22;SOCS5;LRRK2;PSMD10;RACK1;PLK1;USP5;NOP53;RNF144A;NKD2;HSPA1B
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.25330107290125065,-1.004515526007792,0.40119760479041916,0.7265458115746085,1.0,18/54,20.35%,RPL5;MALSU1;RPL35A;RPF1;RPF2;RPL6;RPL10;MRPL1;RPL14;RPL23A;MDN1;RPL3;NPM1;NOP53;GTF3A;RPL26;SDAD1;RPL11
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.23853209306503023,-1.0045073079065747,0.45110410094637227,0.7259303349797178,1.0,16/70,16.29%,CYBB;PSMA6;CD36;PSMB2;PSME2;TAPBP;PSMD11;PSMC6;PSMA3;SNAP23;CYBA;MFSD6;PSMD10;B2M;PSMB5;FCER1G
prerank,positive regulation of DNA recombination (GO:0045911),0.33156256903396913,1.0044369386296421,0.44773790951638065,0.9675913316977218,1.0,10/27,24.08%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;SHLD3;MRNIP;SHLD2;ERCC2;ARID2
prerank,regulation of cellular pH (GO:0030641),0.3234859565124586,1.004436502505357,0.4551282051282051,0.9664898310767492,1.0,6/29,14.07%,LACC1;SLC4A8;SLC9A4;SLC4A10;SLC4A7;SLC9A5
prerank,protein localization to microtubule organizing center (GO:1905508),-0.35716256788509637,-1.003981729973213,0.428246013667426,0.7266442932934748,1.0,3/15,5.75%,PCM1;PIBF1;CCDC14
prerank,triglyceride biosynthetic process (GO:0019432),0.3587527962422233,1.0037581446136996,0.4614065180102916,0.9676667526580089,1.0,2/18,6.61%,DGAT2;PNPLA3
prerank,cell chemotaxis (GO:0060326),0.2807721358079214,1.0031641395049131,0.4441176470588235,0.9684762968001674,1.0,14/60,16.08%,ACKR4;ACKR3;HOXB9;ARRB2;CCR1;BIN2;CXCR6;CX3CR1;CXCR4;PDGFB;CCR6;DOCK4;ACKR2;CCR9
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.25091029960384503,-1.0031609117052642,0.44126984126984126,0.7282429977166657,1.0,12/63,16.17%,BCL2;RIC1;PTPN22;MCL1;MET;MTMR2;TIMP4;RRAGA;APOC1;RGP1;FOXK2;MFSD2A
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.2958978921919462,1.0030030716193454,0.4801829268292683,0.9679262109909589,1.0,9/43,11.07%,WNT4;WWTR1;DNAI3;IL6;MEF2C;FBN2;CCN4;BMP4;NPNT
prerank,electron transport chain (GO:0022900),0.3825843483821666,1.0029489338984623,0.43252595155709345,0.9670126082717149,1.0,3/15,4.44%,CYB561;PPARGC1A;NDOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.40863065731315307,-1.0028856100727799,0.42152466367713004,0.7277719834198869,1.0,2/10,2.80%,GIT1;CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),-0.40863065731315307,-1.0028856100727799,0.42152466367713004,0.7277719834198869,1.0,2/10,2.80%,GIT1;CBFA2T3
prerank,keratan sulfate catabolic process (GO:0042340),0.4127538515225914,1.0028710717546927,0.45898778359511344,0.9661885931642271,1.0,2/11,2.81%,HEXB;ACAN
prerank,maturation of LSU-rRNA (GO:0000470),0.33227937670588314,1.0027493309520832,0.4609120521172638,0.9655136258668788,1.0,6/26,13.47%,RPL7A;NIFK;RRP15;EIF6;NOP2;NSA2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.30224664965642717,-1.0026792791042007,0.42857142857142855,0.7276883244194468,1.0,8/27,14.19%,FXYD5;UTRN;CAMK2D;SCN2B;FXYD1;SLMAP;FXYD2;FXYD6
prerank,cardiolipin metabolic process (GO:0032048),0.3937571647849993,1.0025888007816497,0.46787479406919275,0.9649373045896674,1.0,7/13,34.03%,PTPMT1;PGS1;PNPLA8;TAMM41;PLA2G4A;CRLS1;LCLAT1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3475356339570306,-1.0025498408938505,0.44360902255639095,0.7273784534835649,1.0,10/16,30.84%,PROX1;NOTCH1;BMP2;HEY2;NOTCH2;ISL1;BMPR2;DLL4;SHOX2;TGFB2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.3246672080709227,-1.002470751828463,0.4413265306122449,0.7269625525960622,1.0,5/20,11.61%,ITCH;UBQLN1;ZMIZ1;HIF1A;DCUN1D1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.40216847422857444,1.002435587821932,0.4554794520547945,0.9643667356969942,1.0,4/12,18.38%,PPARGC1A;PPARA;IRS1;ABCD2
prerank,intestinal absorption (GO:0050892),0.39241016246911664,1.0022167990817803,0.4563279857397504,0.9639716964590007,1.0,3/13,6.94%,F11R;SLC2A2;ADRA2A
prerank,positive regulation of organelle organization (GO:0010638),-0.2907066913510833,-1.0021079210665,0.4638888888888889,0.7273530377139584,1.0,8/32,16.92%,ANXA1;UVRAG;SMCR8;TMED9;SORBS3;LIG4;STX18;RAB3GAP2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3014554208712872,-1.0020442001827454,0.4420485175202156,0.7268917802500994,1.0,6/26,14.06%,B4GALT5;RRM1;ST8SIA6;TKT;GK;GK5
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3630647999415372,-1.0018509927080987,0.4496487119437939,0.7267761771413723,1.0,6/15,24.68%,CCT6A;CCT3;NOP10;DKC1;NAF1;NHP2
prerank,translational elongation (GO:0006414),0.2573081230786655,1.0018083100835555,0.46765498652291104,0.9642328815954292,1.0,33/101,26.75%,MRPS6;GADD45GIP1;MRPL45;GTPBP1;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;EEF1A2;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;LTN1;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9;EEF2K
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.29449523333630223,1.0017826310887508,0.4423676012461059,0.9632179926343849,1.0,15/45,20.90%,SCRIB;BMP4;ZFP36L2;FOXC1;TGFB1;ZW10;PTPN3;BTG3;BTG2;TOM1L1;ANGEL2;PLK2;BTG1;HECA;NABP1
prerank,calcium ion import across plasma membrane (GO:0098703),0.38997849714975186,1.0016924299876127,0.4809027777777778,0.9624286559265633,1.0,5/14,18.76%,TRPM2;SLC8A1;SLC8A3;CACNA2D1;TRPV6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.37221040561313384,-1.0013140280047577,0.43498817966903075,0.7276106666576097,1.0,6/12,22.14%,CD36;CYBA;SLC5A3;TLR4;MMP8;ADGRB1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.42622151042516215,1.000832215437329,0.46422018348623856,0.9641925271230649,1.0,3/10,13.17%,CX3CR1;SMARCD3;DCT
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.414836353383748,1.0007612762157394,0.45614035087719296,0.9633366844993604,1.0,4/11,18.54%,COMMD1;ACTN2;NEDD4L;SNX33
prerank,cellular response to drug (GO:0035690),0.3343212857639325,1.000705509988422,0.45024469820554647,0.9624341953396333,1.0,7/25,16.55%,KCNH2;PPM1E;KCNE2;MEF2C;CRHBP;REST;CERS1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.27147121502732996,-1.0002857165699686,0.4584615384615385,0.7297252551024928,1.0,11/45,19.37%,ATP7A;MTHFR;KMO;RIMKLA;PYCR2;GOT1;MTHFD1;MTRR;CBS;GNMT;GADL1
prerank,positive regulation of cell differentiation (GO:0045597),-0.20033265341142784,-1.0000038199042467,0.4530386740331492,0.7298254258916579,1.0,63/237,22.48%,DAB2;SUCO;IGF1;PRKCH;SOX6;GCNT2;NOCT;BRINP1;RIPOR2;MSR1;SDCBP;PPARG;CD36;SLC6A6;ASXL2;SOX11;IL6ST;CTNNA1;KITLG;NFKB1;VHL;PPARD;PF4;SMAD3;CEBPB;YAP1;GLIPR2;IL1B;ZC3H12A;LPL;GPRC5B;CTNNB1;AAMDC;TRPM4;CCN1;CEACAM1;KDR;PTN;BMP2;CDH2;GJA1;RAP1A;ASB4;RGCC;SMAD4;ECT2;ARHGEF2;MAPK12;PKDCC;ACVR1;ACVR2A;GDF3;PA2G4;BMP7;LTF;BAMBI;IFITM1;HEYL;FFAR4;ID2;SERPINF2;ISL1;TWIST1
prerank,bile acid metabolic process (GO:0008206),-0.29529840864983814,-0.9998827116625094,0.4258241758241758,0.7295064344301526,1.0,5/27,9.14%,ACOT8;OSBP;OSBPL9;OSBPL1A;OSBPL2
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3937879133987279,-0.9998556637760863,0.45537757437070936,0.7289539844962476,1.0,4/10,17.84%,RARA;IRF4;SPHK2;GATA3
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.38215945321437134,-0.9996819175140341,0.418013856812933,0.7287866814996136,1.0,5/12,16.27%,IFIH1;IFIT1;CAV1;RALB;MUL1
prerank,sensory perception of smell (GO:0007608),-0.3874326502605406,-0.9995353227133694,0.4652173913043478,0.7285057983601603,1.0,2/11,12.72%,DRD2;ADCY3
prerank,negative regulation of cell migration (GO:0030336),0.2470665188526453,0.9992146068624543,0.46553966189856955,0.9661625665842342,1.0,28/137,15.95%,ADTRP;SRGAP3;SRGAP2;STK26;LDLRAD4;SLURP1;THY1;PTPRT;DNAI3;PTPRU;NAV3;MAPK15;TRIB1;CLASP2;DAB2IP;EPHA1;ITGB1BP1;ADAM15;FGF2;SFRP1;SCAI;EVL;NDRG4;EPHA4;FLCN;ADORA3;MIA3;PHLDB2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.43287646074315017,0.9991584901915612,0.4492753623188406,0.9652545303087049,1.0,4/10,23.07%,ADTRP;APOD;MIA3;WASL
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.2033725776827916,-0.9990608396323025,0.4878048780487805,0.7291519802194143,1.0,49/214,17.73%,CD74;APOE;NRP1;GAS6;PTPN22;GCNT2;CD44;PTPRC;BRAF;CD36;FBXW7;PTPN1;RANBP9;CCL25;C5AR1;RPS6KA6;CRKL;NOD2;GPR183;PDGFD;SYK;LYN;GLIPR2;CIB1;IL1B;PDGFC;SPRY2;NOTCH1;SEMA6A;CCN1;CEACAM1;KDR;SPRY1;ZDHHC17;SLAMF1;BMP2;EGFR;AGER;SHC1;TNF;PTK2B;SCIMP;RAP1A;EPHA2;ARHGEF5;TLR4;MAP2K7;ADRA1A;SMAD4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.35023047017972203,0.9988408039333954,0.46815834767641995,0.965240012458968,1.0,8/20,20.80%,MRAP;ADA;MGRN1;APLP1;RGS2;BICD1;CCL5;YWHAB
prerank,tRNA methylation (GO:0030488),0.318060436580109,0.9988358242032153,0.46677215189873417,0.9641811960551067,1.0,8/34,12.46%,DALRD3;METTL2A;METTL2B;TRMT44;METTL1;TRMT61B;FTSJ1;PRORP
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.35466582628360277,0.9988293362975679,0.4606164383561644,0.9631256185323606,1.0,6/20,18.08%,ZC3H7B;SPOUT1;DROSHA;TSN;AGO4;TSNAX
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.33578872417729555,0.998684027544012,0.4519867549668874,0.9625118233868684,1.0,7/25,15.00%,LDB1;NELFB;NELFCD;RNF168;RNF8;EAF2;BRD4
prerank,regulation of small molecule metabolic process (GO:0062012),0.32655379341456553,0.9984966488211441,0.4744645799011532,0.9620343182273086,1.0,10/28,25.70%,GNB3;PPARA;NCOR2;DGKQ;PRKN;TTC39B;RORA;PDK1;FMO5;PANK2
prerank,establishment of vesicle localization (GO:0051650),0.36528593436315093,0.9981154408696891,0.4420529801324503,0.9621739864801655,1.0,6/18,23.96%,SNAPIN;LIMK2;SPG11;TMEM230;CCDC186;SYT11
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.36285447455461495,-0.9980381800019568,0.4523809523809524,0.7313486221507668,1.0,3/14,12.04%,FTSJ3;RPF2;ZNHIT3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.30272250317839966,-0.9979891634950931,0.4629156010230179,0.7308613600958606,1.0,7/26,9.54%,CCBE1;CCR2;IL6ST;HIF1A;BRCA1;IL1B;HPSE
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.36546090250593777,0.9977818548555416,0.4425956738768719,0.962190958358067,1.0,3/18,5.65%,CTR9;SOCS3;IL6
prerank,response to amino acid (GO:0043200),0.3172940705501395,0.9977535025121892,0.4683333333333333,0.9612325069635366,1.0,10/31,19.04%,GLRA3;RPTOR;GLRB;SLC38A9;GRIN1;GLRA2;IPO5;SH3BP4;XBP1;NSMF
prerank,regulation of stress fiber assembly (GO:0051492),-0.23503149194307268,-0.9977067270686282,0.46179401993355484,0.7310136833045492,1.0,20/74,17.30%,NRP1;PXN;ARHGEF10L;CD47;MET;CGNL1;PTGER4;ARHGEF18;ARAP1;CARMIL1;STMN1;SORBS3;S100A10;ARHGAP28;GPR65;MYOC;INPP5K;ARHGEF5;PFN2;RGCC
prerank,rRNA transcription (GO:0009303),0.3627997609445,0.9976899230747948,0.488013698630137,0.9603886988924198,1.0,4/17,12.54%,ANG;NIFK;SPIN1;POLR1E
prerank,cellular response to heat (GO:0034605),-0.2804300394083771,-0.9976224067667475,0.44857142857142857,0.7306210527964118,1.0,8/35,10.56%,VCP;RBBP7;PRKACA;IER5;THBS1;FGF1;HSF1;HIKESHI
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3403427564008569,-0.9975147559258191,0.4568764568764569,0.7302933273208954,1.0,6/17,19.53%,PPP1R12A;S1PR2;IL1B;VCL;TNF;S1PR3
prerank,negative regulation of viral life cycle (GO:1903901),-0.35547341932206633,-0.9974315656034773,0.4484536082474227,0.7299136534517789,1.0,7/15,21.63%,CIITA;IFITM3;BST2;TRIM5;GSN;PTX3;IFITM1
prerank,microtubule anchoring (GO:0034453),0.3965757081838537,0.997292791586548,0.48034188034188036,0.9606410942703041,1.0,5/12,17.35%,CLASP2;CAMSAP3;PEX14;BICD2;BICD1
prerank,connective tissue development (GO:0061448),-0.2812624986553713,-0.9969896264710134,0.4489247311827957,0.7305466048717875,1.0,6/35,5.28%,SOX6;CD44;ATP7A;NAMPT;SH3PXD2B;COL11A2
prerank,acidic amino acid transport (GO:0015800),-0.33861581749369385,-0.9969624009876518,0.47174447174447176,0.7299996210764246,1.0,3/17,3.14%,ARL6IP5;LRRC8D;SLC6A6
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.35939276435322665,-0.9968367135047504,0.4431818181818182,0.7297363939637964,1.0,5/14,18.69%,FASTKD1;EARS2;MTERF2;SLC25A33;FASTKD5
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2826075126779561,0.9963108261925212,0.4663805436337625,0.9615788954056631,1.0,17/56,19.08%,NDUFA6;DMAC1;NDUFAF8;TIMM21;FOXRED1;NDUFS1;NDUFA8;NDUFS6;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2826075126779561,0.9963108261925212,0.4663805436337625,0.9615788954056631,1.0,17/56,19.08%,NDUFA6;DMAC1;NDUFAF8;TIMM21;FOXRED1;NDUFS1;NDUFA8;NDUFS6;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.256665746233023,0.9961430616703074,0.47067039106145253,0.961051921034923,1.0,21/90,18.81%,KSR2;G0S2;ESRRG;KDM6B;PPARGC1A;GATM;PRLR;MFAP2;ADCYAP1;OGT;ACHE;CXCR4;ELOVL6;EPAS1;PRDM16;GNAS;ALMS1;IL18;ZBTB7B;HDAC3;GHRL
prerank,regulation of filopodium assembly (GO:0051489),0.3047764780953069,0.996140969213072,0.4715447154471545,0.9599978310533446,1.0,13/38,23.07%,AGRN;FSCN1;ARHGAP44;TENM1;TRPM2;RAB5A;RHOQ;PALM;CDC42;GPM6A;PPP1R16B;FXR1;WASL
prerank,protein targeting to mitochondrion (GO:0006626),0.2855787846149499,0.9959962451722543,0.47289156626506024,0.9594165668461232,1.0,11/52,14.53%,TOMM40L;TIMM21;FIS1;FBXO7;TIMM29;TOMM34;PITRM1;TIMM13;TSPO;TIMM22;TOMM70
prerank,non-motile cilium assembly (GO:1905515),-0.28818502221569753,-0.9956747188198977,0.4605263157894737,0.7321110490821331,1.0,5/30,5.60%,PCM1;PIBF1;CEP250;ARL13B;TBC1D32
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.42463246805441823,0.9952168389933649,0.46815834767641995,0.9608160755319176,1.0,2/10,6.41%,WNT3;RYK
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.327665599943874,-0.9951155839616344,0.4613466334164589,0.7329723520174722,1.0,7/18,20.16%,RIPOR2;KIF20B;SHTN1;RACK1;PTK2B;RAP1B;BCAS3
prerank,snRNA metabolic process (GO:0016073),0.36647589699886873,0.9949784583347105,0.47145187601957583,0.9605058066219765,1.0,6/17,20.66%,MEPCE;INTS10;INTS8;INTS5;INTS9;INTS11
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.27665025439982877,-0.9949711187675444,0.42036553524804177,0.7327467379346733,1.0,14/36,23.83%,PTPRC;DOT1L;BCL3;VHL;CAV1;CENPJ;GHR;NOTCH1;NLK;TNF;HES1;SOCS1;CYP1B1;EGF
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.37253957363503,-0.9948160882500351,0.43896713615023475,0.732563264775872,1.0,4/13,12.91%,SEC16A;TMEM30A;TM9SF4;EDEM1
prerank,actin filament depolymerization (GO:0030042),0.41122993984740064,0.9947417303233264,0.4598290598290598,0.9602480367810713,1.0,4/11,16.04%,MICAL3;TWF2;CFL1;TWF1
prerank,apoptotic process (GO:0006915),-0.2030796072872644,-0.9944289654763575,0.44508670520231214,0.732976956177913,1.0,38/203,12.50%,BCL2;STK3;PAEP;HIP1;BCL2L1;PRKCE;RAF1;TLR2;IFIT2;RRAGC;BAX;AHR;CD14;TRPC5;ARHGEF6;PPARD;FAS;HSPD1;RIPK1;DDX41;CIT;CIB1;IL1B;BAG6;PIK3CA;PIDD1;MRPS30;EP300;TNFRSF19;FOXO1;SEMA6A;LIG4;DAPK1;BRAT1;CD2;ESPL1;MCM2;PRUNE2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.37774486189362155,0.9944062980775246,0.4833887043189369,0.9602617188734855,1.0,3/15,4.81%,SLC45A3;PPARGC1A;PPARA
prerank,ncRNA transcription (GO:0098781),0.3898901324118759,0.9942993857008441,0.47758620689655173,0.959548912039403,1.0,5/13,22.40%,ANG;NIFK;SPIN1;SNAPC3;POLR1G
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.34696753340804465,0.994042944005929,0.4596375617792422,0.9593429602642267,1.0,5/21,9.35%,WWTR1;SH2B1;TGFBR1;BMP4;TGFB1
prerank,acylglycerol metabolic process (GO:0006639),0.30087427741202394,0.9939048035178942,0.4538216560509554,0.9587496554993553,1.0,12/37,20.70%,DGKI;DGAT2;AWAT2;PNPLA3;ABHD12;DGKQ;DGKZ;DGKE;LMF1;ABHD2;PGS1;DGKH
prerank,phospholipid translocation (GO:0045332),0.3236521521629386,0.9938792771219528,0.4613003095975232,0.9577848668825851,1.0,8/28,21.52%,ATP8A2;ATP9A;ABCB4;ATP11A;ATP8B1;ATP8A1;ABCA7;PLSCR4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.3671968294962329,0.993867606300173,0.4761061946902655,0.9567784222266685,1.0,6/16,10.75%,ZFPM2;MEF2C;TGFBR3;ERBB4;TBX2;FGF2
prerank,glycolipid biosynthetic process (GO:0009247),0.30184114646818655,0.9937410916477026,0.46656534954407297,0.9561564192613516,1.0,17/38,32.36%,ST3GAL5;PIGQ;PIGB;PIGP;MPPE1;SCCPDH;DPM3;PGAP2;LARGE1;PGAP3;DPM1;DPM2;PIGZ;A4GALT;ST8SIA3;PIGG;PIGC
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.2665839061725415,-0.9936366004201002,0.4515235457063712,0.734430945550397,1.0,11/43,15.40%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B;IGF2;SORBS1;SIK2;INPP5K;TNS2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.26874328424519534,0.9931412568592751,0.4811594202898551,0.9570519823146723,1.0,21/72,17.85%,STMN2;NAV3;CLU;CLASP2;SHANK3;TWF2;PRKN;CAMSAP3;FGF13;CAMSAP1;CORO1A;CHADL;ARFGEF1;APC2;TWF1;SSH1;SSH2;TAOK1;HDGFL3;SSH3;SHANK1
prerank,apoptotic mitochondrial changes (GO:0008637),0.3122360597341799,0.9929962329806885,0.5,0.9564900421625528,1.0,12/32,17.61%,FIS1;CLU;BAK1;ERBB4;GGCT;NDUFS1;DNM1L;BIK;BBC3;HK2;CCAR2;MFF
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.2617179480305737,-0.9928523303324114,0.4423676012461059,0.7359380030760015,1.0,22/50,32.08%,GAS6;RAF1;CD44;SIAH2;LAMTOR5;THBS1;PLAUR;SH3RF1;TNF;DNAJB6;GPX1;KLF4;DHCR24;CAAP1;XIAP;RPS6KA3;AQP1;FNIP1;CDKN2D;USP47;HGF;MMP9
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.3244429409481925,-0.9925947766451505,0.45901639344262296,0.7360021414580704,1.0,3/20,6.06%,HSPA4;PSMG1;HSPD1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.24782905092291493,0.9922518312099651,0.46612466124661245,0.9577831024322435,1.0,14/117,6.44%,HOGA1;CYP2S1;ACSF2;AKR1C1;ALOX12;CPT1B;GATM;BCO2;MECR;PPARA;ACADSB;VDAC1;MTHFD1L;GGT5
prerank,carbohydrate transport (GO:0008643),0.41073503864453065,0.9920748022245115,0.47810858143607704,0.9573248433527366,1.0,2/11,6.70%,SLC50A1;SLC2A2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.3904908518891666,-0.9920273798190699,0.45363408521303256,0.7369231902712821,1.0,3/11,15.37%,RFTN1;RIPK1;SCIMP
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4003708038125752,0.9919801650210419,0.4707846410684474,0.9566041758971279,1.0,2/12,2.48%,VANGL2;SCRIB
prerank,cilium organization (GO:0044782),-0.2021153820428794,-0.9919747905359175,0.46153846153846156,0.7364336038586828,1.0,38/210,12.56%,EHD4;ATP6V0D1;RAB8B;ACTR3;KIF3A;PTPN23;PCM1;RILPL2;FAM161A;PIBF1;RAB1A;MKS1;RPGR;SCLT1;CDC14B;EXOC4;CPLANE1;GBF1;CEP250;ARL13B;TCTN1;SSX2IP;BBS7;FHDC1;ASAP1;DNAH5;TMEM231;KIF24;CEP164;WDPCP;CENPJ;SNAP29;CCDC28B;TMEM138;NOTCH1;FOXJ1;IFT52;EXOC8
prerank,regulation of vasculature development (GO:1901342),-0.3074279894328942,-0.9918682131130891,0.45382585751978893,0.7360982020641986,1.0,11/26,26.34%,SP100;CTNNB1;ADGRA2;EMP2;EPHA2;HMOX1;RNH1;WARS1;HTATIP2;GPNMB;EGLN1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.35344014460761586,-0.9916619270602808,0.4433249370277078,0.7360318027816638,1.0,9/15,32.63%,RTEL1;NBN;TERF2;SLX4;SMG6;TNKS;PINX1;ATM;RAD50
prerank,activation of protein kinase B activity (GO:0032148),-0.29192401052118455,-0.99164490939164,0.47093023255813954,0.7354578745476399,1.0,5/29,8.19%,OSBPL8;GAS6;IGF1;FGF1;TXN
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.2554833915648272,-0.9915520089827697,0.4806451612903226,0.7350758378626242,1.0,14/52,19.35%,PRKCH;PRKCE;CIB1;SORBS1;LRP1;RACK1;EGFR;TNF;EPHA2;PLS1;CLN3;SQSTM1;AKAP5;NKD2
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.29089454504044865,-0.9913796087776955,0.44,0.7349208321341998,1.0,8/29,19.58%,ZCWPW1;STAG3;PRDM9;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3101688218340202,0.9912760783329059,0.4720496894409938,0.9577966988306462,1.0,10/33,14.20%,MEOX2;MEF2C;MAP2K5;VASH1;HDAC5;TGFB1;ITGB1BP1;FGF2;GADD45A;HMGB1
prerank,necroptotic process (GO:0070266),0.3664725645051038,0.9912031899602417,0.46153846153846156,0.9570056290219444,1.0,6/16,20.40%,ITPK1;RIPK3;IPMK;DNM1L;TLR3;CYLD
prerank,positive regulation of protein localization to membrane (GO:1905477),0.255526047317502,0.9911884202921281,0.47043010752688175,0.9560046982586382,1.0,27/98,21.39%,YWHAE;FIS1;E2F1;PRNP;PDCD5;PRKCI;ZDHHC8;CD81;MYO1C;PRKN;ITGB1BP1;STX3;PPP3CC;MTCL1;PPP1R13B;SPTBN1;BBC3;EPHB2;HRAS;YWHAQ;NMT1;MFF;CASP8;ITGAM;PDPK1;YWHAB;TFDP2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2329832077740945,-0.9906024036885457,0.46959459459459457,0.7362874610593945,1.0,24/85,19.86%,DAB2;VCP;ARIH1;CBFA2T3;FBXW7;TAF1;BBS7;ARIH2;PSMC6;BAG6;RNF14;SOCS5;LRRK2;PSMD10;TMTC3;RACK1;PLK1;USP5;NOP53;ECSCR;RNF144A;RNFT1;NKD2;HSPA1B
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3220367605842671,-0.9902051662770353,0.4477211796246649,0.736733998496714,1.0,5/20,17.30%,ITGA4;THBS1;ECSCR;GSN;RGCC
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3544235037634996,0.989901992967647,0.4931506849315068,0.9590120427417004,1.0,5/18,12.39%,SLC25A4;HEBP2;SLC25A31;BAK1;SLC25A5
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4051336037861978,0.9896243784218395,0.47703180212014135,0.9588402948007919,1.0,4/11,21.89%,STK26;PRKN;REST;LANCL1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.24579560354695246,-0.9894505398460948,0.4582043343653251,0.7382091420245456,1.0,14/61,10.45%,MECP2;PCNA;SMCHD1;RTEL1;ZCWPW1;CEBPG;TOX;NBN;BRCA1;EYA1;ABRAXAS1;EYA3;USP9X;EYA2
prerank,regulation of hydrolase activity (GO:0051336),0.26452771459309543,0.9894224745247812,0.4787701317715959,0.9584419393586483,1.0,22/71,19.02%,STMN3;PLXNB2;ARHGAP44;CHN1;CHN2;FGD2;DAB2IP;CFAP100;EPHA1;ITGB1BP1;OCRL;RAP1GAP;VAV1;PRKG1;RALBP1;EPHA4;NTRK2;PTK2;SCARB2;ARHGAP12;WRN;PLXNB1
prerank,regulation of cellular component organization (GO:0051128),-0.21156837256170424,-0.9892746704238127,0.5080645161290323,0.7380646245263216,1.0,32/135,18.05%,ITCH;APOE;HIP1;ABL2;ATAD3A;CD36;PTPN1;MKI67;ZFYVE16;HIP1R;MLLT3;TFRC;PICALM;NUBP1;PRKCQ;OGFR;RASGRP2;CAMK2D;MAD2L2;ATF5;CEACAM1;PACSIN2;TNF;RAB4B;RAP1B;WNT5A;RAP1A;BCAR1;RAB33B;KLK8;SGK3;SGK2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.3743606623987629,0.9890926809871208,0.4816666666666667,0.9585021358742996,1.0,4/15,9.80%,YWHAE;TCF7L2;RAPGEF3;EMD
prerank,protein targeting (GO:0006605),0.2488384700718086,0.9890311105903005,0.4829467939972715,0.9576706109942821,1.0,43/118,26.99%,LTBP2;FUT10;SPCS2;GIPC1;CHM;FIS1;FBXO7;PRKCI;ZDHHC22;MYO1C;TOMM34;ZDHHC1;SRPRB;ZDHHC2;SRP14;PITRM1;TIMM13;TSPO;MICALL1;TIMM22;TOMM70;HAP1;RASSF9;ZDHHC23;CACNG3;SRPRA;MFF;PEX6;GOLGA7;AP4E1;TIMM23;GABARAP;ZDHHC15;ZFAND6;TIMM44;HACL1;TOMM22;TAOK2;TIMM10;ZDHHC19;TIMM10B;SEC61G;ZDHHC12
prerank,proteolysis (GO:0006508),0.22606882999255518,0.9889782051336539,0.48372093023255813,0.9568121656094202,1.0,61/252,21.54%,RNF123;F3;PLAT;CAPN3;MMP16;RNPEPL1;ACAN;PRSS56;CAPN12;ASPRV1;XPNPEP1;CNDP1;PGPEP1;TMPRSS7;BACE1;GGT5;XPNPEP3;UBE3A;SPPL2B;LGMN;ATG4A;OGT;VASH1;PHEX;FBXL6;AEBP1;TRHDE;CAPN11;CASP3;LAP3;CASP4;PSENEN;CASP7;PITRM1;VASH2;MMP1;PSMC4;ENPEP;HM13;HPN;UBA3;ERMP1;THOP1;FBXL2;SUFU;TMPRSS6;LACTB;MMP17;PCSK2;ADAMTS3;DPP8;FOLH1;CTSK;NAALAD2;CASP8;TYSND1;FBXO6;METAP2;APEH;CASP2;CTSS
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3742175253442247,0.9889654827017093,0.4731369150779896,0.9558349663303221,1.0,10/15,34.91%,ENTPD6;AK5;AK1;AK4;ENTPD1;ENTPD2;NME2;ENTPD3;ENTPD7;AK7
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.30071281220491375,-0.9888358748060069,0.4566929133858268,0.7385543213598513,1.0,4/25,3.14%,CHMP4B;CHMP4A;VCP;LYST
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3439791020061258,-0.9884659545031163,0.46883468834688347,0.7388979861668405,1.0,4/17,10.83%,FTSJ3;RPF1;EXOSC10;MPHOSPH6
prerank,carbohydrate homeostasis (GO:0033500),0.27416036775092223,0.9883586341547368,0.45925925925925926,0.9566432171035107,1.0,12/67,15.05%,ADCY8;SOX4;STK11;IL6;RFX6;ADRA2A;TCF7L2;KLF7;IRS1;USF1;INSR;PTPN2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.21147516139224365,-0.9880621066737377,0.4666666666666667,0.7393290429456095,1.0,27/148,12.76%,PPP2R5C;RBBP8;RBBP7;RPL5;PRKAB1;TOPBP1;RPS20;TAF1;PHF20;RPF2;TAF12;NBN;PRKAG2;BRCA1;RMI1;ATRIP;EP300;HIPK1;RHNO1;BARD1;RPA1;CDK1;HDAC2;RMI2;EHMT1;KAT5;HDAC1
prerank,negative regulation of neurogenesis (GO:0050768),0.3109513000808796,0.9880272186464876,0.45222929936305734,0.9566612557932588,1.0,9/34,15.67%,THY1;OMG;EFNB3;IL6;ARHGDIA;GDI1;MAG;WNT7A;REST
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.3075397555263133,-0.9879131843510925,0.4748743718592965,0.739115583192138,1.0,10/22,35.19%,HSPD1;IL1B;B2M;CD55;FADD;IL12RB1;MALT1;IL12A;IL23R;IL12B
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.26269601359770367,-0.9878035201827515,0.47678018575851394,0.738812378820594,1.0,11/43,15.17%,CBLB;RAB7A;EPS15;SOCS5;SPRY2;GRB2;CBL;SPRY1;STAM;EGFR;ITGA1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41680070119132756,0.9877853545796026,0.46536412078152756,0.9564136259238575,1.0,2/10,8.42%,EMC6;EMC2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.2751543436671467,-0.9875541614324294,0.4497354497354497,0.7388412969257347,1.0,11/35,15.23%,ABL2;RIPOR2;CUL3;MET;CCDC125;STMN1;ARHGAP24;SPRY2;SPRY1;MYOC;SPRY4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.2305480288074071,-0.9874464204274277,0.4787234042553192,0.7384841738260901,1.0,25/80,25.06%,ARL6IP5;GAS6;RAF1;CD44;SIAH2;LAMTOR5;GRAMD4;THBS1;UACA;SYK;SH3RF1;DAPK1;PMAIP1;TNF;DNAJB6;GPX1;PPM1F;KLF4;CASP1;DHCR24;TNFSF10;NDUFA13;XIAP;RPS6KA3;CTSD
prerank,histone H3-K4 trimethylation (GO:0080182),-0.379839735199083,-0.9873489885202607,0.47596153846153844,0.7381128566847268,1.0,7/11,23.37%,TET2;PRDM9;WDR82;TET3;KMT2D;SETD1A;KMT2A
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.20582614154772405,-0.9869469880725881,0.4794520547945205,0.7385458226276741,1.0,26/186,7.94%,DAB2;STK3;APOE;PSMA6;MCC;LIMD1;CUL3;DVL3;IGFBP4;PSMB2;SIAH2;RNF213;PSME2;CCDC88C;DKK2;HECW1;HMGXB4;PSMD11;MLLT3;TMEM131L;PSMC6;CAV1;PFDN5;WWOX;ZNRF3;PSMA3
prerank,actin cytoskeleton reorganization (GO:0031532),0.27400031206919445,0.9868608049807098,0.5,0.9582422755013152,1.0,11/63,12.15%,FGF10;CTTN;MKLN1;THSD7A;PAK1;FGF7;PTK7;CDC42BPA;ATP2C1;MINK1;FARP2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.350585793497242,0.98683405125518,0.46293245469522243,0.957293082132251,1.0,5/18,14.13%,TMEM14A;ZNF205;BAK1;SLC25A5;CHCHD10
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.21725866805309957,-0.9866662770710461,0.4867924528301887,0.7387009377247743,1.0,24/110,15.31%,FNIP2;APOE;RAF1;VCP;CD36;GNL3L;BAX;SH3GLB1;MTLN;SYK;TFRC;HSF1;HCK;EP300;AJUBA;ATF7IP;FBLIM1;RB1;RACK1;RALB;CDT1;TNF;BCL2L11;ICE1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3084036188679306,0.9865816874966151,0.4772370486656201,0.9570690321380999,1.0,10/33,16.65%,P2RY12;NCKAP1L;ADA;PIK3CG;PDE3B;SNAI2;ITGB1BP1;EFNA1;JAM3;PTK2
prerank,post-translational protein modification (GO:0043687),0.22094214389289346,0.9863530590520363,0.5111111111111111,0.9567533852355846,1.0,80/332,20.53%,KLHL25;KLHL22;FBXW8;PSMB1;C3;OBSL1;RAB1B;CST3;FBXW9;RAB3A;AFP;COPS8;CHM;SOCS3;UBE2M;FSTL1;ELOC;IL6;FBXO7;NUB1;RAB8A;COMMD1;PSMF1;BTRC;ASB2;FBXO11;PSMA1;BMP4;SOCS2;PSMD7;COPS3;PSMA8;HSP90B1;FBXW10;RAB5A;RAB38;FBXL20;PSME3;SENP8;KLHL2;CUL2;SCG3;EPAS1;PSMD14;VCAN;NUCB1;SPSB3;FBXL4;FBXL19;PSMC4;DDB2;DCAF11;LRRC41;SOCS6;COPS6;FBXW5;APLP2;SKP2;UBA3;MIA3;FN3K;KLHL5;KLHL11;COP1;ESCO1;FBXO9;PSMB4;QSOX1;FBXL7;KLHL42;FBXL3;WSB1;FBXL22;RABGGTB;SDC2;SPARCL1;FBXO31;COPS5;PSME1;FBXO6
prerank,skin development (GO:0043588),-0.24198194230489056,-0.9863522134864454,0.4523809523809524,0.7388773565560137,1.0,28/65,33.25%,ATP7A;MET;ST14;ADAM9;CLIC4;STMN1;ANXA1;TXNIP;ALOXE3;WNT5A;EPHA2;CLDN1;COL3A1;OPN3;DHCR24;BCR;DSP;ASCL4;EVPL;PDGFA;SCEL;KRT10;TMEM79;DLL1;KDF1;ASAH1;ITGA3;UGCG
prerank,ameboidal-type cell migration (GO:0001667),0.2842998195077213,0.986330077226903,0.49544072948328266,0.955814648315819,1.0,12/51,12.37%,SEMA7A;NANOS1;SRGAP2;PKN1;SOX10;SEMA6C;MEGF8;SEMA6B;SEMA3D;ERBB4;FAT2;SEMA4F
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2593021309840578,0.986321339472582,0.49445983379501385,0.9548244461643344,1.0,28/80,27.40%,AGRN;P2RY12;FSCN1;EPS8L3;TENM1;NCKAP1;CDC42EP5;TWF2;ARHGAP35;CYFIP1;EPS8L2;HRAS;RHOQ;WASF2;PALM;CDC42EP4;CDC42EP1;CDC42;GPM6A;CEP120;WASL;EPS8L1;CLRN1;FNBP1L;FUZ;BRK1;ENTR1;DEF8
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3258778454945236,0.9862259402692404,0.48575949367088606,0.9541066771858003,1.0,7/26,18.53%,PAK1;PSRC1;STMN2;NAV3;DCTN1;CLIP1;FES
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.26649114593427087,0.9859589946070155,0.48206599713055953,0.95393052573095,1.0,20/69,23.69%,POLR2L;CDK7;POLR2F;POU2F2;GTF2F1;GTF2E2;TAF9;ZC3H8;INTS10;POLR2G;CCNK;INTS8;SNAPC3;INTS5;INTS9;INTS11;NABP1;POLR2C;GTF2B;POLR2D
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.30398103972959944,-0.9859199181144589,0.4857142857142857,0.7394072556994881,1.0,9/23,26.08%,ALOX5;LTA4H;GSTM1;ASAH2;CYP1A1;ALOXE3;LTC4S;GSTP1;ALOX15
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.3751320941234473,-0.985897191616438,0.48931116389548696,0.7388509104202347,1.0,3/13,8.49%,MPDU1;ALG12;ALG13
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.35479867605267235,-0.9857390848106223,0.46522781774580335,0.7386815031961552,1.0,6/15,12.39%,TSEN2;CPSF1;FAM98B;ERN1;CPSF4;CSTF2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3562636110291309,-0.9857322409219509,0.46766169154228854,0.738093881325208,1.0,4/14,15.43%,CD74;GPRC5B;LILRB1;WNT5A
prerank,transition metal ion homeostasis (GO:0055076),0.3181101759284904,0.9856958088409514,0.44894651539708263,0.9537197773138493,1.0,5/28,9.79%,IREB2;TMC8;COMMD1;NEO1;PRKN
prerank,regulation of protein processing (GO:0070613),-0.3131524262134372,-0.9856426091432328,0.45614035087719296,0.7376970953309808,1.0,6/21,19.35%,CCBE1;NLRC4;ADAM8;LRRK2;CLN3;NKD2
prerank,tRNA export from nucleus (GO:0006409),-0.27681921878435833,-0.9847709451754421,0.4985507246376812,0.7387400473812955,1.0,7/32,10.31%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.27681921878435833,-0.9847709451754421,0.4985507246376812,0.7387400473812955,1.0,7/32,10.31%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB
prerank,cellular response to fatty acid (GO:0071398),-0.37550426280027205,-0.9842556312579254,0.457002457002457,0.7395612276230943,1.0,3/12,9.52%,PID1;ZC3H12A;LPL
prerank,regulation of translation (GO:0006417),-0.20906228528993953,-0.9841391204501652,0.5497630331753555,0.7392535260883227,1.0,59/173,25.15%,EIF2A;UPF3A;NIBAN1;RPL5;CNOT9;MALSU1;EIF4B;NCBP1;ETF1;BCL3;TCOF1;SAMD4A;THBS1;SHFL;MTG2;EIF4ENIF1;RPL10;DDX6;CAPRIN1;EIF2B2;LARP6;VIM;CD28;PIWIL2;DAPK1;PLD1;PAIP2B;SYNCRIP;TYMS;LARP1;RACK1;MIF4GD;NPM1;ZCCHC4;TRIM71;EIF2B4;HSPB1;LARP4B;FXR2;UPF3B;HNRNPD;EIF1B;IGFBP5;NAT10;RPL26;DHFR;CPEB3;EIF3E;APP;ILF3;CTIF;PYM1;EIF2AK2;RIDA;MTG1;CSDE1;RPS6KA3;EIF4A2;MTPN
prerank,lamellipodium organization (GO:0097581),0.3164936722429158,0.9841103048153235,0.48408710217755446,0.957744617561387,1.0,4/29,8.02%,CTTN;P2RY12;PTPRO;ABLIM2
prerank,macrophage activation (GO:0042116),-0.28227974531692124,-0.9839936056738546,0.4824561403508772,0.7390172369094642,1.0,16/34,30.54%,C5AR1;SYK;DYSF;SLC11A1;FOXP1;LBP;AGER;TNF;TLR4;TLR1;APP;FPR2;TMEM106A;CRTC3;CD93;ITGB2
prerank,positive regulation of mRNA processing (GO:0050685),0.3396742406595073,0.9839598640059359,0.48538961038961037,0.9572153992061663,1.0,8/21,20.28%,PRDX6;TRA2B;CIRBP;RBMXL1;RBM3;PAF1;TRA2A;DHX36
prerank,polarized epithelial cell differentiation (GO:0030859),0.3908732474596662,0.9838152506475251,0.5008695652173913,0.9566499474229734,1.0,7/13,27.16%,SH3BP1;SCRIB;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.28965966722190856,-0.9837920976692995,0.4930747922437673,0.7389387732001634,1.0,14/30,24.67%,CHST11;CHST9;IDUA;UGDH;IDS;DSEL;CSPG4;CHST7;CHPF;DSE;CHST12;CHSY3;CHST3;HEXA
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.3302777045659859,-0.9837848381019171,0.44660194174757284,0.7383536880965657,1.0,10/17,28.59%,RBPJ;NOTCH1;BMP2;HEY2;ACVR1;NOTCH2;HEYL;GALNT11;DLL4;BMPR1A
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2946118697345597,0.9836359464435205,0.4914196567862715,0.9561296282838238,1.0,10/41,15.58%,ITPR2;TRPM2;PKD2;GRIN1;GRIN2B;SLC8A1;FGF2;ITPR3;SLC8A3;CACNA2D1
prerank,regulation of chromatin binding (GO:0035561),-0.39317928308252803,-0.9835525302998595,0.4691358024691358,0.7382893719667298,1.0,3/10,14.25%,DTX3L;PARP9;CDT1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4090082309486337,0.9835314838626688,0.47593582887700536,0.9554298499899585,1.0,4/10,17.14%,SCRIB;PRNP;CRTAM;PRKAR1A
prerank,RNA modification (GO:0009451),0.286779214861709,0.9834794834468201,0.48527131782945737,0.9545884091141931,1.0,10/54,11.37%,TYW5;ADAT2;ELP5;CTU1;ADAR;METTL1;MEPCE;DTWD2;FTSJ1;NOP2
prerank,integrated stress response signaling (GO:0140467),0.38751845937166607,0.9831605439957652,0.483704974271012,0.9545909259106189,1.0,8/14,31.07%,NFE2L2;HERPUD1;EIF2AK4;OMA1;IMPACT;ATF4;DDIT3;CCL2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.2713539786545033,-0.982774193500966,0.4691011235955056,0.7396318581903422,1.0,11/38,18.58%,SP100;BCL2L1;THBS1;FAS;RIPK1;BRCA1;BMP5;PMAIP1;GPX1;HMOX1;ARHGEF2
prerank,mitotic nuclear division (GO:0140014),-0.237209922089799,-0.9826335225353807,0.49477351916376305,0.7393480325525897,1.0,22/71,19.39%,KPNB1;CHMP4B;EPS8;MIS12;PIBF1;KIF11;KIFC2;CDCA8;NCAPG2;KIFC1;ABRAXAS1;NUSAP1;ESPL1;NUP62;NDC80;PLK1;UBE2C;MZT1;FLNA;KIF18B;TPX2;ZWINT
prerank,protein insertion into membrane (GO:0051205),0.31048202451585316,0.9824642703810367,0.4711388455538221,0.9558789311529776,1.0,8/32,15.22%,SGTA;PRNP;OTOF;EMD;TRAM2;CCDC47;TRAM1;OXA1L
prerank,neuronal action potential (GO:0019228),0.3413740646655509,0.9823443420191261,0.4960127591706539,0.9552681211729878,1.0,9/22,31.08%,CACNA1G;SCN2A;KCNMB3;SCN8A;SCN7A;ANK3;CACNA1H;SCN1A;CACNA1I
prerank,cytoplasmic microtubule organization (GO:0031122),0.2813824958062198,0.9821165680258775,0.4717800289435601,0.9550128638577172,1.0,16/54,22.45%,TPPP;STMN3;DST;LIMK2;FSD1;PLK3;CAMSAP3;CAMSAP1;DCTN1;HOOK2;TUBGCP2;CLIP1;HOOK1;CCDC13;TUBGCP6;SPAST
prerank,positive regulation of macrophage migration (GO:1905523),0.3488087350937359,0.9821087142572493,0.47145187601957583,0.9540429234365283,1.0,9/19,28.92%,P2RY12;RARRES2;MAPK3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,postsynaptic membrane organization (GO:0001941),0.35561761696309524,0.9820831831434914,0.4975206611570248,0.9531292714864227,1.0,3/17,7.90%,LHFPL4;NRXN1;SHANK3
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3075121514946663,-0.9816056988490907,0.5,0.7414299558699532,1.0,5/22,10.93%,IGF1;P2RX4;IL6ST;CAMK2D;NOTCH1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2588956266666583,0.9815326188917677,0.503586800573888,0.9538708372368231,1.0,25/84,23.05%,GAPDH;RTN1;NANOS1;GGA3;BIN1;ENC1;PRNP;CLU;ORMDL2;BTG2;CNOT8;HAP1;NTRK2;EPRS1;ROCK1;CHRNA7;PIN1;TOB1;PUS7;DHX36;ABCA7;CNOT10;FXR1;IGF2BP3;RNF139
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.24521313232598563,0.9814680844881685,0.4847682119205298,0.9530831577518271,1.0,34/119,22.29%,INPP4B;PIK3C2G;IP6K1;INPP5D;SLA2;MTMR9;SOCS3;PIGQ;PIK3CG;PIGB;PI4K2A;SACM1L;PIGP;SOCS2;MPPE1;OCRL;INPP5F;RAB5A;FGF2;MTMR1;SOCS6;SOCS4;VAC14;DPM3;PTPN13;SMG1;INPPL1;PLEKHA2;INPP5J;PLEKHA1;PGAP2;PIK3C2A;PIP4K2B;ARF1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3202699311201079,-0.9813253277504658,0.4469135802469136,0.7409714436347924,1.0,7/20,22.59%,IGF1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP
prerank,positive regulation of glycolytic process (GO:0045821),-0.3202699311201079,-0.9813253277504658,0.4469135802469136,0.7409714436347924,1.0,7/20,22.59%,IGF1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.23520372663859695,-0.9811594538713676,0.5264900662251656,0.7408092226504998,1.0,18/77,16.52%,BCL2;IGF1;BCL2L1;BIRC6;MCL1;SIAH2;THBS1;RIPK1;PLAUR;ACAA2;SH3RF1;ASAH2;PSMD10;RB1;QARS1;TNF;GPX1;SLC35F6
prerank,isotype switching (GO:0045190),0.4029867977243239,0.9810336871605716,0.4515539305301645,0.9534699769998031,1.0,4/10,15.32%,RNF168;RNF8;CCR6;BATF
prerank,Rap protein signal transduction (GO:0032486),0.4017840192577811,0.9808835090581391,0.4838709677419355,0.9529365287344862,1.0,5/10,25.09%,SGSM3;RAPGEF3;PLK2;RAP2C;RAPGEF2
prerank,RNA 3'-end processing (GO:0031123),0.26786883287919927,0.9804349294323035,0.5014450867052023,0.9533218789761994,1.0,19/69,21.33%,RNPS1;SRSF5;CASC3;SRSF6;SRSF11;MTPAP;SRSF1;CPSF3;CSTF1;NUDT21;CDC40;DDX39B;THOC5;SARNP;SRSF9;CHTOP;ALYREF;SRSF2;LIN28B
prerank,positive regulation of cellular process (GO:0048522),-0.18285930426038846,-0.9799590881372627,0.59375,0.7433307555805073,1.0,148/565,22.55%,FCGR2B;IL15;BCL2;GAS6;ANKRD17;MECP2;ITGAX;ACER3;IGF1;CELF1;GCNT2;DPP4;SDCBP;CUL3;CD47;LIFR;CAPN1;TLR2;FAM98B;LILRA5;P2RX4;CD36;IL12RB2;MEIS1;SLC6A6;RARA;DOCK2;NCBP1;FAM98A;NAMPT;CDCA7L;SOX11;IL6ST;DOT1L;IER5;CXCL16;KITLG;PROX1;PRC1;DDX49;S1PR2;MTLN;THBS1;VHL;CRKL;PDGFD;FLT1;EGR2;CCND1;KIF20B;CAV1;PDCD10;LYN;DHPS;CIB1;GAB2;IL1B;FGF1;HSF1;HCK;H3-3A;BMP5;VIPR1;ZC3H12A;KRAS;PDGFC;ADAM8;BIRC5;NOTCH1;TRPM4;PPP3CA;HDAC2;IGF2;TNFRSF1B;CYBA;BRAT1;SLC11A1;HDAC1;KDR;EMP2;CCND2;PSMD10;LRP1;PTN;SLAMF1;SCX;GREM1;HAS2;EXOSC9;NPM1;KMT2D;NUMA1;LBP;CIAO1;EGFR;SHC1;TNF;PTK2B;WNT5A;TUB;SLC25A33;ECHDC3;BST1;MFSD2A;ACACA;FCER1G;FXR2;TLR4;SLC35F6;MAPK8;ADAM17;AQP11;ADNP2;PTHLH;HMGA2;FN1;LRP6;PDGFRA;HES1;TFAP2B;IRS2;S1PR3;OSMR;CHP2;PA2G4;BAMBI;TIMP1;EPO;MLC1;TRIM21;SIRT2;CXCL12;HDAC4;CDH3;TGFA;CNOT6L;HPR;HP;LMNA;NOXO1;SERPINF2;HMGN5;ISL1;FGF18;SHH;CCAR1;CAPN10;CCKBR
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3055423509507164,-0.9798839226372313,0.46582278481012657,0.7429203790706892,1.0,7/24,14.06%,CCR2;MOSPD2;LYN;CCN3;CXCL17;GREM1;DUSP1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.2502737129510906,-0.979705305430059,0.4924924924924925,0.7427625355982631,1.0,18/55,16.94%,GALNS;LYVE1;FUCA1;CD44;HGSNAT;IDUA;HMMR;CEMIP2;HPSE2;HPSE;OGN;IDS;STAB2;CSPG4;SDC3;CHP1;SDC1;HYAL3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.23420543944840205,-0.9796471573286868,0.5029585798816568,0.7423176601106102,1.0,14/67,15.00%,CYBB;PSMA6;CD36;PSMB2;PSME2;TAPBP;PSMD11;PSMC6;PSMA3;SNAP23;CYBA;PSMD10;B2M;PSMB5
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3116683637911858,0.9794841398101739,0.4845201238390093,0.9552572051119808,1.0,6/33,10.76%,RELA;IL6;TRPM2;RIPK3;SIGMAR1;NFE2L2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.38782073943502077,0.9793026416413244,0.48914858096828046,0.9548239571302112,1.0,3/13,10.06%,NOP9;EIF6;NUP88
prerank,secondary alcohol metabolic process (GO:1902652),-0.26290781111969924,-0.9789762913088147,0.52,0.743431175253572,1.0,8/42,9.43%,APOE;IDH3A;IDH1;PPARD;OSBPL1A;LDLRAP1;CLN8;ABCG1
prerank,peptide hormone secretion (GO:0030072),0.3256968078558566,0.978949945472635,0.5068027210884354,0.9549150711117683,1.0,8/26,21.02%,PTPRN;EXOC3L1;IL6;ADCYAP1;GAL;LTBP4;GHRL;SNX19
prerank,inner ear morphogenesis (GO:0042472),0.3359202332957467,0.9789129224746511,0.5113636363636364,0.9540310128491385,1.0,4/22,15.48%,MYO6;POU3F4;EPHB2;HPN
prerank,regulation of protein import into nucleus (GO:0042306),-0.27444690647335246,-0.9785284772338968,0.5214899713467048,0.7439525568329605,1.0,10/36,19.89%,MDFIC;ZPR1;SMAD3;PSEN1;ZC3H12A;CHP1;FLNA;ECT2;CDH1;CHP2
prerank,melanosome localization (GO:0032400),-0.31217148223832236,-0.9781269278970616,0.47804878048780486,0.7444031084974826,1.0,6/21,26.38%,MYO5A;BBS7;MLPH;SHROOM2;BLOC1S3;MREG
prerank,dopamine metabolic process (GO:0042417),0.35419886200300643,0.9780946876804387,0.48148148148148145,0.9555678558237702,1.0,5/18,14.74%,LRTOMT;PRKN;MOXD1;DAO;COMT
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.30931927901200573,-0.9780248940411531,0.4945945945945946,0.744075995650688,1.0,5/22,10.80%,MED13;MED16;ESR1;PSMC6;PAXIP1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3800146841072667,0.9778421835774878,0.4982698961937716,0.955359607138298,1.0,3/14,6.05%,ZBTB8OS;TSEN54;DDX1
prerank,regulation of DNA recombination (GO:0000018),-0.2813534996461737,-0.977513376367571,0.46005509641873277,0.744851760211069,1.0,16/32,33.17%,KPNA2;RTEL1;ZCWPW1;ZRANB3;H1-0;PPP4R2;RPA2;SETD2;RAD51AP1;SMARCAD1;THOC1;MSH6;FIGNL1;SPIDR;RAD50;MSH3
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2721405934307602,-0.9773546999458124,0.5128939828080229,0.7446455971114296,1.0,8/36,10.72%,PRPF19;CLSPN;USP28;DOT1L;NBN;ATRIP;HINFP;RHNO1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.24008213519598087,0.97732117706931,0.5077120822622108,0.9559556714571555,1.0,26/150,12.98%,FGF10;F3;FGF16;P2RY12;CD80;FGF9;KLB;NRG4;LRP2;CD86;FGF7;AREG;PIK3CG;TNFAIP8L3;MAZ;TGFBR1;TCF7L2;ERBB4;TGFB1;CX3CR1;ITGB1BP1;FGF2;IRS1;VAV1;PDGFB;TEK
prerank,negative regulation of neuron death (GO:1901215),0.2552291407205294,0.9772418650919694,0.5034867503486751,0.9552453396850009,1.0,21/93,16.74%,CD34;NTRK1;SIX4;PPARGC1A;PLA2G3;PM20D1;FBXO7;MEF2C;LGMN;PRKCI;NRBP2;PRKN;CLCF1;KDM2B;MAG;NDNF;SNX6;NTRK2;REST;KIF14;PRKCG
prerank,regulation of wound healing (GO:0061041),-0.26391198001097116,-0.9770938284597115,0.5057803468208093,0.7447342836765706,1.0,6/42,7.33%,PLAU;ALOX5;CRK;PRKCE;CAV1;ANXA1
prerank,regulation of signal transduction (GO:0009966),0.23151139385381772,0.9765130318200144,0.5269922879177378,0.9565355606980294,1.0,26/190,9.35%,TSC2;NUCKS1;ANKRD54;CD80;IFT81;FRRS1L;WWTR1;IGFBPL1;IGFBP6;PRNP;CLU;RGS11;IGFBP2;YJEFN3;MTCH1;UBASH3B;TSPAN15;PRAG1;POFUT1;GNG4;KIF26A;DGKQ;SOCS2;ADCYAP1;OGT;TGFB1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.27137021614905743,0.9760838367349722,0.4918032786885246,0.9568784431009638,1.0,13/62,12.79%,FGF10;F11R;NTRK1;PIK3CG;PRAG1;MAPRE2;RASGEF1A;GPR17;MAP4K4;RASGRF1;LPAR4;AKAP13;VAV1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.2934457665868807,-0.9759480891969523,0.47540983606557374,0.7470995942930029,1.0,8/28,19.89%,ZPR1;SMAD3;PSEN1;ZC3H12A;FLNA;ECT2;CDH1;CHP2
prerank,muscle tissue morphogenesis (GO:0060415),0.36405625799343055,0.9757521564185079,0.4636963696369637,0.9569367786335885,1.0,3/16,8.32%,ZFPM1;TGFBR3;BMP4
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.29668849580664797,0.9756494884562655,0.5008,0.9562687467563363,1.0,10/39,21.22%,ADTRP;PPARA;SPINT2;MAP2K5;TGFB1;MIA3;PTK2;MBP;WNK1;RDX
prerank,negative regulation of hydrolase activity (GO:0051346),0.28364343214541277,0.975585071376565,0.484304932735426,0.9555125054830222,1.0,16/49,24.08%,F11R;CST3;GCHFR;TMED2;DAB2IP;ARFGEF1;RCC2;SH3BP4;RRP1B;HRAS;WNK1;GMIP;RDX;MAP2;GPSM1;CST7
prerank,neurogenesis (GO:0022008),0.29174354756724685,0.975562411913189,0.5119236883942766,0.9546102802920683,1.0,11/43,18.59%,ROGDI;DCHS1;SIX4;RYK;BTBD3;CXCR4;HAP1;ERCC6;FAT4;NDUFS2;DAGLA
prerank,negative regulation of response to wounding (GO:1903035),-0.3189953893894665,-0.9751449059187387,0.4962025316455696,0.7486331232214389,1.0,6/19,17.05%,ALOX5;CRK;GIT1;AJAP1;CERS2;KLK8
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3739595993209607,0.9749867005433206,0.48697068403908794,0.9553866627967991,1.0,3/14,5.50%,CD80;CD86;PRKCZ
prerank,negative regulation of translational initiation (GO:0045947),-0.3620190121971037,-0.974852155460331,0.46635730858468677,0.7488100398874078,1.0,7/13,26.59%,EIF4EBP2;AGO2;PAIP2B;LARP1;EIF3E;EIF2AK1;PAIP2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3238755542419359,0.9745853990064697,0.49673202614379086,0.9556497725085723,1.0,7/25,18.70%,ABI3;ARHGAP44;LIMK2;RAP1GAP;EVL;CDK10;TCHP
prerank,organelle fusion (GO:0048284),0.3398965886072545,0.9742625973036254,0.5106035889070146,0.9556230068139472,1.0,5/22,17.61%,CYP26C1;FIS1;USP30;MIGA1;MFF
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.32434871891480455,-0.9740698993923972,0.495260663507109,0.7502337563838056,1.0,3/17,8.39%,NRP1;STAP1;HCK
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.31543810901633085,0.9738815339166792,0.49673202614379086,0.9558066551275844,1.0,12/29,29.25%,LDLRAD4;DAB2IP;EFNA1;SFRP1;SDHAF2;HPN;ZNF750;IL17RD;SFRP2;FUZ;PTEN;NKX2-1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3751852829156364,0.9734237391827831,0.49667774086378735,0.956231355796243,1.0,8/14,28.92%,RARRES2;MAPK3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,negative regulation of viral transcription (GO:0032897),-0.3618540484284175,-0.9732832494525269,0.4816753926701571,0.7517544161406285,1.0,3/13,6.61%,TRIM14;IFITM3;TRIM62
prerank,positive regulation of blood coagulation (GO:0030194),0.36243081409746164,0.9731853726674031,0.46357615894039733,0.9559588930383179,1.0,4/17,12.53%,F3;THBD;USF1;ENPP4
prerank,regulation of metal ion transport (GO:0010959),-0.33804517840023307,-0.9730207981924894,0.4975845410628019,0.7517972647115242,1.0,2/16,3.44%,BCL2;IL16
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.38221471654750416,0.9730014366270127,0.49454545454545457,0.9555533087888006,1.0,4/13,12.50%,FSTL1;DAND5;FBN2;GREM2
prerank,regulation of store-operated calcium entry (GO:2001256),0.40927207996669046,0.9727689563634986,0.4880952380952381,0.9553004793042028,1.0,2/10,10.36%,EFHB;HOMER2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3171278237104609,0.9725055349004238,0.4864,0.9551248500630077,1.0,9/26,18.41%,PRKCZ;NRXN1;SHANK3;GRIN1;RIMS1;SLC8A3;WNT7A;SHANK1;CHRNA7
prerank,regulation of cell death (GO:0010941),-0.22546582707972035,-0.9723435369516947,0.5331010452961672,0.7529475936059139,1.0,34/94,25.62%,ACER3;CHMP4B;CELF1;CD36;TBK1;SOX11;VPS35;NCK1;SPEF1;TMEM109;PACRG;ZC3H12A;SNCG;CCN1;TNFRSF1B;LRRK2;CCN3;LRP1;CCN5;CHP1;DUS2;ADNP2;HSPA1B;BMP7;DHCR24;HPR;HP;EPHB1;NOA1;PARP16;CCN6;RAMP3;OLFM4;TRIM13
prerank,miRNA metabolic process (GO:0010586),-0.31249112847904326,-0.9723402703430838,0.45707070707070707,0.7523491782523708,1.0,5/20,21.17%,DIS3L2;AGO2;TRIM71;TENT4B;DGCR8
prerank,phosphatidylinositol metabolic process (GO:0046488),0.24474847895798582,0.9722310295438714,0.5176151761517616,0.9550126201116995,1.0,17/109,10.75%,INPP4B;TPTE;PIK3C2G;INPP5D;PLA2G3;MTMR9;PLCD1;INPP5B;PLA2G4C;PLCG1;PIK3CG;PI4K2A;SACM1L;OCRL;INPP5F;RAB5A;FGF2
prerank,response to metal ion (GO:0010038),0.264547908799676,0.9721302499720471,0.5049088359046283,0.9543393814549729,1.0,18/67,18.76%,KCNMA1;TRPC3;CAPN3;SEC31A;NEDD4;PDCD6;ITPR3;SLC30A3;PPP5C;KHK;NDRG1;NEDD4L;MT2A;MT1A;MT1X;IL1A;SNCB;TRPV6
prerank,endoderm development (GO:0007492),-0.354478439844181,-0.9719956822073169,0.4766355140186916,0.752582699480836,1.0,3/13,14.82%,KIF16B;DUSP1;LHX1
prerank,fibrinolysis (GO:0042730),-0.34870699852455084,-0.9719666871123434,0.49770642201834864,0.752058028334486,1.0,2/13,6.66%,PLAU;PLAUR
prerank,histone lysine methylation (GO:0034968),-0.28161057317959154,-0.9718929360675266,0.5470588235294118,0.7516768635151618,1.0,15/33,25.76%,SETDB2;DOT1L;SETD3;PRDM9;WDR82;KDM6A;PAXIP1;DPY30;KMT2D;RBBP5;SMYD3;KMT2B;KMT2A;EZH2;DYDC2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.29683512870885287,-0.9717929214433985,0.5200945626477541,0.7513281105465477,1.0,6/26,10.04%,CUL4A;CHD1L;UBC;USP45;UBA52;RAD23B
prerank,regulation of steroid metabolic process (GO:0019218),0.33032129894157025,0.9717159314449756,0.5040783034257749,0.9546144286031607,1.0,10/23,25.70%,STAR;GNB3;DGKQ;ABCA2;TTC39B;RORA;FMO5;NR5A1;STUB1;PANK2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.39719883886050283,-0.9715943986296078,0.508695652173913,0.7512154800094747,1.0,5/10,19.94%,PID1;IL1B;INPP5K;RSC1A1;APPL2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.38258561940931324,-0.9715227670847031,0.5011764705882353,0.7508304353312222,1.0,2/11,2.65%,CD274;RUNX3
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2999498576632568,-0.9715132319915122,0.5,0.7502578607029224,1.0,8/27,16.40%,GAS6;PTPN22;ZC3H12A;C1QTNF3;FOXJ1;SLAMF1;TNF;TLR4
prerank,regulation of heart contraction (GO:0008016),0.25108221502953254,0.9709811239558145,0.5020632737276479,0.9558643251461846,1.0,20/90,19.85%,ATP2A3;ATP2A2;ITPR2;ATP1B1;ASPH;ATP1B3;TBX2;SLC8A1;GJA5;ITPR3;ATP2B3;SLC8A3;ADORA3;DMPK;AGT;ANK2;TMEM65;ATP1A3;ATP1A4;ATP1A1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.24932067901849964,0.970714682680557,0.5167336010709505,0.9556977558236976,1.0,28/100,19.62%,TSC2;NTRK1;NTRK3;PIK3CG;MAZ;DAB2IP;NEDD4;FGF2;BECN1;PDGFB;TEK;PIK3IP1;INSR;NTRK2;DIPK2A;MAPK3;FBXL2;PTK2;AGT;FLT3;PTPN13;IL18;PLXNB1;DCN;STAMBP;CCL5;PDGFRB;ROR1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3753141608882137,0.9704434236018403,0.48877374784110533,0.9556148918556889,1.0,6/14,24.52%,ATP1B1;DMD;WNK1;SLC9A1;GLRX;ANK3
prerank,positive regulation of sodium ion transport (GO:0010765),0.3886313836014654,0.9704009867425425,0.4900332225913621,0.9547699335010992,1.0,7/12,33.06%,CNKSR3;SCN1B;SCN3B;ANK3;PKP2;WNK3;SCN4B
prerank,regulation of epithelial cell migration (GO:0010632),-0.25060778881384504,-0.9703376092991443,0.509090909090909,0.7527127326468387,1.0,11/51,13.42%,SASH1;PTPN23;PRKCE;MCC;CORO1C;GLIPR2;HIF1A;RHOJ;CEACAM1;EMP2;PTN
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.3352785947446643,-0.9701322133624325,0.4718826405867971,0.752651776434283,1.0,2/16,2.85%,APOE;CD36
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3695902715019933,-0.9700921183862303,0.47344110854503463,0.7521544155431739,1.0,4/11,14.06%,STAP1;CCN3;GREM1;DUSP1
prerank,regulation of viral transcription (GO:0046782),0.29002926060601947,0.9700660166087597,0.5021961932650073,0.9548030673855546,1.0,6/39,6.89%,POLR2L;POLR2F;NELFB;MID2;NELFCD;GTF2F1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.30754549018654326,0.9700370849672812,0.5015723270440252,0.9539337088906629,1.0,5/32,8.05%,C3;STAR;PPARA;THRSP;EIF6
prerank,positive regulation of JNK cascade (GO:0046330),-0.23765110193389188,-0.9696505648165633,0.5083612040133779,0.7527002561465941,1.0,18/70,18.72%,FCGR2B;SDCBP;PJA2;NOD2;RIPK1;IL1B;TAOK3;SH3RF1;MAP3K11;TNFRSF19;GADD45G;SLAMF1;AGER;PTK2B;TRAF1;HIPK2;MMP8;TRAF4
prerank,cardiac conduction system development (GO:0003161),0.3280995452619109,0.9696095306235564,0.5106732348111659,0.9542428165834118,1.0,4/24,9.91%,BMP4;HEY1;CACNA1G;GJA5
prerank,regulation of kinase activity (GO:0043549),0.2534782851778887,0.9694955460868119,0.5228848821081831,0.9536206681878391,1.0,22/89,20.52%,ANKRD54;MERTK;LDB2;LDB1;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;TEK;EPHA4;RBL2;RBL1;INSR;EPHB2;NTRK2;VAC14;FLT3;PDGFRB;ROR1;EPHA5
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.37041167437764516,-0.9689947153068111,0.5100671140939598,0.7537714592418174,1.0,6/12,28.49%,RAB1A;CDC14B;PLK1;UBE2C;GORASP1;CDC20
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.3874388070527509,-0.968978810166636,0.48826291079812206,0.7532036337766985,1.0,4/10,15.56%,MECP2;PCGF3;IGF2;PCGF5
prerank,aerobic electron transport chain (GO:0019646),0.264052828965271,0.9689535537923443,0.5174337517433751,0.954266467886772,1.0,21/68,23.98%,NDUFA6;UQCRC1;NDUFA4;CYC1;SDHC;COX7B;UQCC3;COX6C;NDUFS1;UQCR11;NDUFA8;NDUFS6;SDHAF2;COX7C;NDUFAB1;NDUFS2;NDUFB6;COX4I1;COX6B1;UQCR10;COX10
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.23829072626386025,-0.9687076843238045,0.5032467532467533,0.7533100464379628,1.0,16/62,15.28%,CDK6;CDC73;MEIS1;PURB;THBS1;PF4;LYN;KMT2C;PRKCQ;H3-3A;EP300;NFE2;HDAC1;DPY30;KMT2D;PTK2B
prerank,lysosome organization (GO:0007040),-0.2701953841536716,-0.9683871514716028,0.49266862170087977,0.7535934555033137,1.0,11/36,16.03%,TMEM165;TPCN2;NAGPA;HPS1;CLN5;MBTPS1;GNPTAB;AKTIP;LRRK2;GAA;CLN3
prerank,regulation of glycolytic process (GO:0006110),-0.233117927636154,-0.968117812858543,0.5454545454545454,0.7537004743925654,1.0,13/68,10.27%,IGF1;GIT1;CBFA2T3;RANBP2;PRKAG2;HIF1A;PSEN1;NUP153;NDC1;NUP43;NUP210;EP300;PGAM1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.25933398737050706,-0.968031787622904,0.5087209302325582,0.7533124815993341,1.0,23/45,36.64%,DAB2;SDCBP;BMP5;RBPMS;BMP2;BMP3;SMAD4;ACVR1;ACVR2A;GDF3;BMP7;GDF10;BMPR2;GDF9;INHBB;BMPR1A;GDF15;TGFB2;BMP8B;LEFTY1;GDF6;BMP15;INHBC
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3218557651839717,0.9678871747099357,0.506578947368421,0.9565863926601305,1.0,4/24,8.93%,OCIAD2;PRLR;IL6;ERBB4
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.39542219733916195,0.9678436600183954,0.5051546391752577,0.9538544215411832,1.0,7/11,27.92%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.39542219733916195,0.9678436600183954,0.5051546391752577,0.9538544215411832,1.0,7/11,27.92%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.39542219733916195,0.9678436600183954,0.5051546391752577,0.9538544215411832,1.0,7/11,27.92%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,macrophage chemotaxis (GO:0048246),-0.3929477919851768,-0.967727888401271,0.5012106537530266,0.7535301539186993,1.0,5/10,34.83%,EDNRB;CXCL17;TAFA4;CKLF;EDN2
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.25729178988687185,-0.9672796277536605,0.4899713467048711,0.7540887686660604,1.0,11/47,15.33%,APOE;EIF2A;VPS35;TCOF1;NFKB1;NR1H2;EDNRB;RPL10;WDR91;NR1H3;EIF2B4
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.291521907823201,0.9672715923183376,0.515015015015015,0.9546051385465736,1.0,8/41,10.39%,LACC1;AAAS;NUP54;EIF6;OGT;NUP88;RAE1;JMJD8
prerank,GPI anchor biosynthetic process (GO:0006506),0.30869496761118836,0.9670764795838324,0.48833592534992226,0.9542395777413032,1.0,12/30,28.05%,PIGQ;PIGB;PIGP;MPPE1;PIGS;DPM3;PGAP2;PGAP3;PIGX;DPM1;DPM2;PIGZ
prerank,positive regulation of kinase activity (GO:0033674),-0.21812030428206303,-0.9668405640113865,0.5330739299610895,0.7546302578018995,1.0,23/107,16.71%,IQGAP1;CD74;GAS6;AXL;PTPRC;MET;LMTK2;FLT1;SNX9;NBN;PRKAG2;RET;LCP2;AGAP2;CCN1;KDR;LMO4;EGFR;TNF;PTK2B;RAP1A;EPHA2;EPHB4
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.33953432444212184,-0.9664908744717183,0.4948453608247423,0.7548918001622672,1.0,2/16,1.07%,CHMP4B;CHMP4A
prerank,nuclear body organization (GO:0030575),0.3819415757956862,0.9663714254507795,0.5008849557522124,0.9553685241324447,1.0,2/12,7.05%,WRAP53;USP50
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.2531898241306512,-0.9662781480656452,0.5303030303030303,0.7548524436491412,1.0,6/49,6.83%,IL15;IGF1;PARP14;PIBF1;IL6ST;LYN
prerank,icosanoid metabolic process (GO:0006690),0.2945741984138034,0.9658592919719204,0.5171339563862928,0.9559612570091859,1.0,5/40,6.44%,CYP2S1;PTGS1;ALOX12;PLA2G4C;GGT5
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.21942373645170832,-0.9655445911471605,0.5483870967741935,0.7561977393021294,1.0,31/95,25.33%,PCM1;CDK5RAP2;PRKACA;MKS1;SCLT1;TUBA4A;CEP250;TCTN1;YWHAG;HAUS2;KIF24;CEP164;MAPRE1;CENPJ;CDK1;HAUS8;PLK1;DCTN2;ODF2;PAFAH1B1;AKAP9;CC2D2A;B9D2;CEP78;OFD1;TUBB4B;MARK4;NDE1;NPHP1;RAB3IP;CEP97
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2993489839117875,0.9655173819426506,0.5031847133757962,0.9560232846717306,1.0,6/33,14.82%,ANG;TRIB1;MEF2C;PRKG1;NDRG4;APOD
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.3694707028802324,-0.9652181309731698,0.4927536231884058,0.7564509458041185,1.0,2/12,8.85%,KPNB1;MBTPS1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.2606624474935137,-0.9651823970752991,0.516042780748663,0.7559456960197142,1.0,16/40,26.25%,DAB2;GCNT2;SDCBP;SMAD3;GLIPR2;IL1B;CTNNB1;NOTCH1;BMP2;RGCC;SMAD4;BAMBI;TWIST1;EZH2;PDPN;LEF1
prerank,negative regulation of translation (GO:0017148),-0.22477149758917767,-0.9644534251392046,0.5467128027681661,0.7570940741670109,1.0,28/87,23.57%,CELF1;CNOT9;MALSU1;SAMD4A;EIF4EBP2;EIF4ENIF1;DDX6;CAPRIN1;CPEB4;DAPK1;AGO2;PAIP2B;SYNCRIP;TYMS;LARP1;RACK1;TRIM71;FXR2;CPEB2;IGFBP5;MEX3D;PUM1;DHFR;CPEB3;EIF3E;ILF3;EIF2AK2;RIDA
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.31990215958155127,-0.9644507185444522,0.49870801033591733,0.7565051384772282,1.0,4/19,6.71%,GAS6;AXL;SYK;ZMIZ1
prerank,protein-containing complex subunit organization (GO:0043933),0.2456984671066466,0.9640678162327361,0.5327102803738317,0.9594537719561664,1.0,39/109,27.09%,WDR19;CAPN3;ADD2;NIFK;PARD6B;PPARGC1A;NCKAP1L;MAGI1;IL1RAP;NUP54;TSPAN4;SH3BGR;ZW10;PEX14;RIMS1;DNM1L;WASF3;CHCHD10;VAMP3;NUP133;TUBGCP2;EPRS1;GEMIN5;PPP2R1A;SHANK1;LIN7A;CLDN14;CAPG;MDM4;TEAD2;WASL;LAMC1;IL2RB;CD40;HFE;LLGL1;DLG4;ST13;DMTN
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2825309317303789,0.9639291212558458,0.528158295281583,0.9588963077127861,1.0,13/45,18.19%,NANOS1;DDX25;ZC3H10;ZC3H7B;SPOUT1;YTHDC1;METTL16;CYFIP1;NUDT21;RBM3;MAPKAPK5;GEMIN5;ATXN2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.30115351313339267,-0.9638173249551465,0.4820936639118457,0.7575372330635506,1.0,9/23,28.40%,PLBD1;PLA2G4E;PLAAT3;LPCAT4;PLA2G4F;PLA2G2D;MBOAT1;ABHD4;PLA2G12A
prerank,regulation of neuron death (GO:1901214),0.25837778257950633,0.9632745533964995,0.5141242937853108,0.9598497274751893,1.0,25/82,21.89%,DCC;FAIM2;CD34;PPARGC1A;PM20D1;PRNP;CLU;MEF2C;GRID2;GRIN2B;SIGMAR1;PRKN;DDIT4;SARM1;REST;KIF14;RRAS2;SNCB;INPP5A;CHRNA7;NSMF;CCL5;ITGAM;BTBD10;LANCL1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3805099959186584,0.9632012677976053,0.5024711696869851,0.9591145664953887,1.0,6/13,23.33%,ASPH;LGMN;BAK1;CASP8;CIDEB;RIPK2
prerank,intracellular protein transport (GO:0006886),0.21824616973047248,0.9631223499152664,0.5702764976958525,0.9583979810888209,1.0,71/304,20.36%,CTTN;TSC2;LTBP2;FUT10;STRADB;RAB6B;GGA3;RAB1B;SCFD2;SGSM2;RAB43;SGSM3;GIPC1;HERC2;NAPB;ARL5A;FAM53C;TMED2;STX16;ARL4C;SEC31A;NXT2;ARL4A;MYO6;PRICKLE1;RAB24;ARFRP1;HEATR3;FAM53B;TGFB1;MYO1C;NUP88;ARL4D;RAB5A;CAMSAP3;RAB38;PDCD6;STX3;EHD1;TBC1D16;RAB28;SNX15;PKD1;TBC1D8;IFT27;TMED5;STXBP2;IPO5;SNX6;HAP1;OXA1L;RASSF9;TBC1D25;NUP133;XPO6;TMED3;CACNG3;VPS33B;SRPRA;PREB;BCS1L;SYNRG;STX17;STRADA;AP4E1;IPO8;ERP29;TMED7;SNF8;RANBP3L;GABARAP
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.41427797436985797,0.9630365192865759,0.5207956600361664,0.9577216872404275,1.0,4/10,23.60%,ACADS;ACADM;ETFB;ETFA
prerank,regulation of lipid kinase activity (GO:0043550),-0.37904302852037103,-0.9630144681244905,0.49061032863849763,0.7590589379945002,1.0,4/11,13.37%,PPP2R5A;WDR91;WDR81;RB1
prerank,fatty acid metabolic process (GO:0006631),0.242868290801248,0.9627365426327315,0.4960212201591512,0.9576782403306525,1.0,35/115,23.84%,ACSF2;ALOX12;CPT1B;PPARGC1A;MECR;PPARA;ACADSB;GGT5;PNPLA3;CBR4;ACSL6;OXSM;ACOT4;ACOX1;ELOVL4;ACOT11;ACLY;NDUFAB1;ACSF3;PEX2;ACSBG1;ANGPTL3;ACADM;LIPC;XBP1;ABCD2;HPGD;PLA2G15;ALOX5AP;FA2H;ACAD9;PNPLA8;ACSL3;GPAT2;HACL1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.34446908767749146,-0.9620003540488054,0.5406091370558376,0.7610690967102076,1.0,5/15,16.27%,STAT2;USP18;NLRC5;OAS3;MUL1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.23555585783746338,0.9616491534294767,0.551948051948052,0.9599217613446237,1.0,24/150,11.54%,TSC2;PPM1E;WWTR1;LDLRAD4;THY1;DMD;CNKSR3;PRKCZ;PRNP;NTRK3;TRIB1;TRIB2;UBASH3B;CACTIN;DAB2IP;DGKQ;EPHA1;SH3GL2;TGFB1;MVP;PRKN;ITGB1BP1;DDIT4;SFRP1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.21915704765679286,-0.9612204415875796,0.5399239543726235,0.7624418161389422,1.0,23/102,17.40%,MYO5A;RAB8B;DENND4C;PPARG;PRKACA;ADCY9;NFKB1;CAV1;GOT1;ADCY5;RAB15;ADCY6;RAB10;FOXO1;ADCY1;SORBS1;CEACAM1;ADCY3;INPP5K;PRKACB;SLC25A33;CPEB2;RAB31
prerank,cellular response to organic substance (GO:0071310),-0.20975920062207382,-0.9611373834774298,0.5421686746987951,0.7620912047277935,1.0,33/116,21.40%,PID1;ARL6IP5;PTPN23;STAT5B;TBK1;NCOA1;SMAD3;LDLRAP1;CIB1;IL1B;PTPN7;CTNNB1;GHR;LRRK2;ASAH2;CYP1A1;RACK1;INPP5K;SHC1;TNF;RAMP2;MAPK7;MAPK8;TIPARP;CRNN;IL18R1;IGFBP5;ACVR1;ACVR2A;KLF4;CDK9;CASP1;PTPN4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.26423895473094494,-0.9610770264137094,0.5423728813559322,0.761670422572199,1.0,8/40,10.04%,RPL5;FBXW7;TAF1;RPS7;GNA12;CCDC22;XPO1;RAD23B
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3807690604579143,-0.960640105313874,0.5128205128205128,0.7621807376491404,1.0,5/10,22.77%,PTPN22;NR1H3;LBP;LTF;TICAM2
prerank,cellular response to glucose stimulus (GO:0071333),0.30896443126483997,0.9605524267832554,0.5164319248826291,0.9622787024156123,1.0,4/30,4.45%,ADCY8;PTPRN;TRA2B;SOX4
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.28443184551479517,-0.9605512450947351,0.5149253731343284,0.7618065492313152,1.0,8/27,18.88%,ZC3H12D;ERN1;ZC3H12A;ZC3H12B;PCF11;POP1;TRIR;RNASEH1
prerank,cellular amide metabolic process (GO:0043603),-0.21698673091829807,-0.9603172460943932,0.5682656826568265,0.761839174880435,1.0,22/102,15.03%,NLN;ACOT8;SGPL1;PLA2G4E;MTHFR;CPD;ORMDL1;PLAAT3;MCCC1;CLN8;SLC46A1;ST6GAL1;MCCC2;HLCS;CPE;MTHFD1;CPM;CERK;ASAH2;MTRR;ORMDL3;BTD
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3495574033619416,0.9603158629818431,0.5207296849087893,0.9620372834679476,1.0,7/17,17.61%,FIS1;CLU;BAK1;GGCT;DNM1L;BBC3;MFF
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.3395005740675102,-0.9602774574638101,0.5193236714975845,0.7613365898627805,1.0,5/16,21.57%,ZC3H12D;ZC3H12A;RC3H1;TRIM71;CPEB3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.3402024314089756,-0.9601286077976527,0.4963680387409201,0.7611197729986837,1.0,6/15,25.07%,NOD2;HIF1A;TNF;TLR4;MYD88;APPL1
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.24362484547827265,-0.960029395080029,0.553623188405797,0.7607486508730583,1.0,18/54,20.41%,EXT1;XYLT1;GCNT2;FUCA1;HGSNAT;CHST9;IDUA;UGDH;HPSE2;HPSE;IDS;SDC3;SDC1;XYLT2;GALNT5;PXYLP1;SDC4;SLC35D2
prerank,pulmonary valve development (GO:0003177),-0.32274870234094155,-0.9599489412101656,0.5205128205128206,0.7603653204751147,1.0,13/18,37.84%,NOTCH1;SMAD6;TNFRSF1B;HEY2;NOTCH2;HEYL;BMPR2;SLIT2;ROBO2;TGFB2;STRA6;NFATC1;TNFRSF1A
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2374090391626316,-0.9598490934141178,0.5174603174603175,0.7600315715395184,1.0,16/61,15.45%,CDK6;CUL3;CUL4A;GPR132;CDC34;CCND1;CDKN2C;HINFP;MAP3K11;CCNH;CDKN3;CCNA2;RB1;MNAT1;TRIM71;CDC25A
prerank,response to thyroid hormone (GO:0097066),0.3804510860050354,0.9597085776115333,0.5264900662251656,0.9628872793009431,1.0,7/13,25.93%,BRD8;LMO2;HPN;RDX;CTSS;GAS2L1;CTSH
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.38451929755796443,0.9596906455357042,0.5245346869712352,0.9620003175611251,1.0,3/12,14.38%,CRMP1;ALDH6A1;DPYSL2
prerank,leukotriene metabolic process (GO:0006691),-0.31453494825721046,-0.9596576587442269,0.5216216216216216,0.7599483871961478,1.0,3/19,3.83%,ALOX5;MGST3;MAPKAPK2
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2768672800726133,-0.9596200099665236,0.5327868852459017,0.7594634476968178,1.0,8/33,14.37%,CPSF1;NCBP1;FIP1L1;SNRPB;CPSF4;CSTF2;CPSF2;PCF11
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3936369506653007,0.9596090891875556,0.5037037037037037,0.9613205000452343,1.0,2/11,2.21%,RAB1B;F11R
prerank,pre-replicative complex assembly (GO:0036388),-0.23767089657033244,-0.9593101725580538,0.544891640866873,0.7596347392720592,1.0,16/64,15.34%,PSMA6;PSMB2;PSME2;ORC5;PSMD11;PSMC6;UBC;PSMA3;UBA52;ORC2;MCM2;ORC4;PSMD10;CDT1;PSMB5;MCM8
prerank,leukotriene biosynthetic process (GO:0019370),-0.33608075540838084,-0.9591280493906252,0.4908616187989556,0.7594788122023005,1.0,4/14,12.03%,ALOX5;MGST3;GGTA1;LTA4H
prerank,negative regulation of cell junction assembly (GO:1901889),-0.29005813021461974,-0.9589605059778887,0.5216216216216216,0.7593326739962691,1.0,5/25,8.08%,TLR2;CORO1C;SLIT1;THBS1;IL1B
prerank,regulation of intracellular pH (GO:0051453),-0.2731213968353463,-0.9586858889041198,0.5207756232686981,0.7594453743375479,1.0,17/34,27.16%,TMEM165;SLC9A9;TM9SF4;SLC9A2;LRRK2;SLC4A9;CHP1;CLN3;GPR89A;GPR89B;SLC9A6;SLC26A6;CA2;SLC26A3;SLC9A3;SLC4A1;SLC4A5
prerank,homeostasis of number of cells (GO:0048872),0.37599966741705326,0.9582090675445203,0.5140845070422535,0.96447840145283,1.0,3/12,15.46%,OCIAD2;CX3CR1;NAPEPLD
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2417166743896847,-0.9581480765853385,0.5341614906832298,0.7602134578767085,1.0,9/63,7.07%,SP100;IGF1;BIRC6;SIAH2;THBS1;FAS;RIPK1;CAV1;WWOX
prerank,endodermal cell differentiation (GO:0035987),0.3046039402566764,0.9581138091009637,0.5184590690208668,0.9638329412310176,1.0,8/31,16.18%,CTR9;RTF1;LAMB3;ITGB5;ITGA5;COL4A2;VTN;PAF1
prerank,peroxisomal membrane transport (GO:0015919),0.31457743140053973,0.9578271262166816,0.5125208681135225,0.9636868908809698,1.0,13/27,27.71%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;PEX6;ABCD2;PEX11B;PEX3;PXMP4;ABCD3;ACBD5
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.3530052978398459,-0.9577725541171352,0.5096618357487923,0.7605898596654833,1.0,4/13,17.07%,ITGA4;SP1;IGF2;ADAM17
prerank,regulation of microtubule polymerization (GO:0031113),0.2911410169042803,0.9577186312391901,0.5248796147672552,0.9630750007926163,1.0,15/40,26.15%,PAK1;PSRC1;STMN2;NAV3;CAMSAP3;CAMSAP1;DCTN1;CLIP1;FES;MAP2;MAPRE3;DRG1;GBA2;TBCD;MAPT
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.27624781807030624,-0.9575671191048044,0.5132978723404256,0.7605490551381457,1.0,12/30,22.25%,IGF1;SHOC2;RASGRP4;CRKL;LYN;GRB2;NOTCH1;SHC1;IRS2;NOTCH2;EPO;LRRC59
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.32940857697847603,-0.957219288816705,0.49747474747474746,0.7608400859331467,1.0,5/16,12.49%,DTX3L;SMCHD1;MAD2L2;SHLD1;PARP9
prerank,regulation of phospholipase C activity (GO:1900274),0.36287160251613465,0.9571474796204874,0.5008488964346349,0.9638052197569765,1.0,6/15,19.42%,NTRK3;PLCG1;FGF2;HRAS;BICD1;PDGFRB
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.19007558572248742,-0.9570496180891408,0.6066666666666667,0.7606460626129016,1.0,59/291,16.66%,PID1;PXN;STAP1;CD274;AXL;ABL2;VCP;BRINP1;CDC73;TLR2;HMGB2;GIT1;P2RX4;RRAGC;LAMTOR5;ESR1;AHR;NFKB1;CAPN2;ADAM9;CD14;TAF1;LCOR;PF4;NOD2;TNIP3;ERCC6L2;LYN;IL1B;CPEB4;RET;SNW1;ZC3H12A;LPL;ADCY6;VIM;FOXO1;ACOD1;TNFRSF1B;DAPK1;RRAGA;KAT5;SHPK;NR1H3;INPP5K;FOS;TESC;LBP;EGFR;LILRB1;PTK2B;RAP1B;WNT5A;RAP1A;FAM210B;PDE2A;TLR4;MAPK8;SESN2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3009403980037105,-0.9568295539314001,0.513715710723192,0.760612694045692,1.0,5/23,8.85%,VCP;OS9;TECPR2;SEC16A;TMED9
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20885064122518024,-0.9566665215292066,0.5655430711610487,0.7604665830605299,1.0,26/114,18.00%,PSMA6;TNFSF8;PSMB2;PSME2;LIMS1;BAG4;PSMD11;RIPK1;PSMC6;PSMA3;STAT1;LTB;BIRC2;TNFRSF1B;PSMD10;EDA;TNFRSF17;PSMB5;TNF;PTK2B;TRAF1;ADAM17;PYDC1;TNFRSF9;TNFRSF25;PSMD5
prerank,membrane lipid catabolic process (GO:0046466),-0.38029334194435926,-0.9565139214426409,0.5150115473441108,0.7602722442989194,1.0,2/10,1.52%,SGPL1;FUCA1
prerank,regulation of endopeptidase activity (GO:0052548),0.26645207946215915,0.9561217728460993,0.5432835820895522,0.9658567344355417,1.0,11/59,16.94%,GAPDH;SPOCK3;VSIR;SPOCK2;SERPINH1;PSME3;PSENEN;VTN;SERPINE2;AGT;PRELID1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2874301284163575,-0.9560244030804812,0.5083932853717026,0.760886542865941,1.0,11/25,26.35%,SDCBP;MTMR2;ANKRD13A;PICALM;PSEN1;APOC1;ITGB3;WDR54;APP;RAC1;ANKRD13B
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.408798303932397,0.9556252593322428,0.5182608695652174,0.9664048935403913,1.0,3/10,9.32%,UBE2B;PDE3B;MGRN1
prerank,regulation of ATP metabolic process (GO:1903578),-0.23633921709295155,-0.955312680351889,0.5858895705521472,0.7621445931261093,1.0,14/54,15.65%,ATP7A;RANBP2;PRKAG2;HIF1A;NUP153;NDC1;NUP43;NUP210;EP300;PGAM1;UQCC2;SPHK2;SLC25A33;NUP62
prerank,skeletal system morphogenesis (GO:0048705),0.2874946278501649,0.9548569799836109,0.5246636771300448,0.9677587844958416,1.0,7/42,14.96%,HOXD4;MEGF8;HOXB9;TGFBR1;FBN2;SPEF2;DSCAML1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.37110757288931123,0.9548477407552355,0.505922165820643,0.9668496830392337,1.0,4/14,10.23%,MEOX2;MAP2K5;HDAC5;ITGB1BP1
prerank,antibacterial humoral response (GO:0019731),0.3503460066015656,0.9548309265555576,0.5301003344481605,0.965969111414903,1.0,3/16,10.19%,ANG;DEFA6;RNASE7
prerank,sterol metabolic process (GO:0016125),0.2669904003665298,0.9541958067818981,0.5329512893982808,0.9669245177851863,1.0,7/60,6.99%,STARD3;TM7SF2;CYP26C1;FDX2;SOAT2;NSDHL;CYP39A1
prerank,response to glucose (GO:0009749),0.27945481766551256,0.9540413969421762,0.5330330330330331,0.9664745100997366,1.0,9/46,15.19%,SELENOS;ADCY8;TRA2B;SOX4;TCF7L2;UNC13B;EIF2B3;KHK;EIF2B1
prerank,androgen receptor signaling pathway (GO:0030521),0.40111127529916235,0.9540279611497977,0.5301418439716312,0.9655800843898887,1.0,2/11,6.32%,DDX5;AR
prerank,production of siRNA involved in RNA interference (GO:0030422),0.40197177833261244,0.9539231130289011,0.5285714285714286,0.9649372408237462,1.0,3/10,18.08%,DROSHA;TSN;TSNAX
prerank,actin filament bundle organization (GO:0061572),-0.2774684867594685,-0.9534191175402711,0.5292479108635098,0.766525033394184,1.0,10/33,22.63%,NEDD9;EPS8;LCP1;PLS1;MICAL1;LIMA1;RFLNA;AIF1L;SHROOM2;BAIAP2L2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.25950323935412056,-0.9533831350630833,0.512396694214876,0.7660210523761181,1.0,8/40,13.83%,DAB2;HIP1;LDLRAP1;HNRNPK;CBL;RAB21;B2M;GREM1
prerank,inner mitochondrial membrane organization (GO:0007007),0.2766740547140675,0.9531734719640155,0.5401234567901234,0.9662149023070387,1.0,21/47,30.52%,TIMM29;ATP5F1C;UQCC3;MICOS13;HSPA9;APOO;TIMM13;TIMM22;TOMM70;MTX2;ATP5MC3;ATP5ME;ATP5MF;TIMM10;TIMM10B;DNAJC11;APOOL;ATP5F1A;MICOS10;SPG7;TMEM11
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.39556025241559084,0.9530291272192299,0.5202205882352942,0.9657293033750659,1.0,5/10,17.49%,SOCS3;INPP5F;SH2B3;PTPN2;PPP2R1A
prerank,response to light stimulus (GO:0009416),0.26578777771183115,0.9528093291901955,0.554380664652568,0.9654466787755808,1.0,11/55,15.47%,UBE2B;CPT1B;GTF2H2;CIRBP;COPS3;USF1;DCT;DDB2;MAPK10;ERCC6;CCAR2
prerank,nucleus organization (GO:0006997),-0.24892008369695867,-0.9526874586025443,0.5358255451713395,0.7671987999298258,1.0,9/47,14.23%,CHMP4B;CHMP4A;ATXN7;CTDNEP1;LEMD3;NDC1;PDCD6IP;CHMP1B;NUMA1
prerank,calcium ion import into cytosol (GO:1902656),0.3585418962522132,0.9522755247627813,0.53184165232358,0.9660728928864663,1.0,5/15,18.76%,TRPM2;SLC8A1;SLC8A3;CACNA2D1;TRPV6
prerank,histone H4 deacetylation (GO:0070933),-0.39087661288769504,-0.9522147421734175,0.502262443438914,0.7677896864372861,1.0,5/10,21.35%,RCOR1;HDAC2;HDAC1;SIRT2;HDAC4
prerank,mitotic recombination (GO:0006312),0.35994450574695286,0.951856010422083,0.517948717948718,0.9663158300208288,1.0,4/15,15.96%,SMC5;DMC1;RAD52;XRCC3
prerank,ganglioside metabolic process (GO:0001573),0.33108782944798365,0.9517359283908501,0.5478991596638656,0.9657388477341203,1.0,4/20,13.97%,ST3GAL5;HEXB;NEU1;ABCA2
prerank,negative regulation of cell activation (GO:0050866),-0.34068102272384415,-0.9514723297023194,0.5239294710327456,0.76907531972632,1.0,2/14,6.67%,APOE;LDLR
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.20519501434529805,-0.951244259475251,0.5955555555555555,0.7690818003396374,1.0,30/138,16.71%,NEDD9;MTSS1;STAP1;AXL;CASS4;LIFR;FRS2;MET;IL6ST;LMTK2;RASGRP4;FLT1;SYK;LYN;FYN;BLNK;HCK;RET;LCP2;LCK;FRK;KDR;PTN;EGFR;SHC1;PTK2B;EPHA2;GFRA2;BCAR1;EPHB4
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2877670540587576,0.9511876928482972,0.5244648318042814,0.9664068606103711,1.0,9/42,19.32%,ACKR3;CCR1;FOXC1;SH2B3;STK39;THPO;CCL15;WNK1;CCL5
prerank,inositol phosphate biosynthetic process (GO:0032958),0.39319223577031015,0.9508962792143428,0.5160744500846024,0.9663849701258296,1.0,3/11,12.25%,IP6K1;FGF2;IPMK
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.25089958758168424,0.950849695505159,0.5462304409672831,0.9655852952904215,1.0,21/87,17.33%,SH3BP1;ABI3;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TRPM2;TWF2;ARHGDIA;RAPGEF3;GRHL3;ARHGAP35;CORO1A;TWF1;RHOQ;CDK10;ROCK1;TAOK1;RHOBTB2
prerank,mitochondrion organization (GO:0007005),-0.20072502619841112,-0.9505136602528576,0.5747663551401869,0.7704512943494132,1.0,34/165,17.24%,PID1;VPS13D;TRAK1;BCL2L1;CHCHD2;ATAD3A;YME1L1;IFIT2;ATP7A;BAX;TOMM7;MTX3;HSPD1;NRF1;AGTPBP1;MTX1;FMC1;ALAS1;DNM2;TOMM20;MTM1;WDR81;LRRK2;STOML2;TIMM17A;AIP;TIMM50;WASF1;IMMP2L;SLC25A33;MUL1;MTFP1;MTFR2;MIEF1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.36423958952235963,0.9503190993588558,0.5362563237774031,0.966246254535397,1.0,6/14,23.35%,PNP;NMNAT2;AK5;AK1;AK4;AK3
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.31563723462119375,-0.9501155283328843,0.5321782178217822,0.7708528656656688,1.0,4/18,8.22%,MSRA;MTHFR;GOT1;MTHFD1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.3745522222203824,-0.949691080865873,0.4942263279445728,0.771361401764257,1.0,1/10,0.22%,IL15
prerank,ncRNA export from nucleus (GO:0097064),-0.2598921663470842,-0.9490279334862697,0.5648414985590778,0.7724849216996564,1.0,9/36,15.65%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB;NPM1;NUP62
prerank,eye development (GO:0001654),0.2683667829319289,0.9488801546522075,0.5462822458270106,0.9694949972098847,1.0,8/54,11.75%,COL5A1;PRSS56;MAB21L2;PBX2;FBN2;CRYBA4;FOXC1;PBX3
prerank,regulation of tissue remodeling (GO:0034103),-0.3234654758463859,-0.9488239860449926,0.526595744680851,0.7724397560844474,1.0,2/18,0.22%,SUCO;IL15
prerank,triglyceride homeostasis (GO:0070328),0.31153174980054554,0.9482549356682426,0.5342019543973942,0.970416765779498,1.0,9/26,22.24%,DGAT2;ANGPTL4;FITM2;ANGPTL3;LIPC;XBP1;IL18;RORA;PNPLA8
prerank,atrioventricular valve morphogenesis (GO:0003181),0.33454364639210954,0.9480275992432227,0.5218855218855218,0.9701218315084345,1.0,4/19,10.90%,ZFPM1;SOX4;HEY1;EFNA1
prerank,import into cell (GO:0098657),0.2867566899614101,0.9480124673712678,0.5585585585585585,0.9692457462440708,1.0,7/41,14.81%,SNAP25;SLC29A2;LRP2;SLC12A6;SLC1A3;SLC19A1;SLC22A4
prerank,protein-containing complex assembly (GO:0065003),0.218183417918691,0.9472764237822215,0.5990621336459554,0.9704804740484265,1.0,52/259,17.91%,BCL9L;TLE3;ADCY8;WDR19;PLEKHA7;CAPN3;TLE2;RAB1B;ADD2;NIFK;CNIH2;PARD6B;SEC16B;PPARGC1A;NCKAP1L;DMD;PDE4DIP;MAGI1;IL1RAP;TMED2;AREG;CDC123;SEC31A;GRIA1;TRAPPC3;TSPAN4;TCF7L2;SH3BGR;BIN2;ZW10;ITGB1BP1;PDCD6;PEX14;CNIH1;RIMS1;FARP2;DNM1L;WASF3;SEC24D;SEC24B;CHCHD10;VAMP3;TRAPPC9;TCF7L1;TUBGCP2;EPRS1;SEC24C;GEMIN5;PYGO2;PPP2R1A;SHANK1;PREB
prerank,cellular response to organic cyclic compound (GO:0071407),-0.203089687412885,-0.9470955039850044,0.6271186440677966,0.7763107578811742,1.0,38/141,18.91%,ARL6IP5;NR3C1;HRH1;P2RX4;ESR1;CTNNA1;AHR;MSN;TAF1;LCOR;GABRB2;EPG5;BRCA1;IL1B;ADCY5;UBE2L3;ZC3H12A;ADCY6;CTNNB1;ADCY1;LRRK2;KAT5;ADCY3;CYP1A1;LARP1;INPP5K;EGFR;TNF;RAP1B;RAP1A;FAM210B;PDE2A;TIPARP;NRIP1;IGFBP5;CASP6;CDH1;KCNQ1
prerank,nucleic acid metabolic process (GO:0090304),0.25692951479664655,0.9470580652273605,0.5462555066079295,0.9702103261470957,1.0,17/69,18.56%,POLR2L;POLR2F;HNRNPH1;POLG;DNASE1L2;LSM1;PTBP1;DDX1;GTF2F1;POLR2G;LSM8;RBFOX2;FEN1;HNRNPA1;ATXN2;WRN;DXO
prerank,cellular response to growth factor stimulus (GO:0071363),0.23256446355728153,0.947008958777797,0.5878467635402906,0.9694423260416626,1.0,34/151,16.30%,WNT4;NTRK1;FLT4;RELA;STMN2;LRP2;NTRK3;PDCD5;PLCG1;MEF2C;LGMN;RPS6KB1;TGFBR1;DAB2IP;BMP4;TWF2;ZFP36L2;MAP2K5;PRKD2;FOXC1;TGFB1;EMD;SNAI2;ITGB1BP1;EHD1;SFRP1;ACVR1B;PDGFB;NDNF;AMHR2;NTRK2;WNT7A;PRKD1;SETX
prerank,mitochondrial translation (GO:0032543),0.2433588677415144,0.9469724110484059,0.5730027548209367,0.9686233762703991,1.0,31/104,26.26%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;HARS1;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;FASTKD2;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,cochlea morphogenesis (GO:0090103),0.39510030317671946,0.9469299975814093,0.5333333333333333,0.967829917945686,1.0,2/10,15.48%,POU3F4;HPN
prerank,base-excision repair (GO:0006284),0.2757546091804387,0.9465482750015453,0.545985401459854,0.9680206514501881,1.0,14/48,22.97%,POLG;POLD3;OGG1;XRCC1;LIG3;ADPRS;PARP1;APEX1;FEN1;ERCC6;WRN;UNG;MPG;RFC4
prerank,ceramide catabolic process (GO:0046514),0.3640052067392592,0.9465159288426273,0.518850987432675,0.9671837271394809,1.0,3/14,8.81%,HEXB;NEU1;NAGA
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.31905131399616277,0.9462127008485621,0.5207296849087893,0.9671561700786024,1.0,8/23,23.02%,DGAT2;ACSL6;ELOVL6;TECR;ACSF3;ACSBG1;ELOVL5;ACSL3
prerank,regulation of immune effector process (GO:0002697),-0.2561550378345487,-0.9462089307746713,0.5311653116531165,0.7779881323372653,1.0,12/41,20.14%,FCGR2B;C3AR1;C5AR1;IRF4;C4B;SERPING1;CD55;CFHR2;C1QC;CFP;C2;C1QB
prerank,cellular glucose homeostasis (GO:0001678),0.2845407275231392,0.9461378813220229,0.541033434650456,0.9664796230272062,1.0,5/41,4.45%,NUCKS1;ADCY8;TRA2B;PPARGC1A;SOX4
prerank,snRNA transcription (GO:0009301),0.2564489719630212,0.9458074111204471,0.5604075691411936,0.9665324412766637,1.0,20/70,23.69%,POLR2L;CDK7;POLR2F;POU2F2;GTF2F1;GTF2E2;TAF9;ZC3H8;INTS10;POLR2G;CCNK;INTS8;SNAPC3;INTS5;INTS9;INTS11;NABP1;POLR2C;GTF2B;POLR2D
prerank,protein processing (GO:0016485),0.24138692991250266,0.9456614488897589,0.5584594222833562,0.9660496514107364,1.0,26/102,21.54%,F3;MMP16;SPCS2;MYRFL;ASPRV1;VSIR;BACE1;XPNPEP3;LGMN;OGT;PHEX;AEBP1;CASP4;PSENEN;PITRM1;MYRF;KLK2;HM13;SEC11C;PCSK2;ADAMTS3;TYSND1;OMA1;METAP2;CASP2;CTSS
prerank,peptide catabolic process (GO:0043171),0.32407911057962413,0.9455670950116026,0.5552099533437014,0.9654132159984343,1.0,9/23,25.93%,GGT7;XPNPEP1;GGT5;TRHDE;ENPEP;CHAC2;NPEPPS;TPP1;CTSH
prerank,DNA recombination (GO:0006310),-0.2620035726910037,-0.9454711284139607,0.5591397849462365,0.7793060631979021,1.0,8/37,13.71%,RAD51B;RTEL1;IGHMBP2;RHNO1;RPA1;LIG4;RAD21;ENDOG
prerank,regulation of developmental growth (GO:0048638),-0.27880145381604404,-0.945271401787734,0.5229591836734694,0.7792111296990774,1.0,5/29,10.76%,APOE;IGF1;STAT5B;DNM2;GHR
prerank,nuclear membrane organization (GO:0071763),-0.3059353560971415,-0.9451969838759855,0.5301837270341208,0.778800516664022,1.0,6/19,16.18%,CHMP4B;TOR1AIP1;TOR1B;NEMP1;UBXN2B;PLK1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3321643783993699,-0.9450418958599298,0.5380710659898477,0.7786012638379339,1.0,6/15,24.32%,ZDHHC3;DRD2;CLN3;ADRA1A;NPAS4;NLGN2
prerank,B cell homeostasis (GO:0001782),0.4112169538888153,0.9449856431284432,0.54,0.9661981142208868,1.0,3/10,11.64%,NCKAP1L;MEF2C;DOCK10
prerank,negative regulation of cell cycle (GO:0045786),0.2568174113432514,0.9448764498826374,0.5482456140350878,0.9656050122271331,1.0,15/73,15.50%,HHEX;SCRIB;SIPA1;BMP4;FOXC1;TGFB1;PTPN3;BTG3;HEXIM2;BTG2;CHMP1A;INHA;PPP1R13B;IPO5;ANGEL2
prerank,peptidyl-tyrosine modification (GO:0018212),0.2672599865119943,0.9448012063540865,0.5425219941348973,0.9649248515515897,1.0,16/56,19.42%,ABI3;NTRK1;FLT4;EPHA1;ERBB4;BTK;PDGFB;TEK;EPHA4;TPST2;INSR;EPHB2;PTK2;FLT3;FES;PDGFRB
prerank,cellular response to retinoic acid (GO:0071300),-0.25323868026838847,-0.9443327959102459,0.5577464788732395,0.7798389955189083,1.0,23/42,36.01%,ABL2;BRINP1;LYN;RET;SNW1;TESC;PTK2B;WNT5A;ADNP2;WNT9A;FZD4;NDUFA13;WNT6;FZD10;LTK;AQP1;CREB1;ATM;FZD7;TBX1;WNT10B;WNT11;WNT2
prerank,regulation of protein neddylation (GO:2000434),-0.38394448962051,-0.9440847406844777,0.5191873589164786,0.7798465617711681,1.0,5/10,25.18%,RPL5;HIF1A;DCUN1D1;RPL11;DCUN1D4
prerank,muscle cell migration (GO:0014812),0.395614192642325,0.9439650973968539,0.5222816399286988,0.9664453011348717,1.0,3/10,17.19%,PLAT;ITGB1BP1;ROCK1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2584348741771639,0.9437390053055877,0.5461095100864554,0.9661886635995997,1.0,20/67,22.71%,IFT20;FSCN1;SGSM3;TRPM2;MAPK15;TWF2;CDKL5;RAB5A;TBC1D16;RABEP2;TBC1D8;IFT88;TWF1;ATP8B1;CYLD;CDKL1;CDC42;RDX;PPP1R16B;FXR1
prerank,regulation of calcium ion transport (GO:0051924),-0.2412853665743112,-0.9436885866053826,0.5351681957186545,0.7802777341378742,1.0,17/54,20.79%,BCL2;LILRA5;P2RX4;IL16;HOMER3;CTNNB1;INPP5K;LILRB1;STIM2;CRACR2A;FFAR1;WFS1;SLC8B1;MYLK;CD33;GRIN3B;HOMER1
prerank,plasma membrane invagination (GO:0099024),-0.2823367521397986,-0.9434743711860872,0.5378151260504201,0.7802000897967727,1.0,4/29,6.79%,FCGR2B;MSR1;CD36;SNX9
prerank,mesoderm development (GO:0007498),0.33979615321781725,0.9434381440882864,0.5487603305785124,0.9661305267651727,1.0,4/18,17.13%,GDF11;BTK;TBX6;MEST
prerank,regulation of actin filament depolymerization (GO:0030834),0.37466092086090574,0.9432706304731074,0.5617597292724196,0.9656856898859811,1.0,1/12,0.33%,SH3BP1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.34172910865105427,-0.9432499645275738,0.5469879518072289,0.7801897841969772,1.0,7/13,32.32%,IDUA;DSEL;CSPG4;DSE;CHST12;NCAN;CHST14
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3767615773673164,0.9432434674303968,0.5370051635111877,0.9648537642101804,1.0,2/13,5.65%,RELA;IL6
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.2643379209737241,-0.9426873729678285,0.5517241379310345,0.7810051695540234,1.0,4/35,1.20%,IQGAP2;NRP1;STAP1;ABL2
prerank,response to X-ray (GO:0010165),0.368375189118371,0.942538648902525,0.5402097902097902,0.9659663473266196,1.0,5/14,23.82%,NUCKS1;XRCC6;XRCC5;XRCC4;IKBIP
prerank,establishment of skin barrier (GO:0061436),-0.3348404464725382,-0.9424316787457846,0.5405405405405406,0.7804850168666407,1.0,4/15,17.39%,MET;STMN1;ALOXE3;CLDN1
prerank,regulation of water loss via skin (GO:0033561),-0.3348404464725382,-0.9424316787457846,0.5405405405405406,0.7804850168666407,1.0,4/15,17.39%,MET;STMN1;ALOXE3;CLDN1
prerank,myeloid dendritic cell activation (GO:0001773),-0.36032825758736875,-0.9424136843471017,0.4964200477326969,0.7799332296791808,1.0,3/12,14.48%,DOCK2;SLAMF1;BATF2
prerank,response to histamine (GO:0034776),-0.3723151693478701,-0.9413167050976048,0.5179856115107914,0.7820187213232311,1.0,5/10,21.30%,HRH1;GABRB2;DRD2;DRD3;DIAPH1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3105310755850874,0.9408615831818521,0.534621578099839,0.9699307705236547,1.0,8/25,20.73%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.25109396859877997,0.9408357886530506,0.5689149560117303,0.9690972115111494,1.0,18/80,17.19%,RAB6B;KLC1;RAB1B;ATP9A;KDELR3;TMED2;COPG1;COG4;KIF26A;ZW10;BICD2;KIF1C;KIF2A;COPE;NBAS;KDELR2;TMED3;COPG2
prerank,neuron projection regeneration (GO:0031102),0.4018243928646625,0.9405379928904969,0.5523978685612788,0.9690535859405278,1.0,4/10,19.69%,OMG;RTN4RL1;MTR;NREP
prerank,cellular response to organonitrogen compound (GO:0071417),0.23951600135319875,0.9401099447891219,0.5940860215053764,0.9693455059007227,1.0,24/99,19.04%,HCN1;P2RY12;RPTOR;RELA;TRPM2;GABRG2;MEF2C;SLC38A9;RAPGEF3;PKD2;GLRA2;CFTR;HSP90B1;SFRP1;P2RY1;CRHBP;IPO5;GABRB1;AOC1;SH3BP4;SSH1;XBP1;ACTB;NSMF
prerank,"wound healing, spreading of cells (GO:0044319)",-0.28921116178661965,-0.9400561958540525,0.5219638242894057,0.7845818351765134,1.0,9/24,17.77%,CD44;PDCD10;ARHGAP24;LCP1;CCN1;CEACAM1;ADAM17;CARMIL2;FLNA
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2790277325257815,0.9399861974395236,0.5625965996908809,0.968789102037417,1.0,11/44,20.28%,NANOS1;GTPBP1;ZFP36L2;METTL16;BTG2;POLR2G;CNOT8;UPF1;ROCK1;TOB1;DHX36
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.25552765264312227,-0.9399757697514014,0.5652173913043478,0.7841969152025566,1.0,13/41,23.68%,GAS6;PTPN22;IGF1;RARA;ZC3H12A;SLAMF1;LBP;LILRB1;TLR4;CD33;NLRC3;NR1H4;GSTP1
prerank,cAMP-mediated signaling (GO:0019933),-0.2967258580875001,-0.9396820001215468,0.5404699738903395,0.7843933584929698,1.0,7/24,16.17%,ADGRG6;PDE7B;AHR;ADCY1;RIMS2;PDE2A;MAPK7
prerank,endocrine system development (GO:0035270),0.3247635995446013,0.9396743707605132,0.5456081081081081,0.9688125597686087,1.0,2/21,7.63%,WNT4;TGFBR1
prerank,ureteric bud development (GO:0001657),0.33942547988229155,0.9396103174784523,0.5551601423487544,0.9681017671294738,1.0,4/17,11.07%,BMP4;PKD2;FOXC1;NPNT
prerank,regulation of actin filament-based process (GO:0032970),0.2586136246829867,0.9394825608377749,0.562406015037594,0.967591947819095,1.0,19/70,20.54%,SH3BP1;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TWF2;GRHL3;ARHGAP35;CORO1A;RHOQ;CDK10;ROCK1;TAOK1;RHOBTB2;PDGFRB;EPHA5;IQGAP3
prerank,hexose metabolic process (GO:0019318),0.28352433247604564,0.9394191982088553,0.5562310030395137,0.9668792222819205,1.0,12/39,20.34%,SLC37A4;GALT;ALDOC;CHST1;FPGT;KHK;APOD;GALK1;GHRL;PGM1;ALDOA;OMA1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.28245556271396843,-0.9388905111062021,0.5805626598465473,0.785844696303039,1.0,8/29,17.63%,DTX3L;FBXW7;BMI1;UBE2L3;DCUN1D1;MAGEC2;PLK1;ARRDC4
prerank,regulation of organelle assembly (GO:1902115),-0.22673671099445705,-0.9388736190482151,0.5789473684210527,0.785290340999918,1.0,22/73,18.94%,TBC1D1;MSN;TRAPPC12;RABGAP1;TBC1D2;HCK;CENPJ;TBC1D10C;TBC1D10A;ATG3;PDCD6IP;STAM;USP6NL;NPM1;DYNLT2B;ADPRH;MTMR3;STX18;GSN;ODAD3;CEP295;TBC1D22A
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.2556745436352398,0.9387591549820026,0.5649717514124294,0.9679022395913298,1.0,20/72,19.62%,NTRK1;NTRK3;PIK3CG;MAZ;NEDD4;FGF2;BECN1;PDGFB;TEK;INSR;NTRK2;PTK2;AGT;FLT3;IL18;PLXNB1;DCN;CCL5;PDGFRB;ROR1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.23736044693756708,-0.9386944616738865,0.5753846153846154,0.7851634756078104,1.0,12/55,15.24%,BCL2;BCL2L1;BAX;FAS;RIPK1;CAV1;WWOX;LCK;RACK1;PMAIP1;TNF;BCL2L11
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.31913363704068876,0.9386844494929298,0.5632,0.9671985689045055,1.0,7/23,13.00%,TPTE;MTMR9;INPP5B;SACM1L;OCRL;INPP5F;MTMR1
prerank,neuron cell-cell adhesion (GO:0007158),-0.3415615678001328,-0.93859461242171,0.5364077669902912,0.7848308068956986,1.0,3/14,9.35%,NINJ2;RET;NRXN2
prerank,lymphocyte migration (GO:0072676),-0.270638178487494,-0.9384262614259075,0.5691056910569106,0.7846624898665228,1.0,9/32,27.31%,MSN;CCL25;RET;ADAM8;ZAP70;GATA3;CCL7;TBX21;CCL24
prerank,phagolysosome assembly (GO:0001845),-0.35898267550851654,-0.9381471931399982,0.5226130653266332,0.784749229037679,1.0,2/12,3.66%,RAB7A;RAB7B
prerank,regulation of feeding behavior (GO:0060259),0.39070481443708993,0.9374135150137506,0.5460636515912898,0.969975384160194,1.0,2/11,15.31%,GNB3;EIF2AK4
prerank,response to purine-containing compound (GO:0014074),0.34614033093516083,0.9370045870127764,0.5292207792207793,0.9702567444961885,1.0,4/17,12.16%,TRPC3;TRPM2;DGKQ;P2RY1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.20606405773888892,-0.9370022464477129,0.640625,0.7870629319856081,1.0,35/128,21.53%,NRROS;PXN;GCNT2;SMURF2;ARHGEF18;ADAM9;ZFYVE16;SMAD3;SMAD9;ZMIZ1;UBC;BMP5;UBA52;USP9X;ID1;SMAD6;CBL;SCX;NLK;BMP2;FOS;PARD6A;SMAD4;HIVEP1;COL3A1;ACVR1;ACVR2A;APPL2;GDF3;BMP7;USP15;CGN;BAMBI;USP9Y;ZMIZ2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2983591477493652,0.936995981715662,0.5621019108280255,0.9693892111204224,1.0,10/30,20.59%,ACSL6;ELOVL6;TECR;ACOT4;ACOX1;ELOVL4;PEX2;ACSBG1;ABCD2;ELOVL5
prerank,regulation of neuroinflammatory response (GO:0150077),-0.3183785937221303,-0.9365880693125416,0.5363408521303258,0.787481863496721,1.0,5/19,18.52%,IGF1;IL1B;TNFRSF1B;TNF;MMP8
prerank,adipose tissue development (GO:0060612),0.38498601070485405,0.936114887709342,0.5384615384615384,0.9709944736748247,1.0,3/11,6.69%,DGAT2;PGRMC2;DYRK1B
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2303801797899098,0.9361046912654055,0.6178343949044586,0.9701264076266792,1.0,27/140,16.42%,ACKR4;ADCY8;TRPC3;ACKR3;FIS1;GNA15;CCR1;GPR17;ADCYAP1;GRIN1;CXCR6;CX3CR1;SLC8A1;CXCR4;LPAR4;ITPR3;P2RY1;JPH1;TAC1;CCR6;HMGB1;CACNA2D1;P2RY10;ACKR2;CCR9;PTGER1;CACNA1A
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2519248397738655,0.9358321206750508,0.5960729312762973,0.9700243751294323,1.0,10/76,8.08%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;NTRK3;FCHSD2;LIMK1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.3900035228660969,0.935831555701025,0.5186567164179104,0.9691363360182865,1.0,3/10,18.41%,NCKAP1L;CD81;ZBTB7B
prerank,protein localization to Golgi apparatus (GO:0034067),0.30437814743360486,0.9355575788890518,0.5439739413680782,0.9690354010730644,1.0,6/27,12.40%,IFT20;OBSL1;ARL5A;SYS1;ARFRP1;BICD2
prerank,toxin transport (GO:1901998),-0.3764140095839065,-0.9353141375192932,0.5198135198135199,0.7901902933645973,1.0,1/10,0.76%,ANTXR2
prerank,mitotic DNA replication (GO:1902969),0.3946731578967614,0.9350998578172767,0.5269784172661871,0.9694315395808784,1.0,2/10,7.47%,GINS3;MCM3
prerank,purine nucleotide metabolic process (GO:0006163),0.316013748036718,0.9349866271164659,0.5456053067993366,0.9688817789662222,1.0,7/24,14.22%,FHIT;PNP;GART;PRPSAP2;HPRT1;ADSL;PRPSAP1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.29460627970659,-0.9347819104521522,0.5246753246753246,0.790884786373257,1.0,10/22,31.78%,STAP1;CDKN2C;INPP5K;PRKRIP1;CDKN2A;BMP7;TESK1;PLEK;CDKN2D;CDA
prerank,regulation of cardiac muscle contraction (GO:0055117),0.2927198638452657,0.9346730307052009,0.558641975308642,0.9688997541075934,1.0,6/34,9.91%,ATP2A2;ATP1B1;TNNI3;PIK3CG;SLC8A1;GJA5
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.21885153689798995,-0.9345446829998484,0.6105919003115264,0.7908931481234311,1.0,21/80,18.25%,CUL3;FBXW7;CAV1;UBQLN1;BRCA1;BMI1;UBE2L3;PTTG1IP;PAXIP1;DCUN1D1;BIRC2;CRY1;LRRK2;PSMD10;FANCI;MAGEC2;PLK1;WFS1;CENPX;ARRDC4;FANCM
prerank,protein localization to vacuole (GO:0072665),-0.34935008344188173,-0.934317233615356,0.5411764705882353,0.790880104211968,1.0,6/13,25.35%,LAMTOR5;SH3GLB1;SZT2;LAMTOR4;LMBRD1;ATP13A2
prerank,actin filament polymerization (GO:0030041),-0.2756125269129275,-0.9342100328201187,0.5483870967741935,0.7905433677767232,1.0,17/29,33.44%,PSTPIP2;DIAPH3;GAS7;COBL;WASF1;CORO7;GSN;MSRB1;DIAPH1;TTC17;WASHC3;RAC1;MICALL2;PSTPIP1;WAS;WASHC5;SPIRE1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3396269997332098,-0.9341402654190953,0.5164556962025316,0.7901583078079931,1.0,8/14,25.19%,NRP1;GAB1;PIK3CA;KDR;NUS1;PIK3CD;VEGFB;PGF
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.23924747937374763,-0.9340198273381576,0.5688073394495413,0.7898856306664667,1.0,14/56,20.01%,DAB2;SDCBP;SNX25;BMP5;RBPMS;SMAD6;GREM1;BMP2;BMP3;SMAD4;ACVR1;ACVR2A;GDF3;BMP7
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3188291221245769,0.9339877119329212,0.5631229235880398,0.9700270331255538,1.0,5/22,10.76%,PSMB1;ENC1;PSMA1;PSMA8;NFE2L2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.25598017099055276,-0.933772564943774,0.5895316804407713,0.7899414269210541,1.0,13/38,27.14%,RBBP7;CABIN1;H3-3A;CENPA;HAT1;NPM1;CENPW;CENPX;MIS18BP1;UBN1;CENPH;HJURP;OIP5
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.2908282785887539,0.9332583845382441,0.568,0.9712235913325782,1.0,9/35,18.91%,MKLN1;C3;CLU;SNAP91;BMP2K;AAK1;VTN;BICD1;RSPO1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.2806477187825349,0.9330521748167299,0.5641838351822503,0.9709290709448322,1.0,6/40,9.64%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,negative regulation of nuclear division (GO:0051784),0.38870019713605203,0.9328365326695603,0.5428051001821493,0.9706264567837045,1.0,3/11,19.92%,BMP4;TOM1L1;FBXO5
prerank,inhibitory synapse assembly (GO:1904862),0.3882690671388528,0.9326574852716801,0.5408695652173913,0.9702554041620812,1.0,4/11,19.02%,GABRG2;GABRA2;FGF13;PLXNB1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2518257314121666,-0.9321593188289734,0.5735735735735735,0.7934154331100781,1.0,15/44,24.62%,GAS6;RAF1;CD44;SIAH2;LAMTOR5;THBS1;SH3RF1;TNF;DNAJB6;GPX1;LTF;KLF4;DHCR24;XIAP;RPS6KA3
prerank,lipid modification (GO:0030258),0.2926668317554418,0.9318680644307032,0.55895865237366,0.9715723227831845,1.0,9/37,20.83%,DGKI;PLPP5;ALOX12;DGKQ;DGKZ;DGKE;PLPPR4;DGKH;PLPP1
prerank,regulation of cholesterol transport (GO:0032374),-0.301999769223993,-0.9317723244817773,0.5244755244755245,0.7937910306098237,1.0,7/20,16.73%,NFKB1;NAXE;NR1H2;APOC1;NR1H3;LRP1;NUS1
prerank,response to muramyl dipeptide (GO:0032495),0.3702189779957502,0.9315917380939128,0.5603448275862069,0.9714521549362121,1.0,6/12,23.33%,TRIM41;INAVA;NOD1;IRF5;CHMP5;RIPK2
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.3082450330514383,-0.9314673110412951,0.5728643216080402,0.7939684522341603,1.0,14/19,37.81%,HRH1;PPP3R1;PPP3CA;NFATC3;PLCE1;NFATC2;GPR62;NFAT5;PPP3CB;EDN3;NFATC4;EDN2;EDN1;NFATC1
prerank,anion transport (GO:0006820),0.29420321470822136,0.931325294682607,0.5627980922098569,0.9713185886435614,1.0,9/33,22.69%,SLCO2B1;VDAC1;SLC26A4;SLC26A7;TSPO;SLC19A1;SLC13A3;ABCG2;LRRC8B
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3577063164668321,-0.931106954373672,0.5261958997722096,0.7942863718566897,1.0,7/12,28.80%,LYN;FOXP1;ORMDL3;IRS2;BCL6;BLK;FNIP1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.38971331036210105,0.9310712694046402,0.5537340619307832,0.9702581018844584,1.0,3/10,19.01%,MAP2K5;MBP;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.38971331036210105,0.9310712694046402,0.5537340619307832,0.9702581018844584,1.0,3/10,19.01%,MAP2K5;MBP;WNK1
prerank,secretion (GO:0046903),0.3613752166554336,0.9309859808083647,0.5492227979274611,0.9696163730683071,1.0,5/14,22.66%,PRKCI;RIMS1;SLC22A4;GUCA1B;NPR1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.30735080244134133,0.9308178797057297,0.5727411944869831,0.969200746860155,1.0,10/26,23.15%,SHANK3;LIMK1;PRKN;ROCK1;SHANK1;ALMS1;ASAP3;CDC42;RDX;SLC9A1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.27639587854254116,-0.9305791672780899,0.568,0.7949519205852171,1.0,3/28,3.68%,BCL2;ZDHHC3;BAX
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.3360000438359597,-0.9305569765043544,0.5623529411764706,0.7944162228518564,1.0,5/14,23.88%,CCR2;PTK2B;WNT5A;ADAM17;CCL7
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2097441438408897,0.9304750378891432,0.6647058823529411,0.9692924197231867,1.0,66/308,20.59%,GAPDH;BCL9L;SCAMP5;AVPR2;PPIB;WWTR1;KSR2;G0S2;TXK;ESRRG;KDM6B;SIX4;AVPR1A;IL17F;CADM1;PPARGC1A;GATM;PLA2G3;PRLR;HILPDA;MFAP2;IL6;FOXD1;PIK3CG;IL2;ADRA2A;S100A13;TGFBR1;BMP4;ADCYAP1;OGT;ACHE;FOXC1;TGFB1;FGF2;CRTAM;CFL1;CXCR4;ACVR1B;ELOVL6;EPAS1;AGPAT1;PDGFB;PRDM16;MAP3K13;HAP1;BATF;REST;SHLD3;AGT;GNAS;ITK;ROCK1;XBP1;ALMS1;IL18;IL1A;ZBTB7B;HDAC3;GHRL;BMPR1B;HCAR2;FBXO5;SHLD2;OMA1;SMAD2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.2590912336434692,-0.9302287619068234,0.59375,0.7946441871878518,1.0,8/36,14.00%,EPC1;RBBP8;RBBP7;BRCA1;BMI1;EHMT1;RYBP;L3MBTL2
prerank,autophagy of mitochondrion (GO:0000422),-0.25492653258947284,-0.9300370067005912,0.5920245398773006,0.7945891053646291,1.0,11/38,17.36%,MAP1LC3B;MARK2;ATG13;ATG7;CISD2;ATG2B;ATG3;AMBRA1;ATG9B;SQSTM1;MAP1LC3A
prerank,positive regulation of protein acetylation (GO:1901985),0.3719769907361534,0.9299014506652915,0.5641476274165202,0.9699698479294829,1.0,7/12,27.65%,DIP2B;RAPGEF3;TAOK1;DDX3X;CAMK1;PRKAA2;DIP2A
prerank,phospholipid catabolic process (GO:0009395),-0.29212846381250823,-0.9297886143239034,0.5461741424802111,0.7946390334388966,1.0,6/24,12.30%,PLBD1;PLA2G4E;PNPLA6;GDPD3;SMPDL3A;GDE1
prerank,regulation of immunoglobulin production (GO:0002637),0.31506181207846684,0.92952639764697,0.5636363636363636,0.9701304508298879,1.0,9/23,20.23%,CD86;IL6;IL2;CLCF1;VAMP3;EPHB2;CD22;XBP1;TNFRSF4
prerank,endomembrane system organization (GO:0010256),0.22191978320398276,0.929423632172823,0.6447028423772609,0.9695472337501582,1.0,55/178,25.51%,FBXW8;ANXA8;ANXA8L1;OBSL1;RAB43;SEC16B;ATL1;MAPK15;TMED2;CLASP2;COG4;SEC31A;USP50;PI4K2A;OTOF;TANGO2;ZW10;TLCD2;SYNGR1;DNM1L;HACE1;LYSMD3;TMED5;ARFGEF1;BLZF1;SPTBN1;HOOK2;MIA3;PRKD1;DMPK;ATP8B1;TMED3;VPS33B;ALS2;STX17;LMAN2L;SNX33;HOOK1;CAV2;TRAPPC8;TMED7;SYNGR2;CDC42;LEMD2;VMP1;ATL2;TMED1;SEC31B;VAPA;ANK3;RNF112;ATP8B2;GOLGA8B;GOLGA5;TJAP1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3817215573394239,0.9290840917231261,0.5388513513513513,0.9696140933829354,1.0,5/11,26.25%,FBXO7;PRKN;REST;NONO;ATF4
prerank,manganese ion transport (GO:0006828),0.35945148580079345,0.928934256120471,0.5714285714285714,0.9691737291963748,1.0,4/14,11.52%,TRPC3;SLC39A8;ATP2C1;TRPC6
prerank,regulation of dendrite extension (GO:1903859),0.3315024474124033,0.9286983769375267,0.5495798319327732,0.9689619364590737,1.0,5/18,15.11%,SYT4;SYT1;CPNE6;RIMS1;NEDD4L
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3730790685993147,0.9285708831827729,0.5424028268551236,0.9684485122475807,1.0,2/12,10.95%,SNAP25;STX3
prerank,regulation of ruffle assembly (GO:1900027),-0.29155677272263997,-0.9284006072875444,0.5629820051413882,0.7975672455377412,1.0,6/23,8.68%,STAP1;EPS8;P2RX4;FAM98A;CAV1;ARHGAP24
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3635500478556766,0.9282966941492758,0.5597269624573379,0.9683319581747462,1.0,5/13,23.35%,GTPBP1;GNAI3;RHOQ;AK4;AK3
prerank,autonomic nervous system development (GO:0048483),0.3385392303410756,0.9278516735694934,0.5468227424749164,0.9687046177612296,1.0,4/17,8.35%,NTRK1;SOX10;SOX4;KIF26A
prerank,myeloid cell development (GO:0061515),-0.32123949133430846,-0.9277673999702184,0.5631067961165048,0.7985941289015042,1.0,6/18,22.74%,NRROS;TLR2;ALAS1;FOXP1;APP;ALAS2
prerank,ether lipid metabolic process (GO:0046485),-0.3400207016677136,-0.9269703140433954,0.5521739130434783,0.7999668057536834,1.0,5/14,23.39%,NCEH1;PLAAT3;TMEM86B;PAFAH1B1;PLA2G7
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2221528976882549,0.9265245572447273,0.625,0.9715250909048254,1.0,22/166,9.70%,POLR2L;CDK7;WWTR1;POLR2F;ESRRG;NR1I2;NR1I3;TFAM;PPARGC1A;GTF2H2;PPARA;NR2F6;AR;GTF2H4;RXRG;GTF2F1;MAZ;NCOR2;GTF2E2;HDAC5;TAF9;MAML3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.26048020494093405,-0.9264674295623022,0.5934959349593496,0.8006121674198631,1.0,7/33,10.87%,UBA5;ESR1;RNF14;H3-3A;RNF6;EP300;PRMT2
prerank,ganglioside biosynthetic process (GO:0001574),-0.331368710118833,-0.9260072393409607,0.5599022004889975,0.8012254164296092,1.0,6/15,22.40%,B4GALT5;ST8SIA6;ST8SIA4;ST8SIA2;ST6GALNAC5;B4GALNT1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.24229263206874424,-0.9259136553695456,0.5859154929577465,0.8008373107840129,1.0,13/44,19.13%,NRP1;PXN;ARHGEF10L;CD47;CARMIL1;SORBS3;S100A10;GPR65;MYOC;ARHGEF5;PFN2;RGCC;PPM1F
prerank,vesicle transport along actin filament (GO:0030050),-0.3050838683406484,-0.9258609703009806,0.5570776255707762,0.8003885487571047,1.0,3/19,6.67%,MYO5A;MYO1F;MYO15A
prerank,dendritic cell migration (GO:0036336),-0.3145227398431727,-0.9257049960266662,0.5561224489795918,0.8001761498430026,1.0,5/16,11.39%,EPS8;ALOX5;CCR2;GPR183;TRPM4
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.2689592411022299,-0.9254202297399541,0.5543766578249337,0.8003820034919208,1.0,10/31,20.53%,CDK6;CDC73;KANK2;CDKN2C;WEE1;PRMT2;RB1;E2F7;CDKN2A;KLF4
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.26947448116516753,0.9253194435133666,0.5893939393939394,0.9739752926019162,1.0,7/48,12.62%,CAPN3;THY1;DMD;PLCG1;UBASH3B;GSTO1;JPH1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.26261867453668186,-0.9252067713744868,0.5754189944134078,0.8003411810908563,1.0,12/35,20.05%,CHMP4B;TACC3;BORA;PDCD6IP;CHMP1B;CCSAP;NUMA1;NUP62;PLK1;TPX2;HSPA1B;HNRNPU
prerank,protein autoprocessing (GO:0016540),0.33059233223812684,0.9251303329994147,0.5688225538971807,0.9736382371929859,1.0,4/17,20.34%,MYRFL;CASP4;MYRF;OMA1
prerank,nucleosome organization (GO:0034728),0.26002564196217326,0.9251054199344466,0.6078431372549019,0.9728335710338815,1.0,13/55,16.18%,ASF1A;SMARCC2;BPTF;MCM3AP;SMARCE1;ZNHIT1;SMARCD3;VPS72;RNF8;DMAP1;SPTY2D1;NAA60;PAF1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3772833121649768,0.9250330419925255,0.5540540540540541,0.972193790953904,1.0,1/11,2.16%,CD34
prerank,smooth muscle cell differentiation (GO:0051145),0.38190087306472814,0.9250241551544128,0.5846153846153846,0.971349620921177,1.0,3/12,9.05%,MEF2C;BMP4;HEY1
prerank,"transcription, DNA-templated (GO:0006351)",0.21734920688188092,0.9249829094045339,0.6354679802955665,0.9705899422092029,1.0,22/207,7.14%,POLR2L;RNPS1;CDK7;CTR9;IVNS1ABP;DRAP1;RTF1;POLR2F;NELFB;DDX5;TFAM;XAB2;GTF2H2;MED4;NELFCD;E2F1;ELOC;SSRP1;GTF2H4;ARRB2;GTF2F1;FUBP3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.36952429025908473,-0.9248979778846251,0.545662100456621,0.8004825613866974,1.0,2/10,1.21%,STAP1;CD300A
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.36158691822254035,-0.9244463746840731,0.5446009389671361,0.8010267548850527,1.0,3/11,10.62%,CABIN1;H3-3A;HAT1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.29328618721021793,0.9243321271072402,0.5959119496855346,0.9715101919575263,1.0,10/31,20.23%,CD86;IL6;IL2;CLCF1;VAMP3;EPHB2;SHLD3;XBP1;SHLD2;TNFRSF4
prerank,regulation of cell population proliferation (GO:0042127),0.1987839837642066,0.9241434056290984,0.7314524555903866,0.9712192560193971,1.0,134/691,19.42%,ATP8A2;P3H2;FGF10;TPTE;HHEX;TSC2;TET1;FGF16;SMYD2;AVPR2;MATK;FGF9;ECRG4;NACC2;WWTR1;PAK1;NTRK1;FOSL1;SIX4;AVPR1A;FLT4;SLURP1;RELA;COPS8;TENM1;BEX4;SOX4;IGFBP6;PTPRU;PRLR;STK11;SERTAD1;CD86;HILPDA;FGF7;IL6;NTRK3;CLU;MAPK15;PDCD5;RNF126;XRCC6;CTBP1;GSDME;AREG;AR;RBM5;LGMN;IL2;ADRA2A;CDC123;S100A13;EEF1E1;MAZ;TGFBR1;HOXC10;MINAR1;DAB2IP;TIMELESS;NME1;BMP4;CD81;SSR1;TCF7L2;EPHA1;ERBB4;PKD2;SST;TGFB1;TBX2;NMI;BTG3;CLCF1;CAPNS1;ITGB1BP1;SETD4;SH2B3;THAP12;TRNP1;FGF2;BTG2;STX3;NOP2;IRS1;SFRP1;CGRRF1;TSPAN31;IL13RA1;SLC25A5;TBRG4;TBC1D8;PDGFB;TBX6;TSPO;CNOT8;INHA;RBFOX2;BAP1;THPO;ZBTB49;INSR;PTPN2;NTRK2;IFI35;CADM4;SH3BP4;ADORA3;REST;COL18A1;KIF14;DNAJA3;HRAS;PTK2;IL7;AGT;OPRM1;CDK10;ENG;FLT3;BTG1;FABP3;UTP20;XBP1;POU3F3;IL1A;CHTOP;CHRNA7;FES;GHRL;MCTS1;STAMBP;MAGI2;TOB1;PDGFRB
prerank,positive regulation of DNA repair (GO:0045739),0.27002113344546186,0.9237416882434093,0.6125574272588055,0.9714829240690102,1.0,11/46,16.74%,FGF10;WRAP53;TIMELESS;XRCC1;UBE2N;RNF168;RNF8;PARP1;HMGB1;ERCC6;PRKCG
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.1918797345691155,-0.92369884213454,0.7163461538461539,0.8023166417577341,1.0,56/185,24.23%,PSMA6;BUB3;PCM1;CUL3;CDK5RAP2;PSMB2;PRKACA;CDC14B;PSME2;TUBA4A;CEP250;PSMD11;PSMC6;UBC;PSMA3;YWHAG;HMMR;HAUS2;CEP164;UBA52;MAPRE1;CENPJ;CDC27;CDK1;MAD2L1;HAUS8;PSMD10;BUB1B;KNTC1;PSMB5;PLK1;UBE2C;KCNH5;MAD2L1BP;RGCC;DCTN2;PSMD5;ODF2;TPX2;XPC;PAFAH1B1;PSMD1;APPL2;AKAP9;SIRT2;ANAPC10;CEP78;ID2;OFD1;CDC14A;ANAPC7;TUBB4B;CCNB1;NDE1;PSMA7;PSMB7
prerank,phospholipid dephosphorylation (GO:0046839),0.28130598857040745,0.9235516618885541,0.5868263473053892,0.9711848218147682,1.0,12/37,21.24%,TPTE;PLPP5;MTMR9;INPP5B;SACM1L;OCRL;INPP5F;MTMR1;PLPPR4;PLPP1;PIP4P1;INPP5J
prerank,dephosphorylation (GO:0016311),-0.19695087340768405,-0.9231023523396129,0.7045454545454546,0.8032131940922387,1.0,31/147,15.83%,PPP2R5C;PTPN22;DUSP16;PPP2R1B;PPP2R2A;PTPRC;PPP2R5A;PPP4R1;PTPN1;MTMR2;CDC14B;PTPN21;PPM1H;PPP1R12A;MTMR4;CTDNEP1;SGPP1;PTPN7;TAB1;DUSP18;PPP4R2;PHPT1;PPP3CA;MTM1;CTDSP1;INPP5K;DUSP1;TIMM50;PPP2CB;ACP6;MTMR3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.32887164851018597,0.9230948309163483,0.5508474576271186,0.971610481333049,1.0,3/20,4.45%,DIP2B;PPARGC1A;SOX4
prerank,acylglycerol homeostasis (GO:0055090),-0.297705941878003,-0.9229237701269373,0.5405405405405406,0.803093614981215,1.0,4/20,13.27%,APOE;MTLN;LPL;NR1H3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.18696414685248536,-0.9224676406281069,0.7526315789473684,0.8036123718169815,1.0,67/208,25.12%,CD74;ANKRD17;ALPK1;TRIM25;TRIM14;LGALS1;TBK1;LAMTOR5;SHISA5;ESR1;BST2;NOD2;TNIP3;RIPK1;TFRC;LITAF;TRIM62;PLEKHG5;CLEC6A;IL1B;CCDC22;S100A4;EEF1D;PIDD1;ZC3H12A;GPRC5B;STAT1;TNFRSF19;BIRC2;IRAK4;PELI1;TRIM5;ZDHHC17;SPHK2;DDX21;TNF;GJA1;HSPB1;WNT5A;OPTN;NUP62;TRAF1;MUL1;HMOX1;SQSTM1;TRAF3IP2;FLNA;ECT2;TRAF4;MYD88;LTF;CASP1;NLRC3;TRIM21;NDFIP1;TNIP1;NR1H4;TNFSF10;GPR89A;TICAM2;TMEM101;GSTP1;GOLT1B;PIM2;FADD;TLR9;TAB3
prerank,adenine nucleotide transport (GO:0051503),0.336546376189288,0.9223074514484203,0.5628227194492255,0.9729440428544108,1.0,5/17,19.65%,SLC25A4;SLC25A5;SLC19A1;SLC35B2;ABCC6
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.26918502954892415,0.9221383133888799,0.5918674698795181,0.9725217349916601,1.0,13/48,19.96%,POLR2L;ASF1A;POLR2F;WBP2;SERTAD1;MYO1C;POLR1E;ERCC6;PHF2;POLR1F;ACTB;ELOF1;ATAD2
prerank,positive regulation of protein import (GO:1904591),-0.2712269121063121,-0.9221286182515286,0.6011080332409973,0.8038533720367507,1.0,9/30,19.89%,ZPR1;SMAD3;PSEN1;ZC3H12A;ARHGEF5;FLNA;ECT2;CDH1;CHP2
prerank,autophagosome organization (GO:1905037),-0.23732018401789556,-0.9218851718049554,0.6047197640117994,0.803806271484633,1.0,14/50,17.36%,PIK3C3;MAP1LC3B;ATG13;STX12;RAB1A;RAB7A;ATG7;UBQLN1;ATG2B;ATG3;UBXN2B;AMBRA1;ATG9B;MAP1LC3A
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2130666121791346,-0.9218728215116142,0.6338028169014085,0.8032617672128461,1.0,38/101,26.37%,UPF3A;NIBAN1;RPL5;VPS35;BCL3;SAMD4A;ATG7;MSN;THBS1;NR1H2;LARP6;VIM;PTTG1IP;CD28;HDAC2;PIWIL2;PLD1;TBC1D10A;NR1H3;NPM1;ZCCHC4;LARP4B;PLK1;FXR2;UPF3B;HNRNPD;NAT10;RPL26;KLF4;CPEB3;EIF3E;PYM1;PERP;FGFR4;FADD;CSF1;HSP90AA1;PASK
prerank,protein localization to lysosome (GO:0061462),-0.27123492019811934,-0.9217231079875504,0.5729442970822282,0.8030352127571199,1.0,7/28,11.69%,RAB7A;LAMTOR5;NAGPA;M6PR;ZFYVE16;AP4M1;SZT2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.34792738079506297,-0.9215648829391725,0.5588235294117647,0.8028527021197327,1.0,7/13,24.91%,TLR2;NAMPT;NOD2;KDR;TLR4;GSTP1;TLR9
prerank,regulation of ERAD pathway (GO:1904292),0.38590953725741683,0.9211857782083726,0.5726495726495726,0.9743311343678204,1.0,3/11,15.95%,TMEM259;HERPUD1;UBXN1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3234782422698176,0.9209900939926463,0.5869918699186992,0.974004621309708,1.0,6/21,15.59%,FIS1;MICU2;SMDT1;RAP1GDS1;SLC8A3;SLC25A23
prerank,canonical glycolysis (GO:0061621),0.3108432578930232,0.9208539442789644,0.5798319327731093,0.97264716417338,1.0,8/24,20.73%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3108432578930232,0.9208539442789644,0.5798319327731093,0.97264716417338,1.0,8/24,20.73%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.297773860682105,0.9206093129877763,0.5871271585557299,0.9724468561167586,1.0,7/30,14.32%,GGA3;RAB26;SYS1;ARFRP1;RAB34;BLZF1;SPTBN1
prerank,fatty acid oxidation (GO:0019395),0.25909295858217074,0.9203248780355823,0.5914454277286135,0.9723699492294924,1.0,12/57,19.94%,ECHDC1;ALOX12;PPARGC1A;MECR;ACAT2;ACADS;ACOX1;PEX2;ACADM;HSD17B10;ABCD2;ECHS1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3434002698872344,0.919964616993177,0.5437710437710438,0.9724897415830464,1.0,8/15,28.50%,GRM3;HOMER2;DAGLA;DAGLB;GRIK3;GRM8;GRM7;GRM1
prerank,cellular response to light stimulus (GO:0071482),-0.22603606593199863,-0.9198522963216101,0.6341463414634146,0.8065998506618042,1.0,28/66,35.07%,PCNA;USP28;TAF1;YY1;EP300;EIF2S1;RHNO1;NPM1;CDC25A;GPR88;PDE6B;RPL26;OPN3;CASP9;TRPM1;PDE6A;RRH;GPR52;AQP1;RHBDD1;USP47;RUVBL2;PTPRK;MAPK13;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,protein trimerization (GO:0070206),0.3569593785948898,0.9194709170563662,0.5689948892674617,0.9721254806522427,1.0,5/14,21.86%,DISP1;SIGMAR1;ASIC1;ALOX5AP;STEAP4
prerank,protein homotrimerization (GO:0070207),0.3569593785948898,0.9194709170563662,0.5689948892674617,0.9721254806522427,1.0,5/14,21.86%,DISP1;SIGMAR1;ASIC1;ALOX5AP;STEAP4
prerank,regulation of mRNA stability (GO:0043488),-0.19642400367539392,-0.9194618831847704,0.6772908366533864,0.8069606407911208,1.0,45/145,25.98%,PSMA6;CELF1;NOCT;PSMB2;MAPKAPK2;PSME2;SAMD4A;PUM2;PSMD11;PSMC6;UBC;EIF4ENIF1;PSMA3;EXOSC8;UBA52;VIM;XPO1;FASTKD1;RC3H1;TENT5A;SLC11A1;PSMD10;LARP1;EXOSC9;NPM1;PSMB5;HSPB1;RC3H2;FXR2;PSMD5;HNRNPD;MEX3D;PSMD1;HNRNPU;PUM1;EXOSC1;TENT5C;RIDA;PSMA7;PSMB7;EXOSC7;SERBP1;VIP;GIGYF2;PSMB3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3565992261470627,-0.9192567398954499,0.5423340961098398,0.8068767908970733,1.0,5/11,25.63%,NRP1;STMN1;BCAR1;SIRT2;RAC1
prerank,axonal transport (GO:0098930),0.28694376242776526,0.9192017176666872,0.5741935483870968,0.9720151827965934,1.0,8/36,14.91%,DST;BLOC1S2;SNAPIN;AP3M1;AP3B2;DCTN1;SYBU;HAP1
prerank,respiratory chain complex IV assembly (GO:0008535),0.31885530109108345,0.9189678618113161,0.5621970920840065,0.9718372500794155,1.0,9/21,26.01%,COA6;TIMM21;OXA1L;BCS1L;COX17;SMIM20;COX18;COX10;FASTKD3
prerank,regulation of JNK cascade (GO:0046328),-0.20849253202954407,-0.9189462437467452,0.6498054474708171,0.807056564939553,1.0,31/101,24.91%,FCGR2B;ITCH;SDCBP;PJA2;NOD2;RIPK1;IL1B;TAOK3;SH3RF1;MAP3K11;TNFRSF19;GADD45G;MAPK8IP3;SLAMF1;EGFR;AGER;PTK2B;TRAF1;HIPK2;MMP8;RAP2A;TRAF4;NCOR1;DUSP19;SERPINF2;EPHB1;MECOM;APP;DUSP3;FKTN;TLR9
prerank,sulfur compound catabolic process (GO:0044273),0.28072877087947007,0.9188901905491221,0.5769230769230769,0.971198384628274,1.0,5/38,6.44%,HEXB;GGT7;ACAN;ARSB;GGT5
prerank,positive regulation of wound healing (GO:0090303),0.2857549482352914,0.9187987929557548,0.58887171561051,0.9705786037940303,1.0,9/36,17.88%,INSL3;SMOC2;ADRA2A;ENPP4;ARFGEF1;VTN;HRAS;PTK2;XBP1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2973619190518455,0.9186968452355807,0.5802861685214626,0.9700006376234651,1.0,5/27,9.91%,SMYD2;DDX5;HIC1;EEF1E1;SNAI2
prerank,endocardial cushion development (GO:0003197),0.3199242193242464,0.9185608692003822,0.5586206896551724,0.9695278291663381,1.0,6/21,21.45%,BMP4;HEY1;TBX2;CRELD1;ENG;MDM4
prerank,activin receptor signaling pathway (GO:0032924),0.35377779680873733,0.918390521595108,0.5429553264604811,0.9691571460102697,1.0,5/15,20.59%,TGFBR1;ACVR1B;AMHR2;ACVR1C;SMAD2
prerank,L-glutamate transmembrane transport (GO:0015813),0.3857126354878656,0.9183516431987723,0.5761821366024519,0.9684070591176749,1.0,3/10,11.08%,SLC1A1;SLC25A18;SLC1A3
prerank,response to organic cyclic compound (GO:0014070),0.262312998253282,0.9182857725015652,0.597684515195369,0.9677463334027973,1.0,15/52,19.32%,GGT7;TRPM2;SLC1A1;GGT5;ABCB4;SOCS2;TGFB1;WNT8B;ALPL;BGLAP;SFRP1;ABCA2;TLR3;IL18;CCL5
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2861285809551136,-0.9182160088613757,0.5815789473684211,0.8082853622168288,1.0,5/24,9.39%,ITCH;NOD2;UBC;TAB1;UBA52
prerank,chromosome organization (GO:0051276),-0.2088675333833662,-0.9181209950880354,0.6738351254480287,0.8079287115561624,1.0,28/99,18.65%,SETD7;HMGB2;CUL4A;MTHFR;SMARCA4;TOP2A;DOT1L;PADI4;CDCA8;UBC;H3-3A;UBA52;RAD23B;HDAC2;LIG4;EHMT1;HMGN3;HDAC1;CDT1;HMGN2;CENPW;NDC80;NUF2;SATB1;HMGA2;COPS4;PHF19;XPC
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.32002495131569586,0.9178224641691791,0.6064,0.9681816265625505,1.0,6/21,19.22%,SH3BP1;DAB2IP;RASAL3;EPHB2;ARHGAP12;STAMBP
prerank,recombinational repair (GO:0000725),0.24751096872794254,0.9173387135136273,0.6166180758017493,0.9686120405177411,1.0,19/77,19.42%,NUCKS1;RNF138;SMC5;XRCC1;LIG3;UBE2N;RECQL;FAN1;RAD52;PSMD14;PARP1;FEN1;XRCC3;RFWD3;TONSL;HUS1;WRN;SEM1;RECQL4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.22053595803637893,-0.917102247718767,0.6698412698412698,0.8098074769956458,1.0,15/74,13.89%,DAB2;PHLDB1;GCNT2;SDCBP;SMAD3;GLIPR2;IL1B;DAG1;BMP5;MAD2L2;SPRY2;CTNNB1;SPRY1;GREM1;BMP2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.31261999471787905,0.9170779631538538,0.5836065573770491,0.9684763576828196,1.0,5/24,11.86%,ITPR2;TRPM2;PKD2;FGF2;ITPR3
prerank,nerve growth factor signaling pathway (GO:0038180),0.3829556820454604,0.9169973046299141,0.5866900175131349,0.9678521470087704,1.0,4/10,25.09%,NTRK1;MAGI2;BDNF;RAPGEF2
prerank,mitochondrial membrane organization (GO:0007006),-0.26393501824422066,-0.9169720358439,0.5951742627345844,0.8095440759944209,1.0,8/32,14.72%,BCL2;BCL2L1;RCC1L;MTX3;MTX1;IMMT;PMAIP1;TIMM50
prerank,autophagosome assembly (GO:0000045),-0.23216115861962072,-0.9166858380656208,0.6131805157593123,0.8096502037617771,1.0,14/52,17.36%,PIK3C3;MAP1LC3B;ATG13;STX12;RAB1A;RAB7A;ATG7;UBQLN1;ATG2B;ATG3;UBXN2B;AMBRA1;ATG9B;MAP1LC3A
prerank,hemopoiesis (GO:0030097),0.24229251562904924,0.9163779546223423,0.6355810616929699,0.9686378765160578,1.0,17/87,13.86%,SELPLG;FUT10;ZFPM1;CD34;FLT4;YJEFN3;TGFBR3;PLD4;BMP4;ZFP36L2;TGFB1;SH2B3;KAT8;SFRP1;PDGFB;TEK;FLCN
prerank,histone H2A acetylation (GO:0043968),-0.3171719471269246,-0.9162876357633476,0.5807174887892377,0.8100530579458574,1.0,5/16,14.38%,EP400;EPC1;TRRAP;SPHK2;MSL3
prerank,DNA-dependent DNA replication (GO:0006261),-0.19778950047012733,-0.9159172459265718,0.7019607843137254,0.810379438826262,1.0,30/128,20.30%,BAZ1A;PSMA6;PSMB2;POLE4;TOPBP1;PSME2;ORC5;PSMD11;CDC34;PSMC6;UBC;PSMA3;UBA52;ORC2;POLD4;RPA1;MCM2;ORC4;PSMD10;CDT1;PRIM2;PSMB5;DDX21;MCM8;RPA2;PSMD5;WDHD1;PSMD1;POLE3;HMGA1
prerank,glycerophospholipid catabolic process (GO:0046475),0.3001472376822717,0.9158330389240341,0.5829307568438004,0.9692402136306951,1.0,5/27,10.38%,PRDX6;PLA2G4C;ABHD12;ENPP2;INPP5F
prerank,positive regulation of phosphorylation (GO:0042327),0.21222423780253571,0.9156444067589038,0.6731470230862697,0.9689123317680094,1.0,56/240,20.52%,FGF10;ADTRP;FGF16;ANG;MERTK;FGF9;C3;PAK1;NTRK1;FLT4;CARD14;NCKAP1L;RARRES2;PFKFB4;FGF7;NTRK3;DSCAM;AR;RYK;LIMK2;CCND3;BMP4;EPHA1;ERBB4;TGFB1;FGF2;EFNA1;P2RY1;TEK;RALBP1;EPHA4;FLCN;THPO;INSR;EPHB2;NTRK2;MAPK3;HRAS;VAC14;PTK2;ITGA6;ENG;FLT3;CHRNA7;PIN1;HDAC3;RSPO1;DVL2;PFKFB2;CCL5;PDGFRB;ROR1;ERP29;IL34;ARRB1;EPHA5
prerank,response to insulin (GO:0032868),0.24530297140494411,0.9153560631460078,0.6040462427745664,0.9688719313066361,1.0,19/80,18.41%,SELENOS;RAB8A;PDE3B;RPS6KB1;PRKCI;EIF6;OGT;HDAC5;IRS1;USF1;PARP1;RAB12;KHK;SORT1;INSR;EPRS1;RHOQ;XBP1;ZBTB7B
prerank,cilium assembly (GO:0060271),-0.18190139190356067,-0.9153030641777992,0.803921568627451,0.8112578703727347,1.0,48/297,12.56%,EHD4;ATP6V0D1;RAB8B;ACTR3;KIF3A;PTPN23;PCM1;RILPL2;FAM161A;CDK5RAP2;PIBF1;RAB1A;PRKACA;MKS1;RPGR;SCLT1;CDC14B;EXOC4;CPLANE1;GBF1;TUBA4A;CEP250;ARL13B;TCTN1;SSX2IP;TBC1D32;BBS7;FHDC1;ASAP1;DNAH5;YWHAG;HAUS2;TMEM231;KIF24;CEP164;CCDC40;WDPCP;MAPRE1;CENPJ;SNAP29;CCDC28B;TMEM138;NOTCH1;CDK1;HAUS8;FOXJ1;IFT52;EXOC8
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2856541568179968,0.9150965497073181,0.5975232198142415,0.9687469667208529,1.0,6/33,14.65%,HOXA5;ANKRD54;NCKAP1L;MTURN;ACVR1B;THPO
prerank,regulation of mitochondrion organization (GO:0010821),-0.23683220914759975,-0.915053131810036,0.628099173553719,0.811282737009519,1.0,11/47,18.81%,PID1;FBXW7;STAT2;VPS35;PARL;EP300;LRRK2;PDE2A;MUL1;SQSTM1;PISD
prerank,mitotic cytokinetic process (GO:1902410),-0.29725047306714714,-0.9148672357087975,0.6224489795918368,0.811112841227573,1.0,5/20,16.22%,CHMP4B;CHMP4A;PDCD6IP;CHMP1B;KIF20A
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.31183628530853863,-0.9147696626990315,0.5869017632241813,0.8107574488135469,1.0,5/17,15.37%,SASH1;CD36;TRIM5;CD55;SCIMP
prerank,negative regulation of macroautophagy (GO:0016242),-0.275277149204625,-0.9145402894189145,0.5871794871794872,0.810738429704168,1.0,6/26,12.17%,CHMP4B;CHMP4A;SMCR8;PIK3CA;MTM1;LRRK2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.21295062814807122,-0.9143116797161086,0.66,0.8107341581338123,1.0,19/84,16.38%,PSMA6;BUB3;CUL3;PSMB2;PSME2;PSMD11;PSMC6;UBC;PSMA3;UBA52;CDC27;CDK1;MAD2L1;PSMD10;BUB1B;RB1;PSMB5;PLK1;UBE2C
prerank,protein autophosphorylation (GO:0046777),0.21993551371785383,0.9141245089860697,0.6513761467889908,0.9705678003896439,1.0,35/157,17.60%,TXK;STK26;PAK1;NTRK1;FLT4;STK16;STK11;MAPK15;MAP3K10;RIPK3;EPHA1;ERBB4;CDKL5;PRKD2;AAK1;STK39;VRK2;MINK1;STK25;ACVR1B;TEK;EPHA4;MAP3K13;INSR;NTRK2;EIF2AK4;MAPK3;PRKD1;PTK2;MAPKAPK5;ITK;AATK;TAOK1;FLT3;SMG1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.23523923578628808,-0.9140181046543919,0.627831715210356,0.8108867950087385,1.0,15/54,17.30%,APOE;MECP2;PPARG;P2RX4;THBS1;SP1;HIF1A;PRCP;KDR;TNF;HSPB1;EPHA2;NUS1;ADAM17;RGCC
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.24719923524192844,0.9138499727911712,0.6239669421487604,0.9704395409331269,1.0,13/78,14.38%,HHEX;CDK7;PSRC1;CCNI;SERTAD1;CCND3;PKD2;HEXIM2;PKD1;PDGFB;GADD45A;CCNK;IPO5
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.30973236226232753,0.9138241236580612,0.5674342105263158,0.969671585348435,1.0,6/23,21.83%,GUCY2F;CNGB1;GUCY2D;NMT1;METAP2;GUCA1B
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.193612907273425,-0.9138190014084161,0.7410714285714286,0.8107579712572335,1.0,50/158,25.12%,CD74;ANKRD17;ALPK1;TRIM25;TRIM14;LGALS1;TBK1;LAMTOR5;SHISA5;BST2;NOD2;RIPK1;TFRC;LITAF;TRIM62;PLEKHG5;CLEC6A;CCDC22;S100A4;EEF1D;GPRC5B;TNFRSF19;BIRC2;IRAK4;PELI1;TRIM5;ZDHHC17;DDX21;TNF;GJA1;NUP62;MUL1;HMOX1;TRAF3IP2;FLNA;ECT2;MYD88;LTF;CASP1;TRIM21;NDFIP1;TNFSF10;GPR89A;TICAM2;TMEM101;GOLT1B;PIM2;FADD;TLR9;TAB3
prerank,negative regulation of angiogenesis (GO:0016525),0.2444840744005597,0.9137649953127983,0.6284916201117319,0.9689967798420999,1.0,14/84,12.98%,HOXA5;HHEX;IL17F;SLC12A2;YJEFN3;PDE3B;GTF2I;MINAR1;DAB2IP;FOXC1;VASH1;EFNA3;COL4A2;TEK
prerank,hyaluronan catabolic process (GO:0030214),-0.30151201448802534,-0.9135435766064955,0.5827338129496403,0.81083007491048,1.0,7/18,16.94%,LYVE1;CD44;HMMR;CEMIP2;STAB2;CHP1;HYAL3
prerank,cellular response to ATP (GO:0071318),0.3556832504748747,0.9134373011624792,0.5924657534246576,0.9690448622249889,1.0,4/14,16.10%,P2RY12;HSP90B1;P2RY1;SSH1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.292029937753786,0.9133960977550292,0.5770491803278689,0.9683215142283622,1.0,10/28,28.51%,KCNE2;CLU;DAB2IP;PRKN;PTK2;AXIN1;RNF139;PSMC5;PTEN;ATP5IF1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.24145594028049377,-0.913162175260954,0.6261980830670927,0.8111652994114371,1.0,26/44,40.00%,ACOT8;OSBP;OSBPL9;OSBPL1A;PRKAG2;OSBPL2;HSD17B1;SC5D;PER2;HSD3B7;INSIG1;SRD5A2;PMVK;ALOX15;ABCB11;INSIG2;EBP;BAAT;SLC27A5;AKR1D1;ACOX2;HMGCR;CH25H;LBR;OSBPL3;SLC27A2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.2732020894423273,0.9128450398189628,0.6076923076923076,0.9689358962008378,1.0,9/43,12.83%,DDX5;FOSL1;NFIB;RELA;PPARA;BMP4;TGFB1;FGF2;PDGFB
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.32996190788842433,-0.9128223685100203,0.5736434108527132,0.811382704000432,1.0,6/14,17.84%,THBS1;SPRY2;SPRY1;CREB3L1;SPRY4;GATA3
prerank,pore complex assembly (GO:0046931),-0.2995632866982847,-0.9127702623677686,0.581081081081081,0.8109197166749208,1.0,4/19,11.62%,AFDN;NUP153;NDC1;AHCTF1
prerank,regulation of focal adhesion assembly (GO:0051893),-0.235802605802078,-0.9127699679211568,0.6191950464396285,0.810341197292049,1.0,6/54,5.53%,PEAK1;SLK;NRP1;CORO1C;LIMS1;THBS1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.36992162781576854,0.9125970222736565,0.577490774907749,0.9687575101586036,1.0,3/11,10.57%,PTPRT;SOCS3;SH2B3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.2450542535862804,-0.9124597641018408,0.6129032258064516,0.8104972538953896,1.0,15/43,21.97%,IGF1;MEF2D;ERN1;THBS1;LDLRAP1;DNMT1;STAT1;HTR1B;FOXP1;TNF;GJA1;HMOX1;IGFBP5;ID2;SERPINF2
prerank,regulation of actomyosin structure organization (GO:0110020),0.3620555398016191,0.9124263446697805,0.5873287671232876,0.9683992819729118,1.0,7/13,26.22%,AKAP13;ROCK1;ALMS1;ASAP3;CDC42;SLC9A1;FHOD1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.36153609231846834,0.9118961363656051,0.5823627287853578,0.968978856859711,1.0,4/13,9.35%,SH2B1;TGFBR1;BMP4;TGFB1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.30321480084316965,0.9118138079625493,0.613747954173486,0.9683452093953157,1.0,7/28,23.08%,CTTN;SH3BP1;FCHSD2;ARHGAP35;PLEKHG2;LATS1;GBA2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.23955030635369862,0.9117671623685418,0.628808864265928,0.967645773408833,1.0,27/87,22.77%,NDUFA6;DMAC1;NDUFAF8;TIMM21;TTC19;FOXRED1;UQCC3;NDUFS1;NDUFA8;NDUFS6;SDHAF2;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6;SDHAF4;OMA1;COX17;ACAD9;SMIM20;NUBPL;COX18
prerank,central nervous system neuron differentiation (GO:0021953),0.2894254560150234,0.9117549284651171,0.6078125,0.966850346163082,1.0,5/33,7.92%,MDGA2;FAIM2;SOX4;RYK;GRID2
prerank,phosphatidylserine metabolic process (GO:0006658),-0.2595595974945747,-0.9113796368705025,0.6076696165191741,0.8124461707676571,1.0,10/32,25.11%,OSBPL8;PLA2G4E;PLAAT3;ABHD16A;LPCAT4;PLA1A;PLA2G4F;PLA2G2D;PLSCR1;MBOAT1
prerank,positive regulation of intracellular transport (GO:0032388),0.2744702954029001,0.9112229596575867,0.613251155624037,0.9674225188244866,1.0,8/38,11.38%,TENM1;STK11;OAZ1;ACTN2;PLK3;NEDD4;EHD1;EHD2
prerank,response to steroid hormone (GO:0048545),-0.25770747249746234,-0.910976494423496,0.6370967741935484,0.8129210571898728,1.0,7/31,9.26%,NR3C1;THBS1;CATSPER3;CAV1;YAP1;CATSPER2;UBE2L3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2969958743478996,0.9108104180117894,0.5905245346869712,0.9676817545226217,1.0,12/29,25.83%,CBR4;ACSL6;PPT2;ELOVL6;TECR;ACLY;ACSF3;ACSBG1;ELOVL5;ACSL3;SLC25A1;FASN
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.3736801846357809,0.9106592841329545,0.5859649122807018,0.9672559030719204,1.0,3/11,17.67%,PLA2G3;AGT;LIPC
prerank,regulation of transforming growth factor beta production (GO:0071634),0.3272469535108753,0.9105808112511429,0.5861513687600645,0.96665051552461,1.0,2/18,4.00%,CD34;ITGB6
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.31645704244376716,-0.9104470993871143,0.5855421686746988,0.8136104400895304,1.0,5/17,11.75%,ADAM9;SYK;CIB1;RET;SKAP1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.3412050971953296,-0.910254794743788,0.5833333333333334,0.8134854572363435,1.0,6/13,21.64%,GNPDA1;UAP1L1;SLC35A3;GNPNAT1;NAGK;RENBP
prerank,glycolytic process (GO:0006096),0.2928310651154143,0.9097325527732288,0.5980707395498392,0.9680650017028639,1.0,9/28,20.73%,GAPDH;PGAM2;ALDOC;PFKM;HK2;PFKFB2;PGM1;ALDOA;ENO3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.31082240324815613,0.9096336383145507,0.5636942675159236,0.967499573785607,1.0,8/23,21.56%,IL17F;TGFBR3;TGFB1;ENG;LTBP4;NREP;SMAD2;LATS1
prerank,regulation of acute inflammatory response (GO:0002673),0.3227464917317407,0.9093046056371368,0.5683333333333334,0.9675590516260351,1.0,2/18,5.65%,DNASE1;IL6
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.27391763847453254,-0.9086260562085716,0.6195372750642674,0.81694340076262,1.0,7/25,15.43%,NOD2;CD226;B2M;CD55;SPHK2;SCIMP;WNT5A
prerank,positive regulation of dendrite extension (GO:1903861),0.33151192848341354,0.9085334054093667,0.5833333333333334,0.9688008990585215,1.0,5/17,15.11%,SYT4;SYT1;CPNE6;RIMS1;NEDD4L
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.273286570710416,0.9083774382075847,0.6009316770186336,0.9683977011434016,1.0,13/39,23.64%,YWHAE;FGF12;FHL1;PTPN3;NEDD4;STK39;TRPC6;CACNA1D;NEDD4L;ANK2;SCN1B;SCN3B;PDZK1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.22780562669069043,-0.9081897918600328,0.6261127596439169,0.8168222332653453,1.0,14/50,15.65%,POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;AGO2;POLR2B;POLR2H;POLR2J;TRIM71;NUP62
prerank,regulation of gene silencing by RNA (GO:0060966),-0.22780562669069043,-0.9081897918600328,0.6261127596439169,0.8168222332653453,1.0,14/50,15.65%,POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;AGO2;POLR2B;POLR2H;POLR2J;TRIM71;NUP62
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.36256420591175537,-0.9080869524726027,0.5835240274599542,0.816499345802717,1.0,5/10,23.91%,GNPDA1;ST6GAL1;NAGK;RENBP;NPL
prerank,regulation of peptidase activity (GO:0052547),-0.30004778051189734,-0.9079821823623766,0.5868421052631579,0.8161410462626674,1.0,7/19,25.35%,NRDC;CAV1;PSMA3;HDAC1;MAPK12;NDUFA13;ATP13A2
prerank,AMP metabolic process (GO:0046033),0.35414388467180496,0.9077008726607895,0.5735537190082645,0.9693201962015083,1.0,6/13,23.54%,NUDT2;AMPD3;ADSL;AK4;AK3;AK9
prerank,catecholamine metabolic process (GO:0006584),0.34942050386543216,0.9076352850246108,0.5768566493955095,0.968655139904525,1.0,4/14,14.74%,LRTOMT;RNF180;PRKN;COMT
prerank,histone lysine demethylation (GO:0070076),-0.2798325795891289,-0.9073643867151184,0.6101694915254238,0.8170204123652661,1.0,7/25,15.26%,RIOX2;KDM7A;KDM8;KDM6A;HR;RIOX1;KDM5C
prerank,regulation of cellular response to stress (GO:0080135),0.22898175373525972,0.9071611383026387,0.6657571623465212,0.9690968522180057,1.0,39/115,28.07%,YWHAE;ADCY8;AAAS;RPTOR;DNAJC2;SLC38A2;CORO2B;USP51;MANF;NUP54;VASH1;CHORDC1;PRKN;NUP88;NEK4;RAE1;DNAJC7;CRHBP;CCAR2;MAPK3;NUP133;OPRM1;SMG1;HSP90AB1;POM121;NUAK1;ING2;NPAS2;CAMK2B;CRYAB;MAPK1;FKBP4;MAPT;ATF4;AMFR;HSPA8;PTGES3;NUP107;NUP155
prerank,fatty acid biosynthetic process (GO:0006633),0.25083963136755205,0.907022213394739,0.6385714285714286,0.9686260183305202,1.0,17/63,20.59%,ALOX12;CBR4;ELOVL6;OXSM;TECR;ELOVL4;ACLY;NDUFAB1;ACSF3;ACSBG1;LIPC;XBP1;HPGD;DECR2;FADS3;ABHD2;ELOVL5
prerank,heart trabecula morphogenesis (GO:0061384),-0.3109081692821943,-0.9062142114184537,0.5831265508684863,0.8192771213320167,1.0,4/18,10.93%,RBPJ;ADGRG6;BMP5;NOTCH1
prerank,negative regulation of vascular permeability (GO:0043116),-0.34041470157950654,-0.906156344517412,0.5691244239631337,0.8188605359965062,1.0,7/12,32.02%,CEACAM1;RAMP2;PDE2A;ANGPT1;SLIT2;DDAH1;PDE3A
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2044992449700722,-0.9059723413913721,0.6743295019157088,0.818714261457382,1.0,22/104,16.35%,CHST11;B4GALT5;PAPSS2;MGST3;CHST9;GGTA1;GSTA3;UGDH;GSTO2;GCLC;OGN;DSEL;GSTZ1;CSPG4;GSTM1;CHST7;MPST;GSTM5;CHPF;DSE;LIAS;CBS
prerank,carboxylic acid transport (GO:0046942),-0.22841989319155326,-0.9058068541079447,0.6614906832298136,0.8185372803518475,1.0,5/55,3.14%,SLC38A6;SLC1A5;SLC7A1;PSAP;SLC6A6
prerank,serine family amino acid metabolic process (GO:0009069),-0.31840613980356025,-0.905717361481041,0.5989974937343359,0.8181694062673365,1.0,6/16,21.76%,MTHFD1;GCLC;CBS;THNSL2;CTH;SEPHS2
prerank,positive regulation of lipid localization (GO:1905954),0.37633019321615857,0.9055948974419873,0.6123595505617978,0.9715833316770007,1.0,2/11,5.43%,C3;HILPDA
prerank,long-term memory (GO:0007616),-0.2968917319156692,-0.9055448888208107,0.6075949367088608,0.8180162133393397,1.0,3/19,6.67%,APOE;PJA2;LDLR
prerank,glucose transmembrane transport (GO:1904659),0.3241220852001652,0.9055013876279845,0.5723905723905723,0.9710012406001561,1.0,4/18,13.98%,SLC2A3;SLC2A2;SLC45A1;SORT1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.24628393033193266,-0.9054725903996282,0.6205962059620597,0.8175962070980064,1.0,19/39,33.16%,ACTN1;MEGF11;VCL;HSPB1;MYH9;FLNA;FN1;PDGFRA;ITGB3;FIBP;TLN1;MYL12A;CLIC1;ILK;PLEK;PLPP3;RAP2B;MYL9;PPIA
prerank,exit from mitosis (GO:0010458),-0.3377118451966621,-0.905414897077848,0.5880952380952381,0.8171613808722509,1.0,2/12,1.14%,CHMP4B;EPS8
prerank,positive regulation of cartilage development (GO:0061036),-0.30461921494429284,-0.9052409090721059,0.6013667425968109,0.817006335718407,1.0,7/17,29.82%,SOX6;SCX;BMP2;PKDCC;BMPR2;TAPT1;SOX5
prerank,actin crosslink formation (GO:0051764),-0.3419412950687646,-0.9051517668646344,0.5537757437070938,0.816648534179924,1.0,5/12,22.63%,EPS8;GAS2L3;LCP1;FLNA;BAIAP2L2
prerank,focal adhesion assembly (GO:0048041),0.3139129469689108,0.9050724053060705,0.5852459016393443,0.9713276214962704,1.0,4/21,9.01%,CTTN;THY1;TRIP6;ACTN2
prerank,proteasomal protein catabolic process (GO:0010498),0.21212393235586044,0.9047490352637625,0.7038834951456311,0.9713767114468012,1.0,45/201,16.39%,KLHL22;UBXN6;UBE2B;PSMB1;HECTD3;ENC1;RNF126;UBE2G1;ARRB2;PSMF1;BTRC;PSMA1;PSMD7;FAF1;HECW2;PRKN;PSMA8;NEDD4;NFE2L2;CCDC47;NHLRC1;TRIM9;KCTD10;KCTD13;PSME3;IFI27;GID4;DERL1;PSMD14;APPBP2;HACE1;SPSB3;FBXL19;PSMC4;DCAF11;SOCS6;KCTD5;RFFL;FBXW5;NEDD4L;SKP2;UBXN1;SIAH1;COP1;KIF14
prerank,zinc ion transport (GO:0006829),0.3196405004105044,0.9047199056089765,0.6189683860232945,0.9706407337051554,1.0,5/21,17.78%,SLC39A4;TRPM2;SLC39A8;SLC30A3;SLC39A3
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.29233711482314456,0.9046837053427627,0.6089743589743589,0.9699206076613466,1.0,9/28,20.43%,ADCY8;LGMN;SHANK3;ZDHHC2;EPHA4;EPHB2;EIF2AK4;CHRNA7;CALB1
prerank,negative regulation of protein modification process (GO:0031400),0.24069670013410752,0.9045568421318356,0.6319543509272468,0.9694425665893928,1.0,12/79,9.79%,TPPP;WWTR1;BEX4;DMD;PRNP;NTRK3;CACTIN;DAB2IP;XRCC1;SH3GL2;TGFB1;PRKN
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.31482925912100174,0.9040099746865435,0.6260032102728732,0.9700831476650905,1.0,6/20,12.75%,ATP2A2;FIS1;BAK1;CCDC47;HERPUD1;RAP1GDS1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.20267899357100197,0.9037102699473848,0.7437923250564334,0.9700184753696341,1.0,79/327,23.78%,ZFHX3;SCRT2;MAGED1;CTR9;DRAP1;DENND4A;LDB1;PQBP1;FUS;WWTR1;ESRRG;NR1I2;SOX21;HIC1;SKOR1;RELA;PPARGC1A;NSD1;UBE2V1;SOX4;HOXB7;E2F1;MEF2C;ZNF35;ZNF205;TGFBR1;OGG1;APBB1;POFUT1;FOXC1;SNAI2;SPIN1;SLC39A8;MLLT6;ACVR1B;WWC1;THAP1;MLF2;TFEB;PLAG1;LMX1B;SPTY2D1;INSR;APBB3;CCAR2;EDF1;REST;TCF3;TCF7L1;SUFU;PAK6;BACH1;ENG;PPP2R1A;BTG1;HMG20A;PHF1;ELAVL2;GCFC2;DVL2;REXO4;RORA;MED23;PRMT5;ZFAT;TEAD2;ING2;ZNF628;NFYB;SKOR2;SSBP2;TULP3;YAF2;SOX13;ACTR5;HES6;NAB2;SMARCA2;MAFB
prerank,regulation of myotube differentiation (GO:0010830),0.3017526564539015,0.9035054192698251,0.6122112211221122,0.9697619650190592,1.0,7/24,18.76%,HDAC5;ATP11A;SMYD1;DMPK;BHLHE41;XBP1;HDAC3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.36245925873921375,0.903384545668342,0.5781512605042017,0.9692777267047056,1.0,5/12,12.62%,SGTA;SEC62;SGTB;SEC61A2;GET3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.1952719000525788,-0.9032665314343149,0.7735042735042735,0.8205507094711157,1.0,44/146,24.23%,RAD51B;PSMA6;MECP2;PCM1;CDK5RAP2;PSMB2;PRKACA;GPR132;PSME2;TUBA4A;CEP250;PSMD11;CCND1;PSMC6;PSMA3;YWHAG;HMMR;HAUS2;CEP164;MAPRE1;CENPJ;CDK1;HAUS8;PSMD10;PSMB5;CDC25A;PLK1;KCNH5;DCTN2;DTL;PSMD5;ODF2;TPX2;PAFAH1B1;PSMD1;AKAP9;CDC25C;CEP78;OFD1;TUBB4B;CCNB1;NDE1;PSMA7;PSMB7
prerank,organelle fission (GO:0048285),-0.27411220690687044,-0.9030774472723371,0.6243386243386243,0.8204108960469129,1.0,9/24,18.90%,TMCC1;ACOT8;CORO1C;DNM2;MUL1;MTFP1;MTFR2;MIEF1;GDAP1
prerank,cellular response to reactive oxygen species (GO:0034614),0.2513570261140391,0.9030532634334392,0.6389280677009873,0.969367192615619,1.0,8/59,10.76%,PRDX5;PJVK;RELA;IL6;TRPM2;RIPK3;PKD2;NFE2L2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.34544019479820587,0.9030527417640071,0.5914742451154529,0.9685572876546749,1.0,7/15,29.65%,REEP2;ATL1;TMEM33;ZFYVE27;ATL2;RTN3;TMEM170A
prerank,striated muscle cell differentiation (GO:0051146),0.3436911334917921,0.9026104375292558,0.5938566552901023,0.9688780908776079,1.0,4/16,13.98%,KDM6B;MEF2C;AKAP13;SORT1
prerank,negative regulation of DNA binding (GO:0043392),-0.2685422055003589,-0.9023666343565597,0.5901639344262295,0.8214625602822184,1.0,6/28,18.14%,SP100;SOX11;MAD2L2;HEY2;HMGA2;PER2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.33101064405970476,0.9023081120961394,0.5986038394415357,0.9688516622051575,1.0,4/17,9.35%,WNT4;VSIR;BMP4;TGFB1
prerank,organelle organization (GO:0006996),0.19858449394760022,0.9019987713407565,0.7584650112866818,0.968846351802791,1.0,106/388,23.63%,FBXW8;ARMC2;CFAP126;CNTNAP1;DST;OBSL1;BIN1;RAB43;ROPN1;SEC16B;CATIP;THY1;CYP26C1;TFAM;PPARGC1A;ATL1;SIPA1;BRWD1;FGD2;FMNL3;HILPDA;GABPB1;MAPK15;TMED2;MICAL3;PNPLA3;NDP;PRKCI;CLASP2;COG4;SEC31A;PI4K2A;RHOT1;TANGO2;PKD2;ARAP3;ZW10;PRKN;RAB38;PEX14;CFL1;CAMSAP1;PAK5;GABPA;DNM1L;CHMP1A;RAB34;WASF3;HACE1;LYSMD3;TMED5;PARP1;ARFGEF1;BLZF1;SORT1;CHCHD10;CHMP2A;DPYSL2;FITM2;MSTO1;MIA3;CFAP61;PRKD1;PEX2;DNAJA3;ATP8B1;CXADR;PAK6;TMED3;CDC42BPB;HSD17B10;BCS1L;MAST2;PEX6;STX17;ABCD2;LMAN2L;ZMYM6;RHOU;IQCG;MTX2;ZMYM3;CAV2;PYROXD2;TRAPPC8;TMED7;HPS3;SNX11;CDC42;SSBP1;ARHGAP4;KIF9;PACSIN3;PEX11B;CHMP5;VMP1;PEX3;PEX11A;CHMP7;ATL2;WASL;CHGA;PCLO;FGD5;TMED1;SEC31B
prerank,cardiac ventricle development (GO:0003231),0.3169210624541695,0.9018650746006391,0.6053511705685619,0.9683712278034527,1.0,8/20,26.27%,DAND5;HEY1;GJA5;ENG;TMEM65;MDM4;HECTD1;SALL1
prerank,mitochondrion morphogenesis (GO:0070584),-0.35573912223419996,-0.9018360439325844,0.5977011494252874,0.8221520631789514,1.0,3/11,15.01%,PID1;MTM1;WASF1
prerank,cell proliferation in forebrain (GO:0021846),-0.3663757606300149,-0.9015056688707672,0.5776255707762558,0.822380475198289,1.0,2/10,2.93%,PCM1;DOCK7
prerank,regulation of membrane depolarization (GO:0003254),0.3229017769785035,0.9011163039725473,0.6009933774834437,0.9695274111979648,1.0,6/18,22.35%,FHL1;PTPN3;GJA5;NEDD4L;SCN1B;SCN3B
prerank,retinol metabolic process (GO:0042572),-0.32540935584577885,-0.9008763676924963,0.5573770491803278,0.8232877273732829,1.0,6/14,24.41%,RDH11;CYP1A1;DHRS9;DHRS3;CYP1B1;RDH12
prerank,response to organophosphorus (GO:0046683),0.3363913579306955,0.9007579535191931,0.6208530805687204,0.969660159988059,1.0,3/16,8.51%,TRPC3;AKR1C1;DGKQ
prerank,iron ion homeostasis (GO:0055072),-0.22636505456037634,-0.900606461740274,0.6310679611650486,0.8233321886951277,1.0,18/58,23.19%,ATP6V0D1;TFRC;PICALM;SLC46A1;NUBP1;CP;SLC11A1;ATP6V1A;LCN2;B2M;FTL;HMOX1;SMAD4;CYBRD1;NDFIP1;HEPH;ALAS2;FBXL5
prerank,"phagocytosis, engulfment (GO:0006911)",-0.2508446499727446,-0.9005907764737402,0.6277777777777778,0.82278925342848,1.0,4/36,5.53%,FCGR2B;MSR1;CD36;THBS1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.27068338250393437,0.9005373147258805,0.639937106918239,0.9694113367769059,1.0,5/39,8.74%,NNAT;SOX4;DOC2B;TCF7L2;ADCYAP1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.25709317908869067,-0.9001876148522923,0.5942028985507246,0.8231312866740671,1.0,13/33,26.29%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.304628907287136,0.8999379548657405,0.6033057851239669,0.9701289553634526,1.0,6/22,18.34%,LTB4R2;GRM3;CACNA1D;GABBR2;GNAI3;PALM
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3281954193889327,0.8997846641289493,0.6120401337792643,0.9697169920578826,1.0,4/17,12.62%,SGTA;EMC6;EMC2;GET3
prerank,positive regulation of filopodium assembly (GO:0051491),0.30311395929147045,0.8997145950868635,0.6278688524590164,0.9690889970904528,1.0,3/24,3.96%,AGRN;FSCN1;TENM1
prerank,positive regulation of ossification (GO:0045778),0.27427102715207485,0.899554096075525,0.6134585289514867,0.9686982075319385,1.0,6/39,9.64%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,phospholipid metabolic process (GO:0006644),0.24558228774457366,0.899319760507477,0.6322674418604651,0.9684518687291374,1.0,24/71,26.06%,PLA2G3;PLCD1;PLA2G4C;PNPLA3;LPCAT1;TNFAIP8L3;ABHD12;ENPP2;AGPAT1;ABCA2;FITM2;PLPPR4;ANGPTL3;PLCB2;PLA2G15;PLPP1;PIP4P1;PIP4K2B;GPAT2;PIP4K2A;PLPP2;PLPPR1;PLA2G4A;SMPD2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.27053783607625137,-0.8992861750577327,0.6191646191646192,0.8247547604451291,1.0,10/29,18.65%,CUL4A;CHD1L;UBC;UBA52;RAD23B;CCNH;RPA1;MNAT1;RPA2;XPC
prerank,response to estradiol (GO:0032355),0.2865092734174899,0.8988719600798424,0.6131498470948012,0.9687930790400762,1.0,7/31,12.73%,GGT7;GGT5;SOCS2;TGFB1;WNT8B;SFRP1;CRHBP
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.21192560984641912,-0.898670822463909,0.7108843537414966,0.8256743588084405,1.0,27/83,23.69%,PCM1;CDK5RAP2;PRKACA;TUBA4A;CEP250;YWHAG;HMMR;HAUS2;CEP164;MAPRE1;CENPJ;ATF5;CDK1;HAUS8;NPM1;PLK1;KCNH5;DCTN2;ODF2;TPX2;PAFAH1B1;AKAP9;CEP78;OFD1;TUBB4B;GTSE1;NDE1
prerank,glucan biosynthetic process (GO:0009250),-0.3448100356662227,-0.8984882498217602,0.5875831485587583,0.8249712533642144,1.0,6/12,30.81%,GYG1;PPP1R3C;PGM2L1;PER2;GBE1;GYS1
prerank,glycogen biosynthetic process (GO:0005978),-0.3448100356662227,-0.8984882498217602,0.5875831485587583,0.8249712533642144,1.0,6/12,30.81%,GYG1;PPP1R3C;PGM2L1;PER2;GBE1;GYS1
prerank,histone H2A monoubiquitination (GO:0035518),0.3236774671573702,0.8982612115217612,0.5910652920962199,0.9695689834925205,1.0,5/17,14.08%,PCGF6;KDM2B;RNF168;DDB2;RNF2
prerank,T cell differentiation in thymus (GO:0033077),0.35125496527559386,0.8980815462412328,0.6105263157894737,0.9692292963556646,1.0,4/14,13.67%,MR1;RIPK3;ZFP36L2;CCR6
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.19973771355772016,0.8976117581146035,0.7726763717805151,0.9696341653073608,1.0,89/366,23.78%,ZFHX3;NUCKS1;SCRT2;MAGED1;CTR9;DRAP1;DENND4A;LDB1;PQBP1;FUS;WWTR1;ESRRG;NR1I2;SOX21;HIC1;SKOR1;RELA;PPARGC1A;DDX25;NSD1;UBE2V1;SOX4;HOXB7;E2F1;MEF2C;ZNF35;ZNF205;TGFBR1;OGG1;APBB1;POFUT1;FOXC1;SNAI2;SPIN1;SLC39A8;MLLT6;ACVR1B;WWC1;THAP1;MLF2;TFEB;PLAG1;TOM1L1;CYFIP1;LMX1B;SPTY2D1;INSR;APBB3;CCAR2;EDF1;REST;TCF3;TCF7L1;RBM3;SUFU;MAPKAPK5;GEMIN5;PAK6;BACH1;ESCO1;ENG;PPP2R1A;BTG1;HMG20A;PHF1;ELAVL2;ATXN2;GCFC2;DVL2;REXO4;RORA;FBXO5;MED23;PRMT5;ZFAT;TEAD2;ING2;ZNF628;NFYB;SKOR2;SSBP2;TULP3;YAF2;SOX13;ACTR5;HES6;NAB2;SMARCA2;MAFB
prerank,placenta development (GO:0001890),-0.3382046356169555,-0.8974270704566805,0.5961995249406176,0.8268784863784983,1.0,4/12,16.06%,ADAM19;PPARG;E2F8;E2F7
prerank,cellular response to cAMP (GO:0071320),0.2824223409888143,0.8973922735018719,0.6029173419773096,0.969408901157381,1.0,5/30,12.73%,HCN1;RAPGEF3;PKD2;CFTR;CRHBP
prerank,visual perception (GO:0007601),0.2369631285518384,0.8973591102511205,0.6845070422535211,0.9687027074446921,1.0,8/84,8.46%,GUCY2F;ROM1;RDH10;COL2A1;CRYGN;CNGB1;CRYBA4;CABP1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3294019510447365,0.8972319359887243,0.5952,0.9682303328567289,1.0,6/17,20.19%,ADTRP;AR;BMP4;ATP1A3;ATP1A1;ABHD2
prerank,positive regulation of cation channel activity (GO:2001259),0.2741611393078148,0.897166421156832,0.6122137404580152,0.9676061433589331,1.0,11/40,24.52%,SHANK3;PKD2;ACTN2;GSTO1;HAP1;EPHB2;GAL;ANK2;CTSS;LRRC55;ANK3
prerank,stress granule assembly (GO:0034063),-0.2889520874858281,-0.896737154498182,0.6167979002624672,0.8279729925771924,1.0,4/20,10.21%,RPS23;UBAP2L;DDX6;EIF2S1
prerank,lytic vacuole organization (GO:0080171),-0.2578311417179817,-0.8964883038862224,0.6601123595505618,0.8279454187428228,1.0,10/32,16.03%,TPCN2;NAGPA;HPS1;CLN5;MBTPS1;GNPTAB;AKTIP;LRRK2;GAA;CLN3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2488927337326184,0.8963646140666236,0.6454545454545455,0.9688404974108741,1.0,24/68,27.54%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;MAZ;CPSF3;POLR1E;CSTF1;NUDT21;SETX;POLR1F;SNRPD3;SSU72;PRMT5;SCAF8;POLR1G;GTF2H3;POLR3K;ERCC2;TAF1A;POLR1A;PAPOLA;GTF2H1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.253975504284599,-0.8961176413866326,0.6464088397790055,0.8282791003232646,1.0,8/33,16.52%,IGF1;BCL2L1;TFRC;ACAA2;PSMD10;GPX1;MUL1;SLC35F6
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3324321967604368,-0.8961102089637234,0.60381861575179,0.8277260520187487,1.0,6/13,26.55%,CIAO2A;NFU1;CIAO2B;CIAO1;LTO1;GLRX5
prerank,COPII-coated vesicle budding (GO:0090114),0.2479474287948892,0.8960353452839543,0.6433770014556041,0.9688929749415105,1.0,17/68,17.91%,RAB1B;CNIH2;SEC16B;TMED2;AREG;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;MIA3;SEC24C;SCAP;PREB
prerank,actin filament-based transport (GO:0099515),-0.2876534468549974,-0.896011183092986,0.6144859813084113,0.8273930497325803,1.0,3/21,6.67%,MYO5A;MYO1F;MYO15A
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3502874372171835,0.8959703453676953,0.6120689655172413,0.968258121251664,1.0,5/13,21.56%,PKD2;PKD1;SUFU;YWHAB;LATS1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.21165256793708578,-0.8958979343422758,0.7126865671641791,0.8270756879992608,1.0,31/83,26.77%,CDK6;CUL3;CDK17;CUL4A;PCNA;GPR132;CDC34;CCND1;CDKN2C;HINFP;CCNH;CDKN3;TYMS;RB1;CDT1;MNAT1;TRIM71;CDK14;CDC25A;KLF11;CDKN2A;ACVR1;CUL5;DHFR;RCC1;CDC45;PIM2;USP26;NPAT;POLE;E2F3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.27664675630892166,-0.8958895451964554,0.6162162162162163,0.8265236810344505,1.0,9/25,20.53%,P2RX4;CD36;SMAD3;IL1B;TNF;TLR4;KLF2;MMP8;KLF4
prerank,regulation of DNA metabolic process (GO:0051052),0.26356438717336733,0.8954094843145873,0.6127080181543116,0.9689115935544292,1.0,15/44,24.50%,NUCKS1;UBE2V1;KDM1B;UBE2N;SUB1;TOM1L1;UPF1;WRNIP1;SMG1;ALYREF;XRCC5;GRHL2;MPHOSPH8;HDAC8;KPNA1
prerank,histone exchange (GO:0043486),0.2723437296965635,0.8953789470257421,0.6347687400318979,0.9681975800027396,1.0,9/37,20.30%,CENPP;ZNHIT1;VPS72;RNF8;DMAP1;SPTY2D1;CENPN;CENPS;CENPC
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3294695702739443,0.894948404630096,0.6157718120805369,0.9686167736133343,1.0,3/16,8.55%,PIGQ;PIGB;PIGP
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.28500484325820385,-0.8947053966463714,0.6237373737373737,0.8286759505182021,1.0,8/22,17.89%,CIAPIN1;NUBP1;CIAO2A;IBA57;NFU1;CIAO2B;CIAO1;LYRM4
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3664663667036998,0.8945246320764443,0.6045751633986928,0.968916487878967,1.0,1/11,2.27%,NOS1AP
prerank,regulation of exosomal secretion (GO:1903541),-0.28814625080140605,-0.8944386666347147,0.6253229974160207,0.8287322713650515,1.0,6/19,20.12%,SDCBP;RAB7A;PDCD6IP;STAM;SDC1;SDC4
prerank,T cell proliferation (GO:0042098),0.3516985296279356,0.89439827437581,0.6017241379310345,0.9684635470990841,1.0,3/13,11.30%,CADM1;PIK3CG;CRTAM
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2585881169858058,-0.8941437155588627,0.6223404255319149,0.8288452714923439,1.0,9/31,21.32%,RTEL1;PKIB;NBN;PRKCQ;HNRNPA2B1;MAP2K7;SLX4;HNRNPD;NAF1
prerank,endothelial cell development (GO:0001885),0.2971234159582042,0.8938782431965835,0.6441515650741351,0.9690058926390374,1.0,8/25,21.68%,ROBO4;MARVELD2;RAPGEF3;ICAM1;COL15A1;COL18A1;RDX;PPP1R16B
prerank,microtubule-based transport (GO:0099111),0.35444599900692025,0.8938232627593041,0.6040268456375839,0.9683372267922773,1.0,4/13,15.29%,ROPN1L;SPA17;SPEF2;DNAAF2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.33767013796965095,0.893744672190589,0.5884413309982487,0.967743655994712,1.0,6/15,24.43%,JMJD8;ITGA5;FGF2;SMAD1;PDPK1;PKM
prerank,regulation of protein phosphorylation (GO:0001932),0.20474027545398285,0.8936345533652363,0.7449101796407186,0.9672282112117403,1.0,57/256,20.43%,FGF10;ANKRD54;ADTRP;FGF16;PLXNB2;FGF9;C3;WWTR1;PAK1;NTRK1;ROPN1;FLT4;ROPN1L;CARD14;NSD1;RARRES2;PRNP;FGF7;NTRK3;CACTIN;AKAP8L;DAB2IP;LIMK2;CCND3;BMP4;ERBB4;SH3GL2;TGFB1;PRKN;FGF2;EFNA1;AKAP8;P2RY1;TEK;RALBP1;FLCN;THPO;INSR;EPHB2;BRD4;NTRK2;CADM4;MAPK3;TWF1;HRAS;PTK2;ENG;PTPN13;CHRNA7;PIN1;HDAC3;RSPO1;DVL2;ERP29;PPIL4;IL34;ARRB1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.20662895054746144,0.8935328637062344,0.7361963190184049,0.9666949762383508,1.0,66/248,22.05%,FGF10;HHEX;TLE3;UBE2B;PSMB1;TLE2;WWTR1;SOX4;IGFBP6;PTPRU;PTPRO;TMEM198;STK11;ANKRD6;IGFBP2;PTK7;PSMF1;BTRC;DAB2IP;PRICKLE1;PSMA1;GPC5;TCF7L2;PSMD7;PPM1A;FAM53B;TGFB1;PRKN;EMD;TPBG;SNAI2;PSMA8;CTNND2;PPM1N;PSME3;SFRP1;PSMD14;AMER2;LRRK1;PSMC4;SDHAF2;TMEM9;CCAR2;APC2;PRDM15;AMER3;CSNK1G3;FRMD8;PSMB4;PIN1;RSPO1;WNK1;DVL2;RBMS3;UBAC2;PSME1;CYLD;GLI3;PSMD2;PSMD4;BICC1;LATS1;FRZB;PSMD8;AXIN1;SFRP2
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.34181140151488015,0.8934023168440591,0.6075533661740559,0.9654816646483654,1.0,10/16,30.39%,CLASP2;ITGB1BP1;APOD;RCC2;PHLDB2;DMTN;PTEN;DLC1;ARHGAP6;FAM107A
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.34181140151488015,0.8934023168440591,0.6075533661740559,0.9654816646483654,1.0,10/16,30.39%,CLASP2;ITGB1BP1;APOD;RCC2;PHLDB2;DMTN;PTEN;DLC1;ARHGAP6;FAM107A
prerank,regulation of JUN kinase activity (GO:0043506),-0.25409592720925717,-0.8929384675395665,0.6342105263157894,0.8310907141488278,1.0,7/33,16.03%,SASH1;PTPN22;DVL3;TAOK3;MAP3K11;TNF;ARHGEF5
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3083204089349036,-0.8927261153336867,0.592255125284738,0.8309770986524323,1.0,2/15,1.14%,IGF1;BCL2L1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.3206487090946176,-0.8926339931776689,0.6235011990407674,0.8306200903016391,1.0,6/15,15.39%,P2RX4;MET;THBS1;FGF1;NOTCH1;HSPB1
prerank,response to axon injury (GO:0048678),0.33134189821282334,0.8923791474070101,0.616580310880829,0.9673204918918434,1.0,6/18,19.69%,P2RY12;RTN4RL1;APOD;SARM1;MTR;NREP
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3440428914625867,0.8923435722003038,0.6275510204081632,0.9666281854774565,1.0,2/14,3.60%,CD80;IL17F
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.3063182798269998,-0.8923361845831651,0.6180904522613065,0.830702228761647,1.0,3/17,2.93%,NRP1;IGF1;DOCK7
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3500335974805453,0.8922006901847579,0.6,0.9661820627295029,1.0,4/13,19.11%,HEXB;ARSB;VCAN;DCN
prerank,RNA metabolic process (GO:0016070),0.22157037755239592,0.8921424001792395,0.7024456521739131,0.9655531790610713,1.0,24/127,16.30%,POLR2L;ADARB2;POLR2F;RNASE1;HNRNPH1;LSM1;PTBP1;ADAR;RBM5;GTF2F1;RNASEL;MPHOSPH10;DROSHA;POLR2G;LSM8;SND1;TBRG4;RBFOX2;AGO4;NOVA1;DDX39B;HNRNPA1;RBM3;SETX
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2686115105824518,-0.8921406679335637,0.640506329113924,0.830591945359295,1.0,7/28,9.91%,BCL2;BAX;ERN1;CEBPB;ITPR1;BAG6;DNAJC10
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.2994476157197993,0.8920262439229678,0.6365105008077544,0.96505946401659,1.0,4/23,10.75%,LBX2;SIX4;BMP4;FGF2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.36268909318874304,-0.8914622712268236,0.6101321585903083,0.8315246491077107,1.0,4/10,27.33%,OS9;INSIG1;UBE2J1;YOD1
prerank,melanosome organization (GO:0032438),0.2913770881036629,0.891357103028405,0.6091205211726385,0.965959925070062,1.0,4/26,10.58%,BLOC1S2;ABCB6;SNAPIN;RAB38
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2519303289585092,0.8913428054221418,0.6676342525399129,0.9652224150486809,1.0,14/59,17.88%,HOGA1;GATM;CYP39A1;CBR4;OXSM;ELOVL4;CYP27A1;ACLY;NDUFAB1;ACSF3;AMACR;LIPC;HSD17B10;XBP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.22254018770955453,-0.8912717196300396,0.6812865497076024,0.8313678223967204,1.0,16/59,20.14%,MARK2;TBK1;LMTK2;TAF1;DYRK1A;CIT;CAMK2D;HIPK1;CAD;CDK1;LRRK2;NLK;MAPK8;HIPK2;ACVR1;CDC42BPG
prerank,regulation of Notch signaling pathway (GO:0008593),0.2385097069703722,0.8911859519065868,0.6768802228412256,0.9648563418589827,1.0,15/76,13.76%,ENHO;TCIM;YJEFN3;PRKCI;TSPAN15;PRAG1;EGFL7;BMP2K;POFUT1;HEY1;MAML3;ITGB1BP1;AAK1;ARRDC1;BEND6
prerank,negative regulation of protein catabolic process (GO:0042177),-0.24189855640116523,-0.8907556158447352,0.6676300578034682,0.8319412243126394,1.0,14/40,22.14%,RIC1;CTSA;MAD2L2;AGAP2;MAD2L1;TIMP4;EGFR;RGP1;FLNA;RILP;FMN2;TIMP1;SIRT2;ADGRB1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.36371363065734635,-0.8905849399608525,0.5899280575539568,0.8317758658673992,1.0,3/10,12.10%,ESR1;PSMC6;ATF7IP
prerank,melanocyte differentiation (GO:0030318),0.36642235252789507,0.8902511899908112,0.6103448275862069,0.9664430958947424,1.0,3/11,16.30%,SLC24A5;MEF2C;LRMDA
prerank,T cell migration (GO:0072678),-0.3348774634181495,-0.8901346047936257,0.6048780487804878,0.8322411005938704,1.0,3/13,6.00%,CXCL16;MSN;GPR183
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3452061233148985,0.8900645112801706,0.5900514579759862,0.9661224361148201,1.0,5/13,18.34%,LTB4R2;GRM3;GABBR2;GNAI3;PALM
prerank,striated muscle tissue development (GO:0014706),0.289368527203831,0.889930112612526,0.6391231028667791,0.9656846877653856,1.0,11/29,23.99%,SIX4;MEF2C;MYL6;TBX2;SGCZ;SGCG;SGCD;IGSF8;CFLAR;RBP4;POPDC3
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.18216522384820819,-0.8898514820492386,0.851063829787234,0.8323189113266125,1.0,41/190,16.87%,PPP2R5C;BCL2;BCL2L1;LIMD1;XDH;DLG5;MCL1;CGNL1;ESR1;THBS1;UACA;TNIP3;RIPK1;CDC34;ITPR1;CAV1;PLAUR;LYN;CIT;CIB1;DAG1;BANK1;CCDC22;RNF157;DRD2;ZC3H12A;STAT1;C1QTNF3;AJUBA;PSMD10;CCN3;RACK1;INPP5K;DUSP1;DEPTOR;SFRP5;EPHA2;PDE2A;MUL1;PEBP1;NOP53
prerank,positive regulation of ATPase activity (GO:0032781),0.26809547305067527,0.8896336636149952,0.6371814092953523,0.965663699112314,1.0,5/41,8.58%,FGF10;ATP1B1;MYBPC3;ATP1B3;DNAL4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.26328617636958185,-0.8894417906090576,0.6256684491978609,0.8326893176795855,1.0,7/28,12.49%,DTX3L;SMCHD1;CYREN;HSF1;MAD2L2;SHLD1;PARP9
prerank,protein phosphorylation (GO:0006468),0.19455159338520367,0.8893923981654703,0.8066298342541437,0.9654720141350869,1.0,122/479,22.52%,CDK7;ABI3;STRADB;DCLK3;MERTK;MATK;CDK15;NIM1K;TXK;STK26;PKN1;PAK1;NTRK1;FLT4;PNCK;COPS8;STK16;STK11;PRKCZ;MAPK15;CTBP1;TRIB1;RYK;TRIB2;GTF2H4;DYRK1B;RPS6KB1;PRKCI;MAP3K10;CDC42BPA;RIPK3;TGFBR3;TGFBR1;NRBP2;PRAG1;DAB2IP;LIMK2;LIMK1;BMP2K;BMP4;STK36;DGKQ;PRKCA;EPHA1;ERBB4;CDKL5;PRKD2;MAP4K4;RNASEL;TGFB1;NEK4;NEK1;AAK1;PRDX4;BTK;STK39;VRK2;CAMKV;MINK1;STK25;ACVR1B;MAP3K7;PAK5;PKD1;STK32B;PRKG1;PDGFB;COQ8A;TEK;EPHA4;MAP3K13;GLYCTK;MAPK10;AMHR2;INSR;EPHB2;NTRK2;EIF2AK4;ERG;MAPK3;PRKD1;DMPK;PTK2;PRKCG;CSNK1G3;MAPKAPK5;PAK6;PLK2;CDK10;ROCK1;AATK;TAOK1;FLT3;CDC42BPB;TLR3;SMG1;AKT3;MAST2;PLK4;FES;MAP4K2;STRADA;WNK1;BMPR1B;PDGFRB;ACVR1C;CDKL1;SBK1;SMAD2;PDPK1;PDK1;NUAK1;ULK2;TOP1;LATS1;SIK3;LIPE;CDK4;CLK3;ULK1;GTF2H3;TLK2
prerank,regulation of cell morphogenesis (GO:0022604),0.28104432061040063,0.8890057071306534,0.6337115072933549,0.9656173839857614,1.0,8/30,19.40%,BCL9L;CFL1;CAMSAP1;FITM2;NTNG2;NTNG1;ZMYM6;ZMYM3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24639549445617454,0.8886929621335528,0.6623748211731044,0.9656028367689425,1.0,20/60,25.50%,WRAP53;SMOC2;MAPK15;PRKD2;FGF2;CCT4;PDGFB;HNRNPA1;MAPK3;MAPKAPK5;PDGFRB;HSP90AB1;CCT7;XRCC5;GRHL2;RFC4;PARM1;TNKS2;MAPK1;ACD
prerank,positive regulation of macroautophagy (GO:0016239),-0.23064706923665496,-0.8885026945221336,0.6676557863501483,0.8343135962295047,1.0,15/48,18.48%,VPS13D;PAFAH1B2;TBK1;SH3GLB1;UVRAG;SMCR8;KDR;LARP1;RALB;HSPB8;OPTN;WAC;SESN2;RAB3GAP2;SPTLC2
prerank,telomere maintenance via telomerase (GO:0007004),-0.2679028337466264,-0.8883414501055645,0.6301369863013698,0.8341481131206044,1.0,13/28,26.29%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1
prerank,RNA methylation (GO:0001510),0.25071047192864976,0.8881204091247729,0.65625,0.9662664208535732,1.0,13/60,14.73%,METTL2A;METTL2B;TRMT44;METTL1;TRMT61B;DIMT1;MEPCE;FTSJ1;METTL16;NOP2;METTL5;CBLL1;FBLL1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3558241721276419,0.8880931417844297,0.5930232558139535,0.9655567310159373,1.0,5/12,19.74%,DCK;TK1;TK2;DHODH;UCK1
prerank,presynaptic endocytosis (GO:0140238),-0.2821141623366994,-0.8879675812418649,0.6279761904761905,0.8343891757127933,1.0,4/24,10.66%,SYNJ2;FCHO2;AMPH;SNCG
prerank,glial cell development (GO:0021782),0.29551450759505926,0.8872907439298302,0.6295081967213115,0.9667711431573794,1.0,6/25,15.19%,TPPP;SOX10;SOX4;EIF2B3;MYRF;EIF2B1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2973387958648245,0.8872709630106915,0.643879173290938,0.9660381848372915,1.0,13/26,30.39%,FGF10;RPTOR;CCND3;MTBP;CDK10;KMT2E;RDX;UBE2E2;DDX3X;ADAMTS1;PLCB1;TFDP1;LSM10
prerank,regulation of complement activation (GO:0030449),0.26225959700705387,0.886997613970064,0.6558139534883721,0.9659627707568562,1.0,10/40,21.60%,C3;C9;CLU;CFH;CD81;C8G;VTN;CR1L;CR2;C5AR2
prerank,regulation of mononuclear cell migration (GO:0071675),-0.27871137723602696,-0.8869746778481512,0.6347607052896725,0.8361015682387546,1.0,6/23,15.14%,MSN;THBS1;LYN;BMP5;CXCL17;TNF
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3440031287760754,-0.8868359316037898,0.5951807228915663,0.8358660147676907,1.0,7/11,38.70%,CTNNB1;WNT5A;LRP6;FZD1;LMX1A;WNT2;NR4A2
prerank,positive regulation of immune system process (GO:0002684),-0.3081975669503115,-0.8866275289045158,0.5966981132075472,0.8357868110890924,1.0,2/16,7.33%,IL15;ANXA1
prerank,replication fork processing (GO:0031297),-0.2455528595090814,-0.8866116474673024,0.6422535211267606,0.8352530260339068,1.0,12/38,21.86%,ETAA1;PCNA;RTEL1;ZRANB3;EME1;MMS22L;CENPX;FANCM;CDK9;ZGRF1;FBH1;BOD1L1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3711246644594584,0.8861625638009089,0.6203389830508474,0.9672761012164057,1.0,2/11,7.47%,SLC25A4;RIPK3
prerank,positive regulation of cell growth (GO:0030307),0.22676928475203076,0.8860136863877187,0.6842818428184282,0.9668438025797326,1.0,15/96,11.54%,KLHL22;SYT4;SEMA7A;RPTOR;SYT1;HDGFL2;LGI1;IL2;TGFBR1;LIMK1;TWF2;CPNE6;CDKL5;RIMS1;SFRP1
prerank,histone deubiquitination (GO:0016578),-0.2943434288839281,-0.8852906673872822,0.6272040302267002,0.8377298808278895,1.0,9/18,33.34%,ATXN7;TRRAP;UIMC1;BRCC3;USP15;ATXN7L3;EPOP;TAF10;USP3
prerank,negative regulation of cell aging (GO:0090344),-0.30548804925754675,-0.8852255603817085,0.6163069544364509,0.8373092474933873,1.0,6/16,27.88%,CDK6;TERF2;HMGA2;TWIST1;TERT;SLC30A10
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.2587913438868809,0.8851455533247315,0.6681887366818874,0.968175735907418,1.0,9/46,14.38%,YWHAE;CPSF6;TCF7L2;RAPGEF3;TGFB1;EMD;NEDD4;DMAP1;IPO5
prerank,neural crest cell migration (GO:0001755),0.27088705365971916,0.8849101678181133,0.6445131375579598,0.9680013436757343,1.0,9/36,16.54%,SEMA7A;SOX10;SEMA6C;SEMA6B;SEMA3D;ERBB4;SEMA4F;SEMA4B;SEMA3C
prerank,regulation of coagulation (GO:0050818),0.3620323382581723,0.8844183309068194,0.5967153284671532,0.968384803491457,1.0,2/11,14.93%,HS3ST5;EPHB2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.23396818545609777,0.8833357970325666,0.6806596701649176,0.9702989714897979,1.0,18/80,16.03%,PLXNB2;RELA;SOX4;IL6;CLU;CIRBP;RPS6KB1;LRRTM3;EIF6;EFNA1;CASP3;METTL5;PRR16;NSMAF;EPHA4;ABCA2;RBM3;IFNGR1
prerank,regulated exocytosis (GO:0045055),0.21310542516351144,0.882578405707924,0.737171464330413,0.9714193074467361,1.0,30/173,15.49%,SNAP25;SYT4;RAB3A;PCDH7;SYTL4;SYT13;SYT1;SNAPIN;TEX264;RAB26;RARRES2;SYT6;CLU;SYNGR3;MANF;OTOF;ACTN2;TGFB1;ISLR;RIMS1;CPLX2;SYNGR1;SCG3;CRHBP;PDGFB;LY6G6F;SCCPDH;STXBP2;ENDOD1;APLP2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2831615438116451,0.8823436386240141,0.6419939577039275,0.9712127871154302,1.0,6/30,18.82%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,regulation of lamellipodium assembly (GO:0010591),0.27444438986089303,0.8821323521356562,0.6384976525821596,0.9709852907776668,1.0,11/34,27.09%,ABI3;FSCN1;NCKAP1;TWF2;CYFIP1;TWF1;WASF2;CDC42;CLRN1;BRK1;DMTN
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.1865435339151275,-0.8816995387689133,0.8201754385964912,0.8447474957157644,1.0,25/151,14.62%,HACD4;APOE;B4GALT5;ACER3;SGPL1;MOCS2;PCYT1A;MGST3;MOCS1;PRKD3;GSTA3;SGPP1;GSTO2;RHD;PCTP;LCMT2;ALAS1;SPTSSB;GSTZ1;GSTM1;PEMT;GSTM5;SPHK2;STARD10;PAM
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.3084025758621447,-0.8814889311343637,0.6137440758293838,0.8446485333316518,1.0,3/15,7.53%,RNF213;SPEF1;ZNRF3
prerank,stem cell differentiation (GO:0048863),0.26920086551652556,0.8812446822848545,0.6259780907668232,0.9723935495682179,1.0,8/39,15.54%,NELFB;SOX21;MEF2C;SETD6;METTL5;SFRP1;BATF;WNT7A
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.24808836247093397,-0.8810161306039421,0.6684491978609626,0.84511077952455,1.0,9/37,16.99%,CUL4A;PCNA;CHD1L;UBC;UBA52;POLD4;RPA1;NTHL1;RPA2
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.2525325939133499,-0.8809348319534065,0.6472222222222223,0.8447243850994578,1.0,6/32,10.27%,EIF2A;TCOF1;PICALM;RPL10;TMED10;PGAM1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.29446805608953425,-0.8809228295587401,0.6529562982005142,0.8441786942518762,1.0,7/18,19.52%,LYN;F7;PTN;PTK2B;ADAM17;SLC8B1;MTUS1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.2987754097414223,-0.8808514553383954,0.6163366336633663,0.8437748889936267,1.0,9/17,27.93%,PTPN22;BCL3;ANXA1;ANXA4;CD33;KLF4;TMSB4X;TLR9;SSC5D
prerank,peripheral nervous system development (GO:0007422),0.29712879052812136,0.880638077222796,0.6567656765676567,0.9731220351381347,1.0,4/23,10.12%,SOX10;GPC1;NFASC;ASIC2
prerank,membrane lipid biosynthetic process (GO:0046467),-0.2212505947013976,-0.8801816044867988,0.7259475218658892,0.8447264231481443,1.0,16/58,22.51%,HACD4;ACER3;SGPL1;PRKD3;ST8SIA6;SGPP1;SPTSSB;SPHK2;CERS2;SPTLC2;HACD1;HACD2;ALDH3A2;SPTLC3;VAPB;ELOVL2
prerank,negative regulation of chemotaxis (GO:0050922),0.27924079485888165,0.8801323740430057,0.6478405315614618,0.9735793151638005,1.0,8/31,16.54%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;PTPN2;SEMA4B;SEMA3C
prerank,adherens junction organization (GO:0034332),0.25733469307409695,0.8800846761335734,0.671850699844479,0.9729390403615663,1.0,10/48,16.23%,ANG;DCHS1;CADM1;INAVA;CDH18;NECTIN3;CDH4;CADM3;JAM3;CADM2
prerank,response to ketone (GO:1901654),0.30152853432683563,0.8798458879436476,0.6416938110749185,0.9727422836482562,1.0,5/24,9.35%,WBP2;UBE3A;ABCB4;TGFBR3;TGFB1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2324387707635326,0.8794392836644599,0.6863033873343152,0.9729437138706765,1.0,14/78,10.94%,RNF19A;SGTA;CLU;NUB1;TRIB1;TRIB2;RNF180;PRICKLE1;PLK3;PRKN;SUMO2;NFE2L2;HERPUD1;ZYG11B
prerank,stem cell development (GO:0048864),-0.2970041351074497,-0.8783901810775862,0.6194029850746269,0.8482313958702609,1.0,5/16,15.06%,PTPRC;SOX11;TCOF1;KBTBD8;CDH2
prerank,copper ion homeostasis (GO:0055070),0.3242323093897942,0.8781204550500974,0.6252072968490879,0.9753937221943585,1.0,4/17,6.64%,ABCB6;PRNP;SLC31A1;COMMD1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.22727302665666235,0.8779889009693006,0.6962552011095701,0.9749520381761768,1.0,20/91,18.53%,LGI3;TSC2;ATP9A;RAB3A;SYT1;RAB26;PLA2G3;RAB8A;RIT2;INPP5F;RAB5A;RAB3D;CPLX2;BET1L;RAB12;HAP1;MAPK3;CD22;STXBP5;FES
prerank,regulation of fibroblast migration (GO:0010762),-0.2882311264357824,-0.8777561256401726,0.640506329113924,0.8491285690717425,1.0,4/20,7.15%,PRKCE;CORO1C;THBS1;GNA12
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.317445691849068,0.8769135840858775,0.6369982547993019,0.9768329205919726,1.0,4/18,9.35%,FSCN1;IL6;CLASP2;TGFB1
prerank,regulation of primary metabolic process (GO:0080090),-0.19179270881381538,-0.8768628757614552,0.8138528138528138,0.8505847834419475,1.0,38/126,24.40%,APOE;PSMA6;PSAP;SIN3B;PPARG;PSMB2;PRKAB1;PSME2;PPARD;NCOA1;PSMD11;SP1;PSMC6;LDLR;TBL1X;PSMA3;IDI1;PSMD10;PSMB5;PRKAB2;ACACA;ODC1;GPAM;SC5D;GGPS1;CERS2;HELZ2;PSMD5;PSMD1;IRS2;NCOR1;MVK;ID2;TBL1XR1;PMVK;PSMA7;PSMB7;FGFR4
prerank,negative regulation of lyase activity (GO:0051350),-0.2979002456765757,-0.8764232218454635,0.6571428571428571,0.8509544294489592,1.0,7/16,19.72%,CCR2;EDNRB;DRD2;PHPT1;MTRR;AKAP5;DRD3
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.20507981176591275,-0.8761875838919735,0.7163636363636363,0.850912041438547,1.0,14/88,10.42%,APOE;NRP1;NRP2;ALOX5;XDH;HMGB2;AIMP1;PROX1;THBS1;AGGF1;CAV1;HIF1A;STAT1;EGR3
prerank,negative regulation of receptor internalization (GO:0002091),0.34943772036519233,0.8759392863022814,0.6378091872791519,0.9784341951580221,1.0,2/12,1.59%,RIN3;ANKRD13D
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.344334173593738,0.8758291502373,0.6605960264900662,0.9779352529847765,1.0,2/13,3.97%,RPP40;NOP9
prerank,nuclear transport (GO:0051169),-0.3054108545278498,-0.8756559659079084,0.6439024390243903,0.8514990680883454,1.0,6/16,14.13%,RSRC1;XPO1;NUTF2;BANF1;NXT1;NPM1
prerank,central nervous system neuron development (GO:0021954),-0.3038226798170185,-0.875625998132228,0.671604938271605,0.8509992161535043,1.0,2/15,2.62%,B4GALT5;ATP7A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.20926555978684885,-0.875393076779527,0.7439024390243902,0.850960575541558,1.0,22/72,23.05%,SP100;CNOT9;BAX;PCNA;BCL3;RPS6KA6;NBN;PIDD1;EP300;PAXIP1;CDK1;KAT5;E2F8;E2F7;SESN2;HIPK2;RGCC;RPL26;CDC25C;CNOT6L;GTSE1;CCNB1
prerank,rRNA catabolic process (GO:0016075),-0.30093484349948324,-0.8753619266813563,0.6237113402061856,0.850462685923024,1.0,6/16,25.45%,EXOSC8;EXOSC10;EXOSC9;TRIR;EXOSC7;ERN2
prerank,Ras protein signal transduction (GO:0007265),0.21482069350214508,0.8750551841349915,0.7339449541284404,0.9790241772005868,1.0,36/137,21.40%,KSR2;EPS8L3;ARHGDIG;SGSM3;RGL2;NCKAP1;CDC42EP5;ADRA2A;USP50;CTNNAL1;RIT2;LIMK1;ARHGDIA;RAPGEF3;ARHGAP5;FGF2;GDI1;CFL1;FARP2;HACE1;CYFIP1;EPS8L2;PRKD1;HRAS;MAPKAPK5;PLK2;RRAS2;ROCK1;SETDB1;RIPOR1;CDC42EP4;CDC42EP1;ARHGAP1;ARHGAP4;RAP2C;SHC3
prerank,synaptic vesicle membrane organization (GO:0048499),0.3152025967904043,0.8748215586167958,0.6325203252032521,0.9787984405906002,1.0,3/17,12.13%,SNAP25;STX3;SYNGR1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.2040057294795926,-0.8747656177015332,0.7891156462585034,0.8511885232471134,1.0,21/86,19.15%,PSMA6;LIMD1;ATF3;PSMB2;PSME2;VHL;PSMD11;PSMC6;UBC;HIF1A;PSMA3;UBA52;EP300;PSMD10;PSMB5;MAPK7;HMOX1;KLF2;DNAJB1;PSMD5;PSMD1
prerank,regulation of histone modification (GO:0031056),0.3469636062125042,0.8747219924931485,0.6523887973640856,0.9782669255056788,1.0,4/13,13.86%,AKAP8L;UBE2N;AKAP8;FLCN
prerank,regulation of autophagosome assembly (GO:2000785),-0.2520123233498958,-0.8746900456258907,0.7005208333333334,0.8508025986718728,1.0,10/33,16.92%,CHMP4B;CHMP4A;SH3GLB1;SMCR8;MTM1;LRRK2;RALB;ADPRH;MTMR3;RAB3GAP2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.33584204693558084,0.8743017614632165,0.6550522648083623,0.9784811637412371,1.0,2/15,5.75%,F3;NTRK3
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.3002571125534449,-0.8742759593837605,0.6456310679611651,0.8511655001915068,1.0,4/16,15.14%,APOE;HDAC1;LRP1;TNF
prerank,folic acid metabolic process (GO:0046655),0.316405598677971,0.8741227277388687,0.643312101910828,0.9781734758251031,1.0,5/18,14.50%,FPGS;MTHFD1L;MTHFD2L;ALDH1L1;SLC19A1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.2960424508926585,0.8735656227175878,0.6508474576271186,0.9787305768116542,1.0,7/24,17.19%,THY1;MAPRE2;MAP4K4;IQSEC1;SFRP1;TEK;ROCK1
prerank,protein lipidation (GO:0006497),0.24511110920426252,0.8733672083592303,0.6749271137026239,0.9784015543374255,1.0,23/59,28.05%,PIGQ;ZDHHC22;PIGB;ZDHHC8;PIGP;MPPE1;ZDHHC1;ZDHHC2;ZDHHC23;DPM3;SELENOK;PGAP2;ZDHHC15;GPLD1;WDR45B;PGAP3;GLUL;WIPI2;ZDHHC12;DPM1;ZDHHC5;DPM2;PIGZ
prerank,COPII vesicle coating (GO:0048208),0.24531784537200577,0.8733631718428734,0.6855072463768116,0.976118395882918,1.0,15/61,17.91%,RAB1B;CNIH2;SEC16B;TMED2;AREG;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;SEC24C;PREB
prerank,vesicle coating (GO:0006901),0.24531784537200577,0.8733631718428734,0.6855072463768116,0.976118395882918,1.0,15/61,17.91%,RAB1B;CNIH2;SEC16B;TMED2;AREG;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;SEC24C;PREB
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.24531784537200577,0.8733631718428734,0.6855072463768116,0.976118395882918,1.0,15/61,17.91%,RAB1B;CNIH2;SEC16B;TMED2;AREG;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;SEC24C;PREB
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.22661804216582168,0.8731593578938381,0.6796536796536796,0.9758577224996786,1.0,28/88,21.81%,PSMB1;PSMF1;BTRC;PSMA1;PSMD7;FBXL6;PSMA8;FBXL20;PSME3;CUL2;PSMD14;FBXL4;PSMC4;FBXW5;SKP2;KIF14;FBXL2;FBXO9;PSMB4;FBXL7;FBXL3;FBXL22;FBXO31;PSME1;FBXO6;PSMD2;PSMD4;PSMD8
prerank,muscle cell development (GO:0055001),0.2818066541085231,0.8729931109621095,0.6425269645608629,0.9754860786975255,1.0,8/30,17.90%,NEBL;BIN1;DMD;SLC8A1;SGCZ;CXADR;ENG;ANK2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.3115482617256519,0.8729370246716157,0.6508474576271186,0.9740877512377968,1.0,2/19,2.31%,POLR2L;POLR2F
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.3115482617256519,0.8729370246716157,0.6508474576271186,0.9740877512377968,1.0,2/19,2.31%,POLR2L;POLR2F
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2719543267867941,-0.8725685858704856,0.6352657004830918,0.8544896813267341,1.0,12/24,32.49%,PRKACA;CAMK2D;CALM3;CALM2;SELENON;JPH4;PDE4D;CASQ2;CALM1;FKBP1A;SRI;NOS1
prerank,ATP transport (GO:0015867),0.36708787516795427,0.8724997754837617,0.6142595978062158,0.9744040908734037,1.0,3/10,19.65%,SLC25A4;SLC25A5;ABCC6
prerank,positive regulation of stem cell differentiation (GO:2000738),0.32249167658886063,0.8718655062622482,0.6158940397350994,0.9751977993937545,1.0,4/16,20.28%,LTBP3;FOXC1;NUDT21;DHX36
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.29141497850312204,-0.8717065009806634,0.6388888888888888,0.8557890154896842,1.0,2/18,4.30%,MDFIC;CTNNA1
prerank,response to tumor necrosis factor (GO:0034612),0.22837152324695903,0.8711869524602268,0.717983651226158,0.9761122500540879,1.0,14/91,12.73%,GGT7;YTHDC2;RELA;NUB1;GSDME;GGT5;CACTIN;DAB2IP;ZFP36L2;NFE2L2;NPNT;CASP3;SFRP1;CRHBP
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.24453208412064165,-0.8711085097347165,0.7073863636363636,0.8565676103393705,1.0,7/35,11.90%,CCT6A;RTEL1;PKIB;PRKCQ;CTNNB1;CCT3;HNRNPA2B1
prerank,positive regulation of viral genome replication (GO:0045070),-0.255311161824327,-0.8709796659456883,0.6542553191489362,0.8563051232094835,1.0,8/29,22.04%,TOP2A;IFIT1;CD28;PPIH;LARP1;STAU1;TOP2B;VAPB
prerank,response to reactive oxygen species (GO:0000302),-0.22051872340682593,-0.8708875981550813,0.7415384615384616,0.8559356615364083,1.0,13/54,16.52%,APOE;PXN;ADAM9;STK24;ERCC6L2;PDCD10;FYN;HIF1A;FOS;EGFR;GPX1;HMOX1;MAPK8
prerank,histone monoubiquitination (GO:0010390),0.2915956112622988,0.8706425021538842,0.6445578231292517,0.9766492185663146,1.0,6/24,16.18%,CTR9;KDM2B;RNF168;DDB2;RNF2;PAF1
prerank,cellular response to hormone stimulus (GO:0032870),0.23986029234588332,0.8704628524232378,0.6690140845070423,0.976340793108634,1.0,17/69,21.54%,ADTRP;AKR1C1;WBP2;BRD8;MEF2C;AR;ADRA2A;LMO2;SOCS2;SFRP1;CRHBP;XBP1;NSMF;ATP1A3;ATP1A1;RDX;CTSS
prerank,cellular protein modification process (GO:0006464),0.1841974278535075,0.8704037206630104,0.9136316337148803,0.975721580603413,1.0,231/983,22.18%,KLHL25;TPTE;KLHL22;SLC35A1;CDK7;FBXW8;ST3GAL5;B3GNT9;HS3ST5;FUT10;STRADB;PSMB1;PLAT;MERTK;MATK;B3GNT6;CDK15;C3;B3GALT2;OBSL1;DDOST;PPM1E;RAB1B;CST3;PTPRD;NIM1K;FBXW9;TXK;RAB3A;STK26;PKN1;PAK1;DUSP29;NTRK1;AFP;COPS8;ALG1;UBA7;CHM;PTPRT;PTPRU;PTPRO;STK11;SOCS3;SERP2;UBE2M;FSTL1;PRKCZ;ELOC;IL6;YES1;FBXO7;NUB1;CTBP1;TRIB1;METAP1D;RYK;TRIB2;RAB8A;COMMD1;DYRK1B;PRKCI;CDC42BPA;PSMF1;ST6GALNAC2;BTRC;RIPK3;TGFBR1;NRBP2;ASB2;PRAG1;FBXO11;LIMK2;LIMK1;BMP2K;PPP1CC;PSMA1;BMP4;STK36;SOCS2;PSMD7;PRKCA;CDKL5;PRKD2;PPM1A;MAP4K4;RNASEL;PHEX;TGFB1;PTPN3;COPS3;PSMA8;B3GALNT1;NEK4;HSP90B1;FBXW10;RAB5A;RAB38;NEK1;AAK1;BTK;FBXL20;PSME3;STK39;VRK2;SENP8;MINK1;STK25;KLHL2;NTAQ1;ACVR1B;CUL2;PAK5;PPP2R3A;SCG3;PPP3CC;EPAS1;TGM4;PSMD14;VCAN;PRKG1;PDGFB;COQ8A;ST3GAL6;NUCB1;SPSB3;FBXL4;PARP1;FBXL19;PPP5C;AGA;PSMC4;DDB2;DCAF11;LRRC41;PGGT1B;SOCS6;COPS6;SDHAF2;MAP3K13;BAP1;GLYCTK;TGM1;MAPK10;AMHR2;INSR;DUSP2;FBXW5;EIF2AK4;ERG;APLP2;SKP2;UBA3;MIA3;MAPK3;FN3K;KLHL5;PDP2;KLHL11;PRKD1;SSH1;PIGS;UBE2I;COP1;DMPK;CTTNBP2NL;FBXL2;PRKCG;CSNK1G3;ALG5;PAK6;PLK2;CDK10;SSH2;ROCK1;AATK;TAOK1;PTPRS;CDC42BPB;PPP2R1A;PTPN13;PARP6;FBXO9;AKT3;PSMB4;MAST2;QSOX1;PLK4;FBXL7;UBL5;KLHL42;MAP4K2;ALG3;FBXL3;STRADA;WNK1;BMPR1B;WSB1;ST3GAL3;FBXL22;RABGGTB;SDC2;SPARCL1;FBXO31;ACVR1C;COPS5;PSME1;CDKL1;FBXO6;UBE2S;PDPK1;PDK1;PSMD2;NUAK1;PPM1L;PSMD4;METAP2;FCGR3A;ABCA7;LATS1;PPP6C;PPP2R5D;SIK3;PSMD8;LIPE;CDK4;OGA;CLK3;LARGE1;PARP10;WDR5
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.2827444492108407,0.8703265500361231,0.6558641975308642,0.9751406029172022,1.0,3/29,1.88%,BCL9L;TLE3;TLE2
prerank,smooth muscle tissue development (GO:0048745),-0.35069874750819974,-0.8701619500576032,0.6462264150943396,0.8569481834059874,1.0,5/10,22.33%,PROX1;EFEMP2;MYLK;PTCH1;SHH
prerank,positive regulation of response to wounding (GO:1903036),0.2944999775870753,0.8699605619026836,0.6401273885350318,0.9752291071264937,1.0,11/24,28.92%,INSL3;ADRA2A;ARFGEF1;VTN;HRAS;PTK2;GRN;DMTN;KANK1;HBEGF;MDK
prerank,negative regulation of TORC1 signaling (GO:1904262),0.34350210116853747,0.8697117991190892,0.611864406779661,0.9750978369846889,1.0,3/13,15.88%,STK11;ITFG2;RNF152
prerank,embryonic hemopoiesis (GO:0035162),0.3501761795022932,0.869647953170147,0.6113138686131386,0.9744979636296679,1.0,5/12,26.25%,ZFPM1;SH2B3;THOC5;FLT3LG;ATF4
prerank,spindle assembly (GO:0051225),0.23647578966321922,0.8695309116159124,0.7055393586005831,0.9740263325400388,1.0,22/67,25.18%,CEP192;AAAS;HAUS4;MISP;CLASP2;SMC1A;MAPRE2;SAC3D1;KIF2A;TUBGCP2;MAP9;STAG2;STARD9;HDAC3;ABRAXAS2;HAUS5;TUBGCP6;MAPRE3;TOGARAM2;RHOA;TUBGCP5;GOLGA8B
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3570292229080535,-0.869502118365885,0.6361607142857143,0.8572214931728233,1.0,3/10,15.14%,RACK1;SPHK2;TNF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3570292229080535,-0.869502118365885,0.6361607142857143,0.8572214931728233,1.0,3/10,15.14%,RACK1;SPHK2;TNF
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3268382926647919,0.869274148164175,0.6295652173913043,0.9738762094985308,1.0,5/15,17.20%,TXK;NTRK1;MAPK3;ITK;AATK
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.26916446160787466,-0.8688423298311458,0.6700507614213198,0.858131394678879,1.0,7/24,13.58%,CCBE1;IL6ST;HIF1A;BRCA1;IL1B;HPSE;CXCL17
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2617215714139158,-0.8684708144794687,0.6648351648351648,0.8583351853862748,1.0,6/29,12.93%,STAP1;TYROBP;CD226;RAET1E;LAMP1;KLRD1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34804580597226437,-0.8683325842193282,0.6328828828828829,0.8580773132475935,1.0,1/10,0.80%,PTPN22
prerank,DNA methylation (GO:0006306),0.29515939638570726,0.868226526034714,0.6548956661316212,0.9755844272280805,1.0,6/23,18.72%,ZFP57;METTL4;DMAP1;N6AMT1;KMT2E;SPOCD1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.35294644555853616,0.8679716923884908,0.6539792387543253,0.9746915885255075,1.0,2/12,10.36%,PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.35294644555853616,0.8679716923884908,0.6539792387543253,0.9746915885255075,1.0,2/12,10.36%,PRNP;HOMER2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.35319982970914854,-0.8676396654970921,0.6255506607929515,0.8590149448511445,1.0,2/10,5.21%,CD36;SLC27A4
prerank,embryonic skeletal system development (GO:0048706),0.2691537514957194,0.8675353931157025,0.6666666666666666,0.9749868164883196,1.0,12/35,27.27%,HOXD4;MEGF8;HOXB9;DSCAML1;KIAA1217;SULF2;UCMA;HOXB3;RBP4;HOXC9;FUZ;SULF1
prerank,regulation of bone mineralization (GO:0030500),0.24283783982260645,0.8675248799683205,0.6815476190476191,0.9742562586905823,1.0,8/55,9.64%,WNT4;MEF2C;CCR1;FBN2;BMP2K;BMP4;TGFB1;SLC8A1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.34147425846536783,-0.8673566183844679,0.6456876456876457,0.8590854345648827,1.0,2/12,1.48%,KIF3A;PCM1
prerank,anion transmembrane transport (GO:0098656),0.23651363543474352,0.8670450775733256,0.7397058823529412,0.9746731491364191,1.0,20/67,25.62%,SLC25A4;SLC35A1;SLC1A1;SLC25A18;SFXN1;SLC1A3;SLC39A8;SLC25A5;SFXN2;SLC19A1;SLC16A12;SLC13A3;SLC25A38;SLC6A9;SLC25A10;LRRC8B;SLC35B1;SLC16A7;SLC25A1;ABCC5
prerank,canonical Wnt signaling pathway (GO:0060070),0.2387065014651716,0.867030773622341,0.6972343522561864,0.9739603016836941,1.0,19/68,26.11%,WNT4;BCL9L;FRAT2;WNT3;RYK;TCF7L2;WNT8B;RAB5A;SFRP1;WNT7A;TCF7L1;DVL2;FRZB;AXIN1;SFRP2;PPP1CA;SCYL2;WNT5B;FZD5
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.26457648891766106,-0.8670081188724257,0.6856368563685636,0.8593226914718395,1.0,9/26,20.53%,P2RX4;CD36;SMAD3;IL1B;TNF;TLR4;KLF2;MMP8;KLF4
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.30235581531865485,0.8668789031305849,0.6313993174061433,0.9735431593806626,1.0,1/20,0.24%,WNT4
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.21256215395096373,0.8668699422679852,0.7570332480818415,0.9728153477415947,1.0,24/142,16.42%,ACKR4;YWHAE;ADCY8;TRPC3;ACKR3;CDH23;FIS1;CCR1;ADCYAP1;CXCR6;CX3CR1;SLC8A1;TRPC6;CXCR4;ITPR3;P2RY1;ATP2B3;TAC1;CCR6;HMGB1;ACKR2;CCR9;PTGER1;CACNA1A
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.2804711182972085,0.8668699111855587,0.6548956661316212,0.9720693237019156,1.0,6/28,13.76%,TCIM;TSPAN15;EGFL7;HEY1;ARRDC1;BEND6
prerank,regulation of hormone secretion (GO:0046883),-0.30180906407739927,-0.8663396949574852,0.6658415841584159,0.8601947391998119,1.0,2/15,7.33%,SOX11;ANXA1
prerank,negative regulation of cell differentiation (GO:0045596),-0.17969323365042109,-0.865864295203954,0.8872549019607843,0.8606549448746793,1.0,50/181,22.48%,NBR1;NOCT;CDK6;LIMD1;CDC73;XDH;PPARG;MEIS1;SMAD3;CAV1;NR1H2;YAP1;ANP32B;BMP5;ABCG1;MAD2L2;SPRY2;FOXO1;NOTCH1;TRPM4;IGF2;SMAD6;SPRY1;NR1H3;RB1;GREM1;RIOX1;EGFR;NOTCH4;TNF;PTK2B;WNT5A;PTHLH;GATA3;NPHP3;ADAMTS12;HES1;ITGB3;NEPRO;BMP7;HNRNPU;ESRRB;BAMBI;WNT9A;SIRT2;PTCH1;ID2;SEMA4D;SHH;TWIST1
prerank,cellular response to BMP stimulus (GO:0071773),0.23851327233451647,0.8656102715424434,0.7339181286549707,0.9743349916830896,1.0,15/66,20.63%,DDX5;MEGF8;SLC33A1;TGFBR3;BMP4;TGFB1;SFRP1;AMHR2;MAPK3;GDF1;ENG;RGMA;BMPR1B;SMAD2;SMAD1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.270418398204942,-0.8652841747717325,0.683377308707124,0.86125467441645,1.0,8/24,17.89%,CIAPIN1;NUBP1;CIAO2A;IBA57;NFU1;CIAO2B;CIAO1;LYRM4
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.25793866720306563,-0.8652705080146269,0.7138888888888889,0.8607105141603396,1.0,4/28,3.34%,MECP2;CDK5RAP2;GIT1;MET
prerank,tRNA wobble base modification (GO:0002097),0.33035170487364673,0.8651242620334813,0.6444444444444445,0.9747101022283728,1.0,2/14,4.07%,ADAT2;CTU1
prerank,interstrand cross-link repair (GO:0036297),-0.22335453364267308,-0.8650325606895598,0.736231884057971,0.8606232833912952,1.0,16/53,19.68%,VCP;ERCC6L2;UBC;ATRIP;UBA52;RPA1;FAAP20;FANCI;MCM9;MCM8;EME1;RPA2;CENPX;SLX4;FANCM;NEIL3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2932183590400424,0.8649369052606332,0.6661264181523501,0.9744024562913658,1.0,7/24,13.80%,NUB1;UBE3A;EFNA1;PSME3;PSMD14;PKD1;EPHA4
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.1833811868586064,0.864632524496682,0.9427402862985685,0.9744041960074404,1.0,179/1082,16.50%,ZFHX3;WNT4;HOXA5;HHEX;AGRN;BCL9L;CDK7;MPND;TET1;CD80;ZFPM1;DRAP1;KCNH2;CAPN3;ASF1A;IL4I1;LDB2;LDB1;SMARCC2;MED24;ONECUT2;MYRFL;WWTR1;BPTF;CSRNP3;POU2F2;USF2;HOXD4;RPTOR;TFCP2;PTPRN;TXK;ESRRG;RAI1;KDM6B;DNAJC2;NR1I2;FOSL1;NRL;SIX4;NR1I3;PSRC1;NFIB;RELA;SOX10;TFAM;PPARGC1A;NSD1;UBE2V1;MEOX2;WBP2;SOX4;BCL11B;MED4;PPARA;PBX2;SERTAD1;BRD8;HOXB7;MLLT11;E2F1;CD86;FGF7;GABPB1;IL6;ZFPM2;CRTC1;XRCC6;RFX6;WDR75;KDM1B;MEF2C;AR;DPF2;RXRG;DYRK1B;BCLAF3;NDP;GTF2F1;TADA3;FUBP3;BTRC;MAZ;AKAP8L;TGFBR1;HOXC10;MYO6;DAB2IP;APBB1;SS18;MACC1;LHX3;LMO2;BMP4;CD81;TCF7L2;ADCYAP1;OGT;MAP2K5;ERBB4;PRKD2;PKD2;FOXC1;PPM1A;HEY1;HDAC5;GRIN1;ZNF462;RNASEL;TGFB1;TAF9;LBH;MAML3;PRKN;ZC3H8;MSANTD1;KLF7;NEK4;SPIN1;SS18L1;ITGB1BP1;AKIRIN2;GRHL3;HSF2;FGF2;NFE2L2;PTOV1;SMARCD3;MLLT6;HOXB2;KAT8;RFXAP;SFRP1;FANK1;USF1;GABPA;EPAS1;HLF;TFEB;PKD1;PHF8;PDGFB;PARP1;PFKM;MYRF;PLAG1;PRDM16;FLCN;GPATCH3;EAF2;CHCHD10;BARX2;HMGB1;CCNK;LMX1B;ZBTB49;RBL1;APEX1;PRDM10;BRD4;GAL;ERCC6;IRF5;ERG;DDX39B;EDF1;WNT7A;REST;THOC5;TCF3;MAPK3;PRKD1;PRDM15;LHX2;MED25;CALCOCO1;SETX;RRP1B;HRAS
prerank,mitochondrial gene expression (GO:0140053),0.25941747824527067,0.8644527061846872,0.692429022082019,0.974089431531025,1.0,10/42,24.84%,MRPS6;TFAM;MRPS7;GFM2;MRPL23;PTCD3;HARS1;FASTKD2;MRPS34;MRPS2
prerank,response to chemokine (GO:1990868),0.344095784617843,0.8644416619032531,0.6557971014492754,0.9733693007424836,1.0,4/13,11.28%,SLC12A2;FOXC1;SH2B3;STK39
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3155209474885431,-0.864422578523701,0.6304849884526559,0.8613408062516142,1.0,7/14,37.33%,TYROBP;TNF;CSF1;IL23R;IL12B;POU4F2;POU4F1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.28106103403110094,-0.8641859681847986,0.6504629629629629,0.8612968352967554,1.0,5/22,10.04%,CUL4A;CHD1L;UBC;UBA52;RAD23B
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.18117557228587466,0.8641139421401,0.9547738693467337,0.9734349081240027,1.0,302/1667,18.65%,ZFHX3;HOXA5;HHEX;AGRN;NUCKS1;BCL9L;DCAF1;SCRT2;CDK7;MPND;TET1;CTR9;SMYD2;MED12L;HSF4;ZFPM1;ZFP57;SALL3;IKZF4;DRAP1;IL4I1;NACC2;RTF1;LDB2;LDB1;SMARCC2;MED24;ONECUT2;BRD9;FUS;WWTR1;BPTF;CSRNP3;POU2F2;USF2;HOXD4;TFCP2;CNOT2;ZNF394;PTPRN;TXK;ESRRG;PKN1;DDX5;RAI1;KDM6B;LBX2;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;ELP2;SP2;KCNIP3;SOX10;TFCP2L1;SLA2;PPARGC1A;NSD1;MEOX2;RIPPLY2;WBP2;SOX4;GTF2H2;BCL11B;MED4;ZBTB12;PPARA;HOXB9;HOXC6;BRWD1;PBX2;BRD8;HOXB7;TCF25;E2F1;ELOC;GABPB1;IL6;HDGFL2;ZFPM2;CRTC1;SMARCE1;XRCC6;CBX2;FOXD1;NR2F6;RFX6;CTBP1;KDM1B;MEF2C;AR;GTF2H4;DPF2;RXRG;BCLAF3;MED31;GTF2F1;PCGF6;TADA3;FUBP3;ZNF35;ZNF205;MAZ;AKAP8L;HOXC10;REPIN1;MYO6;PHF6;NCOR2;DAB2IP;APBB1;SS18;CBX6;MACC1;LHX3;LMO2;BMP4;SP4;EBF1;DGKQ;CD81;ZBTB22;TCF7L2;PRDM6;ADCYAP1;OGT;MAP2K5;PRKD2;PKD2;FOXC1;PPM1A;HEY1;HDAC5;GRIN1;ZNF462;ZFP82;RNASEL;HTATSF1;TGFB1;TAF9;ZFP91;TSHZ2;TBX2;ZNF23;MAML3;PLK3;AEBP1;PRKN;ZKSCAN8;SNAI2;HEXIM2;KLF7;SS18L1;ITGB1BP1;AKIRIN2;DMRTA1;GBX1;GRHL3;NKAP;HSF2;FGF2;NFE2L2;PTOV1;EFNA1;ZNF32;ZFP1;ZFP69;KDM2B;CBX4;SMARCD3;MLLT6;ZFP41;HOXB2;VPS72;IFI27;NOP2;KAT8;RFXAP;POU3F4;SUV39H2;PBX3;ZNF383;WWC1;THAP1;USF1;GABPA;EPAS1;HLF;TFEB;HOXB5;PKD1;PHF8;SAP130;TBX6;PARP1;PFKM;TEF;FBXL19;SMARCAL1;GADD45A;LHX5;SUB1;PLAG1;PRDM16;ZSCAN12;FLCN;ABCA2;ZBTB32;MYNN;DMAP1;EAF2;RNF2;BARX2;HMGB1;CCNK;AGO4;PPP1R13L;LMX1B;TAF3;ZBTB49;OTUD7B;RBL1;NKX2-2;IKZF2;APEX1;PRDM10;BRD4;GAL;ZNF740;NEDD4L;IRF5;HMGB3;PRDM1;BATF;ERG;BHLHA9;WNT7A;REST;UXT;TCF3;TCF7L1;MAPK3;PRKD1;PRDM15;LHX2;UBE2I;MED25;CALCOCO1;PAF1;PEX2;SETX;DNAJA3;RRP1B;HRAS;BHLHE41;EN2;SUFU;KLF16;IRF2BP1;BRIP1;BACH1;RHOQ;ITGA6;PRKAR1A;ENG;TMPRSS6;HDGFL3;KLF12;ZIC5;TLR3;ZNF750;ZFP30;ZEB1;BACH2;ZBTB34;PHF2;XBP1;RGMA;POU3F3;IL18;TEAD3;MAX;ZFP92;PSIP1;ZBTB7B;FOSL2;ECD;PIN1;UBE2D1
prerank,regulation of RNA export from nucleus (GO:0046831),0.35957346349537367,0.8640764545807005,0.6348408710217756,0.9727740064254077,1.0,2/11,7.60%,CPSF6;AKAP8L
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.20825563377076267,-0.863652847975866,0.7731958762886598,0.8618986790731514,1.0,10/70,7.94%,ITCH;PSMA6;TCF12;PSMB2;N4BP2L2;PSME2;PSMD11;PSMC6;YAP1;PSMA3
prerank,programmed necrotic cell death (GO:0097300),0.30771104573795727,0.8633194423330071,0.6559485530546624,0.9737973770888069,1.0,6/18,20.40%,ITPK1;RIPK3;IPMK;DNM1L;TLR3;CYLD
prerank,glucose metabolic process (GO:0006006),0.24035345621231782,0.8633033833116113,0.7323741007194244,0.9731006405939707,1.0,19/58,28.06%,GAPDH;PPARGC1A;SLC37A4;PGAM2;ALDOC;MDH1;APOD;GHRL;PGM1;ALDOA;OMA1;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1;DCXR
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.21515459416018945,0.8630977448986772,0.7591836734693878,0.9728392159230471,1.0,35/129,22.05%,FGF10;HHEX;UBE2B;PSMB1;SOX4;TMEM198;PTK7;PSMF1;PSMA1;GPC5;PSMD7;PPM1A;FAM53B;TGFB1;PSMA8;PPM1N;PSME3;SFRP1;PSMD14;LRRK1;PSMC4;TMEM9;CCAR2;PRDM15;CSNK1G3;PSMB4;PIN1;RSPO1;WNK1;PSME1;PSMD2;PSMD4;PSMD8;AXIN1;SFRP2
prerank,positive regulation of viral process (GO:0048524),0.24084918767955085,0.8630557185500377,0.7067988668555241,0.9722166864981122,1.0,7/60,6.89%,POLR2L;POLR2F;NELFB;PPARA;NELFCD;ADAR;GTF2F1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.30516102387311367,-0.8629864909583781,0.6453900709219859,0.8627471589020845,1.0,4/15,14.71%,CCR2;SYK;CD55;EBI3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3095911997409173,0.8629252284394158,0.6616161616161617,0.9717805007026984,1.0,3/19,5.83%,FIS1;PRNP;TRPM2
prerank,chromatin disassembly (GO:0031498),0.33406995051391497,0.8626634849319142,0.6296928327645052,0.9708892129560254,1.0,3/14,11.23%,SMARCC2;SMARCE1;SMARCD3
prerank,nucleosome disassembly (GO:0006337),0.33406995051391497,0.8626634849319142,0.6296928327645052,0.9708892129560254,1.0,3/14,11.23%,SMARCC2;SMARCE1;SMARCD3
prerank,regulation of integrin activation (GO:0033623),-0.3082170044401743,-0.8626220450854106,0.6683417085427136,0.8629468959808447,1.0,4/15,15.33%,PTGER4;SKAP1;FBLIM1;RAP1B
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.18379069018947208,-0.8623545323979066,0.8565022421524664,0.8629798193608383,1.0,73/152,36.93%,ADGRE5;ADGRG6;AKAP12;PSAP;ADCY9;PTGER4;S1PR2;CHRM2;PF4;GNA12;ADCY5;VIPR1;GNA13;NPY1R;ADCY6;ADCY1;HTR1B;GPR65;ADCY3;GNA14;PRKACB;RAMP2;CALCRL;PDE2A;AKAP5;PTHLH;OPRK1;ADGRG5;GPR37;S1PR3;LPAR2;ADGRL2;ADGRB1;VIPR2;RXFP2;PTH1R;CALCA;GLP1R;RAMP3;GRK5;SCTR;S1PR4;ADORA2A;VIP;LPAR3;ADGRG7;FPR2;GPR4;PTGIR;TBXA2R;ADGRG1;OPRL1;GPR26;ADGRG2;GIPR;LGR4;HTR1D;PTGFR;MC2R;CORT;CXCL9;CRHR2;ADGRD1;DRD1;GPER1;GPR3;CALCR;FPR1;FSHR;LHCGR;GHRH;CALCB;ADCY4
prerank,cell differentiation in hindbrain (GO:0021533),-0.3397380851411149,-0.8622403010321691,0.6448598130841121,0.862678918167935,1.0,4/11,14.82%,ATP7A;PROX1;AGTPBP1;LHX1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.2873387526143626,-0.8622286607060105,0.6710875331564987,0.8621334437441289,1.0,9/18,25.05%,RPS26;ESR1;RPS13;ZC3H12A;TNF;NCOR1;PTBP3;KAT2B;TERT
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.23264899233324968,0.8620611059659516,0.7046109510086456,0.9715362439392408,1.0,23/65,27.53%,PSMB1;PSMF1;PSMA1;FHL1;PSMD7;PSMA8;ZFYVE19;PSME3;PSMD14;PSMC4;PSMB4;FBXL7;PSME1;PSMD2;NABP1;PSMD4;PSMD8;AURKA;PABIR1;PSMC5;PSMD3;PSMB8;PSMA4
prerank,negative regulation of secretion by cell (GO:1903531),-0.2397459041310394,-0.8619840321839597,0.7377521613832853,0.8620819248448854,1.0,12/38,20.09%,APOE;ANXA1;DRD2;NOTCH1;HTR1B;TNFRSF1B;STXBP6;LILRB1;SLC30A1;DPH3;DRD3;SERGEF
prerank,renal system development (GO:0072001),0.24607603922175847,0.8617139312477562,0.700589970501475,0.9715991648118075,1.0,10/52,17.16%,WNT4;TGFBR1;BMP4;FOXC1;C1GALT1;PKD1;IFT27;IFT88;AGT;PYGO2
prerank,negative regulation of cyclase activity (GO:0031280),0.3295368650898175,0.8614017110460592,0.6302816901408451,0.9716256468807142,1.0,5/14,18.34%,LTB4R2;GRM3;GABBR2;GNAI3;PALM
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.3252815119482779,-0.8613272201911631,0.675609756097561,0.8628691375881506,1.0,4/12,15.14%,UVRAG;SMCR8;JMJD4;TNF
prerank,blood circulation (GO:0008015),0.24760732432674992,0.8610526204066805,0.7002967359050445,0.9717074561500977,1.0,10/49,17.19%,AVPR1A;TNNI3;MEOX2;SGCZ;ITGB1BP1;HOXB2;SGCG;TBC1D8;SGCD;ROCK1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.25403733426313146,0.8607233983598392,0.6885758998435054,0.9717225133829237,1.0,19/42,27.49%,SMARCC2;SMARCE1;ZNHIT1;VPS72;RNF8;DMAP1;SPTY2D1;ERCC6;ACTB;ACTR5;MBD3;SMARCA2;ACTR6;ACTR8;PBRM1;MTA2;CHD8;ACTL6B;CHD4
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.2225291231833299,-0.8606496859396258,0.7910863509749304,0.8637437209503738,1.0,15/51,21.23%,UBE2D3;PPARG;SMURF2;SMAD9;LEMD3;NOTCH1;SMAD6;GREM1;BMP2;HIPK2;SMAD4;ACVR2A;GDF3;BAMBI;TRIM33
prerank,Rac protein signal transduction (GO:0016601),0.3119163353205764,0.8602857718951926,0.6474694589877836,0.9719878104807117,1.0,4/18,14.08%,NCKAP1;FARP2;HACE1;CYFIP1
prerank,nucleocytoplasmic transport (GO:0006913),-0.232183730943103,-0.8602380746167672,0.6883852691218131,0.8640383428304331,1.0,10/40,15.89%,RSRC1;NCBP1;SNRPD1;ATXN1;SNRPB;XPO1;NUTF2;NXT1;NPM1;DDX20
prerank,negative regulation of cellular process (GO:0048523),0.18808298234753998,0.8601896110165099,0.8829321663019694,0.9714496198884727,1.0,95/521,17.82%,ATP8A2;P3H2;TPTE;TSC2;WFDC1;SMYD2;AVPR2;SRGAP2;PLXNB2;NACC2;CD34;NTRK1;PSRC1;SUSD2;SLURP1;ARHGDIG;COPS8;TENM1;SOX4;IGFBP6;PTPRU;JAM2;SIPA1;STK11;IL6;SRSF6;DSCAM;CLU;PDCD5;CTBP1;GSDME;AR;RBM5;PDE3B;EEF1E1;TGFBR3;ADAM22;MINAR1;DAB2IP;APBB1;CCN4;FHL1;NME1;BMP4;GNG4;ARHGDIA;ERBB4;PKD2;SST;TGFB1;NMI;PRKN;BTG3;ITGB1BP1;ADAM15;SH2B3;THAP12;FGF2;BTG2;SFRP1;BECN1;CGRRF1;ACVR1B;CHMP1A;DCBLD2;INHA;PPP1R13B;FLCN;BAP1;TXNDC12;CHMP2A;VAMP3;CBLL1;ZBTB49;EI24;EPHB2;PTPN2;IFI35;CCAR2;SH3BP4;ADORA3;REST;MIA3;COL18A1;PRKD1;CTTNBP2NL;DNAJA3;HRAS;OPRM1;CDK10;NDRG3;PPP2R1A;BTG1;FABP3;UTP20
prerank,regulation of double-strand break repair (GO:2000779),0.2582873544282429,0.8599948705782099,0.7066666666666667,0.9711514419057152,1.0,4/39,7.91%,WRAP53;PPP4C;USP51;TIMELESS
prerank,JNK cascade (GO:0007254),0.2581552133048126,0.8595391163738558,0.6953846153846154,0.9714996044233174,1.0,10/40,14.70%,UBE2V1;TRIB1;MAP3K10;NOD1;SH2D3C;UBE2N;MINK1;MAP3K7;MAP3K13;MAPK10
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.25803607492084885,-0.859522945971147,0.6628571428571428,0.8649470374238948,1.0,13/29,26.29%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1
prerank,long-term synaptic potentiation (GO:0060291),0.2986841529391486,0.8592213200802683,0.6645468998410174,0.9714726826293155,1.0,5/21,17.00%,MPP2;PRKCZ;GRIN2B;SLC8A3;PLK2
prerank,regulation of mitochondrial fission (GO:0090140),-0.265734377188356,-0.8590250853328032,0.6773333333333333,0.8654007429958619,1.0,7/24,17.24%,DDHD1;STAT2;VPS35;LRRK2;KDR;MUL1;MIEF1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.2997667102282748,0.858979478688381,0.6684027777777778,0.9712805738371794,1.0,4/20,11.83%,PRKCZ;IL6;CD81;MAP3K7
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2987991248123624,0.8587852623072487,0.6428571428571429,0.970957381159966,1.0,3/22,3.97%,RPP40;ERI3;NOP9
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.34474338177911307,-0.8587492062808822,0.6359223300970874,0.8654534470540893,1.0,5/10,20.95%,MTHFR;MTHFD1;TYMS;MTHFD2;DHFR
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.25343282822686924,-0.8585646547464262,0.6776859504132231,0.8653091592816942,1.0,7/29,16.49%,PLBD1;PLA2G4E;PLAAT3;NR1H2;NR1H3;TMEM86B;LPCAT4
prerank,cellular response to interleukin-1 (GO:0071347),-0.18625167145625077,-0.8584704046527575,0.851528384279476,0.8649404125008401,1.0,34/143,19.81%,PSMA6;CD47;MAP3K8;PSMB2;PSME2;NFKB1;CCL25;PSMD11;NOD2;PSMC6;GBP3;UBC;HIF1A;PSMA3;IL1B;TAB1;UBA52;ZC3H12A;PTGIS;RC3H1;ACOD1;IRAK4;PELI1;PSMD10;HAS2;PSMB5;RBMX;SQSTM1;HYAL3;PSMD5;ADAMTS12;IL1R2;PSMD1;MYD88
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.2859907817589342,0.85828497956643,0.6477093206951027,0.9713554976987224,1.0,5/25,12.77%,TRA2B;BCAS2;LSM1;MPHOSPH10;SF3B3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.33807393186065676,-0.8582449756905138,0.6455399061032864,0.8648792688989781,1.0,4/10,23.05%,RACGAP1;ECT2;SIRT2;CCNB1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.29058066078993416,-0.8580690500602579,0.6533665835411472,0.8646791065668299,1.0,9/18,23.37%,SETD7;SETD3;PRDM9;EHMT1;KMT2D;KMT2B;SETD2;SETD1A;KMT2A
prerank,transcription by RNA polymerase III (GO:0006383),0.277068888932054,0.8579594450305332,0.6863711001642037,0.9713884437161895,1.0,2/27,1.03%,POLR2L;IVNS1ABP
prerank,protein maturation (GO:0051604),0.22601500827412876,0.8575118687086996,0.7559607293127629,0.9716970746263954,1.0,34/95,28.55%,F3;MMP16;NNAT;ASPRV1;BACE1;XPNPEP3;TSPAN15;TSPAN32;OGT;PHEX;AEBP1;PSENEN;PITRM1;NAA35;NDUFAB1;NAA60;PCSK2;ADAMTS3;LMF1;GALNT2;TYSND1;METAP2;CASP2;CTSS;PCSK7;SDE2;STUB1;TMPRSS4;AANAT;EEF1AKMT4-ECE2;ECE2;LONP2;BOLA2;TSPAN33
prerank,glutamate metabolic process (GO:0006536),0.3026053888302005,0.857422197343464,0.6504065040650406,0.9711910498331805,1.0,10/19,32.90%,FPGS;ALDH5A1;PRODH;GLUL;GLS2;DGLUCY;GAD1;MTHFS;GCLM;ALDH18A1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2852258857370032,0.8571212715894242,0.7,0.9711615522827312,1.0,5/26,11.86%,ITPR2;TRPM2;PKD2;FGF2;ITPR3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.23798456233526286,-0.8570419513385802,0.7091988130563798,0.8663553633751743,1.0,14/38,24.10%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB11;NDUFB10;NDUFS7;NDUFA7;NDUFB2;NDUFB8;NDUFAF1;NDUFA13;NDUFA11
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.19903795895354492,-0.8568786868654628,0.7818791946308725,0.8661661452824532,1.0,21/87,19.15%,PSMA6;CDK6;CDC73;KANK2;PSMB2;GPR132;PSME2;PSMD11;PSMC6;PSMA3;CDKN2C;WEE1;PRMT2;PSMD10;RB1;PSMB5;E2F7;RGCC;PSMD5;CDKN2A;PSMD1
prerank,glycerolipid catabolic process (GO:0046503),0.30566809411943985,0.856871111096178,0.6477462437395659,0.9709854098187182,1.0,3/19,7.16%,PRDX6;PLA2G4C;ABHD12
prerank,respiratory electron transport chain (GO:0022904),-0.30962465704005837,-0.8567336411607389,0.6473429951690821,0.8658885066811522,1.0,3/14,6.35%,GPD2;NDUFA5;SDHB
prerank,cellular senescence (GO:0090398),0.28673433675716886,0.8564767946155637,0.6962233169129721,0.97114095315807,1.0,6/27,20.17%,ECRG4;SMC5;TBX2;HRAS;MAPKAPK5;SRF
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.266226528846637,-0.8562212452848247,0.691566265060241,0.8664320012284182,1.0,6/23,16.03%,SASH1;DVL3;TAOK3;MAP3K11;TNF;ARHGEF5
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.22668240971189035,-0.8562028378008979,0.7455621301775148,0.8659067837399236,1.0,9/41,10.27%,RANBP2;PRKAG2;HIF1A;NUP153;NDC1;NUP43;NUP210;EP300;PGAM1
prerank,reticulophagy (GO:0061709),-0.3324349161616964,-0.8560410924930544,0.6412776412776413,0.8656629346833168,1.0,3/12,11.32%,UBA5;UFC1;ATG2B
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2344306782143331,-0.8558776862415238,0.7159090909090909,0.865445310715615,1.0,11/38,18.66%,PRPF19;CLNS1A;SNRPD1;PRPF6;SNRPB;LSM2;CD2BP2;DDX20;SNRPC;PRPF3;USP4
prerank,organic acid transport (GO:0015849),-0.19795668427363458,-0.8558095647907481,0.8113207547169812,0.865020861582192,1.0,10/94,6.31%,LRRC8D;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11;SLC27A4;PPARD;NCOA1;SLC46A1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2929880973643591,0.8557931061418192,0.6751269035532995,0.9719574376969479,1.0,3/23,8.93%,OCIAD2;IL6;ERBB4
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.34577240919110497,0.8557600992491533,0.6366906474820144,0.9713090972996801,1.0,3/12,18.66%,GSS;GGCT;CHAC2
prerank,cellular copper ion homeostasis (GO:0006878),-0.30585026169177654,-0.8557577442207559,0.655011655011655,0.8645791250126904,1.0,4/14,8.48%,COX19;ATP7A;SLC31A2;CCDC22
prerank,regulation of cytoplasmic transport (GO:1903649),0.34897239093523774,0.8555860200629755,0.6678571428571428,0.9709918175714777,1.0,4/11,25.08%,ATP9A;MAPK3;USP7;MAPK1
prerank,nitrogen compound transport (GO:0071705),-0.1839525212691213,-0.8552874072046114,0.8384615384615385,0.8650562609639254,1.0,29/141,18.64%,ARL6IP5;LRRC8D;KIF3A;SLC1A5;SLC7A1;SLC43A2;SLC6A6;RAB7A;SLC15A3;SLC7A11;TMEM30A;TXNIP;NDC1;SLC52A2;HIKESHI;SLC11A1;CHMP1B;SLC6A8;RAMP2;SLC25A47;CALCRL;MYH9;SLC16A10;SLC7A6;SLC3A2;ARRDC4;RILP;SLC52A1;TOM1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.20167054876815188,-0.8552668103517628,0.7961165048543689,0.8645348913621694,1.0,23/79,21.23%,UBE2D3;PPARG;PTPN1;SMURF2;THBS1;SMAD9;LEMD3;SPRY2;NOTCH1;SMAD6;SPRY1;GREM1;BMP2;CREB3L1;SPRY4;HIPK2;SMAD4;NIBAN2;ADAMTS12;ACVR2A;GDF3;BAMBI;TRIM33
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.19071174064236207,-0.8552384892394799,0.8726591760299626,0.8640257774010294,1.0,55/116,36.93%,FCGR2B;CD163;PRKACA;ADCY9;PTGER4;SYK;LYN;FYN;HCK;ADCY5;VIPR1;ADCY6;ADCY1;ADCY3;NPSR1;PRKACB;RAMP2;CALCRL;GPR27;MYH9;ADAM17;PTHLH;CD247;VIPR2;RXFP2;PTH1R;CRH;CALCA;GLP1R;RAMP3;SCTR;ADORA2A;VIP;CREB1;GPR83;PTGDR;PTGIR;GPR15;RHBDF2;FGR;GGT1;GIPR;MC2R;CRHR2;CYSLTR2;DRD1;CALCR;CD3G;FSHR;LHCGR;POMC;NPS;GHRH;CALCB;ADCY4
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.341932208101663,0.8550614530163365,0.666083916083916,0.9714790879372985,1.0,6/12,28.16%,IL5RA;MAPK3;PTK2;IL34;MAPK1;CSF1R
prerank,gene silencing by miRNA (GO:0035195),0.27433236642182435,0.8547302720881412,0.6882067851373183,0.9715093506899684,1.0,6/32,14.29%,ZC3H7B;ADAR;SPOUT1;EIF6;CNOT8;AGO4
prerank,positive regulation of vacuole organization (GO:0044090),-0.3426612989489447,-0.8546032570935086,0.648471615720524,0.8647941962638518,1.0,3/10,16.92%,SH3GLB1;RALB;RAB3GAP2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.346878975843587,-0.8545799565016964,0.6357308584686775,0.8642811309181048,1.0,2/10,5.70%,APOE;TMEM30A
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.30009674971465594,0.8544445622238906,0.6755407653910149,0.9714586942940294,1.0,5/20,13.85%,PFAS;GART;AMPD3;HPRT1;ADSL
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.28851278277366,0.8541255125814563,0.6607431340872375,0.9714391504788094,1.0,5/23,14.05%,MEF2C;ATP11A;TGFB1;LMOD3;SMYD1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3086596913135799,0.8540740419700202,0.6896551724137931,0.9708133959409988,1.0,2/17,6.72%,PLA2G3;LPCAT1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3155627383538996,-0.8539888100158902,0.6474820143884892,0.8649293038584194,1.0,5/13,21.94%,METRNL;PIM1;BMP7;HNRNPU;RREB1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.32442424164399825,0.8538020633290807,0.6795952782462057,0.9707031409096067,1.0,4/14,14.27%,PFAS;GART;ADSL;RFK
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.2914663629090517,0.8535117555516099,0.6955810147299509,0.9706152530629715,1.0,4/23,11.30%,CADM1;SLAMF6;ARRB2;CRTAM
prerank,positive regulation of dendrite development (GO:1900006),-0.3396762228665888,-0.8534193135151301,0.6317016317016317,0.8655029233441713,1.0,6/10,31.17%,BMP5;COBL;PTN;BMP7;VLDLR;PACSIN1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.26914742944559183,-0.8530411079049599,0.7190721649484536,0.8657412133547425,1.0,10/23,25.73%,UBE2K;S1PR2;PRKAG2;CALM3;CALM2;PLK1;BMP7;APP;EGF;TNKS1BP1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2829794563426947,0.8526292064463313,0.6591639871382636,0.971904266085232,1.0,8/25,22.78%,MLLT11;PDCD5;DNM1L;BIK;BBC3;MFF;CIDEB;HRK
prerank,response to hydroxyurea (GO:0072710),0.34362512714769367,0.8519344484271192,0.6642728904847397,0.9726936954214174,1.0,2/11,14.44%,TIMELESS;NSMCE3
prerank,amino sugar biosynthetic process (GO:0046349),-0.3206855465720151,-0.8518984999036012,0.645083932853717,0.8675756336271822,1.0,5/12,21.64%,GNPDA1;UAP1L1;GNPNAT1;NAGK;RENBP
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.32665815050634034,-0.8518955950976966,0.6439024390243903,0.8670136794395122,1.0,6/12,21.63%,CIITA;IFITM3;TRIM5;GSN;PTX3;IFITM1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.22835890082198043,0.8517762727149052,0.7468354430379747,0.9723246855939525,1.0,15/75,14.20%,F3;ANG;FLT4;PLCG1;TGFBR1;EGFL7;BMP4;PRKCA;PRKD2;FGF2;PDCD6;PDGFB;VASH2;TEK;HMGB1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.34375082539906493,0.8516236857242576,0.6756302521008404,0.9719550564858292,1.0,6/12,25.93%,BRD8;LMO2;RDX;CTSS;GAS2L1;CTSH
prerank,negative regulation of protein ubiquitination (GO:0031397),0.24701582234855982,0.8515578791740882,0.7232142857142857,0.9713810583664632,1.0,14/50,22.81%,IVNS1ABP;SOX4;NXN;ARRB2;MINAR1;LIMK1;OGT;UBXN1;PRKCG;PRMT3;FBXO5;ARRB1;HDAC8;CAMLG
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.21754897844832577,0.8514068081371247,0.7611731843575419,0.9709975475397893,1.0,16/100,10.94%,FHIT;RNF19A;GIPC1;CLU;NUB1;TRIB1;TRIB2;COMMD1;RNF180;PRICKLE1;OGT;TAF9;PRKN;SUMO2;HERPUD1;ZYG11B
prerank,regulation of protein kinase A signaling (GO:0010738),-0.27543328238889986,-0.8513290778342132,0.682741116751269,0.8676455729091487,1.0,4/20,17.20%,AKAP12;PJA2;LRRK2;AKAP5
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.3183432174663934,0.8512667126720879,0.6578014184397163,0.9705948390311034,1.0,2/15,9.00%,ROGDI;FOXC1
prerank,regulation of viral release from host cell (GO:1902186),0.2953472271058456,0.8512574732271414,0.6870967741935484,0.9699017145912144,1.0,4/21,14.27%,MID2;TRIM26;TRIM8;CHMP2A
prerank,axonal transport of mitochondrion (GO:0019896),0.34570737636364696,0.8511529476317086,0.6805807622504537,0.9694307555472919,1.0,6/11,26.15%,ACTR10;SYBU;HAP1;NEFL;SPAST;MAPT
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.31925159862832747,0.851150651254075,0.6637931034482759,0.9687238490429331,1.0,7/16,23.72%,TRPC3;PRKCA;PARP1;AGT;ROCK1;SLC9A1;MEF2A
prerank,linoleic acid metabolic process (GO:0043651),-0.29189649684488533,-0.8509976679385062,0.6799065420560748,0.8677605836740232,1.0,7/17,29.76%,ALOX5;ALOXE3;ELOVL2;GSTP1;ALOX15;ABCD1;FADS2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.3577856346693645,0.8509060310106206,0.6795774647887324,0.9685569883933915,1.0,2/10,14.74%,LRTOMT;COMT
prerank,Golgi to plasma membrane transport (GO:0006893),-0.225972978518321,-0.8509021009862202,0.7550432276657061,0.8673853710472091,1.0,14/47,18.30%,RABEP1;GOLPH3L;EXOC4;GGA2;CCDC22;RAB10;EXOC8;STXBP6;OPTN;EXOC6;RAB31;GCC2;GOPC;CCDC93
prerank,DNA double-strand break processing (GO:0000729),-0.2878848180083903,-0.8507470482143527,0.6734177215189874,0.8671414822678883,1.0,5/18,12.57%,RBBP8;NBN;BRCA1;BARD1;KAT5
prerank,regulation of secretion (GO:0051046),0.33892901659326635,0.8507162226120519,0.6352201257861635,0.9682670142472675,1.0,2/13,7.80%,FGF10;MYO6
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.25440778335257,0.8505509129233478,0.7217928902627512,0.9679305895651789,1.0,7/39,12.51%,FGF10;PAK1;BMP4;PKD2;FGF2;NPNT;PKD1
prerank,plasma membrane repair (GO:0001778),0.3411662118413864,0.8501658284087737,0.6527545909849749,0.9680781170557264,1.0,2/13,3.46%,RAB3A;SYTL4
prerank,peptidyl-threonine modification (GO:0018210),0.2289214881828059,0.8501276013016095,0.7574850299401198,0.9674597437672218,1.0,18/66,20.75%,DYRK1B;MAP3K10;CDC42BPA;TGFBR1;GALNTL6;PRKCA;PRKD2;STK39;ACVR1B;PRKD1;CDK10;ROCK1;CDC42BPB;WNK1;GALNT4;GALNT2;SBK1;PDPK1
prerank,pharyngeal system development (GO:0060037),0.321360244519182,0.85012515443979,0.6822742474916388,0.9667533496865726,1.0,3/15,8.32%,SIX4;TGFBR1;BMP4
prerank,positive regulation of cellular component organization (GO:0051130),0.21328672831681464,0.849633922383916,0.7924016282225237,0.9671437672499371,1.0,21/107,15.58%,TPPP;NEUROD2;FRMPD4;NRXN1;CLU;AR;ABCB4;TGFBR1;DAB2IP;SHANK3;RAPGEF3;BAK1;FAF1;TGFB1;DCTN1;MMP1;BIK;CBLL1;INSR;NEDD4L;ANAPC2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.308885624940738,-0.8495603151055064,0.6541019955654102,0.86902617572035,1.0,5/13,21.01%,SEC16A;TMEM30A;TM9SF4;GCC2;INSIG1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3119080160398466,0.848875263728886,0.6956521739130435,0.9681177148890014,1.0,5/17,12.83%,PSRC1;CCND3;PKD2;PKD1;PDGFB
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2234907992734187,0.8487315400460009,0.7354925775978407,0.9677350527764851,1.0,15/86,13.89%,FGF10;CD80;PRKCZ;PRNP;FGF7;IL6;DGKQ;CD81;ENPP2;TGFB1;ITGA5;EFNA1;SFRP1;PDGFB;VTN
prerank,intracellular lipid transport (GO:0032365),-0.27007308471249164,-0.8486486995911003,0.6853658536585366,0.8703954687137821,1.0,10/21,26.69%,NPC2;PRKAG2;SGPP1;MID1IP1;PRKAB2;ACACA;SLC25A20;ABCD4;CERT1;ABCD1
prerank,negative regulation of cation channel activity (GO:2001258),-0.2593151016266382,-0.8486261369992903,0.7291666666666666,0.869879233403024,1.0,15/26,32.61%,UBQLN1;DRD2;CALM3;CALM2;KCNAB1;DRD3;EPO;GNB5;KCNE3;CASQ2;CALM1;FKBP1A;SRI;MMP9;GPR35
prerank,neural crest cell differentiation (GO:0014033),-0.2836185304083684,-0.8482853572086816,0.7,0.870037323556648,1.0,6/18,18.47%,FBXL17;SOX11;TCOF1;KBTBD8;CDH2;LRP6
prerank,regulation of humoral immune response (GO:0002920),-0.22700063516382124,-0.8482068597904501,0.7146974063400576,0.8696206789362978,1.0,11/44,20.14%,FCGR2B;C3AR1;C5AR1;C4B;SERPING1;CD55;CFHR2;C1QC;CFP;C2;C1QB
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.19329504774073408,-0.8473401685440185,0.8181818181818182,0.8708398704475829,1.0,27/104,20.26%,UBE2D3;PPARG;SMURF2;SMAD3;MTMR4;SMAD9;CAV1;UBC;LEMD3;SNX25;UBA52;SPRY2;NOTCH1;SMAD6;SPRY1;CCN3;GREM1;BMP2;FAM89B;ASPN;ADAM17;HIPK2;SMAD4;ACVR1;ACVR2A;GDF3;BAMBI
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.3423857593892096,-0.8469813314950049,0.628175519630485,0.8709820740932511,1.0,3/10,11.11%,XDH;SPRY2;SEMA6A
prerank,cellular response to fluid shear stress (GO:0071498),0.34210072699433847,0.8466942279007609,0.6690391459074733,0.9715571703010317,1.0,4/12,10.76%,MEF2C;MAP2K5;PKD2;NFE2L2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.26921562287745565,-0.8466113889798984,0.7247474747474747,0.8711698271919103,1.0,9/21,27.71%,DLG5;TUBD1;TEDC2;UCHL5;KIF7;SHH;ULK3;TEDC1;EVC
prerank,tetrapyrrole metabolic process (GO:0033013),0.3037681764432576,0.8465323456151667,0.6739864864864865,0.9712065000354123,1.0,5/18,24.28%,ABCB6;MTR;MMAA;TCN2;MMAB
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.1869470561355656,-0.8460354057466675,0.8945454545454545,0.8718310712063125,1.0,55/117,36.93%,CD163;PRKACA;ADCY9;PTGER4;SYK;LYN;FYN;HCK;ADCY5;VIPR1;ADCY6;ADCY1;ADCY3;NPSR1;PRKACB;RAMP2;CALCRL;GPR27;MYH9;ADAM17;PTHLH;CD247;VIPR2;PLA2G2D;RXFP2;PTH1R;CRH;CALCA;GLP1R;RAMP3;SCTR;ADORA2A;VIP;CREB1;GPR83;PTGDR;PTGIR;GPR15;RHBDF2;FGR;GGT1;GIPR;MC2R;CRHR2;CYSLTR2;DRD1;CALCR;CD3G;FSHR;LHCGR;POMC;NPS;GHRH;CALCB;ADCY4
prerank,regulation of neuroblast proliferation (GO:1902692),0.324502945063748,0.8460089484331013,0.6701030927835051,0.9716710065976866,1.0,4/15,15.24%,CX3CR1;SMARCD3;DCT;TAFA1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.17740373412821062,0.8458060846828408,0.9728370221327968,0.9714184303569645,1.0,281/1645,17.98%,ZFHX3;POLR2L;WNT4;HOXA5;HHEX;NUCKS1;SCRT2;MAGED1;TSC22D4;CTR9;MED12L;CD80;HSF4;ZFP57;SALL3;IKZF4;DRAP1;CDK15;DENND4A;KCNH2;CAPN3;TLE2;NACC2;LDB1;SMARCC2;MED24;PQBP1;ONECUT2;BRD9;MYRFL;FUS;WWTR1;BPTF;CSRNP3;POU2F2;USF2;HOXD4;TFCP2;CNOT2;ZNF394;ESRRG;PKN1;DDX5;RAI1;DNAJC2;LBX2;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;PSRC1;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;ELP2;SP2;SOX10;TENM1;TFCP2L1;TFAM;PPARGC1A;NSD1;UBE2V1;MEOX2;WBP2;SOX4;GTF2H2;BCL11B;MED4;ZBTB12;PPARA;HOXB9;SPINDOC;HOXC6;BRWD1;PBX2;HOXB7;MLLT11;E2F1;CD86;ELOC;FGF7;TCIM;IL6;HDGFL2;ZFPM2;SMARCE1;XRCC6;FOXD1;NR2F6;RFX6;ZMYND15;CTBP1;MEF2C;AR;DPF2;RXRG;DYRK1B;NDP;MED31;PCGF6;MAP3K10;TADA3;FUBP3;ZNF35;ZNF205;BTRC;MAZ;TGFBR1;OGG1;HOXC10;REPIN1;PHF6;NCOR2;DAB2IP;TIMELESS;APBB1;PRICKLE1;LHX3;POFUT1;BMP4;SP4;EBF1;DGKQ;ZBTB22;TCF7L2;PHC1;OGT;ERBB4;FOXC1;PPM1A;HEY1;HDAC5;ZFP82;HTATSF1;TGFB1;ZFP91;TSHZ2;LBH;TBX2;ZNF23;ZC3H8;ZKSCAN8;SNAI2;HEXIM2;MSANTD1;KLF7;NEK4;SPIN1;SS18L1;DMRTA1;GBX1;GRHL3;NKAP;HSF2;FGF2;NFE2L2;PEX14;ZNF32;ZFP1;ZFP69;SLC39A8;KDM2B;CBX4;SMARCD3;MLLT6;ZFP41;HOXB2;NOP2;KAT8;RFXAP;POU3F4;SFRP1;ACVR1B;SUV39H2;PBX3;ZNF383;POLR3F;METTL4;FANK1;WWC1;THAP1;MLF2;USF1;GABPA;EPAS1;HLF;TFEB;HOXB5;SAMD1;PHF8;CHMP1A;PDGFB;TBX6;SCML2;TEF;FBXL19;SMARCAL1;LHX5;SUB1;RBFOX2;MYRF;KDM4A;PLAG1;PRDM16;ZSCAN12;GPATCH3;ABCA2;ZBTB32;MYNN;DMAP1;BAP1;BARX2;HMGB1;CCNK;PPP1R13L;LMX1B;SPTY2D1;ZBTB49;SNX6;NKX2-2;INSR;IKZF2;BRD4;ZNF740;APBB3;ERCC6;IRF5;HMGB3;PRDM1;BATF;ERG;CCAR2;BHLHA9;EDF1;WNT7A;REST;UXT;TCF3;TCF7L1;PRDM15;LHX2;UBE2I;CALCOCO1;ATP8B1;BHLHE41;EN2;SUFU;KLF16;YWHAQ;IRF2BP1;AGT;PAK6;BRIP1;BACH1;PRKAR1A;ENG;TMPRSS6;HDGFL3;KMT2E;PPP2R1A;KLF12;ZIC5;BTG1;ZFP30;ZEB1;BACH2;HMG20A;ZBTB34;PHF1;PHF2;ELAVL2;POU3F3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.277841501727673,0.8457321963474521,0.6959349593495935,0.9708676985078302,1.0,10/25,25.24%,SGTA;PSMF1;EFNA1;EPHA4;PRKCG;ALAD;HSP90AB1;OPHN1;TRIM39;HFE
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.35357098364417355,0.8453714538452246,0.6852791878172588,0.9709551119248007,1.0,2/10,10.80%,WRAP53;CCT4
prerank,fatty acid beta-oxidation (GO:0006635),-0.21655029036958426,-0.8453254751192689,0.782051282051282,0.8727532103872512,1.0,8/51,10.06%,ACOT8;ACOX3;MTLN;PPARD;DECR1;ACAA2;CROT;ACAD10
prerank,regulation of cell-substrate adhesion (GO:0010810),0.24999892978433585,0.8446355564748281,0.7205438066465257,0.9717910607511874,1.0,10/42,16.65%,THY1;CORO2B;PTPRO;NPNT;MINK1;PDGFB;NDNF;FBLN2;RSU1;PTK2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.292883089837883,-0.8445080983388084,0.6942528735632184,0.8738058297045278,1.0,3/15,9.60%,IGF1;IL6ST;CAMK2D
prerank,mitochondrial fission (GO:0000266),0.31882542822187376,0.8443271832982812,0.6783333333333333,0.971713845626303,1.0,5/16,17.61%,FIS1;PRKN;DNM1L;SLC25A46;MFF
prerank,positive regulation of isotype switching (GO:0045830),-0.29317162632346316,-0.843842679050781,0.6649746192893401,0.8745877901504808,1.0,4/15,12.43%,TFRC;MAD2L2;PAXIP1;SHLD1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2152500970624648,-0.8436915981845775,0.7745664739884393,0.8743544599675938,1.0,8/53,10.04%,APOE;FBXW7;PRKACA;PSME2;PSMC6;GNA12;XPO1;RAD23B
prerank,TOR signaling (GO:0031929),0.2785675603289858,0.8436638192143472,0.6866883116883117,0.9724415587462278,1.0,9/26,28.38%,RPTOR;RPS6KB1;PRR5;FLCN;SMG1;RHEBL1;MEAK7;EIF4EBP1;TIPRL
prerank,protein import into mitochondrial matrix (GO:0030150),0.3095696485397937,0.8434499202932156,0.6733668341708543,0.9722267034468267,1.0,5/18,22.82%,TOMM40L;TIMM21;TOMM70;TIMM23;TIMM44
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2397358082650181,0.8434170670905833,0.7336244541484717,0.9716046201777385,1.0,7/54,8.76%,IVNS1ABP;CAPN3;SOX4;NXN;ARRB2;MINAR1;OGT
prerank,regulation of cilium assembly (GO:1902017),0.23552944306272922,0.8432998062310334,0.7354651162790697,0.9711639288804281,1.0,22/62,28.99%,IFT20;SGSM3;MAPK15;LIMK2;CDKL5;TBC1D16;RABEP2;ARHGAP35;TBC1D8;IFT88;CDK10;TCHP;CYLD;CDKL1;CEP120;TBC1D30;FUZ;TBC1D22B;TBC1D24;ENTR1;TBC1D9B;DCDC2
prerank,coenzyme A metabolic process (GO:0015936),0.32044139450058884,0.8427738370592093,0.6716417910447762,0.9715794398059953,1.0,5/14,16.10%,PPCDC;COASY;DCAKD;ACLY;PPCS
prerank,endosome organization (GO:0007032),0.25313315657904306,0.8424857870757952,0.7089783281733746,0.9714810403630121,1.0,10/41,18.74%,ANXA8;ANXA8L1;USP50;PI4K2A;TMEM9;HOOK2;VPS33B;ALS2;SNX33;HOOK1
prerank,protein import into nucleus (GO:0006606),-0.20269545427190994,-0.8424790054415137,0.8181818181818182,0.8762818631209736,1.0,19/66,22.21%,CBLB;KPNB1;RANBP2;KPNA2;SYK;EIF4ENIF1;NUP153;PTTG1IP;NUTF2;HIKESHI;NXT1;RGPD1;NUP62;IPO7;IPO13;KPNA3;APPL2;RANBP6;SPRN
prerank,negative regulation of transposition (GO:0010529),-0.2985097813890526,-0.8422760360174273,0.6708860759493671,0.8761352977182848,1.0,9/16,41.68%,PIWIL2;TDRD9;MYBL1;AICDA;PIWIL4;PIWIL1;TUT7;MOV10;UBR2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.23784317935967247,-0.8422619622393274,0.7446236559139785,0.875596936317466,1.0,5/31,11.65%,ALOX5;MOCS2;MOCS1;PYCR2;HSD17B1
prerank,regulation of protein ubiquitination (GO:0031396),0.21568200726476625,0.8416240355273905,0.7940379403794038,0.9726069934159323,1.0,29/108,23.33%,IVNS1ABP;MYCBP2;SOX4;INAVA;NXN;UBE3A;COMMD1;ARRB2;TGFBR1;MINAR1;PRICKLE1;OGT;PRKN;UBE2N;DERL1;NSMCE3;HSPBP1;UBXN1;PRKCG;CENPS;PRMT3;UBE2D1;HDAC3;ARRB1;HSP90AB1;AXIN1;HDAC8;CAMLG;RIPK2
prerank,mRNA stabilization (GO:0048255),-0.22944037635934245,-0.8412668140877166,0.7493188010899182,0.8770266729142563,1.0,18/40,33.39%,NOCT;MAPKAPK2;EIF4ENIF1;TENT5A;SLC11A1;SYNCRIP;LARP1;MYD88;HNRNPC;HNRNPU;TENT5C;VIP;PAIP1;DAZL;THRAP3;HNRNPA0;YBX3;AXIN2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.24300173484269227,0.8411733608742477,0.7492581602373887,0.972914629216373,1.0,10/52,15.56%,HOGA1;FPGS;MTHFD1L;MTHFD2L;ALDH1L1;MDH1;ACOT4;ALDH5A1;SLC19A1;ACLY
prerank,positive regulation of transporter activity (GO:0032411),0.32666883804318386,0.8411150771489657,0.6637323943661971,0.9723397052063029,1.0,3/13,11.52%,SYNGR3;STK39;TRPC6
prerank,cellular response to interleukin-4 (GO:0071353),-0.34749473254909935,-0.8409721671090007,0.6850961538461539,0.8770372038464123,1.0,6/10,36.28%,TCF7;SHPK;GATA3;LEF1;DCSTAMP;RUFY4
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.32120746637849396,-0.8409518276674599,0.6459770114942529,0.8765071585804769,1.0,4/11,21.53%,ARID1B;ZMIZ1;SERTAD2;ZMIZ2
prerank,O-glycan processing (GO:0016266),0.2389819688733266,0.8407420697164669,0.7378787878787879,0.9724651071293835,1.0,13/54,22.98%,B3GNT6;ST6GALNAC2;POFUT1;GXYLT1;C1GALT1;POMGNT1;GCNT4;ST3GAL3;GALNT4;GALNT2;GCNT1;ST6GALNAC4;GALNT9
prerank,tRNA wobble uridine modification (GO:0002098),-0.3046818758178113,-0.8407173254525079,0.6788154897494305,0.8764080450519006,1.0,7/14,24.58%,ALKBH8;MTO1;TRMT9B;KTI12;DPH3;URM1;CTU2
prerank,glutathione biosynthetic process (GO:0006750),0.345784117613015,0.8405825582709145,0.6767857142857143,0.9721152415101747,1.0,3/11,18.66%,GSS;GGCT;CHAC2
prerank,cellular component disassembly (GO:0022411),-0.21808972706413854,-0.8404955575944477,0.7647058823529411,0.8763203964397417,1.0,16/53,21.94%,CD44;CAPN1;SH3PXD2B;CAPN2;CTSL;SCUBE1;LCP1;ADAM8;EXOC8;GSN;TLL2;HTRA1;MMP8;MMP11;TIMP1;NOXO1
prerank,glutathione metabolic process (GO:0006749),0.2551797931589312,0.8402595106098815,0.7357032457496137,0.9720918410173457,1.0,5/38,11.22%,GGT7;GSS;GGT5;GGCT;CTNS
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.2551851528211072,-0.8401713903518464,0.7493261455525606,0.876414154685567,1.0,7/25,12.83%,PTPRC;CCR2;IRF4;ANXA1;IL1B;CD28;STOML2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3004347035443673,-0.839559727827836,0.6898263027295285,0.8770879146586815,1.0,4/15,19.65%,PRKCH;NUMA1;TRIM16;SULT2B1
prerank,positive regulation of T cell migration (GO:2000406),-0.2776079600488847,-0.8394985273581366,0.7183098591549296,0.876643096053924,1.0,6/20,22.59%,CCR2;WNT5A;SPN;ADAM17;CXCL12;APP
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.3298473864625441,-0.8394941141007315,0.6762589928057554,0.8755404210938973,1.0,4/11,15.28%,STAT5B;SYK;SHC1;PTK2B
prerank,cellular response to interleukin-2 (GO:0071352),-0.3298473864625441,-0.8394941141007315,0.6762589928057554,0.8755404210938973,1.0,4/11,15.28%,STAT5B;SYK;SHC1;PTK2B
prerank,T cell mediated immunity (GO:0002456),0.3316289164848999,0.8393823078071696,0.7196581196581197,0.9732102169137953,1.0,2/13,11.30%,CADM1;CRTAM
prerank,response to peptide hormone (GO:0043434),-0.21877395173290148,-0.8392147383391236,0.7839335180055401,0.8755622643230275,1.0,11/43,18.57%,STAT5B;STAT4;STAT2;CAV1;ANXA1;EIF2B2;STAT1;CRY1;EIF2B4;IGFBP5;TRIM16
prerank,response to hexose (GO:0009746),0.27492327695757324,0.8391849219278048,0.723916532905297,0.9729331539308533,1.0,5/25,15.19%,SELENOS;TCF7L2;EIF2B3;KHK;EIF2B1
prerank,regulation of myoblast differentiation (GO:0045661),0.2663538316668605,0.8391487604596825,0.712241653418124,0.9723170662271248,1.0,7/32,20.29%,BOC;MEF2C;BMP4;TGFB1;SMYD1;BTG1;RANBP3L
prerank,cellular response to virus (GO:0098586),0.2707974265517377,0.8387830979303864,0.6971153846153846,0.9724000415539196,1.0,13/30,27.28%,POU2F2;IL6;GSDME;TOMM70;RRP1B;CCL5;EIF5A;ARF1;IRF3;IRGM;POU2AF1;DDX3X;LGALS8
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.2721592387010858,-0.8387767185062216,0.6863270777479893,0.8759192361979481,1.0,4/20,12.50%,CELF1;LIMD1;AJUBA;AGO2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.2210512073924158,-0.8387195767496849,0.7537537537537538,0.8754678985585017,1.0,16/46,26.81%,PTPRC;PTPN1;RANBP9;RPS6KA6;LYN;SPRY2;SEMA6A;SPRY1;TLR4;SMAD4;TNIP1;GSTP1;DUSP3;TIMP3;FBLN1;SPRED1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.29453486601812495,0.8386834203296348,0.6839378238341969,0.9719176276138654,1.0,5/20,9.91%,TGFBR3;TGFBR1;BMP4;HEY1;SNAI2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.27289058184581705,-0.8386533591083689,0.7213541666666666,0.8750266737217861,1.0,10/20,38.10%,ADCY9;DRD2;ADRA1A;DRD3;GPR101;ZDHHC21;PDE4D;DRD1;ADRA2C;ADRB2
prerank,regulation of neuron differentiation (GO:0045664),0.22377189240853246,0.8385483276037862,0.7586206896551724,0.9715241133307009,1.0,20/76,25.64%,ZFHX3;BIN1;NEUROD2;MEF2C;HEY1;NRCAM;BEND6;EIF2AK4;VWC2;REST;TCF3;ROCK1;ZEB1;NREP;IMPACT;ZC4H2;BDNF;TIAM1;RHOA;DISP3
prerank,regulation of centrosome cycle (GO:0046605),-0.27426058855637936,-0.8382502343558224,0.7051597051597052,0.8752697774794098,1.0,8/21,24.25%,CHMP4B;ATF5;PDCD6IP;CHMP1B;NPM1;NAT10;MARK4;PKHD1
prerank,macrophage activation involved in immune response (GO:0002281),-0.3145438716504921,-0.8373692022631977,0.6770334928229665,0.8764254164381189,1.0,4/13,14.57%,TYROBP;SYK;DYSF;LBP
prerank,import into nucleus (GO:0051170),0.2263021151427243,0.8372501681113919,0.7861189801699717,0.973593538523661,1.0,18/73,20.69%,TSC2;FAM53C;NXT2;PRICKLE1;HEATR3;FAM53B;SNUPN;SNRPD2;NUP88;IPO5;HNRNPA1;NUP133;GEMIN5;GEMIN6;BACH2;SNRPD3;IPO8;POM121
prerank,regulation of protein metabolic process (GO:0051246),0.2456439620378807,0.8368955772002903,0.750367107195301,0.9736651977518566,1.0,14/44,21.35%,IL17F;CNDP1;MAP2K5;FAF1;CENATAC;ZDHHC2;TMEM9;NEDD4L;SSH1;CHRNA7;LTBP4;SNF8;HSP90AB1;ABCA7
prerank,positive regulation of lipid catabolic process (GO:0050996),0.29673258687781845,0.8368113452476343,0.6817420435510888,0.973158434372876,1.0,6/19,22.70%,PPARA;IRS1;ABHD5;ANGPTL3;ABCD2;DAGLB
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.2882373919701886,0.8366440303788513,0.6919191919191919,0.9728051891967915,1.0,8/21,22.46%,HS3ST5;GPC1;HS6ST3;HS6ST1;B3GAT3;SULF2;SGSH;EXT2
prerank,protein localization to nucleus (GO:0034504),0.21485336477664133,0.8363269933910055,0.8054794520547945,0.972799508340164,1.0,17/102,16.18%,HHEX;TSC2;YWHAE;SIX4;FAM53C;NXT2;PRICKLE1;BMP4;HEATR3;FAM53B;NUP88;ARL2BP;CHCHD10;IPO5;TAF3;NUP133;PAF1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2604637671949366,0.8362679624824348,0.711755233494364,0.9722387129868203,1.0,9/32,17.40%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,extracellular matrix assembly (GO:0085029),0.28714875398500517,0.8362200739476086,0.7034596375617792,0.9716505886428258,1.0,7/23,18.43%,LTBP3;LAMB3;TGFB1;PXDN;NTNG2;NTNG1;QSOX1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.2709375772946241,0.8358785743583305,0.7101449275362319,0.9717126459916616,1.0,9/30,21.56%,IL17F;FSTL1;TGFBR3;TGFB1;ENG;LTBP4;NREP;SMAD2;LATS1
prerank,activation of GTPase activity (GO:0090630),-0.19300188470072052,-0.8354381158171524,0.8741721854304636,0.8797312871571801,1.0,22/89,18.94%,TBC1D1;DOCK7;CORO1C;CCDC125;SLC27A4;RABGAP1;TBC1D2;ARHGAP24;ABR;RALGAPA2;FOXJ1;ARHGEF26;TBC1D10C;TBC1D10A;GPR65;USP6NL;ADPRH;EPHA2;ARHGEF5;TBCK;ECT2;TBC1D22A
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.27596814366070754,-0.8349036908721272,0.7139423076923077,0.8802157337911057,1.0,5/17,22.93%,ADCY9;DRD2;ADRA1A;DRD3;GPR101
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2748375774930949,0.834830561226219,0.6965742251223491,0.9732605757237173,1.0,6/28,15.23%,C3;NOS1AP;EIF6;CX3CR1;CTNS;FITM2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.35094930685957326,0.8348295637844053,0.6538461538461539,0.9725702444946299,1.0,1/10,7.89%,CNGB1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.20204147573932152,-0.8346786994242079,0.8464285714285714,0.8801100256562608,1.0,18/75,20.01%,APOE;CD300A;STK38;PTPN1;PKIB;LYN;IL1B;SPRY2;SPRY1;RB1;INPP5K;DUSP1;SPRY4;PLK1;IPO7;LRP6;CDKN2A;BMP7
prerank,negative regulation of cellular senescence (GO:2000773),-0.3138897757207141,-0.8345002578695605,0.6739130434782609,0.8799068327677086,1.0,6/13,27.88%,CDK6;TERF2;HMGA2;TWIST1;TERT;SLC30A10
prerank,acetyl-CoA metabolic process (GO:0006084),0.31629234371167964,0.8343757949224001,0.6707964601769911,0.9728261811061207,1.0,8/15,32.37%,ACLY;PPCS;ACACB;ACSS1;HMGCS1;DIP2A;ACAT1;MLYCD
prerank,regulation of protein localization to centrosome (GO:1904779),-0.34703597029065175,-0.8343232104108094,0.6607929515418502,0.8796909470593803,1.0,5/10,23.41%,CEP250;UBXN2B;NUP62;PARD6A;MARK4
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.26901006039658265,-0.8342855202441339,0.7381546134663342,0.8792104582297005,1.0,7/22,23.78%,PTPA;BOD1;CRY2;TNF;PPP1R15A;BOD1L1;MASTL
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2312027599803389,-0.8340115509864569,0.776,0.8791936016669532,1.0,5/39,6.67%,MYO5A;TRAK1;RAB1A;MYO1F;MYO15A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3215853329465353,-0.833903395329707,0.6857142857142857,0.8788303634325103,1.0,5/11,21.64%,GNPDA1;UAP1L1;GNPNAT1;NAGK;RENBP
prerank,protein destabilization (GO:0031648),0.26190459249107967,0.8338071791702877,0.7172523961661342,0.9733418719774471,1.0,9/32,18.77%,GGA3;CAPN3;PRNP;BTRC;PRKN;DERL1;SERF2;PEX2;FBXL3
prerank,histone H3 acetylation (GO:0043966),0.2489770292761821,0.8328226919914555,0.7282282282282282,0.9747044144227182,1.0,6/40,11.83%,LDB1;JADE2;MEAF6;TADA3;TAF9;MAP3K7
prerank,cellular response to leucine starvation (GO:1990253),0.3560462958666507,0.8328220497966499,0.7084048027444254,0.9740161391803558,1.0,6/10,31.35%,EIF2AK4;IMPACT;RRAGD;GCN1;SESN3;RRAGB
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.17879825948492756,0.8327548815071929,0.9655891553701773,0.9734714901143673,1.0,167/834,20.63%,ZFHX3;HOXA5;HHEX;AGRN;BCL9L;CDK7;MPND;TET1;ZFPM1;DRAP1;IL4I1;LDB2;LDB1;MED24;ONECUT2;WWTR1;BPTF;CSRNP3;POU2F2;USF2;HOXD4;TFCP2;PTPRN;TXK;KDM6B;NR1I2;FOSL1;NRL;NR1I3;NFIB;RELA;PPARGC1A;MEOX2;WBP2;SOX4;BCL11B;MED4;PPARA;PBX2;BRD8;HOXB7;E2F1;GABPB1;IL6;ZFPM2;CRTC1;XRCC6;RFX6;KDM1B;MEF2C;AR;DPF2;RXRG;BCLAF3;GTF2F1;FUBP3;AKAP8L;HOXC10;MYO6;DAB2IP;APBB1;SS18;MACC1;LHX3;LMO2;BMP4;CD81;TCF7L2;ADCYAP1;OGT;MAP2K5;PRKD2;PKD2;FOXC1;HEY1;HDAC5;GRIN1;ZNF462;RNASEL;TGFB1;TAF9;MEPCE;MAML3;PRKN;KLF7;SS18L1;ITGB1BP1;AKIRIN2;GRHL3;HSF2;FGF2;NFE2L2;PTOV1;SMARCD3;MLLT6;HOXB2;KAT8;RFXAP;WWC1;USF1;GABPA;EPAS1;HLF;TFEB;PKD1;PDGFB;PARP1;PFKM;SUB1;PLAG1;FLCN;EAF2;BARX2;HMGB1;CCNK;LMX1B;ZBTB49;RBL1;APEX1;PRDM10;BRD4;GAL;IRF5;ERG;WNT7A;REST;TCF3;MAPK3;PRKD1;PRDM15;MED25;CALCOCO1;SETX;RRP1B;HRAS;RHOQ;ITGA6;ENG;TMPRSS6;TLR3;ZNF750;XBP1;RGMA;IL18;MAX;FOSL2;ECD;PIN1;HDAC3;ZBED4;DVL2;DCN;BMPR1B;REL;RORA;TNIP2;ATAD2;EIF5A;COPS5;SRF;DHX36;ARRB1;IRF2BPL;RNF10;SMAD2;SMAD1;GLI3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.2662684576063389,0.8326538984306675,0.7317829457364341,0.9730002853066742,1.0,6/32,10.75%,SRPX2;MEOX2;MAP2K5;HDAC5;ITGB1BP1;FGF2
prerank,negative regulation of cellular component organization (GO:0051129),0.226767875372972,0.832206918094865,0.7851959361393324,0.973240303909057,1.0,24/74,25.30%,SCAMP5;HSPA2;TMC8;PEX5;PRKCZ;CLU;AR;RAPGEF3;PRKD1;SNX33;OPRD1;XRCC5;CDC42;RDX;ABCA7;PACSIN3;ULK1;IMPACT;WASL;AIDA;SYT11;TMEFF2;CRYAB;DDX3X
prerank,keratan sulfate metabolic process (GO:0042339),0.2634852281394012,0.8319477005459699,0.7156398104265402,0.9730869978494551,1.0,3/31,2.81%,HEXB;B4GAT1;ACAN
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2652551163128462,-0.8319377655419894,0.7045454545454546,0.881986262856633,1.0,2/22,1.32%,VPS37C;PTPN23
prerank,negative regulation of cell division (GO:0051782),0.3412042006938616,0.8318547146828931,0.6909413854351687,0.9725886176065761,1.0,2/11,11.24%,SUSD2;ZFYVE19
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.21496471223959512,0.831458823631554,0.8153409090909091,0.9727280812000912,1.0,24/94,21.81%,PSMB1;RELA;UBE2V1;IL1RAP;PSMF1;BTRC;PSMA1;NOD1;PSMD7;PELI3;PSMA8;UBE2N;PSME3;MAP3K7;PSMD14;PSMC4;MAPK3;IL1A;PSMB4;TNIP2;PSME1;PSMD2;PSMD4;PSMD8
prerank,protein kinase B signaling (GO:0043491),0.2843168477323313,0.8309002421701207,0.7184942716857611,0.9732266333113434,1.0,4/23,9.72%,TSC2;ADTRP;TGFB1;PLK3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3128658874922687,0.8306407270034104,0.7008547008547008,0.9730854596965721,1.0,3/16,11.30%,CADM1;SLAMF6;CRTAM
prerank,regulation of transmembrane transport (GO:0034762),0.26331338733473814,0.8306263325315439,0.7384370015948963,0.972425508477906,1.0,8/31,19.00%,KCNJ3;KCNJ8;KCNJ13;NEDD4;NEDD4L;KCNJ5;CTTNBP2NL;ACTB
prerank,positive regulation of cell cycle (GO:0045787),0.23247985237277524,0.830618214263965,0.7704918032786885,0.9717559275309002,1.0,11/62,14.66%,PSRC1;SMOC2;LGMN;RPS6KB1;CCND3;PRKCA;CCDC57;PKD2;PKD1;PDGFB;TGM1
prerank,ruffle organization (GO:0031529),-0.2912964674378194,-0.8305476319816175,0.7115384615384616,0.8841217977621002,1.0,10/16,38.84%,CARMIL1;INPP5K;LIMA1;AIF1L;RAC1;PLEK;ARF6;CCR7;TPM1;PIP5K1A
prerank,endoplasmic reticulum organization (GO:0007029),0.22591221093670086,0.8303810979197032,0.7687776141384389,0.9715922049414277,1.0,15/72,15.74%,SEC16B;REEP2;ATL1;SGTA;PRNP;MAPK15;SEC31A;OTOF;EMD;TRAM2;CCDC47;DNM1L;MOSPD3;TRAM1;MIA3
prerank,fatty acid catabolic process (GO:0009062),-0.20435908939043027,-0.8303728233971224,0.8032258064516129,0.8838997708193758,1.0,10/67,10.06%,ACOT8;AIG1;SLC27A4;MTLN;PPARD;DECR1;ACAA2;CROT;PEX13;ACAD10
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.27142369652838355,-0.8302496065646423,0.7208121827411168,0.8835920709804518,1.0,8/21,23.78%,ENSA;PTPA;BOD1;CRY2;ARPP19;PPP1R15A;BOD1L1;MASTL
prerank,positive regulation of glial cell differentiation (GO:0045687),0.30439081771688953,0.830143401827839,0.7035175879396985,0.9713704308171995,1.0,6/17,20.16%,BIN1;TGFB1;CLCF1;CXCR4;SERPINE2;IL34
prerank,wound healing (GO:0042060),0.23353745052913594,0.8295581524467395,0.7670850767085077,0.9718717152119601,1.0,6/62,3.46%,FGF10;FUT10;DST;RAB3A;PAK1;SYTL4
prerank,positive regulation of phosphatase activity (GO:0010922),-0.2674056732672743,-0.8291576522343811,0.7369791666666666,0.8851315780766615,1.0,8/21,19.89%,CD300A;PTPA;CALM3;CALM2;BMP2;ITGA1;PPP1R15A;CHP2
prerank,transcription by RNA polymerase II (GO:0006366),0.18766375629660942,0.8289945039348685,0.8895417156286721,0.9723761740867185,1.0,72/305,22.53%,POLR2L;CDK7;CTR9;DRAP1;RTF1;WWTR1;POLR2F;POU2F2;NELFB;TFCP2;ESRRG;DDX5;NR1I2;NR1I3;ELP2;PPARGC1A;GTF2H2;MED4;PPARA;NELFCD;ELOC;SSRP1;NR2F6;AR;GTF2H4;RXRG;ARRB2;GTF2F1;GTF2I;MAZ;NCOR2;GTF2E2;HDAC5;TAF9;MAML3;ZC3H8;CPSF3;INTS10;POLR2G;PARP1;EAF2;CSTF1;CCNK;NUDT21;TAF3;ERCC6;PAF1;SETX;INTS8;XBP1;TEAD3;ZBTB7B;HDAC3;SNAPC3;TAF9B;SNRPD3;INTS5;ELOF1;RORA;INTS9;SSU72;MED23;INTS11;NABP1;NFE2L3;RPAP1;TEAD2;POLR2C;TAF4;SCAF8;GTF2H3;MAML2
prerank,regulation of superoxide anion generation (GO:0032928),-0.2969173503019352,-0.8288263651945188,0.6964285714285714,0.8852157997663248,1.0,7/14,34.54%,TYROBP;SYK;GSTP1;CD177;FPR2;ITGB2;CRP
prerank,regulation of fat cell differentiation (GO:0045598),0.22437132034543494,0.8287012637970399,0.7837037037037037,0.9722866982481724,1.0,10/74,9.35%,ZFPM1;WWTR1;GNB3;RARRES2;E2F1;IL6;ZFPM2;TRIB2;ZFP36L2;TGFB1
prerank,retina homeostasis (GO:0001895),0.2812969169687785,0.8285496432145362,0.7078464106844741,0.9719205935800415,1.0,4/23,19.00%,WHRN;CNGB1;POTEF;ACTB
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.21090827928403516,-0.8284408817800005,0.8239202657807309,0.8853822744240187,1.0,16/52,25.73%,CNOT9;SAMD4A;EXOSC8;DDX6;DCP1B;RC3H1;LSM2;LSM5;EXOSC9;RC3H2;LSM7;PAN3;CNOT6L;EXOSC1;EXOSC7;TNKS1BP1
prerank,regulation of phosphatase activity (GO:0010921),-0.25845246397010124,-0.8271890993103865,0.760705289672544,0.8871595306380805,1.0,12/24,28.03%,PPP6R1;PTPA;PPP6R3;PPP1R35;BMP2;PPP1R2;CHP1;CHP2;SH2D4A;PPP1R26;PPP1R17;TSC1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3292112796233483,-0.8271482757436914,0.6893617021276596,0.8861159240025815,1.0,1/10,4.69%,CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3292112796233483,-0.8271482757436914,0.6893617021276596,0.8861159240025815,1.0,1/10,4.69%,CEP250
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.23193842082664506,0.8269868338312685,0.7647058823529411,0.9744832228834625,1.0,10/57,10.78%,FIS1;ASPH;PDCD5;LGMN;USP50;NOD1;BAK1;GRIN1;GRIN2B;PDCD6
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.34164565520602586,0.826796491791327,0.6939130434782609,0.9741978950086293,1.0,2/10,6.94%,AREG;ADRA2A
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2734505412030086,-0.8266737287229218,0.729064039408867,0.8864825180369977,1.0,6/18,25.96%,WDR43;PTN;HMGA2;ESRRB;TAF6L;ZC3H13
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3120122743993921,-0.8265344796475015,0.7270642201834863,0.8862098060958524,1.0,1/12,1.06%,ACOT8
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.19938329150371203,0.826451297412474,0.8467635402906208,0.9742460311715367,1.0,39/152,22.05%,FGF10;HHEX;UBE2B;PSMB1;LBX2;SOX4;TMEM198;PTK7;PSMF1;PSMA1;GPC5;PSMD7;PPM1A;FAM53B;TGFB1;PSMA8;SPIN1;PPM1N;PSME3;SFRP1;PSMD14;LRRK1;PSMC4;TMEM9;CCAR2;PRDM15;CSNK1G3;PSMB4;PIN1;RSPO1;WNK1;SULF2;PSME1;PSMD2;PSMD4;RSPO2;PSMD8;AXIN1;SFRP2
prerank,negative regulation of cell cycle process (GO:0010948),-0.2053595529929489,-0.8264466220090072,0.8401162790697675,0.8858306008894751,1.0,15/61,20.01%,EPC1;RBBP8;RBBP7;BRCA1;BMI1;EHMT1;ESPL1;RYBP;E2F8;L3MBTL2;TERF2;E2F7;NME6;EED;BMP7
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.25219998262689736,-0.8258411779565353,0.7647058823529411,0.886407658720504,1.0,7/25,19.90%,STAT5B;HMGB2;HIF1A;STAT1;FAM210B;HSPA1B;ACVR2A
prerank,cholesterol biosynthetic process (GO:0006695),0.263690240091149,0.825231194195647,0.7326283987915407,0.9760338703510446,1.0,6/31,18.82%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.2716488510636124,-0.824946161731237,0.7149532710280374,0.8875943257545618,1.0,5/19,13.52%,NRP1;LIMS1;S100A10;KDR;MYOC
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.2949713138004127,0.8249406089009507,0.7212317666126418,0.9759548951850971,1.0,4/20,10.75%,SMOC2;GPC1;PRKD2;FGF2
prerank,modulation by host of symbiont process (GO:0051851),0.26253310151753756,0.8247879432005946,0.7508250825082509,0.9755772882101625,1.0,8/31,19.32%,NUCKS1;CX3CR1;SAP30BP;NAPEPLD;HPN;REST;RRP1B;CCL5
prerank,regulation of mRNA catabolic process (GO:0061013),-0.18306311001349115,-0.8242361845404832,0.890625,0.8884041548456888,1.0,25/121,18.03%,PSMA6;PSMB2;MAPKAPK2;PSME2;SAMD4A;PUM2;PSMD11;PSMC6;UBC;PSMA3;EXOSC8;UBA52;ZC3H12A;VIM;XPO1;RC3H1;PSMD10;EXOSC9;PSMB5;HSPB1;RC3H2;FXR2;PSMD5;ZC3HAV1;HNRNPD
prerank,DNA catabolic process (GO:0006308),0.34280001281068256,0.8238926768538206,0.6983842010771992,0.9767545660734712,1.0,2/11,5.23%,DNASE1;DNASE1L2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.33160575961827454,0.8237896249153109,0.7140495867768595,0.9762602400978115,1.0,2/11,10.80%,WRAP53;CCT4
prerank,negative regulation of protein secretion (GO:0050709),0.25292869920088223,0.8236541661582583,0.7605633802816901,0.9758755105434628,1.0,11/38,23.25%,ADTRP;RAB11FIP3;ADRA2A;PRKN;IRS1;SFRP1;REST;OPRM1;ERP29;MIDN;CHGA
prerank,Wnt signaling pathway (GO:0016055),-0.1932235688045667,-0.8235992580564185,0.8646616541353384,0.8890646291030342,1.0,15/92,12.54%,CSNK1G1;VPS26A;DVL3;DIXDC1;VPS35;CCDC88C;CD24;UBC;CPE;WNT2B;UBA52;CTNNB1;FZD2;LRRK2;TCF7
prerank,dicarboxylic acid transport (GO:0006835),0.2704629569678465,0.8234573081906544,0.7555555555555555,0.975575413873007,1.0,6/28,14.50%,GIPC1;SLC1A1;SLC25A18;SLC26A7;SLC1A3;SLC19A1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.26263078631216114,0.823314331024692,0.7492211838006231,0.9751851073052028,1.0,7/30,17.39%,FLT4;PLD4;BMP4;TGFB1;SFRP1;BATF;FLT3
prerank,alanine transport (GO:0032328),-0.3350866488526403,-0.8226925674019016,0.6822222222222222,0.8901306874678253,1.0,2/10,9.21%,SLC6A6;SLC6A17
prerank,reverse cholesterol transport (GO:0043691),-0.3113999467416215,-0.8222593230320974,0.6885245901639344,0.8903848068894222,1.0,2/13,9.43%,APOE;ABCG1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.19659451444494797,-0.8220855410900677,0.8466898954703833,0.8901680350958628,1.0,10/73,7.94%,ITCH;PSMA6;TCF12;PSMB2;PSME2;KITLG;PSMD11;PSMC6;YAP1;PSMA3
prerank,neutrophil migration (GO:1990266),-0.2040086544679041,-0.8219916458670756,0.8721311475409836,0.8897933559674531,1.0,24/58,37.82%,GBF1;CCL25;PF4;SYK;JAML;IRAK4;FCER1G;PIK3CD;CCL7;PRTN3;CCL24;CD177;CXCR2;ITGB2;TGFB2;CKLF;PPIA;EDN3;CCL8;CXCL9;EDN2;EDN1;CXCL1;PECAM1
prerank,organonitrogen compound catabolic process (GO:1901565),-0.2059309659827431,-0.8218955158651268,0.8421052631578947,0.8894242430537888,1.0,18/57,23.91%,SGPL1;ANPEP;CPQ;GNPDA1;CLN8;CLN5;ERAP1;LTA4H;UCHL3;MPST;NAGK;GADL1;CTH;ADO;RENBP;PLA2G7;RIDA;NPL
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2531307647235138,-0.8218513324598736,0.742296918767507,0.8889596123216019,1.0,10/27,21.75%,FBXL17;FBXL8;CRY2;CRY1;SIK1;PDE6B;PER2;FBXL12;BHLHE40;ID2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.26922022092364883,0.8213127841609911,0.735632183908046,0.978439362519422,1.0,4/25,6.32%,ANG;NCKAP1L;DSCAM;AR
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3006280323260355,-0.8212160553105012,0.699228791773779,0.8895973408580309,1.0,2/13,7.28%,ACOT8;GOT1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3103930262939467,-0.8211541358873156,0.7182741116751269,0.8891518430179425,1.0,1/13,0.97%,IGF1
prerank,regulation of response to interferon-gamma (GO:0060330),0.3217857773426089,0.8211041182209211,0.6895910780669146,0.9781737597688397,1.0,6/14,28.54%,SOCS3;PTPN2;IFNGR1;HSP90AB1;SUMO1;CDC37
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.20841994050438775,-0.8210730967525148,0.845679012345679,0.8887653953856766,1.0,6/57,6.83%,IL15;IGF1;PARP14;PIBF1;IL6ST;LYN
prerank,cellular iron ion homeostasis (GO:0006879),-0.20663563448484207,-0.8209103371093758,0.8061538461538461,0.8885124457604334,1.0,16/55,23.19%,ATP6V0D1;TFRC;SLC46A1;NUBP1;CP;SLC11A1;ATP6V1A;LCN2;FTL;HMOX1;SMAD4;CYBRD1;NDFIP1;HEPH;ALAS2;FBXL5
prerank,cholesterol homeostasis (GO:0042632),0.22483622554908553,0.8208077012001724,0.8105413105413105,0.9780674804947245,1.0,15/64,19.61%,DGAT2;ABCG8;AKR1C1;SOAT2;CYP39A1;EHD1;MTTP;ABCA2;ANGPTL3;FABP3;LIPC;XBP1;IL18;TTC39B;RORA
prerank,protein import (GO:0017038),0.2145561884328517,0.8201066016230536,0.8217270194986073,0.978800479719046,1.0,35/84,30.92%,TSC2;PEX5;FIS1;FAM53C;CLU;ATAD1;NXT2;PRICKLE1;PEX26;HEATR3;FAM53B;NUP88;PEX14;IPO5;NUP133;PEX2;ABCD2;SNX33;IPO8;POM121;PEX11B;PEX3;RANBP17;TOMM22;IPO9;PXMP4;ABCD3;ACBD5;NUP107;NUP155;NUP85;MMP12;TPR;SEC13;PEX12
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2243565983612225,0.8198117524735484,0.7913669064748201,0.9787404377906903,1.0,17/70,21.54%,DCC;BLOC1S2;G0S2;MLLT11;DAB2IP;BAK1;TGFB1;CASP3;IFI27;ACVR1B;SORT1;DDX47;TLR3;CASP8;GABARAP;PDPK1;CASP2
prerank,BMP signaling pathway (GO:0030509),0.22910463324853841,0.8196954039565812,0.7987987987987988,0.9782888453764823,1.0,14/62,20.63%,DDX5;MEGF8;SLC33A1;TGFBR3;BMP4;TGFB1;AMHR2;MAPK3;GDF1;ENG;RGMA;BMPR1B;SMAD2;SMAD1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.35213999700922266,0.819471468126344,0.7060931899641577,0.9780920464644756,1.0,4/10,15.11%,HECW2;NEDD4;STK39;NEDD4L
prerank,regulation of translational initiation (GO:0006446),-0.20324993904995653,-0.8194353555812032,0.8438438438438438,0.8906170846597975,1.0,14/63,15.39%,ATF3;EIF4B;NCBP1;NCK1;CEBPB;EIF4EBP2;EIF2B2;UHMK1;AGO2;PAIP2B;LARP1;MIF4GD;NPM1;HSPB1
prerank,synaptic vesicle transport (GO:0048489),0.34096667920850143,0.819319124885003,0.6701754385964912,0.97770652974991,1.0,3/11,20.99%,SNAPIN;SPG11;TMEM230
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2884509303648638,0.8190084239495976,0.6988543371522095,0.9776244871898728,1.0,7/21,20.28%,MED24;FOSL1;MED4;SUB1;SETX;SRF;DHX36
prerank,urogenital system development (GO:0001655),-0.32680296807288156,-0.8189441524992889,0.6875,0.8909640999756653,1.0,6/11,40.84%,ANXA1;LHX1;SHH;PAX8;OSR1;SOX9
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.24022037535924828,-0.8189147078984477,0.7560321715817694,0.8904667040743166,1.0,11/30,25.80%,BCL2L1;FAS;RIPK1;BRCA1;BMP5;GPX1;HMOX1;ARHGEF2;TNFSF10;FADD;TMBIM1
prerank,carnitine metabolic process (GO:0009437),0.32463108555865317,0.8188254195675342,0.7125850340136054,0.9772840104479142,1.0,2/12,6.95%,CPT1B;ALDH9A1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.31088724265744544,-0.818819585850671,0.7165178571428571,0.8901068385539175,1.0,5/12,28.30%,TAF1;TAF12;TAF7;GTF2A2;TBP
prerank,positive regulation of phospholipase activity (GO:0010518),0.2799835295841395,0.8187031474868022,0.729818780889621,0.9768753246166043,1.0,7/22,20.75%,NTRK3;PLCG1;FGF2;HRAS;CCL5;PDGFRB;PDPK1
prerank,negative regulation of signal transduction (GO:0009968),0.18869704648148605,0.8186429149340866,0.907673860911271,0.9763261254323229,1.0,65/249,24.72%,HHEX;TSC2;DCC;HIC1;CYP26C1;MEGF8;PTPRT;GPC1;PRKCZ;TCIM;NXN;TRIB1;LGMN;RPS6KB1;UBASH3B;TSPAN15;CACTIN;BTRC;MAZ;DAB2IP;EGFL7;KIF26A;HEY1;MGRN1;CX3CR1;SNAI2;NEDD4;FGF2;DDIT4;PDCD6;IRS1;SFRP1;CRHBP;NDRG4;ARRDC1;BEND6;APOD;PTPN2;CADM4;SIAH1;CARD16;RGS2;SUFU;AGT;PALM;LRRC14;DCN;CCL5;SULF2;ARRB1;GLI3;RNF43;YWHAB;FRZB;SFRP2;PIP4K2B;TULP3;TMEM25;HIF1AN;BDNF;GPS2;CXXC4;TMBIM6;ASXL1;PIP4K2A
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.2741958997651824,-0.8180564152557619,0.7188264058679706,0.8909450969607173,1.0,9/19,38.81%,GOT1;ALDH7A1;PIPOX;AASS;SDS;HYKK;PHYKPL;CRYM;GOT2
prerank,negative regulation of bone remodeling (GO:0046851),0.3319345195906151,0.817979651518166,0.7201365187713311,0.9769860949312419,1.0,3/11,11.54%,IL6;UBASH3B;SFRP1
prerank,cell-matrix adhesion (GO:0007160),0.21442938495288263,0.81749056771135,0.820855614973262,0.9772513310939033,1.0,17/95,15.06%,CTTN;MKLN1;CD34;STRC;THY1;ITGB6;ITGB5;TRIP6;SGCE;ACTN2;ITGB1BP1;ADAM15;ITGA10;NPNT;PKD1;VTN;RCC2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.2669196322160115,0.8174009367183045,0.7387096774193549,0.9767606286712679,1.0,8/27,17.93%,F11R;RHPN2;CLASP2;SHANK3;PRKN;PHLDB2;SHANK1;WASF2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.2540333524282607,-0.8170159620573505,0.799492385786802,0.8922643003622369,1.0,7/24,13.79%,IGF1;PPP1R3C;IGF2;SORBS1;PPP1R3F;PPP1R3E;INPP5K
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.28153176805206936,-0.8168776774780283,0.743073047858942,0.891969790075971,1.0,3/17,8.49%,MPDU1;ALG12;ALG13
prerank,response to cAMP (GO:0051591),0.24941473595834063,0.8166728272874904,0.7592891760904685,0.9775139934873771,1.0,6/37,12.73%,HCN1;DGKQ;RAPGEF3;PKD2;CFTR;CRHBP
prerank,spinal cord development (GO:0021510),0.32932410044529803,0.81660115432068,0.7083333333333334,0.9769988163156331,1.0,3/12,12.51%,SOX4;PKD2;PKD1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.3372156139916497,0.81638276281857,0.7274305555555556,0.9767729344084862,1.0,1/11,3.68%,NEUROD2
prerank,cellular response to hexose stimulus (GO:0071331),0.2749101841383157,0.8159816472919339,0.7265500794912559,0.9768747802848461,1.0,3/23,4.45%,ADCY8;TRA2B;SOX4
prerank,regulation of actin filament-based movement (GO:1903115),0.3501782502887474,0.8159718098788399,0.7018181818181818,0.9762164696304609,1.0,2/10,17.90%,MYBPC3;ANK2
prerank,platelet aggregation (GO:0070527),-0.2307329380464123,-0.8159537724837399,0.7768595041322314,0.8930978843020494,1.0,17/33,33.16%,ACTN1;VCL;HSPB1;MYH9;FLNA;FN1;PDGFRA;ITGB3;FIBP;TLN1;MYL12A;CLIC1;ILK;PLEK;RAP2B;MYL9;PPIA
prerank,aminoglycan catabolic process (GO:0006026),0.262924671742864,0.8159298012423358,0.734959349593496,0.9756305201927212,1.0,5/28,8.57%,AGRN;OVGP1;GPC1;GPC2;GPC5
prerank,protein deacylation (GO:0035601),0.27960938823333187,0.8158262903045893,0.7332214765100671,0.9751654696337575,1.0,5/23,18.86%,LYPLA1;HDAC5;LYPLAL1;HDAC3;ABHD17C
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.21555900791073906,-0.8158153775255087,0.8317152103559871,0.8928175461074814,1.0,17/48,24.85%,P2RX4;THBS1;SP1;ANXA1;CIB1;HIF1A;RHOJ;KDR;HSPB1;HMOX1;NUS1;ADAM17;TMSB4X;FGF18;FGFBP1;MAP2K3;ANGPT1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.29316403908528244,0.8158101383319637,0.7052810902896082,0.9745264460025278,1.0,7/18,23.02%,ACSL6;ELOVL6;TECR;ACSF3;ACSBG1;ELOVL5;ACSL3
prerank,cell-cell junction maintenance (GO:0045217),-0.32299905026554676,-0.8150112616750665,0.6946386946386947,0.8936986970370584,1.0,6/11,27.56%,PARD6A;MYADM;NLGN2;PRTN3;TJP1;CD177
prerank,extracellular matrix disassembly (GO:0022617),-0.20987334763597695,-0.8149641345988536,0.8384401114206128,0.8932289968735251,1.0,16/53,21.94%,CD44;CAPN1;SH3PXD2B;CAPN2;CTSL;SCUBE1;LCP1;ADAM8;EXOC8;GSN;TLL2;HTRA1;MMP8;MMP11;TIMP1;NOXO1
prerank,endocardial cushion morphogenesis (GO:0003203),0.2924803348069551,0.8144189623782941,0.7179930795847751,0.9765796845284186,1.0,5/18,21.45%,BMP4;HEY1;TBX2;ENG;MDM4
prerank,protein O-linked glycosylation via serine (GO:0018242),0.34068672983474213,0.8143862281731867,0.6987740805604203,0.975970799259971,1.0,5/10,30.67%,MGAT5B;GALNT4;GALNT2;GALNT3;GALNT13
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3251117193151253,0.8140604369336097,0.743455497382199,0.9759114011581531,1.0,2/13,8.54%,BLOC1S2;RHOT1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.27599252142600117,0.813964239772874,0.7516025641025641,0.975449367233335,1.0,7/24,17.88%,SELENOS;CLU;PRKN;HERPUD1;TXNDC12;UBXN1;XBP1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.286705112655748,0.8139231718230775,0.7205651491365777,0.9748570506030638,1.0,5/20,12.83%,PSRC1;CCND3;PKD2;PKD1;PDGFB
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.3011812469734542,-0.8136149739041414,0.7448275862068966,0.8950473412059968,1.0,7/13,34.54%,TYROBP;SYK;GSTP1;CD177;FPR2;ITGB2;CRP
prerank,myotube cell development (GO:0014904),-0.3317539472664732,-0.8132252409254215,0.7159090909090909,0.8951741167240733,1.0,1/10,0.97%,IGF1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.20161003423506868,-0.8129384520809221,0.8381877022653722,0.8951470263237271,1.0,20/66,21.75%,ANKRD17;CDK6;CDC73;KANK2;PSME2;CCND1;ANXA1;CDKN2C;WEE1;PRMT2;CCND2;RB1;EGFR;E2F7;ADAM17;RGCC;CDKN2A;APPL2;KLF4;ID2
prerank,cellular response to oxidative stress (GO:0034599),-0.17924462510834843,-0.8126701596268746,0.908745247148289,0.895041063096954,1.0,28/118,21.17%,CYBB;MSRA;PXN;CHCHD2;ETV5;ERCC6L2;PYCR2;HIF1A;ZC3H12A;EIF2S1;FOXO1;DAPK1;CYBA;LRRK2;TXNRD1;FOS;EGFR;GPX1;HMOX1;MAPK8;SESN2;ADNP2;CPEB2;PDGFRA;HSPA1B;SOD3;GSR;SIRT2
prerank,lipid biosynthetic process (GO:0008610),0.21746595078587305,0.8122713449351241,0.8008534850640113,0.9774155795353863,1.0,15/77,17.88%,STAR;PRLR;LPCAT1;CBR4;ACSL6;LSS;OXSM;PDSS1;ELOVL4;FITM2;ACLY;NDUFAB1;ACSF3;LIPC;XBP1
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.22657895677993178,-0.812238846518909,0.7815126050420168,0.895224654525768,1.0,10/37,18.88%,RNASE3;DNASE1L1;NCBP1;XRN2;NUDT5;ENTPD5;RNASEH2A;ADPRM;HNRNPD;RNASEH1
prerank,cellular response to chemokine (GO:1990869),0.24132397861400604,0.8121776319195062,0.765625,0.9769529269492598,1.0,9/46,19.32%,ACKR3;SLC12A2;CCR1;FOXC1;SH2B3;STK39;CCL15;WNK1;CCL5
prerank,cardiocyte differentiation (GO:0035051),0.3488295200978718,0.8118484139439686,0.7056737588652482,0.9769054269119635,1.0,2/10,12.52%,KDM6B;AKAP13
prerank,macrophage differentiation (GO:0030225),-0.2994409974054101,-0.8115857241590352,0.7227979274611399,0.8958548850499506,1.0,1/13,0.22%,IL15
prerank,regulation of cell-cell adhesion (GO:0022407),0.24607024861375787,0.8114676252525078,0.7830342577487766,0.9769595364459283,1.0,7/39,11.50%,MAGI1;ADA;SPINT2;TGFB1;TENM3;ZDHHC2;MINK1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.292047774282468,0.8113444124559195,0.7206611570247934,0.9765378720150315,1.0,4/17,18.19%,SLA2;BACH2;IL18;IL18BP
prerank,regulation of spindle organization (GO:0090224),0.2943978137906669,0.8112869088505136,0.7204658901830283,0.9759794273249109,1.0,5/18,16.28%,PSRC1;FSD1;RAE1;DCTN1;MAP9
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2312572258649445,-0.8109848251871261,0.7982456140350878,0.8963494425798477,1.0,7/31,14.09%,DIS3L2;EXOSC8;DDX6;DCP1B;LSM2;LSM5;EXOSC9
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.24847529023724685,-0.810232317779299,0.7582417582417582,0.8971682909708486,1.0,5/25,15.14%,CBLB;PPARG;SOCS5;CBL;TNF
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3076149488142608,-0.8101967113764859,0.7238095238095238,0.8966873397250554,1.0,5/12,29.23%,MTLN;PTK2B;DIAPH1;RYR2;CASQ2
prerank,response to retinoic acid (GO:0032526),-0.20357520572958102,-0.8100390280451095,0.8496732026143791,0.8964102086920558,1.0,24/59,31.59%,ABL2;BRINP1;RARA;LYN;RET;SNW1;OVCA2;RXRB;TESC;PTK2B;WNT5A;ADNP2;TRIM16;WNT9A;FZD4;NDUFA13;WNT6;FZD10;LTK;AQP1;CREB1;CDKN2D;ATM;FZD7
prerank,negative regulation of calcium ion transport (GO:0051926),0.3144152810646431,0.8097329143484409,0.7395659432387313,0.978328892934474,1.0,2/15,6.94%,CBARP;ADRA2A
prerank,glycoprotein catabolic process (GO:0006516),-0.277175886427168,-0.8094383766180725,0.7272727272727273,0.8969073929335005,1.0,5/17,24.73%,CTSL;EDEM1;FBXO2;ADAMTS12;NEU4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.26699951220669416,0.8092891038107122,0.7385103011093502,0.9785335216665052,1.0,9/24,29.90%,PLA2G3;LPCAT1;PGS1;PLA2G15;PNPLA8;PLA2G4A;ABCA3;CDS2;CRLS1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.30658699212987395,0.809157584436807,0.7285223367697594,0.9781006894299683,1.0,2/15,7.63%,MTHFD1L;TGFBR1
prerank,regulation of angiogenesis (GO:0045765),0.19176020227599394,0.8090933855335616,0.8842364532019704,0.9775753406760156,1.0,29/192,12.98%,HOXA5;HHEX;F3;FGF16;CD34;ANGPTL4;IL17F;SMOC2;IL6;PLCG1;YJEFN3;PDE3B;GTF2I;MINAR1;DAB2IP;RAPGEF3;PRKCA;EPHA1;PRKD2;FOXC1;VASH1;FGF2;PDCD6;SFRP1;ADAM12;EFNA3;COL4A2;VASH2;TEK
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2514637517497255,0.8090434315709617,0.7971246006389776,0.9769993720418744,1.0,16/33,32.90%,FPGS;SLC39A8;KYAT1;ALDH5A1;ALDH4A1;DDAH2;PRODH;PYCR3;ART4;GLUL;GLS2;DGLUCY;RIMKLB;MTHFS;GCLM;ALDH18A1
prerank,GTP metabolic process (GO:0046039),0.304261689409816,0.8087624792900758,0.6921768707482994,0.9768778547735508,1.0,7/15,29.94%,GTPBP1;GNAI3;RHOQ;AK4;AK3;IMPDH2;MFN1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2822769570488704,-0.808399000577276,0.7195402298850575,0.8981331982521427,1.0,4/15,10.18%,SMARCA4;SP1;SNW1;EP300
prerank,phosphate ion homeostasis (GO:0055062),-0.3209986231933761,-0.8082962778464542,0.7208237986270023,0.897779724023936,1.0,4/10,42.72%,TFAP2B;FGFR4;FGF23;ENPP1
prerank,Golgi organization (GO:0007030),0.2029281270203094,0.8079760316910551,0.874828060522696,0.9777182284017177,1.0,35/112,25.51%,FBXW8;OBSL1;RAB43;SEC16B;TMED2;STX16;CLASP2;COG4;PI4K2A;TANGO2;ZW10;PLK3;STK25;HACE1;LYSMD3;TMED5;ARFGEF1;BLZF1;PRKD1;ATP8B1;TMED3;STX17;LMAN2L;TRAPPC8;TMED7;CDC42;PRMT5;VTI1B;VMP1;ATL2;TMED1;ATP8B2;GOLGA8B;GOLGA5;TJAP1
prerank,negative chemotaxis (GO:0050919),0.24875100481019807,0.8079471161909879,0.7786624203821656,0.9771134501329184,1.0,7/33,16.54%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,negative regulation of synaptic transmission (GO:0050805),0.2748138851648666,0.807709229197467,0.7553719008264462,0.9769142446554347,1.0,11/23,28.40%,ATAD1;PNKD;ACHE;PLK2;ARF1;GRIK3;TMEM25;SYT11;PRRT1;CBLN1;PTEN
prerank,positive regulation of histone methylation (GO:0031062),0.2768189770007483,0.8074362685781583,0.7742448330683624,0.9767712644715587,1.0,6/24,18.33%,TET1;CTR9;OGT;PAF1;PHF1;CHTOP
prerank,regulation of phospholipid metabolic process (GO:1903725),0.34234058240660786,0.8074352219633152,0.7487352445193929,0.9761145655130697,1.0,3/10,13.00%,GNB3;MTMR9;MTMR1
prerank,DNA modification (GO:0006304),0.2819079403151691,0.8073214733746643,0.7545304777594728,0.9756721628129661,1.0,10/22,30.27%,OGG1;EXOSC5;PARP1;UNG;MPG;EXOSC3;ACD;TERF1;PARP3;NEIL1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.2342555382959685,-0.8072757541241875,0.8083333333333333,0.899011839282815,1.0,10/33,20.53%,CDK6;CDC73;KANK2;CDKN2C;WEE1;PRMT2;RB1;E2F7;CDKN2A;KLF4
prerank,regulation of neurotransmitter secretion (GO:0046928),0.25480988369876845,0.8072113641080354,0.7799043062200957,0.9752128070866456,1.0,7/32,14.59%,SNAPIN;MEF2C;PNKD;RAB5A;RIMS1;CPLX2;BAIAP3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.3093825711363082,-0.8067538649168517,0.7339667458432304,0.8994011609862704,1.0,2/12,8.08%,PAEP;IL1B
prerank,photoperiodism (GO:0009648),-0.24386636636647507,-0.806626743961128,0.7939560439560439,0.8990650587295865,1.0,10/28,21.75%,FBXL17;FBXL8;CRY2;CRY1;SIK1;PDE6B;PER2;FBXL12;BHLHE40;ID2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2514160831990091,-0.8055344973323881,0.7675,0.9003815730157426,1.0,5/23,13.26%,PRCC;ZWILCH;WEE1;BUB1;BUB1B
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.32271552507066126,-0.8054781199033916,0.6957547169811321,0.8999404183172586,1.0,3/10,9.64%,RUNX3;IRF4;SH3RF1
prerank,positive regulation of telomerase activity (GO:0051973),0.2532242185774437,0.8054398398032034,0.7707006369426752,0.9778690367663913,1.0,13/33,29.02%,WRAP53;MAPK15;CCT4;MAPK3;MAPKAPK5;HSP90AB1;XRCC5;GRHL2;PARM1;MAPK1;ACD;PTGES3;MYC
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.2998692336403192,0.8051788619617447,0.7375643224699828,0.9776908412314383,1.0,3/17,11.30%,CADM1;SLAMF6;CRTAM
prerank,histone mRNA metabolic process (GO:0008334),-0.24549391524973121,-0.8049350663405926,0.7866323907455013,0.9003448592415569,1.0,6/27,13.60%,NCBP1;TENT2;SNRPB;EXOSC10;SSB;CPSF2
prerank,gland development (GO:0048732),0.22421997461897897,0.8047600259787129,0.8152492668621701,0.9778005562062191,1.0,6/59,8.99%,FGF10;WNT4;RIPK3;TGFBR3;TGFBR1;PKD2
prerank,peptidyl-serine modification (GO:0018209),0.19298942871065555,0.804358947761708,0.88745148771022,0.9779037586203417,1.0,44/166,23.42%,DCLK3;PKN1;PNCK;PRKCZ;DYRK1B;RPS6KB1;PRKCI;MAP3K10;TGFBR1;DGKQ;PRKCA;PRKD2;STK39;VRK2;CAMKV;PKD1;MGAT5B;STK32B;PDGFB;PARP1;MAP3K13;NDNF;PRKD1;DMPK;PRKCG;CSNK1G3;MAPKAPK5;PLK2;ROCK1;SMG1;AKT3;MAST2;WNK1;GALNT4;GALNT2;SBK1;PDPK1;ULK2;TOP1;LATS1;ULK1;TLK2;AURKA;STK32A
prerank,sterol homeostasis (GO:0055092),0.21988552232983502,0.80415014092573,0.8347578347578347,0.9776622943360406,1.0,15/65,19.61%,DGAT2;ABCG8;AKR1C1;SOAT2;CYP39A1;EHD1;MTTP;ABCA2;ANGPTL3;FABP3;LIPC;XBP1;IL18;TTC39B;RORA
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2943354770831379,0.8041458867227859,0.7222222222222222,0.9770090588646774,1.0,3/18,10.76%,NME5;PRKN;NFE2L2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.2946442040905013,-0.8040405712969013,0.7412587412587412,0.9013207022782332,1.0,7/14,28.26%,LIMS1;EMP2;BST1;FLNA;TIMP1;CD177;PHACTR4
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3119078559771907,-0.8037567255967055,0.7444444444444445,0.9012685663463476,1.0,3/11,17.07%,CCR2;WNT5A;ADAM17
prerank,positive regulation of RNA splicing (GO:0033120),0.2583967082356545,0.8037186738560617,0.7619783616692427,0.9771512262448083,1.0,9/29,20.60%,PRDX6;TRA2B;SLC38A2;CIRBP;RBMXL1;RBM3;SETX;TRA2A;RBM20
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2806355780116936,0.803397563544923,0.7356902356902357,0.9771196989171277,1.0,7/21,24.38%,SELENOS;PRKN;HERPUD1;TXNDC12;XBP1;CREB3;TMBIM6
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.34303338240547676,0.803330791413466,0.7253521126760564,0.976580210247732,1.0,3/10,13.80%,DAB2IP;EFNA1;EPHA4
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2488241114719636,0.8029248886561885,0.795144157814871,0.9766748353252237,1.0,8/36,14.32%,GGA3;RAB26;SYS1;ARFRP1;NECTIN3;RAB34;BLZF1;SPTBN1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3195712768024564,0.802848040190079,0.7365684575389948,0.9761632914695685,1.0,3/12,9.35%,ZC3H10;NCOR2;TGFB1
prerank,sphingolipid metabolic process (GO:0006665),0.20194558519563907,0.8028184030288823,0.8575380359612724,0.9755643307448365,1.0,29/108,21.76%,HEXB;ESYT2;TEX2;NEU1;ORMDL2;CERS4;ENPP2;PRKD2;B3GALNT1;SPTSSA;NSMAF;ELOVL6;TECR;ABCA2;GAL3ST1;SPNS2;ELOVL4;CERS5;CERS6;PRKD1;KDSR;CERS1;SERINC1;PPP2R1A;PLA2G15;ELOVL5;PLPP1;PPM1L;FA2H
prerank,protein-DNA complex disassembly (GO:0032986),0.30096262220900033,0.8021741920504283,0.7232597623089984,0.9761054608086474,1.0,3/16,11.23%,SMARCC2;SMARCE1;SMARCD3
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.31057529053347327,0.8020437797679135,0.7389830508474576,0.9750258488559665,1.0,1/14,0.83%,SLCO2B1
prerank,heme catabolic process (GO:0042167),0.31057529053347327,0.8020437797679135,0.7389830508474576,0.9750258488559665,1.0,1/14,0.83%,SLCO2B1
prerank,actin filament bundle assembly (GO:0051017),-0.2318572531770228,-0.8016126300624105,0.8078947368421052,0.9043912969168106,1.0,9/33,22.63%,NEDD9;EPS8;LCP1;PLS1;MICAL1;LIMA1;AIF1L;SHROOM2;BAIAP2L2
prerank,regulation of phospholipase activity (GO:0010517),0.34389873047334163,0.8014857644920242,0.7409420289855072,0.9754273511267756,1.0,5/10,33.91%,RGS2;ANGPTL3;PDPK1;FGFR3;RASGRP1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.29612315227583924,0.8014045140288665,0.745819397993311,0.9749344628478246,1.0,5/17,19.97%,ANGPTL4;SORT1;ANGPTL3;LIPC;LMF1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.20586142633175866,-0.8013879648461055,0.8312883435582822,0.9042012816025479,1.0,12/52,17.20%,PRKCH;PRKCE;CIB1;SORBS1;LRP1;NUMA1;EGFR;TNF;EPHA2;PLS1;SQSTM1;AKAP5
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.2516898654415262,0.8007465397316864,0.7728,0.9755052094474371,1.0,8/30,20.43%,F11R;PRAG1;GPR17;LPAR4;AKAP13;P2RY10;GPR174;ARRB1
prerank,positive regulation of telomere capping (GO:1904355),-0.2684064600153313,-0.8007382482686535,0.7711670480549199,0.9047519921279238,1.0,5/17,18.03%,RTEL1;PKIB;PRKCQ;MAP2K7;HNRNPD
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.2416041364148304,0.8005676093931341,0.7834394904458599,0.9751762312104986,1.0,12/41,25.80%,PTGS1;ALOX12;PLA2G4C;ACOX1;DAGLA;DECR2;FADS3;ELOVL5;PNPLA8;DAGLB;PLA2G4A;EPHX1
prerank,mitochondrion distribution (GO:0048311),-0.3035024446036436,-0.8004878863064838,0.7565011820330969,0.9046075680363234,1.0,3/12,12.17%,TRAK1;MTM1;LRRK2
prerank,centromere complex assembly (GO:0034508),-0.22526163482021708,-0.8003006947424445,0.8146067415730337,0.9043597925014872,1.0,7/36,17.98%,MIS12;RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3086001712983463,-0.8002550814185946,0.709832134292566,0.9039004233891481,1.0,3/12,16.28%,ATP7A;DDC;ODC1
prerank,aortic valve morphogenesis (GO:0003180),0.25017308326450866,0.7998922625672843,0.7917981072555205,0.9757318881115933,1.0,5/30,10.90%,BMP4;HEY1;TGFB1;SNAI2;EFNA1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.3153766893929969,-0.7997251999848227,0.735224586288416,0.904234078670321,1.0,5/10,33.02%,CARMIL1;CFL2;CARMIL2;PLEK;PDXP
prerank,superoxide anion generation (GO:0042554),-0.2978350847176188,-0.7996795136374618,0.7427937915742794,0.9037637686370329,1.0,4/13,24.23%,CYBB;CYBA;TAFA4;NOX4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2778946726508309,0.7994921711190107,0.735,0.9751451656683937,1.0,9/22,26.99%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;ZDHHC19;ZDHHC12
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2778946726508309,0.7994921711190107,0.735,0.9751451656683937,1.0,9/22,26.99%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;ZDHHC19;ZDHHC12
prerank,regulation of macrophage differentiation (GO:0045649),-0.2861236078920208,-0.7994127393453316,0.7592137592137592,0.903678215049404,1.0,7/15,25.83%,PF4;RIPK1;HSF1;C1QC;ID2;FADD;CSF1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.2279835720380641,-0.7988960734764614,0.7888888888888889,0.904027087377263,1.0,5/33,7.90%,NR3C1;PPARG;SMARCA4;SMAD3;HIF1A
prerank,hepaticobiliary system development (GO:0061008),0.2814110303279068,0.7986903485631285,0.7562604340567612,0.9758987405513585,1.0,5/20,17.88%,WNT4;TGFBR3;PKD2;PHF2;XBP1
prerank,endothelial cell differentiation (GO:0045446),0.320461332158744,0.7985533020522253,0.7504302925989673,0.9754952312104613,1.0,2/12,5.49%,KDM6B;FSTL1
prerank,response to laminar fluid shear stress (GO:0034616),-0.32351188567938016,-0.798549256106868,0.7191283292978208,0.9040669096743708,1.0,4/10,20.53%,SMAD6;MAPK7;KLF2;KLF4
prerank,glucose import (GO:0046323),0.3236274640496206,0.7981517925819066,0.7452006980802792,0.9755352418612799,1.0,1/13,0.51%,SLC2A3
prerank,cardiac muscle cell development (GO:0055013),0.28045678358423953,0.7979662659330987,0.759349593495935,0.9752150889892901,1.0,4/20,19.42%,OBSL1;SLC8A1;CXADR;PDGFRB
prerank,dopaminergic neuron differentiation (GO:0071542),0.28903263298648446,0.7979236967147536,0.7667731629392971,0.9746383841796256,1.0,3/19,14.40%,RYK;MANF;LMX1B
prerank,primary miRNA processing (GO:0031053),-0.32404500317315765,-0.7978570783813715,0.7482993197278912,0.9046980004819446,1.0,3/10,11.90%,SMAD3;SRRT;HNRNPA2B1
prerank,vasoconstriction (GO:0042310),-0.30816349267692716,-0.7968692751374966,0.7236533957845434,0.9058467574357144,1.0,8/11,36.51%,EDNRB;EDNRA;ACTA2;KEL;EDN3;CRP;EDN2;EDN1
prerank,regulation of lipid storage (GO:0010883),0.27170196043179573,0.7968174823441907,0.7530224525043178,0.9759864027255544,1.0,3/22,5.65%,C3;HILPDA;IL6
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.23378396942858765,-0.7967741043504887,0.8149171270718232,0.90548590775414,1.0,10/31,19.86%,PTPN1;BAX;ERN1;HSF1;PACRG;HSPB8;TM7SF3;OPTN;HSPA13;HSPA1B
prerank,transition metal ion transport (GO:0000041),0.2478971580576607,0.7964131541046153,0.7993579454253612,0.9760776223151576,1.0,6/35,11.52%,IREB2;TRPC3;SLC31A1;SLC39A8;ATP2C1;TRPC6
prerank,neuromuscular process (GO:0050905),0.29525059008547205,0.7962558082762695,0.7335701598579041,0.9757313730896694,1.0,4/16,17.85%,MYCBP2;NRXN1;DCTN1;SHANK1
prerank,"phototransduction, visible light (GO:0007603)",0.31083756673129187,0.796193497005483,0.7342657342657343,0.9752027360411492,1.0,5/14,31.75%,CNGB1;GNA11;GNAQ;ABCA4;PDE6G
prerank,negative regulation of cartilage development (GO:0061037),0.312164460377208,0.7960894272480729,0.7373029772329247,0.9747398707825436,1.0,3/13,13.31%,TGFBR1;SNAI2;CHADL
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3037082835693502,0.7960297459657363,0.7466216216216216,0.974191777349816,1.0,4/14,25.09%,PKIA;PRKAR1A;PRKAR2B;RAPGEF2
prerank,positive regulation of cell development (GO:0010720),0.25410588689220226,0.7959680550559501,0.7693548387096775,0.9736589645813334,1.0,6/31,16.91%,NUMB;LRP2;BMP4;CX3CR1;LMOD3;OPRM1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.24415489395021905,0.7953615466743117,0.7906602254428341,0.9741051745269776,1.0,13/37,25.24%,FHIT;GIPC1;SGTA;OGT;TAF9;CCAR2;UBXN1;HSP90AB1;TLK2;CAMLG;USP7;TRIM39;HFE
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.30625203722276195,-0.7952743684239829,0.7313084112149533,0.9074494332203719,1.0,4/12,18.76%,XDH;SPRY2;SEMA6A;ADAMTS12
prerank,keratan sulfate biosynthetic process (GO:0018146),0.26286910255526297,0.7949823506540513,0.7576736672051696,0.9741307542460274,1.0,6/26,19.53%,B4GAT1;ACAN;CHST1;ST3GAL6;B4GALT2;ST3GAL3
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3048005632457589,-0.7946847245184178,0.7452380952380953,0.9078753950230276,1.0,6/11,25.83%,PF4;RIPK1;HSF1;ID2;FADD;CSF1
prerank,sensory perception of taste (GO:0050909),0.33497289862173973,0.7943508459686318,0.7658450704225352,0.9745978580122534,1.0,3/10,17.24%,ASIC1;ASIC2;ASIC3
prerank,T-helper cell differentiation (GO:0042093),0.3065581655074787,0.7940806795632139,0.7422145328719724,0.9744234465459317,1.0,4/14,15.32%,ZFPM1;IL6;HMGB1;BATF
prerank,positive regulation of ruffle assembly (GO:1900029),0.3132283869679041,0.7938167366513965,0.7444253859348199,0.9742487463818337,1.0,4/13,16.50%,P2RY12;EPS8L3;EPS8L2;HRAS
prerank,telomere capping (GO:0016233),-0.2758817183005055,-0.7937837984548896,0.7657004830917874,0.9088213110195175,1.0,5/16,32.63%,NBN;TERF2;TINF2;DCLRE1C;RAD50
prerank,regulation of establishment of planar polarity (GO:0090175),-0.18385530912499928,-0.7935727971171564,0.9124579124579124,0.9086452496089616,1.0,29/88,25.98%,PSMA6;AP2A2;DVL3;PSMB2;SMURF2;PSME2;AP2B1;SPEF1;PSMD11;PSMC6;PSMA3;FZD2;PSMD10;PSMB5;WNT5A;PARD6A;PSMD5;NPHP3;PSMD1;DAAM1;FZD4;ARHGEF19;PSMA7;PSMB7;PKHD1;AP2A1;FZD1;RAC1;PSMB3
prerank,pyroptosis (GO:0070269),-0.27580182507366324,-0.7933585508392682,0.7530864197530864,0.9084537967499963,1.0,2/15,4.17%,ZBP1;NLRC4
prerank,positive regulation of TOR signaling (GO:0032008),0.24021929938814052,0.793009588896366,0.7864992150706437,0.9750877002823526,1.0,11/40,21.77%,KLHL22;RPTOR;NCKAP1L;SLC38A9;FLCN;WDR59;HTR6;WDR24;HDAC3;PIP4P1;SIK3
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.2675301502071784,0.7924060908806403,0.7739273927392739,0.975496022082836,1.0,9/24,28.86%,FSCN1;NCKAP1;TWF2;CYFIP1;WASF2;CDC42;CLRN1;BRK1;AUTS2
prerank,UV protection (GO:0009650),0.3265163288042091,0.7923446443646933,0.7384898710865562,0.9749630830393735,1.0,5/10,28.99%,FEN1;SDF4;ERCC2;CAT;SCARA3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.22210284090566745,-0.7920274254338495,0.8055555555555556,0.9100657394270747,1.0,19/36,39.14%,PPP3R1;CTNNB1;PPP3CA;FZD2;AGO2;NLK;WNT5A;PDE6B;FZD4;PDE6A;LEF1;TNRC6A;CALM1;PPP3CB;WNT11;NFATC1;FZD6;AGO3;MOV10
prerank,response to interleukin-1 (GO:0070555),-0.191498876052886,-0.7918882883294003,0.933993399339934,0.9097506257176395,1.0,20/73,23.88%,CD47;NFKB1;CCL25;ANXA1;GBP3;HIF1A;IL1B;ZC3H12A;PTGIS;RC3H1;ACOD1;HAS2;RBMX;HYAL3;ADAMTS12;MYD88;HDAC4;APP;MAPK11;CCL7
prerank,embryonic organ development (GO:0048568),0.22041558072859355,0.7917458708955932,0.8346094946401225,0.9753730180602318,1.0,19/61,26.27%,ZFPM1;COL2A1;RARRES2;PBX2;HEY1;TGFB1;TBX2;SH2B3;PBX3;NDRG4;TEAD3;GLI3;TEAD2;RBP4;FLT3LG;COL13A1;RNF112;ATF4;SALL1
prerank,regulation of myelination (GO:0031641),0.2639284647853617,0.7914543799697915,0.760586319218241,0.9752189275167246,1.0,2/25,4.67%,TPPP;JAM2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.2997306152340734,0.7911613234192618,0.7875647668393783,0.9750903302334739,1.0,4/14,16.63%,PKD2;FAF1;PKD1;SUFU
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.2323205001113371,-0.7911553569606562,0.8465608465608465,0.9104023798278175,1.0,4/29,9.18%,MCTP1;APOE;SLC8A2;DRD2
prerank,negative regulation of cell communication (GO:0010648),-0.257205154184771,-0.790963955762352,0.8087431693989071,0.9101480677536568,1.0,3/21,8.88%,PTPN1;IL1B;SOCS5
prerank,vitamin transport (GO:0051180),-0.23060197262109902,-0.790400506998592,0.8136482939632546,0.9105408886034855,1.0,10/29,29.21%,SLC46A1;SLC2A8;SLC52A2;SLC52A1;AFM;PDPN;AMN;CD320;FOLR2;FOLR1
prerank,purine ribonucleotide transport (GO:0015868),0.2901610867021204,0.7901191714666652,0.7563025210084033,0.9762865042907654,1.0,4/16,19.65%,SLC25A4;SLC19A1;SLC35B2;ABCC6
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.24737960615874327,-0.7900602737076253,0.7715736040609137,0.9105339185057124,1.0,6/24,16.29%,TAPBP;ERAP1;SEC23A;MFSD6;B2M;FCER1G
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2614128544525356,-0.7897795324409631,0.7995226730310262,0.9104607159850803,1.0,9/19,35.54%,APOE;CHRNB2;COLQ;CHRNA4;CHRNA5;CHRNA3;RAPSN;CHRNB4;CHRNB3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.22306261702509234,-0.7897550589524004,0.8376068376068376,0.9099617892264839,1.0,12/37,26.69%,ALOX5;NOD2;HIF1A;ZC3H12A;TNF;TLR4;MYD88;APPL2;NLRC3;MEFV;APPL1;ABCD1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.27177830836949435,0.7892752618325012,0.8022875816993464,0.9771053324725467,1.0,3/22,7.53%,DDX5;HIC1;EEF1E1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.26206022800919615,-0.7892609487076933,0.7796610169491526,0.9102165569838987,1.0,5/18,16.50%,ANXA1;CIB1;RHOJ;KDR;HMOX1
prerank,morphogenesis of an epithelium (GO:0002009),-0.2444477775818844,-0.7891434839211809,0.8036649214659686,0.909840821381945,1.0,10/25,23.71%,DAG1;PRKX;VCL;RIPK4;LHX1;LRP6;TRAF3IP1;LAMA5;LIN7C;LAMA3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.27022553519335885,0.7887451268194666,0.7710437710437711,0.9767047745017696,1.0,9/21,29.79%,GTF2H2;GTF2H4;PARP1;DDB2;GTF2H3;ERCC2;ERCC4;GTF2H1;RBX1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.27022553519335885,0.7887451268194666,0.7710437710437711,0.9767047745017696,1.0,9/21,29.79%,GTF2H2;GTF2H4;PARP1;DDB2;GTF2H3;ERCC2;ERCC4;GTF2H1;RBX1
prerank,regulation of lipid metabolic process (GO:0019216),0.2081802691052107,0.7886855283170803,0.8628808864265928,0.9761594257525349,1.0,23/88,22.04%,TM7SF2;GNB3;PPARA;RARRES2;THRSP;TNFAIP8L3;CHD9;NCOR2;LSS;ZFP69;SMARCD3;ELOVL6;CCDC3;EDF1;ACACB;LACTB;HDAC3;FDPS;RORA;RUBCNL;PLPP1;ABCA7;NFYB
prerank,phospholipid homeostasis (GO:0055091),0.3227376958373172,0.7883195058726424,0.7448979591836735,0.9761386850172332,1.0,3/11,17.66%,TLCD2;ANGPTL3;FABP3
prerank,cellular response to chemical stress (GO:0062197),0.20097582066517802,0.7881172250749512,0.8867403314917127,0.9758672407124098,1.0,16/96,16.30%,SELENOS;PRDX5;PRDX6;NUDT2;PPARGC1A;VKORC1L1;PRDX2;PKD2;NFE2L2;PYROXD1;VRK2;RAD52;PARP1;PRKD1;ERMP1;SETX
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.23335138463298036,-0.7875616454772435,0.815028901734104,0.9118208392688993,1.0,11/29,26.15%,UTP6;RPS16;RPS14;UTP4;TSR1;TBL3;KRI1;ABT1;HEATR1;TSR2;RPS21
prerank,ribonucleoprotein complex assembly (GO:0022618),0.19462660384663563,0.7875217769335366,0.9078947368421053,0.976240539267307,1.0,40/132,25.49%,SRSF5;XAB2;CPSF6;ISY1;SRSF6;DDX1;RBM5;EIF6;SNUPN;SRSF1;SNRPD2;YTHDC1;MRPS7;NOP2;CELF6;RAMAC;CRNKL1;NUDT21;RPS27;TRAF7;RSL24D1;DDX39B;SETX;GEMIN5;GEMIN6;SRSF9;PUF60;GCFC2;MCTS1;SNRPD3;HSP90AB1;XRCC5;PRMT5;LSM4;SART1;POLR2D;COIL;CELF4;RRS1;SF1
prerank,granulocyte chemotaxis (GO:0071621),-0.20108125449198377,-0.787363972489166,0.9014084507042254,0.91159135571787,1.0,6/55,9.11%,GBF1;CCL25;PF4;SYK;ANXA1;JAML
prerank,cellular macromolecule catabolic process (GO:0044265),-0.20733289380829628,-0.7872759002430648,0.8558558558558559,0.9111885819545189,1.0,11/49,18.88%,RNASE3;DNASE1L1;NCBP1;SIAH2;RIPK1;XRN2;FBXO2;MAGEC2;RNASEH2A;HNRNPD;RNASEH1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.3135878936399167,-0.7871273774419466,0.7389380530973452,0.9108864565994761,1.0,3/10,17.07%,CCR2;WNT5A;ADAM17
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.23329337427371358,-0.7870640020625222,0.8276762402088773,0.910425984417112,1.0,2/27,1.35%,ARL6IP5;SLC7A1
prerank,positive regulation of embryonic development (GO:0040019),-0.2608900558592687,-0.7870635390783439,0.8037383177570093,0.9098830947424447,1.0,5/19,18.41%,B4GALT5;RACK1;SCX;LHX1;NIBAN2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2958705680174072,-0.7865686432745669,0.7704545454545455,0.9100635325274434,1.0,4/13,27.33%,OS9;EDEM1;UBE2J1;YOD1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.26119145336389227,0.7862905089923269,0.7984,0.977747866028811,1.0,5/26,15.67%,NME5;FBXO7;PRKN;NFE2L2;REST
prerank,acylglycerol catabolic process (GO:0046464),0.25260574105775807,0.786173044218344,0.824212271973466,0.9772959153861144,1.0,10/30,29.72%,PNPLA3;ABHD12;FABP3;LIPC;DAGLA;ABHD2;LIPE;FABP5;MGLL;FAAH
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.20497545209840845,0.786161156397836,0.8776371308016878,0.9766795422824082,1.0,32/85,28.30%,VANGL2;PSMB1;RYK;ARRB2;PSMF1;PRICKLE1;PSMA1;PSMD7;PSMA8;PSME3;VANGL1;PSMD14;PSMC4;WNT7A;PSMB4;DVL2;MAGI2;PSME1;CDC42;PSMD2;PSMD4;PSMD8;TIAM1;RHOA;PSMC5;FZD5;PSMD3;PSMB8;PSMA4;CLTC;ROR2;CELSR2
prerank,regulation of proteolysis (GO:0030162),0.23454797845632933,0.7860469832318866,0.8315629742033384,0.9762396285315393,1.0,7/48,8.78%,PLAT;CAPN3;CST3;ASPH;BTRC;OGT;BAK1
prerank,regulation of protein modification process (GO:0031399),0.22815142458185467,0.7859471837016092,0.8114630467571644,0.9757757205876808,1.0,5/50,3.64%,PPP1R16A;PLXNB2;PPIB;ROPN1;ROPN1L
prerank,histone mRNA catabolic process (GO:0071044),0.30440590276631674,0.7858036357404173,0.7896613190730838,0.9753952711317242,1.0,3/15,14.65%,LSM1;MTPAP;UPF1
prerank,regulation of phosphate metabolic process (GO:0019220),0.28933506469361386,0.7852792119811441,0.7643207855973814,0.9756700665099503,1.0,2/16,3.27%,SRPX2;GNB3
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.2017410674677135,-0.7851054043440651,0.8892128279883382,0.9118247434987615,1.0,6/50,7.26%,MOSMO;FBXL17;VCP;DLG5;TUBD1;TEDC2
prerank,vasculature development (GO:0001944),0.2929560154609089,0.7848927058489049,0.7752613240418118,0.9756880871449611,1.0,2/16,5.04%,FLT4;STK11
prerank,carboxylic acid catabolic process (GO:0046395),0.31328404296617696,0.7842015245863633,0.7357512953367875,0.9762364549022172,1.0,2/12,3.75%,IL4I1;GNPDA2
prerank,cellular response to amino acid stimulus (GO:0071230),0.246625342721977,0.7841975617670104,0.7876254180602007,0.9756148901740418,1.0,8/33,19.04%,KLHL22;RPTOR;SLC38A9;GLRA2;IPO5;SH3BP4;XBP1;NSMF
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.30043472141991456,-0.7831595967364897,0.7374701670644391,0.9143032420104507,1.0,4/12,13.70%,GMPS;ATIC;PAICS;IMPDH1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.22385026123786558,0.7825070374628278,0.8419452887537994,0.9778439212951262,1.0,14/50,21.81%,PSMB1;PSMF1;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;PSME1;PSMD2;PSMD4;PSMD8
prerank,cellular response to acid chemical (GO:0071229),-0.23485667959303225,-0.7823323613029249,0.8181818181818182,0.9150690390194202,1.0,10/27,22.16%,RRAGC;LAMTOR5;CAPN2;CPEB4;RRAGA;SESN2;KLF2;CPEB3;LARS1;LAMTOR4
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3154214146274424,0.7818104638498152,0.7258883248730964,0.9783327696375793,1.0,3/12,18.41%,PRKCZ;IRS1;ZBTB7B
prerank,regulation of cellular localization (GO:0060341),0.22852272082118902,0.781684268474042,0.8358433734939759,0.9779080933607353,1.0,13/46,21.28%,PARD6B;PARD6G;PRKN;WWC1;PARP1;STXBP2;STXBP4;FES;TRIM67;MAD1L1;EPHA5;HSP90AB1;MAP2
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.22780078358857564,-0.7816440100958173,0.860655737704918,0.9156198265658303,1.0,5/32,9.15%,ACTR3;CORO1C;ARPC2;CARMIL1;PIK3CA
prerank,regulation of cellular protein localization (GO:1903827),-0.2035142291545535,-0.7814653495331231,0.8782608695652174,0.9153554083346752,1.0,9/45,14.70%,VCPIP1;VCP;DVL3;PTPN1;GBF1;LCP1;CTNNB1;RALB;RAB11FIP5
prerank,homologous chromosome segregation (GO:0045143),0.2712444083356689,0.7813008222147646,0.8221476510067114,0.9779337570405017,1.0,5/20,21.67%,SGO1;TERB1;FANCD2;CENPC;IHO1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.2897358087798702,-0.7811768461932341,0.7576470588235295,0.9152946185217203,1.0,2/13,4.28%,NR3C1;ESR1
prerank,ERBB2 signaling pathway (GO:0038128),0.24722433451708214,0.7810636550782797,0.790519877675841,0.9776909074065164,1.0,4/31,8.93%,MATK;NRG4;PRKCA;ERBB4
prerank,modified amino acid transport (GO:0072337),0.2988693725084272,0.7810446535619676,0.762063227953411,0.9770967263925571,1.0,4/15,18.22%,CTNS;SLC1A4;SLC19A1;SLC16A12
prerank,regulation of stem cell differentiation (GO:2000736),-0.18141521147586362,-0.7807975121629958,0.9382239382239382,0.9153682839611584,1.0,30/89,26.41%,ITCH;PSMA6;TCF12;PSMB2;PSME2;PSMD11;PSMC6;YAP1;PSMA3;NOTCH1;NSUN2;PSMD10;PTN;PSMB5;GATA3;PSMD5;PDGFRA;HES1;PSMD1;LMO1;HNRNPU;ESRRB;SETD1A;EIF2AK2;KMT2A;PSMA7;PSMB7;PSMB3;MYB;CBFB
prerank,cytoskeleton organization (GO:0007010),0.1963551686250934,0.7807970599846943,0.9059139784946236,0.9768593000479895,1.0,26/114,19.40%,CNTNAP1;DST;OBSL1;BIN1;THY1;SIPA1;RHOBTB1;BRWD1;FGD2;FMNL3;MICAL3;PRKCI;ARAP3;CFL1;CAMSAP1;PAK5;WASF3;DPYSL2;FITM2;PAK6;RHOBTB2;CDC42BPB;MAST2;ZMYM6;RHOU;ZMYM3
prerank,cellular component assembly (GO:0022607),0.1808282317236575,0.7806316556712171,0.9584352078239609,0.9765044391341844,1.0,75/253,27.26%,SH3BP1;FSCN1;WDR19;CAPN3;ADD2;NIFK;RHOV;PARD6B;RAD21L1;PPARGC1A;NCKAP1;NCKAP1L;MAGI1;IL1RAP;LRRTM3;TSPAN4;SH3BGR;TGFB1;ZW10;PEX14;RIMS1;STK25;TLCD2;LRGUK;DNM1L;WASF3;CYFIP1;CHCHD10;SPTBN1;VAMP3;SPAG16;WNT7A;PAWR;TUBGCP2;EPRS1;GEMIN5;RHOQ;PPP2R1A;SHANK1;QSOX1;RHOU;ACTB;LIN7A;ESPN;CLDN14;HORMAD1;CAPG;CDC42;TEX12;GRHL2;MDM4;TEAD2;ZFYVE27;VMP1;DNAJB13;OPHN1;LIMS2;WASL;PCLO;LAMC1;IL2RB;ANK3;CD40;RHOA;HFE;SHROOM1;ACD;LLGL1;DLG4;ADD1;ST13;ABCA3;DMTN;MYO9A;CFAP74
prerank,activation of adenylate cyclase activity (GO:0007190),-0.2202954442021822,-0.7804061631979586,0.8288770053475936,0.9154604703171779,1.0,7/35,12.72%,RAF1;ADCY9;ADCY5;ADCY6;EDNRA;ADCY1;ADCY3
prerank,regulation of axon guidance (GO:1902667),-0.3069697702228208,-0.7798237181071974,0.7346938775510204,0.9158023976763773,1.0,1/10,0.66%,NRP1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3358488788211986,0.779623157298896,0.7602131438721137,0.9775757055529554,1.0,5/10,31.07%,NFE2L2;HERPUD1;ATF4;DDIT3;CCL2
prerank,intermediate filament organization (GO:0045109),0.28491336145519597,0.7795848776451656,0.784965034965035,0.9770013746637025,1.0,8/17,31.30%,BFSP2;TCHH;NEFL;KLHL24;GFAP;PKP2;BFSP1;DES
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2655367369505613,-0.779439456180187,0.7742718446601942,0.9158489641432301,1.0,4/16,14.25%,CLSPN;TOPBP1;TICRR;CDT1
prerank,regulation of cell junction assembly (GO:1901888),-0.22979749474198033,-0.7792937017267189,0.8374384236453202,0.9155409304915448,1.0,3/27,3.29%,PRKCH;PDLIM5;PRKACA
prerank,regulation of cell growth (GO:0001558),0.18325810621676553,0.7791670708116119,0.9441624365482234,0.9770538451200999,1.0,41/204,19.18%,KLHL22;WFDC1;RPTOR;PSRC1;TMC8;SIPA1;STK11;HDGFL2;LGI1;EBAG9;IL2;TGFBR1;MINAR1;APBB1;FHL1;GNG4;KIF26A;SOCS2;TGFB1;ADAM15;NRG3;SFRP1;CGRRF1;ACVR1B;PAK5;DCBLD2;FLCN;BAP1;EI24;CCAR2;HPN;SH3BP4;KIF14;AGT;N6AMT1;NDRG3;PPP2R1A;BTG1;LTBP4;TCHP;TAF9B
prerank,carbohydrate biosynthetic process (GO:0016051),-0.2496414553990651,-0.778675042499066,0.7800511508951407,0.9159330531939663,1.0,6/21,22.46%,MPDU1;ST8SIA6;FUT8;B3GALT5;ST6GALNAC5;FUT4
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2363940635762064,-0.7783704908800431,0.824607329842932,0.9158415201796944,1.0,7/27,21.09%,RRM1;CMPK1;TXNRD1;TYMS;NME4;GSR;AK2
prerank,rRNA modification (GO:0000154),-0.25073263634242404,-0.7780765493387993,0.8024691358024691,0.9157484829852957,1.0,7/21,19.48%,FTSJ3;MRM2;ZCCHC4;NOP10;FBL;NAT10;DKC1
prerank,carnitine shuttle (GO:0006853),0.32383846858457754,0.7779212168117858,0.7715827338129496,0.9784173000621527,1.0,2/11,5.43%,CPT1B;THRSP
prerank,long-chain fatty acid metabolic process (GO:0001676),0.21623095061931008,0.7778101867845231,0.8306569343065694,0.9779821443376419,1.0,19/64,25.80%,ADTRP;ALOX12;PLA2G4C;PNPLA3;ACSL6;ELOVL6;ACOT4;ACOX1;ACSBG1;DAGLA;HPGD;ELOVL5;ACAD9;PNPLA8;DAGLB;ACSL3;HACL1;PLA2G4A;EPHX1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2676377669489821,0.7777707121404756,0.7762938230383973,0.9774161047799071,1.0,9/21,28.62%,DMD;CNKSR3;DDIT4;GADD45A;INPP5J;PAQR3;DMTN;PTEN;NLRP2B
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.19731912221589984,-0.7776347917007942,0.92,0.9158271722273513,1.0,16/52,25.45%,ATP6V0D1;ERN1;DNAJB9;EDEM1;SHC1;WFS1;PDIA5;YIF1A;TLN1;LMNA;GOSR2;VAPB;PARP16;EXTL1;HYOU1;ERN2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2582454830988592,0.7776232086121877,0.8032,0.9770392397726169,1.0,3/25,7.78%,NEUROD2;SLA2;RIT2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.30900860555558923,-0.7775943081709991,0.7358490566037735,0.9153404930524258,1.0,3/10,19.33%,BRCA1;THAP7;TAF7
prerank,regulation of cellular response to heat (GO:1900034),0.20754483702698767,0.7775397024415452,0.8652482269503546,0.9765346133984786,1.0,13/77,15.90%,YWHAE;AAAS;CD34;RPTOR;DNAJC2;NUP54;CHORDC1;NUP88;RAE1;DNAJC7;CCAR2;MAPK3;NUP133
prerank,glucan catabolic process (GO:0009251),-0.27411303180778834,-0.7774860361397209,0.7627118644067796,0.9149606165437852,1.0,4/15,14.83%,PHKB;AGL;GAA;PGM2L1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.22110652242668927,0.7773607971672731,0.8586466165413534,0.976208244412666,1.0,16/54,24.34%,CNOT2;SOX4;E2F1;PLK3;BTG2;CNOT8;GADD45A;RBL2;PLK2;TFDP2;MDM4;CASP2;CNOT10;AURKA;TRIAP1;CNOT4
prerank,regulation of DNA repair (GO:0006282),0.2281925011238038,0.7772244066824018,0.8421052631578947,0.9758076638341668,1.0,9/44,16.31%,FGF10;WRAP53;UBE2V1;UBE2N;RAD52;RNF168;RNF8;ERCC6;WRNIP1
prerank,cellular response to interleukin-7 (GO:0098761),0.28517027882401247,0.7769551348046756,0.7772194304857621,0.974967750758551,1.0,4/17,16.73%,BRWD1;SOCS2;IRS1;IL7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.28517027882401247,0.7769551348046756,0.7772194304857621,0.974967750758551,1.0,4/17,16.73%,BRWD1;SOCS2;IRS1;IL7
prerank,lysine metabolic process (GO:0006553),-0.30263454519115807,-0.7764476301158377,0.7699530516431925,0.9154706223801781,1.0,6/12,35.05%,ALDH7A1;PIPOX;AASS;HYKK;PHYKPL;CRYM
prerank,lysine catabolic process (GO:0006554),-0.30263454519115807,-0.7764476301158377,0.7699530516431925,0.9154706223801781,1.0,6/12,35.05%,ALDH7A1;PIPOX;AASS;HYKK;PHYKPL;CRYM
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.22915432256303,-0.7764371544590075,0.8393782383419689,0.914409021522774,1.0,9/29,27.14%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.22915432256303,-0.7764371544590075,0.8393782383419689,0.914409021522774,1.0,9/29,27.14%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,positive regulation of transferase activity (GO:0051347),0.19066532126198435,0.7763396364342482,0.9003931847968545,0.9753634202788085,1.0,33/142,21.10%,WRAP53;MERTK;NTRK1;FLT4;NTRK3;MAPK15;RYK;DCUN1D2;EPHA1;ERBB4;TGFB1;UBE2N;CCT4;TEK;DBI;EPHA4;INSR;EPHB2;NTRK2;MAPK3;UBE2I;VAC14;MAPKAPK5;SERINC1;FLT3;CHRNA7;PIN1;PDGFRB;ROR1;EPHA5;HSP90AB1;XRCC5;GRHL2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.19665552111722379,-0.7759840429362616,0.8846153846153846,0.9145274919633261,1.0,17/54,24.60%,GAS6;UBE2K;SYK;RIPK1;HIPK1;BIRC2;RACK1;TNF;OTULIN;TRAF1;ADAM17;PYDC1;HSPA1B;CASP1;CLIP3;GSTP1;FADD
prerank,regulation of dephosphorylation (GO:0035303),0.2947867479203116,0.7756765987054778,0.791095890410959,0.9758003305882131,1.0,5/15,21.68%,PPP1R16A;MTMR9;MTMR1;SMG7;PPP1R16B
prerank,phospholipid biosynthetic process (GO:0008654),-0.2126893499264259,-0.7756110013532078,0.8607242339832869,0.9145720462805251,1.0,8/36,16.73%,AGPAT4;AGPAT5;IDI1;SPHK2;CPNE7;CLN3;GPAM;NUS1
prerank,mitochondrion disassembly (GO:0061726),0.2396389873894909,0.7754747766504579,0.8288288288288288,0.9755033252859387,1.0,12/34,24.55%,FUNDC1;FIS1;FBXO7;USP30;PRKN;BECN1;CTSK;GABARAP;ULK2;ULK1;ATG2A;WDR45B
prerank,cellular response to inorganic substance (GO:0071241),0.2701544129479685,0.7752681629765401,0.7892976588628763,0.9752343266201337,1.0,4/21,17.77%,TIMELESS;NSMCE3;AOC1;MTR
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2357837438647135,0.7747419807886209,0.8280757097791798,0.9754305261231052,1.0,10/40,19.90%,NUCKS1;DONSON;TIMELESS;SMARCAL1;TRAIP;RFWD3;CENPS;TONSL;WRN;ALYREF
prerank,cartilage development (GO:0051216),0.22161886210450804,0.7746705125811872,0.8392036753445635,0.9749286335366953,1.0,15/49,25.61%,COL2A1;IL17F;NFIB;MEF2C;BMP4;TGFB1;FGF2;PKD1;WNT7A;GHRL;SULF2;SNX19;GPLD1;RUNX1;WNT5B
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.2797875629323167,0.7746211290603947,0.7723577235772358,0.9743847639186006,1.0,3/18,11.62%,OPALIN;SLC45A3;CXCR4
prerank,negative regulation of actin filament polymerization (GO:0030837),0.26564492946304424,0.7741927244121163,0.7990353697749196,0.9744187906818965,1.0,6/22,17.44%,TWF2;ARFGEF1;TWF1;SSH1;SSH2;SSH3
prerank,regulation of Wnt signaling pathway (GO:0030111),0.1940332327502862,0.774118281065565,0.9185580774365821,0.9739285130250785,1.0,36/108,29.15%,HHEX;TSC2;HIC1;NXN;PTK7;BTRC;FAM53B;PRKN;EMD;SPIN1;CTNND2;SFRP1;AMER2;TCF7L1;AMER3;PPP2R1A;RSPO1;SULF2;RNF43;FRZB;RSPO2;AXIN1;SFRP2;PPP1CA;RUNX1;CXXC4;TIAM1;SALL1;GNAQ;NKD1;SULF1;SENP2;KANK1;SOX7;DCDC2;DAAM2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.27617184356182467,-0.7740694540563067,0.7604651162790698,0.9163797401833631,1.0,5/15,18.88%,ZC3H12D;ZC3H12A;ZC3H12B;POP1;RNASEH1
prerank,skeletal muscle tissue development (GO:0007519),0.2475683390428087,0.7739945529901259,0.806930693069307,0.9735159213036961,1.0,9/32,23.99%,SIX4;MEF2C;MYL6;LMOD3;CAV2;IGSF8;LEMD2;CFLAR;POPDC3
prerank,telomere maintenance (GO:0000723),-0.2053202616956176,-0.7739218557898341,0.8793650793650793,0.9160739271394781,1.0,7/50,11.08%,SP100;NSMCE2;PCNA;RTEL1;NBN;POLD4;RPA1
prerank,pseudouridine synthesis (GO:0001522),-0.2868252269662693,-0.7736257317762552,0.7717647058823529,0.915993416400711,1.0,5/13,24.68%,TRUB2;NOP10;DKC1;PUS3;NHP2
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.23041488441857982,-0.7735414819664936,0.8463611859838275,0.9155673825182555,1.0,14/27,31.62%,PARP4;TERF2;DACH1;RGCC;SMG6;NIBAN2;FGFR4;BMPR2;PDGFA;TNKS;PINX1;SMG5;ATM;HGF
prerank,replicative senescence (GO:0090399),-0.29593822587733065,-0.7733929042425495,0.7818627450980392,0.9152545877057779,1.0,12/12,70.43%,CDKN2A;TERT;PLA2R1;ATM;ROMO1;WNT16;CHEK2;ATR;SERPINE1;CHEK1;TP53;MME
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.29916811943679883,-0.7733353176540328,0.7744874715261959,0.9148047136036461,1.0,4/11,19.51%,ITM2B;NECAB1;AGO2;ITM2A
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.23295599434323977,0.7732374939631076,0.8336025848142165,0.9741310407188055,1.0,7/39,13.58%,GTF2H2;POLD3;GTF2H4;OGG1;FAN1;PARP1;DDB2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.21147485521886683,0.7731061987460981,0.8552238805970149,0.9737193438573859,1.0,19/65,25.67%,BCL9L;LDLRAD4;PPARA;DAND5;TGFBR1;FBN2;PPM1A;TGFB1;PRDM16;SNX6;PIN1;IL17RD;SMAD2;PDPK1;SKOR2;HTRA3;FBN1;ZBTB7A;STUB1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2300110505754532,-0.7729965437307104,0.8125,0.9147650662879282,1.0,15/27,36.46%,C3AR1;GPR157;DRD2;GPR65;GPR18;DRD3;CALCA;GPR4;HTR2C;OPRL1;F2RL2;GPR35;GPR55;DRD1;AGTR1
prerank,mitochondrial fusion (GO:0008053),0.28232863374228845,0.7728316971723076,0.7520661157024794,0.9735568986654618,1.0,4/18,17.61%,FIS1;USP30;MIGA1;MFF
prerank,protein polymerization (GO:0051258),0.21705985342860748,0.7728172979726164,0.8473282442748091,0.9729624037739475,1.0,15/56,23.07%,TPPP;ANG;CATIP;CKAP5;PRKN;FGF13;WASF3;CHMP2A;RNF135;HDGFL3;PIN1;UBE2S;MAP7D3;TPPP3;WASL
prerank,muscle tissue development (GO:0060537),-0.28986192643576025,-0.7723477152613946,0.7880184331797235,0.9151884029087376,1.0,5/13,22.33%,PGM5;CSRP2;POGLUT1;PTCH1;SHH
prerank,negative regulation of innate immune response (GO:0045824),-0.21822703701689605,-0.7722384355614346,0.8595988538681948,0.9148127452931818,1.0,14/34,30.00%,STAT2;USP18;ACOD1;SERPING1;NLRC5;OAS3;MUL1;USP15;NLRC3;TRIM21;DHX58;RPS19;VSIG4;TNFAIP3
prerank,positive regulation of double-strand break repair (GO:2000781),0.23603704933605196,0.7719541671782547,0.8381240544629349,0.9737264615988905,1.0,8/39,20.01%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;SHLD3;MRNIP;SHLD2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.21282244087299448,0.7717538851013054,0.8621700879765396,0.9734376991636352,1.0,19/63,24.62%,CNOT2;SOX4;E2F1;PLK3;BTG2;CNOT8;GADD45A;RBL2;RFWD3;PLK2;FBXO31;TFDP2;MDM4;CASP2;CNOT10;AURKA;TRIAP1;CNOT4;SDE2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2265006858792293,0.7712545363222896,0.8571428571428571,0.9736171054953183,1.0,10/48,15.90%,AAAS;NUP54;EIF6;OGT;NUP88;RAE1;JMJD8;PRDM16;KHK;NUP133
prerank,mesenchymal cell development (GO:0014031),0.28099365719454195,0.7711189012816476,0.7625418060200669,0.9732018182655776,1.0,4/18,10.78%,CYP26C1;FOXC1;SNAI2;PDCD6
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.1975838938172749,0.7711152819755974,0.907859078590786,0.9725915131321005,1.0,11/104,9.64%,CDK7;FGF16;RPTOR;THY1;CCNI;SERTAD1;TRIB1;TRIB2;DAB2IP;CCND3;SLC8A1
prerank,protein palmitoylation (GO:0018345),0.2521531806796016,0.7710458770035606,0.8045602605863192,0.9720859037768483,1.0,12/30,27.25%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;SELENOK;GOLGA7;ZDHHC15;GLUL;ZDHHC19;ZDHHC12;ZDHHC5
prerank,protein export from nucleus (GO:0006611),0.25527316709371484,0.7706487329725634,0.8037676609105181,0.9720972489134605,1.0,9/27,25.04%,STRADB;STYX;TGFB1;PKD1;XPO6;STRADA;RANBP3L;RANBP17;CCHCR1
prerank,protein localization to synapse (GO:0035418),0.31289611458691213,0.7706032055011117,0.7603448275862069,0.9715548454680133,1.0,6/12,26.99%,NRXN1;SHANK1;ZDHHC15;PCLO;DLG4;ZDHHC12
prerank,histone acetylation (GO:0016573),-0.1857683130136658,-0.7703836375976828,0.8984615384615384,0.917029338372917,1.0,22/69,26.42%,EP400;EPC1;KAT6B;PHF20;TAF12;TRRAP;EP300;HAT1;KAT5;CHD5;MSL3;KAT7;TADA2A;TRIM16;YEATS2;POLE3;KAT2B;TAF6L;NAA40;ACTL6A;LEF1;ATF2
prerank,anterograde axonal transport (GO:0008089),0.23525112417603075,0.770193949662752,0.8451816745655608,0.9715665109373509,1.0,7/37,14.91%,DLG2;BLOC1S2;SNAPIN;AP3M1;AP3B2;KIF1C;HAP1
prerank,polyol biosynthetic process (GO:0046173),0.28813743848767326,0.7696194486760455,0.7842809364548495,0.9718901439529676,1.0,4/16,15.42%,IP6K1;FGF2;IPMK;CYP27A1
prerank,negative regulation of heart contraction (GO:0045822),-0.2977137393981678,-0.7694111631146852,0.7683215130023641,0.9179406238255027,1.0,6/11,31.00%,ZC3H12A;SPX;GRK2;PDE4D;AGTR2;SRI
prerank,odontogenesis (GO:0042476),0.23545867213681476,0.7688226936701242,0.8279742765273312,0.972550435464222,1.0,3/35,9.00%,ROGDI;BMP4;FOXC1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.2732156899975956,-0.7682665376879729,0.8120481927710843,0.9191351259771223,1.0,6/15,30.91%,LEMD3;ACVR1;ACVR2A;FST;IGSF1;FKBP1A
prerank,establishment of spindle localization (GO:0051293),-0.2760476329526439,-0.7682616652318319,0.7961165048543689,0.9186060370031649,1.0,3/14,12.30%,KPNB1;NUSAP1;ESPL1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.2126660435039573,0.7681202581141052,0.8531157270029673,0.9730077841123429,1.0,11/61,13.54%,PSMB1;PPARA;PSMF1;NCOR2;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4
prerank,regulation of glycogen metabolic process (GO:0070873),-0.2874406502703635,-0.7678496123480415,0.7738095238095238,0.9187210240197583,1.0,4/12,13.79%,PPP1R3C;PPP1R3F;PPP1R3E;INPP5K
prerank,negative regulation of cell death (GO:0060548),0.20184017914257013,0.7676246101935525,0.8898305084745762,0.9731739564798058,1.0,14/88,14.27%,SRGAP2;CD34;PPARGC1A;SOX4;PM20D1;SRSF6;CLU;CCN4;BMP4;PRKN;FGF2;BECN1;TXNDC12;CHMP2A
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3082849771043981,-0.7674571271276425,0.7878787878787878,0.9187134605340963,1.0,4/10,16.54%,CEACAM1;KDR;RAP1A;ASB4
prerank,regulation of mitotic cell cycle (GO:0007346),0.1825246804700113,0.7673351921065079,0.9421813403416557,0.9729945839073961,1.0,40/171,21.20%,PSMB1;OBSL1;SCRIB;SMOC2;LGMN;RPS6KB1;PSMF1;BTRC;PSMA1;PSMD7;PRKCA;CCDC57;FOXC1;TGFB1;PTPN3;BTG3;PSMA8;BTG2;PSME3;TTC28;THAP1;PSMD14;PSMC4;TTLL12;ANGEL2;ANAPC2;CDK10;BTG1;PSMB4;PIN1;UBE2D1;CAV2;FBXO5;PSME1;CYLD;HECA;UBE2S;PSMD2;PRMT5;PSMD4
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29175334933003516,0.7671061068873709,0.7854671280276817,0.9727185262181527,1.0,4/15,17.53%,SPCS2;SRPRB;SRP14;SRPRA
prerank,steroid biosynthetic process (GO:0006694),-0.19112041463344667,-0.7669978051399797,0.9130434782608695,0.9188552623218535,1.0,29/56,40.00%,ACOT8;OSBP;OSBPL9;OSBPL1A;PRKAG2;OSBPL2;HSD17B1;HSD11B1;SC5D;HSD3B7;INSIG1;SRD5A2;PMVK;HSD3B2;ABCB11;INSIG2;EBP;BAAT;HSD17B3;SLC27A5;AKR1D1;CYP19A1;ACOX2;HMGCR;CH25H;FDFT1;LBR;OSBPL3;SLC27A2
prerank,cellular defense response (GO:0006968),0.2310797080218236,0.7669646817998051,0.8484848484848485,0.9723192823477865,1.0,9/40,18.88%,FOSL1;RELA;CX3CR1;BECN1;CCR6;CLEC5A;CCR9;ITK;NCF2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.2536407155922746,-0.7669107852338365,0.8168674698795181,0.9184506360817668,1.0,4/19,10.02%,EXT1;XYLT1;UGDH;NDST3
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.302393842032571,-0.7661573151671859,0.7949886104783599,0.9189574472619535,1.0,1/11,0.36%,VCPIP1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3204599523018503,0.7660292427615588,0.7855887521968365,0.9731965710335452,1.0,1/10,1.25%,CBARP
prerank,inositol phosphate catabolic process (GO:0071545),0.3088428235570951,0.7659537643621622,0.7711442786069652,0.9727057348963795,1.0,5/12,21.24%,INPP5B;NUDT3;OCRL;INPP5A;INPP5J
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.29277813332762964,0.7656083769239918,0.7935943060498221,0.9725987313906802,1.0,9/14,35.31%,NUDT9;ENTPD6;ENTPD1;ENTPD2;NUDT16;ENTPD3;ENTPD7;NUDT1;NUDT18
prerank,positive regulation of heart contraction (GO:0045823),0.2710622872600678,0.7653922027144483,0.8222591362126246,0.9723109699521263,1.0,5/19,23.25%,ATP2A2;ADM;RGS2;SCN3B;CHGA
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.31857578052594465,0.7644722930252746,0.7553191489361702,0.9730816412048356,1.0,3/10,13.89%,PRKD2;ITGA5;VTN
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2602266947638681,0.7643105358371584,0.8132427843803056,0.9727250188386151,1.0,7/22,22.17%,CCNK;BRD4;ERCC6;DDX39B;THOC5;ALYREF;SCAF8
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.26432705990192357,0.7642841337301799,0.8098256735340729,0.9721592628630445,1.0,7/22,29.92%,HHEX;HEXIM2;IPO5;LATS1;HEXIM1;PTEN;CDK5RAP1
prerank,positive regulation of cilium assembly (GO:0045724),0.28089690742668383,0.7642400428966993,0.8160136286201022,0.9716276462592036,1.0,6/18,27.01%,SEPTIN9;ARHGAP35;HAP1;CEP120;FUZ;ENTR1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.21043475078610985,-0.7641511696856285,0.8879310344827587,0.9212472691756906,1.0,14/37,26.81%,UBE2K;S1PR2;PRKAG2;SPRY2;CALM3;CALM2;INPP5K;PLK1;BMP7;SIRT2;APP;EGF;TNKS1BP1;SPRED1
prerank,L-serine metabolic process (GO:0006563),0.32157001681478425,0.763930468136338,0.7718360071301248,0.9714735629291381,1.0,6/10,33.76%,SERINC3;PSPH;PHGDH;SRR;SERINC5;PSAT1
prerank,vasculogenesis (GO:0001570),-0.21977760618248923,-0.7638228476166999,0.8641304347826086,0.9211471104495259,1.0,14/32,30.89%,RASA1;AGGF1;CAV1;NOTCH1;KDR;HAS2;RAMP2;HEY2;SHH;APLNR;SPRED1;ITGB8;WT1;RASIP1
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.30958581673499963,-0.7634382386472304,0.768348623853211,0.9211262823026914,1.0,2/10,14.59%,RTEL1;TERF2
prerank,zinc ion transmembrane transport (GO:0071577),0.2659878768869879,0.7632436595006036,0.8260869565217391,0.9718912534529369,1.0,5/22,17.78%,SLC39A4;TRPM2;SLC39A8;SLC30A3;SLC39A3
prerank,microvillus assembly (GO:0030033),0.2894199118027556,0.762649283416978,0.8006932409012132,0.9721818116293498,1.0,6/14,25.09%,STK26;MAP4K4;MINK1;ESPN;RAP2C;RAPGEF2
prerank,serine family amino acid catabolic process (GO:0009071),0.32400585308076807,0.7625601648466523,0.7945670628183361,0.9716971158026059,1.0,3/10,15.61%,AMT;DAO;DLD
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2443439450981028,0.7602616401206526,0.8432956381260097,0.9745366143256785,1.0,12/30,27.65%,HSPA2;SDF2;SDF2L1;HSPA9;DNAJC7;HSPE1;HSPA14;DNAJB4;DNAJB13;ST13;HSPA8;PTGES3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.24428146642140325,0.7602063466637843,0.8223684210526315,0.974009911366198,1.0,8/29,21.33%,ZC3H7B;ADAR;SPOUT1;DROSHA;AGO4;SMAD2;SMAD1;LIN28B
prerank,positive regulation of vasculature development (GO:1904018),0.19556621877096342,0.7601053313872707,0.914364640883978,0.9735602287921035,1.0,21/94,18.41%,F3;CD34;ANGPTL4;SMOC2;PLCG1;RAPGEF3;PRKCA;EPHA1;PRKD2;FGF2;PDCD6;ADAM12;VASH2;TEK;HK2;PRKD1;ANGPTL3;BTG1;XBP1;IL1A;CHRNA7
prerank,negative regulation of leukocyte migration (GO:0002686),-0.30559609715624875,-0.7600325026430561,0.7898230088495575,0.925344939531103,1.0,3/10,16.50%,CD300A;BMP5;HMOX1
prerank,histone H4-K16 acetylation (GO:0043984),0.2782514750763113,0.7597921097935784,0.8079470198675497,0.9734281191292341,1.0,8/19,25.68%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MSL1;MCRS1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.2941395600195188,-0.7586864679258631,0.769406392694064,0.9266493737293954,1.0,5/11,25.04%,LYN;ANXA1;CDKN2A;PIK3CD;BLK
prerank,response to hydrogen peroxide (GO:0042542),0.22438025961901836,0.7582123146529686,0.852017937219731,0.975144275665755,1.0,7/45,11.55%,STK26;RELA;IL6;TRPM2;RIPK3;NFE2L2;STK25
prerank,regulation of cell communication (GO:0010646),-0.21303321887859072,-0.7575906289785077,0.8631284916201117,0.9275197471560706,1.0,15/35,29.23%,CRK;PTPN1;ANXA1;YWHAG;CAMK2D;NUP62;IGFBP7;CDC42SE2;VEPH1;GLRX2;GRK5;RYR2;GRK2;GRK4;CASQ2
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.25953181010382453,-0.7575492657707944,0.8179611650485437,0.9270392681582461,1.0,4/16,16.03%,ETF1;SHFL;TNF;CLN3
prerank,positive regulation of peptidase activity (GO:0010952),0.2637993490911077,0.7575229008091707,0.8085808580858086,0.9755551731035187,1.0,7/20,25.93%,VSIR;PSME3;PSENEN;PRELID1;PSME1;GRN;CTSH
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.28177073970118016,-0.7572698774717276,0.8111888111888111,0.9268895025175959,1.0,6/12,32.32%,DSEL;CSPG4;DSE;CHST12;NCAN;CHST14
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2595394488319923,0.7572464199840311,0.8208695652173913,0.975374706317338,1.0,5/23,13.87%,COPS8;COPS3;PARP1;DDB2;COPS6
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.27045082373399465,0.7571693344897481,0.8035426731078905,0.9748855546271509,1.0,7/20,29.92%,HHEX;HEXIM2;IPO5;LATS1;HEXIM1;PTEN;CDK5RAP1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.22227125443116735,-0.7571224805079141,0.8586666666666667,0.9265559818773637,1.0,13/26,30.00%,ITCH;ACOD1;MUL1;TRAF3IP1;LTF;NLRC3;TRIM21;SIRT2;DHX58;RNF26;SIGIRR;C1QBP;TNFAIP3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.29891283773008775,0.7569440349884082,0.7825311942959001,0.9746179390562182,1.0,2/12,16.82%,SIX4;AGT
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.23986780137500807,-0.7565009450260617,0.845771144278607,0.9268768745252507,1.0,4/21,12.11%,DVL3;CAV1;CTNNB1;FZD2
prerank,regulation of vasoconstriction (GO:0019229),0.2535292860496322,0.756094354984079,0.8525641025641025,0.9752440647368966,1.0,2/27,3.31%,AVPR2;AVPR1A
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.3180232179533643,0.7559875341579909,0.78,0.9747958437009729,1.0,3/10,12.13%,SHANK3;RAB5A;SYNGR1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.21367007387373355,0.7557900008111325,0.8895612708018155,0.9744757184949552,1.0,14/53,21.81%,PSMB1;PSMF1;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;PSME1;PSMD2;PSMD4;PSMD8
prerank,sphingoid metabolic process (GO:0046519),-0.2897045742923269,-0.7556820101806101,0.7942583732057417,0.9273866312604641,1.0,4/12,20.32%,SGPP1;ASAH2;SPHK2;SPTLC3
prerank,lipoxygenase pathway (GO:0019372),-0.27029019871957655,-0.7554344240885872,0.7887323943661971,0.9271621487545995,1.0,4/14,18.56%,ALOX5;ALOXE3;GPX1;LTC4S
prerank,regulation of sodium ion transport (GO:0002028),0.23414903727083775,0.7552220716394223,0.8369565217391305,0.9747203287868628,1.0,16/34,33.33%,FGF12;CNKSR3;NKAIN2;NEDD4;WNK1;ATP1A1;SCN1B;SCN3B;SNTA1;ANK3;PKP2;WNK4;P2RX7;WNK3;SCN4B;SPTBN4
prerank,cellular response to osmotic stress (GO:0071470),0.26447268632278176,0.754937646144995,0.8284789644012945,0.9745153885460803,1.0,4/21,14.13%,CAPN3;PKD2;STK39;SCN2A
prerank,regulation of lymphocyte activation (GO:0051249),0.302169970375801,0.7547085759319476,0.8003533568904594,0.9742193520021762,1.0,3/12,19.32%,PAG1;CRTAM;CCL5
prerank,limb development (GO:0060173),0.24792626706647058,0.7546962907462491,0.792,0.9736357195560172,1.0,2/28,4.53%,FGF10;MEGF8
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.18205287818620247,-0.7545786645572785,0.9313725490196079,0.9277562095935464,1.0,10/68,10.10%,MTHFR;FLAD1;MCCC1;SLC46A1;MCCC2;HLCS;GSTO2;MTHFD1;SLC52A2;SLC25A19
prerank,angiogenesis involved in wound healing (GO:0060055),-0.2868136182633072,-0.7543986099984542,0.8009049773755657,0.9274593583639293,1.0,5/11,19.21%,HPSE;PRCP;KDR;ADIPOR2;ITGB3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.2732007297341793,0.7542664469580401,0.831946755407654,0.973623035008137,1.0,7/18,23.35%,FIS1;PRKN;DNM1L;RALBP1;MFF;DCN;AURKA
prerank,pulmonary valve morphogenesis (GO:0003184),0.272213525943774,0.7530448552392932,0.7870216306156406,0.9748519716813884,1.0,3/17,9.91%,BMP4;HEY1;GJA5
prerank,positive regulation of protein depolymerization (GO:1901881),0.3096033100875607,0.7526412955360067,0.8020477815699659,0.974835646060066,1.0,1/11,4.04%,STMN2
prerank,negative regulation of DNA replication (GO:0008156),-0.27969613259668513,-0.7526017859240199,0.8055555555555556,0.9293049262132378,1.0,13/13,72.06%,PDS5A;WAPL;S100A11;TSPYL2;RAD17;CDC6;MCIDAS;GMNN;ATR;GMNC;CDAN1;GTPBP4;TERF1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.23579409977124133,0.7524344916046237,0.8395061728395061,0.9745039924551403,1.0,9/33,22.39%,PPARA;TCF7L2;NFE2L2;ICAM1;TEK;NDNF;TNIP2;PDPK1;CAST
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.24378982515932618,0.7520593556099185,0.8390243902439024,0.9744433628532723,1.0,5/27,17.90%,ATP2A2;GJA5;FGF13;CTNNA3;ANK2
prerank,positive regulation of angiogenesis (GO:0045766),0.19051103991108245,0.7515627893484311,0.9352617079889807,0.9745613338226706,1.0,23/108,18.41%,F3;CD34;ANGPTL4;SMOC2;PLCG1;RAPGEF3;PRKCA;EPHA1;PRKD2;JMJD8;ITGA5;FGF2;PDCD6;ADAM12;VASH2;TEK;HK2;PRKD1;ANGPTL3;BTG1;XBP1;IL1A;CHRNA7
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.22656760054005504,-0.7512655532225441,0.8534704370179949,0.930560283660211,1.0,3/27,8.21%,FCGR2B;VPS35;PSEN1
prerank,regulation of blood circulation (GO:1903522),-0.2156818989884654,-0.7507307377945864,0.8952879581151832,0.9307604983754094,1.0,17/34,39.39%,CAMK2D;S100A1;FXYD1;AGER;PER2;KCNQ1;CELF2;KCNG2;ACE2;SRI;TNNT2;MYH6;TH;AGTR1;TPM1;KCNMB4;ECE1
prerank,cholesterol metabolic process (GO:0008203),0.2056148743592679,0.7504320852116959,0.8968481375358166,0.9755533524290946,1.0,14/68,21.11%,STARD3;TM7SF2;SOAT2;ACAT2;NSDHL;LSS;CYP27A1;ACLY;SCAP;ANGPTL3;FDPS;CLN6;PIP4P1;FDX1
prerank,signal peptide processing (GO:0006465),0.306890829928956,0.7502918349222625,0.8053691275167785,0.9751568381054467,1.0,3/11,16.05%,SPCS2;HM13;SEC11C
prerank,mitochondrial transcription (GO:0006390),0.31700654597240613,0.7497420761568314,0.7862190812720848,0.9753639778747085,1.0,1/10,4.03%,TFAM
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.17884080277730502,0.7493208826227066,0.9624060150375939,0.9753623699147089,1.0,39/172,22.45%,INPP4B;PIK3C2G;INPP5D;MTMR9;PLA2G4C;PIK3CG;PNPLA3;LPCAT1;PI4K2A;SACM1L;DGKQ;CPNE6;ACHE;CHAT;PTDSS2;OCRL;INPP5F;RAB5A;FGF2;LPCAT2;SLC44A2;AGPAT1;MTMR1;ABHD5;DGKZ;DGKE;VAC14;PTPN13;ABHD8;INPPL1;PGS1;DGKH;PLEKHA2;INPP5J;PLEKHA1;PIK3C2A;PIP4K2B;ARF1;SELENOI
prerank,regulation of macrophage cytokine production (GO:0010935),-0.28339651173675895,-0.7490616519596026,0.7917675544794189,0.9323528228312542,1.0,4/13,15.43%,CD74;GPRC5B;LILRB1;WNT5A
prerank,cellular component maintenance (GO:0043954),-0.2855357964216564,-0.7487441156724658,0.7878048780487805,0.9322307720954559,1.0,2/12,6.99%,MTMR2;FYN
prerank,regulation of T cell differentiation (GO:0045580),0.2374509526714319,0.7484466958077959,0.8330683624801272,0.9759757336296446,1.0,7/33,17.88%,IL2RA;IL2;CRTAM;PRDM1;IL7;PRELID1;XBP1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.21300174249072198,-0.7483242844939156,0.8780487804878049,0.9322037739755623,1.0,13/33,28.53%,TYROBP;GBF1;PICALM;TM9SF4;CTNNB1;RAB11FIP5;TNF;GOPC;EGF;GPD1L;KCNAB2;RANGRF;TAX1BP3
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2618843693241726,0.7482464948946496,0.8012820512820513,0.975654646739723,1.0,5/20,15.40%,RELA;SPPL2B;TGFB1;PSENEN;HM13
prerank,positive regulation of establishment of protein localization (GO:1904951),0.26748363738554787,0.7480519710812126,0.8261589403973509,0.975332507399112,1.0,3/19,10.80%,WRAP53;CORO2B;CCT4
prerank,synaptic vesicle localization (GO:0097479),0.2967235143551482,0.7477343180185018,0.8030560271646859,0.9751691571828319,1.0,3/13,20.99%,SNAPIN;SPG11;TMEM230
prerank,outflow tract septum morphogenesis (GO:0003148),0.24991007161135056,0.7477245306859212,0.8226600985221675,0.9745835563015959,1.0,6/24,17.26%,LRP2;ZFPM2;BMP4;TBX2;SEMA3C;ENG
prerank,positive regulation of coagulation (GO:0050820),-0.29743299648266003,-0.7476977252702984,0.7980997624703088,0.9319555633630796,1.0,2/10,9.54%,THBS1;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.29743299648266003,-0.7476977252702984,0.7980997624703088,0.9319555633630796,1.0,2/10,9.54%,THBS1;HPSE
prerank,positive regulation of neuron migration (GO:2001224),-0.2920561644795688,-0.7472672601212436,0.800982800982801,0.9319914135527242,1.0,4/11,18.58%,KIF20B;SEMA6A;SHTN1;ARHGEF2
prerank,tRNA 5'-leader removal (GO:0001682),0.2950187626327973,0.746341347064259,0.8042328042328042,0.9758667993780226,1.0,3/13,13.22%,RPP40;PRORP;RPP30
prerank,membrane lipid metabolic process (GO:0006643),0.25606112807777553,0.7462803895331812,0.8183306055646481,0.9753651054752347,1.0,5/22,17.08%,TEX2;TECR;ST3GAL6;GAL3ST1;SERINC1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.2313406053247901,-0.7461231625304602,0.8658227848101265,0.9329929493081306,1.0,5/24,18.57%,PRKCH;CTSL;SGPP1;NUMA1;TRIM16
prerank,mRNA catabolic process (GO:0006402),0.22149227305677502,0.7457296939453085,0.8623298033282905,0.9755157504068052,1.0,8/44,15.18%,NUDT12;DDX5;ZFP36L2;METTL16;NBDY;AGO4;UPF1;NBAS
prerank,sensory organ development (GO:0007423),-0.19523783380289925,-0.7454157066629876,0.9166666666666666,0.9333660523046224,1.0,27/51,39.39%,MEIS1;SMCHD1;SH3PXD2B;PBX4;HIPK1;SMOC1;HIPK2;GATA3;GDF3;SHROOM2;PAX6;BLOC1S3;CPAMD8;SIPA1L3;ADAMTS18;SALL2;MAB21L1;PAX8;TGFB2;RAB18;SOX3;NTF4;STRA6;MEIS3;AHI1;FREM2;ECE1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.20477902591874636,-0.7449188621136449,0.8988095238095238,0.9334768576188739,1.0,8/39,15.23%,GCNT2;CORO1C;RASA1;THBS1;NOTCH1;MYOC;AJAP1;SPRY4
prerank,aerobic respiration (GO:0009060),-0.24422746763016664,-0.7442166955273679,0.8582278481012658,0.9338664436695066,1.0,5/20,17.36%,NDUFS8;SDHB;NDUFS7;MTFR2;SURF1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.2661896882552408,0.7439814204868229,0.8217179902755267,0.9772774971759042,1.0,9/19,28.92%,RARRES2;MAPK3;JAM3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.23941808983645288,-0.7439331838523522,0.836104513064133,0.9336848139762194,1.0,9/21,31.00%,PRKACA;CAMK2D;CALM3;CALM2;RYR2;PDE4D;CASQ2;CALM1;SRI
prerank,cellular transition metal ion homeostasis (GO:0046916),0.1980458153482719,0.7438109238034651,0.9274537695590327,0.976915449227833,1.0,24/91,20.97%,IREB2;SLC39A4;ABCB6;PRNP;SLC31A1;FLVCR1;SLC39A8;FRRS1;ATOX1;CYB561A3;TMPRSS6;MT2A;ISCU;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;ABCG2;ABCB7;ATP6V1G1
prerank,neural tube development (GO:0021915),0.28301118440860307,0.7435639038092565,0.8023064250411862,0.9766525970604564,1.0,4/15,12.51%,SOX4;PKD2;TGFB1;PKD1
prerank,relaxation of cardiac muscle (GO:0055119),0.29644703206846307,0.7435510121343032,0.7946902654867256,0.9760714618894423,1.0,5/13,23.25%,ATP1B1;SLC8A1;RGS2;ATP1A1;CHGA
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.1848496201056181,0.7430156405539305,0.9474393530997305,0.9762126009456243,1.0,41/124,28.30%,WNT4;VANGL2;PSMB1;RYK;ARRB2;PSMF1;PRICKLE1;PSMA1;TCF7L2;PSMD7;PSMA8;PSME3;SFRP1;MAP3K7;VANGL1;PSMD14;PSMC4;AGO4;WNT7A;PSMB4;DVL2;PLCB2;PSME1;CDC42;PSMD2;PSMD4;FRZB;PSMD8;SFRP2;TIAM1;GNG2;RHOA;PSMC5;FZD5;PSMD3;PSMB8;PSMA4;PLCB1;CLTC;ROR2;CELSR2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.18032119076784114,-0.74297123542761,0.9471947194719472,0.9343789560952415,1.0,12/69,13.69%,VCP;TRIM25;OS9;PSMC6;UBQLN1;DNAJB9;ERLIN2;BAG6;DNAJC10;RNF103;EDEM1;FBXO2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.3070469819979111,0.7424181910314087,0.8080808080808081,0.9764042916047447,1.0,1/10,3.98%,HSPA2
prerank,negative regulation of myotube differentiation (GO:0010832),0.29285437427615607,0.7418059693824325,0.7962328767123288,0.9766607886644734,1.0,5/12,23.80%,HDAC5;BHLHE41;XBP1;HDAC3;BDNF
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.26898661991232203,0.7417128858974198,0.8231173380035026,0.9762010217463238,1.0,5/18,16.19%,DAB2IP;EMD;SFRP1;MED25;PEX2
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.20786108835452105,-0.7414494538698156,0.8922155688622755,0.9356829770348287,1.0,8/36,16.07%,BCL2;FAS;ASAH2;RB1;QARS1;DEPTOR;TNF;TRAF1
prerank,negative regulation of chemokine production (GO:0032682),0.2773530913699128,0.7411562992081149,0.8232235701906413,0.9763770859127499,1.0,3/14,14.82%,IL6;MAP2K5;APOD
prerank,sensory perception (GO:0007600),0.2189528116394457,0.7409131651871813,0.8989598811292719,0.9761032638036309,1.0,8/45,18.41%,WHRN;CDH23;NTSR2;NIPSNAP1;OPRM1;GNAS;ASIC3;CHRNA7
prerank,negative regulation of cellular protein localization (GO:1903828),-0.21266753314889963,-0.7404555459589207,0.9239130434782609,0.9363751840411096,1.0,7/34,17.88%,RIPOR2;CTNNA1;ANKRD13A;PICALM;CDT1;UBXN2B;GOPC
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.21914677297134988,-0.7403378783762774,0.8731343283582089,0.9359744100565434,1.0,6/29,15.14%,GAS6;CCR2;MOSPD2;CXCL17;AGER;TNF
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.25468195275141525,0.7403005366185927,0.8444444444444444,0.9763373765121506,1.0,10/23,29.48%,MAP6;KIF1C;HOOK2;HOOK1;KIF1B;CCDC186;TUBA1B;DYNC1I1;TUBA1A;TUBA1C
prerank,regulation of striated muscle contraction (GO:0006942),-0.22314032136031633,-0.7400295584466032,0.847769028871391,0.93580533136891,1.0,12/27,32.49%,P2RX4;PRKACA;CALM3;ASB3;CALM2;RNF207;RYR2;SCN10A;GRK2;CALM1;SRI;NOS1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.28390172384171725,-0.7397505642519165,0.8484848484848485,0.935619326629104,1.0,3/12,17.92%,HDAC1;INPP5K;HMGA2
prerank,monocyte differentiation (GO:0030224),0.3125886573333432,0.7396554131175046,0.8013468013468014,0.9765716825730524,1.0,5/10,28.16%,BMP4;THOC5;MT1G;PDE1B;CSF1R
prerank,regulation of mRNA processing (GO:0050684),0.23547755790623193,0.7395804143653845,0.8657407407407407,0.9760738113148164,1.0,6/32,12.25%,CWC22;SON;YTHDC1;METTL16;KHDRBS2;QKI
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.2833329243938938,0.7392579312160619,0.8217993079584776,0.9758875041328816,1.0,3/14,13.31%,TGFBR1;SNAI2;CHADL
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.20686901221791187,0.7388926071676638,0.9085457271364318,0.9757823280798072,1.0,20/55,27.53%,PSMB1;PSMF1;PSMA1;FHL1;PSMD7;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;FBXL7;PSME1;PSMD2;PSMD4;PSMD8;AURKA;PSMC5;PSMD3;PSMB8;PSMA4
prerank,divalent inorganic cation homeostasis (GO:0072507),0.24811583419774264,0.7384643707228599,0.8778877887788779,0.9757510017264434,1.0,4/25,9.79%,TMC8;GRIN1;SLC8A1;PRKN
prerank,endoderm formation (GO:0001706),-0.20702500300844462,-0.7380377502659027,0.8956043956043956,0.9371374541973125,1.0,15/35,32.08%,ITGA4;COL11A1;DUSP1;LHX1;HMGA2;FN1;MMP8;SETD2;LAMA3;COL12A1;ITGA7;ITGB2;DUSP4;COL7A1;MMP9
prerank,tRNA 5'-end processing (GO:0099116),-0.2658964121971741,-0.7374007965461057,0.8423645320197044,0.9373395261454963,1.0,4/15,10.31%,TRMT10C;RPP38;RPP21;SSB
prerank,cellular response to hypoxia (GO:0071456),0.18292179219032637,0.737369763537199,0.9525101763907734,0.9765729540871287,1.0,38/126,26.14%,PSMB1;KCND2;HILPDA;ELOC;PSMF1;PSMA1;PSMD7;PLK3;PSMA8;PSME3;SFRP1;SUV39H2;CUL2;EPAS1;PSMD14;PSMC4;NDNF;SCN2A;SLC8A3;NDRG1;CARD16;BACH1;PSMB4;OPRD1;RORA;PSME1;PSMD2;TBL2;PSMD4;MDM4;PSMD8;AK4;HIF1AN;NPEPPS;HIGD1A;STUB1;PSMC5;PSMD3
prerank,stress-activated MAPK cascade (GO:0051403),0.20414147882814732,0.7371216698111418,0.9300291545189504,0.9762993849464019,1.0,19/61,25.08%,UBE2V1;TRIB1;MAP3K10;BTRC;NOD1;SH2D3C;UBE2N;MINK1;MAP3K7;MAP3K13;MAPK10;MAPK3;MAP4K2;TNIP2;RIPK2;GPS2;ADORA2B;TAOK2;MAPK1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.25684522184602754,-0.736434275336826,0.8305084745762712,0.9379460832954494,1.0,5/15,21.57%,EIF4ENIF1;AGO2;TENT4B;TENT4A;CPEB3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.21518718646855622,-0.7363988788344822,0.8545994065281899,0.937455725756002,1.0,9/33,17.30%,ANKRD17;CDC73;CCND1;ANXA1;CCND2;EGFR;CRNN;ADAM17;RGCC
prerank,protein K11-linked ubiquitination (GO:0070979),-0.21666898138266028,-0.7362076136734507,0.9154929577464789,0.937149819390186,1.0,13/27,33.35%,UBE2D3;UBE2L3;CDC27;UBE2E3;UBE2C;ANAPC10;ANAPC7;RNF26;CDC23;UBE2T;ANAPC11;UBE2A;ANAPC1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.27925571150702655,-0.7360929880801046,0.8032036613272311,0.9367442239168846,1.0,8/12,40.91%,CTDNEP1;CDK1;PLK1;CCNB1;LPIN1;PRKCB;CNEP1R1;VRK1
prerank,smooth muscle contraction (GO:0006939),-0.25661581047539567,-0.7353304259448633,0.8356164383561644,0.9371908576840609,1.0,5/14,19.19%,TPCN2;EDNRA;CHRNB2;ADRA1A;MYLK
prerank,negative regulation of cholesterol transport (GO:0032375),0.3082311916221228,0.7352591202919897,0.8115942028985508,0.9781194068608908,1.0,2/10,13.97%,ABCG8;ABCA2
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.2868298722112617,-0.735044152784445,0.8228155339805825,0.9369785747795478,1.0,5/11,25.74%,EXOSC10;FBL;TENT4B;DKC1;LARP7
prerank,organophosphate catabolic process (GO:0046434),0.3032537795612097,0.7349512025645951,0.8282647584973166,0.9779130869451604,1.0,3/11,16.98%,ABHD12;ENPP2;ANGPTL3
prerank,regulation of fatty acid oxidation (GO:0046320),0.2786170525692623,0.7341857259878116,0.8481675392670157,0.9783097216320017,1.0,2/16,4.81%,PPARGC1A;PPARA
prerank,regulation of sensory perception of pain (GO:0051930),-0.28035153797865664,-0.7336355277514316,0.82560706401766,0.9381027324839281,1.0,11/11,71.99%,CCN3;VIP;SPX;ATPSCKMT;ACP3;TMEM100;CCL3;SCN11A;F2R;ZFHX2;MGLL
prerank,neuron migration (GO:0001764),0.21099062158893178,0.7332989597613282,0.9103343465045592,0.9788907051251267,1.0,10/48,16.00%,MEF2C;ADGRL3;CDKL5;FGF13;DDIT4;NRCAM;TUBB2A;NDNF;NTRK2;TUBGCP2
prerank,regulation of smooth muscle contraction (GO:0006940),0.2568364936401071,0.733199207992995,0.8538205980066446,0.9784337443328409,1.0,1/20,0.21%,CTTN
prerank,response to nitric oxide (GO:0071731),-0.2741872463303504,-0.7328390176084834,0.8140096618357487,0.9385029598783544,1.0,4/13,27.78%,TXN;FOXO1;EGLN1;AQP1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.26939389202568764,0.7324294503624146,0.8333333333333334,0.9788317177554474,1.0,2/16,5.65%,RELA;IL6
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.195691745417025,-0.7324257223829735,0.9156626506024096,0.9384387643160269,1.0,16/46,28.40%,DDHD1;AGPAT4;AGPAT5;PLD1;DGKA;ACP6;LPCAT4;GPAM;PLD2;AGPAT2;PLA2G2D;GPD1L;ABHD4;GPAT3;AGPAT3;PLA2G12A
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.28642879865168025,-0.732250848176925,0.8137472283813747,0.9381126474301879,1.0,6/11,40.84%,STAT1;WNT5A;PDGFA;TBX1;CTNNBIP1;SOX9
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.21979892184771124,0.7313291405682341,0.8868501529051988,0.9796100257803354,1.0,12/40,23.56%,MLLT11;CLU;PDCD5;PRKN;DNM1L;BIK;BBC3;PRELID1;MFF;CIDEB;HRK;TRIAP1
prerank,microvillus organization (GO:0032528),0.2816074136111254,0.7312612257293447,0.852233676975945,0.9791080696583351,1.0,3/13,11.50%,STK26;MAP4K4;MINK1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.20327656465022895,-0.7310001606769778,0.9128065395095368,0.9389516884669401,1.0,14/42,22.90%,AIMP1;FARS2;IARS2;YARS2;PARS2;EARS2;QARS1;NARS1;WARS2;VARS2;WARS1;FARSA;LARS1;PPA2
prerank,myelination in peripheral nervous system (GO:0022011),0.2864430566505422,0.7307250787072026,0.8324607329842932,0.9791907154217289,1.0,1/13,1.12%,CNTNAP1
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.2689600287894135,-0.7306097895070085,0.8418604651162791,0.9388819441622741,1.0,5/13,27.37%,ENPP3;SMPDL3A;ENTPD5;NUDT15;DCTPP1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.2691486633012438,-0.7302820924469071,0.8181818181818182,0.938719694857848,1.0,4/13,21.53%,ARID1B;ZMIZ1;SERTAD2;ZMIZ2
prerank,t-circle formation (GO:0090656),0.3067736267676612,0.7302338791677931,0.8024263431542461,0.9780537870979491,1.0,5/10,31.19%,SMARCAL1;XRCC3;WRN;TERF1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.3067736267676612,0.7302338791677931,0.8024263431542461,0.9780537870979491,1.0,5/10,31.19%,SMARCAL1;XRCC3;WRN;TERF1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.3067736267676612,0.7302338791677931,0.8024263431542461,0.9780537870979491,1.0,5/10,31.19%,SMARCAL1;XRCC3;WRN;TERF1;DNA2
prerank,embryonic digit morphogenesis (GO:0042733),-0.2499555865191603,-0.7299038206403632,0.8441247002398081,0.9386339675259269,1.0,7/18,27.36%,WDPCP;HDAC2;HDAC1;MAP3K20;SHH;TWIST1;MSX1
prerank,histone H2B ubiquitination (GO:0033523),-0.2921913529928035,-0.7297225546416302,0.8251748251748252,0.9383140562146811,1.0,5/10,23.56%,CDC73;DTX3L;WAC;RNF20;LEO1
prerank,cellular respiration (GO:0045333),-0.19658753128411863,-0.7294280372091554,0.9181818181818182,0.9381377681283417,1.0,5/41,6.35%,NDUFS4;NDUFA5;MTLN;NDUFS8;SDHB
prerank,sterol biosynthetic process (GO:0016126),0.23027538519196544,0.7294098056870165,0.8723723723723724,0.9784743601402124,1.0,6/33,18.82%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.18059008172931998,-0.729143254965137,0.9629629629629629,0.9379193405155282,1.0,25/65,28.25%,UBQLN1;ACAA2;HIF1A;CPEB4;ADAM8;PTGIS;PMAIP1;HP1BP3;HMOX1;NOP53;HIPK2;CPEB2;RGCC;BMP7;FMN2;SIRT2;LMNA;TWIST1;HYOU1;TERT;EGLN1;FAM162A;AQP1;TSC1;MDM2
prerank,regulation of intracellular protein transport (GO:0033157),0.2267700834571447,0.7288692447699541,0.8734567901234568,0.9785232201051203,1.0,6/32,11.37%,TENM1;BMP4;OAZ1;TGFB1;PLK3;IFI27
prerank,cell junction maintenance (GO:0034331),0.2794531134394405,0.7284584281725592,0.8310344827586207,0.9784670339061884,1.0,3/14,14.13%,CBLN2;DCTN1;CHCHD10
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.25252567570482837,0.7283473755807377,0.8530884808013356,0.9780133289322623,1.0,4/21,20.71%,PPARA;PRKN;ABCD2;ABCB7
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.19021063870319121,0.7278532119544688,0.9330422125181951,0.9780398053513792,1.0,20/95,19.82%,AGRN;HS3ST6;HS3ST5;B4GAT1;ACAN;GPC1;GPC2;GPC5;CHST1;HS6ST1;VCAN;CSGALNACT1;ST3GAL6;GPC4;B3GAT3;B4GALT2;DCN;ST3GAL3;CHSY1;SDC2
prerank,atrioventricular valve development (GO:0003171),-0.26094971230499375,-0.7277976314308763,0.8412322274881516,0.9389975253092704,1.0,9/14,30.84%,NOTCH1;BMP2;ACVR1;HEYL;APLNR;BMPR2;BMPR1A;SLIT3;TGFB2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.2960320214884751,0.7277286788141701,0.8061749571183533,0.9776113343292582,1.0,4/11,29.33%,GCHFR;QDPR;SPR;PTS
prerank,chondrocyte differentiation (GO:0002062),0.22835362202738393,0.7276458956810159,0.8646003262642741,0.9771307707991947,1.0,12/32,27.27%,NFIB;MEF2C;BMP4;TGFB1;WNT7A;BMPR1B;SULF2;SNX19;GPLD1;RUNX1;WNT5B;SULF1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.22995767472169304,-0.7276304613508292,0.8940568475452196,0.938643528859576,1.0,9/23,27.10%,MOSMO;VCP;RACK1;KCTD21;GLIS2;KIF7;PTCH1;ULK3;PTCH2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.27350130485637414,-0.7276196286619554,0.8409638554216867,0.9381247059713284,1.0,6/12,29.12%,SNW1;KLF2;TRIM16;DHRS3;EZH2;CYP26B1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.30752211745758823,0.7275460962767539,0.8191126279863481,0.9766723721859777,1.0,1/10,0.98%,ADTRP
prerank,regulation of axon regeneration (GO:0048679),0.2911061227426847,0.7274258225724451,0.8419182948490231,0.9762445429501144,1.0,5/12,23.29%,RTN4RL1;INPP5F;EPHA4;PTPRS;GRN
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.2924285270268962,-0.727277377440569,0.7976470588235294,0.9380235223459263,1.0,5/10,27.66%,NOP10;DKC1;NAF1;NHP2;RPUSD3
prerank,ceramide metabolic process (GO:0006672),0.2093096549732709,0.7272391213887349,0.9018691588785047,0.9758861418456009,1.0,14/49,21.76%,TLCD3B;ORMDL2;CERS4;SPTSSA;NSMAF;ABCA2;CERS5;CERS6;CERS1;PPP2R1A;CLN6;PLA2G15;PLPP1;FA2H
prerank,glycosphingolipid metabolic process (GO:0006687),0.21685880204264052,0.7263750089526363,0.9069400630914827,0.9763725060495635,1.0,5/42,10.08%,ST3GAL5;HEXB;ESYT2;NEU1;B3GALNT1
prerank,estrogen metabolic process (GO:0008210),0.2766546551124878,0.7261618155708633,0.8353982300884956,0.9760580048793415,1.0,5/15,24.76%,HSD17B2;HSD17B11;HSD17B10;SULT1A1;HSD17B14
prerank,positive regulation of dephosphorylation (GO:0035306),0.2379269201485576,0.7260622700763297,0.8888888888888888,0.9755903735351258,1.0,8/27,21.68%,MTMR9;PTBP1;RIPK3;TGFB1;PPP1R7;PIN1;NSMF;PPP1R16B
prerank,regulation of brown fat cell differentiation (GO:0090335),0.26226320360424704,0.7256435469964019,0.8466666666666667,0.9755185225142037,1.0,6/16,25.06%,FNDC5;FLCN;NAPEPLD;ZBTB7B;SOX13;FTO
prerank,negative regulation of binding (GO:0051100),0.19445193799217106,0.7247771400303543,0.9499304589707928,0.9760090922027902,1.0,16/81,19.00%,ZFPM1;TMC8;EFHB;E2F1;GTF2F1;STYX;SUMO3;ITGB1BP1;PEX14;USP33;PDGFB;MITD1;CARD16;ROCK1;PIN1;ACTB
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.23317446395763158,-0.7243287100373067,0.8638613861386139,0.9408010458803621,1.0,4/21,12.88%,IGF1;PTGER4;CDK1;KDR
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.2950066945029598,-0.7238647124627444,0.8400900900900901,0.940797438734229,1.0,4/10,19.48%,RIPK1;TXN;LRRK2;GPR37
prerank,engulfment of apoptotic cell (GO:0043652),0.2782168796387558,0.7238146749971831,0.8330464716006885,0.9765761625122313,1.0,3/15,17.33%,RHOBTB1;XKR6;RHOBTB2
prerank,visual system development (GO:0150063),0.22082528727050624,0.7230141618196142,0.8966049382716049,0.9769240559852053,1.0,5/37,11.75%,C3;MAB21L2;PBX2;FOXC1;PBX3
prerank,calcium import into the mitochondrion (GO:0036444),0.303139470410571,0.7225126809543198,0.8067978533094812,0.976937442011242,1.0,3/10,15.59%,MICU2;SMDT1;SLC25A23
prerank,fatty acid elongation (GO:0030497),-0.2670442453739961,-0.7222799817566798,0.8439716312056738,0.9420007188575278,1.0,5/13,26.69%,HACD4;HACD1;HACD2;ELOVL2;ABCD1
prerank,glycolipid metabolic process (GO:0006664),0.20897480175787397,0.722243661160151,0.919629057187017,0.9766696108471542,1.0,8/47,13.97%,HEXB;ESYT2;NEU1;NAGA;B3GALNT1;ST3GAL6;SCCPDH;ABCA2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.30698685408930204,0.7214431808247733,0.8146788990825689,0.9770471254456602,1.0,1/10,3.06%,KCNE2
prerank,peptidyl-amino acid modification (GO:0018193),0.30503252450741075,0.7214268604184183,0.8278985507246377,0.9764879643673919,1.0,3/10,21.27%,METAP1D;FKBP10;METAP2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.1985611823641952,0.7213007202248134,0.9264069264069265,0.9760570140784269,1.0,18/62,25.30%,SELENOS;ACKR3;NME5;CLU;PRKN;SNAI2;NFE2L2;HERPUD1;TXNDC12;CCAR2;XBP1;ARMC10;SFRP2;RTKN2;CREB3;TMBIM6;SOD2;DDX3X
prerank,cellular response to catecholamine stimulus (GO:0071870),0.24495380445241646,0.7206346957543547,0.8653530377668309,0.9762364965110876,1.0,9/23,27.07%,APLP1;PRKN;GABPA;MAPK3;SLC9A1;GNG2;MAPK1;ATF4;TGM2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.229794633095662,-0.720458212884757,0.8809523809523809,0.9434677975497515,1.0,5/22,15.14%,PPP2R5A;IL1B;CEACAM1;APOC1;TNF
prerank,cranial nerve development (GO:0021545),0.2908898617827884,0.720449460054905,0.8240574506283662,0.9758852467961097,1.0,1/11,3.50%,ATOH7
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.28714258555925687,0.72038434583339,0.8608695652173913,0.9753866412402951,1.0,2/13,5.65%,PTPRT;IL6
prerank,epidermis development (GO:0008544),-0.18426382800865054,-0.7199048394990515,0.9541284403669725,0.9435469482385083,1.0,30/56,36.79%,FLOT2;EMP1;HDAC2;HDAC1;PTHLH;ALDH3A2;LAMA3;DSP;EVPL;SCEL;FOXN1;CRABP2;SPINK5;KRTDAP;POU2F3;DLL1;SVEP1;WAS;COL7A1;GRHL1;UGCG;OVOL2;TGM5;EDAR;OVOL1;EDA2R;GLI1;RBP2;SPRR1A;NTF4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.22639540103450884,-0.7198065985119494,0.8597883597883598,0.9431154409069475,1.0,2/21,4.59%,CNOT9;SAMD4A
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.28930226445618323,0.7196378378982097,0.8432055749128919,0.9756637280783413,1.0,2/12,12.71%,SOAT2;MTTP
prerank,insulin secretion (GO:0030073),0.2592249996323882,0.7196221108940944,0.8367346938775511,0.9751031819510843,1.0,5/19,22.19%,PTPRN;ADCYAP1;GAL;SNX19;RAB11FIP2
prerank,actin polymerization or depolymerization (GO:0008154),-0.1868122239407852,-0.7189759224393825,0.9369369369369369,0.9434724105794536,1.0,13/50,17.61%,SVIL;PSTPIP2;DIAPH3;GAS7;COBL;VILL;WASF1;CORO7;CFL2;MICAL1;GSN;MICAL2;MSRB1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.22919263798868372,-0.7187606884767246,0.875,0.9431607083930514,1.0,5/18,16.34%,IGF1;CD24;IGF2;AGER;IL27RA
prerank,regulation of transposition (GO:0010528),-0.27987873680742625,-0.7185827025904368,0.8711340206185567,0.9428302508393294,1.0,6/13,35.60%,PIWIL2;TDRD9;MYBL1;AICDA;PIWIL4;PIWIL1
prerank,nuclear membrane disassembly (GO:0051081),0.27704708543306483,0.718435731338029,0.8342151675485009,0.9759168016958941,1.0,3/14,12.69%,AKAP8L;PRKCA;DCTN1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.2791118688999219,-0.7183607992119346,0.8325581395348837,0.9425421699553678,1.0,4/11,15.43%,ETV6;ARIH2;WNT2B;WNT5A
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.23865664053533908,0.7180521489128693,0.8661157024793389,0.9758045967635807,1.0,6/26,18.94%,GCHFR;PM20D1;ABCA2;DDAH2;CYB5B;ARG2
prerank,regulation of fibrinolysis (GO:0051917),-0.26544230843228583,-0.7179977223895556,0.8605769230769231,0.9423788341605048,1.0,8/13,34.36%,THBS1;APOH;SERPINF2;F11;KLKB1;PLG;F12;HRG
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.28258221740197215,-0.716658618457094,0.8390022675736961,0.9426809905202701,1.0,6/11,31.00%,CALM3;CALM2;CASQ2;CALM1;FKBP1A;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.28258221740197215,-0.716658618457094,0.8390022675736961,0.9426809905202701,1.0,6/11,31.00%,CALM3;CALM2;CASQ2;CALM1;FKBP1A;SRI
prerank,chromatin organization (GO:0006325),0.17621982894665938,0.7161904695490431,0.9708222811671088,0.9773683513246337,1.0,22/132,18.76%,NUCKS1;MPND;SMARCC2;BPTF;FAM50A;PAK1;KDM6B;MCM3AP;BRWD1;SMARCE1;PWWP3A;HDAC5;SMARCD3;SUV39H2;KDM4A;PRDM16;NPM2;TCF7L1;HMG20A;PHF1;SETDB1;HDAC3
prerank,response to cholesterol (GO:0070723),0.2600486837498621,0.7150882077267007,0.8517241379310345,0.9780162117754779,1.0,6/17,27.36%,TGFBR1;TGFB1;ABCA2;SMAD2;GPLD1;CCR5
prerank,mesenchyme morphogenesis (GO:0072132),0.26361315141083635,0.714456374506014,0.863716814159292,0.9781394492990807,1.0,5/17,21.45%,HEY1;TBX2;ENG;SMAD2;MDM4
prerank,negative regulation of signaling (GO:0023057),-0.2191045247039687,-0.714249627668273,0.8958333333333334,0.9446325395165233,1.0,5/25,19.80%,PTPN1;IL1B;SOCS5;OPTN;ACVR1
prerank,RNA interference (GO:0016246),0.26081357748620815,0.7133776313948533,0.8716216216216216,0.9787731460163123,1.0,4/17,18.08%,DROSHA;TSN;AGO4;TSNAX
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.26443360805694693,0.7130999817463318,0.8322147651006712,0.9785056707655762,1.0,4/16,21.76%,PPARA;APOD;ABCD2;CUEDC2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.2918233417019639,-0.7130422464159859,0.8321513002364066,0.9453138045085556,1.0,4/10,20.73%,YY1;LILRB1;RELB;NLRC3
prerank,bone morphogenesis (GO:0060349),-0.2595124683233613,-0.712932139069297,0.8687350835322196,0.9449065551563989,1.0,6/14,36.80%,LRP6;LTF;BMPR2;CYP26B1;TFAP2A;MMP13
prerank,muscle organ development (GO:0007517),-0.1833972403736741,-0.7115447207553243,0.952076677316294,0.9458235084017806,1.0,21/54,29.18%,IGF1;SOX6;TCF12;MEF2D;UTRN;EGR3;MEF2B;CHODL;NEB;MKX;TAGLN;MAPK12;TEAD4;ITGA11;TRIM72;FKTN;CHD2;LAMA2;EVC;ZBTB42;ITGA7
prerank,cristae formation (GO:0042407),0.23119678370100927,0.7112956906730221,0.8868852459016393,0.9798720034630041,1.0,11/27,30.51%,ATP5F1C;UQCC3;MICOS13;APOO;ATP5MC3;ATP5ME;ATP5MF;DNAJC11;APOOL;ATP5F1A;SPG7
prerank,nuclear pore organization (GO:0006999),-0.2524445747224012,-0.711071353916403,0.849009900990099,0.945797364715724,1.0,3/14,11.62%,NUP153;NDC1;AHCTF1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.25361720162333706,0.7105469322728885,0.851063829787234,0.9801203673591524,1.0,7/18,26.01%,TIMM21;OXA1L;BCS1L;COX17;SMIM20;COX18;FASTKD3
prerank,negative regulation of biosynthetic process (GO:0009890),0.25697129874138513,0.7105297970085933,0.8595600676818951,0.979562339917426,1.0,2/16,5.65%,PPARA;IL6
prerank,regulation of dendritic spine development (GO:0060998),0.25303323518299947,0.7103001945808448,0.8732638888888888,0.9792341572651626,1.0,5/19,17.85%,TANC2;MEF2C;SHANK3;PTPRS;SHANK1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.22802974606638887,0.709987035903578,0.880248833592535,0.9790091348688846,1.0,5/29,17.19%,RAB6B;COPG1;TRAPPC3;COPE;COPG2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.2470101995417316,0.7093053579192301,0.8665568369028006,0.9791579305812326,1.0,4/21,13.17%,LRP2;CX3CR1;SMARCD3;DCT
prerank,secretory granule organization (GO:0033363),-0.2843515932451219,-0.7090301882193457,0.8465227817745803,0.9473374602073548,1.0,2/10,7.63%,LYST;SRGN
prerank,regulation of transferase activity (GO:0051338),0.26528856821136065,0.7083689936893159,0.852991452991453,0.9795970275735979,1.0,2/17,1.96%,LDB2;LDB1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.22727258597197253,0.7079498040157289,0.9037520391517129,0.9794554605977965,1.0,3/29,6.27%,FUS;E2F1;CIRBP
prerank,gliogenesis (GO:0042063),-0.24974985719291087,-0.7073772972687605,0.8612975391498882,0.9484239357185289,1.0,3/15,15.06%,CDK6;ANXA1;CDH2
prerank,regulation of telomere maintenance (GO:0032204),-0.21257374950402308,-0.7062368896225846,0.9052631578947369,0.9490575485447059,1.0,8/26,24.03%,RTEL1;NBN;YLPM1;TERF2;HNRNPD;SMG6;TINF2;PIF1
prerank,cellular response to nutrient levels (GO:0031669),-0.17615365486434023,-0.7055842097678406,0.99,0.9491616710491215,1.0,13/62,17.55%,MAP1LC3B;RRAGC;STK24;ATG7;LAMP2;LPL;FOXO1;LRRK2;RRAGA;RALB;MFSD2A;MAP1LC3A;NUPR2
prerank,regulation of monooxygenase activity (GO:0032768),-0.2223676828790457,-0.7051511553766429,0.8698979591836735,0.9490586789389571,1.0,12/23,31.50%,CAV1;IL1B;NOSIP;DNM2;EGFR;POR;NOSTRIN;CYGB;HSP90AA1;ZDHHC21;CALM1;DDAH1
prerank,embryonic axis specification (GO:0000578),0.27132591648036564,0.7048067612666103,0.8491525423728814,0.9822715156083832,1.0,5/15,26.11%,RIPPLY2;WNT7A;SMAD2;CXXC4;FZD5
prerank,regulation of establishment of protein localization (GO:0070201),-0.25854339899797774,-0.7038898226829798,0.8488372093023255,0.949771211640059,1.0,7/14,32.56%,GAPVD1;CENPJ;CEP295;PTP4A3;CTSD;SCFD1;SPIDR
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.25283946923823847,0.7038838656073807,0.8633440514469454,0.9826588572121219,1.0,6/19,19.11%,SMOC2;DAB2IP;MYO1C;CADM4;ADAMTS3;DCN
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.26200473555778164,0.7033826663865822,0.8647746243739566,0.9826103616316987,1.0,4/16,17.90%,DMD;SLC8A1;GSTO1;ANK2
prerank,dorsal/ventral pattern formation (GO:0009953),0.2470851381383968,0.7030296029141608,0.8826530612244898,0.98239301066893,1.0,6/20,23.41%,WNT8B;SFRP1;LMX1B;DSCAML1;BMPR1B;AIDA
prerank,response to UV-A (GO:0070141),-0.2579722150241696,-0.7029603650786452,0.8508557457212714,0.9501587877785498,1.0,4/14,20.52%,CCND1;EGFR;OPN3;TIMP1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.20662380669944577,0.7025923902538745,0.9138461538461539,0.982286467392849,1.0,6/42,11.56%,RARRES2;DEFA6;IL6;MR1;RNASE7;DROSHA
prerank,N-terminal protein amino acid modification (GO:0031365),0.27028527489110454,0.7025118922700526,0.8493377483443708,0.9817921864225083,1.0,4/14,21.27%,METAP1D;NAA35;NAA60;METAP2
prerank,establishment of epithelial cell polarity (GO:0090162),0.2499494864558339,0.7023434905423378,0.8539682539682539,0.9813800398990898,1.0,6/19,27.16%,SH3BP1;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2571669145475908,-0.7023402578921183,0.8452088452088452,0.9502052948920848,1.0,2/13,5.56%,BRAF;ACSL5
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.2875895653170429,0.7022770819963567,0.8453237410071942,0.9808818234115158,1.0,3/11,20.71%,PPARA;ABCD2;ABCB7
prerank,lipoprotein catabolic process (GO:0042159),-0.27271188875198105,-0.701954410934162,0.852803738317757,0.950024027239069,1.0,1/11,0.52%,APOE
prerank,histone H4 acetylation (GO:0043967),0.20323334869171725,0.7009745965833482,0.9351432880844646,0.9816986032721877,1.0,16/47,25.68%,JADE2;MEAF6;BRD8;TADA3;APBB1;OGT;KAT8;DMAP1;NAA60;MORF4L2;ING3;WDR5;JADE1;YEATS4;MSL1;MCRS1
prerank,establishment of protein localization to organelle (GO:0072594),0.18775940370544414,0.6997272093320412,0.9541029207232267,0.9823616627459797,1.0,11/72,15.90%,TSC2;LAMP5;FAM53C;NXT2;PRICKLE1;HEATR3;FAM53B;NUP88;IPO5;HK2;NUP133
prerank,positive regulation of lipid transport (GO:0032370),0.2815047947527107,0.6996117493933266,0.8666666666666667,0.9818984862680368,1.0,5/12,27.08%,ABCB4;DBI;PRELID1;TRIAP1;ABCA3
prerank,lymphocyte mediated immunity (GO:0002449),0.27578893835612284,0.6992091373391791,0.8780918727915195,0.9817035728264248,1.0,1/12,4.03%,SLA2
prerank,zymogen activation (GO:0031638),0.2105951038644992,0.6992030243302231,0.9279411764705883,0.98114223159023,1.0,5/39,8.78%,PLAT;VSIR;ASPH;LGMN;BAK1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.2240452950429867,0.6990850394303482,0.9115323854660348,0.9806869554427172,1.0,7/32,15.95%,CLASP2;MAP4K4;ITGB1BP1;ADAM15;APOD;RCC2;PHLDB2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.20140123929924236,0.6988517858359817,0.9431137724550899,0.9803516984978747,1.0,17/51,28.92%,PRSS56;RARRES2;IL6;LGMN;CCR1;CCR6;HMGB1;MAPK3;PTK2;CCL5;IL34;IL6R;CREB3;MAPK1;CSF1R;VEGFD;MDK
prerank,motor neuron axon guidance (GO:0008045),0.2610848778417546,0.6987342868519802,0.8505154639175257,0.9798828207830659,1.0,4/15,24.05%,CHN1;EPHA4;LAMC2;SEMA3A
prerank,androgen metabolic process (GO:0008209),-0.23999297821242882,-0.6983896115487329,0.8740359897172236,0.9528690169476249,1.0,8/18,36.18%,DHRS9;SHH;SRD5A2;HSD17B7;HSD3B2;HSD17B3;AKR1D1;CYP19A1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.2802521184731904,0.6979879838271184,0.8432343234323433,0.9800577200788708,1.0,3/12,15.67%,NELFB;ZFP36L2;REST
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.235945028447376,0.6979804492987002,0.8711755233494364,0.9794980420055797,1.0,6/23,20.40%,RELA;PPM1A;NMI;IFI35;TSPAN6;CYLD
prerank,rRNA methylation (GO:0031167),0.24431937252777816,0.6974278647248273,0.880718954248366,0.9794955028234923,1.0,5/22,14.73%,DIMT1;METTL16;NOP2;METTL5;FBLL1
prerank,ERAD pathway (GO:0036503),0.18297387385472572,0.6971684903652807,0.9669876203576341,0.9791878229108827,1.0,13/83,17.17%,SELENOS;UBXN6;FOXRED2;SGTA;PRKN;HSP90B1;CCDC47;HERPUD1;SGTB;DERL1;JKAMP;UBQLN2;UBXN4
prerank,bone development (GO:0060348),-0.18683459123886942,-0.6960253938606454,0.9589442815249267,0.9545069969409051,1.0,4/39,5.41%,PTPRC;PTGER4;SH3PXD2B;DYM
prerank,relaxation of muscle (GO:0090075),0.27795182092520243,0.6953974267786964,0.8658536585365854,0.98037124871757,1.0,4/13,19.85%,ATP1B1;SLC8A1;RGS2;ATP1A1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.16467263508693292,-0.6950592542048475,0.9794520547945206,0.9548168585349085,1.0,12/70,16.49%,PLBD1;PCYT1A;PLA2G4E;PLAAT3;NR1H2;PCTP;PEMT;NR1H3;TMEM86B;STARD10;MFSD2A;LPCAT4
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.22903181373181228,-0.6948912899098295,0.9066339066339066,0.9544583077639135,1.0,3/19,19.65%,PAPSS2;BPNT2;SULT2B1
prerank,negative regulation by host of viral process (GO:0044793),0.2959306357960243,0.6948305575477631,0.8447971781305115,0.9803650307038606,1.0,3/10,15.31%,PRKN;CCNK;EIF2AK4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.27703598821987274,0.6939496018286742,0.8745704467353952,0.9806725153591446,1.0,2/12,10.80%,WRAP53;CCT4
prerank,myeloid cell differentiation (GO:0030099),0.2037437988169042,0.6909537599581496,0.9508196721311475,0.9829632734254734,1.0,11/47,21.62%,ZFPM1;FLVCR1;HSPA9;CASP3;KAT8;SLC25A5;INHA;PTPN2;KMT2E;SLC25A38;TIRAP
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.2744708577543685,0.6907302060755031,0.8522522522522522,0.982613672217095,1.0,1/12,1.87%,BIN1
prerank,secondary palate development (GO:0062009),0.26634229944861737,0.6899459900786241,0.8641765704584041,0.9827865477490656,1.0,3/14,20.59%,TGFBR3;WNT7A;SMAD2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.2532945951184856,0.6899173925255404,0.8800675675675675,0.9822435966198626,1.0,4/16,19.75%,CRMP1;NT5C3A;DPYSL2;NT5C
prerank,regulation of protein acetylation (GO:1901983),-0.26093493362133346,-0.6896704424435474,0.8709677419354839,0.9585846826700785,1.0,3/12,18.79%,FAM161A;KAT5;CEP295
prerank,C4-dicarboxylate transport (GO:0015740),-0.24864735341912747,-0.6894744733658138,0.8927738927738927,0.9582380183151334,1.0,4/14,22.11%,LRRC8D;SLC25A11;SLC25A22;SLC13A5
prerank,regulation of DNA damage checkpoint (GO:2000001),0.2907372565947653,0.6888781336822364,0.8620689655172413,0.9826401044733248,1.0,4/10,16.47%,DDX39B;CCAR2;THOC5;RFWD3
prerank,monocyte chemotaxis (GO:0002548),0.2203416980520398,0.6888548445860031,0.9046875,0.9820960515470657,1.0,7/32,25.14%,PTPRO;IL6;PDGFB;CCL15;CCL5;IL6R;CCL14
prerank,regulation of acrosome reaction (GO:0060046),-0.27512397212980977,-0.6885315624823934,0.8760869565217392,0.9585104668371917,1.0,10/10,72.51%,GLRA1;PLA2G10;SERPINA10;CCDC87;FAM170B;PRSS37;ZP3;SPINK13;PLCB1;CACNA1H
prerank,quinone biosynthetic process (GO:1901663),0.2640626188672744,0.6876457509443931,0.884083044982699,0.9826328072042865,1.0,3/14,13.75%,COQ7;COQ8A;PDSS1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.2612014089586203,-0.6848286480154631,0.8778801843317973,0.9610663573959312,1.0,3/12,13.87%,FUT8;SLC35A3;GMDS
prerank,regulation of cell cycle phase transition (GO:1901987),0.17574325121222775,0.6837688523937502,0.9757834757834758,0.9856489170232947,1.0,30/91,28.31%,MN1;PSMB1;TCIM;PSMF1;BTRC;PSMA1;PSMD7;PSMA8;PSME3;PSMD14;PSMC4;ANAPC2;PSMB4;UBE2D1;FBXO5;PSME1;UBE2S;PSMD2;PSMD4;PSMD8;ERCC2;TRIM39;PSMC5;DBF4;PSMD3;NEK10;PSMB8;PSMA4;NEK11;ANAPC4
prerank,cellular response to superoxide (GO:0071451),0.2896941958683078,0.6833468131728385,0.8800705467372134,0.9854545399816996,1.0,2/10,10.85%,PRDX2;ADPRS
prerank,ubiquinone metabolic process (GO:0006743),0.2567101549812465,0.6831080996133371,0.8928571428571429,0.9851168495329039,1.0,3/15,13.75%,COQ7;COQ8A;PDSS1
prerank,chromatin remodeling at centromere (GO:0031055),-0.19850370347817048,-0.6823640869844663,0.9376623376623376,0.9626121835835999,1.0,9/31,27.14%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,regulation of myoblast fusion (GO:1901739),-0.27065859234420997,-0.6819300871008759,0.8780487804878049,0.9624160438704739,1.0,2/11,11.98%,RIPOR2;CD53
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.2537490719206894,-0.6817877307618029,0.8719806763285024,0.9619877623901758,1.0,4/13,22.51%,HACD4;HACD1;HACD2;ELOVL2
prerank,gas transport (GO:0015669),-0.2739913824969501,-0.6817841342383723,0.9027149321266968,0.9614584931378403,1.0,5/10,36.42%,CA2;CYGB;AQP1;RHAG;NGB
prerank,positive regulation of vascular permeability (GO:0043117),-0.25918301494801893,-0.6802570033743065,0.8816120906801007,0.9621984814613358,1.0,5/12,32.31%,PDE2A;ANGPT1;TJP1;PDE3A;TRPV4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.19563875572087708,0.6800574856390414,0.9459459459459459,0.9872457814676181,1.0,6/50,14.24%,CDK7;CCNI;SERTAD1;CCND3;GADD45A;CCNK
prerank,regulation of inclusion body assembly (GO:0090083),0.2756224370104593,0.6798530594672753,0.8797250859106529,0.9868402749055489,1.0,1/11,3.98%,HSPA2
prerank,maintenance of protein localization in organelle (GO:0072595),0.24649997267654594,0.6783929832621275,0.9185059422750425,0.9875563176406061,1.0,4/19,14.61%,ARL2BP;CHCHD10;TAF3;HK2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.2820915097798876,0.6782613967228072,0.8714285714285714,0.9871056129528443,1.0,3/10,20.11%,PFKM;HK2;PFKP
prerank,sphingolipid biosynthetic process (GO:0030148),0.1829802743237172,0.6781526609009043,0.9677891654465594,0.9866315690085686,1.0,18/71,22.16%,ST3GAL5;TLCD3B;CERS4;PRKD2;SPTSSA;ELOVL6;SPNS2;ELOVL4;CERS5;CERS6;PRKD1;KDSR;CERS1;ELOVL5;PLPP1;PPM1L;FA2H;LARGE1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.18801993980889556,-0.6773680004575228,0.9447513812154696,0.9639969298557878,1.0,6/39,15.66%,APOE;CD36;MSN;NOTCH1;RAP1B;RAP1A
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.274496265143431,-0.6769006244270752,0.8758169934640523,0.9638650948295846,1.0,10/10,72.57%,STAT1;SHH;PDGFA;TBX1;SOX9;TGFBR2;FGFR2;LRP5;MYC;CHRD
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.23578354073216534,-0.6761827792110684,0.9030732860520094,0.9638863845026486,1.0,7/16,25.96%,GBF1;SEC16A;LRRK2;PPP1R15A;GABARAPL2;TAPT1;RYR2
prerank,positive regulation of neuron differentiation (GO:0045666),0.20273218072059954,0.6758687451494839,0.9397590361445783,0.9879870549168078,1.0,11/40,24.68%,NEUROD2;MEF2C;NRCAM;BEND6;VWC2;REST;TCF3;ZEB1;IMPACT;ZC4H2;RHOA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2603540763876107,0.6752071906177982,0.8843537414965986,0.987981049547831,1.0,4/14,20.22%,PPARA;IRS1;ABCD2;TYSND1
prerank,regulation of TORC1 signaling (GO:1903432),0.2126421381997088,0.6750091950504861,0.9342948717948718,0.9875715690509166,1.0,6/33,15.88%,KLHL22;STK11;DGKQ;ITFG2;FLCN;RNF152
prerank,regulation of nuclear division (GO:0051783),-0.21843926577308825,-0.6746930303634754,0.9354838709677419,0.9645192335451148,1.0,3/20,6.57%,MKI67;BORA;KIF20B
prerank,negative regulation of histone acetylation (GO:0035067),-0.25644420980658744,-0.6723004622503529,0.8761682242990654,0.9658742469337659,1.0,3/11,19.33%,BRCA1;THAP7;TAF7
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.23821448869909928,-0.6707868800259612,0.9066059225512528,0.9664581443116803,1.0,5/14,23.14%,NT5E;CAD;DPYS;UMPS;UPB1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.266393946220818,0.6704555504299513,0.8831385642737897,0.9907796984600411,1.0,3/13,18.41%,PRKCZ;IRS1;ZBTB7B
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.22522537954952843,-0.6697480697923134,0.9278846153846154,0.966732371663488,1.0,5/17,16.71%,NRP1;EGR3;KDR;GREM1;EPHB4
prerank,somite development (GO:0061053),-0.26352860878126333,-0.6696049308427334,0.8766816143497758,0.9663152894858397,1.0,4/11,22.33%,SOX11;MTHFD1;PTCH1;SHH
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.17960619909243486,0.6687399308352908,0.9759547383309759,0.9916037380341256,1.0,15/76,19.03%,P2RY12;NMUR1;ADRA2A;GNA15;GPR17;ACTN2;CX3CR1;LPAR4;P2RY1;GNA11;P2RY10;AGT;OPRM1;OPRD1;GPR174
prerank,aortic valve development (GO:0003176),0.20349668656495792,0.6686895689153205,0.9374021909233177,0.9910807580297604,1.0,5/34,10.90%,BMP4;HEY1;TGFB1;SNAI2;EFNA1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2530650040324763,0.6683892469511847,0.9075907590759076,0.9907479995294668,1.0,3/16,15.68%,NAA30;NAA35;NAA60
prerank,response to acidic pH (GO:0010447),-0.24765030799892357,-0.6681600683120096,0.8995098039215687,0.9668927533182765,1.0,4/13,16.93%,GPR65;RAB11FIP5;CHP1;PKD1L3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.26077662579211286,0.6678413302884904,0.8743801652892562,0.9906091702280451,1.0,3/13,21.14%,OGG1;NT5C;UNG
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2407174537273552,-0.6662315938519734,0.9119047619047619,0.9677063918892806,1.0,6/14,33.35%,MAPKAPK2;MYD88;HNRNPC;DAZL;HNRNPA0;YBX3
prerank,regulation of histone acetylation (GO:0035065),0.21169307285355576,0.6660381420645978,0.9304897314375987,0.9914896441578667,1.0,8/33,21.92%,PPARGC1A;CTBP1;RAPGEF3;HDAC5;FLCN;MAPK3;ARRB1;BRD7
prerank,carboxylic acid transmembrane transport (GO:1905039),0.19838958790113786,0.665365091148769,0.9566563467492261,0.9914812284537524,1.0,10/40,25.62%,SLC38A2;SLC38A9;SLC38A7;SLC19A1;SLC13A3;SLC38A3;SLC25A10;SLC38A10;SLC16A7;ABCC5
prerank,negative regulation of protein polymerization (GO:0032272),0.21576766339507075,0.6640353725844983,0.9296235679214403,0.9919071220743076,1.0,12/27,29.63%,STMN2;TWF2;ARFGEF1;TWF1;SSH1;SSH2;SSH3;MAP2;TBCD;CYRIB;KANK1;PFN1
prerank,regulation of osteoblast proliferation (GO:0033688),0.23829117296240912,0.6636162244895054,0.8970840480274442,0.9916597720322454,1.0,1/17,0.19%,MN1
prerank,ribosomal small subunit assembly (GO:0000028),-0.2299472051569103,-0.662719976527649,0.9486552567237164,0.9696853556535338,1.0,2/16,6.04%,RPS14;RPS5
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.24110899916888193,0.6627121326462985,0.9085072231139647,0.9917808354826521,1.0,3/17,17.57%,BMP4;FGF2;BTG1
prerank,response to prostaglandin E (GO:0034695),0.2805123735836507,0.6625816235867551,0.9055944055944056,0.9913141545782987,1.0,2/10,11.54%,TGFBR3;SFRP1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.22167868122369616,0.6623437053622678,0.9384615384615385,0.9909341300860773,1.0,6/24,20.75%,NFE2L2;ICAM1;TEK;NDNF;TNIP2;PDPK1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.2405481313240217,0.6620809792336929,0.9283276450511946,0.99057371415656,1.0,5/17,28.40%,MEF2C;PRKG1;TAFA5;SOD2;PTEN
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.2451485503745393,-0.6616470911934633,0.9,0.9699391584901678,1.0,6/13,28.20%,CHST7;NAGK;RENBP;CHST3;CHST5;CHST2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.27820769619873154,0.6616098533890188,0.8769771528998243,0.9903661533072711,1.0,3/10,20.59%,SLC45A3;ABCD2;ELOVL5
prerank,neuron maturation (GO:0042551),0.2405235306243676,0.6615115990111686,0.8984771573604061,0.9898741529171141,1.0,3/18,12.15%,C3;MTCH1;FARP2
prerank,protein acylation (GO:0043543),-0.18555451690429153,-0.6612288706104993,0.9511494252873564,0.969744457600175,1.0,13/38,27.98%,ZDHHC14;ZDHHC3;NAA10;EP300;FOXO1;ZDHHC17;NAT10;ZDHHC7;KAT2B;HHAT;NAT9;ZDHHC13;ZDHHC21
prerank,regulation of centrosome duplication (GO:0010824),0.21089376084799166,0.6603921625597646,0.9514563106796117,0.9901685713345789,1.0,9/30,21.90%,CENATAC;CHMP1A;CHMP2A;FBXW5;XRCC3;PLK2;ALMS1;CHMP5;CEP120
prerank,neutrophil chemotaxis (GO:0030593),0.18971929123686038,0.66006788965394,0.9715099715099715,0.9898516770773458,1.0,7/53,19.32%,PPIB;NCKAP1L;PIK3CG;BSG;CXADR;CCL15;CCL5
prerank,cellular response to nitrogen compound (GO:1901699),0.23478558305472932,0.6599291112479102,0.8989547038327527,0.9894030513991448,1.0,3/20,14.71%,TIMELESS;NSMCE3;AOC1
prerank,ceramide biosynthetic process (GO:0046513),0.1971191368094253,0.6589984208056427,0.9489164086687306,0.989546109228836,1.0,7/40,16.55%,ST3GAL5;TLCD3B;CERS4;SPTSSA;CERS5;CERS6;CERS1
prerank,anterior/posterior axis specification (GO:0009948),0.2557771506023192,0.6587477639210039,0.9063604240282686,0.9891634657398064,1.0,1/15,4.35%,RIPPLY2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.18936679669943324,-0.6581915197648844,0.9668508287292817,0.9713090972508481,1.0,5/32,11.33%,CCT6A;PKIB;PRKCQ;CTNNB1;CCT3
prerank,negative regulation of lipid catabolic process (GO:0050995),0.24095220127676276,0.6575669597121896,0.9199346405228758,0.9894951943585336,1.0,2/17,6.94%,PDE3B;ADRA2A
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.24401247275217236,0.6567623000479939,0.9162393162393162,0.9895256915486791,1.0,1/16,0.65%,ST3GAL5
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.27604901121181147,0.6564928780645317,0.8916083916083916,0.989164993576913,1.0,2/10,10.57%,MAP2K5;SH2B3
prerank,epithelial structure maintenance (GO:0010669),-0.25013045699573305,-0.6561614436085871,0.9053117782909931,0.9721240618832532,1.0,4/11,35.22%,NOD2;TLR9;PIWIL4;MUC6
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.16614699183703618,-0.6556882782362445,0.9855907780979827,0.9719336992493126,1.0,21/53,37.65%,HRH1;CHRM2;ANXA1;VIPR1;NPY1R;HTR1B;CALCRL;NPY;LPAR3;XCR1;HRH3;HTR1A;PTGIR;AGTR2;HTR2C;HTR1D;MC2R;CHRM1;DRD1;LHCGR;HRH2
prerank,response to muscle stretch (GO:0035994),0.2504633620658139,0.6554104010235484,0.9142857142857143,0.9893857936879143,1.0,4/15,23.15%,DMD;SLC8A1;PTK2;SLC9A1
prerank,negative regulation of protein processing (GO:0010955),0.2651579414181878,0.6549043440752954,0.9016949152542373,0.9891855010121007,1.0,4/12,24.13%,PRNP;SERPINE2;TMEM59;ACP4
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2628198345958753,-0.6537370189390553,0.8956310679611651,0.9727265970652929,1.0,4/10,31.70%,ZNHIT3;NAF1;PIH1D2;RUVBL2
prerank,I-kappaB phosphorylation (GO:0007252),0.278971718916073,0.6532390363985093,0.9026086956521739,0.9898301911824029,1.0,4/10,17.56%,DAB2IP;PRDX4;MAP3K7;TLR3
prerank,phosphatidic acid metabolic process (GO:0046473),0.19088296789809514,0.6525897549168459,0.9701492537313433,0.9897179306721934,1.0,9/48,18.16%,PLA2G3;PNPLA3;LPCAT1;DGKQ;AGPAT1;ABHD5;DGKZ;DGKE;ABHD8
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.24975754910703274,-0.652345876726609,0.9050925925925926,0.972573306316383,1.0,3/11,15.12%,AGO2;NOTCH4;TRIM71
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.24975754910703274,-0.652345876726609,0.9050925925925926,0.972573306316383,1.0,3/11,15.12%,AGO2;NOTCH4;TRIM71
prerank,ubiquinone biosynthetic process (GO:0006744),0.24492851029290577,0.6521714287766951,0.9117147707979627,0.9894611811554714,1.0,3/15,13.75%,COQ7;COQ8A;PDSS1
prerank,mRNA modification (GO:0016556),-0.20421354105788841,-0.6515907592556894,0.9371584699453552,0.9725532509259369,1.0,4/22,12.69%,TRUB2;TRMT10C;METTL8;NSUN2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.21996209761992472,-0.6515215469125832,0.9259259259259259,0.9720624389270007,1.0,4/17,13.79%,SPRY2;CALM3;CALM2;INPP5K
prerank,protein localization to mitochondrion (GO:0070585),0.26956611261587604,0.6510943525527052,0.8941798941798942,0.9896683775340642,1.0,4/11,27.43%,MTCH2;HK2;COX18;DNAJA1
prerank,ovarian follicle development (GO:0001541),0.25682722715445133,0.6509663883429981,0.9094138543516874,0.9892135972249503,1.0,2/13,13.42%,ANG;INHA
prerank,hematopoietic stem cell differentiation (GO:0060218),0.2749533263567774,0.6500992258000731,0.9064124783362218,0.9892599925598867,1.0,2/10,15.32%,SFRP1;BATF
prerank,artery development (GO:0060840),0.22184341580077654,0.6484986610783691,0.9222042139384117,0.9897965723183492,1.0,5/23,17.26%,TGFBR1;PKD2;GJA5;ANGPTL3;ENG
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.22024005567392896,0.6480755253005784,0.9349593495934959,0.9895294723072982,1.0,8/23,26.74%,TIMM29;TIMM13;TIMM22;TOMM70;COX18;TOMM22;TIMM10;TIMM10B
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.20268066845570598,0.6451938035880483,0.9543307086614173,0.9908851199830023,1.0,4/32,11.39%,LPCAT1;ACHE;CHAT;SLC44A2
prerank,regulation of telomerase activity (GO:0051972),0.18863663756307347,0.6446717981594337,0.9557926829268293,0.990674977082781,1.0,16/45,29.02%,WRAP53;MAPK15;CCT4;MAPK3;CERS1;MAPKAPK5;HSP90AB1;XRCC5;GRHL2;PARM1;ERCC4;MAPK1;ACD;PTGES3;TERF1;MYC
prerank,regulation of osteoclast differentiation (GO:0045670),0.2003721460656904,0.6445653218702582,0.9697452229299363,0.9901929820698971,1.0,4/33,10.02%,LRRC17;UBASH3B;CCR1;BGLAP
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.2770376881125086,0.6444841422496863,0.9005424954792043,0.9896877642850572,1.0,2/10,9.07%,RAPGEF3;HDAC5
prerank,plasma membrane tubulation (GO:0097320),0.25088123653903116,0.644376519882379,0.897887323943662,0.9892112565074311,1.0,7/13,28.05%,BIN2;EHD2;MICALL1;SNX33;PACSIN3;FNBP1L;WHAMM
prerank,ear morphogenesis (GO:0042471),0.22492305759688483,0.6443462136148863,0.9229480737018425,0.9886781412263171,1.0,20/20,77.54%,MYO6;EPHB2;CHD7;PAX2;TIFAB;FGFR2;SIX1;HOXA1;USH1C;OSR2;NIPBL;NOG;ZIC1;OSR1;ATP6V1B1;TFAP2A;TBX1;TMIE;PAX8;TWIST1
prerank,histone H3-K9 demethylation (GO:0033169),-0.2529414187245622,-0.6432588856556298,0.9328358208955224,0.9767857559649675,1.0,2/11,11.58%,KDM7A;HR
prerank,oogenesis (GO:0048477),0.2422137274612848,0.6423760874570321,0.9262435677530018,0.9893826558804997,1.0,1/15,1.00%,NANOS1
prerank,regulation of cell killing (GO:0031341),-0.2236282368826521,-0.6411573710559257,0.9468354430379747,0.9775519178069095,1.0,8/16,31.59%,CYBA;CD55;WNT5A;MAPK8;NOXO1;RAC1;TGFB2;FZD7
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.18273779689812952,-0.6403957445506409,0.9830028328611898,0.9774535833572864,1.0,3/34,3.44%,PTPN22;DUSP16;PTPN1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.20802560825311672,-0.6402992580383445,0.93048128342246,0.9769796994684007,1.0,5/21,19.52%,STAP1;THBS1;CXCL17;PTK2B;MTUS1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2412956655406267,-0.640155457686016,0.9333333333333333,0.9765366921339347,1.0,2/11,16.23%,ATG13;ATG9B
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24130342092137275,0.6386422658284937,0.9263157894736842,0.9912081405720021,1.0,3/15,18.34%,RAD9B;FANCD2;HUS1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.24600117075647082,-0.6384096108566095,0.924433249370277,0.97652648444799,1.0,3/11,13.79%,SYNJ2;IMPA2;INPP5K
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.24600117075647082,-0.6384096108566095,0.924433249370277,0.97652648444799,1.0,3/11,13.79%,SYNJ2;IMPA2;INPP5K
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.2575978503787133,0.638139379383927,0.9267461669505963,0.9909793300747942,1.0,4/12,21.42%,KDELR3;KDELR2;RER1;ANKRD13C
prerank,regulation of neutrophil migration (GO:1902622),-0.2526605282356412,-0.6378893948983421,0.9038901601830663,0.9762818450090446,1.0,4/10,25.63%,MPP1;BST1;OLFM4;RAC1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.24604470115519833,0.6378491706383865,0.916083916083916,0.9906021044644163,1.0,13/13,75.42%,MR1;CYRIB;PVR;NECTIN2;STX7;XCL1;IL23A;SLC22A13;IL12B;IL23R;IL12A;IL12RB1;FADD
prerank,negative regulation of establishment of protein localization (GO:1904950),0.2732257233000557,0.6365436918708558,0.9089285714285714,0.9908086896606062,1.0,4/10,27.95%,CORO2B;MAPT;DNAJA1;TERF1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.2667486798734497,0.6364049841936581,0.9333333333333333,0.9903351658670053,1.0,3/10,20.61%,GPATCH3;TSPAN6;SEC14L1
prerank,fatty acid transmembrane transport (GO:1902001),-0.20686291244236893,-0.6351996253313889,0.9440389294403893,0.977279616156702,1.0,8/19,26.69%,CD36;PRKAG2;MID1IP1;PRKAB2;ACACA;SLC25A20;ABCD4;ABCD1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.25146091974359047,0.6330186874398696,0.9168110918544194,0.9917640715558981,1.0,1/12,5.80%,DSCAM
prerank,regulation of lipase activity (GO:0060191),0.251789022784335,0.63297073498147,0.9180887372013652,0.9912362832429641,1.0,4/13,24.68%,ANGPTL3;LIPC;LMF1;RHOA
prerank,gastrulation (GO:0007369),0.23712078311684992,0.6319025821510736,0.9294117647058824,0.9913161044954333,1.0,2/15,9.77%,MEGF8;WNT8B
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.224853219275569,-0.631449504778481,0.9492753623188406,0.9787873713236187,1.0,7/15,28.20%,GNPDA1;CHST7;NAGK;RENBP;CHST3;CHST5;CHST2
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.20482145684049297,-0.6312417685327508,0.9551451187335093,0.9783529436079669,1.0,8/21,31.59%,CTSL;SGPP1;MAFG;SULT2B1;GDF3;CBFB;DLL1;KDF1
prerank,positive regulation of heart rate (GO:0010460),0.23155188265996626,0.6307777221582765,0.9515050167224081,0.9914325530597186,1.0,1/17,1.44%,ATP2A2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.2261262699446228,0.6300548709999633,0.9334500875656743,0.9913099145911333,1.0,3/19,9.91%,F11R;MYO1C;SNAI2
prerank,negative regulation of cilium assembly (GO:1902018),0.2505165079925107,0.6295613103276141,0.924006908462867,0.9910442041667641,1.0,4/12,24.42%,LIMK2;CDK10;TCHP;TBC1D30
prerank,tRNA aminoacylation (GO:0043039),-0.18001256726270992,-0.6282598124144095,0.9807162534435262,0.9794187981793703,1.0,11/37,22.90%,AIMP1;FARS2;IARS2;YARS2;QARS1;NARS1;WARS2;WARS1;FARSA;LARS1;PPA2
prerank,regulation of plasminogen activation (GO:0010755),-0.2389202039129698,-0.6272306903521152,0.9346733668341709,0.9794261623556637,1.0,2/12,5.53%,ENO1;THBS1
prerank,cardiac cell development (GO:0055006),0.2623753094315103,0.6265001684027509,0.9209138840070299,0.9922196740364206,1.0,2/11,16.53%,SLC8A1;CXADR
prerank,SNARE complex assembly (GO:0035493),-0.24817040262992218,-0.6261073298991933,0.9370629370629371,0.9794556266690149,1.0,2/10,14.89%,UVRAG;STXBP6
prerank,amino sugar metabolic process (GO:0006040),-0.25279086112138954,-0.6258619415333819,0.9293598233995585,0.9790534475709566,1.0,7/10,39.63%,ST6GAL1;SLC35A3;B4GALNT2;GFPT1;ST3GAL1;GNE;GFPT2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.24842741351891698,0.6240344250221858,0.9276672694394213,0.9930636947871013,1.0,1/12,0.98%,ADTRP
prerank,snRNA 3'-end processing (GO:0034472),0.22410625159673841,0.6228177380140999,0.9369817578772802,0.9931836487448359,1.0,4/19,19.45%,INTS6L;EXOSC5;INTS8;INTS5
prerank,Golgi localization (GO:0051645),0.26083987510284967,0.6216114034144489,0.9063063063063063,0.9933069551586008,1.0,4/11,20.78%,COPG1;STK25;RIPOR1;CDC42
prerank,amyloid-beta metabolic process (GO:0050435),0.23003512403419044,0.621503534574788,0.9496527777777778,0.9928209968169385,1.0,4/16,21.47%,BACE1;PSENEN;ABCA7;APEH
prerank,eosinophil chemotaxis (GO:0048245),0.23883970615935207,0.6194156563851602,0.9320066334991708,0.9928270898106322,1.0,14/14,76.14%,CCL5;CCL2;CCL1;CCL11;CCL26;LGALS3;CCL4;CCL3;CX3CL1;SCG2;CCL13;CCL8;CCL24;CCL7
prerank,eosinophil migration (GO:0072677),0.23883970615935207,0.6194156563851602,0.9320066334991708,0.9928270898106322,1.0,14/14,76.14%,CCL5;CCL2;CCL1;CCL11;CCL26;LGALS3;CCL4;CCL3;CX3CL1;SCG2;CCL13;CCL8;CCL24;CCL7
prerank,rRNA 3'-end processing (GO:0031125),-0.25000498538443,-0.6188932906160912,0.9391727493917275,0.982040896040569,1.0,5/10,26.15%,EXOSC8;EXOSC10;EXOSC9;EXOSC7;RPS21
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.2293112122448166,0.618873441250974,0.9495652173913044,0.9925395464320718,1.0,5/17,23.59%,LGMN;CCR1;HMGB1;CCL5;CREB3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.2504169791349164,0.6180589336767773,0.9427609427609428,0.9923922106159022,1.0,4/12,20.64%,MYCBP2;ARHGAP35;EPHB2;HSP90AB1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.25211661897585713,-0.6168135000421311,0.958139534883721,0.9825140274851542,1.0,2/10,11.75%,DPP4;SKAP1
prerank,regulation of T cell migration (GO:2000404),-0.2097276540482585,-0.6162551814485823,0.9594272076372315,0.9822483600391532,1.0,4/18,22.59%,RIPOR2;SPN;CXCL12;APP
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.26215811018060975,0.6128965460043333,0.9383802816901409,0.9943778405113022,1.0,2/10,15.22%,PRKN;OXA1L
prerank,regulation of calcium ion import (GO:0090279),0.21288609894050264,0.6122399835447672,0.9493670886075949,0.994152842694464,1.0,3/21,12.83%,PRNP;PKD2;PDGFB
prerank,negative regulation of complement activation (GO:0045916),-0.24476898457687213,-0.6121233064543897,0.927400468384075,0.9836542578700906,1.0,7/10,41.90%,SERPING1;CD55;VSIG4;C4BPB;C4BPA;SUSD4;CD46
prerank,telomere maintenance via recombination (GO:0000722),0.24808727285543414,0.6103174899271673,0.9365079365079365,0.99452403002992,1.0,3/11,24.18%,SMC5;XRCC3;ERCC4
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.23853184692296875,0.608844754064239,0.9362416107382551,0.9946620269623576,1.0,3/13,19.30%,BTG2;POLR2G;TOB1
prerank,regulation of tube diameter (GO:0035296),-0.2214074368996579,-0.6055077453415947,0.9328358208955224,0.985517383651789,1.0,2/13,9.75%,GCLC;ADCY6
prerank,vascular process in circulatory system (GO:0003018),-0.2214074368996579,-0.6055077453415947,0.9328358208955224,0.985517383651789,1.0,2/13,9.75%,GCLC;ADCY6
prerank,tRNA metabolic process (GO:0006399),0.22115139955401114,0.6053408201178022,0.9522998296422487,0.9956966939495283,1.0,10/17,33.15%,ADAT1;DTD1;RPP30;DTD2;DARS2;POP7;AARS1;SARS1;TRPT1;POP5
prerank,RNA destabilization (GO:0050779),-0.2009999943654715,-0.6040985045815939,0.9601990049751243,0.9855669250415502,1.0,6/18,25.85%,CELF1;ZC3H18;MEX3D;PUM1;RIDA;GIGYF2
prerank,male meiosis I (GO:0007141),0.23114997982024493,0.6028678492423114,0.9606837606837607,0.9962513152506759,1.0,5/16,29.30%,SLC25A31;ING2;FOXJ2;DDX4;ZSCAN21
prerank,embryonic digestive tract development (GO:0048566),-0.20572348724970124,-0.6026625579747236,0.9524940617577197,0.9856200800142297,1.0,5/18,21.75%,SOX11;TNF;PDGFRA;PKDCC;ID2
prerank,oligosaccharide metabolic process (GO:0009311),0.17637554254679366,0.6025148829173058,0.9907407407407407,0.9958653480692344,1.0,6/46,13.04%,B3GALT2;NEU1;NAGA;MAN2B2;GAL3ST4;ST3GAL6
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.24909877923266108,0.6023216425868836,0.9451327433628318,0.9953984884915936,1.0,2/11,12.56%,NT5C3A;DCK
prerank,cellular response to UV (GO:0034644),-0.14265610442598065,-0.6022838241010537,1.0,0.9852495174027952,1.0,16/76,21.79%,PCNA;USP28;TAF1;YY1;EP300;EIF2S1;RHNO1;NPM1;CRIP1;CDC25A;HYAL3;XPC;RPL26;OPN3;TIMP1;CASP9
prerank,smoothened signaling pathway (GO:0007224),0.18828528963486585,0.6021874609565581,0.9820554649265906,0.9949109588728386,1.0,9/32,26.30%,MAP3K10;GPC2;STK36;IFT27;GLI3;TCTN2;EVC2;DISP3;TMEM17
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.23809833402134373,0.599738091629575,0.9243986254295533,0.9954289333473415,1.0,4/12,24.62%,PLK3;RFWD3;FBXO31;SDE2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.22024672064662615,0.5995443470005024,0.9671052631578947,0.9949708536915192,1.0,2/17,10.76%,NME5;NFE2L2
prerank,cellular response to UV-A (GO:0071492),0.24700118583539588,0.5994553226734671,0.9327433628318584,0.9944640752928715,1.0,4/11,29.82%,MMP1;CERS1;MME;PPID
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.2075368324534176,-0.5988576922514911,0.9653465346534653,0.9861291392834406,1.0,6/17,24.73%,TERF2;NTHL1;MUTYH;NEIL3;TINF2;TDG
prerank,regulation of cytoplasmic translation (GO:2000765),-0.21578322381752718,-0.5984954962468174,0.9529702970297029,0.9857469862026172,1.0,6/14,36.26%,CPEB4;CPEB2;CPEB3;CPEB1;YBX3;RBM24
prerank,mesenchymal to epithelial transition (GO:0060231),-0.24077127657231853,-0.5971587490659848,0.9421686746987952,0.9857648042588132,1.0,6/10,34.51%,GATA3;BASP1;WT1;PAX8;FZD7;CITED1
prerank,chromatin assembly or disassembly (GO:0006333),0.2454591407848215,0.5963423324727508,0.9506172839506173,0.9952441351362349,1.0,4/11,32.34%,SUV39H2;HDAC8;MTA2;TP53
prerank,positive regulation of TORC1 signaling (GO:1904263),0.22141836216382169,0.5947131474874929,0.9594356261022927,0.9953637380804268,1.0,1/16,0.40%,KLHL22
prerank,positive regulation of lymphocyte migration (GO:2000403),0.24370477649071742,0.5925988411858715,0.9572490706319703,0.9956598698269034,1.0,5/12,33.49%,JAM2;CCL5;RHOA;AIF1;PYCARD
prerank,negative regulation of transferase activity (GO:0051348),-0.17647003326268984,-0.5899073736338712,0.9898477157360406,0.9880426431271544,1.0,7/28,24.79%,DTX3L;PHPT1;INPP5K;IRS2;HNRNPU;PIF1;EIF4A2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.2524909830769094,0.5896094677316215,0.9333333333333333,0.9962734912825888,1.0,2/10,11.47%,SLC45A3;IRS1
prerank,synaptic vesicle recycling (GO:0036465),-0.17316089115909417,-0.589457465272858,0.984984984984985,0.9876681201207234,1.0,4/31,10.66%,SYNJ2;FCHO2;AMPH;SNCG
prerank,regulation of autophagosome maturation (GO:1901096),-0.2220493055557069,-0.5883233130668422,0.9769820971867008,0.9875489850452783,1.0,4/13,22.86%,UVRAG;SMCR8;CLN3;PHF23
prerank,response to UV (GO:0009411),0.15052454274628999,0.5877881226215542,0.9985754985754985,0.996385449165679,1.0,14/95,15.47%,UBE2B;RELA;GTF2H2;CIRBP;BAK1;NEDD4;USF1;PARP1;DDB2;NSMCE3;FEN1;ERCC6;EIF2AK4;CCAR2
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.1926745620835063,-0.5877619059435426,0.9846938775510204,0.987232815457914,1.0,5/20,22.46%,MPDU1;FUT8;B3GALT5;ST6GALNAC5;FUT4
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.23769030566152266,0.5854236329990716,0.9477477477477477,0.9967132307229988,1.0,1/12,5.66%,INAVA
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.24911141288195,0.5846582009787321,0.9485903814262023,0.9964499217759262,1.0,3/10,22.40%,MVP;ENG;IMPACT
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.18932007836587905,0.5834997949303053,0.9765258215962441,0.9963231156242656,1.0,4/29,13.34%,PATL1;LSM1;EXOSC5;CNOT8
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.21389762340978694,0.5825936574461864,0.9550173010380623,0.9961118426419013,1.0,4/16,20.89%,RECQL;WRN;RECQL4;SSBP1
prerank,water transport (GO:0006833),0.23274515712631177,0.5824236602386824,0.9545454545454546,0.995619222725271,1.0,1/12,9.94%,CFTR
prerank,catecholamine biosynthetic process (GO:0042423),0.23610435704865254,0.5821573712261647,0.948306595365419,0.9951674654087247,1.0,2/11,14.72%,MOXD1;DAO
prerank,cellular response to ionizing radiation (GO:0071479),0.16958910223457999,0.5804994767865399,0.9847560975609756,0.9951981331697383,1.0,9/47,22.52%,NUCKS1;RAD9B;XRCC6;GADD45A;HRAS;HUS1;WRN;XRCC5;TLK2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.215227933323838,-0.5797009363403179,0.9682539682539683,0.9894020865615201,1.0,4/12,21.76%,MTHFD1;CBS;CTH;SEPHS2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.23276405695419877,-0.5796457829093087,0.9517543859649122,0.9888853951675439,1.0,1/10,5.13%,PRKD3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.22013896508860556,0.5767874393281388,0.9452991452991453,0.9959332757210375,1.0,5/15,25.01%,VCAN;CSGALNACT1;B3GAT3;DCN;BCAN
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2223570359286493,-0.5756675633917915,0.9620853080568721,0.9896283409939047,1.0,3/13,15.14%,TYROBP;TM9SF4;TNF
prerank,presynapse organization (GO:0099172),-0.2314943309701996,-0.5750545798805714,0.9458823529411765,0.989289876128952,1.0,4/10,25.50%,C5AR1;WNT5A;NLGN2;FZD1
prerank,microglial cell activation (GO:0001774),-0.18798683004674324,-0.5739914235112756,0.9874371859296482,0.9890952439398314,1.0,4/21,15.14%,TYROBP;C5AR1;AGER;TNF
prerank,positive regulation of bone resorption (GO:0045780),0.23542467492816282,0.5739071661497254,0.9628378378378378,0.9963279769335015,1.0,2/11,11.76%,PRKCA;MC4R
prerank,cellular response to gamma radiation (GO:0071480),0.20895601928696664,0.5724628424668632,0.9816360601001669,0.9962128492167674,1.0,6/17,24.55%,XRCC6;HRAS;WRN;XRCC5;TLK2;CRYAB
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.207069755760658,-0.5709644491346815,0.9639423076923077,0.9894845887648062,1.0,14/14,79.32%,TERF2;TINF2;TERT;TNKS;PINX1;TERF2IP;ATRX;ATR;NABP2;BRCA2;TPP1;ACD;TNKS2;XRCC5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.22308789641713173,-0.5707614550871677,0.9603729603729604,0.9884922331096904,1.0,4/11,25.74%,CCT6A;CCT3;DKC1;LARP7
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.22308789641713173,-0.5707614550871677,0.9603729603729604,0.9884922331096904,1.0,4/11,25.74%,CCT6A;CCT3;DKC1;LARP7
prerank,female gonad development (GO:0008585),0.20059263945235065,0.5699627779556419,0.9716666666666667,0.9964375472664656,1.0,1/19,1.37%,ANG
prerank,mesoderm formation (GO:0001707),0.2085907227989227,0.5696830821406179,0.9639794168096055,0.9959769823590691,1.0,1/17,2.85%,KDM6B
prerank,protein auto-ADP-ribosylation (GO:0070213),0.2309261531138217,0.5679720443778683,0.9634146341463414,0.9959532623766681,1.0,5/12,29.88%,PARP1;PARP6;PARP10;TNKS2;PARP3
prerank,mRNA methylation (GO:0080009),0.21674507415206085,0.5679522762392012,0.9651162790697675,0.9954178560950516,1.0,3/15,14.64%,TRMT61B;METTL16;CBLL1
prerank,meiosis I (GO:0007127),0.19285687312011635,0.5643042718926619,0.9752066115702479,0.9958798582184791,1.0,2/23,8.50%,SGO1;SLC25A31
prerank,RNA biosynthetic process (GO:0032774),-0.16329352608422376,-0.563113721111185,0.9943977591036415,0.9901203490087109,1.0,31/31,83.71%,TAF12;PRIM2;NAT14;TAF7;BRF2;TERT;TBP;TAF10;NCOA6;HELB;TAF13;POLR2A;RSF1;TCEA2;POLA2;SMARCA5;BRF1;TTF2;ELL3;TBPL2;TAF6;SMN1;TAF5;TBPL1;TTF1;GTF2B;POLA1;TAF4;PRMT5;PRIM1;SETX
prerank,glycine metabolic process (GO:0006544),0.22707012367380255,0.5620820196575803,0.9712351945854484,0.995969298488224,1.0,12/12,77.31%,AMT;DLD;GLYAT;GCSH;SHMT1;SDSL;BAAT;SHMT2;GCAT;SDS;RIDA;GLDC
prerank,positive regulation of lyase activity (GO:0051349),0.2118593941532138,0.5600946165907087,0.9713322091062394,0.9959797496200561,1.0,2/14,17.68%,CACNA1D;ISCU
prerank,epithelial cell development (GO:0002064),0.19684941338202905,0.5557364548577736,0.978369384359401,0.9966141668007953,1.0,5/20,25.61%,LRTOMT;SLC4A7;WNT7A;GRHL2;WNT5B
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.1955013518942002,0.5554161200098505,0.9753086419753086,0.9961416185192196,1.0,4/22,15.01%,PPM1E;PPM1A;PPP5C;DUSP2
prerank,response to gamma radiation (GO:0010332),-0.16769398944762365,-0.5542447396946314,0.9897959183673469,0.9918883676241862,1.0,4/24,11.56%,YAP1;HSF1;TMEM109;LIG4
prerank,negative regulation of ATPase activity (GO:0032780),-0.1932265092889942,-0.5531395145376882,0.9754299754299754,0.9916298159373036,1.0,6/16,28.03%,IFIT1;VCPKMT;LTF;PPIF;TLR9;TSC1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.18967568763904188,-0.5513844074425412,0.9801980198019802,0.9915079462455615,1.0,8/17,36.98%,ZDHHC17;TFAP2B;XIAP;FST;SLIT2;PCSK6;ITGA3;FSTL3
prerank,detection of calcium ion (GO:0005513),0.21791078630136806,0.5484191676346604,0.9667832167832168,0.9972848890128805,1.0,1/13,3.85%,SYT1
prerank,negative regulation of ion transport (GO:0043271),0.18296178711058306,0.5465973933205518,0.9904458598726115,0.9971814176271666,1.0,6/24,23.96%,ADRA2A;ACTN2;NEDD4;WNK1;PACSIN3;SYT11
prerank,genitalia development (GO:0048806),-0.20813258481993197,-0.5455781240275176,0.9791183294663574,0.9922868835373907,1.0,6/12,39.43%,WNT5A;SHH;WT1;LHCGR;STRA6;PTPN11
prerank,oxoacid metabolic process (GO:0043436),0.17741169087218,0.5426210053268414,0.9932885906040269,0.9975458808258799,1.0,5/27,22.23%,PPA1;TPST2;DAO;AGXT;SULT1A1
prerank,positive regulation of calcium ion import (GO:0090280),-0.20560976423660487,-0.5402067273817935,0.9663461538461539,0.9928678480599303,1.0,6/12,38.39%,SPHK2;CXCL12;RAMP3;ATP2A1;CALCR;STC1
prerank,positive regulation of behavior (GO:0048520),0.22959751040525406,0.5323754734317443,0.975736568457539,0.9990533727506755,1.0,4/10,32.26%,MEF2C;NPAS2;CFAP20;NLGN1
prerank,receptor recycling (GO:0001881),-0.21423683636209886,-0.5301224741961487,0.9681818181818181,0.9942914120802658,1.0,1/10,4.57%,LMTK2
prerank,aorta development (GO:0035904),-0.1916395004111468,-0.5282327461703079,0.9893048128342246,0.9940735406852443,1.0,5/14,22.53%,EFEMP2;LRP1;PDE2A;TFAP2B;APLNR
prerank,regulation of protein kinase C signaling (GO:0090036),0.2024434883826476,0.5265217461385253,0.9914821124361158,0.9995918898359047,1.0,1/14,3.56%,FLT4
prerank,DNA biosynthetic process (GO:0071897),0.19628791204502538,0.5258980014312661,0.9870967741935484,0.9991642729738456,1.0,4/16,22.60%,POLD3;WRNIP1;WRN;POLA1
prerank,regulation of neuron projection arborization (GO:0150011),0.20316589455649536,0.5246442812899234,0.9721739130434782,0.9988347235960351,1.0,6/15,27.16%,MAP3K13;NTNG2;NTNG1;DVL2;DLG4;MYO9A
prerank,regulation of tau-protein kinase activity (GO:1902947),0.22307860895378423,0.5232828338065173,0.9736842105263158,0.9985076498867853,1.0,3/10,23.73%,CLU;HSP90AB1;NAB2
prerank,regulation of actin nucleation (GO:0051125),0.2130438972853656,0.5226072208944645,0.9850249584026622,0.9980855462249731,1.0,6/12,37.41%,CORO1A;ARF1;WHAMM;ARFIP1;ARFIP2;ARPIN
prerank,steroid catabolic process (GO:0006706),0.22314808378290155,0.5217950338235311,0.9720767888307156,0.9976778785204237,1.0,2/10,24.76%,HSD17B11;HSD17B14
prerank,cobalamin metabolic process (GO:0009235),-0.17784476262245666,-0.5181506757543185,0.9925558312655087,0.9951135941510554,1.0,17/17,82.24%,MTRR;LMBRD1;ABCD4;AMN;CD320;CUBN;ABCC1;MMADHC;MMUT;CBLIF;TCN1;CTRC;MMACHC;MMAB;TCN2;MMAA;MTR
prerank,positive regulation of chromatin organization (GO:1905269),-0.19335744248811657,-0.5171368081125928,0.9838337182448037,0.9947508657467078,1.0,4/12,29.18%,H3-3A;TERF2;TINF2;MIER1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.21572179644821748,0.5146629125781907,0.9784172661870504,0.9982196326095466,1.0,1/10,4.95%,NT5C3A
prerank,detection of visible light (GO:0009584),0.1904105334908952,0.5095808469346833,0.9947916666666666,0.9984090947587541,1.0,2/16,15.43%,CNGB1;GNA11
prerank,nucleoside catabolic process (GO:0009164),0.2071176238439542,0.5091449635080748,0.9845094664371773,0.997943111802219,1.0,1/11,4.95%,NT5C3A
prerank,positive regulation of hormone secretion (GO:0046887),-0.17126592023479492,-0.5075233301192914,0.9975,0.995550185559152,1.0,8/17,36.51%,SOX11;C1QTNF3;RASL10B;VAMP7;NMB;EDN3;CYP19A1;EDN1
prerank,glycine transport (GO:0015816),-0.20821040738183413,-0.5057124656183984,0.985781990521327,0.9952425197289134,1.0,10/10,79.20%,SLC6A17;SLC36A2;SLC38A5;SLC7A8;SLC6A20;SLC36A1;SLC36A3;SLC6A5;SLC6A9;SLC25A38
prerank,negative regulation of neuron differentiation (GO:0045665),0.1726423121458418,0.4997169379102061,0.993431855500821,0.9985798227302227,1.0,3/22,15.67%,HEY1;EIF2AK4;REST
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.16204131672443414,0.49522168896762037,1.0,0.9985575089391164,1.0,2/27,4.62%,PLAAT5;PLA2G3
prerank,regulation of cell projection organization (GO:0031344),-0.18176299736163698,-0.4951044220632907,0.9926108374384236,0.9959930735942379,1.0,3/13,22.12%,SPRY2;MFSD2A;SEMA4D
prerank,regulation of microtubule-based movement (GO:0060632),0.204316508503013,0.49051070423696597,0.9895833333333334,0.9985639374478185,1.0,3/11,21.28%,CCDC65;HAP1;MAP2
prerank,piRNA metabolic process (GO:0034587),0.17479091848707387,0.4890847412591397,0.9900826446280991,0.9981832909326593,1.0,4/19,29.12%,EXD1;TDRKH;GPAT2;DDX4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.1974369901557585,0.48892646509308024,0.9897260273972602,0.9971246918231256,1.0,5/12,28.60%,ITGB1BP1;RCC2;DMTN;AP1AR;KANK1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.1974369901557585,0.48892646509308024,0.9897260273972602,0.9971246918231256,1.0,5/12,28.60%,ITGB1BP1;RCC2;DMTN;AP1AR;KANK1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.18922651933701642,0.48758302613720184,0.9948186528497409,0.996726462228948,1.0,13/13,81.09%,TPST2;SULT1A1;ABHD14B;SULT1C4;SULT1C2;BPNT1;TPST1;ENPP1;SULT6B1;SULT4A1;SULT2A1;SULT2B1;BPNT2
prerank,diol metabolic process (GO:0034311),-0.1610414816091416,-0.48210744474603334,0.9974554707379135,0.9966692167787754,1.0,7/19,30.36%,SGPP1;ASAH2;SPHK2;HSP90AA1;GCH1;PLPP3;CALM1
prerank,positive regulation of cyclase activity (GO:0031281),0.18281591951332224,0.4746032641433958,0.9928952042628775,0.9973062631931652,1.0,2/14,15.76%,CACNA1D;MAPK3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.17991754822431447,0.47135132558978887,0.9948186528497409,0.9970051864075709,1.0,3/15,25.24%,TGFB1;CUEDC2;HFE
